data_2kif_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kif _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.439 ' O ' HG22 ' A' ' 6' ' ' VAL . 3.8 m-20 . . . . . 0 N--CA 1.469 0.504 0 N-CA-C 112.42 0.526 . . . . 70.510000000000005 112.42 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.512 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 23.0 tp60 -52.97 -44.27 67.03 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.416 -0.357 . . . . 73.140000000000001 111.655 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -54.74 -50.72 67.7 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.095 0.474 . . . . 72.510000000000005 111.069 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.1 mt -61.11 -42.24 98.17 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.942 -0.572 . . . . 73.420000000000002 111.322 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 2' ' ' ASP . 64.8 t -59.51 -41.58 85.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.007 0.432 . . . . 74.120000000000005 111.35 177.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 25.8 mm-40 -66.29 -54.31 26.4 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.345 -0.388 . . . . 73.439999999999998 111.896 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.492 HG22 HG23 ' A' ' 39' ' ' VAL . 37.2 pt -63.31 -43.86 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 111.746 0.276 . . . . 74.120000000000005 111.746 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 12.5 m-30 -60.67 -45.23 94.92 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.742 0.306 . . . . 75.310000000000002 111.147 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.435 ' O ' ' NE2' ' A' ' 14' ' ' GLN . . . -52.36 -43.86 64.9 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.365 -0.379 . . . . 72.209999999999994 111.226 177.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 93.5 t -64.46 -47.14 90.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.339 -0.391 . . . . 70.430000000000007 111.356 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 8' ' ' ILE . 79.7 mt -55.69 -33.98 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 116.084 -0.507 . . . . 60.109999999999999 112.303 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 74.9 m-70 -61.21 -16.15 41.97 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 112.702 0.63 . . . . 71.030000000000001 112.702 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.435 ' NE2' ' O ' ' A' ' 10' ' ' ALA . 1.0 OUTLIER -82.88 -7.3 59.67 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.073 0.397 . . . . 70.200000000000003 112.073 177.925 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.415 HG21 ' HB3' ' A' ' 56' ' ' ARG . 56.1 mt -80.46 116.48 62.15 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 122.421 -0.174 . . . . 74.430000000000007 111.203 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -69.94 170.2 17.35 Favored 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 123.062 2.508 . . . . 72.349999999999994 113.764 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.9 tttp -65.79 121.0 14.03 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.078 -0.51 . . . . 74.400000000000006 111.362 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.27 17.59 45.91 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 121.017 -0.611 . . . . 73.510000000000005 113.901 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -119.94 146.28 45.96 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 117.103 0.451 . . . . 71.299999999999997 111.389 176.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 56' ' ' ARG . 34.6 m -130.0 140.24 49.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.142 0.496 . . . . 75.230000000000004 111.307 177.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.556 ' HG ' HD12 ' A' ' 26' ' ' ILE . 83.9 p -122.47 170.27 10.14 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.842 0.354 . . . . 74.25 111.1 177.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 44.4 p -95.83 147.5 23.58 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.005 0.431 . . . . 65.150000000000006 111.487 178.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -52.91 -32.9 47.85 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 116.289 -0.414 . . . . 74.409999999999997 111.993 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.78 -44.02 95.37 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 121.094 -0.574 . . . . 73.409999999999997 112.965 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 29' ' ' MET . 46.7 mt-10 -64.59 -44.9 89.18 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.811 0.338 . . . . 73.140000000000001 111.347 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.556 HD12 ' HG ' ' A' ' 21' ' ' SER . 47.2 mm -60.58 -50.01 82.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 120.809 0.338 . . . . 62.409999999999997 111.307 177.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.5 -43.84 84.49 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.96 0.41 . . . . 71.230000000000004 111.517 177.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -59.21 -48.2 82.49 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.174 -0.466 . . . . 73.540000000000006 111.298 178.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.431 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 63.1 mtt -65.95 -28.75 69.15 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.878 0.371 . . . . 72.129999999999995 111.621 178.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.35 -20.55 51.1 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.928 0.394 . . . . 65.439999999999998 111.573 177.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.87 22.41 28.22 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.199 -0.524 . . . . 54.549999999999997 113.459 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -124.94 81.82 61.89 Favored Pre-proline 0 CA--C 1.543 0.68 0 O-C-N 122.393 -0.474 . . . . 74.430000000000007 111.79 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.62 131.72 37.03 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.732 2.288 . . . . 74.5 112.658 177.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.95 -8.46 79.77 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.014 -0.613 . . . . 64.439999999999998 113.649 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -89.68 22.6 2.99 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.482 0.549 . . . . 65.349999999999994 112.482 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.36 -57.58 11.24 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.012 0.434 . . . . 73.25 112.167 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 46.6 ttp180 -58.66 -32.3 68.97 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.008 0.433 . . . . 73.099999999999994 111.552 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.56 ' HA ' ' HE2' ' A' ' 41' ' ' LYS . 80.5 m-70 -65.2 -41.28 94.67 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.35 -0.386 . . . . 70.400000000000006 111.284 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.492 HG23 HG22 ' A' ' 8' ' ' ILE . 53.6 t -58.43 -37.95 67.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.264 0.554 . . . . 64.230000000000004 110.171 172.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.79 -37.66 95.01 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 115.808 -0.633 . . . . 73.140000000000001 112.999 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.56 ' HE2' ' HA ' ' A' ' 38' ' ' HIS . 41.1 mtmt -62.75 -47.27 84.26 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.006 0.431 . . . . 74.209999999999994 110.476 176.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.07 -51.42 66.41 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.869 -0.605 . . . . 72.409999999999997 111.921 -178.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.5 mt -63.56 -43.35 97.31 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.297 -0.41 . . . . 74.549999999999997 111.459 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.11 -22.72 72.69 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 120.853 -0.689 . . . . 61.509999999999998 112.884 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -79.85 -21.08 44.56 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.995 0.426 . . . . 73.319999999999993 111.277 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 91.6 mt -75.77 155.39 85.08 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 116.444 -0.344 . . . . 72.329999999999998 111.897 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.57 164.87 19.51 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.46 2.107 . . . . 64.299999999999997 112.192 174.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.47 ' O ' ' HE2' ' A' ' 77' ' ' LYS . 0.8 OUTLIER -64.91 -26.57 68.37 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.211 0.448 . . . . 74.150000000000006 112.211 -175.203 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -131.88 64.38 0.61 Allowed Glycine 0 CA--C 1.528 0.857 0 C-N-CA 121.094 -0.574 . . . . 71.310000000000002 113.325 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.6 t -79.72 172.77 13.34 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.182 0.515 . . . . 72.420000000000002 111.772 178.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? -67.79 -28.94 68.03 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.17 -0.468 . . . . 72.420000000000002 110.78 174.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.525 HD13 ' HD2' ' A' ' 53' ' ' PRO . 33.0 tp -86.71 124.8 68.74 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 116.017 -0.538 . . . . 74.420000000000002 111.02 177.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.525 ' HD2' HD13 ' A' ' 52' ' ' LEU . 38.0 Cg_endo -67.19 95.08 0.36 Allowed 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 121.285 1.324 . . . . 64.129999999999995 111.386 173.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.41 ' HH2' ' HG2' ' A' ' 73' ' ' ARG . 65.9 p-90 -82.51 -30.49 29.78 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.685 -0.689 . . . . 74.430000000000007 111.716 -177.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.453 ' O ' HD21 ' A' ' 78' ' ' LEU . 11.9 p90 -67.32 -11.53 57.85 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.335 0.865 . . . . 74.5 113.335 -175.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.468 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 94.2 mtt180 -86.27 8.08 22.73 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.024 0.75 . . . . 72.519999999999996 113.024 -174.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 20.9 t -127.86 116.23 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 O-C-N 121.81 -0.556 . . . . 72.530000000000001 111.652 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.429 HG21 HD12 ' A' ' 91' ' ' ILE . 28.0 pt -118.98 -174.52 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 116.472 -0.331 . . . . 75.040000000000006 111.376 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 35.4 p30 -83.78 168.75 15.89 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.139 0.495 . . . . 74.409999999999997 111.906 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.1 t -67.93 -9.24 43.5 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.234 -0.439 . . . . 62.240000000000002 111.951 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -88.14 0.69 55.73 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.619 -0.264 . . . . 73.5 111.53 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.41 42.59 89.36 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 121.015 -0.612 . . . . 41.200000000000003 112.396 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -141.15 157.32 45.44 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.096 0.474 . . . . 74.010000000000005 111.378 -176.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 63.8 mt -73.34 128.07 35.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 116.258 -0.428 . . . . 73.329999999999998 111.001 177.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.9 p -74.29 -31.04 62.35 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 120.973 0.416 . . . . 71.430000000000007 111.408 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.458 HD13 ' HB3' ' A' ' 70' ' ' ASP . 92.5 mt -74.91 152.51 38.85 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.171 -0.468 . . . . 73.430000000000007 111.09 177.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -129.45 171.4 12.59 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.017 0.436 . . . . 72.109999999999999 111.973 -176.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 57.58 -128.75 48.23 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 116.24 -0.436 . . . . 72.030000000000001 113.327 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -61.71 -39.41 91.4 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 122.586 -0.361 . . . . 74.219999999999999 111.339 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.458 ' HB3' HD13 ' A' ' 66' ' ' LEU . 19.7 m-20 -65.43 -25.9 67.73 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.026 0.38 . . . . 64.409999999999997 112.026 -178.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.8 tt -64.11 -55.92 18.55 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.881 -0.414 . . . . 71.239999999999995 109.881 174.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.546 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 33.0 t70 -65.99 -27.04 67.84 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.997 0.427 . . . . 73.040000000000006 111.219 177.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.462 ' HE ' ' HA ' ' A' ' 48' ' ' GLU . 51.9 ttt180 -57.44 -55.11 39.06 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.245 0.545 . . . . 72.409999999999997 110.878 173.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -64.84 -41.95 95.31 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.129 0.49 . . . . 74.049999999999997 110.562 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.546 ' HB3' ' HA ' ' A' ' 72' ' ' ASP . 32.0 tttm -54.81 -55.14 33.35 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.67 -0.696 . . . . 74.310000000000002 112.37 178.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -58.74 -36.96 75.17 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.932 0.396 . . . . 61.350000000000001 111.499 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.47 ' HE2' ' O ' ' A' ' 48' ' ' GLU . 45.3 mmtm -64.16 -42.44 96.74 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.923 0.392 . . . . 64.540000000000006 111.224 174.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.499 HD23 HD13 ' A' ' 83' ' ' ILE . 95.9 mt -68.99 -31.89 71.05 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.916 0.389 . . . . 73.549999999999997 111.631 178.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 46.6 mt-10 -65.81 -30.54 71.19 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.886 0.374 . . . . 72.109999999999999 110.516 175.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.26 -11.86 60.16 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.321 0.581 . . . . 74.010000000000005 111.12 173.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -97.82 -11.31 23.44 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.917 -0.583 . . . . 75.219999999999999 111.137 176.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.91 50.4 5.22 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.494 -0.384 . . . . 74.200000000000003 113.098 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.499 HD13 HD23 ' A' ' 78' ' ' LEU . 71.4 mt -119.97 129.54 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 O-C-N 122.682 -0.305 . . . . 70.420000000000002 111.248 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -75.64 91.52 2.88 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.347 0.594 . . . . 74.0 111.438 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.2 t -96.68 121.1 46.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.624 -0.716 . . . . 73.040000000000006 110.837 177.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.583 ' OG ' ' HB3' ' A' ' 90' ' ' LYS . 6.3 p -72.91 151.27 41.98 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 122.331 -0.23 . . . . 71.540000000000006 110.644 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -42.36 -44.7 4.03 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.584 1.327 . . . . 72.0 114.584 -173.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.424 HD13 ' HB2' ' A' ' 90' ' ' LYS . 2.9 pp -81.1 9.53 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 112.461 0.541 . . . . 62.240000000000002 112.461 -176.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.57 45.59 5.75 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 121.622 -0.323 . . . . 71.209999999999994 113.624 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.583 ' HB3' ' OG ' ' A' ' 86' ' ' SER . 1.2 tmtp? -114.35 132.84 56.06 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-O 121.009 0.433 . . . . 74.409999999999997 111.425 -178.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.429 HD12 HG21 ' A' ' 58' ' ' ILE . 60.0 mt -127.08 138.8 53.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 116.152 -0.476 . . . . 74.019999999999996 111.426 -178.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.29 93.93 6.01 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.947 0.403 . . . . 71.319999999999993 111.838 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.542 ' O ' ' HG3' ' A' ' 97' ' ' LYS . 38.5 mt -53.79 -52.33 60.62 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.09 0.404 . . . . 75.109999999999999 112.09 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -52.82 -14.07 0.5 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.296 0.85 . . . . 74.319999999999993 113.296 -174.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -112.98 -33.91 5.9 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 122.03 -0.419 . . . . 74.400000000000006 112.068 175.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -99.33 0.32 42.67 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.808 1.04 . . . . 73.409999999999997 113.808 -173.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.542 ' HG3' ' O ' ' A' ' 93' ' ' LEU . 33.0 mtpt -57.18 138.18 54.94 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.213 0.53 . . . . 74.450000000000003 112.22 -178.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 16.3 t90 -64.96 105.26 0.99 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.692 -0.686 . . . . 73.310000000000002 111.268 175.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -112.09 99.53 46.29 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 116.1 -0.5 . . . . 74.400000000000006 110.653 175.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 CA--C 1.548 1.188 0 C-N-CA 122.948 2.432 . . . . 71.25 113.596 178.24 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 . . . . . 0 CA--C 1.536 0.43 0 CA-C-O 120.877 0.37 . . . . 55.530000000000001 111.354 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.554 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 52.5 tp60 -60.49 -33.21 72.28 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.385 -0.37 . . . . 63.140000000000001 111.236 -178.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -51.49 -49.69 61.34 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.265 0.555 . . . . 73.040000000000006 110.906 175.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.7 mt -61.67 -45.0 95.9 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.695 -0.684 . . . . 72.140000000000001 111.016 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.1 t -56.45 -41.11 71.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 120.958 0.409 . . . . 75.340000000000003 111.349 177.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.554 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 25.6 mm-40 -65.33 -58.94 4.66 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.316 -0.402 . . . . 74.519999999999996 111.758 -178.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.459 HG22 HG23 ' A' ' 39' ' ' VAL . 33.4 pt -61.02 -42.41 92.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 111.751 0.278 . . . . 75.420000000000002 111.751 -178.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -58.53 -49.78 76.17 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.794 0.331 . . . . 65.409999999999997 111.106 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.2 -39.94 67.12 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.326 -0.397 . . . . 70.299999999999997 111.916 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.41 HG21 ' O ' ' A' ' 7' ' ' GLN . 78.6 t -66.65 -42.5 89.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.058 0.456 . . . . 74.530000000000001 111.243 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.54 ' HB ' HD11 ' A' ' 52' ' ' LEU . 80.5 mt -61.85 -31.87 52.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 116.202 -0.453 . . . . 74.430000000000007 112.014 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -62.15 -15.44 45.92 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.312 0.486 . . . . 75.019999999999996 112.312 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -86.74 -5.85 59.0 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.471 0.545 . . . . 73.329999999999998 112.471 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.472 HD13 HD12 ' A' ' 26' ' ' ILE . 58.0 mt -81.21 117.96 70.32 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-O 120.677 0.275 . . . . 72.420000000000002 111.5 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.6 160.03 38.58 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.5 2.133 . . . . 72.209999999999994 113.082 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -62.9 131.03 47.37 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.318 -0.401 . . . . 74.519999999999996 111.359 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.89 2.04 61.3 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 120.88 -0.676 . . . . 73.030000000000001 113.55 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -122.13 148.31 45.06 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.075 0.464 . . . . 74.409999999999997 111.62 176.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.6 m -125.4 147.53 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-O 121.309 0.576 . . . . 65.230000000000004 111.374 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 44.4 t -123.2 174.51 7.23 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.199 -0.455 . . . . 73.239999999999995 110.355 175.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 67.6 p -105.82 147.44 28.66 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.598 0.237 . . . . 73.209999999999994 111.408 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -50.55 -36.75 35.86 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.129 0.49 . . . . 73.329999999999998 110.697 175.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.47 -48.0 85.24 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 115.735 -0.666 . . . . 74.099999999999994 113.243 177.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' A' ' 29' ' ' MET . 44.3 mt-10 -64.81 -48.41 74.52 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 117.073 0.437 . . . . 74.200000000000003 111.893 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.472 HD12 HD13 ' A' ' 15' ' ' ILE . 49.0 mm -55.53 -49.4 73.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 121.085 0.469 . . . . 74.120000000000005 111.052 177.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.479 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -62.99 -42.76 99.93 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.213 -0.449 . . . . 62.329999999999998 111.488 177.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -59.82 -42.56 93.76 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.985 0.421 . . . . 73.129999999999995 111.431 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.44 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 66.0 mtt -70.07 -34.87 73.74 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.0 0.429 . . . . 74.5 111.044 178.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.28 -30.68 66.57 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.132 -0.485 . . . . 74.219999999999999 111.672 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.39 13.73 14.41 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.512 -0.375 . . . . 74.540000000000006 113.355 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.533 ' HB3' ' HB2' ' A' ' 35' ' ' TYR . 52.2 m-85 -128.55 63.1 63.37 Favored Pre-proline 0 CA--C 1.548 0.898 0 O-C-N 122.556 -0.379 . . . . 74.319999999999993 111.766 -178.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -55.96 -43.08 60.26 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.646 2.23 . . . . 61.340000000000003 113.408 -175.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.04 -22.66 78.73 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.186 -0.53 . . . . 70.329999999999998 113.116 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.533 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 90.2 m-85 -86.23 6.67 28.5 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 111.962 0.356 . . . . 74.340000000000003 111.962 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.47 -36.18 32.44 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.244 0.545 . . . . 75.140000000000001 111.407 177.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.472 ' O ' ' HG3' ' A' ' 41' ' ' LYS . 14.8 ptp180 -55.41 -43.55 75.37 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.848 -0.615 . . . . 74.450000000000003 111.416 175.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -72.55 -30.3 64.32 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.334 -0.394 . . . . 73.540000000000006 111.443 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.459 HG23 HG22 ' A' ' 8' ' ' ILE . 58.5 t -57.74 -52.28 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 120.899 0.38 . . . . 63.420000000000002 110.569 175.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.16 -37.72 93.33 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.081 -0.58 . . . . 63.509999999999998 113.039 176.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 37' ' ' ARG . 28.2 mtpp -65.05 -44.14 89.99 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 122.515 -0.403 . . . . 73.140000000000001 111.192 177.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.47 -52.36 61.7 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.437 -0.347 . . . . 75.129999999999995 111.788 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.411 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 88.9 mt -56.92 -34.46 67.99 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.873 0.368 . . . . 72.310000000000002 111.592 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.98 -8.15 33.81 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 121.397 -0.43 . . . . 73.329999999999998 114.077 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.415 ' ND2' ' O ' ' A' ' 41' ' ' LYS . 45.7 m-80 -93.41 -12.63 29.39 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 117.379 0.589 . . . . 62.210000000000001 112.108 178.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.537 HD12 ' HB3' ' A' ' 54' ' ' TRP . 94.1 mt -74.02 143.68 81.11 Favored Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 112.189 0.441 . . . . 75.230000000000004 112.189 -175.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.25 177.51 6.52 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 122.898 2.398 . . . . 74.140000000000001 114.094 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -57.79 -45.66 85.7 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.542 -0.754 . . . . 73.209999999999994 111.736 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -114.75 56.17 0.51 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.3 -0.476 . . . . 54.119999999999997 112.897 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.4 t -66.9 159.35 28.53 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.266 0.469 . . . . 73.310000000000002 112.266 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -71.44 -11.18 60.75 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.168 0.508 . . . . 72.230000000000004 111.148 175.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.54 HD11 ' HB ' ' A' ' 12' ' ' ILE . 42.0 tp -117.59 124.26 29.07 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 115.849 -0.614 . . . . 75.439999999999998 110.713 177.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.522 ' HD2' HD13 ' A' ' 52' ' ' LEU . 58.6 Cg_endo -72.3 95.26 0.76 Allowed 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 121.364 1.376 . . . . 75.120000000000005 112.115 176.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.537 ' HB3' HD12 ' A' ' 46' ' ' LEU . 65.7 p-90 -83.5 -32.43 25.96 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.176 0.513 . . . . 74.310000000000002 111.89 -177.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -56.7 -24.81 51.74 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.227 0.825 . . . . 72.239999999999995 113.227 -177.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -77.85 2.43 17.28 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.444 0.535 . . . . 75.540000000000006 112.444 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 18.8 t -115.59 107.87 23.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.239 0.542 . . . . 72.329999999999998 111.479 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.501 HG21 HD11 ' A' ' 91' ' ' ILE . 33.7 pt -108.89 -169.73 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 116.164 -0.471 . . . . 71.25 111.339 178.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.586 ' HB3' ' OG ' ' A' ' 65' ' ' SER . 30.9 p30 -93.44 171.79 8.68 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.737 0.643 . . . . 73.109999999999999 112.737 -175.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 48.2 t -72.03 -8.08 52.47 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.88 -0.6 . . . . 73.400000000000006 111.712 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -84.59 -6.37 59.36 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.496 -0.32 . . . . 74.200000000000003 111.502 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.05 31.94 54.08 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 121.006 -0.616 . . . . 45.240000000000002 112.084 -174.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.795 ' HB3' ' HZ1' ' A' ' 63' ' ' LYS . 9.5 mtpm? -139.93 173.27 11.69 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.534 0.683 . . . . 71.140000000000001 112.02 -176.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.476 HG21 ' OE1' ' A' ' 74' ' ' GLN . 73.8 mt -86.45 116.12 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.415 -0.812 . . . . 74.340000000000003 110.469 173.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.586 ' OG ' ' HB3' ' A' ' 59' ' ' ASN . 58.0 m -71.62 -31.92 67.43 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.055 0.391 . . . . 71.150000000000006 112.055 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 81.9 mt -72.56 121.94 20.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.038 0.447 . . . . 73.010000000000005 111.594 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -115.16 159.56 20.77 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.02 0.438 . . . . 75.530000000000001 111.042 177.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.36 -141.59 15.65 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.95 -0.643 . . . . 71.439999999999998 111.689 -172.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 67.7 mtt-85 -72.45 -22.69 61.05 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 117.624 0.712 . . . . 74.230000000000004 110.782 177.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.552 ' HA ' ' HD2' ' A' ' 73' ' ' ARG . 23.3 m-20 -67.72 -23.3 65.26 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.017 -0.538 . . . . 64.099999999999994 111.561 177.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.4 tt -67.22 -56.07 11.43 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.87 0.366 . . . . 73.319999999999993 110.452 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.19 -27.79 68.94 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.536 -0.302 . . . . 73.239999999999995 111.802 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.552 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 97.5 mtt180 -57.33 -62.02 2.06 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.906 0.384 . . . . 74.430000000000007 111.223 172.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.476 ' OE1' HG21 ' A' ' 64' ' ' ILE . 55.5 tt0 -63.88 -40.69 97.11 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.315 -0.402 . . . . 74.129999999999995 111.584 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.453 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 58.9 tttm -57.58 -61.91 2.16 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 111.917 0.34 . . . . 74.329999999999998 111.917 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -57.59 -37.93 74.02 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 111.959 0.355 . . . . 75.430000000000007 111.959 -176.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -55.4 -49.34 72.6 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.023 0.44 . . . . 73.510000000000005 111.533 176.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.8 mt -70.02 -40.16 75.38 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.052 0.454 . . . . 71.540000000000006 111.265 -177.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 45.0 mt-10 -61.76 -35.21 77.44 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.996 0.427 . . . . 72.420000000000002 110.767 176.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.26 -31.99 71.8 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.294 -0.412 . . . . 62.219999999999999 111.486 176.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -81.49 -9.95 59.59 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.67 0.271 . . . . 71.030000000000001 111.679 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.86 27.28 8.45 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 121.346 -0.454 . . . . 72.120000000000005 113.386 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 68.4 mt -98.34 130.78 46.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 120.91 0.386 . . . . 73.239999999999995 111.83 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.419 ' HG3' ' OH ' ' A' ' 96' ' ' TYR . 45.0 mt-10 -67.62 118.6 11.12 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.447 -0.342 . . . . 72.219999999999999 111.243 175.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.9 t -128.57 109.5 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 120.785 0.326 . . . . 74.349999999999994 110.85 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.631 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 40.9 m -61.7 147.05 47.26 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.524 -0.307 . . . . 74.239999999999995 111.184 177.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -45.38 -44.65 12.04 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.952 1.093 . . . . 75.329999999999998 113.952 -170.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.8 pp -80.45 14.27 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 112.404 0.52 . . . . 74.310000000000002 112.404 -177.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.15 57.49 3.18 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 121.432 -0.413 . . . . 53.240000000000002 112.984 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.631 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 62.1 tttm -125.8 127.09 45.58 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 120.703 0.287 . . . . 71.439999999999998 111.334 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.501 HD11 HG21 ' A' ' 58' ' ' ILE . 56.0 mt -126.26 152.16 33.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-O 120.903 0.382 . . . . 74.230000000000004 111.469 -175.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -84.02 99.52 10.48 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.274 0.472 . . . . 73.010000000000005 112.274 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.57 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 23.4 mt -70.7 -1.61 11.92 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.041 0.756 . . . . 73.109999999999999 113.041 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 53.3 mtp85 -96.99 -42.03 8.1 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 122.067 -0.396 . . . . 73.129999999999995 111.302 173.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -76.66 -37.39 56.31 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.101 0.408 . . . . 74.129999999999995 112.101 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.419 ' OH ' ' HG3' ' A' ' 84' ' ' GLU . 84.6 m-85 -109.82 14.2 23.3 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.461 0.541 . . . . 73.519999999999996 112.461 -171.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.57 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 59.2 tttp -62.37 132.71 53.51 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 120.999 0.428 . . . . 73.329999999999998 111.613 -177.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 23.0 t90 -69.51 109.52 4.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.235 0.54 . . . . 75.420000000000002 111.568 176.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -115.23 98.09 49.7 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 115.713 -0.676 . . . . 74.109999999999999 110.758 174.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo . . . . . 0 CA--C 1.541 0.86 0 C-N-CA 122.629 2.219 . . . . 72.530000000000001 112.473 173.455 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.538 ' HB2' ' HG ' ' A' ' 5' ' ' LEU . 5.6 m-20 . . . . . 0 CA--C 1.536 0.437 0 CA-C-O 120.648 0.261 . . . . 63.329999999999998 111.438 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.429 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 14.3 mm100 -60.15 -25.9 65.87 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.625 0.25 . . . . 73.120000000000005 110.993 175.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -53.57 -50.66 65.08 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.171 0.51 . . . . 74.439999999999998 110.336 170.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.538 ' HG ' ' HB2' ' A' ' 2' ' ' ASP . 65.0 mt -62.39 -45.76 91.66 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.769 -0.65 . . . . 74.430000000000007 110.788 177.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.4 t -56.7 -43.56 79.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 116.018 -0.537 . . . . 73.409999999999997 111.797 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 30.2 mm-40 -68.27 -52.0 38.82 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.044 0.387 . . . . 63.310000000000002 112.044 -178.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.479 HG23 HG23 ' A' ' 39' ' ' VAL . 32.2 pt -59.6 -41.79 86.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 121.065 -0.254 . . . . 73.120000000000005 111.325 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -63.91 -44.21 93.63 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.124 0.488 . . . . 74.230000000000004 110.71 175.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.423 ' O ' ' NE2' ' A' ' 14' ' ' GLN . . . -56.5 -32.23 64.83 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.914 -0.585 . . . . 74.549999999999997 111.819 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.414 HG21 ' O ' ' A' ' 7' ' ' GLN . 88.3 t -73.35 -47.04 47.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.97 0.414 . . . . 73.349999999999994 111.492 176.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.565 ' HB ' HD11 ' A' ' 52' ' ' LEU . 80.9 mt -58.6 -31.69 44.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 112.888 0.699 . . . . 73.200000000000003 112.888 -175.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -60.7 -11.33 7.1 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 112.663 0.616 . . . . 75.420000000000002 112.663 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.423 ' NE2' ' O ' ' A' ' 10' ' ' ALA . 1.6 mp0 -92.23 -2.17 56.65 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.217 0.451 . . . . 72.239999999999995 112.217 178.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.485 HD12 HD12 ' A' ' 26' ' ' ILE . 53.7 mt -84.75 112.53 43.32 Favored Pre-proline 0 CA--C 1.541 0.634 0 O-C-N 122.221 -0.299 . . . . 64.019999999999996 110.591 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -72.37 165.4 32.79 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.471 2.114 . . . . 74.219999999999999 113.573 -177.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.455 ' HG3' ' OE1' ' A' ' 81' ' ' GLU . 61.5 tttm -59.73 133.35 56.02 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.861 -0.609 . . . . 72.109999999999999 112.08 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.96 -7.91 80.51 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-N 116.239 -0.437 . . . . 73.219999999999999 114.083 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -108.19 155.25 20.66 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 117.335 0.567 . . . . 74.5 112.034 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.5 m -134.17 159.26 42.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 115.965 -0.561 . . . . 74.439999999999998 111.468 178.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 44.6 t -139.24 175.28 9.69 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.948 0.404 . . . . 55.310000000000002 110.783 176.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.4 p -109.28 154.62 22.2 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.835 0.35 . . . . 74.010000000000005 111.551 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.527 ' HE2' ' HG ' ' A' ' 65' ' ' SER . 37.1 m-85 -52.92 -34.78 56.75 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.454 -0.339 . . . . 75.340000000000003 111.461 177.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.09 -51.32 54.07 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.334 -0.46 . . . . 63.219999999999999 112.86 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.429 ' O ' ' HG3' ' A' ' 29' ' ' MET . 41.3 mt-10 -58.93 -47.85 83.58 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.85 0.357 . . . . 73.349999999999994 111.257 178.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.485 HD12 HD12 ' A' ' 15' ' ' ILE . 49.7 mm -60.02 -47.63 91.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 116.42 -0.355 . . . . 73.219999999999999 111.579 178.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.23 -45.72 90.39 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.875 0.369 . . . . 73.299999999999997 111.907 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -61.96 -43.76 98.17 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.759 0.314 . . . . 74.409999999999997 111.453 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.429 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 64.8 mtt -67.06 -34.27 77.31 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.751 0.31 . . . . 75.540000000000006 111.248 178.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.74 -18.31 62.14 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.347 -0.388 . . . . 74.120000000000005 112.009 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.34 14.65 32.35 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 121.423 -0.418 . . . . 73.310000000000002 113.533 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -127.39 72.95 77.65 Favored Pre-proline 0 CA--C 1.541 0.632 0 O-C-N 122.38 -0.482 . . . . 65.450000000000003 111.276 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.21 97.34 0.84 Allowed 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.184 1.923 . . . . 70.230000000000004 112.969 -177.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 142.89 -35.25 1.72 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 120.803 -0.713 . . . . 74.319999999999993 113.258 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -84.06 34.57 0.51 Allowed 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.257 0.465 . . . . 74.310000000000002 112.257 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.77 -39.35 88.45 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.99 0.424 . . . . 72.219999999999999 111.676 -178.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.5 ttt85 -61.15 -29.33 69.72 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 116.363 -0.381 . . . . 75.549999999999997 111.525 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -76.65 -33.39 58.33 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.828 0.347 . . . . 75.439999999999998 110.705 177.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.479 HG23 HG23 ' A' ' 8' ' ' ILE . 47.3 t -58.46 -42.57 84.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 121.346 0.593 . . . . 71.519999999999996 109.706 170.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.97 -37.48 92.74 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 115.532 -0.758 . . . . 71.019999999999996 113.105 175.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -62.12 -44.52 96.46 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.017 0.437 . . . . 73.150000000000006 111.27 176.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.49 -55.21 25.89 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.099 0.476 . . . . 74.109999999999999 111.807 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.5 mt -65.64 -32.71 74.43 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.211 -0.45 . . . . 75.219999999999999 111.648 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.84 -15.77 62.82 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.322 -0.466 . . . . 73.099999999999994 113.18 177.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -89.59 -29.54 18.8 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 122.552 -0.381 . . . . 71.299999999999997 110.802 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 97.5 mt -61.8 112.19 5.74 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-O 120.988 0.423 . . . . 75.040000000000006 111.323 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -93.33 -170.1 0.24 Allowed 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.946 2.43 . . . . 65.530000000000001 114.597 -173.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.433 ' CD ' ' HZ2' ' A' ' 77' ' ' LYS . 10.4 tp10 -62.81 107.16 0.92 Allowed 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.206 -0.906 . . . . 62.219999999999999 111.171 176.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 128.11 -2.43 6.76 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 121.092 -0.575 . . . . 74.439999999999998 113.503 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.4 t -64.24 137.8 58.11 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.24 0.459 . . . . 75.420000000000002 112.24 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -68.9 -43.91 74.29 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.308 0.575 . . . . 75.340000000000003 110.618 175.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.565 HD11 ' HB ' ' A' ' 12' ' ' ILE . 35.9 tp -71.93 125.26 91.62 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.419 -0.809 . . . . 75.219999999999999 110.797 177.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.524 ' HD2' HD13 ' A' ' 52' ' ' LEU . 58.2 Cg_endo -71.98 94.95 0.73 Allowed 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 121.138 1.225 . . . . 75.0 111.757 176.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 60.9 p-90 -81.01 -30.95 34.84 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.754 -0.657 . . . . 74.010000000000005 111.338 -178.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -60.49 -16.82 40.61 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.649 0.611 . . . . 70.129999999999995 112.649 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.444 ' NH2' ' HA ' ' A' ' 17' ' ' LYS . 64.3 mtt-85 -78.3 -11.75 59.96 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.098 0.407 . . . . 75.319999999999993 112.098 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 22.7 t -111.71 120.21 61.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.278 0.561 . . . . 64.439999999999998 111.934 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.703 HD12 HD23 ' A' ' 93' ' ' LEU . 37.0 pt -120.48 -169.89 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 121.268 0.556 . . . . 65.430000000000007 111.731 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.9 p30 -89.78 172.65 8.76 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 121.221 0.534 . . . . 73.450000000000003 112.329 -176.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 63.4 p -72.27 -2.99 21.05 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 116.25 -0.432 . . . . 70.209999999999994 111.968 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -89.02 -12.0 42.61 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.969 0.414 . . . . 75.329999999999998 110.868 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.65 27.05 55.3 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.277 -0.487 . . . . 63.509999999999998 112.814 -177.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.567 ' HB3' ' HZ1' ' A' ' 63' ' ' LYS . 8.4 mtpm? -128.1 163.22 25.08 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.388 0.613 . . . . 75.209999999999994 112.324 -177.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.547 HG22 ' OE1' ' A' ' 74' ' ' GLN . 67.3 mt -71.39 116.4 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 115.428 -0.805 . . . . 73.099999999999994 109.728 170.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.527 ' HG ' ' HE2' ' A' ' 23' ' ' TYR . 67.1 m -75.17 -17.5 60.38 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.02 0.748 . . . . 75.219999999999999 113.02 -173.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 90.9 mt -77.23 176.33 8.86 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.107 0.48 . . . . 74.120000000000005 112.141 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.1 ptmm? -130.6 142.25 50.45 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.394 0.516 . . . . 73.140000000000001 112.394 -174.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 48.9 -124.26 12.26 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-N 115.947 -0.57 . . . . 61.43 114.076 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 19.7 mtm180 -43.3 -53.68 5.07 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.805 0.812 . . . . 73.450000000000003 111.157 177.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.449 ' O ' ' HB2' ' A' ' 73' ' ' ARG . 4.3 m-20 -63.7 -34.1 77.11 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.784 -1.098 . . . . 72.420000000000002 111.507 -176.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.3 tt -63.72 -49.06 74.55 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 109.536 -0.542 . . . . 75.030000000000001 109.536 175.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -63.88 -19.44 65.07 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.841 -0.618 . . . . 55.240000000000002 112.066 177.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.558 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 39.1 mmt180 -66.75 -59.49 3.52 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.034 0.445 . . . . 72.319999999999993 110.927 172.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.547 ' OE1' HG22 ' A' ' 64' ' ' ILE . 50.0 tt0 -58.99 -38.87 80.17 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.939 0.4 . . . . 74.549999999999997 110.225 177.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.513 ' HG3' HG13 ' A' ' 85' ' ' VAL . 81.2 tttt -59.66 -56.72 18.32 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.999 -0.546 . . . . 73.0 112.209 177.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.558 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 20.8 pt20 -54.27 -36.68 63.88 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 120.896 0.379 . . . . 74.310000000000002 111.64 -176.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.433 ' HZ2' ' CD ' ' A' ' 48' ' ' GLU . 72.6 mmtt -67.76 -49.38 62.8 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.945 0.403 . . . . 75.530000000000001 111.231 177.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 74' ' ' GLN . 64.8 mt -58.1 -45.36 87.35 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.241 -0.436 . . . . 73.230000000000004 111.375 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -62.9 -40.77 98.57 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.757 0.313 . . . . 73.25 110.976 177.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.03 -23.69 67.57 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.158 0.504 . . . . 72.319999999999993 111.216 175.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.455 ' OE1' ' HG3' ' A' ' 17' ' ' LYS . 42.1 mm-40 -80.43 -23.15 40.5 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.986 -0.552 . . . . 73.140000000000001 111.556 175.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.55 14.86 52.31 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 116.234 -0.439 . . . . 65.129999999999995 112.487 -174.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 76.9 mt -82.83 130.0 36.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 122.506 0.322 . . . . 71.450000000000003 111.007 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.413 ' HG3' ' OH ' ' A' ' 96' ' ' TYR . 51.6 mt-10 -66.95 92.83 0.24 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.314 0.578 . . . . 74.129999999999995 112.115 -177.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.513 HG13 ' HG3' ' A' ' 75' ' ' LYS . 61.2 t -90.49 113.89 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 115.897 -0.592 . . . . 73.030000000000001 110.91 174.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.515 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 39.6 t -66.23 142.1 57.82 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.502 -0.317 . . . . 74.349999999999994 111.034 174.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -42.37 -42.85 3.33 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.672 0.99 . . . . 65.329999999999998 113.672 -174.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.8 pp -82.33 22.64 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 N-CA-C 112.481 0.548 . . . . 74.019999999999996 112.481 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.24 57.97 7.06 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-N 116.428 -0.351 . . . . 52.240000000000002 113.36 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.515 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 84.2 tttt -132.28 149.91 52.27 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.769 0.319 . . . . 72.549999999999997 111.244 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.54 HD13 HD13 ' A' ' 58' ' ' ILE . 57.1 mt -125.16 150.49 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 120.861 0.362 . . . . 74.219999999999999 111.441 -177.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.9 92.68 7.85 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.804 0.335 . . . . 64.319999999999993 111.065 175.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.703 HD23 HD12 ' A' ' 58' ' ' ILE . 50.7 mt -59.25 -56.1 26.49 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.36 0.504 . . . . 75.109999999999999 112.36 -177.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 41.0 mtm-85 -56.16 -19.62 14.29 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.13 0.419 . . . . 70.049999999999997 112.13 -175.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -95.09 -29.0 14.81 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.491 -0.322 . . . . 72.340000000000003 111.796 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.413 ' OH ' ' HG3' ' A' ' 84' ' ' GLU . 91.8 m-85 -118.05 9.01 12.59 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.66 0.985 . . . . 74.219999999999999 113.66 -175.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.512 ' HG3' ' O ' ' A' ' 93' ' ' LEU . 24.9 mtpp -54.67 133.7 46.91 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 118.489 0.586 . . . . 73.219999999999999 112.142 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 16.2 t90 -57.29 113.09 1.6 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.692 -0.685 . . . . 74.150000000000006 111.636 177.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.415 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 65.7 mt-30 -113.57 92.51 24.16 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 115.537 -0.756 . . . . 71.450000000000003 110.28 177.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo . . . . . 0 CA--C 1.54 0.82 0 C-N-CA 122.712 2.275 . . . . 73.120000000000005 114.078 -177.184 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.504 ' HB2' ' HG ' ' A' ' 5' ' ' LEU . 5.0 m-20 . . . . . 0 CA--C 1.543 0.709 0 N-CA-C 112.055 0.391 . . . . 73.099999999999994 112.055 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -58.32 -34.74 70.93 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.901 0.381 . . . . 64.549999999999997 110.314 173.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.433 ' O ' HG12 ' A' ' 8' ' ' ILE . 34.2 t80 -51.95 -49.97 62.13 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.786 -0.643 . . . . 74.209999999999994 111.174 174.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.504 ' HG ' ' HB2' ' A' ' 2' ' ' ASP . 84.3 mt -60.97 -52.11 66.41 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.01 -0.541 . . . . 75.239999999999995 111.064 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 40.0 t -55.85 -45.81 79.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 116.126 -0.488 . . . . 74.200000000000003 111.661 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.414 ' O ' HG21 ' A' ' 11' ' ' VAL . 26.8 mm-40 -63.36 -56.89 12.66 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.161 0.43 . . . . 74.340000000000003 112.161 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.513 ' O ' HG13 ' A' ' 12' ' ' ILE . 34.0 pt -58.44 -45.14 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 121.109 -0.237 . . . . 70.129999999999995 111.567 -178.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -60.64 -45.3 94.59 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.015 0.436 . . . . 72.129999999999995 111.016 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.1 -26.75 64.95 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.17 -0.468 . . . . 73.099999999999994 111.817 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.414 HG21 ' O ' ' A' ' 7' ' ' GLN . 99.2 t -80.99 -43.36 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-O 120.88 0.372 . . . . 73.430000000000007 111.213 176.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.513 HG13 ' O ' ' A' ' 8' ' ' ILE . 81.7 mt -54.91 -36.65 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 112.631 0.604 . . . . 74.430000000000007 112.631 -178.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -55.15 -19.43 7.69 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.895 0.702 . . . . 74.239999999999995 112.895 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -77.12 -23.36 51.77 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.561 0.578 . . . . 74.329999999999998 112.561 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.441 ' O ' ' NH1' ' A' ' 56' ' ' ARG . 38.9 mt -70.56 118.7 67.11 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 122.201 0.2 . . . . 74.239999999999995 111.495 -177.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -79.68 170.32 17.14 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 122.758 2.305 . . . . 61.439999999999998 114.005 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 49.7 tttp -64.02 135.41 56.42 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.992 -0.549 . . . . 74.409999999999997 111.294 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 86.31 2.51 85.37 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.078 -0.582 . . . . 42.32 113.402 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.445 ' HB3' ' HA ' ' A' ' 98' ' ' TRP . 47.0 mmtm -118.23 145.44 45.0 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.103 0.478 . . . . 65.239999999999995 111.739 177.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.435 HG12 HD12 ' A' ' 83' ' ' ILE . 18.7 m -131.46 150.4 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 115.91 -0.586 . . . . 75.439999999999998 111.321 177.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 88.7 p -129.19 164.53 23.21 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.537 -0.302 . . . . 73.099999999999994 110.724 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.6 p -90.22 146.91 23.89 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.836 0.35 . . . . 73.040000000000006 111.62 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -49.57 -37.37 27.11 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.025 0.44 . . . . 74.540000000000006 111.3 176.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.05 -40.19 98.15 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 115.95 -0.568 . . . . 75.310000000000002 113.466 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -69.07 -50.54 47.43 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.983 0.392 . . . . 73.329999999999998 111.603 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.5 mm -59.35 -47.61 89.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 120.841 0.353 . . . . 75.129999999999995 110.965 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.533 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -60.81 -44.78 96.42 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.405 -0.361 . . . . 71.530000000000001 111.591 177.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -54.99 -51.34 66.53 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.977 0.418 . . . . 75.420000000000002 111.731 177.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 67.9 mtm -71.24 -27.3 63.37 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.07 -0.513 . . . . 74.340000000000003 112.049 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.44 -30.81 62.04 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.946 0.403 . . . . 73.099999999999994 111.521 176.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.07 17.04 10.52 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.405 -0.426 . . . . 73.439999999999998 113.243 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.533 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 53.1 m-85 -133.48 61.66 55.19 Favored Pre-proline 0 CA--C 1.549 0.91 0 O-C-N 122.665 -0.315 . . . . 75.239999999999995 111.237 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -52.0 -38.47 69.52 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.022 2.481 . . . . 75.329999999999998 114.307 -173.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.8 -1.32 86.97 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 121.133 -0.555 . . . . 72.239999999999995 113.619 -178.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.48 ' O ' HG22 ' A' ' 39' ' ' VAL . 11.2 m-85 -97.51 10.61 39.34 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.925 0.713 . . . . 73.239999999999995 112.925 -177.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.68 -50.18 34.38 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.565 0.698 . . . . 75.439999999999998 111.083 176.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -52.41 -44.43 65.39 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.299 -0.864 . . . . 74.510000000000005 111.697 172.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.401 ' HD2' ' HA ' ' A' ' 35' ' ' TYR . 99.2 m-70 -72.18 -26.17 61.96 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.381 -0.372 . . . . 74.25 111.725 -177.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.48 HG22 ' O ' ' A' ' 35' ' ' TYR . 58.9 t -62.83 -46.72 95.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 120.894 0.378 . . . . 72.450000000000003 110.295 174.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -57.48 -42.63 94.01 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.102 -0.571 . . . . 65.519999999999996 112.355 174.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -64.17 -37.49 87.66 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.898 0.38 . . . . 74.340000000000003 111.223 175.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.76 -44.26 81.89 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.321 -0.399 . . . . 64.200000000000003 112.065 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 39' ' ' VAL . 61.4 mt -63.61 -29.08 70.38 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.801 0.334 . . . . 71.450000000000003 111.355 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.43 -16.3 49.31 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 121.238 -0.506 . . . . 65.140000000000001 113.29 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -77.19 -21.45 53.91 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.011 0.434 . . . . 73.340000000000003 111.247 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 95.0 mt -89.8 135.75 30.12 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-O 121.058 0.456 . . . . 73.420000000000002 112.163 -175.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -81.88 178.56 6.37 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.83 2.353 . . . . 72.439999999999998 113.539 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.53 ' HB3' ' HG3' ' A' ' 73' ' ' ARG . 1.2 pm0 -86.19 23.46 1.53 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.95 -0.568 . . . . 75.349999999999994 112.211 -177.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -147.29 35.81 1.22 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 121.195 -0.526 . . . . 38.170000000000002 112.693 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 34.6 t -86.52 166.76 15.2 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.47 0.653 . . . . 74.430000000000007 112.759 -176.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -82.23 -10.27 59.19 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.374 -0.83 . . . . 64.120000000000005 111.4 176.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.53 HD13 ' HD2' ' A' ' 53' ' ' PRO . 41.3 tp -109.68 122.56 38.88 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 116.028 -0.533 . . . . 71.540000000000006 110.792 178.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.53 ' HD2' HD13 ' A' ' 52' ' ' LEU . 67.8 Cg_endo -76.1 94.3 1.02 Allowed 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 121.182 1.255 . . . . 62.109999999999999 111.716 175.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 53.3 p-90 -84.46 -33.92 23.54 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.72 -0.673 . . . . 73.420000000000002 111.707 -176.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.449 ' O ' HD21 ' A' ' 78' ' ' LEU . 9.6 p90 -56.73 -19.45 16.83 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.209 0.818 . . . . 71.25 113.209 -178.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.441 ' NH1' ' O ' ' A' ' 15' ' ' ILE . 98.0 mtt180 -73.53 4.9 4.29 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 112.31 0.485 . . . . 75.230000000000004 112.31 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.5 t -122.92 116.44 48.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 CA-C-O 121.22 0.534 . . . . 64.340000000000003 111.303 177.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.495 HG21 HD13 ' A' ' 91' ' ' ILE . 28.9 pt -120.18 -170.81 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 116.329 -0.396 . . . . 71.219999999999999 111.433 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.455 ' HB3' ' OG ' ' A' ' 65' ' ' SER . 32.5 p30 -86.74 169.72 12.39 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.375 0.607 . . . . 72.230000000000004 112.46 -176.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.2 m -63.8 -26.71 68.75 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.835 -0.621 . . . . 70.409999999999997 112.16 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -76.24 -7.59 55.22 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.257 0.466 . . . . 72.030000000000001 112.257 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.55 42.67 13.57 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 121.242 -0.504 . . . . 52.530000000000001 112.627 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.448 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 58.3 mtpt -140.94 171.08 14.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.993 0.425 . . . . 73.329999999999998 110.757 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 59.2 mt -84.56 122.69 38.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 116.407 -0.361 . . . . 73.099999999999994 110.661 176.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.455 ' OG ' ' HB3' ' A' ' 59' ' ' ASN . 58.4 m -81.77 -12.11 58.71 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.234 0.457 . . . . 55.240000000000002 112.234 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.6 mt -80.61 148.57 30.22 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.821 0.343 . . . . 74.319999999999993 110.79 174.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -116.5 157.78 24.66 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.249 0.463 . . . . 73.310000000000002 112.249 -176.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 55.2 -128.11 43.19 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 116.076 -0.511 . . . . 62.340000000000003 113.965 176.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -55.07 -44.64 74.98 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.134 0.492 . . . . 73.019999999999996 111.924 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -60.99 -32.93 72.48 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.965 -0.561 . . . . 72.340000000000003 111.624 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.0 tt -65.79 -53.28 42.38 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.817 0.342 . . . . 72.099999999999994 110.185 176.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -58.71 -34.18 71.03 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.802 0.334 . . . . 60.119999999999997 111.526 177.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.53 ' HG3' ' HB3' ' A' ' 48' ' ' GLU . 39.5 ttm180 -61.15 -56.37 21.56 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.098 0.475 . . . . 75.5 110.998 176.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.402 ' NE2' HG23 ' A' ' 58' ' ' ILE . 48.1 tt0 -63.13 -41.81 99.37 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.062 0.458 . . . . 73.510000000000005 110.951 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 49.0 tttm -55.61 -61.78 2.13 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.864 -0.607 . . . . 74.310000000000002 111.804 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -54.74 -36.85 65.22 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.415 -0.357 . . . . 71.340000000000003 111.553 -175.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.424 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 73.4 mmtt -63.02 -43.87 97.51 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.846 0.355 . . . . 74.340000000000003 111.546 176.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.449 HD21 ' O ' ' A' ' 55' ' ' PHE . 96.2 mt -67.94 -33.55 74.9 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.902 0.382 . . . . 73.329999999999998 111.25 177.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -58.06 -41.97 84.45 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.347 0.594 . . . . 64.120000000000005 109.97 172.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.32 -21.28 66.69 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.692 -0.686 . . . . 72.409999999999997 111.897 177.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 77' ' ' LYS . 7.4 mm-40 -85.31 -10.11 56.83 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.832 0.348 . . . . 75.430000000000007 111.532 177.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.08 25.96 25.3 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.249 -0.5 . . . . 72.129999999999995 112.701 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.435 HD12 HG12 ' A' ' 20' ' ' VAL . 66.3 mt -102.49 146.06 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 120.972 0.415 . . . . 75.409999999999997 111.774 -177.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.746 ' HG3' ' HH ' ' A' ' 96' ' ' TYR . 43.8 mt-10 -88.43 95.47 10.23 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 111.776 0.288 . . . . 73.430000000000007 111.776 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.4 t -95.74 98.33 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-O 121.162 0.506 . . . . 74.340000000000003 110.218 173.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.551 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 50.4 m -56.88 152.52 12.59 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.838 -0.619 . . . . 64.450000000000003 112.333 -178.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -41.31 -36.87 0.88 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 115.037 1.495 . . . . 72.319999999999993 115.037 -171.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.45 HD11 ' HB2' ' A' ' 90' ' ' LYS . 2.9 pp -92.81 13.11 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 112.706 0.632 . . . . 72.230000000000004 112.706 -176.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.92 42.6 7.09 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 121.587 -0.34 . . . . 50.009999999999998 113.439 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.551 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 62.6 tttp -116.45 142.65 46.59 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 122.622 -0.34 . . . . 63.039999999999999 111.46 -177.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.495 HD13 HG21 ' A' ' 58' ' ' ILE . 62.2 mt -129.45 146.7 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 120.928 0.394 . . . . 73.329999999999998 111.607 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.85 97.35 10.15 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.94 0.4 . . . . 62.420000000000002 111.601 177.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.46 HD23 HD13 ' A' ' 58' ' ' ILE . 67.7 mt -60.31 -55.37 34.53 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.01 0.374 . . . . 74.439999999999998 112.01 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 29.6 mtp180 -57.11 -9.29 0.86 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.17 0.804 . . . . 75.209999999999994 113.17 -175.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -105.59 -37.86 6.63 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 111.751 0.278 . . . . 74.010000000000005 111.751 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.746 ' HH ' ' HG3' ' A' ' 84' ' ' GLU . 69.6 m-85 -116.56 13.7 15.36 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.281 0.474 . . . . 70.230000000000004 112.281 -173.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 80.3 tttt -65.63 139.05 58.39 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.097 0.475 . . . . 74.209999999999994 111.46 -178.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.445 ' HA ' ' HB3' ' A' ' 19' ' ' LYS . 17.5 t90 -59.96 111.94 1.68 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.065 0.459 . . . . 75.140000000000001 111.432 178.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -107.25 92.42 8.02 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 116.096 -0.502 . . . . 65.019999999999996 111.001 177.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo . . . . . 0 CA--C 1.542 0.879 0 C-N-CA 122.579 2.186 . . . . 72.239999999999995 112.936 177.823 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 . . . . . 0 CA--C 1.539 0.551 0 CA-C-O 120.717 0.294 . . . . 70.120000000000005 111.267 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -52.8 -35.18 56.49 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.319 0.489 . . . . 72.230000000000004 112.319 -177.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -54.32 -49.61 69.3 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.245 0.545 . . . . 72.150000000000006 110.75 176.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 77.8 mt -65.71 -42.59 90.92 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.768 -0.651 . . . . 75.109999999999999 110.919 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 92.2 t -55.28 -46.56 78.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.362 -0.381 . . . . 75.450000000000003 111.559 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.418 ' O ' HG22 ' A' ' 11' ' ' VAL . 27.4 mm-40 -66.98 -56.39 10.36 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.252 0.464 . . . . 74.510000000000005 112.252 -177.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.499 ' O ' HG13 ' A' ' 12' ' ' ILE . 29.9 pt -58.66 -41.85 83.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 O-C-N 122.199 -0.313 . . . . 71.299999999999997 111.722 -178.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.41 ' CD1' HG13 ' A' ' 8' ' ' ILE . 9.0 m-30 -62.34 -43.7 98.2 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.813 0.34 . . . . 73.209999999999994 110.915 177.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.32 -28.34 64.96 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.018 0.437 . . . . 73.400000000000006 111.664 177.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 7' ' ' GLN . 57.6 t -80.66 -41.47 20.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 120.81 0.338 . . . . 72.430000000000007 110.998 176.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 8' ' ' ILE . 83.2 mt -61.23 -42.38 93.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 112.206 0.447 . . . . 75.439999999999998 112.206 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -59.94 -20.69 58.85 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.096 0.406 . . . . 74.310000000000002 112.096 178.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.48 -2.34 55.69 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.007 0.373 . . . . 74.140000000000001 112.007 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.513 HD12 HD11 ' A' ' 26' ' ' ILE . 61.0 mt -84.61 113.82 51.48 Favored Pre-proline 0 CA--C 1.543 0.673 0 O-C-N 122.374 -0.204 . . . . 71.230000000000004 110.472 175.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -69.54 147.66 64.79 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.003 2.468 . . . . 72.140000000000001 113.537 -178.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -52.2 120.02 5.01 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 116.021 -0.536 . . . . 72.120000000000005 111.791 176.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.69 -8.84 40.34 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.118 -0.563 . . . . 65.040000000000006 113.037 -177.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -115.18 152.1 33.23 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.985 0.421 . . . . 65.519999999999996 111.23 176.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.449 HG13 HD11 ' A' ' 83' ' ' ILE . 32.8 m -130.18 159.14 42.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-O 121.168 0.509 . . . . 62.509999999999998 110.962 177.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 45.4 t -138.98 168.44 19.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.997 0.427 . . . . 61.149999999999999 111.131 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.4 p -103.78 148.44 26.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.456 -0.338 . . . . 73.349999999999994 111.343 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -51.72 -33.14 33.12 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.749 0.309 . . . . 74.439999999999998 111.394 175.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.16 -44.26 98.36 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.18 -0.533 . . . . 72.120000000000005 112.691 176.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.463 ' O ' ' HG3' ' A' ' 29' ' ' MET . 41.3 mt-10 -70.79 -49.57 45.14 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.575 0.226 . . . . 73.219999999999999 111.519 178.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.513 HD11 HD12 ' A' ' 15' ' ' ILE . 51.4 mm -56.07 -56.53 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 111.958 0.355 . . . . 70.319999999999993 111.958 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.403 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -58.97 -39.99 83.42 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.095 0.474 . . . . 74.230000000000004 111.305 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -60.82 -42.41 97.63 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.136 -0.484 . . . . 75.430000000000007 111.149 178.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.463 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 66.5 mtt -72.65 -36.26 67.93 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 120.898 0.38 . . . . 74.239999999999995 111.462 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.04 -21.28 65.02 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.981 0.42 . . . . 75.209999999999994 111.517 178.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.73 18.06 28.8 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.319 -0.467 . . . . 63.420000000000002 113.217 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.403 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 88.0 m-85 -123.44 85.94 52.28 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-O 120.783 0.325 . . . . 60.240000000000002 111.282 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.76 135.47 25.91 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.412 2.075 . . . . 73.420000000000002 112.672 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.5 -26.65 8.84 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.28 -0.486 . . . . 43.350000000000001 113.24 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -73.36 3.62 5.7 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 112.423 0.527 . . . . 65.109999999999999 112.423 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.0 -44.43 30.77 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.056 0.455 . . . . 65.340000000000003 112.027 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -63.43 -33.79 76.32 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 116.043 -0.526 . . . . 72.319999999999993 111.821 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -75.09 -34.61 61.77 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.799 0.333 . . . . 71.430000000000007 111.032 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.457 HG11 HD12 ' A' ' 8' ' ' ILE . 51.2 t -59.46 -40.11 80.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 121.118 0.485 . . . . 75.450000000000003 110.18 173.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.94 -41.01 99.19 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 115.92 -0.582 . . . . 54.119999999999997 112.665 174.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -57.98 -49.13 77.88 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.074 0.464 . . . . 74.010000000000005 110.424 174.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.71 -53.9 52.42 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.815 -0.629 . . . . 71.409999999999997 111.54 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.3 mt -62.98 -32.3 73.61 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.9 0.381 . . . . 75.420000000000002 111.03 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.97 -22.81 65.14 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.324 -0.465 . . . . 75.340000000000003 113.306 176.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.504 ' N ' HD21 ' A' ' 45' ' ' ASN . 0.8 OUTLIER -80.17 -20.13 45.52 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.841 0.353 . . . . 74.25 111.223 177.133 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 82.0 mt -76.94 140.66 67.03 Favored Pre-proline 0 CA--C 1.539 0.546 0 N-CA-C 112.255 0.465 . . . . 72.239999999999995 112.255 -178.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -88.48 172.95 4.7 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.941 2.427 . . . . 65.340000000000003 112.648 176.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.33 -31.36 72.49 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.489 -0.323 . . . . 63.229999999999997 111.859 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.02 52.43 4.39 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 120.96 -0.638 . . . . 75.540000000000006 113.101 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.8 t -102.32 142.38 33.63 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.131 0.419 . . . . 72.409999999999997 112.131 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -69.39 -35.76 76.1 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.24 0.543 . . . . 73.439999999999998 110.678 174.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.506 HD13 ' HD2' ' A' ' 53' ' ' PRO . 39.7 tp -80.92 121.49 80.93 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.884 -0.598 . . . . 73.349999999999994 110.733 175.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.506 ' HD2' HD13 ' A' ' 52' ' ' LEU . 60.8 Cg_endo -72.71 94.56 0.78 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 121.269 1.313 . . . . 65.510000000000005 111.725 176.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 55.7 p-90 -84.46 -25.36 28.99 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.201 0.524 . . . . 75.439999999999998 111.922 -177.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.545 ' HA ' ' HG3' ' A' ' 74' ' ' GLN . 29.9 p90 -62.97 -22.6 66.94 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.219 0.822 . . . . 72.340000000000003 113.219 -177.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -75.63 -3.46 34.62 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.455 0.539 . . . . 74.409999999999997 112.455 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.4 t -115.2 114.05 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 120.989 0.423 . . . . 75.239999999999995 111.673 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.631 HD12 HD22 ' A' ' 93' ' ' LEU . 39.1 pt -115.99 -171.09 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 120.942 0.401 . . . . 74.310000000000002 111.807 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 34.7 p30 -83.06 178.01 8.33 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.267 0.556 . . . . 74.010000000000005 112.1 -176.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 57.2 p -81.63 -1.31 46.13 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 116.229 -0.442 . . . . 75.129999999999995 111.98 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -86.94 -21.14 26.43 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.771 0.319 . . . . 65.450000000000003 111.372 177.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.08 22.67 24.63 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 121.257 -0.497 . . . . 72.239999999999995 112.212 -173.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.49 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 55.2 mtpt -129.4 172.77 11.18 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.126 0.488 . . . . 72.219999999999999 111.489 -177.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.66 HD13 HG13 ' A' ' 85' ' ' VAL . 55.3 mt -72.55 144.22 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.224 0.535 . . . . 73.439999999999998 111.329 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.4 p -88.47 -44.04 11.0 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.214 -0.448 . . . . 72.409999999999997 111.465 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.419 HD13 ' HB3' ' A' ' 70' ' ' ASP . 74.9 mt -76.42 159.87 30.06 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.291 0.567 . . . . 74.400000000000006 112.037 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -131.73 165.91 22.68 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.037 -0.529 . . . . 75.129999999999995 111.879 -175.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.04 -138.0 41.37 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-N 116.23 -0.441 . . . . 70.049999999999997 113.13 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 65.1 mtm180 -59.11 -26.59 64.82 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.925 0.393 . . . . 74.329999999999998 111.58 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.419 ' HB3' HD13 ' A' ' 66' ' ' LEU . 13.2 m-20 -73.21 -29.39 62.77 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.393 -0.367 . . . . 74.129999999999995 111.637 177.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.9 tt -62.26 -48.11 81.4 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 109.199 -0.667 . . . . 75.209999999999994 109.199 174.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.93 -43.24 95.05 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.887 -0.597 . . . . 72.200000000000003 111.364 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 64.1 mtt180 -53.69 -57.49 10.64 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 120.805 0.336 . . . . 73.409999999999997 111.314 175.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.545 ' HG3' ' HA ' ' A' ' 55' ' ' PHE . 43.3 tt0 -62.88 -47.12 84.7 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.037 0.446 . . . . 73.040000000000006 111.094 -177.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.434 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 61.6 tttp -58.37 -60.7 3.37 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.967 -0.56 . . . . 75.450000000000003 111.978 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -62.14 -26.27 68.22 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.644 0.609 . . . . 72.319999999999993 112.644 -173.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -64.12 -48.73 74.98 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.207 0.527 . . . . 75.540000000000006 110.715 170.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.528 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 41.1 mt -61.04 -47.21 87.45 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.89 -0.595 . . . . 74.319999999999993 110.994 176.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 57.4 mm-40 -50.08 -39.67 43.18 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.719 -0.673 . . . . 75.349999999999994 111.02 175.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.38 -32.89 74.44 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.138 -0.483 . . . . 72.540000000000006 112.144 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -91.48 0.1 57.55 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 111.875 0.324 . . . . 74.439999999999998 111.875 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.24 5.81 59.15 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.351 -0.452 . . . . 64.010000000000005 113.247 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.528 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 61.4 mt -85.46 102.54 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 121.229 0.537 . . . . 74.239999999999995 110.617 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -78.69 110.62 13.99 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.683 0.623 . . . . 73.129999999999995 112.683 -171.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.66 HG13 HD13 ' A' ' 64' ' ' ILE . 40.3 t -97.41 121.12 47.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 116.096 -0.502 . . . . 73.530000000000001 111.988 -178.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.506 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 30.9 t -59.1 150.7 24.34 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.161 0.43 . . . . 71.230000000000004 112.161 177.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -50.42 -39.86 48.52 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.331 0.863 . . . . 75.549999999999997 113.331 -174.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.8 pp -81.04 18.9 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-O 121.114 0.483 . . . . 75.099999999999994 111.859 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.72 50.25 9.49 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 116.164 -0.471 . . . . 37.18 113.407 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 50.1 tttm -125.25 149.4 48.04 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 122.423 -0.457 . . . . 75.420000000000002 112.073 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.519 HD12 HD13 ' A' ' 58' ' ' ILE . 49.1 mt -123.45 152.93 28.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.235 -0.439 . . . . 75.200000000000003 110.322 174.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -86.68 93.29 9.19 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.816 0.341 . . . . 65.329999999999998 111.141 176.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.631 HD22 HD12 ' A' ' 58' ' ' ILE . 51.0 mt -58.88 -53.96 52.48 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.039 0.385 . . . . 72.219999999999999 112.039 -178.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 21.7 ttp180 -56.18 -19.02 11.84 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-O 121.222 0.534 . . . . 71.519999999999996 111.606 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.449 ' HD3' ' O ' ' A' ' 95' ' ' LYS . 7.8 tmtt? -91.43 -45.13 8.72 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 116.501 -0.318 . . . . 75.439999999999998 110.985 177.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -107.92 10.37 28.48 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.902 0.704 . . . . 73.530000000000001 112.902 -170.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 59.1 tttp -58.9 132.23 53.36 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.413 0.523 . . . . 71.140000000000001 112.413 -172.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 17.0 t90 -58.51 105.56 0.31 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.937 -0.574 . . . . 75.109999999999999 112.181 -179.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -102.89 102.07 25.01 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 115.6 -0.727 . . . . 65.349999999999994 110.434 171.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo . . . . . 0 CA--C 1.54 0.777 0 C-N-CA 122.378 2.052 . . . . 72.299999999999997 112.871 177.798 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.42 ' O ' HG22 ' A' ' 6' ' ' VAL . 15.1 t70 . . . . . 0 CA--C 1.543 0.682 0 N-CA-C 112.553 0.575 . . . . 73.519999999999996 112.553 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -60.83 -27.72 68.27 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.881 0.697 . . . . 74.329999999999998 112.881 -175.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.419 ' O ' HG12 ' A' ' 8' ' ' ILE . 59.7 t80 -58.74 -51.64 69.1 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.23 0.538 . . . . 72.0 110.086 174.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 70.0 mt -67.47 -46.42 73.04 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.543 -0.753 . . . . 70.129999999999995 111.128 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 2' ' ' ASP . 94.1 t -54.39 -48.82 68.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 116.285 -0.416 . . . . 74.25 112.02 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.418 ' O ' HG21 ' A' ' 11' ' ' VAL . 30.8 mm-40 -68.62 -51.44 42.25 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.747 0.647 . . . . 72.010000000000005 112.747 -177.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.474 HD13 HG13 ' A' ' 39' ' ' VAL . 30.2 pt -58.92 -41.54 83.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 120.751 0.31 . . . . 73.530000000000001 111.368 -178.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -64.01 -44.45 92.55 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.081 0.467 . . . . 74.129999999999995 110.591 174.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.98 -20.4 37.89 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.316 0.487 . . . . 73.239999999999995 112.316 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.418 HG21 ' O ' ' A' ' 7' ' ' GLN . 59.1 t -83.8 -43.95 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 120.978 0.418 . . . . 75.329999999999998 111.03 174.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.537 ' HB ' HD13 ' A' ' 52' ' ' LEU . 72.7 mt -61.02 -30.77 48.3 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 112.655 0.613 . . . . 75.209999999999994 112.655 -177.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -55.64 -18.03 6.96 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 112.8 0.667 . . . . 74.420000000000002 112.8 178.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -91.18 -0.89 57.78 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.239 0.459 . . . . 74.019999999999996 112.239 -178.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.494 HD11 HD11 ' A' ' 26' ' ' ILE . 61.2 mt -87.28 113.54 54.38 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-O 120.417 0.151 . . . . 75.319999999999993 110.905 178.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -77.74 170.31 19.3 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.685 2.257 . . . . 75.030000000000001 113.87 -177.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.2 tttp -61.32 130.52 46.53 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.085 -0.507 . . . . 74.230000000000004 111.247 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.67 2.97 75.0 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.035 -0.603 . . . . 72.209999999999994 113.688 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -120.72 148.33 44.09 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 117.272 0.536 . . . . 75.310000000000002 111.315 176.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.6 m -128.69 157.27 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.224 0.535 . . . . 71.209999999999994 111.898 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.4 m -133.1 163.46 29.2 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.158 -0.474 . . . . 72.409999999999997 110.796 176.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 44.5 p -93.88 149.09 21.54 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.734 0.302 . . . . 65.540000000000006 111.416 178.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.484 ' HE2' ' HG ' ' A' ' 65' ' ' SER . 55.5 m-85 -51.12 -38.81 54.12 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.866 0.365 . . . . 75.099999999999994 111.19 177.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.23 -47.78 89.13 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-N 116.154 -0.475 . . . . 72.510000000000005 112.875 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.46 ' O ' ' HG3' ' A' ' 29' ' ' MET . 46.0 mt-10 -59.63 -55.63 32.01 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.705 0.288 . . . . 72.439999999999998 111.537 178.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.494 HD11 HD11 ' A' ' 15' ' ' ILE . 49.8 mm -53.57 -50.43 49.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 120.956 0.408 . . . . 75.400000000000006 111.784 -178.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.471 ' HB2' HG22 ' A' ' 39' ' ' VAL . . . -64.13 -45.78 87.03 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.889 0.376 . . . . 72.129999999999995 111.802 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.9 tttp -64.49 -35.83 82.2 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.508 -0.314 . . . . 75.319999999999993 111.4 -177.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.46 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 65.9 mtt -68.4 -43.44 77.26 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.054 0.454 . . . . 75.409999999999997 110.769 176.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.54 -23.03 66.77 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.03 -0.532 . . . . 65.329999999999998 111.963 178.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.12 31.7 4.61 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.473 -0.394 . . . . 64.140000000000001 113.414 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -129.73 89.32 46.8 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-O 120.874 0.368 . . . . 73.420000000000002 111.402 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -73.72 125.37 9.95 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.135 2.556 . . . . 72.319999999999993 113.124 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.33 -13.99 66.31 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 121.323 -0.465 . . . . 71.5 113.584 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.424 ' HA ' ' HD2' ' A' ' 38' ' ' HIS . 74.5 m-85 -84.58 10.57 10.72 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.838 0.681 . . . . 74.439999999999998 112.838 -176.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.48 -52.72 20.99 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.719 0.637 . . . . 52.240000000000002 112.719 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -65.69 -26.47 67.79 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.887 0.375 . . . . 73.219999999999999 111.872 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.424 ' HD2' ' HA ' ' A' ' 35' ' ' TYR . 99.5 m-70 -74.83 -32.28 61.9 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.95 0.405 . . . . 73.239999999999995 110.921 177.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.474 HG13 HD13 ' A' ' 8' ' ' ILE . 81.3 t -59.44 -40.46 81.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-O 121.252 0.549 . . . . 74.340000000000003 110.195 170.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -57.93 -41.99 94.55 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.869 -0.605 . . . . 71.310000000000002 112.732 174.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -56.68 -40.16 75.07 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.094 0.473 . . . . 71.25 111.218 175.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.1 -51.72 23.51 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.914 -0.585 . . . . 73.420000000000002 112.179 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.9 mt -60.65 -45.14 95.23 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.2 0.444 . . . . 74.140000000000001 112.2 -176.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.59 -20.93 64.32 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 120.692 -0.766 . . . . 55.229999999999997 113.05 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -83.63 -20.97 32.69 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 120.71 0.291 . . . . 74.010000000000005 111.489 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.413 HD12 ' HB3' ' A' ' 54' ' ' TRP . 94.4 mt -67.05 147.68 99.02 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 111.889 0.329 . . . . 73.430000000000007 111.889 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.53 ' HG2' ' HB3' ' A' ' 50' ' ' SER . 30.1 Cg_endo -63.56 165.54 17.71 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.402 2.068 . . . . 70.129999999999995 112.715 176.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -57.3 -41.14 79.28 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.584 0.587 . . . . 74.420000000000002 112.584 -177.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -128.43 60.27 0.67 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.981 -0.628 . . . . 70.010000000000005 113.744 -177.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.53 ' HB3' ' HG2' ' A' ' 47' ' ' PRO . 24.5 p -76.97 -178.7 5.07 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 122.459 -0.436 . . . . 72.329999999999998 110.878 176.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.681 ' HZ3' ' HB2' ' A' ' 51' ' ' LYS . 5.2 ttmp? -61.04 -28.52 69.12 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.065 0.46 . . . . 75.140000000000001 110.825 174.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.537 HD13 ' HB ' ' A' ' 12' ' ' ILE . 26.0 tp -103.38 130.78 22.92 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 116.017 -0.538 . . . . 73.530000000000001 111.812 -177.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.502 ' HD2' HD12 ' A' ' 52' ' ' LEU . 72.0 Cg_endo -79.42 95.89 1.06 Allowed 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 121.657 1.571 . . . . 70.439999999999998 111.511 170.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.413 ' HB3' HD12 ' A' ' 46' ' ' LEU . 64.8 p-90 -76.51 -28.77 56.53 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.162 -0.472 . . . . 74.319999999999993 112.202 -175.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.479 ' O ' HD21 ' A' ' 78' ' ' LEU . 24.8 p90 -60.7 -19.96 59.89 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.409 0.892 . . . . 73.209999999999994 113.409 -175.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -76.82 6.76 5.59 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.864 0.69 . . . . 70.25 112.864 -176.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 45.1 t -123.62 125.85 72.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 O-C-N 121.929 -0.482 . . . . 63.299999999999997 111.624 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.511 HG23 HD13 ' A' ' 91' ' ' ILE . 32.5 pt -127.35 -169.63 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 121.157 0.503 . . . . 74.230000000000004 111.357 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.413 ' HB3' ' OG ' ' A' ' 65' ' ' SER . 30.9 p30 -87.26 173.97 8.87 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.068 0.461 . . . . 71.200000000000003 111.824 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 33.3 p -84.79 9.74 13.32 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.965 0.412 . . . . 70.329999999999998 111.646 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -93.14 -14.79 26.75 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.003 0.43 . . . . 75.140000000000001 110.542 173.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.38 37.17 18.45 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 121.081 -0.58 . . . . 75.430000000000007 112.161 -174.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -137.35 167.71 21.06 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.645 0.736 . . . . 72.120000000000005 112.379 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.489 ' CG2' HD12 ' A' ' 71' ' ' LEU . 74.9 mt -83.68 108.53 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.109 -0.95 . . . . 74.310000000000002 110.209 172.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.484 ' HG ' ' HE2' ' A' ' 23' ' ' TYR . 71.2 m -69.7 -25.9 64.09 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.73 0.641 . . . . 75.129999999999995 112.73 -175.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.478 HD13 ' HB3' ' A' ' 70' ' ' ASP . 88.6 mt -64.78 124.38 21.82 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.696 0.284 . . . . 74.409999999999997 111.018 178.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -113.05 141.59 46.7 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.14 0.495 . . . . 72.030000000000001 111.211 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 107.88 -136.43 13.44 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.462 -0.655 . . . . 63.020000000000003 111.462 -173.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -81.76 -24.94 35.73 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 117.511 0.656 . . . . 75.439999999999998 110.896 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.478 ' HB3' HD13 ' A' ' 66' ' ' LEU . 7.8 m-20 -62.36 -24.83 67.58 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.121 -0.49 . . . . 72.439999999999998 111.936 176.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.489 HD12 ' CG2' ' A' ' 64' ' ' ILE . 16.2 tp -56.84 -60.65 3.26 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.414 0.626 . . . . 74.349999999999994 110.561 174.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.555 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 18.8 m-20 -67.03 -32.48 73.72 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.605 -0.725 . . . . 74.120000000000005 111.178 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -50.13 -59.01 4.33 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-O 121.3 0.572 . . . . 75.140000000000001 111.204 174.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -62.29 -43.55 98.58 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.007 -0.542 . . . . 64.519999999999996 110.7 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -50.0 -58.24 5.9 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.722 -0.672 . . . . 74.409999999999997 112.306 176.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.555 ' HG3' ' O ' ' A' ' 72' ' ' ASP . 96.0 mt-30 -52.75 -49.19 65.97 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.142 0.496 . . . . 74.25 111.467 -178.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -68.91 -27.06 65.43 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.5 0.556 . . . . 75.109999999999999 112.5 -177.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.479 HD21 ' O ' ' A' ' 55' ' ' PHE . 57.6 mt -77.79 -39.03 45.3 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.169 0.433 . . . . 75.5 112.169 177.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -62.8 -30.69 71.66 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.025 0.441 . . . . 73.219999999999999 110.617 175.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.82 -20.06 66.19 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 116.04 -0.527 . . . . 62.399999999999999 111.483 174.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -86.98 2.67 48.72 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.201 -0.454 . . . . 74.549999999999997 111.443 177.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.2 15.67 71.37 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.092 -0.575 . . . . 74.409999999999997 112.832 -177.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 73.0 mt -92.1 124.5 44.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 120.959 0.409 . . . . 73.519999999999996 111.643 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.504 ' HG2' ' OH ' ' A' ' 96' ' ' TYR . 9.0 pt-20 -72.76 90.84 1.44 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.6 0.714 . . . . 75.209999999999994 111.308 175.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 62.3 t -85.73 112.53 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 116.071 -0.513 . . . . 72.530000000000001 110.477 176.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.542 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 42.1 t -61.26 142.57 56.73 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.757 -0.201 . . . . 74.109999999999999 111.055 178.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -48.52 -38.47 20.37 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.744 1.016 . . . . 73.439999999999998 113.744 -172.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.8 pp -80.32 16.42 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 CA-C-O 121.083 0.468 . . . . 75.25 112.23 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.37 52.31 6.18 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 116.373 -0.376 . . . . 75.420000000000002 113.443 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.542 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 1.3 tmtp? -125.4 136.23 53.22 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.052 0.453 . . . . 72.439999999999998 111.214 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.511 HD13 HG23 ' A' ' 58' ' ' ILE . 69.7 mt -125.59 126.49 70.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 116.018 -0.537 . . . . 75.140000000000001 110.864 178.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.98 98.29 1.26 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 111.973 0.36 . . . . 73.409999999999997 111.973 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.441 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 86.2 mt -53.47 -53.22 54.6 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.337 -0.392 . . . . 65.510000000000005 111.838 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 18.5 ttm180 -56.21 -26.58 51.54 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 112.189 0.44 . . . . 75.219999999999999 112.189 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -89.66 -28.88 19.17 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.137 0.421 . . . . 75.150000000000006 112.137 -177.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.504 ' OH ' ' HG2' ' A' ' 84' ' ' GLU . 70.9 m-85 -124.73 12.76 8.57 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.658 0.614 . . . . 75.239999999999995 112.658 -174.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 63.6 tttp -60.08 131.5 51.02 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.093 0.473 . . . . 74.040000000000006 111.825 -177.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 19.8 t90 -56.15 124.26 17.27 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.954 -0.566 . . . . 74.140000000000001 111.735 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -108.82 88.87 5.78 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 116.035 -0.53 . . . . 74.400000000000006 111.029 176.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo . . . . . 0 CA--C 1.536 0.583 0 C-N-CA 122.02 1.814 . . . . 72.219999999999999 111.385 173.874 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 CA--C 1.539 0.547 0 N-CA-C 112.666 0.617 . . . . 71.400000000000006 112.666 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -57.0 -30.31 64.05 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.22 -0.446 . . . . 74.549999999999997 110.964 175.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -57.69 -52.39 65.62 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.041 0.448 . . . . 75.209999999999994 110.717 174.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.4 mt -63.8 -48.19 77.89 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.964 -0.562 . . . . 74.239999999999995 111.471 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 67.4 t -53.03 -49.52 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 120.931 0.396 . . . . 75.329999999999998 111.703 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.457 ' O ' HG21 ' A' ' 11' ' ' VAL . 28.9 mm-40 -67.28 -53.29 31.19 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.632 0.604 . . . . 74.519999999999996 112.632 -177.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.416 ' O ' HG13 ' A' ' 12' ' ' ILE . 35.9 pt -59.64 -41.62 85.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 O-C-N 122.148 -0.345 . . . . 74.200000000000003 111.468 -178.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 14.8 m-30 -63.69 -43.91 95.23 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.958 0.408 . . . . 75.530000000000001 110.818 177.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.75 -43.18 80.48 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.31 -0.405 . . . . 74.140000000000001 111.366 177.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.457 HG21 ' O ' ' A' ' 7' ' ' GLN . 74.3 t -61.74 -43.2 96.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 121.082 0.468 . . . . 71.510000000000005 110.742 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.456 ' HB ' HD11 ' A' ' 52' ' ' LEU . 72.6 mt -62.77 -37.26 78.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 116.146 -0.479 . . . . 72.140000000000001 111.645 177.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -64.22 -10.43 23.34 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.196 0.443 . . . . 74.530000000000001 112.196 176.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.46 -9.92 42.77 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.65 0.262 . . . . 73.049999999999997 111.667 177.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.414 HD12 HD12 ' A' ' 26' ' ' ILE . 54.9 mt -76.92 114.67 41.54 Favored Pre-proline 0 CA--C 1.543 0.684 0 O-C-N 122.448 -0.157 . . . . 75.420000000000002 110.831 177.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -60.62 150.25 82.95 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 122.734 2.289 . . . . 72.25 113.515 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 67.2 tttm -62.05 95.35 0.06 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.076 0.465 . . . . 75.219999999999999 111.255 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 139.11 -18.64 3.11 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 121.155 -0.545 . . . . 74.219999999999999 113.148 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -103.86 162.4 13.14 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.994 0.426 . . . . 75.010000000000005 111.676 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.7 m -136.29 156.2 35.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 122.932 0.493 . . . . 74.540000000000006 111.561 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 98.4 p -138.13 179.43 6.45 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 120.764 0.316 . . . . 71.219999999999999 111.15 178.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.8 p -110.72 153.12 25.74 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 120.991 0.424 . . . . 74.519999999999996 111.651 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -53.48 -39.91 64.9 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.257 0.466 . . . . 73.299999999999997 112.257 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.16 -40.62 93.96 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.172 -0.537 . . . . 70.019999999999996 113.098 178.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.468 ' HB3' ' HE3' ' A' ' 29' ' ' MET . 47.3 mt-10 -67.29 -51.61 50.73 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 122.493 -0.416 . . . . 74.219999999999999 111.396 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.414 HD12 HD12 ' A' ' 15' ' ' ILE . 50.5 mm -53.85 -51.53 43.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-N 116.141 -0.481 . . . . 74.299999999999997 111.397 178.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.02 -54.18 49.86 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.215 -0.448 . . . . 71.310000000000002 111.961 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.555 ' HB2' ' HZ2' ' A' ' 28' ' ' LYS . 10.7 mtmp? -62.09 -41.48 98.24 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.083 0.401 . . . . 74.420000000000002 112.083 -177.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.468 ' HE3' ' HB3' ' A' ' 25' ' ' GLU . 70.7 mtm -76.63 -10.39 59.35 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 111.995 0.369 . . . . 74.319999999999993 111.995 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.34 -14.39 33.21 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.091 0.472 . . . . 71.310000000000002 110.929 172.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.8 18.31 27.89 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 116.012 -0.54 . . . . 72.129999999999995 113.203 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -125.59 91.11 49.29 Favored Pre-proline 0 CA--C 1.544 0.741 0 O-C-N 122.522 -0.399 . . . . 75.349999999999994 111.397 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.01 137.12 26.03 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.861 2.374 . . . . 70.519999999999996 113.092 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.33 -6.18 52.42 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 121.261 -0.495 . . . . 70.420000000000002 113.968 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.409 ' HA ' ' HD2' ' A' ' 38' ' ' HIS . 61.0 m-85 -84.19 11.26 8.47 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.634 0.605 . . . . 62.240000000000002 112.634 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.25 -47.34 69.16 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.963 0.411 . . . . 74.099999999999994 111.895 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.0 ptt180 -57.86 -40.05 79.24 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.18 -0.464 . . . . 75.510000000000005 111.957 175.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.409 ' HD2' ' HA ' ' A' ' 35' ' ' TYR . 88.9 m-70 -67.84 -39.29 83.86 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.861 0.362 . . . . 73.400000000000006 111.19 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.9 t -59.9 -42.62 89.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.013 0.435 . . . . 73.140000000000001 110.611 174.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.97 -41.56 96.41 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-N 116.078 -0.51 . . . . 54.509999999999998 112.718 176.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -61.65 -47.32 85.91 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 120.835 0.35 . . . . 73.430000000000007 111.085 176.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.6 -54.41 47.22 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.989 0.423 . . . . 54.329999999999998 111.727 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.4 mt -63.91 -32.62 74.21 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.846 0.355 . . . . 74.109999999999999 111.461 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.99 -13.99 62.7 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.439 -0.41 . . . . 73.430000000000007 113.507 178.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.468 ' N ' HD21 ' A' ' 45' ' ' ASN . 0.8 OUTLIER -93.53 -4.08 51.67 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 117.087 0.444 . . . . 63.340000000000003 111.945 177.17 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 94.2 mt -85.88 142.34 36.52 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 112.509 0.559 . . . . 75.209999999999994 112.509 -176.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.78 159.5 48.31 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.54 2.16 . . . . 75.420000000000002 112.27 173.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.59 -35.82 73.02 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.401 0.519 . . . . 73.329999999999998 112.401 -176.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -113.94 53.12 0.61 Allowed Glycine 0 CA--C 1.526 0.75 0 C-N-CA 121.23 -0.51 . . . . 53.009999999999998 112.913 178.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 90.9 p -72.93 -179.14 3.06 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 122.297 -0.531 . . . . 71.409999999999997 111.454 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -84.59 4.5 31.92 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.007 0.432 . . . . 73.230000000000004 111.425 176.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.537 HD13 ' HD2' ' A' ' 53' ' ' PRO . 35.6 tp -127.1 126.08 24.23 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 116.159 -0.473 . . . . 74.340000000000003 110.34 178.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.537 ' HD2' HD13 ' A' ' 52' ' ' LEU . 53.0 Cg_endo -70.1 94.36 0.56 Allowed 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 120.94 1.093 . . . . 62.100000000000001 111.879 176.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 68.1 p-90 -84.88 -29.7 25.02 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.305 0.574 . . . . 75.400000000000006 111.051 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.445 ' O ' HD21 ' A' ' 78' ' ' LEU . 33.6 p90 -61.56 -14.16 27.62 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.008 0.744 . . . . 71.230000000000004 113.008 -177.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 69.6 mtt-85 -85.34 7.95 20.52 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.108 0.41 . . . . 74.239999999999995 112.108 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.6 t -125.13 126.91 71.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 120.98 0.419 . . . . 73.430000000000007 111.521 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.582 HD12 HD23 ' A' ' 93' ' ' LEU . 34.9 pt -130.21 -172.11 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-N 116.444 -0.344 . . . . 64.219999999999999 111.504 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 34.6 p30 -84.96 175.39 9.1 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.217 0.532 . . . . 71.430000000000007 111.988 -178.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.2 p -72.51 -12.42 61.07 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.303 -0.408 . . . . 62.119999999999997 112.053 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -80.34 -16.32 54.83 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.633 0.254 . . . . 73.439999999999998 111.59 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.63 21.6 46.84 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 121.059 -0.591 . . . . 71.120000000000005 112.189 -174.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.499 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 62.1 mttp -118.67 159.64 23.27 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.112 0.482 . . . . 75.230000000000004 111.463 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 58.0 mt -67.23 130.03 32.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.242 -0.435 . . . . 74.510000000000005 110.525 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.6 p -64.78 -53.92 39.41 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.962 0.411 . . . . 63.140000000000001 111.589 -177.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.422 ' HB3' ' HB2' ' A' ' 70' ' ' ASP . 85.6 mt -63.48 150.73 43.09 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.253 0.549 . . . . 73.439999999999998 112.075 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.653 ' HZ3' ' HB2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -122.82 157.31 32.73 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.087 -0.506 . . . . 72.430000000000007 111.497 -176.043 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.96 -129.19 10.54 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.284 -0.484 . . . . 72.329999999999998 113.281 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.43 ' H ' ' HG3' ' A' ' 69' ' ' ARG . 9.0 mtm180 -54.61 -51.22 66.03 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 122.451 1.119 . . . . 74.430000000000007 110.515 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.504 ' HA ' ' HB3' ' A' ' 73' ' ' ARG . 3.6 m-20 -63.45 -18.47 63.79 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.121 -1.4 . . . . 75.129999999999995 112.293 -171.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.1 tt -65.55 -56.07 14.32 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 110.087 -0.338 . . . . 75.219999999999999 110.087 175.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -70.22 -26.3 63.8 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 122.315 -0.241 . . . . 65.340000000000003 111.013 178.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.504 ' HB3' ' HA ' ' A' ' 70' ' ' ASP . 29.4 ttm180 -57.2 -55.19 37.93 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.22 0.533 . . . . 75.439999999999998 110.751 171.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -64.56 -40.62 95.9 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.302 -0.408 . . . . 73.299999999999997 110.789 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.435 ' HG3' ' HB ' ' A' ' 85' ' ' VAL . 60.7 tttp -57.15 -56.94 15.34 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 111.931 0.345 . . . . 74.120000000000005 111.931 177.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -56.57 -34.36 67.05 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.505 0.193 . . . . 72.109999999999999 111.506 -177.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.483 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 75.6 mmtt -59.13 -47.42 85.35 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.165 0.507 . . . . 74.450000000000003 110.99 172.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.474 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 58.2 mt -68.85 -42.08 77.59 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.928 -0.578 . . . . 73.349999999999994 111.984 -178.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -55.1 -39.78 69.7 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.245 0.545 . . . . 70.319999999999993 110.86 176.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.65 -22.96 66.7 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.788 -0.642 . . . . 74.010000000000005 111.827 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 77' ' ' LYS . 4.9 mm-40 -94.33 -1.38 53.94 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 111.985 0.365 . . . . 75.519999999999996 111.985 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.07 19.83 51.84 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 120.851 -0.69 . . . . 74.099999999999994 113.37 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.474 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 65.4 mt -99.77 110.77 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 O-C-N 122.704 -0.291 . . . . 72.540000000000006 110.721 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -73.19 102.83 3.72 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.973 0.416 . . . . 75.140000000000001 111.815 -177.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.435 ' HB ' ' HG3' ' A' ' 75' ' ' LYS . 22.0 t -98.54 126.39 51.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 116.453 -0.34 . . . . 74.5 111.328 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.591 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 42.6 t -72.57 159.04 34.56 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 111.979 0.363 . . . . 65.140000000000001 111.979 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -38.98 -55.76 1.51 Allowed 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 114.748 1.388 . . . . 73.150000000000006 114.748 -171.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 pp -82.45 16.96 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 112.543 0.571 . . . . 73.400000000000006 112.543 -175.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.44 52.57 4.43 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 121.347 -0.454 . . . . 62.100000000000001 113.107 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.591 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 86.7 tttt -116.25 125.54 52.35 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 122.352 -0.499 . . . . 74.549999999999997 111.86 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.519 HD13 HD13 ' A' ' 58' ' ' ILE . 57.4 mt -113.95 138.46 43.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 116.274 -0.421 . . . . 74.329999999999998 111.342 -178.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.48 92.52 4.02 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.011 0.434 . . . . 73.420000000000002 111.071 176.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.582 HD23 HD12 ' A' ' 58' ' ' ILE . 82.0 mt -56.26 -48.95 75.55 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.384 -0.371 . . . . 74.439999999999998 111.732 -178.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -52.85 -22.05 4.97 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.877 0.695 . . . . 73.120000000000005 112.877 -176.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -102.67 -38.84 7.31 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.085 0.402 . . . . 71.140000000000001 112.085 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -101.68 3.83 40.11 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 111.968 0.359 . . . . 74.329999999999998 111.968 -172.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.56 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 57.4 tttp -59.51 141.59 54.47 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.042 0.448 . . . . 75.450000000000003 111.91 -175.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 16.2 t90 -60.75 119.47 8.22 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.258 0.551 . . . . 72.329999999999998 111.414 178.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -118.56 90.8 40.33 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 115.776 -0.647 . . . . 75.310000000000002 111.261 -178.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo . . . . . 0 CA--C 1.54 0.795 0 C-N-CA 122.778 2.319 . . . . 61.310000000000002 113.341 178.912 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 CA--C 1.54 0.561 0 N-CA-C 112.716 0.635 . . . . 73.439999999999998 112.716 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -56.41 -38.33 71.39 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.296 -0.411 . . . . 72.010000000000005 111.499 175.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -49.03 -50.78 34.63 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.121 0.486 . . . . 73.230000000000004 110.787 173.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 61.9 mt -63.7 -48.27 77.77 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.759 -0.655 . . . . 71.519999999999996 111.176 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 63.1 t -57.33 -41.09 77.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 116.32 -0.4 . . . . 61.530000000000001 111.997 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.473 ' O ' HG21 ' A' ' 11' ' ' VAL . 27.9 mm-40 -73.75 -49.57 24.87 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.195 0.443 . . . . 74.319999999999993 112.195 -177.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.446 ' O ' HG13 ' A' ' 12' ' ' ILE . 31.4 pt -59.7 -40.2 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 O-C-N 122.055 -0.403 . . . . 72.25 111.259 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -58.23 -48.11 81.42 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.035 0.445 . . . . 75.299999999999997 110.448 171.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.37 -17.31 42.66 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.041 -0.527 . . . . 73.510000000000005 112.407 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.473 HG21 ' O ' ' A' ' 7' ' ' GLN . 49.9 t -92.41 -50.16 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-O 120.808 0.337 . . . . 74.530000000000001 111.3 175.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.493 HD12 HD23 ' A' ' 52' ' ' LEU . 79.8 mt -57.85 -37.82 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 112.849 0.685 . . . . 75.400000000000006 112.849 -175.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 -58.23 -21.3 47.48 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.402 0.519 . . . . 74.140000000000001 112.402 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -83.28 -6.24 59.4 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.509 0.559 . . . . 65.010000000000005 112.509 -178.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 45.3 mt -78.27 122.9 85.81 Favored Pre-proline 0 CA--C 1.544 0.72 0 O-C-N 122.419 -0.175 . . . . 64.200000000000003 110.655 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -79.88 178.76 6.9 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.801 2.334 . . . . 74.439999999999998 114.176 -175.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.521 ' HE3' ' HA ' ' A' ' 81' ' ' GLU . 49.3 tptt -67.18 122.88 18.79 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.627 -0.715 . . . . 63.140000000000001 111.502 -178.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.535 ' HA2' ' HB3' ' A' ' 81' ' ' GLU . . . 91.12 3.5 69.9 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 114.407 0.523 . . . . 71.430000000000007 114.407 175.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -117.81 146.86 43.55 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 117.575 0.688 . . . . 73.319999999999993 111.648 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.6 m -129.13 157.62 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.172 0.51 . . . . 75.030000000000001 111.747 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 89.3 p -132.43 171.11 14.18 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.236 -0.438 . . . . 74.230000000000004 110.793 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.9 p -103.52 152.03 22.17 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.808 0.337 . . . . 74.140000000000001 111.697 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -49.46 -41.47 40.44 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.442 0.534 . . . . 72.329999999999998 112.442 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.7 -40.99 95.57 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 121.239 -0.505 . . . . 72.340000000000003 113.252 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -66.91 -55.17 15.82 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.64 0.257 . . . . 74.019999999999996 111.073 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.6 mm -54.11 -49.99 57.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.208 0.528 . . . . 63.350000000000001 111.365 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.515 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -59.8 -43.77 94.29 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.062 -0.517 . . . . 55.130000000000003 111.737 179.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -62.35 -45.57 92.6 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.79 0.329 . . . . 75.310000000000002 111.182 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 65.4 mtt -63.15 -37.1 85.88 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.406 -0.361 . . . . 74.120000000000005 111.167 178.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.29 -29.38 67.24 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.935 0.397 . . . . 72.239999999999995 111.673 176.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.48 10.05 27.96 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 116.282 -0.417 . . . . 75.239999999999995 112.935 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.515 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 26.8 m-85 -127.27 63.5 58.23 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 122.451 0.3 . . . . 75.319999999999993 111.152 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.69 -35.7 87.99 Favored 'Trans proline' 0 N--CA 1.483 0.862 0 C-N-CA 122.829 2.353 . . . . 75.530000000000001 114.181 -172.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -82.35 -7.96 86.93 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 121.06 -0.59 . . . . 72.439999999999998 113.59 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.435 ' CD1' ' HB3' ' A' ' 32' ' ' TYR . 23.0 m-85 -86.2 16.14 4.61 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.529 0.566 . . . . 74.129999999999995 112.529 -178.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.09 -43.58 61.09 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.216 0.532 . . . . 74.519999999999996 111.618 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -57.55 -40.25 78.47 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.781 -0.645 . . . . 72.329999999999998 111.855 175.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -75.35 -28.23 59.5 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.651 -0.25 . . . . 72.319999999999993 111.673 -178.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 46.5 t -61.18 -43.85 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 109.814 -0.439 . . . . 53.030000000000001 109.814 173.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.02 -41.94 96.69 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 115.992 -0.549 . . . . 53.030000000000001 112.631 174.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.4 mttp -57.46 -53.83 53.75 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.975 0.417 . . . . 74.150000000000006 111.303 173.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.33 -47.64 78.35 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.165 -0.47 . . . . 73.299999999999997 112.08 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.415 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 79.8 mt -68.1 -41.39 81.88 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.861 0.362 . . . . 74.0 111.496 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.7 -18.79 62.09 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.156 -0.545 . . . . 73.040000000000006 113.374 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -86.06 -4.49 59.18 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 122.606 -0.349 . . . . 72.310000000000002 111.649 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 96.2 mt -92.61 121.53 65.99 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-O 120.761 0.315 . . . . 73.099999999999994 111.653 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.89 160.86 36.83 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.326 2.017 . . . . 75.349999999999994 112.469 177.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -67.13 119.32 11.85 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.287 0.565 . . . . 65.420000000000002 110.962 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 110.89 -2.51 28.74 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 115.983 -0.553 . . . . 62.32 112.673 -173.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 31.0 t -61.85 167.82 3.49 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.165 0.507 . . . . 73.239999999999995 112.162 177.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -66.93 -29.51 69.4 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.737 0.643 . . . . 74.25 112.737 -177.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.535 HD13 ' HD2' ' A' ' 53' ' ' PRO . 25.7 tp -102.46 131.84 22.03 Favored Pre-proline 0 N--CA 1.472 0.639 0 N-CA-C 111.558 0.207 . . . . 72.129999999999995 111.558 -178.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.535 ' HD2' HD13 ' A' ' 52' ' ' LEU . 59.4 Cg_endo -73.62 95.1 0.86 Allowed 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 121.591 1.527 . . . . 71.209999999999994 111.813 171.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.415 ' HB2' ' HB3' ' A' ' 43' ' ' LEU . 55.2 p-90 -81.35 -24.51 37.03 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.225 0.536 . . . . 72.25 112.222 -176.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.44 ' CG ' ' HB3' ' A' ' 77' ' ' LYS . 29.3 p90 -65.24 -17.99 64.94 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.381 0.882 . . . . 71.340000000000003 113.381 -175.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -83.23 7.33 16.58 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.545 0.572 . . . . 74.209999999999994 112.545 -177.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.6 t -123.19 117.93 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 121.029 0.443 . . . . 62.32 111.131 176.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.468 HD13 HD23 ' A' ' 93' ' ' LEU . 42.3 pt -123.21 -170.35 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 121.112 0.482 . . . . 65.209999999999994 111.714 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.7 p30 -86.28 163.48 17.69 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.078 0.466 . . . . 74.420000000000002 111.585 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 88.1 p -79.6 9.43 5.0 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 120.983 0.42 . . . . 55.229999999999997 111.665 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -93.61 -8.74 40.28 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.161 -0.472 . . . . 73.5 111.13 178.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.5 40.59 27.29 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.311 -0.471 . . . . 64.310000000000002 112.821 -177.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.591 ' HG2' ' HG2' ' A' ' 90' ' ' LYS . 53.5 mtpt -137.45 166.78 23.02 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.101 0.477 . . . . 73.530000000000001 111.441 178.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 63.6 mt -67.15 109.88 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.505 -0.554 . . . . 73.409999999999997 109.505 170.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.4 t -57.7 -40.09 78.72 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.143 -0.48 . . . . 74.409999999999997 112.013 -175.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.522 HD11 ' HB3' ' A' ' 70' ' ' ASP . 84.9 mt -76.78 160.15 29.53 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.995 0.426 . . . . 75.140000000000001 111.399 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -130.82 157.51 42.66 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.051 0.453 . . . . 75.439999999999998 111.869 -176.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.48 -130.19 31.51 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.267 -0.492 . . . . 62.130000000000003 113.398 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.427 ' H ' ' HG3' ' A' ' 69' ' ' ARG . 10.2 mtm180 -48.69 -50.93 31.1 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.902 0.858 . . . . 74.439999999999998 110.947 178.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.522 ' HB3' HD11 ' A' ' 66' ' ' LEU . 21.5 m-20 -70.72 -18.85 62.79 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 114.627 -1.17 . . . . 72.340000000000003 112.035 -172.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.0 tt -66.7 -51.07 60.18 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.608 -0.516 . . . . 73.099999999999994 109.608 174.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -61.6 -36.36 80.49 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.08 -0.509 . . . . 73.409999999999997 111.528 175.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.2 mtt180 -56.1 -62.81 1.45 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.51 0.195 . . . . 71.310000000000002 111.473 174.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -58.83 -36.47 74.6 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.714 0.293 . . . . 74.010000000000005 111.086 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.498 ' HG3' HG13 ' A' ' 85' ' ' VAL . 79.2 tttt -52.46 -65.95 0.47 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.991 0.424 . . . . 74.420000000000002 111.62 174.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -63.18 -30.87 71.93 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.084 -0.507 . . . . 75.230000000000004 112.224 -175.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.44 ' HB3' ' CG ' ' A' ' 55' ' ' PHE . 72.3 mmtt -61.02 -45.89 92.98 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.974 0.416 . . . . 74.450000000000003 110.626 174.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.464 HD21 HD12 ' A' ' 83' ' ' ILE . 83.6 mt -72.17 -28.09 63.0 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.397 -0.365 . . . . 73.150000000000006 111.633 177.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 49.7 mt-10 -66.88 -28.06 68.02 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.067 0.46 . . . . 75.439999999999998 110.325 172.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.6 -23.66 59.95 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.165 0.507 . . . . 53.25 110.858 172.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.535 ' HB3' ' HA2' ' A' ' 18' ' ' GLY . 39.7 mm-40 -81.77 -26.25 34.61 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.024 -0.535 . . . . 61.100000000000001 110.989 174.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.85 37.18 4.26 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 116.304 -0.407 . . . . 75.319999999999993 113.057 -178.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.464 HD12 HD21 ' A' ' 78' ' ' LEU . 58.6 mt -105.8 136.98 37.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 112.301 0.482 . . . . 75.230000000000004 112.301 -176.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -67.95 93.7 0.43 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.887 0.375 . . . . 72.120000000000005 111.582 172.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.498 HG13 ' HG3' ' A' ' 75' ' ' LYS . 60.2 t -86.94 107.11 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 110.116 -0.328 . . . . 74.420000000000002 110.116 174.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.549 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 23.8 t -64.83 147.74 52.65 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.637 -0.256 . . . . 72.129999999999995 111.352 -177.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.444 ' HG3' ' N ' ' A' ' 88' ' ' ILE . 12.3 pt-20 -36.31 -55.76 0.8 Allowed 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 115.424 1.638 . . . . 74.310000000000002 115.424 -167.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.444 ' N ' ' HG3' ' A' ' 87' ' ' GLU . 2.8 pp -87.35 10.12 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 112.866 0.691 . . . . 74.450000000000003 112.866 -173.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 97.74 47.98 2.03 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 121.363 -0.446 . . . . 74.019999999999996 113.999 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.591 ' HG2' ' HG2' ' A' ' 63' ' ' LYS . 90.8 mttt -114.77 146.36 41.07 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 122.305 -0.526 . . . . 74.510000000000005 111.515 176.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.418 HD12 HG21 ' A' ' 58' ' ' ILE . 58.3 mt -130.97 138.77 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 115.873 -0.603 . . . . 73.239999999999995 111.137 -177.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.56 93.55 8.83 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.621 -0.263 . . . . 73.340000000000003 111.679 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.468 HD23 HD13 ' A' ' 58' ' ' ILE . 62.2 mt -53.97 -57.18 11.97 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 111.79 0.292 . . . . 74.109999999999999 111.79 177.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 52.9 ttp180 -46.25 -30.65 2.1 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.727 0.639 . . . . 75.049999999999997 112.727 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -90.59 -25.63 20.08 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 112.242 0.46 . . . . 72.400000000000006 112.242 -176.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -127.11 13.08 7.21 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 113.129 0.788 . . . . 75.400000000000006 113.129 -176.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 93' ' ' LEU . 55.2 tttm -64.61 125.98 26.44 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.029 0.443 . . . . 72.209999999999994 111.777 -175.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 22.4 t90 -58.94 113.8 2.26 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.853 0.686 . . . . 74.129999999999995 112.853 -175.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -107.71 92.41 8.73 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 115.909 -0.587 . . . . 63.229999999999997 110.481 172.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo . . . . . 0 CA--C 1.54 0.808 0 C-N-CA 122.585 2.19 . . . . 75.030000000000001 113.184 179.885 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.5 t70 . . . . . 0 CA--C 1.546 0.823 0 N-CA-C 112.742 0.645 . . . . 71.430000000000007 112.742 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -52.72 -39.57 62.18 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.677 0.621 . . . . 74.5 112.677 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -57.74 -48.71 78.84 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.898 0.38 . . . . 74.319999999999993 110.754 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.28 -46.58 89.76 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.034 -0.53 . . . . 74.239999999999995 111.26 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 73.2 t -56.48 -52.31 54.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 116.286 -0.415 . . . . 72.549999999999997 111.62 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -63.98 -49.85 70.87 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.947 0.721 . . . . 64.140000000000001 112.947 -176.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 36.9 pt -60.73 -41.76 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 O-C-N 122.114 -0.366 . . . . 73.450000000000003 111.401 -178.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -66.03 -41.78 90.48 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.747 0.308 . . . . 74.519999999999996 110.998 177.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.04 -37.95 69.93 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.011 0.434 . . . . 71.439999999999998 111.586 177.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 95.9 t -66.85 -41.85 88.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-O 121.015 0.436 . . . . 74.329999999999998 110.982 177.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.534 ' HB ' HD11 ' A' ' 52' ' ' LEU . 73.7 mt -62.5 -37.32 78.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 116.117 -0.492 . . . . 75.120000000000005 111.801 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -57.16 -21.17 30.91 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 122.194 -0.316 . . . . 73.109999999999999 111.717 174.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -87.46 -4.13 59.01 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 112.447 0.536 . . . . 74.209999999999994 112.447 -177.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.511 HD11 HD12 ' A' ' 26' ' ' ILE . 60.0 mt -76.32 122.26 86.44 Favored Pre-proline 0 CA--C 1.542 0.658 0 O-C-N 122.349 -0.219 . . . . 75.340000000000003 110.776 177.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -68.21 169.51 16.61 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.582 2.188 . . . . 74.5 112.782 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -67.24 149.46 50.39 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.035 0.445 . . . . 75.400000000000006 112.015 -177.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.99 -32.78 1.73 Allowed Glycine 0 CA--C 1.529 0.966 0 C-N-CA 121.337 -0.459 . . . . 63.420000000000002 113.839 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -77.75 159.92 28.74 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.447 0.641 . . . . 75.439999999999998 112.562 -177.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.5 m -130.54 156.33 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 115.543 -0.753 . . . . 72.040000000000006 110.621 177.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 51.0 m -133.3 155.95 48.48 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.07 0.462 . . . . 73.040000000000006 111.558 176.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.5 p -94.17 155.05 17.26 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.982 0.42 . . . . 72.219999999999999 111.282 176.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -55.8 -33.91 64.84 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.307 -0.406 . . . . 75.439999999999998 111.823 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.99 -43.47 97.35 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.195 -0.526 . . . . 75.030000000000001 112.832 178.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.49 ' HB3' ' HE2' ' A' ' 29' ' ' MET . 42.3 mt-10 -62.36 -54.68 36.83 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.913 0.387 . . . . 73.319999999999993 111.11 177.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.511 HD12 HD11 ' A' ' 15' ' ' ILE . 50.1 mm -54.79 -49.74 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 116.208 -0.451 . . . . 71.319999999999993 111.464 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.07 -43.53 82.2 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.454 -0.339 . . . . 64.040000000000006 111.596 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.03 -56.1 22.47 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 111.752 0.279 . . . . 71.409999999999997 111.752 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.49 ' HE2' ' HB3' ' A' ' 25' ' ' GLU . 4.4 mpp? -61.53 -25.63 67.41 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.148 0.425 . . . . 65.109999999999999 112.148 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.3 -21.22 53.87 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.042 0.386 . . . . 74.430000000000007 112.042 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.09 21.29 20.98 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.251 -0.499 . . . . 63.030000000000001 113.157 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -134.43 54.04 10.95 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 122.529 0.331 . . . . 73.540000000000006 111.74 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -62.25 132.45 38.86 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 121.983 1.789 . . . . 74.099999999999994 112.237 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.65 -28.38 15.74 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.146 -0.55 . . . . 43.420000000000002 113.008 -176.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -82.77 27.57 0.53 Allowed 'General case' 0 CA--C 1.542 0.662 0 O-C-N 122.452 -0.44 . . . . 72.299999999999997 111.989 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.09 -39.96 76.04 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.399 0.518 . . . . 74.349999999999994 112.399 -177.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -60.4 -32.02 70.93 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.946 0.403 . . . . 75.109999999999999 111.1 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -74.57 -41.05 61.21 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.309 -0.405 . . . . 70.329999999999998 110.791 177.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.2 t -56.2 -42.2 72.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.074 0.464 . . . . 73.25 110.641 175.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.26 -45.34 96.27 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-N 116.064 -0.516 . . . . 64.140000000000001 112.731 175.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -64.47 -33.34 75.66 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.938 0.399 . . . . 74.340000000000003 111.392 177.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.32 -48.12 71.34 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.298 -0.41 . . . . 71.200000000000003 111.435 177.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.1 mt -67.34 -38.96 85.67 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.948 0.404 . . . . 75.409999999999997 111.319 177.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.62 -13.21 50.22 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 121.145 -0.55 . . . . 55.219999999999999 113.142 176.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -93.9 -8.0 41.49 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 120.987 0.422 . . . . 73.230000000000004 111.186 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 70.6 mt -82.22 144.78 51.03 Favored Pre-proline 0 N--CA 1.472 0.634 0 N-CA-C 112.665 0.617 . . . . 73.329999999999998 112.665 -177.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.05 144.24 37.55 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.479 2.12 . . . . 63.130000000000003 111.733 172.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.508 ' HB3' ' HE ' ' A' ' 73' ' ' ARG . 16.6 pt-20 -65.04 -26.37 68.23 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 122.102 -0.374 . . . . 64.010000000000005 111.997 -176.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -88.37 20.96 27.57 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 121.066 -0.588 . . . . 52.450000000000003 113.856 177.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.9 t -73.1 150.29 42.39 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 117.083 0.442 . . . . 71.25 112.173 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -64.56 -46.3 83.39 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.275 0.559 . . . . 74.129999999999995 110.77 175.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.534 HD11 ' HB ' ' A' ' 12' ' ' ILE . 51.8 tp -58.22 117.16 17.91 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 115.602 -0.726 . . . . 75.510000000000005 111.382 175.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.47 ' HD2' HD13 ' A' ' 52' ' ' LEU . 58.9 Cg_endo -72.49 94.52 0.77 Allowed 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 121.465 1.443 . . . . 74.129999999999995 111.992 178.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 67.4 p-90 -82.79 -26.79 31.45 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.372 0.606 . . . . 73.439999999999998 110.964 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.515 ' HA ' ' HG3' ' A' ' 74' ' ' GLN . 29.1 p90 -62.27 -20.39 64.23 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.507 -0.769 . . . . 73.519999999999996 112.909 -176.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 79.9 mtt-85 -79.32 1.72 24.06 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.397 0.518 . . . . 74.310000000000002 112.397 -178.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 21' ' ' SER . 33.5 t -109.57 124.79 66.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 O-C-N 121.892 -0.505 . . . . 75.420000000000002 111.89 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.6 pt -132.91 177.04 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 116.414 -0.357 . . . . 72.519999999999996 111.564 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.429 HD22 ' HB2' ' A' ' 63' ' ' LYS . 36.7 p30 -80.61 177.78 8.78 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.773 0.657 . . . . 73.420000000000002 112.773 -174.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 76.0 p -67.3 -17.7 64.88 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.913 -0.585 . . . . 64.120000000000005 112.494 -177.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -83.58 -10.69 58.09 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.066 0.46 . . . . 72.319999999999993 111.13 177.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.67 49.42 14.32 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.88 -0.676 . . . . 73.400000000000006 111.665 -172.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.429 ' HB2' HD22 ' A' ' 59' ' ' ASN . 96.7 mttt -135.1 158.36 44.55 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.922 0.391 . . . . 70.400000000000006 111.015 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 67.9 mt -72.58 119.39 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.4 -0.364 . . . . 74.140000000000001 110.915 177.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.5 m -65.62 -44.2 87.25 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.804 0.335 . . . . 70.340000000000003 111.881 -178.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 84.7 mt -74.92 117.31 16.63 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.807 0.337 . . . . 74.310000000000002 110.896 178.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -108.78 169.87 8.39 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.847 0.356 . . . . 73.219999999999999 111.702 -177.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.02 -132.06 10.94 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 121.18 -0.533 . . . . 65.319999999999993 111.834 -173.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -81.59 -26.41 34.96 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 122.188 -0.595 . . . . 75.219999999999999 110.93 174.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.494 ' O ' ' HB3' ' A' ' 73' ' ' ARG . 17.6 m-20 -63.89 -17.33 63.09 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.994 0.426 . . . . 71.439999999999998 110.798 174.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.1 tt -65.11 -52.33 56.02 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.094 -0.503 . . . . 73.140000000000001 109.937 173.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.554 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 19.3 m-20 -63.59 -31.89 73.19 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.99 0.424 . . . . 72.140000000000001 111.359 176.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.508 ' HE ' ' HB3' ' A' ' 48' ' ' GLU . 70.8 ttt180 -51.1 -63.84 1.0 Allowed 'General case' 0 CA--C 1.547 0.832 0 CA-C-O 121.236 0.541 . . . . 74.030000000000001 110.897 173.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.515 ' HG3' ' HA ' ' A' ' 55' ' ' PHE . 48.1 tt0 -67.77 -43.64 79.35 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.093 0.473 . . . . 73.319999999999993 110.944 178.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.554 ' HB3' ' HA ' ' A' ' 72' ' ' ASP . 85.0 tttt -48.93 -60.94 2.34 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.702 -0.681 . . . . 73.200000000000003 112.149 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -65.02 -34.36 78.26 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.184 0.438 . . . . 64.200000000000003 112.184 -176.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -60.19 -29.67 68.86 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 120.605 -0.438 . . . . 74.310000000000002 111.373 172.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 80.5 mt -86.43 -34.37 20.15 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.227 -0.442 . . . . 73.430000000000007 111.548 175.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -66.08 -31.89 73.04 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 122.192 -0.317 . . . . 74.010000000000005 111.262 178.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.27 -25.86 62.28 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.222 0.534 . . . . 73.239999999999995 111.187 174.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.424 ' HB2' HG13 ' A' ' 83' ' ' ILE . 14.1 mm-40 -80.05 -26.15 39.84 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.347 0.594 . . . . 64.120000000000005 111.066 176.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 99.88 22.82 11.49 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 115.906 -0.588 . . . . 63.119999999999997 112.29 -172.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.424 HG13 ' HB2' ' A' ' 81' ' ' GLU . 73.1 mt -83.86 125.72 40.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.011 0.434 . . . . 71.430000000000007 111.169 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -72.24 99.07 2.3 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.583 0.706 . . . . 75.140000000000001 112.145 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.415 HG12 ' HG3' ' A' ' 75' ' ' LYS . 44.7 t -100.14 111.15 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 115.994 -0.548 . . . . 74.120000000000005 110.879 178.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.566 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 40.3 t -67.12 158.22 31.71 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.278 -0.419 . . . . 61.520000000000003 111.629 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -43.69 -53.43 5.8 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 114.281 1.215 . . . . 71.239999999999995 114.281 -170.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.8 pp -79.47 12.96 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 112.524 0.565 . . . . 75.219999999999999 112.524 -176.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.51 48.97 5.09 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-N 116.365 -0.38 . . . . 64.209999999999994 112.986 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.566 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 61.3 tttm -116.19 123.46 47.84 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 120.992 0.425 . . . . 74.129999999999995 111.941 -178.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 64.6 mt -116.27 142.92 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 122.769 0.428 . . . . 72.010000000000005 111.33 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.25 101.84 5.6 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 111.896 0.332 . . . . 74.519999999999996 111.896 178.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.4 ' O ' ' N ' ' A' ' 97' ' ' LYS . 57.5 mt -54.54 -62.54 1.59 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.15 0.426 . . . . 74.120000000000005 112.15 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 45.3 mtm180 -49.88 -29.9 9.03 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.311 0.485 . . . . 71.329999999999998 112.311 -176.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -79.94 -35.27 38.01 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.083 -0.508 . . . . 73.420000000000002 111.581 -176.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -115.71 5.98 14.35 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.292 0.479 . . . . 75.019999999999996 112.292 -177.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.4 ' N ' ' O ' ' A' ' 93' ' ' LEU . 55.5 tttm -59.32 133.82 56.44 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.074 0.464 . . . . 75.519999999999996 111.971 -174.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 13.6 t90 -55.2 114.29 1.72 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.995 -0.548 . . . . 64.109999999999999 111.491 178.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -109.45 91.83 10.69 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 116.157 -0.474 . . . . 62.030000000000001 110.44 175.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo . . . . . 0 CA--C 1.537 0.628 0 C-N-CA 122.221 1.947 . . . . 75.430000000000007 112.082 177.963 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 N--CA 1.475 0.777 0 N-CA-C 112.248 0.462 . . . . 73.430000000000007 112.248 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.484 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 17.4 mm100 -55.21 -37.47 67.16 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.346 0.498 . . . . 73.239999999999995 112.346 -177.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -55.86 -54.48 44.1 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.231 0.538 . . . . 72.219999999999999 110.603 176.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 68.9 mt -62.74 -44.72 95.46 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.556 -0.747 . . . . 73.120000000000005 111.201 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 85.5 t -57.11 -52.27 58.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 112.078 0.399 . . . . 73.430000000000007 112.078 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 28.6 mm-40 -62.32 -51.08 69.09 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.156 0.428 . . . . 74.540000000000006 112.156 -175.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.526 HD12 HG11 ' A' ' 39' ' ' VAL . 31.4 pt -59.55 -45.69 93.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 111.633 0.235 . . . . 73.140000000000001 111.633 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 19.6 m-30 -63.98 -41.33 97.56 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.132 0.491 . . . . 74.25 110.886 177.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.47 -20.4 63.11 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.87 -0.605 . . . . 64.040000000000006 111.798 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 7' ' ' GLN . 99.2 t -85.71 -41.0 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 120.745 0.307 . . . . 74.319999999999993 111.05 173.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 8' ' ' ILE . 79.3 mt -55.28 -41.23 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 112.664 0.616 . . . . 74.209999999999994 112.664 -177.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -58.38 -12.52 3.9 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 113.424 0.898 . . . . 74.040000000000006 113.424 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -85.64 -7.46 58.81 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 112.079 0.4 . . . . 63.399999999999999 112.079 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 63.8 mt -75.71 119.77 78.62 Favored Pre-proline 0 CA--C 1.542 0.661 0 O-C-N 122.407 -0.183 . . . . 74.010000000000005 110.696 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -76.75 161.1 33.94 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.545 2.164 . . . . 71.409999999999997 113.269 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.457 ' HZ1' ' CD ' ' A' ' 81' ' ' GLU . 45.3 tttp -63.88 107.84 1.32 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.253 -0.431 . . . . 70.140000000000001 111.235 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 128.87 -15.61 5.9 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.923 -0.656 . . . . 72.209999999999994 113.483 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -116.6 163.42 16.12 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.386 0.612 . . . . 64.120000000000005 112.254 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.4 m -135.82 162.75 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-N 115.444 -0.798 . . . . 74.430000000000007 110.895 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.489 ' HG ' HD11 ' A' ' 26' ' ' ILE . 89.0 p -137.36 171.02 15.11 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.747 0.308 . . . . 71.200000000000003 110.613 175.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 40.2 p -107.05 154.03 21.73 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.829 0.347 . . . . 71.439999999999998 111.541 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -50.65 -41.25 55.15 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 116.223 -0.444 . . . . 71.209999999999994 112.074 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -57.66 -41.6 93.81 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 121.23 -0.51 . . . . 74.200000000000003 112.912 178.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.476 ' O ' ' HG3' ' A' ' 29' ' ' MET . 42.2 mt-10 -65.93 -52.63 48.2 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.655 0.264 . . . . 71.319999999999993 111.063 178.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.489 HD11 ' HG ' ' A' ' 21' ' ' SER . 44.4 mm -56.54 -47.33 82.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 120.984 0.421 . . . . 73.349999999999994 111.571 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.84 -45.97 90.13 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.34 -0.391 . . . . 75.530000000000001 111.593 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -61.04 -41.61 96.9 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 111.768 0.284 . . . . 74.0 111.768 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.476 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 64.8 mtt -67.86 -34.76 77.31 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.634 0.254 . . . . 55.210000000000001 111.477 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.69 -27.28 50.72 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.877 0.37 . . . . 73.319999999999993 111.731 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.81 44.99 1.84 Allowed Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.442 -0.409 . . . . 41.009999999999998 113.644 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -137.41 83.09 26.89 Favored Pre-proline 0 CA--C 1.544 0.716 0 O-C-N 122.412 -0.464 . . . . 74.219999999999999 111.576 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.4 126.49 14.31 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 122.791 2.327 . . . . 72.540000000000006 113.024 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.19 -8.71 79.22 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 121.396 -0.431 . . . . 54.520000000000003 113.709 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -94.35 11.13 31.58 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.569 0.581 . . . . 75.230000000000004 112.569 -177.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.81 -47.7 70.6 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.208 0.527 . . . . 52.109999999999999 111.457 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.8 ptt180 -53.44 -38.02 63.13 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.678 -0.692 . . . . 75.030000000000001 112.119 174.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -69.49 -35.89 76.0 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.781 0.324 . . . . 65.040000000000006 111.203 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.526 HG11 HD12 ' A' ' 8' ' ' ILE . 55.5 t -57.42 -39.65 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 121.195 0.521 . . . . 72.400000000000006 110.378 174.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.31 -40.9 99.25 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 116.031 -0.531 . . . . 42.539999999999999 112.528 174.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -58.95 -38.0 78.04 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.031 0.443 . . . . 75.329999999999998 111.089 175.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.95 -55.34 19.74 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.87 -0.605 . . . . 74.310000000000002 111.838 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.0 mt -62.47 -32.27 73.12 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.67 0.271 . . . . 74.310000000000002 111.536 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.72 -21.54 58.34 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 121.192 -0.528 . . . . 75.030000000000001 113.542 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -84.4 -10.56 57.43 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.091 0.472 . . . . 72.430000000000007 110.977 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.422 HD13 HD21 ' A' ' 52' ' ' LEU . 97.5 mt -87.5 139.96 31.79 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 116.361 -0.381 . . . . 73.239999999999995 111.924 -178.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -88.08 173.31 4.95 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.701 2.267 . . . . 71.409999999999997 112.667 175.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.741 ' HB3' ' HD3' ' A' ' 73' ' ' ARG . 9.7 pt-20 -67.48 -12.86 61.31 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.785 0.326 . . . . 73.340000000000003 111.82 177.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -96.78 32.84 6.18 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 121.353 -0.451 . . . . 43.229999999999997 113.445 176.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.8 t -95.45 135.36 37.18 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 122.294 -0.533 . . . . 63.399999999999999 111.507 177.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -70.14 -28.57 65.46 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.923 0.392 . . . . 74.239999999999995 111.185 174.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.519 HD13 ' HD2' ' A' ' 53' ' ' PRO . 48.5 tp -72.78 117.65 61.31 Favored Pre-proline 0 C--O 1.237 0.423 0 CA-C-N 116.219 -0.446 . . . . 75.209999999999994 110.441 176.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.519 ' HD2' HD13 ' A' ' 52' ' ' LEU . 44.5 Cg_endo -67.1 95.32 0.36 Allowed 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 121.562 1.508 . . . . 75.209999999999994 112.496 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 -80.81 -31.54 35.6 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.406 0.622 . . . . 70.25 110.723 177.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.472 ' O ' HD21 ' A' ' 78' ' ' LEU . 20.8 p90 -63.25 -21.89 66.52 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.242 0.83 . . . . 73.400000000000006 113.242 -178.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -84.4 -1.25 55.25 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.6 0.593 . . . . 74.019999999999996 112.6 -177.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.8 t -118.11 106.97 20.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-O 121.342 0.592 . . . . 71.140000000000001 111.58 -178.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.564 HD13 HD22 ' A' ' 93' ' ' LEU . 28.6 pt -112.67 -169.64 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 121.263 0.554 . . . . 75.230000000000004 112.114 -177.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 28.2 p30 -95.23 170.3 9.48 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.545 0.572 . . . . 74.409999999999997 112.545 -175.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 31.1 t -63.62 -17.88 63.35 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 112.46 0.541 . . . . 72.200000000000003 112.46 -178.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -75.75 -14.62 60.33 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.058 0.456 . . . . 60.409999999999997 111.113 177.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.99 43.64 33.06 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.036 -0.602 . . . . 52.119999999999997 111.934 -174.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.405 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 89.7 mttt -133.85 162.45 31.98 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.164 0.507 . . . . 75.540000000000006 111.596 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.405 HG22 ' OE1' ' A' ' 74' ' ' GLN . 66.5 mt -70.13 119.03 15.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 115.759 -0.655 . . . . 72.319999999999993 110.178 172.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.0 m -67.16 -27.75 67.55 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.198 0.444 . . . . 72.239999999999995 112.198 -177.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.521 HD13 ' HB3' ' A' ' 70' ' ' ASP . 77.1 mt -77.33 165.93 23.81 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.144 0.497 . . . . 64.420000000000002 111.727 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -133.68 148.96 51.53 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.066 0.46 . . . . 75.129999999999995 112.084 -171.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.34 -123.82 30.36 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-N 116.081 -0.509 . . . . 73.540000000000006 113.553 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 48.0 mtp180 -64.72 -38.96 92.77 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.175 0.512 . . . . 71.140000000000001 110.924 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.521 ' HB3' HD13 ' A' ' 66' ' ' LEU . 4.3 m-20 -60.49 -30.19 69.55 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.949 -0.568 . . . . 72.319999999999993 111.233 176.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.1 tt -65.74 -59.09 4.26 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.351 -0.386 . . . . 73.420000000000002 110.784 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -69.13 -21.63 64.01 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 122.267 -0.271 . . . . 72.430000000000007 111.468 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.741 ' HD3' ' HB3' ' A' ' 48' ' ' GLU . 35.9 ttm180 -61.91 -52.27 64.75 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.069 0.461 . . . . 63.149999999999999 110.319 172.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.405 ' OE1' HG22 ' A' ' 64' ' ' ILE . 53.5 tt0 -60.63 -39.45 88.28 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.1 -0.5 . . . . 72.140000000000001 110.714 178.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.451 ' HG3' ' HB ' ' A' ' 85' ' ' VAL . 85.5 tttt -57.73 -53.08 62.26 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.081 -0.509 . . . . 71.540000000000006 111.236 176.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -55.75 -39.59 71.38 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.948 0.404 . . . . 70.25 111.441 178.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.446 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 69.0 mmtt -58.59 -48.5 80.73 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.189 -0.46 . . . . 75.540000000000006 111.415 173.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.472 HD21 ' O ' ' A' ' 55' ' ' PHE . 85.6 mt -66.28 -39.87 89.69 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.247 -0.433 . . . . 72.049999999999997 111.934 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 46.2 mt-10 -64.15 -26.64 68.62 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.948 0.404 . . . . 73.340000000000003 110.909 177.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.57 -14.53 60.8 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.234 -0.439 . . . . 74.040000000000006 111.576 174.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.457 ' CD ' ' HZ1' ' A' ' 17' ' ' LYS . 22.5 mm-40 -103.6 10.06 37.11 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 111.855 0.317 . . . . 74.239999999999995 111.855 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.46 30.49 40.49 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 121.066 -0.588 . . . . 63.130000000000003 113.535 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.1 mt -112.04 138.67 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 O-C-N 122.449 -0.442 . . . . 74.510000000000005 111.383 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.517 ' HB2' ' HH ' ' A' ' 96' ' ' TYR . 40.1 mt-10 -100.47 114.33 27.83 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.826 0.346 . . . . 73.329999999999998 110.696 175.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.451 ' HB ' ' HG3' ' A' ' 75' ' ' LYS . 79.7 t -107.63 131.44 57.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 116.398 -0.365 . . . . 73.549999999999997 111.177 -178.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.548 ' OG ' ' HB3' ' A' ' 90' ' ' LYS . 25.6 p -74.32 148.0 41.76 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.88 0.372 . . . . 73.239999999999995 111.412 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.409 ' HG3' ' N ' ' A' ' 88' ' ' ILE . 12.4 pt-20 -42.59 -53.92 4.19 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.891 1.441 . . . . 74.299999999999997 114.891 -166.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.409 ' N ' ' HG3' ' A' ' 87' ' ' GLU . 2.8 pp -73.59 11.92 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 112.868 0.692 . . . . 75.129999999999995 112.868 -175.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.43 50.79 4.36 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 121.426 -0.416 . . . . 71.349999999999994 113.127 177.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.562 ' HD3' ' N ' ' A' ' 91' ' ' ILE . 6.6 tmtm? -122.88 138.58 54.62 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 122.446 -0.443 . . . . 71.5 110.488 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.562 ' N ' ' HD3' ' A' ' 90' ' ' LYS . 66.6 mt -121.2 132.34 70.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 120.883 0.373 . . . . 62.530000000000001 111.463 -178.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.86 93.51 2.66 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.899 0.38 . . . . 71.129999999999995 111.454 177.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.564 HD22 HD13 ' A' ' 58' ' ' ILE . 63.4 mt -51.99 -49.58 63.02 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.024 0.75 . . . . 73.340000000000003 113.024 -176.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -49.87 -44.52 49.82 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 121.256 0.55 . . . . 75.329999999999998 111.829 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -76.29 -34.25 59.08 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.718 -0.673 . . . . 73.310000000000002 112.367 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.517 ' HH ' ' HB2' ' A' ' 84' ' ' GLU . 78.8 m-85 -112.28 14.63 20.51 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.273 0.471 . . . . 73.040000000000006 112.273 -172.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 61.9 tttp -65.02 130.05 41.94 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.095 0.474 . . . . 74.530000000000001 111.943 -177.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 19.7 t90 -62.51 113.73 3.12 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.979 -0.555 . . . . 73.230000000000004 111.195 175.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -113.33 92.64 23.41 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 116.4 -0.364 . . . . 74.109999999999999 110.524 176.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo . . . . . 0 C--N 1.354 0.855 0 C-N-CA 122.731 2.288 . . . . 74.209999999999994 112.938 -179.0 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 . . . . . 0 CA--C 1.542 0.64 0 N-CA-C 112.043 0.386 . . . . 74.209999999999994 112.043 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 62.3 mm-40 -53.61 -32.39 50.93 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.618 0.599 . . . . 73.510000000000005 112.618 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.406 ' O ' HG12 ' A' ' 8' ' ' ILE . 73.0 t80 -55.61 -48.9 74.15 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.247 0.546 . . . . 73.400000000000006 109.993 173.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 72.2 mt -67.07 -46.91 72.89 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.523 -0.762 . . . . 74.310000000000002 111.162 178.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 85.3 t -52.38 -50.24 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.8 0.334 . . . . 75.129999999999995 111.847 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 26.3 mm-40 -63.71 -52.7 59.35 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.157 0.428 . . . . 75.430000000000007 112.157 -177.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.424 ' O ' HG13 ' A' ' 12' ' ' ILE . 31.6 pt -65.32 -45.67 92.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 O-C-N 122.315 -0.241 . . . . 73.319999999999993 111.647 -178.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.402 ' CD1' HG13 ' A' ' 8' ' ' ILE . 14.2 m-30 -61.1 -43.28 99.13 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.755 0.312 . . . . 74.209999999999994 111.069 178.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.74 -43.08 65.49 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.439 -0.346 . . . . 75.0 111.383 177.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.419 HG21 ' O ' ' A' ' 7' ' ' GLN . 61.4 t -64.36 -42.4 95.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 121.142 0.496 . . . . 73.340000000000003 111.182 177.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.5 ' HB ' HD11 ' A' ' 52' ' ' LEU . 73.7 mt -62.85 -32.59 56.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 116.016 -0.538 . . . . 72.430000000000007 112.086 -178.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 72.3 m-70 -60.58 -22.25 63.51 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.299 0.481 . . . . 75.150000000000006 112.299 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -77.31 -14.07 59.81 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.256 0.465 . . . . 75.030000000000001 112.256 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.511 HD13 HD12 ' A' ' 26' ' ' ILE . 51.4 mt -75.08 113.76 28.3 Favored Pre-proline 0 CA--C 1.542 0.662 0 O-C-N 122.455 -0.153 . . . . 74.310000000000002 111.122 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -69.89 175.23 8.49 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.016 2.477 . . . . 74.010000000000005 113.751 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -67.81 140.13 56.61 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.92 -0.582 . . . . 75.329999999999998 111.768 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.76 17.25 71.04 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.188 -0.529 . . . . 70.230000000000004 113.378 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -118.3 141.18 48.79 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.688 0.28 . . . . 75.109999999999999 110.579 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.9 m -122.52 146.47 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.433 0.635 . . . . 65.140000000000001 112.284 -177.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.4 t -134.51 178.28 7.11 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.692 -0.685 . . . . 73.349999999999994 110.217 175.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 72.7 p -115.05 150.57 35.69 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.079 0.466 . . . . 70.25 111.835 -177.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -51.8 -36.6 48.41 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.086 -0.506 . . . . 75.010000000000005 112.163 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.62 -51.0 60.47 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 121.014 -0.612 . . . . 71.010000000000005 113.039 178.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -55.65 -48.14 75.49 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.0 0.429 . . . . 73.109999999999999 111.135 179.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.511 HD12 HD13 ' A' ' 15' ' ' ILE . 49.9 mm -61.42 -54.17 38.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 116.115 -0.493 . . . . 72.109999999999999 111.746 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.56 -48.66 78.72 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.227 0.454 . . . . 75.219999999999999 112.227 -178.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -60.24 -43.1 96.38 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.677 0.275 . . . . 74.230000000000004 111.589 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 77.7 mtm -73.35 -21.78 60.46 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 111.901 0.334 . . . . 75.219999999999999 111.901 178.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.58 -28.41 33.82 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.961 0.41 . . . . 73.030000000000001 111.186 174.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.94 29.09 5.06 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.298 -0.477 . . . . 74.340000000000003 113.468 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -134.43 79.93 53.13 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-O 120.893 0.378 . . . . 74.540000000000006 111.169 178.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.01 126.89 14.38 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.364 2.043 . . . . 74.319999999999993 112.614 -178.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.38 -22.85 36.47 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.175 -0.535 . . . . 73.140000000000001 113.274 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -78.61 12.19 2.17 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.36 0.504 . . . . 74.200000000000003 112.36 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.05 -44.37 61.09 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.021 0.438 . . . . 73.319999999999993 111.777 177.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 30.7 ptt-85 -58.37 -39.66 80.18 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 116.24 -0.436 . . . . 74.400000000000006 111.922 177.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -70.77 -34.53 71.91 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.662 0.268 . . . . 64.340000000000003 111.015 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.5 t -57.94 -43.39 84.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 CA-C-O 121.13 0.49 . . . . 74.230000000000004 110.267 172.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.47 -38.65 95.17 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-N 115.838 -0.619 . . . . 62.240000000000002 112.905 175.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -62.17 -47.27 85.25 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.982 0.42 . . . . 71.439999999999998 110.873 175.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.93 -45.65 89.88 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.017 -0.538 . . . . 72.540000000000006 111.668 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.562 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 58.2 mt -68.64 -38.49 80.53 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.908 0.385 . . . . 74.530000000000001 111.352 178.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.7 -15.76 66.97 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.268 -0.491 . . . . 70.209999999999994 113.081 176.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -76.6 -23.11 53.43 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.174 0.511 . . . . 74.349999999999994 110.52 175.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 82.6 mt -81.27 143.84 52.91 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 115.956 -0.566 . . . . 72.129999999999995 111.966 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -86.52 -176.7 2.11 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.708 2.272 . . . . 71.409999999999997 112.587 174.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.06 -23.58 64.06 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 122.131 -0.356 . . . . 74.040000000000006 111.937 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -90.02 39.39 3.11 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.534 -0.365 . . . . 74.230000000000004 113.43 177.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.0 t -93.03 140.08 29.85 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 122.437 -0.449 . . . . 73.140000000000001 111.404 177.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -72.42 -42.28 65.25 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.227 0.537 . . . . 75.230000000000004 110.29 175.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.5 HD11 ' HB ' ' A' ' 12' ' ' ILE . 33.3 tp -67.01 118.79 58.89 Favored Pre-proline 0 CA--C 1.535 0.404 0 CA-C-N 115.616 -0.72 . . . . 71.200000000000003 110.707 173.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.69 94.64 0.53 Allowed 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 121.392 1.394 . . . . 64.030000000000001 111.972 177.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.562 ' HB2' ' HB3' ' A' ' 43' ' ' LEU . 58.4 p-90 -84.96 -33.39 22.65 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.565 0.698 . . . . 74.310000000000002 111.0 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -59.91 -20.55 57.98 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.296 -0.865 . . . . 74.409999999999997 112.911 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.409 ' NH1' ' O ' ' A' ' 15' ' ' ILE . 95.8 mtt180 -79.98 -1.14 38.25 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.426 0.528 . . . . 75.120000000000005 112.426 -178.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.3 t -117.01 118.24 58.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 121.038 0.447 . . . . 74.530000000000001 111.744 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.527 HG21 HD13 ' A' ' 91' ' ' ILE . 35.6 pt -127.58 -169.87 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 116.347 -0.388 . . . . 74.540000000000006 111.521 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 32.1 p30 -84.44 163.64 19.35 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 120.94 0.4 . . . . 73.540000000000006 111.857 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 69.2 m -66.02 -15.44 63.03 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.573 0.583 . . . . 65.200000000000003 112.573 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -77.32 -12.59 59.97 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.741 0.305 . . . . 75.439999999999998 111.473 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.26 37.08 12.94 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 121.225 -0.512 . . . . 74.099999999999994 112.621 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.656 ' HZ3' ' HB3' ' A' ' 63' ' ' LYS . 10.0 mtpm? -138.96 162.28 35.28 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.3 0.572 . . . . 74.120000000000005 111.91 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.492 HG22 ' OE1' ' A' ' 74' ' ' GLN . 70.7 mt -69.28 139.71 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 115.725 -0.67 . . . . 75.209999999999994 110.886 175.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 89.1 p -90.18 -50.37 6.03 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.155 0.503 . . . . 73.420000000000002 111.345 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 83.9 mt -64.08 142.92 58.24 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.816 -0.629 . . . . 73.420000000000002 111.951 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -118.06 171.59 7.99 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.004 0.431 . . . . 75.120000000000005 111.234 177.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.78 -138.96 20.9 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.884 -0.674 . . . . 51.340000000000003 112.33 -176.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -74.97 -26.08 59.32 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.086 0.47 . . . . 73.150000000000006 111.474 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.65 -28.04 69.63 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.914 0.388 . . . . 74.129999999999995 111.284 176.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.1 tt -63.35 -60.97 2.68 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.273 -0.421 . . . . 63.420000000000002 110.625 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -64.15 -28.49 69.8 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 122.324 -0.235 . . . . 61.039999999999999 111.234 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -58.53 -53.74 54.88 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.902 0.382 . . . . 74.040000000000006 111.534 176.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.492 ' OE1' HG22 ' A' ' 64' ' ' ILE . 53.9 tt0 -59.38 -40.63 87.16 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.974 0.416 . . . . 75.310000000000002 110.884 177.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -60.13 -53.86 52.71 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.177 -0.465 . . . . 74.400000000000006 112.075 177.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -53.55 -42.46 67.52 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.15 0.5 . . . . 63.310000000000002 111.821 -178.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -59.61 -48.71 80.6 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.024 -0.534 . . . . 75.120000000000005 111.597 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.486 HD23 HD11 ' A' ' 83' ' ' ILE . 89.8 mt -67.69 -43.23 80.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.175 -0.466 . . . . 75.430000000000007 111.581 -177.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -57.03 -42.18 79.94 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.942 0.401 . . . . 64.329999999999998 110.861 175.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.34 -33.97 71.79 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.271 -0.422 . . . . 71.349999999999994 111.414 176.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -86.94 5.74 35.62 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.808 0.337 . . . . 74.209999999999994 111.678 178.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.01 30.89 16.06 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 114.238 0.455 . . . . 63.020000000000003 114.238 174.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.486 HD11 HD23 ' A' ' 78' ' ' LEU . 69.4 mt -104.43 124.77 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 117.129 0.464 . . . . 74.310000000000002 111.723 178.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.8 103.18 4.26 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.503 0.668 . . . . 73.510000000000005 111.601 177.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.2 t -95.78 117.13 39.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.309 -0.405 . . . . 75.420000000000002 111.099 178.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.565 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 41.4 t -67.87 151.15 47.61 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.938 0.399 . . . . 75.219999999999999 112.056 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -40.16 -56.55 1.89 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.322 1.231 . . . . 74.209999999999994 114.322 -171.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.406 ' CD1' ' HB2' ' A' ' 90' ' ' LYS . 2.8 pp -80.15 22.92 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 N-CA-C 112.961 0.726 . . . . 71.319999999999993 112.961 -174.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.06 46.97 11.99 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.17 -0.538 . . . . 74.329999999999998 112.925 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.565 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 1.4 tmtp? -116.74 133.15 56.36 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.91 0.386 . . . . 73.530000000000001 110.765 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.527 HD13 HG21 ' A' ' 58' ' ' ILE . 60.2 mt -121.29 142.4 37.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 120.978 0.418 . . . . 74.209999999999994 111.356 -176.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.58 94.87 4.42 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.98 0.419 . . . . 72.200000000000003 112.039 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.613 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 39.3 mt -63.0 -13.31 33.64 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 116.077 -0.51 . . . . 73.420000000000002 112.334 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -90.27 -48.76 6.94 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.076 0.465 . . . . 75.409999999999997 111.59 175.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.99 -22.65 65.9 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.768 0.655 . . . . 73.409999999999997 112.768 -175.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -128.28 15.11 6.69 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.293 0.479 . . . . 53.310000000000002 112.293 -176.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.613 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 85.0 tttt -56.29 128.98 38.44 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.478 0.547 . . . . 73.319999999999993 112.478 -175.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 16.5 t90 -57.3 114.87 2.37 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.105 -0.498 . . . . 75.340000000000003 111.351 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -105.07 96.42 11.05 Favored Pre-proline 0 CA--C 1.543 0.694 0 CA-C-N 116.209 -0.45 . . . . 74.420000000000002 110.217 174.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo . . . . . 0 CA--C 1.54 0.814 0 C-N-CA 123.16 2.574 . . . . 71.230000000000004 113.98 -178.715 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.47 0.532 0 N-CA-C 112.483 0.549 . . . . 60.350000000000001 112.483 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -57.87 -28.12 63.87 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.814 0.34 . . . . 74.129999999999995 111.149 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -57.15 -50.67 72.09 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.0 0.429 . . . . 72.319999999999993 110.651 173.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 76.9 mt -64.57 -44.7 89.88 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.857 -0.61 . . . . 74.420000000000002 110.902 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.0 t -57.1 -49.48 79.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 116.113 -0.494 . . . . 64.030000000000001 111.648 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.423 ' O ' HG21 ' A' ' 11' ' ' VAL . 32.3 mm-40 -62.65 -52.7 62.31 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.527 0.566 . . . . 73.510000000000005 112.527 -178.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.494 HD12 HG11 ' A' ' 39' ' ' VAL . 25.3 pt -60.73 -44.2 96.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 111.757 0.28 . . . . 75.430000000000007 111.757 -177.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.9 m-30 -63.16 -43.61 97.8 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.175 0.512 . . . . 74.530000000000001 110.797 177.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.91 -30.38 61.51 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.007 -0.542 . . . . 62.119999999999997 111.959 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.423 HG21 ' O ' ' A' ' 7' ' ' GLN . 59.4 t -75.87 -41.77 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 121.017 0.437 . . . . 72.239999999999995 111.459 176.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 8' ' ' ILE . 71.2 mt -57.22 -34.93 46.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 112.214 0.45 . . . . 72.109999999999999 112.214 -177.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -59.2 -9.41 2.12 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 113.658 0.984 . . . . 75.030000000000001 113.658 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -92.9 -2.36 55.91 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 112.563 0.579 . . . . 72.239999999999995 112.563 178.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 50.1 mt -84.49 119.03 72.49 Favored Pre-proline 0 CA--C 1.543 0.71 0 O-C-N 122.331 -0.231 . . . . 53.240000000000002 111.188 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -77.94 171.1 17.8 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.392 2.728 . . . . 73.5 113.498 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -67.81 133.84 49.91 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.25 0.548 . . . . 72.219999999999999 111.885 -178.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.38 7.21 82.94 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 116.09 -0.505 . . . . 71.129999999999995 113.439 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -123.77 145.52 48.97 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.941 0.4 . . . . 72.010000000000005 111.119 178.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.406 HG11 ' HA ' ' A' ' 56' ' ' ARG . 34.2 m -133.2 154.99 40.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-O 120.979 0.419 . . . . 74.010000000000005 111.341 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 92.1 p -133.56 170.68 15.17 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.094 0.473 . . . . 75.109999999999999 111.036 177.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.2 p -98.72 152.31 19.81 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.102 0.477 . . . . 73.420000000000002 111.82 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -55.06 -33.5 62.78 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.145 -0.48 . . . . 75.239999999999995 112.139 178.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -60.68 -38.18 94.7 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 120.988 -0.625 . . . . 73.109999999999999 112.772 177.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.421 ' O ' ' HG3' ' A' ' 29' ' ' MET . 42.2 mt-10 -71.2 -51.32 25.42 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.852 0.358 . . . . 73.519999999999996 111.309 178.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.2 mm -58.29 -49.83 80.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-N 116.338 -0.392 . . . . 74.409999999999997 111.827 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.58 -41.6 90.59 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.848 0.356 . . . . 72.340000000000003 111.596 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.574 ' HZ3' ' HB2' ' A' ' 28' ' ' LYS . 4.6 ttmp? -60.01 -47.59 85.2 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.952 0.406 . . . . 75.120000000000005 111.03 178.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.421 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 62.0 mtt -67.22 -29.96 69.75 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.151 -0.477 . . . . 73.409999999999997 111.442 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.67 -20.49 53.63 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.131 0.419 . . . . 63.210000000000001 112.131 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.89 28.35 10.19 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.204 -0.522 . . . . 55.520000000000003 113.455 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -130.9 78.89 72.71 Favored Pre-proline 0 N--CA 1.47 0.552 0 O-C-N 122.48 -0.424 . . . . 72.239999999999995 110.89 177.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -66.71 115.08 3.38 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.666 2.244 . . . . 72.530000000000001 113.073 -176.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.93 -15.58 40.26 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.029 -0.605 . . . . 52.200000000000003 113.624 178.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.416 ' O ' HG23 ' A' ' 39' ' ' VAL . 34.0 m-85 -81.35 18.09 1.21 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.649 0.611 . . . . 62.119999999999997 112.649 -178.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.86 -54.59 18.5 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.31 0.485 . . . . 74.409999999999997 112.31 -178.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.438 ' O ' ' HG3' ' A' ' 41' ' ' LYS . 33.1 ttm180 -57.74 -38.81 75.98 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.026 0.441 . . . . 75.120000000000005 111.614 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.604 ' HA ' ' HE3' ' A' ' 41' ' ' LYS . 81.6 m-70 -68.39 -32.5 72.61 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.282 -0.417 . . . . 73.310000000000002 111.704 -177.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.494 HG11 HD12 ' A' ' 8' ' ' ILE . 56.9 t -60.57 -40.91 85.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 121.156 0.503 . . . . 64.219999999999999 109.886 171.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.82 -44.94 95.45 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 115.947 -0.569 . . . . 55.299999999999997 112.804 176.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.604 ' HE3' ' HA ' ' A' ' 38' ' ' HIS . 8.5 mtmp? -63.04 -22.23 66.71 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.992 0.425 . . . . 74.540000000000006 111.3 178.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.33 -45.88 17.06 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.432 -0.349 . . . . 73.430000000000007 111.442 176.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 66.7 mt -65.51 -35.15 80.03 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 111.976 0.362 . . . . 74.329999999999998 111.976 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.4 -20.81 38.62 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 121.248 -0.501 . . . . 75.439999999999998 113.834 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -81.83 -21.19 37.75 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.804 0.335 . . . . 72.310000000000002 111.832 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 78.7 mt -67.56 142.64 96.36 Favored Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 112.018 0.377 . . . . 73.140000000000001 112.018 -178.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.72 -175.73 2.83 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.681 2.254 . . . . 74.530000000000001 113.202 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -76.19 -38.45 56.55 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.989 -0.551 . . . . 75.219999999999999 110.635 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -95.72 57.69 1.58 Allowed Glycine 0 CA--C 1.528 0.852 0 CA-C-N 116.018 -0.537 . . . . 72.329999999999998 113.729 -178.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.2 t -102.37 159.29 15.55 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 122.32 -0.518 . . . . 63.219999999999999 111.303 173.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -85.85 -15.58 41.42 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.221 0.534 . . . . 74.040000000000006 110.527 176.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.448 HD13 ' HD2' ' A' ' 53' ' ' PRO . 55.9 tp -93.35 116.3 66.28 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 115.908 -0.587 . . . . 73.109999999999999 110.829 178.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.448 ' HD2' HD13 ' A' ' 52' ' ' LEU . 61.6 Cg_endo -74.04 94.4 0.89 Allowed 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 121.251 1.301 . . . . 74.219999999999999 112.299 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 54.9 p-90 -80.11 -30.33 39.11 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.372 0.606 . . . . 72.430000000000007 111.318 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -59.93 -22.63 62.68 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.617 -0.72 . . . . 74.340000000000003 112.876 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.406 ' HA ' HG11 ' A' ' 20' ' ' VAL . 97.8 mtt180 -79.61 -0.94 35.8 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.584 0.587 . . . . 73.430000000000007 112.584 -177.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.9 t -118.63 109.59 27.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.062 0.458 . . . . 65.319999999999993 110.892 178.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.525 HD12 HD23 ' A' ' 93' ' ' LEU . 32.9 pt -114.98 -172.48 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 116.221 -0.445 . . . . 75.049999999999997 111.983 -176.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 32.1 p30 -81.32 165.71 21.14 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.207 0.527 . . . . 73.530000000000001 112.08 -176.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 80.4 p -70.61 -2.73 15.23 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.809 0.67 . . . . 75.519999999999996 112.809 -175.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -94.16 -9.37 36.63 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.042 0.386 . . . . 74.450000000000003 112.042 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.3 44.33 13.71 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 120.667 -0.778 . . . . 64.310000000000002 112.393 -176.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -133.46 172.29 12.91 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 122.753 0.421 . . . . 73.040000000000006 110.588 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.543 HD12 HG13 ' A' ' 85' ' ' VAL . 66.7 mt -67.7 118.73 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 109.938 -0.393 . . . . 74.299999999999997 109.938 173.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.6 p -71.07 -33.58 70.37 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.414 0.524 . . . . 74.129999999999995 112.414 -172.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.504 HD13 ' HB3' ' A' ' 70' ' ' ASP . 85.7 mt -79.85 -174.61 4.48 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.119 0.485 . . . . 75.150000000000006 111.755 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -147.25 161.7 40.42 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.884 0.373 . . . . 75.0 111.758 -176.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 60.45 -134.94 49.98 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.173 -0.537 . . . . 73.439999999999998 112.969 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 49.9 mtp180 -62.51 -33.5 75.0 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.112 0.482 . . . . 75.25 110.95 178.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.504 ' HB3' HD13 ' A' ' 66' ' ' LEU . 7.8 m-20 -62.38 -30.27 71.07 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.218 -0.446 . . . . 73.129999999999995 111.458 176.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.443 ' HG ' HG23 ' A' ' 64' ' ' ILE . 10.2 tt -59.66 -54.98 40.16 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.011 0.434 . . . . 74.340000000000003 110.662 177.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -71.58 -21.78 61.82 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 111.812 0.301 . . . . 72.420000000000002 111.812 177.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.494 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 15.0 ttp180 -66.55 -50.35 63.43 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.385 0.612 . . . . 74.400000000000006 110.408 174.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -63.38 -42.18 98.82 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.896 -0.593 . . . . 73.409999999999997 110.597 175.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.403 ' HG3' HG13 ' A' ' 85' ' ' VAL . 33.0 ttpt -60.81 -50.15 74.63 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.023 -0.535 . . . . 74.420000000000002 111.941 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 19.9 pt20 -60.29 -38.0 82.25 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.964 0.411 . . . . 54.420000000000002 111.354 -177.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -63.93 -34.01 77.01 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 120.887 0.375 . . . . 74.549999999999997 111.129 174.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.9 mt -78.56 -30.05 46.63 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.282 -0.417 . . . . 73.099999999999994 111.98 178.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -68.82 -28.06 66.41 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 121.964 -0.46 . . . . 70.329999999999998 110.408 174.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.41 -23.79 65.59 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.262 0.553 . . . . 73.019999999999996 110.798 171.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -81.94 -9.04 59.7 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.818 -0.628 . . . . 70.209999999999994 111.319 175.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.61 21.87 55.07 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.39 -0.433 . . . . 72.099999999999994 112.891 -177.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 64.6 mt -89.63 127.79 42.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 121.023 0.439 . . . . 75.010000000000005 112.102 -177.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -78.5 97.2 5.64 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.054 0.454 . . . . 73.25 111.012 176.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.543 HG13 HD12 ' A' ' 64' ' ' ILE . 41.2 t -94.89 119.58 43.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.714 0.292 . . . . 73.049999999999997 110.811 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.534 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 49.7 m -61.14 141.31 57.55 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 110.388 -0.227 . . . . 62.240000000000002 110.388 177.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -54.36 -32.96 58.1 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 113.379 0.881 . . . . 74.109999999999999 113.379 -170.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.8 pp -75.22 -2.83 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 112.244 0.461 . . . . 73.329999999999998 112.244 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.28 43.46 2.77 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 116.212 -0.449 . . . . 60.439999999999998 113.966 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.534 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 61.3 tttm -115.35 131.14 57.02 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 117.62 0.71 . . . . 70.109999999999999 112.018 -178.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.466 HD13 HG23 ' A' ' 58' ' ' ILE . 56.6 mt -119.12 115.58 48.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.976 -0.556 . . . . 74.219999999999999 110.89 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.31 93.61 0.23 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.475 0.546 . . . . 72.129999999999995 112.475 -177.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.568 ' O ' ' HG3' ' A' ' 97' ' ' LYS . 76.1 mt -56.33 -46.31 79.97 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.609 -0.269 . . . . 74.129999999999995 111.255 177.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 63.8 mtp180 -51.05 -19.93 1.24 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.415 0.524 . . . . 73.109999999999999 112.415 -177.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -106.22 -36.7 6.8 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 111.922 0.341 . . . . 74.439999999999998 111.922 176.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -105.49 13.76 29.63 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.636 0.976 . . . . 74.299999999999997 113.636 -172.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.568 ' HG3' ' O ' ' A' ' 93' ' ' LEU . 41.8 mtpt -56.14 138.77 49.2 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.553 0.575 . . . . 72.409999999999997 112.553 178.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 14.9 t90 -69.14 115.02 7.94 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.007 -0.542 . . . . 74.329999999999998 110.692 173.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -102.74 96.05 7.11 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-N 116.075 -0.511 . . . . 74.230000000000004 111.166 176.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo . . . . . 0 CA--C 1.542 0.904 0 C-N-CA 122.628 2.219 . . . . 70.5 112.762 175.74 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.463 ' O ' HG22 ' A' ' 6' ' ' VAL . 12.2 t70 . . . . . 0 CA--C 1.544 0.74 0 N-CA-C 112.09 0.404 . . . . 74.329999999999998 112.09 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -56.81 -40.12 75.42 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.632 0.604 . . . . 73.150000000000006 112.632 -178.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -58.1 -47.79 82.15 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.18 0.514 . . . . 72.200000000000003 110.477 177.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 85.9 mt -61.07 -47.14 87.71 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.724 -0.671 . . . . 73.239999999999995 110.801 177.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.463 HG22 ' O ' ' A' ' 2' ' ' ASP . 94.1 t -53.91 -50.13 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.173 -0.467 . . . . 74.239999999999995 111.648 178.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.441 ' O ' HG22 ' A' ' 11' ' ' VAL . 27.8 mm-40 -64.67 -50.21 67.92 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.375 0.509 . . . . 73.019999999999996 112.375 -176.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.464 ' O ' HG13 ' A' ' 12' ' ' ILE . 38.5 pt -64.93 -44.15 96.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 121.019 -0.272 . . . . 72.099999999999994 111.554 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.8 m-30 -65.19 -42.51 93.52 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.813 0.339 . . . . 75.099999999999994 111.133 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.85 -40.1 69.29 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.454 -0.339 . . . . 73.230000000000004 111.67 178.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 7' ' ' GLN . 86.9 t -67.59 -41.63 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 120.917 0.389 . . . . 65.409999999999997 111.297 178.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.537 ' HB ' HD13 ' A' ' 52' ' ' LEU . 80.4 mt -59.17 -32.25 47.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 116.405 -0.361 . . . . 73.420000000000002 111.819 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -61.15 -18.51 58.46 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.131 0.419 . . . . 75.219999999999999 112.131 176.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -83.3 -9.17 59.25 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.531 0.567 . . . . 73.310000000000002 112.531 178.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.476 HD13 HD12 ' A' ' 26' ' ' ILE . 54.8 mt -74.46 116.27 51.46 Favored Pre-proline 0 CA--C 1.542 0.669 0 O-C-N 122.203 -0.311 . . . . 74.420000000000002 111.055 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -64.29 157.55 53.58 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.114 2.543 . . . . 74.120000000000005 113.514 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -65.54 120.77 13.5 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.21 -0.45 . . . . 74.299999999999997 111.495 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.34 17.07 56.27 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 120.988 -0.625 . . . . 73.099999999999994 113.22 -176.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -121.11 149.93 42.0 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 122.621 -0.341 . . . . 73.230000000000004 111.22 175.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.6 m -128.08 145.38 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 121.535 0.683 . . . . 75.310000000000002 111.795 -178.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.537 ' HG ' HD12 ' A' ' 26' ' ' ILE . 94.8 p -128.98 177.82 6.84 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.871 -0.604 . . . . 73.310000000000002 110.555 175.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.4 p -111.6 154.77 24.37 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.811 0.338 . . . . 70.120000000000005 111.376 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.408 ' HB2' ' HB3' ' A' ' 36' ' ' ALA . 74.8 m-85 -54.72 -40.12 68.92 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.852 0.358 . . . . 75.120000000000005 111.446 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -57.73 -44.7 94.02 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.268 -0.491 . . . . 73.310000000000002 113.043 177.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.434 ' O ' ' HG3' ' A' ' 29' ' ' MET . 49.8 mt-10 -63.27 -54.0 44.05 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.731 0.3 . . . . 73.329999999999998 111.181 178.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.537 HD12 ' HG ' ' A' ' 21' ' ' SER . 46.4 mm -54.3 -53.1 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 120.818 0.342 . . . . 74.209999999999994 111.72 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.99 -46.72 82.06 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.422 -0.354 . . . . 64.340000000000003 111.674 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -60.99 -42.95 99.41 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.781 0.324 . . . . 73.310000000000002 111.584 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.434 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 64.6 mtt -68.39 -30.67 69.64 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.043 0.449 . . . . 75.109999999999999 111.236 178.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.06 -19.65 59.9 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.197 -0.456 . . . . 71.400000000000006 111.914 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.24 15.18 24.21 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.137 -0.554 . . . . 71.230000000000004 113.014 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.424 ' HB3' ' CD1' ' A' ' 35' ' ' TYR . 69.5 m-85 -128.37 63.94 65.6 Favored Pre-proline 0 CA--C 1.548 0.873 0 O-C-N 122.55 -0.382 . . . . 70.030000000000001 111.54 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -61.72 110.94 1.05 Allowed 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.484 2.123 . . . . 71.299999999999997 112.568 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 123.64 -24.76 6.37 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 121.238 -0.506 . . . . 72.340000000000003 112.922 -177.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.451 ' O ' HG23 ' A' ' 39' ' ' VAL . 58.2 m-85 -79.96 30.54 0.26 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.242 0.46 . . . . 74.310000000000002 112.242 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.408 ' HB3' ' HB2' ' A' ' 23' ' ' TYR . . . -55.24 -64.88 0.7 Allowed 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.452 0.538 . . . . 74.109999999999999 112.452 -177.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -54.7 -31.69 58.41 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.361 0.504 . . . . 74.420000000000002 112.361 177.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 78.1 m-70 -65.63 -40.27 92.37 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.749 0.309 . . . . 71.129999999999995 111.11 178.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 35' ' ' TYR . 67.9 t -57.14 -45.18 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.097 0.475 . . . . 72.140000000000001 110.243 173.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -57.8 -42.98 94.81 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 116.037 -0.529 . . . . 74.129999999999995 112.714 175.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.595 ' HB3' ' HZ3' ' A' ' 41' ' ' LYS . 9.5 mtpm? -62.15 -33.02 73.71 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.071 0.462 . . . . 75.230000000000004 111.154 176.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.0 -42.78 66.03 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.202 -0.454 . . . . 61.140000000000001 111.449 177.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 39' ' ' VAL . 90.0 mt -62.38 -33.32 74.51 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.907 0.384 . . . . 74.439999999999998 111.483 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.62 -12.39 46.63 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 121.405 -0.426 . . . . 74.310000000000002 113.458 176.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -85.8 -15.81 40.82 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.135 0.493 . . . . 52.399999999999999 110.953 177.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.476 HD13 HD22 ' A' ' 52' ' ' LEU . 90.8 mt -81.68 148.12 60.9 Favored Pre-proline 0 N--CA 1.47 0.563 0 N-CA-C 112.42 0.526 . . . . 74.129999999999995 112.42 -177.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.52 163.2 32.33 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.39 2.06 . . . . 70.439999999999998 112.125 173.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.525 ' HG2' ' HE ' ' A' ' 73' ' ' ARG . 42.2 mt-10 -57.02 -52.88 63.5 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 111.984 0.364 . . . . 52.0 111.984 -178.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -93.62 54.61 2.34 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.039 -0.601 . . . . 73.340000000000003 113.294 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.7 t -79.6 156.39 27.7 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.866 0.365 . . . . 73.409999999999997 111.556 178.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -67.12 -26.54 66.74 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.389 0.614 . . . . 63.340000000000003 110.313 174.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.537 HD13 ' HB ' ' A' ' 12' ' ' ILE . 55.3 tp -92.78 117.75 67.68 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 115.5 -0.773 . . . . 74.129999999999995 110.802 176.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.535 ' HD2' HD12 ' A' ' 52' ' ' LEU . 56.8 Cg_endo -71.77 96.58 0.77 Allowed 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 121.639 1.56 . . . . 72.310000000000002 112.47 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 60.9 p-90 -80.52 -25.25 38.81 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.34 0.591 . . . . 72.239999999999995 112.153 -178.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -68.65 -12.71 61.71 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.625 0.972 . . . . 75.239999999999995 113.625 -174.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -87.06 1.55 52.56 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.6 0.593 . . . . 75.219999999999999 112.6 -175.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.8 t -109.75 108.83 26.35 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 CA-C-O 121.266 0.555 . . . . 73.129999999999995 111.659 -178.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.509 HD11 HD22 ' A' ' 93' ' ' LEU . 18.2 pt -113.6 -170.81 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-N 116.093 -0.503 . . . . 75.420000000000002 111.964 -178.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.7 p30 -90.19 175.41 7.15 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.022 0.439 . . . . 73.329999999999998 111.991 -177.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 87.6 p -64.26 -22.58 67.0 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.376 0.509 . . . . 74.140000000000001 112.376 -176.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -82.27 -12.76 57.84 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.851 0.357 . . . . 75.0 111.546 -179.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.64 30.6 20.91 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.163 -0.541 . . . . 54.350000000000001 112.804 -177.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.422 ' HE3' HD11 ' A' ' 88' ' ' ILE . 56.6 mtpt -125.6 163.28 23.09 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.11 0.481 . . . . 75.430000000000007 111.864 -177.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 52.7 mt -75.95 130.38 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 116.09 -0.504 . . . . 75.510000000000005 111.685 -177.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.3 m -80.26 -30.5 38.42 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.393 -0.367 . . . . 74.230000000000004 111.756 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.415 HD11 ' HB2' ' A' ' 74' ' ' GLN . 75.3 mt -72.1 151.99 42.66 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.123 0.487 . . . . 72.409999999999997 111.564 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -129.33 153.32 47.96 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.191 -0.458 . . . . 73.340000000000003 111.89 -174.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 62.27 -129.06 42.7 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 121.283 -0.484 . . . . 71.200000000000003 113.415 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -66.03 -30.14 70.62 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.816 0.341 . . . . 74.540000000000006 111.781 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.524 ' HA ' ' HD3' ' A' ' 73' ' ' ARG . 9.6 m-20 -68.92 -31.03 69.63 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.888 0.375 . . . . 74.209999999999994 111.237 177.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.7 tt -61.32 -42.01 97.97 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 109.524 -0.547 . . . . 61.149999999999999 109.524 173.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -59.3 -43.5 92.6 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.984 -0.553 . . . . 74.439999999999998 111.173 176.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.525 ' HE ' ' HG2' ' A' ' 48' ' ' GLU . 79.9 mtp180 -50.62 -56.14 13.15 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.332 0.587 . . . . 74.129999999999995 111.338 176.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.415 ' HB2' HD11 ' A' ' 66' ' ' LEU . 43.7 tt0 -65.87 -42.63 90.11 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.069 -0.514 . . . . 74.129999999999995 111.065 -177.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -61.61 -50.63 71.79 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.14 0.422 . . . . 73.510000000000005 112.14 -178.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -58.46 -39.05 78.84 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.757 0.313 . . . . 73.019999999999996 111.294 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -62.92 -43.75 97.93 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 120.809 0.338 . . . . 75.030000000000001 111.36 176.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 75.8 mt -66.42 -48.78 68.94 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.291 -0.413 . . . . 74.519999999999996 111.683 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -54.55 -31.48 56.58 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.116 0.484 . . . . 55.240000000000002 111.327 176.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.46 -26.76 64.74 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.636 0.606 . . . . 63.409999999999997 112.636 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -102.44 9.03 39.92 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.417 0.525 . . . . 74.140000000000001 112.417 -176.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.92 41.98 7.37 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 120.938 -0.648 . . . . 75.400000000000006 113.644 176.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 68.2 mt -117.21 128.5 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 O-C-N 122.648 -0.325 . . . . 72.129999999999995 111.052 177.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -78.64 103.36 8.53 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.732 0.301 . . . . 72.230000000000004 111.424 177.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.9 t -90.62 105.21 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 120.826 0.346 . . . . 75.329999999999998 110.985 175.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.509 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 50.0 m -56.61 144.35 32.32 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.475 -0.33 . . . . 43.25 110.997 177.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.486 ' HG3' ' N ' ' A' ' 88' ' ' ILE . 12.3 pt-20 -43.2 -44.19 5.06 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 113.867 1.062 . . . . 70.099999999999994 113.867 -171.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.486 ' N ' ' HG3' ' A' ' 87' ' ' GLU . 2.6 pp -78.72 9.69 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 112.625 0.602 . . . . 73.299999999999997 112.625 -176.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.87 55.67 2.91 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 116.292 -0.413 . . . . 65.200000000000003 113.084 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.509 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 49.1 tttm -127.61 150.1 49.88 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.166 0.508 . . . . 73.140000000000001 112.256 177.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.504 HD12 HD12 ' A' ' 58' ' ' ILE . 50.2 mt -124.15 156.8 31.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-N 115.695 -0.684 . . . . 74.319999999999993 110.228 176.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.427 ' HB2' ' HB3' ' A' ' 95' ' ' LYS . . . -85.37 102.65 13.59 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.028 0.442 . . . . 74.239999999999995 111.796 178.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.644 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 40.2 mt -71.07 -8.32 52.55 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.241 0.83 . . . . 74.209999999999994 113.241 -177.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -97.58 -11.06 24.09 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.337 0.589 . . . . 73.319999999999993 111.015 174.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.427 ' HB3' ' HB2' ' A' ' 92' ' ' ALA . 27.8 tptp -106.31 -35.39 7.17 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.672 0.619 . . . . 70.030000000000001 112.672 -172.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -127.52 15.02 7.11 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.15 0.426 . . . . 74.150000000000006 112.15 -175.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.644 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 63.9 tttp -60.14 135.25 57.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.732 0.301 . . . . 70.120000000000005 111.727 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 17.7 t90 -65.6 96.86 0.28 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.024 0.44 . . . . 73.329999999999998 110.983 176.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -98.66 99.8 8.28 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 116.032 -0.531 . . . . 73.040000000000006 110.885 173.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo . . . . . 0 CA--C 1.544 0.979 0 C-N-CA 122.685 2.256 . . . . 75.109999999999999 112.969 176.387 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 . . . . . 0 CA--C 1.54 0.578 0 N-CA-C 112.579 0.585 . . . . 75.019999999999996 112.579 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 74.3 mm-40 -56.28 -27.83 56.63 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.472 -0.331 . . . . 74.349999999999994 111.569 176.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.434 ' O ' HG12 ' A' ' 8' ' ' ILE . 90.7 t80 -54.96 -52.22 63.72 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.211 0.529 . . . . 72.349999999999994 110.027 172.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 58.0 mt -65.56 -49.79 67.56 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.373 -0.831 . . . . 74.299999999999997 110.988 178.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 85.3 t -53.64 -50.99 47.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 116.119 -0.491 . . . . 73.540000000000006 111.979 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -62.37 -54.95 32.97 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.295 0.48 . . . . 75.510000000000005 112.295 -177.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.512 HD11 HG11 ' A' ' 39' ' ' VAL . 31.4 pt -61.43 -42.98 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 120.641 0.258 . . . . 63.210000000000001 111.693 -177.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.412 ' HA ' HD12 ' A' ' 12' ' ' ILE . 17.6 m-30 -62.58 -43.75 98.03 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.962 0.411 . . . . 65.319999999999993 111.265 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.85 -41.99 68.06 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.131 -0.486 . . . . 74.340000000000003 111.432 178.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 55.2 t -66.95 -36.51 77.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 121.047 0.451 . . . . 74.230000000000004 111.362 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 8' ' ' ILE . 83.3 mt -61.12 -36.01 69.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 116.306 -0.406 . . . . 74.420000000000002 112.054 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -60.06 -22.38 62.63 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 112.324 0.49 . . . . 73.329999999999998 112.324 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -78.73 -5.7 53.9 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 112.792 0.664 . . . . 71.120000000000005 112.792 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.426 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 58.9 mt -76.53 122.02 85.9 Favored Pre-proline 0 CA--C 1.545 0.783 0 O-C-N 122.243 -0.286 . . . . 74.25 111.324 178.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 15' ' ' ILE . 6.3 Cg_exo -75.28 151.28 38.11 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.861 2.374 . . . . 72.049999999999997 112.681 177.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -58.18 110.37 0.93 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.477 0.656 . . . . 74.409999999999997 111.721 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.428 ' H ' ' NH1' ' A' ' 56' ' ' ARG . . . 131.55 -30.17 3.32 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.568 -0.742 . . . . 71.150000000000006 112.387 178.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -93.81 159.83 15.02 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.438 0.637 . . . . 75.219999999999999 112.328 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.1 m -130.35 148.22 33.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 115.214 -0.903 . . . . 71.5 110.353 174.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 95.4 p -119.37 159.88 23.35 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.951 0.405 . . . . 73.099999999999994 110.996 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 72.0 p -102.79 148.92 25.01 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.731 0.3 . . . . 62.210000000000001 111.371 176.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.412 ' HB2' ' HB1' ' A' ' 36' ' ' ALA . 53.5 m-85 -50.76 -39.77 53.19 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 111.909 0.337 . . . . 74.099999999999994 111.909 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.75 -33.99 80.3 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 121.275 -0.488 . . . . 72.319999999999993 113.213 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.422 ' HG3' ' OG1' ' A' ' 22' ' ' THR . 47.1 mt-10 -74.12 -54.48 7.71 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.785 0.326 . . . . 51.43 111.258 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.7 mm -56.4 -53.46 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 116.215 -0.448 . . . . 74.010000000000005 111.386 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.403 ' HB1' HG22 ' A' ' 39' ' ' VAL . . . -57.64 -51.88 67.71 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.874 0.369 . . . . 72.209999999999994 111.717 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.633 ' HB2' ' HZ2' ' A' ' 28' ' ' LYS . 4.2 ttmp? -57.6 -48.76 78.5 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.883 0.373 . . . . 74.340000000000003 111.337 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 74.5 mtm -74.01 -8.3 55.6 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.173 0.434 . . . . 65.329999999999998 112.173 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.86 -9.27 26.67 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.892 0.377 . . . . 75.549999999999997 111.079 172.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.05 37.47 5.16 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 116.038 -0.528 . . . . 75.030000000000001 113.693 178.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -138.58 90.57 12.79 Favored Pre-proline 0 CA--C 1.542 0.639 0 O-C-N 122.564 -0.374 . . . . 72.109999999999999 111.268 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.59 127.86 9.88 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.478 2.118 . . . . 74.329999999999998 113.3 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.84 8.38 87.73 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 121.099 -0.572 . . . . 74.109999999999999 114.195 178.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -101.3 22.61 12.21 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 117.382 0.591 . . . . 74.129999999999995 111.974 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.412 ' HB1' ' HB2' ' A' ' 23' ' ' TYR . . . -56.47 -52.0 66.35 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.103 0.477 . . . . 72.310000000000002 111.855 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -55.96 -32.76 64.16 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.096 -0.502 . . . . 74.140000000000001 111.748 177.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.403 ' HA ' ' HD2' ' A' ' 41' ' ' LYS . 98.6 m-70 -74.79 -32.26 61.96 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.687 0.28 . . . . 73.230000000000004 111.463 -178.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.512 HG11 HD11 ' A' ' 8' ' ' ILE . 58.4 t -61.21 -40.31 85.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 121.138 0.494 . . . . 73.209999999999994 110.292 172.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.61 -37.81 94.0 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 121.133 -0.556 . . . . 72.319999999999993 112.484 173.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.403 ' HD2' ' HA ' ' A' ' 38' ' ' HIS . 66.1 mttm -61.27 -40.02 92.56 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.878 0.37 . . . . 64.430000000000007 111.006 174.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.48 -50.92 69.5 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.066 -0.515 . . . . 73.109999999999999 111.579 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.5 mt -63.42 -36.97 85.48 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.901 0.382 . . . . 74.400000000000006 111.309 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.98 -6.58 45.99 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 121.353 -0.451 . . . . 71.019999999999996 113.681 178.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -100.21 -6.5 25.99 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 120.98 0.419 . . . . 73.510000000000005 111.038 177.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 91.5 mt -79.52 152.23 75.32 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 112.542 0.571 . . . . 74.310000000000002 112.542 -176.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.516 ' HD2' ' HB2' ' A' ' 50' ' ' SER . 22.2 Cg_exo -64.04 148.31 91.51 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.644 2.229 . . . . 73.510000000000005 112.464 173.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -62.98 -12.17 23.88 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-O 121.08 0.466 . . . . 74.340000000000003 111.757 -178.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -135.97 47.71 0.96 Allowed Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.312 -0.47 . . . . 41.350000000000001 113.233 175.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.516 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 43.0 t -74.83 165.84 24.59 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.991 0.424 . . . . 73.5 112.071 176.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -74.02 -19.37 60.66 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.237 -0.438 . . . . 73.319999999999993 111.532 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.535 HD13 ' HD2' ' A' ' 53' ' ' PRO . 30.1 tp -89.45 126.4 58.45 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.281 -0.418 . . . . 75.049999999999997 111.144 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.535 ' HD2' HD13 ' A' ' 52' ' ' LEU . 60.1 Cg_endo -73.42 95.69 0.87 Allowed 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 121.379 1.386 . . . . 72.049999999999997 111.908 174.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 66.1 p-90 -80.5 -31.68 37.15 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.282 0.563 . . . . 72.430000000000007 111.187 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -60.5 -18.68 53.37 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.419 0.896 . . . . 72.0 113.419 -176.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.428 ' NH1' ' H ' ' A' ' 18' ' ' GLY . 90.1 mtt-85 -86.75 11.64 12.64 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.955 0.724 . . . . 72.319999999999993 112.955 -177.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.2 t -125.93 109.72 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-O 121.407 0.622 . . . . 72.230000000000004 111.742 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.497 HD13 HD13 ' A' ' 91' ' ' ILE . 18.9 pt -114.16 -174.56 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 CA-C-N 115.827 -0.624 . . . . 73.439999999999998 111.328 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 34.2 p30 -87.22 171.38 10.69 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.647 -0.658 . . . . 73.439999999999998 111.871 -177.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 71.1 p -65.07 -14.8 61.36 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 112.68 0.622 . . . . 63.020000000000003 112.68 -174.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -75.0 -30.19 61.09 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.127 0.489 . . . . 64.030000000000001 111.297 175.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.49 11.97 34.35 Favored Glycine 0 CA--C 1.521 0.467 0 CA-C-N 115.691 -0.686 . . . . 72.400000000000006 111.676 -170.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.47 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 97.7 mttt -103.22 155.71 18.24 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.338 0.59 . . . . 73.209999999999994 112.19 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 63.6 mt -73.21 129.02 36.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 115.748 -0.66 . . . . 73.010000000000005 110.527 174.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.5 t -67.87 -38.7 83.42 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 120.83 0.348 . . . . 70.400000000000006 111.798 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 84.4 mt -74.25 143.37 45.11 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.856 0.36 . . . . 73.450000000000003 111.169 178.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -125.37 161.72 26.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.132 0.492 . . . . 74.530000000000001 111.336 -177.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 77.54 -138.95 22.41 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.111 -0.566 . . . . 73.439999999999998 112.518 -176.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 68.9 mtm180 -61.36 -38.23 86.23 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.26 0.552 . . . . 72.219999999999999 111.515 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -61.73 -26.78 68.27 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 116.101 -0.5 . . . . 73.129999999999995 111.61 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.6 tt -65.7 -61.37 2.12 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.503 -0.317 . . . . 64.340000000000003 111.098 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.477 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 3.3 p30 -64.75 -24.5 67.58 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.785 0.326 . . . . 64.209999999999994 111.467 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -60.53 -52.45 65.13 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.974 0.416 . . . . 74.230000000000004 110.688 173.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -62.63 -38.93 92.15 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.25 0.547 . . . . 74.439999999999998 110.579 176.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.542 ' HG3' ' HB ' ' A' ' 85' ' ' VAL . 48.0 tttp -52.18 -56.38 14.99 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.601 -0.727 . . . . 73.409999999999997 111.729 174.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -61.88 -35.76 79.27 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 111.969 0.359 . . . . 73.019999999999996 111.969 -178.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -59.59 -45.33 92.22 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.02 0.438 . . . . 75.329999999999998 111.219 175.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.6 mt -71.79 -45.47 61.47 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.13 -0.486 . . . . 75.230000000000004 112.177 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.507 ' CD ' ' HZ2' ' A' ' 75' ' ' LYS . 47.6 mt-10 -68.7 -26.31 65.22 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 122.17 -0.331 . . . . 75.400000000000006 111.786 -178.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.77 -23.71 67.33 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.313 0.577 . . . . 52.310000000000002 110.966 172.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -87.42 -10.84 50.88 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.782 -0.644 . . . . 73.230000000000004 111.462 176.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 108.27 19.29 9.02 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 121.341 -0.457 . . . . 54.009999999999998 114.022 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 57.1 mt -99.98 159.19 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 O-C-N 122.187 -0.596 . . . . 73.019999999999996 111.498 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.422 ' HG3' ' HH ' ' A' ' 96' ' ' TYR . 42.5 mt-10 -105.52 117.71 34.72 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 122.209 -0.307 . . . . 71.420000000000002 110.988 177.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.542 ' HB ' ' HG3' ' A' ' 75' ' ' LYS . 39.2 t -119.94 114.22 43.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.793 0.33 . . . . 65.109999999999999 111.391 178.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.0 m -62.84 141.9 58.46 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 122.386 -0.196 . . . . 53.009999999999998 110.627 176.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -47.06 -42.08 17.99 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.626 0.973 . . . . 71.040000000000006 113.626 -172.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 pp -74.66 8.52 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 112.553 0.575 . . . . 75.400000000000006 112.553 -178.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.92 51.52 3.77 Favored Glycine 0 CA--C 1.524 0.594 0 CA-C-N 116.305 -0.407 . . . . 51.310000000000002 113.706 176.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -128.96 137.3 51.3 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.145 0.498 . . . . 75.230000000000004 111.641 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.497 HD13 HD13 ' A' ' 58' ' ' ILE . 52.0 mt -127.62 141.66 45.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 115.716 -0.675 . . . . 73.400000000000006 110.382 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.19 93.5 4.59 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 122.215 -0.303 . . . . 71.030000000000001 111.654 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.485 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 94.2 mt -55.42 -53.21 59.09 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.667 0.27 . . . . 73.450000000000003 111.56 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -51.37 -15.22 0.37 Allowed 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 113.264 0.838 . . . . 74.239999999999995 113.264 -177.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.5 ' HE3' ' CE2' ' A' ' 96' ' ' TYR . 38.1 ttpt -113.13 -26.64 8.35 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 121.562 -0.711 . . . . 74.430000000000007 112.511 177.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.5 ' CE2' ' HE3' ' A' ' 95' ' ' LYS . 85.4 m-85 -117.92 11.31 13.42 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.361 0.504 . . . . 70.219999999999999 112.361 -176.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 57.2 tttm -65.55 134.68 53.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.085 0.469 . . . . 72.439999999999998 111.733 -176.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 22.5 t90 -66.36 96.51 0.36 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.185 0.516 . . . . 72.219999999999999 111.517 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.421 ' OE1' ' NZ ' ' A' ' 97' ' ' LYS . 14.8 mm100 -105.73 93.68 7.73 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 115.804 -0.634 . . . . 75.510000000000005 110.608 173.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo . . . . . 0 CA--C 1.544 0.984 0 C-N-CA 122.839 2.359 . . . . 73.549999999999997 113.45 179.591 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 CA--C 1.541 0.599 0 N-CA-C 111.93 0.344 . . . . 63.219999999999999 111.93 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 52.8 tp60 -58.68 -31.45 68.21 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.887 0.375 . . . . 73.349999999999994 110.781 177.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -54.22 -50.27 67.54 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.256 -0.429 . . . . 75.299999999999997 110.688 171.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 76.7 mt -62.16 -46.54 88.51 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.747 -0.66 . . . . 75.450000000000003 111.24 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.9 t -56.7 -49.43 78.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.915 0.388 . . . . 75.439999999999998 111.66 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.422 ' O ' HG21 ' A' ' 11' ' ' VAL . 27.6 mm-40 -60.61 -55.99 26.68 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.349 0.5 . . . . 72.409999999999997 112.349 -178.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.509 ' O ' HG13 ' A' ' 12' ' ' ILE . 26.5 pt -59.37 -45.14 93.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 111.86 0.319 . . . . 70.209999999999994 111.86 -177.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -64.55 -41.93 96.02 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.983 0.421 . . . . 73.409999999999997 111.175 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.27 -37.56 69.98 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.247 -0.433 . . . . 71.239999999999995 111.317 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.422 HG21 ' O ' ' A' ' 7' ' ' GLN . 63.1 t -69.57 -36.98 73.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 121.095 0.474 . . . . 74.310000000000002 111.234 178.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 8' ' ' ILE . 75.1 mt -62.18 -34.25 62.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 116.122 -0.49 . . . . 75.030000000000001 112.168 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -60.82 -12.16 9.96 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 112.921 0.712 . . . . 73.030000000000001 112.921 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -87.52 -5.36 58.82 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 112.827 0.677 . . . . 63.340000000000003 112.827 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 56.2 mt -76.72 115.6 49.44 Favored Pre-proline 0 CA--C 1.546 0.802 0 O-C-N 122.101 -0.375 . . . . 73.420000000000002 111.448 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -67.82 159.34 53.25 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.909 2.406 . . . . 74.340000000000003 113.496 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -66.94 97.02 0.46 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.853 -0.612 . . . . 73.530000000000001 111.395 -176.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 136.23 -22.19 3.42 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 121.222 -0.513 . . . . 71.409999999999997 113.045 176.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -98.42 164.73 12.16 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.144 0.497 . . . . 74.299999999999997 111.996 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.6 m -135.79 157.47 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.732 -0.667 . . . . 73.25 110.607 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.436 ' HG ' HD12 ' A' ' 26' ' ' ILE . 98.0 p -130.35 172.71 11.55 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.043 0.449 . . . . 75.400000000000006 110.965 178.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 46.4 p -108.26 152.39 24.68 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.91 0.386 . . . . 61.329999999999998 111.325 177.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.457 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 67.5 m-85 -55.32 -34.22 64.0 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.287 0.477 . . . . 75.129999999999995 112.287 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.3 -48.93 83.55 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.915 -0.66 . . . . 70.450000000000003 112.426 176.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -59.32 -52.45 65.6 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.849 0.357 . . . . 72.340000000000003 111.52 178.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.436 HD12 ' HG ' ' A' ' 21' ' ' SER . 48.2 mm -59.61 -50.27 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 111.954 0.353 . . . . 72.310000000000002 111.954 -178.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . -58.67 -50.41 73.96 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.047 0.388 . . . . 74.230000000000004 112.047 -178.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -62.45 -44.05 97.34 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.647 0.26 . . . . 75.219999999999999 111.622 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 74.7 mtm -69.17 -24.14 64.03 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.591 0.234 . . . . 73.109999999999999 111.623 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.82 -20.98 44.82 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.026 0.441 . . . . 74.430000000000007 111.229 174.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.96 16.62 20.96 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 121.405 -0.426 . . . . 74.120000000000005 113.645 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.407 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 69.7 m-85 -126.93 89.33 52.33 Favored Pre-proline 0 CA--C 1.542 0.651 0 O-C-N 122.54 -0.388 . . . . 75.019999999999996 111.938 -177.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.24 141.85 40.25 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 122.437 2.091 . . . . 75.140000000000001 112.414 177.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.65 -37.17 2.46 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 121.003 -0.617 . . . . 73.019999999999996 113.637 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -63.8 -2.81 1.97 Allowed 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.744 0.646 . . . . 74.340000000000003 112.744 -178.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.457 ' HB1' ' HB3' ' A' ' 23' ' ' TYR . . . -48.02 -42.44 28.19 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.693 0.627 . . . . 71.150000000000006 112.693 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -59.05 -36.12 74.5 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.236 0.458 . . . . 72.150000000000006 112.236 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -72.65 -33.52 66.64 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.788 0.328 . . . . 74.409999999999997 110.755 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.496 HG11 HD11 ' A' ' 8' ' ' ILE . 60.6 t -58.02 -45.97 88.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 116.195 -0.457 . . . . 73.439999999999998 110.573 174.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.32 -45.4 96.2 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 121.15 -0.548 . . . . 64.430000000000007 113.0 176.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -64.79 -28.48 69.6 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.817 0.341 . . . . 72.329999999999998 111.261 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.65 -48.5 47.32 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.87 0.367 . . . . 71.219999999999999 111.077 174.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.551 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 44.6 mt -64.06 -40.0 95.31 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.864 0.364 . . . . 54.350000000000001 111.298 178.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.529 ' HA2' HD12 ' A' ' 66' ' ' LEU . . . -65.01 -13.85 58.06 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.155 -0.545 . . . . 64.420000000000002 112.924 176.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -86.79 -16.42 36.31 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 120.977 0.418 . . . . 72.540000000000006 110.962 177.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 95.7 mt -77.73 149.17 77.28 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 116.344 -0.389 . . . . 75.420000000000002 111.918 -178.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -77.2 165.93 27.16 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.537 2.158 . . . . 64.5 112.702 176.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.534 ' HB3' ' HD3' ' A' ' 73' ' ' ARG . 11.3 pt-20 -84.02 25.35 0.83 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.044 0.387 . . . . 64.450000000000003 112.044 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -141.87 19.59 2.54 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 121.195 -0.526 . . . . 63.229999999999997 113.482 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 56.4 p -81.11 155.75 26.11 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 117.085 0.442 . . . . 72.549999999999997 111.629 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -69.85 -21.35 63.36 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.325 0.583 . . . . 74.420000000000002 111.413 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.451 HD11 ' HD2' ' A' ' 53' ' ' PRO . 48.5 tp -87.42 116.3 65.65 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 115.882 -0.599 . . . . 74.310000000000002 111.388 178.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.451 ' HD2' HD11 ' A' ' 52' ' ' LEU . 64.2 Cg_endo -74.44 95.1 0.92 Allowed 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 121.419 1.413 . . . . 74.439999999999998 112.02 177.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.551 ' HB2' ' HB3' ' A' ' 43' ' ' LEU . 64.1 p-90 -83.78 -26.73 29.38 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.113 -0.494 . . . . 74.540000000000006 111.665 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -62.43 -12.98 24.9 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 113.102 0.779 . . . . 74.519999999999996 113.102 -178.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.472 HH22 ' HB3' ' A' ' 81' ' ' GLU . 80.4 mtt-85 -86.21 -13.23 47.53 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.846 0.684 . . . . 72.530000000000001 112.846 -178.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.7 t -102.74 99.81 9.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 120.97 0.414 . . . . 74.519999999999996 110.806 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.526 ' HA ' ' OG ' ' A' ' 65' ' ' SER . 44.8 pt -104.29 -170.23 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 121.303 0.573 . . . . 74.150000000000006 111.787 -178.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.1 p30 -89.38 158.96 17.56 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.199 0.523 . . . . 74.209999999999994 111.928 -177.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.7 p -66.01 -3.85 6.1 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.143 0.423 . . . . 63.520000000000003 112.143 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -86.55 -1.88 58.01 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 122.647 0.379 . . . . 64.409999999999997 111.896 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.78 31.88 67.17 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.147 -0.549 . . . . 72.519999999999996 112.69 -178.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -133.04 173.32 11.55 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.114 0.483 . . . . 74.349999999999994 111.324 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.58 HD11 HG13 ' A' ' 85' ' ' VAL . 38.1 mt -65.53 146.65 13.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 116.029 -0.532 . . . . 74.329999999999998 112.015 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.526 ' OG ' ' HA ' ' A' ' 58' ' ' ILE . 14.8 m -70.22 -47.86 59.58 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.002 -0.545 . . . . 75.209999999999994 111.91 -176.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.529 HD12 ' HA2' ' A' ' 44' ' ' GLY . 86.8 mt -103.54 158.2 16.53 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.084 -0.507 . . . . 63.229999999999997 111.794 -176.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.467 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 53.4 mtpt -120.24 163.66 17.44 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.02 0.438 . . . . 71.230000000000004 111.48 -178.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 77.53 -139.35 22.95 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 121.069 -0.586 . . . . 62.520000000000003 112.831 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -63.9 -34.95 79.11 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.206 0.526 . . . . 73.430000000000007 110.952 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -61.38 -27.77 68.76 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.764 -0.653 . . . . 73.329999999999998 111.195 177.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.467 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 10.1 tt -67.07 -48.31 68.64 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.103 -0.499 . . . . 72.140000000000001 110.663 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.582 ' HA ' ' HD3' ' A' ' 75' ' ' LYS . 11.9 m-20 -65.05 -34.22 77.9 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.68 0.276 . . . . 61.409999999999997 111.417 176.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.534 ' HD3' ' HB3' ' A' ' 48' ' ' GLU . 38.8 ttm180 -56.82 -50.71 71.55 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.108 0.48 . . . . 71.430000000000007 110.684 174.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.463 ' OE1' HG22 ' A' ' 64' ' ' ILE . 45.6 tt0 -66.84 -34.5 77.94 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.17 -0.468 . . . . 54.020000000000003 111.108 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.582 ' HD3' ' HA ' ' A' ' 72' ' ' ASP . 47.2 mtpt -55.7 -62.75 1.48 Allowed 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 120.963 0.411 . . . . 71.230000000000004 111.434 173.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -53.58 -37.57 63.08 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.795 -0.639 . . . . 74.329999999999998 112.053 -175.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -61.28 -53.51 55.83 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.027 0.442 . . . . 74.439999999999998 111.592 175.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.7 mt -65.26 -40.97 94.64 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.357 -0.383 . . . . 72.219999999999999 111.525 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -55.54 -44.63 76.93 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.152 0.501 . . . . 74.340000000000003 111.043 174.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.71 -31.86 71.13 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.008 -0.542 . . . . 70.430000000000007 111.278 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.472 ' HB3' HH22 ' A' ' 56' ' ' ARG . 14.1 mm-40 -87.65 9.85 20.02 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.562 0.578 . . . . 65.040000000000006 112.562 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.27 4.3 83.92 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.398 -0.43 . . . . 74.230000000000004 113.813 175.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 67.0 mt -87.39 132.79 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 O-C-N 122.6 -0.353 . . . . 71.099999999999994 111.171 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -87.99 101.01 13.35 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.918 0.39 . . . . 52.43 111.424 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.58 HG13 HD11 ' A' ' 64' ' ' ILE . 48.8 t -89.87 120.58 38.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 120.844 0.354 . . . . 74.140000000000001 110.731 176.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.571 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 36.5 m -68.18 146.2 53.62 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.595 -0.275 . . . . 74.450000000000003 111.1 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -41.22 -51.96 3.44 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 115.246 1.573 . . . . 53.420000000000002 115.246 -169.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 pp -75.01 -5.7 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 112.924 0.713 . . . . 73.519999999999996 112.924 -175.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 105.99 46.93 1.13 Allowed Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.29 -0.481 . . . . 73.319999999999993 113.171 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.571 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 48.5 tttm -116.81 139.65 50.35 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.829 0.347 . . . . 73.120000000000005 111.916 -178.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.445 HD13 HG21 ' A' ' 58' ' ' ILE . 65.8 mt -131.11 126.36 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 116.267 -0.424 . . . . 72.25 111.216 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.22 95.88 1.04 Allowed 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 111.958 0.355 . . . . 54.350000000000001 111.958 179.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.434 HD23 HD12 ' A' ' 58' ' ' ILE . 70.7 mt -56.24 -51.1 69.34 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 111.918 0.34 . . . . 73.230000000000004 111.918 179.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -61.71 -9.29 6.02 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.193 0.442 . . . . 75.349999999999994 112.193 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -107.92 -22.11 12.56 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 122.507 0.323 . . . . 73.140000000000001 111.608 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -127.92 13.67 6.82 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.241 0.46 . . . . 64.129999999999995 112.241 -177.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -62.99 131.41 48.55 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.535 0.568 . . . . 71.340000000000003 112.535 -175.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 20.4 t90 -72.64 109.82 6.55 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.101 -0.499 . . . . 71.329999999999998 111.024 174.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.424 ' HA ' ' HD2' ' A' ' 100' ' ' PRO . 20.8 mm-40 -108.72 93.7 12.69 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 115.982 -0.554 . . . . 72.019999999999996 110.735 176.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 99' ' ' GLN . 22.5 Cg_endo . . . . . 0 C--N 1.352 0.736 0 C-N-CA 122.971 2.447 . . . . 71.430000000000007 112.857 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 . . . . . 0 CA--C 1.54 0.558 0 N-CA-C 111.896 0.332 . . . . 63.530000000000001 111.896 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.411 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 26.4 mm-40 -60.19 -27.6 67.29 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.595 0.236 . . . . 64.030000000000001 111.363 176.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -52.59 -49.13 65.62 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.237 0.541 . . . . 72.430000000000007 110.222 172.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 73.1 mt -66.61 -47.54 72.36 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.485 -0.78 . . . . 64.150000000000006 111.055 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.7 t -55.19 -44.92 76.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.324 -0.398 . . . . 71.450000000000003 111.589 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 31.8 mm-40 -66.58 -52.28 47.14 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.208 0.447 . . . . 75.239999999999995 112.208 -178.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.425 ' O ' HG13 ' A' ' 12' ' ' ILE . 31.8 pt -60.73 -41.62 89.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 O-C-N 122.146 -0.346 . . . . 64.540000000000006 111.47 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 17.6 m-30 -61.72 -46.56 89.12 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.068 0.461 . . . . 74.420000000000002 110.705 176.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.28 -39.55 64.01 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.109 -0.496 . . . . 72.230000000000004 111.448 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 7' ' ' GLN . 92.1 t -65.25 -43.2 95.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 120.776 0.322 . . . . 75.340000000000003 111.476 178.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.532 ' HB ' HD12 ' A' ' 52' ' ' LEU . 72.8 mt -56.84 -33.97 42.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 120.927 0.394 . . . . 74.310000000000002 111.763 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -59.4 -16.94 26.36 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 113.22 0.822 . . . . 74.230000000000004 113.22 178.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.408 ' HB3' ' HZ2' ' A' ' 98' ' ' TRP . 2.0 mp0 -80.97 -11.7 59.52 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.375 0.509 . . . . 73.239999999999995 112.375 177.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.47 HD12 HD11 ' A' ' 26' ' ' ILE . 51.0 mt -75.33 115.3 44.0 Favored Pre-proline 0 N--CA 1.472 0.626 0 O-C-N 122.311 -0.243 . . . . 74.430000000000007 111.086 178.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -66.95 169.29 15.17 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.778 2.319 . . . . 72.319999999999993 113.523 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -70.06 115.65 9.51 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.822 -0.626 . . . . 74.010000000000005 110.891 -178.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.32 19.25 21.55 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 120.97 -0.633 . . . . 71.340000000000003 113.643 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -127.11 152.45 47.29 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 117.169 0.485 . . . . 73.010000000000005 111.347 176.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.6 m -128.04 150.04 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 121.136 0.493 . . . . 73.519999999999996 111.731 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.7 t -138.75 175.0 9.93 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.362 -0.381 . . . . 52.210000000000001 111.091 175.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 67.6 p -104.88 150.78 24.57 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.907 0.384 . . . . 75.510000000000005 111.988 -177.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -52.54 -36.68 56.12 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.27 -0.423 . . . . 63.210000000000001 111.659 178.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -60.96 -48.25 87.23 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 116.086 -0.506 . . . . 55.340000000000003 112.789 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.4 ' O ' ' HG3' ' A' ' 29' ' ' MET . 45.1 mt-10 -61.14 -51.95 66.93 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.848 0.356 . . . . 65.409999999999997 111.107 178.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.47 HD11 HD12 ' A' ' 15' ' ' ILE . 49.4 mm -53.14 -53.31 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 121.131 0.491 . . . . 75.230000000000004 111.622 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.62 -44.63 96.11 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.157 0.504 . . . . 63.409999999999997 111.322 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.4 ttpp -62.46 -33.99 75.93 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.168 -0.469 . . . . 73.329999999999998 111.531 -178.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.4 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 67.2 mtt -72.99 -41.33 64.43 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.984 0.421 . . . . 73.099999999999994 111.161 175.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.73 -24.81 67.05 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.236 -0.438 . . . . 61.210000000000001 112.171 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.42 24.55 6.14 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.286 -0.483 . . . . 62.100000000000001 113.254 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -135.65 66.07 62.64 Favored Pre-proline 0 CA--C 1.543 0.674 0 O-C-N 122.665 -0.315 . . . . 75.319999999999993 111.57 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -61.91 138.28 72.78 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.588 2.192 . . . . 73.25 112.757 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.33 -27.8 9.96 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.274 -0.488 . . . . 54.009999999999998 113.127 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -79.88 22.94 0.47 Allowed 'General case' 0 N--CA 1.473 0.715 0 O-C-N 122.214 -0.58 . . . . 73.319999999999993 112.542 -177.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.93 -37.86 69.52 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.414 0.524 . . . . 74.329999999999998 112.414 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -58.82 -38.22 78.17 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.825 0.345 . . . . 70.140000000000001 111.782 178.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -69.74 -35.02 74.63 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.537 -0.301 . . . . 73.439999999999998 111.124 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.403 HG11 HD11 ' A' ' 8' ' ' ILE . 46.6 t -59.67 -44.5 93.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.002 0.43 . . . . 74.540000000000006 110.655 175.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.68 -40.58 98.71 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 121.169 -0.539 . . . . 74.120000000000005 112.718 176.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -67.0 -27.89 67.8 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.982 0.42 . . . . 74.430000000000007 111.157 175.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.89 -53.61 12.64 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.308 -0.406 . . . . 70.540000000000006 111.625 177.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.1 mt -61.13 -39.46 90.1 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.501 -0.318 . . . . 73.530000000000001 111.558 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.45 -15.91 57.73 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 120.88 -0.676 . . . . 54.509999999999998 113.507 178.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -103.41 10.78 37.17 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 122.622 -0.34 . . . . 73.349999999999994 111.804 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 57.9 mt -86.12 155.89 57.65 Favored Pre-proline 0 N--CA 1.47 0.568 0 CA-C-O 120.999 0.428 . . . . 75.230000000000004 112.031 177.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.447 ' HG2' ' HB2' ' A' ' 50' ' ' SER . 55.2 Cg_endo -70.29 153.16 66.75 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.266 1.977 . . . . 70.140000000000001 111.819 172.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -49.28 -70.8 0.08 Allowed 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 121.239 0.542 . . . . 64.340000000000003 111.372 -176.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -91.53 59.46 2.96 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 121.201 -0.523 . . . . 70.140000000000001 113.364 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.447 ' HB2' ' HG2' ' A' ' 47' ' ' PRO . 40.2 t -70.25 165.41 22.27 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.028 0.442 . . . . 70.239999999999995 111.621 176.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -67.09 -24.73 65.98 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.234 0.54 . . . . 74.510000000000005 110.545 174.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.532 HD12 ' HB ' ' A' ' 12' ' ' ILE . 28.0 tp -90.37 126.8 55.37 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 115.722 -0.672 . . . . 73.239999999999995 111.747 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.526 ' HD2' HD11 ' A' ' 52' ' ' LEU . 74.0 Cg_endo -76.24 94.99 1.02 Allowed 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 121.574 1.516 . . . . 75.5 111.553 170.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 60.4 p-90 -83.71 -26.98 29.31 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.352 0.596 . . . . 54.200000000000003 111.678 -177.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -62.66 -13.95 37.99 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.571 0.952 . . . . 73.099999999999994 113.571 -177.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -86.36 3.57 43.0 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 112.541 0.571 . . . . 74.219999999999999 112.541 -178.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.8 t -116.62 123.23 71.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 121.194 0.521 . . . . 75.25 111.795 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.504 HG21 HD13 ' A' ' 91' ' ' ILE . 21.1 pt -126.97 -172.65 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 116.068 -0.514 . . . . 64.239999999999995 111.269 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.6 p30 -90.29 172.64 8.63 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.899 -0.501 . . . . 74.230000000000004 112.126 -177.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 43.9 m -63.32 -16.57 60.8 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 112.587 0.588 . . . . 72.109999999999999 112.587 -176.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -88.38 -2.71 58.75 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.809 0.338 . . . . 73.109999999999999 111.662 -178.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.63 40.75 58.5 Favored Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.977 -0.63 . . . . 64.230000000000004 112.358 -175.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -130.76 155.11 47.2 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.101 0.477 . . . . 73.519999999999996 111.387 -177.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.544 HG21 ' OE1' ' A' ' 74' ' ' GLN . 65.5 mt -77.2 130.78 35.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 116.252 -0.431 . . . . 74.439999999999998 110.966 176.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.9 m -73.17 -41.17 64.18 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 112.101 0.408 . . . . 74.519999999999996 112.101 -179.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.504 HD13 ' HB3' ' A' ' 70' ' ' ASP . 93.8 mt -73.15 146.15 45.85 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.453 -0.34 . . . . 74.299999999999997 110.789 178.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -116.2 157.09 25.39 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.17 0.509 . . . . 74.340000000000003 112.121 -176.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.6 -124.14 30.57 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 115.858 -0.61 . . . . 74.510000000000005 114.007 177.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.5 mtp180 -61.27 -46.96 88.19 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.948 0.404 . . . . 75.340000000000003 111.972 -177.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.504 ' HB3' HD13 ' A' ' 66' ' ' LEU . 15.1 m-20 -63.08 -29.59 70.93 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.85 0.357 . . . . 71.129999999999995 111.174 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.8 tt -63.88 -53.44 50.49 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.312 -0.404 . . . . 75.040000000000006 110.463 175.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -62.27 -30.2 70.96 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.303 -0.408 . . . . 64.430000000000007 111.22 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.542 ' O ' ' HG2' ' A' ' 77' ' ' LYS . 43.5 ttm180 -58.94 -60.38 3.96 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.743 0.306 . . . . 74.200000000000003 110.946 174.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.544 ' OE1' HG21 ' A' ' 64' ' ' ILE . 43.3 tt0 -55.73 -43.3 76.45 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.086 0.47 . . . . 75.409999999999997 110.962 177.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.412 ' HG3' ' HB ' ' A' ' 85' ' ' VAL . 31.5 tttm -55.07 -56.54 18.7 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.728 -0.669 . . . . 71.129999999999995 111.837 176.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -59.14 -37.97 78.54 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.154 0.427 . . . . 64.099999999999994 112.154 -178.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.542 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 75.0 mmtt -58.8 -46.46 87.52 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.934 0.397 . . . . 74.439999999999998 110.942 176.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.479 HD22 HD13 ' A' ' 83' ' ' ILE . 95.8 mt -71.26 -35.33 71.35 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.198 -0.455 . . . . 74.209999999999994 111.628 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -54.6 -41.16 69.61 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.075 0.464 . . . . 62.240000000000002 110.741 173.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.61 -8.18 39.6 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.419 0.526 . . . . 71.400000000000006 112.419 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -107.64 4.45 25.86 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.969 0.414 . . . . 63.32 111.47 177.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.67 5.17 63.25 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.285 -0.483 . . . . 52.109999999999999 113.926 177.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.479 HD13 HD22 ' A' ' 78' ' ' LEU . 66.4 mt -82.64 133.13 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 O-C-N 122.242 -0.563 . . . . 75.430000000000007 111.435 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -92.36 97.64 10.99 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.891 0.377 . . . . 72.299999999999997 111.455 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.412 ' HB ' ' HG3' ' A' ' 75' ' ' LYS . 44.8 t -91.22 124.53 43.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 120.883 0.373 . . . . 75.349999999999994 111.49 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.548 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 42.7 t -67.63 144.56 55.47 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 111.635 0.235 . . . . 75.230000000000004 111.635 177.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -41.94 -48.25 4.47 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.081 1.141 . . . . 75.450000000000003 114.081 -173.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.8 pp -80.74 16.11 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 112.87 0.693 . . . . 73.439999999999998 112.87 -175.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.82 51.59 4.73 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 121.414 -0.422 . . . . 64.150000000000006 113.51 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.548 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 60.4 tttm -125.72 132.17 52.41 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 122.532 -0.393 . . . . 75.129999999999995 111.256 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.504 HD13 HG21 ' A' ' 58' ' ' ILE . 61.0 mt -124.09 134.41 66.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 120.934 0.397 . . . . 75.400000000000006 111.475 -177.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.8 100.22 1.14 Allowed 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 111.947 0.351 . . . . 73.230000000000004 111.947 178.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 39.4 mt -59.06 -62.27 2.01 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.355 0.502 . . . . 73.329999999999998 112.355 -178.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -50.19 -34.46 22.78 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 112.314 0.487 . . . . 73.209999999999994 112.314 -175.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -73.71 -47.29 40.56 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 112.32 0.489 . . . . 73.430000000000007 112.32 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -102.41 14.1 32.85 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 120.973 0.416 . . . . 73.200000000000003 111.528 -177.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -55.02 114.09 1.61 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.905 -0.589 . . . . 75.549999999999997 111.894 -175.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.408 ' HZ2' ' HB3' ' A' ' 14' ' ' GLN . 21.4 t90 -56.45 121.28 9.25 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.101 0.778 . . . . 65.150000000000006 113.101 -177.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.436 ' O ' ' HG3' ' A' ' 99' ' ' GLN . 12.9 pt20 -127.16 109.98 21.55 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 115.662 -0.699 . . . . 74.450000000000003 109.924 167.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo . . . . . 0 CA--C 1.538 0.686 0 C-N-CA 122.152 1.901 . . . . 75.230000000000004 112.27 174.945 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.459 ' O ' HG22 ' A' ' 6' ' ' VAL . 5.8 m-20 . . . . . 0 N--CA 1.472 0.626 0 N-CA-C 112.088 0.403 . . . . 74.140000000000001 112.088 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -57.66 -31.73 66.6 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.395 -0.366 . . . . 74.310000000000002 111.767 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.405 ' O ' HG12 ' A' ' 8' ' ' ILE . 53.2 t80 -54.83 -52.41 62.81 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.309 0.576 . . . . 72.140000000000001 110.49 172.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 72.5 mt -64.53 -45.32 87.7 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.629 -0.714 . . . . 70.120000000000005 111.17 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 2' ' ' ASP . 58.6 t -55.37 -51.49 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 120.931 0.396 . . . . 63.43 111.697 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -65.27 -50.81 64.32 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 112.539 0.57 . . . . 74.519999999999996 112.539 -176.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.456 ' O ' HG13 ' A' ' 12' ' ' ILE . 32.6 pt -62.16 -45.55 98.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 O-C-N 122.192 -0.317 . . . . 75.420000000000002 111.58 -178.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 19.5 m-30 -62.31 -43.37 98.98 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.081 0.467 . . . . 74.140000000000001 110.91 177.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.03 -48.15 67.83 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.927 -0.579 . . . . 61.32 111.413 178.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 78.0 t -62.87 -41.84 94.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 120.795 0.331 . . . . 75.120000000000005 111.502 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 8' ' ' ILE . 81.5 mt -57.4 -35.86 50.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 112.06 0.393 . . . . 71.340000000000003 112.06 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -56.72 -15.17 4.1 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.15 0.796 . . . . 71.5 113.15 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -86.79 -11.19 51.73 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.699 0.629 . . . . 72.109999999999999 112.699 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.474 HD12 HD12 ' A' ' 26' ' ' ILE . 52.1 mt -73.32 111.64 12.6 Favored Pre-proline 0 CA--C 1.543 0.679 0 O-C-N 122.245 -0.284 . . . . 73.329999999999998 110.677 178.021 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -81.57 178.05 6.99 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.635 2.223 . . . . 71.140000000000001 113.736 -175.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.4 tptt -58.56 140.92 53.49 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.842 -0.617 . . . . 75.349999999999994 111.482 -178.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.611 ' H ' ' NH2' ' A' ' 56' ' ' ARG . . . 82.45 -32.53 2.84 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 116.176 -0.465 . . . . 71.239999999999995 114.142 179.281 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -85.67 158.3 20.1 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.019 0.748 . . . . 74.439999999999998 113.019 -175.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.8 m -139.97 166.84 19.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 115.636 -0.711 . . . . 75.219999999999999 110.734 177.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.8 t -149.28 -178.66 6.52 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.448 -0.342 . . . . 72.430000000000007 110.314 176.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 72.3 p -112.53 158.7 19.61 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.391 0.515 . . . . 73.140000000000001 112.391 -177.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -54.34 -41.82 69.52 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.203 -0.453 . . . . 72.420000000000002 110.903 176.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.12 -47.5 89.46 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.911 -0.586 . . . . 75.409999999999997 113.094 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -55.9 -53.48 56.25 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.925 0.363 . . . . 75.420000000000002 111.389 177.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.474 HD12 HD12 ' A' ' 15' ' ' ILE . 49.3 mm -58.72 -49.62 82.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 120.834 0.35 . . . . 72.439999999999998 111.491 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.51 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -57.89 -49.04 78.09 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 120.995 0.426 . . . . 73.5 112.05 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.734 ' HB3' ' HZ2' ' A' ' 28' ' ' LYS . 9.4 mtpm? -62.71 -39.43 94.02 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.438 -0.346 . . . . 73.540000000000006 111.825 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 72.5 mtm -79.48 -16.07 56.68 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.649 0.261 . . . . 72.310000000000002 111.657 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -85.85 -30.62 22.79 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.028 0.442 . . . . 74.109999999999999 111.363 174.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.41 12.23 10.96 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.286 -0.483 . . . . 54.119999999999997 113.448 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.51 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 71.1 m-85 -130.35 67.53 80.15 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 117.011 0.405 . . . . 73.439999999999998 111.062 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.48 -49.24 16.72 Favored 'Trans proline' 0 N--CA 1.482 0.819 0 C-N-CA 122.842 2.362 . . . . 72.430000000000007 114.096 -174.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -81.38 41.82 2.7 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.105 -0.569 . . . . 72.239999999999995 113.897 -177.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -141.26 21.42 2.24 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.668 0.618 . . . . 75.209999999999994 112.668 -178.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.35 -51.51 64.54 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.076 0.398 . . . . 63.229999999999997 112.076 -177.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -55.11 -36.89 66.2 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.873 0.368 . . . . 75.329999999999998 111.968 176.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -72.39 -37.45 68.72 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.553 -0.294 . . . . 73.040000000000006 111.367 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.445 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 99.7 t -56.85 -47.2 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 120.874 0.369 . . . . 64.430000000000007 110.7 175.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.26 -46.69 92.54 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.281 -0.485 . . . . 70.420000000000002 113.069 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.34 -36.63 82.81 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.984 0.421 . . . . 74.010000000000005 111.337 177.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.29 -40.39 95.86 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.978 0.418 . . . . 75.5 111.265 175.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.479 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 89.9 mt -69.75 -38.83 76.94 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.271 -0.422 . . . . 72.219999999999999 111.338 178.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.05 -13.55 48.97 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 121.285 -0.483 . . . . 72.430000000000007 113.337 178.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -90.59 -12.38 37.18 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 122.556 -0.379 . . . . 72.049999999999997 111.445 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 88.8 mt -66.43 133.58 94.4 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 112.116 0.413 . . . . 62.140000000000001 112.116 -178.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.95 161.33 39.08 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.661 2.241 . . . . 73.109999999999999 113.725 -177.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -61.96 -12.99 21.16 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.331 -0.85 . . . . 70.400000000000006 112.556 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -107.77 18.27 34.82 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 121.139 -0.553 . . . . 75.549999999999997 113.949 -179.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 41.6 t -79.79 152.96 29.48 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 117.413 0.606 . . . . 72.230000000000004 111.583 177.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -101.2 6.55 43.09 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.222 0.534 . . . . 73.239999999999995 110.938 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.508 HD11 ' HD2' ' A' ' 53' ' ' PRO . 56.4 tp -95.16 115.26 65.25 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 116.125 -0.488 . . . . 74.349999999999994 110.681 176.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.508 ' HD2' HD11 ' A' ' 52' ' ' LEU . 63.7 Cg_endo -73.66 95.0 0.86 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 121.39 1.394 . . . . 65.420000000000002 112.059 178.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.479 ' HB2' ' HB3' ' A' ' 43' ' ' LEU . 68.5 p-90 -89.07 -26.24 21.49 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.171 0.51 . . . . 75.450000000000003 111.426 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.439 ' O ' HD21 ' A' ' 78' ' ' LEU . 35.8 p90 -58.48 -21.79 52.78 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.007 -0.542 . . . . 74.150000000000006 112.299 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.611 ' NH2' ' H ' ' A' ' 18' ' ' GLY . 88.0 mtt-85 -81.31 5.78 16.23 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.086 0.402 . . . . 63.130000000000003 112.086 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 18.6 t -115.31 111.44 35.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-O 121.228 0.537 . . . . 72.109999999999999 111.195 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.533 HD13 HD12 ' A' ' 91' ' ' ILE . 20.2 pt -117.79 -169.06 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 122.835 0.454 . . . . 74.040000000000006 111.047 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -92.12 167.35 12.13 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.57 -0.706 . . . . 63.229999999999997 111.764 -178.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 80.8 p -59.13 -18.76 38.72 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 112.644 0.609 . . . . 51.350000000000001 112.644 -176.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -85.94 4.6 36.84 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.786 0.327 . . . . 74.230000000000004 111.702 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.03 38.21 88.31 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 121.122 -0.561 . . . . 61.420000000000002 112.426 -177.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.485 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 54.5 mtpt -131.55 156.9 44.94 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.511 0.672 . . . . 74.420000000000002 112.009 -176.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.545 HG21 ' OE1' ' A' ' 74' ' ' GLN . 68.4 mt -78.59 104.28 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 115.575 -0.739 . . . . 73.319999999999993 110.047 173.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.2 t -63.38 -25.37 68.26 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.398 -0.365 . . . . 74.340000000000003 111.845 -176.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 83.1 mt -74.99 145.17 42.72 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.354 -0.384 . . . . 72.430000000000007 110.873 177.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.426 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -133.86 171.41 14.21 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.16 0.505 . . . . 74.420000000000002 112.0 -175.128 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.5 -121.75 24.83 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.918 -0.658 . . . . 62.420000000000002 112.663 -177.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 69' ' ' ARG . 35.3 mtt180 -71.6 -33.88 69.38 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.019 0.438 . . . . 74.450000000000003 111.277 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.424 ' O ' ' HB3' ' A' ' 73' ' ' ARG . 25.4 m-20 -73.32 -18.19 61.22 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 111.959 0.355 . . . . 70.519999999999996 111.959 -178.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.426 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 6.8 tt -66.11 -55.03 18.49 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.949 -0.389 . . . . 75.099999999999994 109.949 177.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.543 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 19.8 m-20 -67.45 -26.16 66.25 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.766 0.317 . . . . 72.019999999999996 111.304 176.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.424 ' HB3' ' O ' ' A' ' 70' ' ' ASP . 76.0 ttt180 -53.31 -62.5 1.61 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.203 0.525 . . . . 73.510000000000005 110.493 173.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.545 ' OE1' HG21 ' A' ' 64' ' ' ILE . 48.6 tt0 -67.1 -46.71 73.4 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.202 -0.454 . . . . 74.219999999999999 111.356 177.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.543 ' HB3' ' HA ' ' A' ' 72' ' ' ASP . 47.1 tttm -51.97 -50.36 61.4 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.616 0.598 . . . . 70.5 112.616 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -71.0 -30.88 67.24 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 111.904 0.335 . . . . 74.120000000000005 111.904 -176.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -64.75 -35.08 79.91 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.07 0.462 . . . . 73.120000000000005 110.873 171.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.439 HD21 ' O ' ' A' ' 55' ' ' PHE . 57.8 mt -70.15 -47.36 61.99 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.185 -0.461 . . . . 71.340000000000003 111.286 175.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -57.88 -31.22 66.51 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.193 -0.458 . . . . 74.049999999999997 111.389 176.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.55 -34.07 70.62 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.836 0.351 . . . . 74.420000000000002 111.32 173.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -88.09 -11.81 45.99 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 111.813 0.301 . . . . 75.109999999999999 111.813 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.77 54.76 3.15 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.285 -0.484 . . . . 71.519999999999996 113.029 -178.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.506 HD13 HH12 ' A' ' 56' ' ' ARG . 68.3 mt -116.2 137.06 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 122.605 0.362 . . . . 75.310000000000002 111.223 -179.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.46 ' HG3' ' OH ' ' A' ' 96' ' ' TYR . 66.9 mt-10 -66.71 92.98 0.23 Allowed 'General case' 0 N--CA 1.471 0.588 0 O-C-N 122.012 -0.43 . . . . 61.520000000000003 111.868 -179.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.41 HG13 ' HG3' ' A' ' 75' ' ' LYS . 42.9 t -89.99 102.79 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 120.815 0.341 . . . . 74.420000000000002 110.722 173.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.569 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 69.9 m -64.46 163.46 13.31 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.317 0.488 . . . . 71.129999999999995 112.317 -178.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -35.04 -58.09 0.54 Allowed 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 115.247 1.573 . . . . 75.340000000000003 115.247 -169.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.429 HD13 ' HE3' ' A' ' 63' ' ' LYS . 2.6 pp -92.82 23.06 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 112.505 0.557 . . . . 75.319999999999993 112.505 -174.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.71 47.8 7.03 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 121.266 -0.492 . . . . 74.219999999999999 112.604 -176.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.569 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 49.3 tttm -111.8 131.88 55.04 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 122.432 -0.452 . . . . 74.519999999999996 111.452 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.533 HD12 HD13 ' A' ' 58' ' ' ILE . 53.5 mt -116.46 135.87 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 120.921 0.391 . . . . 75.120000000000005 111.699 -176.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.99 93.92 1.42 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.948 0.404 . . . . 70.109999999999999 111.453 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.47 HD22 HD12 ' A' ' 58' ' ' ILE . 66.6 mt -54.24 -56.85 14.31 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.384 0.513 . . . . 74.140000000000001 112.384 -178.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -53.05 -28.21 23.54 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.522 0.564 . . . . 74.349999999999994 112.522 -177.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -84.52 -33.09 23.58 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.033 0.383 . . . . 74.120000000000005 112.033 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.46 ' OH ' ' HG3' ' A' ' 84' ' ' GLU . 80.3 m-85 -117.59 6.92 12.52 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.84 0.682 . . . . 73.420000000000002 112.84 -173.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 61.5 tttp -63.31 128.8 37.51 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.159 0.504 . . . . 75.099999999999994 112.209 -173.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 15.7 t90 -69.72 116.81 10.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.761 -0.654 . . . . 75.450000000000003 110.798 175.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -114.38 92.04 26.37 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 116.476 -0.329 . . . . 71.450000000000003 111.187 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo . . . . . 0 CA--C 1.538 0.683 0 C-N-CA 122.514 2.143 . . . . 73.420000000000002 112.043 174.662 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 112.737 0.643 . . . . 75.439999999999998 112.737 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.58 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 22.2 mm-40 -53.74 -40.04 65.83 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.063 -0.517 . . . . 74.25 111.38 175.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.413 ' O ' HG12 ' A' ' 8' ' ' ILE . 64.5 t80 -50.42 -53.38 29.9 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.131 0.491 . . . . 74.540000000000006 111.105 177.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 59.5 mt -61.61 -46.55 89.34 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.748 -0.66 . . . . 65.049999999999997 111.182 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.4 t -60.44 -44.86 97.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 116.137 -0.483 . . . . 62.119999999999997 111.896 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.58 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 24.4 mm-40 -68.51 -52.1 35.89 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.014 0.376 . . . . 75.530000000000001 112.014 -176.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.506 ' O ' HG13 ' A' ' 12' ' ' ILE . 30.9 pt -58.16 -43.42 85.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 121.055 -0.258 . . . . 73.349999999999994 111.306 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.5 m-30 -63.34 -46.76 85.08 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.036 0.446 . . . . 74.329999999999998 110.671 175.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.35 -44.67 65.32 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.926 -0.579 . . . . 75.219999999999999 111.661 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.426 HG21 ' O ' ' A' ' 7' ' ' GLN . 99.7 t -63.48 -43.78 98.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 120.825 0.345 . . . . 74.200000000000003 111.4 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.53 ' HB ' HD11 ' A' ' 52' ' ' LEU . 72.6 mt -58.63 -32.09 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 112.161 0.43 . . . . 74.530000000000001 112.161 -178.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -60.55 -10.24 4.83 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.064 0.764 . . . . 70.329999999999998 113.064 178.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -92.86 -2.52 55.81 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 112.564 0.579 . . . . 71.230000000000004 112.564 178.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 55.3 mt -81.5 114.1 47.05 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-O 120.653 0.263 . . . . 73.430000000000007 111.176 179.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.55 171.47 13.04 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.926 2.417 . . . . 70.430000000000007 113.054 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 44.9 tttp -66.68 133.04 49.42 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.064 0.459 . . . . 70.209999999999994 111.25 -178.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.464 ' H ' ' NH2' ' A' ' 56' ' ' ARG . . . 95.19 -25.14 25.63 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 121.319 -0.467 . . . . 64.299999999999997 113.184 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -86.72 157.31 19.67 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.587 0.588 . . . . 71.010000000000005 112.587 -177.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.3 m -140.51 153.98 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.621 -0.718 . . . . 71.150000000000006 110.722 176.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.5 t -135.07 179.98 5.98 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 122.189 -0.319 . . . . 70.519999999999996 110.726 176.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.2 p -110.9 155.52 22.51 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.09 0.471 . . . . 72.25 112.14 -176.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -54.3 -34.87 61.88 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.197 -0.456 . . . . 73.519999999999996 111.978 177.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.98 -49.9 60.5 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.095 -0.574 . . . . 75.540000000000006 112.752 177.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -56.39 -53.84 52.63 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.0 0.428 . . . . 74.409999999999997 111.364 177.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.5 mm -56.63 -48.23 80.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-N 116.12 -0.491 . . . . 74.549999999999997 111.729 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . -60.12 -49.39 77.81 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 120.88 0.371 . . . . 74.430000000000007 111.971 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -60.63 -36.63 79.1 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.9 0.381 . . . . 72.519999999999996 111.878 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.445 ' HE3' ' CZ3' ' A' ' 98' ' ' TRP . 73.6 mtm -84.81 -9.71 57.89 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.746 0.308 . . . . 65.219999999999999 111.773 179.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.3 -11.5 32.3 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.933 0.396 . . . . 71.230000000000004 111.356 173.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.13 21.68 37.87 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 121.312 -0.47 . . . . 72.120000000000005 113.482 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.438 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 97.2 m-85 -133.59 77.78 63.71 Favored Pre-proline 0 CA--C 1.543 0.699 0 O-C-N 122.522 -0.399 . . . . 74.510000000000005 111.916 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.52 135.71 24.71 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.305 2.004 . . . . 75.219999999999999 112.712 178.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.63 -1.87 76.2 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 121.238 -0.506 . . . . 70.420000000000002 113.738 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -99.88 23.21 10.04 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 117.258 0.529 . . . . 70.0 112.29 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.65 -48.4 58.3 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.723 0.638 . . . . 72.030000000000001 112.723 -177.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.0 ttp180 -68.08 -32.42 72.73 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.738 0.304 . . . . 75.400000000000006 111.711 -178.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -67.99 -35.98 79.24 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.848 0.356 . . . . 74.109999999999999 110.993 178.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.45 HG21 HG22 ' A' ' 8' ' ' ILE . 47.1 t -60.01 -42.84 91.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 121.393 0.615 . . . . 74.129999999999995 109.851 172.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.31 -37.93 92.61 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 115.681 -0.69 . . . . 62.240000000000002 112.781 174.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -58.19 -50.76 72.39 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.139 0.495 . . . . 74.109999999999999 110.602 174.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.29 -46.75 82.85 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.66 -0.7 . . . . 73.340000000000003 112.125 -177.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 62.2 mt -65.17 -39.26 92.69 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.794 0.331 . . . . 75.340000000000003 111.596 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.7 -25.19 65.22 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 120.805 -0.712 . . . . 72.340000000000003 113.249 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -87.3 5.58 37.66 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 120.877 0.37 . . . . 72.430000000000007 111.84 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 97.0 mt -94.48 155.71 39.34 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-O 120.664 0.268 . . . . 75.430000000000007 111.084 176.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.9 160.47 46.82 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.241 1.961 . . . . 74.329999999999998 112.367 174.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -53.83 -41.46 67.4 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.174 0.435 . . . . 74.140000000000001 112.174 -174.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -124.77 65.51 0.54 Allowed Glycine 0 CA--C 1.526 0.735 0 C-N-CA 121.334 -0.46 . . . . 72.109999999999999 112.577 178.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.8 t -69.72 163.96 24.55 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.206 0.447 . . . . 63.039999999999999 112.206 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -60.38 -30.61 69.68 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.384 0.611 . . . . 74.25 110.259 173.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.533 HD13 ' HD2' ' A' ' 53' ' ' PRO . 48.5 tp -86.36 121.93 72.29 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 115.592 -0.731 . . . . 74.129999999999995 110.456 173.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.533 ' HD2' HD13 ' A' ' 52' ' ' LEU . 58.1 Cg_endo -72.95 94.9 0.81 Allowed 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 121.12 1.213 . . . . 72.540000000000006 111.745 177.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 69.2 p-90 -79.67 -31.28 41.36 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.978 -0.555 . . . . 75.120000000000005 111.605 -177.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -62.81 -11.01 15.1 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.726 0.639 . . . . 75.299999999999997 112.726 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.66 HH12 HD11 ' A' ' 83' ' ' ILE . 71.9 mtt-85 -90.2 9.33 28.9 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.142 0.423 . . . . 73.200000000000003 112.142 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.3 t -124.69 105.87 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.038 0.447 . . . . 73.239999999999995 111.004 176.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.496 HD13 HD13 ' A' ' 91' ' ' ILE . 22.3 pt -115.41 -170.19 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 121.069 0.461 . . . . 60.25 112.013 -176.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -88.1 169.99 11.46 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.896 0.379 . . . . 74.109999999999999 111.852 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 33.4 t -63.27 -24.51 67.9 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.494 0.553 . . . . 52.340000000000003 112.494 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -72.68 -10.34 59.68 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.73 0.3 . . . . 70.439999999999998 111.803 178.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.11 44.18 24.06 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.84 -0.695 . . . . 72.530000000000001 111.878 -175.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.427 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 99.6 mttt -135.93 159.54 41.37 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.936 0.398 . . . . 70.439999999999998 111.286 -178.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 61.5 mt -62.26 132.83 28.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.115 -0.493 . . . . 74.420000000000002 110.888 177.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.5 p -76.18 -47.68 23.28 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.866 0.365 . . . . 60.350000000000001 111.29 -178.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.575 ' HB3' ' HB3' ' A' ' 70' ' ' ASP . 76.6 mt -67.36 156.8 35.59 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.081 0.467 . . . . 63.25 111.584 178.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.458 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 13.7 ptmm? -131.83 162.36 30.77 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.18 0.437 . . . . 70.200000000000003 112.18 -172.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 61.97 -131.07 45.59 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 116.255 -0.43 . . . . 60.210000000000001 113.243 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 -54.18 -41.62 68.76 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.264 0.554 . . . . 74.219999999999999 111.35 175.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.575 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 2.1 m-20 -66.12 -27.69 68.24 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.78 -0.645 . . . . 74.019999999999996 111.99 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.458 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 7.3 tt -64.0 -53.47 49.59 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.949 0.404 . . . . 73.299999999999997 110.053 176.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.432 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 67.7 m-20 -63.51 -29.82 71.03 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.246 -0.434 . . . . 61.109999999999999 111.25 177.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.41 ' HB3' ' O ' ' A' ' 70' ' ' ASP . 34.5 ttm180 -56.9 -58.24 8.99 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.111 -0.495 . . . . 75.200000000000003 111.247 174.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.437 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 49.5 tt0 -63.56 -40.75 97.79 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.983 0.421 . . . . 72.409999999999997 110.417 177.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.432 ' HB3' ' HA ' ' A' ' 72' ' ' ASP . 84.2 tttt -48.99 -52.95 22.04 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.77 -0.65 . . . . 75.349999999999994 112.075 176.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -63.07 -39.13 93.8 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.059 0.392 . . . . 71.540000000000006 112.059 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 75.0 mmtt -64.35 -36.37 83.9 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.122 0.487 . . . . 75.310000000000002 111.004 177.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.504 HD11 HD11 ' A' ' 91' ' ' ILE . 73.4 mt -69.48 -52.38 27.15 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.093 -0.503 . . . . 73.329999999999998 111.414 178.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -52.78 -45.03 66.95 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.968 0.413 . . . . 63.109999999999999 111.529 177.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.69 -16.47 57.41 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.285 0.476 . . . . 62.350000000000001 112.285 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.547 ' HB3' HH22 ' A' ' 56' ' ' ARG . 28.2 mm-40 -104.57 13.15 32.17 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.025 0.38 . . . . 64.420000000000002 112.025 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.91 6.79 88.67 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.156 -0.545 . . . . 74.5 113.539 178.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.66 HD11 HH12 ' A' ' 56' ' ' ARG . 57.5 mt -88.39 149.51 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 O-C-N 122.475 -0.427 . . . . 72.200000000000003 110.656 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.433 ' HG2' ' CE2' ' A' ' 96' ' ' TYR . 12.4 pt-20 -97.83 130.31 44.75 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.191 0.52 . . . . 63.399999999999999 111.548 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.4 HG22 ' HA ' ' A' ' 75' ' ' LYS . 45.4 t -110.42 100.85 11.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 116.186 -0.461 . . . . 75.5 110.951 174.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.558 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 47.0 m -58.82 153.7 16.51 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.331 -0.395 . . . . 63.530000000000001 110.788 176.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.462 ' HG3' ' N ' ' A' ' 88' ' ' ILE . 10.8 pt-20 -40.46 -46.79 2.51 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 114.663 1.357 . . . . 73.400000000000006 114.663 -167.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.462 ' N ' ' HG3' ' A' ' 87' ' ' GLU . 2.6 pp -90.13 21.29 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-O 121.192 0.52 . . . . 75.200000000000003 112.197 -176.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.61 51.74 7.02 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 116.04 -0.527 . . . . 73.129999999999995 113.391 -178.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.558 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 62.2 tttp -118.7 135.98 54.19 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 117.34 0.57 . . . . 71.5 112.42 179.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.504 HD11 HD11 ' A' ' 78' ' ' LEU . 52.7 mt -113.93 138.24 44.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 123.028 0.531 . . . . 72.340000000000003 110.968 178.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.26 92.92 1.42 Allowed 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.851 0.357 . . . . 73.25 111.568 177.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.492 HD23 HD12 ' A' ' 58' ' ' ILE . 45.3 mt -53.23 -60.47 3.25 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.517 0.562 . . . . 73.530000000000001 112.517 -178.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -62.36 1.23 0.36 Allowed 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.192 0.812 . . . . 73.219999999999999 113.192 -172.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.419 ' HD2' ' CE2' ' A' ' 96' ' ' TYR . 9.1 tmtm? -112.9 -34.71 5.67 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 122.104 -0.373 . . . . 75.209999999999994 110.954 173.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.433 ' CE2' ' HG2' ' A' ' 84' ' ' GLU . 97.6 m-85 -108.85 5.79 24.83 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.364 0.505 . . . . 75.239999999999995 112.364 -177.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 50.9 tttm -63.31 133.13 53.64 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.144 0.497 . . . . 74.049999999999997 111.759 -174.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.445 ' CZ3' ' HE3' ' A' ' 29' ' ' MET . 16.0 t90 -57.28 125.12 21.34 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.046 -0.525 . . . . 71.109999999999999 111.827 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -107.24 90.39 5.61 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 116.061 -0.518 . . . . 74.549999999999997 110.918 177.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 CA--C 1.539 0.728 0 C-N-CA 122.636 2.224 . . . . 73.319999999999993 112.595 178.201 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 37.9 t70 . . . . . 0 CA--C 1.542 0.643 0 N-CA-C 112.609 0.596 . . . . 75.040000000000006 112.609 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -52.03 -37.69 54.39 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.928 -0.578 . . . . 64.340000000000003 112.244 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -53.66 -49.25 68.34 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.22 0.533 . . . . 75.239999999999995 110.607 177.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 77.8 mt -67.21 -45.75 75.93 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.601 -0.727 . . . . 72.310000000000002 111.218 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.9 t -55.79 -47.58 79.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.027 0.441 . . . . 74.129999999999995 111.655 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -67.16 -51.29 55.56 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.335 0.494 . . . . 74.310000000000002 112.335 -177.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.466 ' O ' HG13 ' A' ' 12' ' ' ILE . 33.5 pt -60.79 -42.72 93.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 O-C-N 122.154 -0.341 . . . . 73.310000000000002 111.576 -177.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -62.85 -43.83 97.76 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.061 0.458 . . . . 73.5 110.941 177.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.97 -39.64 66.15 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.983 -0.553 . . . . 61.130000000000003 111.725 177.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 67.6 t -69.68 -39.49 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 120.966 0.412 . . . . 72.439999999999998 111.521 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.504 ' HB ' HD11 ' A' ' 52' ' ' LEU . 82.8 mt -59.3 -33.87 52.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 116.21 -0.45 . . . . 75.439999999999998 111.955 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 83.0 m-70 -55.37 -25.28 34.31 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 113.171 0.804 . . . . 75.019999999999996 113.171 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -80.7 1.51 29.84 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.071 0.767 . . . . 73.450000000000003 113.071 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 57.2 mt -83.34 111.44 31.23 Favored Pre-proline 0 CA--C 1.543 0.676 0 O-C-N 121.961 -0.462 . . . . 73.409999999999997 110.943 177.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.85 157.72 57.49 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.675 2.25 . . . . 72.310000000000002 113.312 -176.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.8 tttp -62.67 94.81 0.07 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.218 0.532 . . . . 73.099999999999994 111.734 -177.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.423 ' H ' ' CZ ' ' A' ' 56' ' ' ARG . . . 142.94 -28.74 2.12 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-N 116.054 -0.521 . . . . 50.130000000000003 112.473 178.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -95.66 165.49 12.29 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.273 0.558 . . . . 73.140000000000001 112.067 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.7 m -141.43 159.68 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.677 -0.692 . . . . 73.310000000000002 110.482 176.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 94.1 p -138.35 -179.37 5.76 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.817 0.341 . . . . 61.329999999999998 111.023 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 51.2 p -106.21 155.91 18.99 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.855 0.36 . . . . 71.319999999999993 111.971 -179.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -54.91 -38.59 67.82 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.944 0.402 . . . . 74.019999999999996 110.945 177.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.26 -52.75 51.41 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-N 115.788 -0.642 . . . . 54.140000000000001 113.18 178.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -56.37 -48.3 77.13 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.905 0.383 . . . . 73.409999999999997 111.513 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.6 mm -58.75 -49.29 83.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 116.292 -0.413 . . . . 61.450000000000003 111.258 178.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.458 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -59.93 -45.28 93.09 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.965 0.412 . . . . 72.510000000000005 111.973 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.554 ' HZ1' ' HB3' ' A' ' 28' ' ' LYS . 9.4 mtpm? -57.79 -52.53 65.07 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.788 0.328 . . . . 75.25 111.408 178.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.49 ' HE3' ' CZ3' ' A' ' 98' ' ' TRP . 72.7 mtm -66.65 -28.18 68.27 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.399 -0.364 . . . . 74.439999999999998 111.879 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.72 -30.44 64.18 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.027 0.442 . . . . 62.350000000000001 111.417 176.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.71 13.15 19.33 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.333 -0.46 . . . . 71.209999999999994 113.057 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.458 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 76.3 m-85 -127.74 66.78 71.59 Favored Pre-proline 0 CA--C 1.543 0.679 0 O-C-N 122.61 -0.347 . . . . 63.210000000000001 111.714 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.71 144.73 60.86 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.224 1.95 . . . . 74.420000000000002 112.41 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.77 -11.78 65.56 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 121.032 -0.604 . . . . 71.310000000000002 113.523 -177.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -99.4 19.16 16.07 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 122.394 -0.474 . . . . 74.030000000000001 111.757 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.26 -42.92 66.99 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.263 0.468 . . . . 74.319999999999993 112.263 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -57.0 -37.51 71.75 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.009 0.374 . . . . 74.319999999999993 112.009 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -72.43 -31.9 65.87 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 120.653 0.264 . . . . 74.439999999999998 111.296 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.1 t -56.7 -51.78 62.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 120.887 0.375 . . . . 72.439999999999998 110.335 173.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -57.48 -42.41 93.88 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 121.219 -0.515 . . . . 43.329999999999998 113.039 176.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.758 ' HB3' ' HZ3' ' A' ' 41' ' ' LYS . 8.9 mtpm? -60.22 -34.54 73.81 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.795 0.331 . . . . 75.439999999999998 111.753 178.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.9 -41.75 59.13 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.324 -0.398 . . . . 55.229999999999997 111.475 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 86.2 mt -65.66 -42.15 91.71 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.316 -0.402 . . . . 75.219999999999999 111.908 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.28 -26.84 51.56 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 121.195 -0.526 . . . . 72.230000000000004 113.542 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -78.94 -20.15 50.0 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 122.584 -0.362 . . . . 70.049999999999997 111.751 -178.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 81.5 mt -68.03 147.17 98.43 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-O 120.851 0.357 . . . . 73.510000000000005 111.601 -179.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -84.13 177.53 5.88 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.693 2.262 . . . . 74.420000000000002 112.971 178.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.447 ' OE1' ' HD2' ' A' ' 73' ' ' ARG . 1.4 mp0 -71.72 -37.21 70.65 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.983 0.42 . . . . 71.140000000000001 111.156 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -94.38 43.54 2.35 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 121.371 -0.442 . . . . 71.420000000000002 113.344 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.0 t -84.19 159.75 20.97 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.99 0.424 . . . . 74.209999999999994 111.472 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -81.91 -12.91 58.19 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.435 0.635 . . . . 75.409999999999997 110.726 178.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.527 HD13 ' HD2' ' A' ' 53' ' ' PRO . 33.0 tp -107.05 126.05 31.09 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 115.735 -0.666 . . . . 75.549999999999997 110.983 179.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.527 ' HD2' HD13 ' A' ' 52' ' ' LEU . 57.0 Cg_endo -72.94 94.53 0.8 Allowed 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 121.205 1.27 . . . . 72.120000000000005 111.637 174.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 69.2 p-90 -86.66 -17.69 33.15 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.291 0.567 . . . . 73.549999999999997 111.673 -177.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.476 ' O ' HD21 ' A' ' 78' ' ' LEU . 37.4 p90 -73.88 -5.72 42.76 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.985 0.735 . . . . 62.350000000000001 112.985 -176.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.466 HH12 HD11 ' A' ' 83' ' ' ILE . 87.1 mtt-85 -99.24 12.92 34.83 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.771 0.656 . . . . 74.219999999999999 112.771 -177.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.4 t -123.11 112.76 35.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 121.263 0.554 . . . . 72.430000000000007 111.214 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.549 HD11 HD23 ' A' ' 93' ' ' LEU . 27.4 pt -122.04 -169.98 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-N 116.087 -0.506 . . . . 72.400000000000006 111.386 -178.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 32.9 p30 -85.22 167.75 15.39 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.83 -0.544 . . . . 73.510000000000005 112.048 -177.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.482 ' HA ' HG21 ' A' ' 22' ' ' THR . 50.3 p -66.3 -10.71 45.22 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.941 0.719 . . . . 74.140000000000001 112.941 -177.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -96.33 11.32 35.14 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.762 0.315 . . . . 54.210000000000001 111.628 179.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.33 39.0 87.89 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 116.438 -0.346 . . . . 72.510000000000005 113.53 176.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.451 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 56.4 mttp -139.45 157.97 44.93 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.208 0.528 . . . . 73.230000000000004 111.6 -178.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.419 HG21 ' OE1' ' A' ' 74' ' ' GLN . 59.2 mt -73.26 117.57 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.806 -0.634 . . . . 75.040000000000006 110.903 177.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.3 t -69.19 -33.01 72.69 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.06 0.457 . . . . 71.310000000000002 110.99 178.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.53 HD13 ' HB3' ' A' ' 70' ' ' ASP . 66.6 mt -65.08 148.28 51.95 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.162 -0.472 . . . . 71.219999999999999 111.118 177.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -130.25 149.38 51.97 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.965 0.412 . . . . 75.129999999999995 112.098 -176.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.15 -120.37 7.81 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-N 116.263 -0.426 . . . . 72.099999999999994 113.451 178.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -65.03 -46.19 82.34 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.943 0.402 . . . . 74.209999999999994 111.653 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.53 ' HB3' HD13 ' A' ' 66' ' ' LEU . 67.6 m-20 -59.38 -36.08 75.12 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.552 -0.294 . . . . 74.230000000000004 111.568 177.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.9 tt -62.99 -54.99 29.76 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.963 -0.384 . . . . 75.209999999999994 109.963 177.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -58.98 -32.88 70.05 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.134 0.492 . . . . 73.349999999999994 111.312 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.447 ' HD2' ' OE1' ' A' ' 48' ' ' GLU . 11.2 ttp180 -67.84 -51.95 42.55 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.005 -0.543 . . . . 64.239999999999995 111.572 -178.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.419 ' OE1' HG21 ' A' ' 64' ' ' ILE . 34.2 tt0 -62.87 -47.28 84.02 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.181 0.515 . . . . 74.439999999999998 110.216 174.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.0 tttt -47.77 -55.17 10.21 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.206 -0.906 . . . . 71.409999999999997 112.576 175.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -56.41 -42.7 78.43 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.087 0.403 . . . . 62.039999999999999 112.087 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -62.57 -42.02 99.3 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.093 0.473 . . . . 74.439999999999998 111.517 177.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.476 HD21 ' O ' ' A' ' 55' ' ' PHE . 81.2 mt -64.19 -44.1 93.05 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.204 -0.453 . . . . 73.140000000000001 111.767 178.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -55.48 -42.42 74.34 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.923 0.392 . . . . 75.109999999999999 111.111 176.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.93 -33.76 73.66 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.056 0.455 . . . . 71.230000000000004 111.833 177.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.418 ' HB3' HH22 ' A' ' 56' ' ' ARG . 8.2 mm-40 -83.6 1.72 40.83 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.377 -0.374 . . . . 72.430000000000007 111.952 -179.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.84 9.93 70.46 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 121.379 -0.439 . . . . 62.43 113.949 177.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.466 HD11 HH12 ' A' ' 56' ' ' ARG . 67.0 mt -89.15 136.18 24.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 117.023 0.411 . . . . 65.400000000000006 111.405 -178.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' A' ' 84' ' ' GLU . 9.2 pt-20 -76.44 114.66 15.39 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.143 0.497 . . . . 75.540000000000006 111.79 178.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.8 t -101.54 105.05 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 120.965 0.412 . . . . 74.209999999999994 110.666 172.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.616 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 25.2 t -69.48 157.96 36.11 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.423 -0.353 . . . . 73.430000000000007 111.77 178.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -37.55 -56.55 1.02 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.638 1.347 . . . . 71.129999999999995 114.638 -168.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.409 HD12 ' HB2' ' A' ' 90' ' ' LYS . 2.7 pp -86.54 18.27 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 112.69 0.626 . . . . 71.439999999999998 112.69 -174.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.2 44.83 7.85 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.113 -0.565 . . . . 36.710000000000001 112.518 -177.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.616 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 0.6 OUTLIER -105.52 128.15 53.42 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 122.539 -0.389 . . . . 72.109999999999999 110.389 -179.602 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.504 HD13 HD12 ' A' ' 58' ' ' ILE . 62.3 mt -116.53 139.67 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.899 0.381 . . . . 71.340000000000003 111.118 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.58 92.61 4.08 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.925 0.393 . . . . 71.209999999999994 111.786 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.587 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 57.4 mt -59.79 -44.19 94.05 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.733 0.302 . . . . 71.420000000000002 111.251 178.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 80.9 mtt-85 -56.48 -12.52 1.76 Allowed 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 112.173 0.434 . . . . 75.120000000000005 112.173 -177.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -109.92 -42.37 4.25 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 120.964 0.411 . . . . 73.519999999999996 111.814 176.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -101.7 6.46 41.87 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.149 0.425 . . . . 75.519999999999996 112.149 -171.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.587 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 78.0 tttt -61.56 129.35 40.7 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.143 0.497 . . . . 71.310000000000002 111.914 -175.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.49 ' CZ3' ' HE3' ' A' ' 29' ' ' MET . 21.2 t90 -71.03 116.96 11.93 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.978 -0.555 . . . . 73.129999999999995 111.991 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -124.65 92.66 47.51 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 115.971 -0.559 . . . . 65.340000000000003 110.58 175.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo . . . . . 0 CA--C 1.545 1.06 0 C-N-CA 122.959 2.44 . . . . 74.239999999999995 113.797 -177.94 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 . . . . . 0 CA--C 1.539 0.527 0 N-CA-C 112.744 0.646 . . . . 74.430000000000007 112.744 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -51.19 -31.74 21.22 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.625 -0.716 . . . . 64.299999999999997 112.318 178.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -57.61 -55.54 33.48 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.848 0.356 . . . . 75.439999999999998 110.727 177.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 77.0 mt -59.97 -45.19 93.49 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.964 -0.562 . . . . 75.25 111.218 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 62.0 t -57.14 -52.62 53.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 116.178 -0.465 . . . . 74.230000000000004 112.053 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.408 ' O ' HG22 ' A' ' 11' ' ' VAL . 28.7 mm-40 -67.58 -44.71 77.5 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.727 0.64 . . . . 73.430000000000007 112.727 -175.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.424 ' O ' HG13 ' A' ' 12' ' ' ILE . 36.8 pt -63.33 -43.43 98.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 120.909 -0.316 . . . . 73.219999999999999 111.281 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -62.87 -44.98 94.65 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.943 0.401 . . . . 75.349999999999994 110.978 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.52 -37.22 62.6 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.08 -0.509 . . . . 71.439999999999998 111.793 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 7' ' ' GLN . 96.0 t -70.21 -42.65 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-O 120.929 0.395 . . . . 73.200000000000003 111.513 178.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.524 ' HB ' HD11 ' A' ' 52' ' ' LEU . 79.9 mt -59.19 -30.57 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 112.28 0.474 . . . . 75.129999999999995 112.28 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -60.85 -12.52 11.22 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 112.966 0.728 . . . . 75.140000000000001 112.966 178.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -90.77 -3.5 57.38 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.481 0.549 . . . . 75.200000000000003 112.481 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.413 HD11 HG21 ' A' ' 12' ' ' ILE . 56.0 mt -84.3 113.79 50.65 Favored Pre-proline 0 CA--C 1.544 0.741 0 O-C-N 122.184 -0.322 . . . . 70.140000000000001 111.44 -179.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -70.5 163.78 37.64 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.961 2.44 . . . . 74.200000000000003 113.843 -177.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.35 120.85 12.99 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.944 -0.571 . . . . 74.420000000000002 111.639 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.33 14.09 46.02 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.092 -0.575 . . . . 75.209999999999994 113.442 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -126.03 148.3 49.34 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.889 0.376 . . . . 72.150000000000006 111.18 176.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.0 m -125.32 149.11 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-O 121.122 0.487 . . . . 71.519999999999996 111.613 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 97.8 p -128.67 167.03 17.8 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.106 -0.497 . . . . 73.010000000000005 110.83 177.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.5 p -103.79 147.45 27.27 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.763 0.316 . . . . 74.239999999999995 111.378 177.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -52.16 -36.52 51.82 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.751 0.31 . . . . 74.219999999999999 111.766 178.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -57.35 -43.82 93.68 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 121.129 -0.558 . . . . 73.329999999999998 112.779 177.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.492 ' O ' ' HG3' ' A' ' 29' ' ' MET . 41.7 mt-10 -65.11 -54.13 34.63 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.78 0.324 . . . . 73.450000000000003 111.112 177.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.8 mm -54.62 -51.12 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.3 -0.409 . . . . 73.239999999999995 111.889 -178.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.49 -46.19 84.0 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.945 0.402 . . . . 61.32 111.748 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -61.19 -48.38 81.82 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.781 0.324 . . . . 75.239999999999995 111.511 178.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.492 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 61.0 mtt -63.37 -30.1 71.29 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.096 0.474 . . . . 71.0 111.522 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.01 -19.57 58.55 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.158 -0.474 . . . . 74.209999999999994 111.858 178.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.57 23.26 12.49 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.191 -0.528 . . . . 74.519999999999996 113.154 -178.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -132.78 62.82 64.63 Favored Pre-proline 0 CA--C 1.542 0.648 0 O-C-N 122.48 -0.423 . . . . 75.200000000000003 111.064 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -62.5 119.82 7.09 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.27 1.98 . . . . 73.030000000000001 112.731 -177.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.44 -6.58 49.79 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.036 -0.602 . . . . 72.420000000000002 113.589 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -97.98 20.74 11.71 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 117.332 0.566 . . . . 74.209999999999994 111.375 177.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.8 -39.43 68.46 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.806 0.669 . . . . 74.040000000000006 112.806 -177.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -58.8 -34.89 72.01 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 120.924 0.392 . . . . 73.340000000000003 111.714 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -77.94 -28.25 49.51 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.687 -0.233 . . . . 65.230000000000004 111.408 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.3 t -59.66 -42.63 89.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.238 0.542 . . . . 74.239999999999995 110.12 172.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -62.7 -42.31 99.71 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 115.771 -0.65 . . . . 53.219999999999999 112.789 175.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -60.66 -41.82 95.78 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.049 0.452 . . . . 72.329999999999998 111.134 176.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.52 -54.47 45.07 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.177 -0.465 . . . . 55.219999999999999 111.418 178.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.471 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 80.6 mt -61.88 -38.53 88.66 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.932 0.396 . . . . 74.109999999999999 111.589 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.29 -17.77 70.65 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.339 -0.458 . . . . 73.420000000000002 113.396 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -101.07 2.84 40.79 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 122.416 -0.461 . . . . 73.230000000000004 111.391 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 69.9 mt -78.54 155.54 78.64 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-O 120.809 0.338 . . . . 73.450000000000003 111.321 176.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.518 ' HG2' ' HB2' ' A' ' 50' ' ' SER . 20.5 Cg_endo -61.02 140.76 91.7 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.116 1.877 . . . . 75.209999999999994 112.083 174.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.642 ' HG3' ' HD3' ' A' ' 73' ' ' ARG . 33.0 tt0 -43.52 -39.35 3.35 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.696 0.628 . . . . 73.400000000000006 112.696 -174.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -123.24 55.64 0.68 Allowed Glycine 0 CA--C 1.529 0.942 0 C-N-CA 121.098 -0.572 . . . . 74.340000000000003 113.491 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.518 ' HB2' ' HG2' ' A' ' 47' ' ' PRO . 37.8 t -63.5 168.2 4.86 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.427 0.632 . . . . 74.120000000000005 112.641 177.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -65.47 -32.66 74.39 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.309 0.576 . . . . 75.239999999999995 110.181 173.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.527 HD13 ' HD2' ' A' ' 53' ' ' PRO . 30.7 tp -84.48 127.04 67.49 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 115.641 -0.709 . . . . 75.319999999999993 110.894 177.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.527 ' HD2' HD13 ' A' ' 52' ' ' LEU . 61.5 Cg_endo -73.67 95.65 0.89 Allowed 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 121.396 1.398 . . . . 65.129999999999995 111.656 174.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.471 ' HB2' ' HB3' ' A' ' 43' ' ' LEU . 65.2 p-90 -79.52 -31.55 42.17 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.188 0.518 . . . . 74.340000000000003 111.891 -176.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.411 ' O ' HD21 ' A' ' 78' ' ' LEU . 27.3 p90 -63.6 -19.87 65.2 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.244 0.831 . . . . 71.230000000000004 113.244 -176.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.404 ' NH1' ' O ' ' A' ' 15' ' ' ILE . 98.5 mtt180 -77.76 2.07 18.14 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.497 0.554 . . . . 75.439999999999998 112.497 -177.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.4 t -122.22 125.62 73.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 O-C-N 121.9 -0.5 . . . . 74.430000000000007 111.426 179.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.633 HD12 HD22 ' A' ' 93' ' ' LEU . 33.8 pt -125.46 -171.39 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 120.978 0.418 . . . . 75.299999999999997 111.646 -179.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.8 p30 -73.03 171.65 12.48 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.243 0.544 . . . . 74.120000000000005 112.23 -179.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 46.6 p -79.69 8.52 6.46 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.074 0.464 . . . . 65.109999999999999 112.128 -179.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -95.64 -46.44 6.62 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.358 0.599 . . . . 74.140000000000001 110.944 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 121.33 32.38 1.06 Allowed Glycine 0 CA--C 1.522 0.475 0 CA-C-N 115.766 -0.652 . . . . 54.32 112.159 -175.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -138.67 163.14 32.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.092 0.472 . . . . 74.140000000000001 111.387 -177.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.48 HG21 ' OE1' ' A' ' 74' ' ' GLN . 65.3 mt -67.81 122.08 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 115.968 -0.56 . . . . 54.409999999999997 110.605 175.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.5 m -63.89 -41.83 97.61 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.166 0.508 . . . . 65.099999999999994 111.464 -178.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.484 HD13 ' HB3' ' A' ' 70' ' ' ASP . 86.6 mt -74.15 161.33 30.1 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.788 -0.642 . . . . 75.109999999999999 111.813 -178.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -130.18 177.11 7.55 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.8 0.333 . . . . 72.340000000000003 111.429 -178.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 57.38 -126.55 42.46 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 121.36 -0.447 . . . . 70.319999999999993 113.106 178.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 38.7 mtp180 -74.54 -32.13 62.35 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.171 0.51 . . . . 74.129999999999995 110.714 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.484 ' HB3' HD13 ' A' ' 66' ' ' LEU . 2.6 m-20 -60.02 -32.47 70.91 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.892 -0.595 . . . . 62.520000000000003 110.676 177.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.9 tt -63.28 -57.05 11.71 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.027 -0.533 . . . . 64.340000000000003 110.212 176.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -55.58 -36.87 67.35 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.902 0.382 . . . . 74.129999999999995 111.462 176.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.642 ' HD3' ' HG3' ' A' ' 48' ' ' GLU . 39.8 ttm180 -59.22 -58.87 6.71 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 116.383 -0.371 . . . . 73.219999999999999 111.65 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.48 ' OE1' HG21 ' A' ' 64' ' ' ILE . 53.6 tt0 -61.66 -41.01 96.94 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.708 0.289 . . . . 73.099999999999994 111.132 177.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -54.88 -58.67 6.66 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.259 -0.428 . . . . 75.439999999999998 111.72 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -52.9 -45.65 67.64 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.079 0.4 . . . . 75.310000000000002 112.079 -178.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -61.46 -30.53 70.65 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.853 0.359 . . . . 75.430000000000007 111.936 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.411 HD21 ' O ' ' A' ' 55' ' ' PHE . 94.8 mt -78.0 -42.08 33.84 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.046 0.45 . . . . 74.519999999999996 111.13 174.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -57.4 -39.4 76.02 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.913 0.387 . . . . 64.430000000000007 111.057 177.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.23 -24.39 63.13 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.119 -0.491 . . . . 73.430000000000007 111.929 178.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -95.38 -1.37 51.22 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 111.831 0.308 . . . . 73.510000000000005 111.831 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.24 12.89 44.05 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.512 -0.375 . . . . 75.340000000000003 113.689 177.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.418 ' HA ' ' CE1' ' A' ' 96' ' ' TYR . 66.6 mt -88.59 109.57 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 122.477 -0.425 . . . . 72.0 111.547 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -73.39 100.66 3.26 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.982 0.42 . . . . 75.329999999999998 111.465 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 58.2 t -92.41 130.45 41.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 120.901 0.381 . . . . 62.329999999999998 111.593 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.58 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 31.0 t -69.73 155.99 39.68 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.515 -0.311 . . . . 75.540000000000006 111.573 177.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.494 ' HG3' HG21 ' A' ' 88' ' ' ILE . 15.3 pt-20 -46.05 -49.84 15.85 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.034 1.124 . . . . 74.140000000000001 114.034 -169.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.494 HG21 ' HG3' ' A' ' 87' ' ' GLU . 2.9 pp -81.34 13.85 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 121.216 0.531 . . . . 74.420000000000002 112.326 -176.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.57 50.03 5.19 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 121.335 -0.459 . . . . 73.400000000000006 112.894 -178.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.58 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 14.4 tmtt? -117.27 129.63 56.03 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 122.326 -0.514 . . . . 73.540000000000006 111.197 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.495 HD12 HD13 ' A' ' 58' ' ' ILE . 60.6 mt -116.35 148.26 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.173 -0.467 . . . . 73.430000000000007 111.462 -177.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.32 99.96 8.16 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.886 0.374 . . . . 72.120000000000005 111.682 177.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.633 HD22 HD12 ' A' ' 58' ' ' ILE . 25.3 mt -69.64 -1.35 8.7 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.112 0.782 . . . . 74.150000000000006 113.112 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -98.05 -52.7 3.61 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.074 0.464 . . . . 74.150000000000006 111.181 173.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -69.28 -29.75 67.7 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.224 -0.444 . . . . 74.140000000000001 112.101 -177.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.418 ' CE1' ' HA ' ' A' ' 83' ' ' ILE . 90.5 m-85 -114.09 13.65 18.15 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 111.796 0.295 . . . . 75.409999999999997 111.796 -176.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.543 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 83.8 tttt -60.85 131.38 50.51 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 111.827 0.306 . . . . 74.530000000000001 111.827 -176.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 19.2 t90 -58.64 105.59 0.32 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.641 0.734 . . . . 74.5 111.151 176.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -113.45 95.29 35.5 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 115.348 -0.842 . . . . 74.0 110.723 177.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo . . . . . 0 CA--C 1.538 0.717 0 C-N-CA 122.511 2.141 . . . . 71.150000000000006 112.524 179.05 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.8 tpt . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 120.565 0.221 . . . . 73.25 110.952 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.439 ' O ' HG22 ' A' ' 6' ' ' VAL . 3.8 m-20 -55.8 129.14 38.2 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.42 0.526 . . . . 70.510000000000005 112.42 -177.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.512 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 23.0 tp60 -52.97 -44.27 67.03 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.416 -0.357 . . . . 73.140000000000001 111.655 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -54.74 -50.72 67.7 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.095 0.474 . . . . 72.510000000000005 111.069 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.1 mt -61.11 -42.24 98.17 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.942 -0.572 . . . . 73.420000000000002 111.322 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 2' ' ' ASP . 64.8 t -59.51 -41.58 85.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.007 0.432 . . . . 74.120000000000005 111.35 177.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 25.8 mm-40 -66.29 -54.31 26.4 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.345 -0.388 . . . . 73.439999999999998 111.896 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.492 HG22 HG23 ' A' ' 39' ' ' VAL . 37.2 pt -63.31 -43.86 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 111.746 0.276 . . . . 74.120000000000005 111.746 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 12.5 m-30 -60.67 -45.23 94.92 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.742 0.306 . . . . 75.310000000000002 111.147 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.435 ' O ' ' NE2' ' A' ' 14' ' ' GLN . . . -52.36 -43.86 64.9 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.365 -0.379 . . . . 72.209999999999994 111.226 177.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 93.5 t -64.46 -47.14 90.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.339 -0.391 . . . . 70.430000000000007 111.356 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 8' ' ' ILE . 79.7 mt -55.69 -33.98 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 116.084 -0.507 . . . . 60.109999999999999 112.303 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 74.9 m-70 -61.21 -16.15 41.97 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 112.702 0.63 . . . . 71.030000000000001 112.702 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.435 ' NE2' ' O ' ' A' ' 10' ' ' ALA . 1.0 OUTLIER -82.88 -7.3 59.67 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.073 0.397 . . . . 70.200000000000003 112.073 177.925 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.415 HG21 ' HB3' ' A' ' 56' ' ' ARG . 56.1 mt -80.46 116.48 62.15 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 122.421 -0.174 . . . . 74.430000000000007 111.203 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -69.94 170.2 17.35 Favored 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 123.062 2.508 . . . . 72.349999999999994 113.764 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.9 tttp -65.79 121.0 14.03 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.078 -0.51 . . . . 74.400000000000006 111.362 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.27 17.59 45.91 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 121.017 -0.611 . . . . 73.510000000000005 113.901 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -119.94 146.28 45.96 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 117.103 0.451 . . . . 71.299999999999997 111.389 176.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 56' ' ' ARG . 34.6 m -130.0 140.24 49.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.142 0.496 . . . . 75.230000000000004 111.307 177.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.556 ' HG ' HD12 ' A' ' 26' ' ' ILE . 83.9 p -122.47 170.27 10.14 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.842 0.354 . . . . 74.25 111.1 177.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 44.4 p -95.83 147.5 23.58 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.005 0.431 . . . . 65.150000000000006 111.487 178.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -52.91 -32.9 47.85 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 116.289 -0.414 . . . . 74.409999999999997 111.993 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.78 -44.02 95.37 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 121.094 -0.574 . . . . 73.409999999999997 112.965 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 29' ' ' MET . 46.7 mt-10 -64.59 -44.9 89.18 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.811 0.338 . . . . 73.140000000000001 111.347 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.556 HD12 ' HG ' ' A' ' 21' ' ' SER . 47.2 mm -60.58 -50.01 82.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 120.809 0.338 . . . . 62.409999999999997 111.307 177.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.5 -43.84 84.49 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.96 0.41 . . . . 71.230000000000004 111.517 177.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -59.21 -48.2 82.49 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.174 -0.466 . . . . 73.540000000000006 111.298 178.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.431 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 63.1 mtt -65.95 -28.75 69.15 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.878 0.371 . . . . 72.129999999999995 111.621 178.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.35 -20.55 51.1 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.928 0.394 . . . . 65.439999999999998 111.573 177.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.87 22.41 28.22 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.199 -0.524 . . . . 54.549999999999997 113.459 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -124.94 81.82 61.89 Favored Pre-proline 0 CA--C 1.543 0.68 0 O-C-N 122.393 -0.474 . . . . 74.430000000000007 111.79 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.62 131.72 37.03 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.732 2.288 . . . . 74.5 112.658 177.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.95 -8.46 79.77 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.014 -0.613 . . . . 64.439999999999998 113.649 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -89.68 22.6 2.99 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.482 0.549 . . . . 65.349999999999994 112.482 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.36 -57.58 11.24 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.012 0.434 . . . . 73.25 112.167 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 46.6 ttp180 -58.66 -32.3 68.97 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.008 0.433 . . . . 73.099999999999994 111.552 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.56 ' HA ' ' HE2' ' A' ' 41' ' ' LYS . 80.5 m-70 -65.2 -41.28 94.67 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.35 -0.386 . . . . 70.400000000000006 111.284 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.492 HG23 HG22 ' A' ' 8' ' ' ILE . 53.6 t -58.43 -37.95 67.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.264 0.554 . . . . 64.230000000000004 110.171 172.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.79 -37.66 95.01 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 115.808 -0.633 . . . . 73.140000000000001 112.999 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.56 ' HE2' ' HA ' ' A' ' 38' ' ' HIS . 41.1 mtmt -62.75 -47.27 84.26 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.006 0.431 . . . . 74.209999999999994 110.476 176.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.07 -51.42 66.41 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.869 -0.605 . . . . 72.409999999999997 111.921 -178.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.5 mt -63.56 -43.35 97.31 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.297 -0.41 . . . . 74.549999999999997 111.459 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.11 -22.72 72.69 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 120.853 -0.689 . . . . 61.509999999999998 112.884 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -79.85 -21.08 44.56 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.995 0.426 . . . . 73.319999999999993 111.277 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 91.6 mt -75.77 155.39 85.08 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 116.444 -0.344 . . . . 72.329999999999998 111.897 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.57 164.87 19.51 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.46 2.107 . . . . 64.299999999999997 112.192 174.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.47 ' O ' ' HE2' ' A' ' 77' ' ' LYS . 0.8 OUTLIER -64.91 -26.57 68.37 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.211 0.448 . . . . 74.150000000000006 112.211 -175.203 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -131.88 64.38 0.61 Allowed Glycine 0 CA--C 1.528 0.857 0 C-N-CA 121.094 -0.574 . . . . 71.310000000000002 113.325 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.6 t -79.72 172.77 13.34 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.182 0.515 . . . . 72.420000000000002 111.772 178.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? -67.79 -28.94 68.03 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.17 -0.468 . . . . 72.420000000000002 110.78 174.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.525 HD13 ' HD2' ' A' ' 53' ' ' PRO . 33.0 tp -86.71 124.8 68.74 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 116.017 -0.538 . . . . 74.420000000000002 111.02 177.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.525 ' HD2' HD13 ' A' ' 52' ' ' LEU . 38.0 Cg_endo -67.19 95.08 0.36 Allowed 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 121.285 1.324 . . . . 64.129999999999995 111.386 173.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.41 ' HH2' ' HG2' ' A' ' 73' ' ' ARG . 65.9 p-90 -82.51 -30.49 29.78 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.685 -0.689 . . . . 74.430000000000007 111.716 -177.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.453 ' O ' HD21 ' A' ' 78' ' ' LEU . 11.9 p90 -67.32 -11.53 57.85 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.335 0.865 . . . . 74.5 113.335 -175.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.468 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 94.2 mtt180 -86.27 8.08 22.73 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.024 0.75 . . . . 72.519999999999996 113.024 -174.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 20.9 t -127.86 116.23 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 O-C-N 121.81 -0.556 . . . . 72.530000000000001 111.652 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.429 HG21 HD12 ' A' ' 91' ' ' ILE . 28.0 pt -118.98 -174.52 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 116.472 -0.331 . . . . 75.040000000000006 111.376 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 35.4 p30 -83.78 168.75 15.89 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.139 0.495 . . . . 74.409999999999997 111.906 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.1 t -67.93 -9.24 43.5 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.234 -0.439 . . . . 62.240000000000002 111.951 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -88.14 0.69 55.73 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.619 -0.264 . . . . 73.5 111.53 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.41 42.59 89.36 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 121.015 -0.612 . . . . 41.200000000000003 112.396 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -141.15 157.32 45.44 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.096 0.474 . . . . 74.010000000000005 111.378 -176.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 63.8 mt -73.34 128.07 35.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 116.258 -0.428 . . . . 73.329999999999998 111.001 177.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.9 p -74.29 -31.04 62.35 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 120.973 0.416 . . . . 71.430000000000007 111.408 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.458 HD13 ' HB3' ' A' ' 70' ' ' ASP . 92.5 mt -74.91 152.51 38.85 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.171 -0.468 . . . . 73.430000000000007 111.09 177.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -129.45 171.4 12.59 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.017 0.436 . . . . 72.109999999999999 111.973 -176.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 57.58 -128.75 48.23 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 116.24 -0.436 . . . . 72.030000000000001 113.327 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -61.71 -39.41 91.4 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 122.586 -0.361 . . . . 74.219999999999999 111.339 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.458 ' HB3' HD13 ' A' ' 66' ' ' LEU . 19.7 m-20 -65.43 -25.9 67.73 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.026 0.38 . . . . 64.409999999999997 112.026 -178.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.8 tt -64.11 -55.92 18.55 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.881 -0.414 . . . . 71.239999999999995 109.881 174.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.546 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 33.0 t70 -65.99 -27.04 67.84 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.997 0.427 . . . . 73.040000000000006 111.219 177.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.462 ' HE ' ' HA ' ' A' ' 48' ' ' GLU . 51.9 ttt180 -57.44 -55.11 39.06 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.245 0.545 . . . . 72.409999999999997 110.878 173.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -64.84 -41.95 95.31 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.129 0.49 . . . . 74.049999999999997 110.562 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.546 ' HB3' ' HA ' ' A' ' 72' ' ' ASP . 32.0 tttm -54.81 -55.14 33.35 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.67 -0.696 . . . . 74.310000000000002 112.37 178.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -58.74 -36.96 75.17 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.932 0.396 . . . . 61.350000000000001 111.499 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.47 ' HE2' ' O ' ' A' ' 48' ' ' GLU . 45.3 mmtm -64.16 -42.44 96.74 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.923 0.392 . . . . 64.540000000000006 111.224 174.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.499 HD23 HD13 ' A' ' 83' ' ' ILE . 95.9 mt -68.99 -31.89 71.05 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.916 0.389 . . . . 73.549999999999997 111.631 178.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 46.6 mt-10 -65.81 -30.54 71.19 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.886 0.374 . . . . 72.109999999999999 110.516 175.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.26 -11.86 60.16 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.321 0.581 . . . . 74.010000000000005 111.12 173.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -97.82 -11.31 23.44 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.917 -0.583 . . . . 75.219999999999999 111.137 176.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.91 50.4 5.22 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.494 -0.384 . . . . 74.200000000000003 113.098 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.499 HD13 HD23 ' A' ' 78' ' ' LEU . 71.4 mt -119.97 129.54 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 O-C-N 122.682 -0.305 . . . . 70.420000000000002 111.248 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -75.64 91.52 2.88 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.347 0.594 . . . . 74.0 111.438 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.2 t -96.68 121.1 46.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.624 -0.716 . . . . 73.040000000000006 110.837 177.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.583 ' OG ' ' HB3' ' A' ' 90' ' ' LYS . 6.3 p -72.91 151.27 41.98 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 122.331 -0.23 . . . . 71.540000000000006 110.644 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -42.36 -44.7 4.03 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.584 1.327 . . . . 72.0 114.584 -173.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.424 HD13 ' HB2' ' A' ' 90' ' ' LYS . 2.9 pp -81.1 9.53 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 112.461 0.541 . . . . 62.240000000000002 112.461 -176.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.57 45.59 5.75 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 121.622 -0.323 . . . . 71.209999999999994 113.624 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.583 ' HB3' ' OG ' ' A' ' 86' ' ' SER . 1.2 tmtp? -114.35 132.84 56.06 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-O 121.009 0.433 . . . . 74.409999999999997 111.425 -178.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.429 HD12 HG21 ' A' ' 58' ' ' ILE . 60.0 mt -127.08 138.8 53.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 116.152 -0.476 . . . . 74.019999999999996 111.426 -178.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.29 93.93 6.01 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.947 0.403 . . . . 71.319999999999993 111.838 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.542 ' O ' ' HG3' ' A' ' 97' ' ' LYS . 38.5 mt -53.79 -52.33 60.62 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.09 0.404 . . . . 75.109999999999999 112.09 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -52.82 -14.07 0.5 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.296 0.85 . . . . 74.319999999999993 113.296 -174.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -112.98 -33.91 5.9 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 122.03 -0.419 . . . . 74.400000000000006 112.068 175.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -99.33 0.32 42.67 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.808 1.04 . . . . 73.409999999999997 113.808 -173.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.542 ' HG3' ' O ' ' A' ' 93' ' ' LEU . 33.0 mtpt -57.18 138.18 54.94 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.213 0.53 . . . . 74.450000000000003 112.22 -178.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 16.3 t90 -64.96 105.26 0.99 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.692 -0.686 . . . . 73.310000000000002 111.268 175.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.43 ' C ' ' H ' ' A' ' 101' ' ' LEU . 83.0 mt-30 -112.09 99.53 46.29 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 116.1 -0.5 . . . . 74.400000000000006 110.653 175.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.25 32.22 0.17 Allowed 'Trans proline' 0 CA--C 1.548 1.188 0 C-N-CA 122.948 2.432 . . . . 71.25 113.596 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.43 ' H ' ' C ' ' A' ' 99' ' ' GLN . 59.7 mt -103.78 -1.76 27.42 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.959 0.409 . . . . 75.239999999999995 111.069 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 . . . . . 0 C--O 1.253 1.253 0 N-CA-C 112.055 0.391 . . . . 74.329999999999998 112.055 -179.213 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ttt . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 120.617 0.246 . . . . 73.140000000000001 111.187 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -71.09 134.17 46.83 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.877 0.37 . . . . 55.530000000000001 111.354 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.554 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 52.5 tp60 -60.49 -33.21 72.28 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.385 -0.37 . . . . 63.140000000000001 111.236 -178.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -51.49 -49.69 61.34 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.265 0.555 . . . . 73.040000000000006 110.906 175.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.7 mt -61.67 -45.0 95.9 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.695 -0.684 . . . . 72.140000000000001 111.016 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.1 t -56.45 -41.11 71.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 120.958 0.409 . . . . 75.340000000000003 111.349 177.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.554 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 25.6 mm-40 -65.33 -58.94 4.66 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.316 -0.402 . . . . 74.519999999999996 111.758 -178.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.459 HG22 HG23 ' A' ' 39' ' ' VAL . 33.4 pt -61.02 -42.41 92.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 111.751 0.278 . . . . 75.420000000000002 111.751 -178.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -58.53 -49.78 76.17 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.794 0.331 . . . . 65.409999999999997 111.106 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.2 -39.94 67.12 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.326 -0.397 . . . . 70.299999999999997 111.916 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.41 HG21 ' O ' ' A' ' 7' ' ' GLN . 78.6 t -66.65 -42.5 89.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.058 0.456 . . . . 74.530000000000001 111.243 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.54 ' HB ' HD11 ' A' ' 52' ' ' LEU . 80.5 mt -61.85 -31.87 52.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 116.202 -0.453 . . . . 74.430000000000007 112.014 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -62.15 -15.44 45.92 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.312 0.486 . . . . 75.019999999999996 112.312 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -86.74 -5.85 59.0 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.471 0.545 . . . . 73.329999999999998 112.471 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.472 HD13 HD12 ' A' ' 26' ' ' ILE . 58.0 mt -81.21 117.96 70.32 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-O 120.677 0.275 . . . . 72.420000000000002 111.5 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.6 160.03 38.58 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.5 2.133 . . . . 72.209999999999994 113.082 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -62.9 131.03 47.37 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.318 -0.401 . . . . 74.519999999999996 111.359 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.89 2.04 61.3 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 120.88 -0.676 . . . . 73.030000000000001 113.55 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -122.13 148.31 45.06 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.075 0.464 . . . . 74.409999999999997 111.62 176.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.6 m -125.4 147.53 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-O 121.309 0.576 . . . . 65.230000000000004 111.374 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 44.4 t -123.2 174.51 7.23 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.199 -0.455 . . . . 73.239999999999995 110.355 175.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 67.6 p -105.82 147.44 28.66 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.598 0.237 . . . . 73.209999999999994 111.408 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -50.55 -36.75 35.86 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.129 0.49 . . . . 73.329999999999998 110.697 175.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.47 -48.0 85.24 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 115.735 -0.666 . . . . 74.099999999999994 113.243 177.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' A' ' 29' ' ' MET . 44.3 mt-10 -64.81 -48.41 74.52 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 117.073 0.437 . . . . 74.200000000000003 111.893 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.472 HD12 HD13 ' A' ' 15' ' ' ILE . 49.0 mm -55.53 -49.4 73.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 121.085 0.469 . . . . 74.120000000000005 111.052 177.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.479 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -62.99 -42.76 99.93 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.213 -0.449 . . . . 62.329999999999998 111.488 177.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -59.82 -42.56 93.76 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.985 0.421 . . . . 73.129999999999995 111.431 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.44 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 66.0 mtt -70.07 -34.87 73.74 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.0 0.429 . . . . 74.5 111.044 178.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.28 -30.68 66.57 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.132 -0.485 . . . . 74.219999999999999 111.672 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.39 13.73 14.41 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.512 -0.375 . . . . 74.540000000000006 113.355 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.533 ' HB3' ' HB2' ' A' ' 35' ' ' TYR . 52.2 m-85 -128.55 63.1 63.37 Favored Pre-proline 0 CA--C 1.548 0.898 0 O-C-N 122.556 -0.379 . . . . 74.319999999999993 111.766 -178.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -55.96 -43.08 60.26 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.646 2.23 . . . . 61.340000000000003 113.408 -175.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.04 -22.66 78.73 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.186 -0.53 . . . . 70.329999999999998 113.116 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.533 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 90.2 m-85 -86.23 6.67 28.5 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 111.962 0.356 . . . . 74.340000000000003 111.962 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.47 -36.18 32.44 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.244 0.545 . . . . 75.140000000000001 111.407 177.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.472 ' O ' ' HG3' ' A' ' 41' ' ' LYS . 14.8 ptp180 -55.41 -43.55 75.37 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.848 -0.615 . . . . 74.450000000000003 111.416 175.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -72.55 -30.3 64.32 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.334 -0.394 . . . . 73.540000000000006 111.443 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.459 HG23 HG22 ' A' ' 8' ' ' ILE . 58.5 t -57.74 -52.28 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 120.899 0.38 . . . . 63.420000000000002 110.569 175.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.16 -37.72 93.33 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.081 -0.58 . . . . 63.509999999999998 113.039 176.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 37' ' ' ARG . 28.2 mtpp -65.05 -44.14 89.99 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 122.515 -0.403 . . . . 73.140000000000001 111.192 177.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.47 -52.36 61.7 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.437 -0.347 . . . . 75.129999999999995 111.788 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.411 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 88.9 mt -56.92 -34.46 67.99 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.873 0.368 . . . . 72.310000000000002 111.592 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.98 -8.15 33.81 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 121.397 -0.43 . . . . 73.329999999999998 114.077 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.415 ' ND2' ' O ' ' A' ' 41' ' ' LYS . 45.7 m-80 -93.41 -12.63 29.39 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 117.379 0.589 . . . . 62.210000000000001 112.108 178.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.537 HD12 ' HB3' ' A' ' 54' ' ' TRP . 94.1 mt -74.02 143.68 81.11 Favored Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 112.189 0.441 . . . . 75.230000000000004 112.189 -175.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.25 177.51 6.52 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 122.898 2.398 . . . . 74.140000000000001 114.094 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -57.79 -45.66 85.7 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.542 -0.754 . . . . 73.209999999999994 111.736 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -114.75 56.17 0.51 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.3 -0.476 . . . . 54.119999999999997 112.897 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.4 t -66.9 159.35 28.53 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.266 0.469 . . . . 73.310000000000002 112.266 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -71.44 -11.18 60.75 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.168 0.508 . . . . 72.230000000000004 111.148 175.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.54 HD11 ' HB ' ' A' ' 12' ' ' ILE . 42.0 tp -117.59 124.26 29.07 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 115.849 -0.614 . . . . 75.439999999999998 110.713 177.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.522 ' HD2' HD13 ' A' ' 52' ' ' LEU . 58.6 Cg_endo -72.3 95.26 0.76 Allowed 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 121.364 1.376 . . . . 75.120000000000005 112.115 176.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.537 ' HB3' HD12 ' A' ' 46' ' ' LEU . 65.7 p-90 -83.5 -32.43 25.96 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.176 0.513 . . . . 74.310000000000002 111.89 -177.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -56.7 -24.81 51.74 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.227 0.825 . . . . 72.239999999999995 113.227 -177.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -77.85 2.43 17.28 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.444 0.535 . . . . 75.540000000000006 112.444 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 18.8 t -115.59 107.87 23.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.239 0.542 . . . . 72.329999999999998 111.479 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.501 HG21 HD11 ' A' ' 91' ' ' ILE . 33.7 pt -108.89 -169.73 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 116.164 -0.471 . . . . 71.25 111.339 178.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.586 ' HB3' ' OG ' ' A' ' 65' ' ' SER . 30.9 p30 -93.44 171.79 8.68 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.737 0.643 . . . . 73.109999999999999 112.737 -175.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 48.2 t -72.03 -8.08 52.47 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.88 -0.6 . . . . 73.400000000000006 111.712 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -84.59 -6.37 59.36 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.496 -0.32 . . . . 74.200000000000003 111.502 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.05 31.94 54.08 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 121.006 -0.616 . . . . 45.240000000000002 112.084 -174.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.795 ' HB3' ' HZ1' ' A' ' 63' ' ' LYS . 9.5 mtpm? -139.93 173.27 11.69 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.534 0.683 . . . . 71.140000000000001 112.02 -176.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.476 HG21 ' OE1' ' A' ' 74' ' ' GLN . 73.8 mt -86.45 116.12 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.415 -0.812 . . . . 74.340000000000003 110.469 173.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.586 ' OG ' ' HB3' ' A' ' 59' ' ' ASN . 58.0 m -71.62 -31.92 67.43 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.055 0.391 . . . . 71.150000000000006 112.055 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 81.9 mt -72.56 121.94 20.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.038 0.447 . . . . 73.010000000000005 111.594 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -115.16 159.56 20.77 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.02 0.438 . . . . 75.530000000000001 111.042 177.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.36 -141.59 15.65 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.95 -0.643 . . . . 71.439999999999998 111.689 -172.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 67.7 mtt-85 -72.45 -22.69 61.05 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 117.624 0.712 . . . . 74.230000000000004 110.782 177.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.552 ' HA ' ' HD2' ' A' ' 73' ' ' ARG . 23.3 m-20 -67.72 -23.3 65.26 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.017 -0.538 . . . . 64.099999999999994 111.561 177.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.4 tt -67.22 -56.07 11.43 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.87 0.366 . . . . 73.319999999999993 110.452 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.19 -27.79 68.94 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.536 -0.302 . . . . 73.239999999999995 111.802 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.552 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 97.5 mtt180 -57.33 -62.02 2.06 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.906 0.384 . . . . 74.430000000000007 111.223 172.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.476 ' OE1' HG21 ' A' ' 64' ' ' ILE . 55.5 tt0 -63.88 -40.69 97.11 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.315 -0.402 . . . . 74.129999999999995 111.584 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.453 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 58.9 tttm -57.58 -61.91 2.16 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 111.917 0.34 . . . . 74.329999999999998 111.917 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -57.59 -37.93 74.02 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 111.959 0.355 . . . . 75.430000000000007 111.959 -176.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -55.4 -49.34 72.6 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.023 0.44 . . . . 73.510000000000005 111.533 176.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.8 mt -70.02 -40.16 75.38 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.052 0.454 . . . . 71.540000000000006 111.265 -177.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 45.0 mt-10 -61.76 -35.21 77.44 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.996 0.427 . . . . 72.420000000000002 110.767 176.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.26 -31.99 71.8 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.294 -0.412 . . . . 62.219999999999999 111.486 176.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -81.49 -9.95 59.59 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.67 0.271 . . . . 71.030000000000001 111.679 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.86 27.28 8.45 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 121.346 -0.454 . . . . 72.120000000000005 113.386 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 68.4 mt -98.34 130.78 46.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 120.91 0.386 . . . . 73.239999999999995 111.83 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.419 ' HG3' ' OH ' ' A' ' 96' ' ' TYR . 45.0 mt-10 -67.62 118.6 11.12 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.447 -0.342 . . . . 72.219999999999999 111.243 175.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.9 t -128.57 109.5 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 120.785 0.326 . . . . 74.349999999999994 110.85 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.631 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 40.9 m -61.7 147.05 47.26 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.524 -0.307 . . . . 74.239999999999995 111.184 177.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -45.38 -44.65 12.04 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.952 1.093 . . . . 75.329999999999998 113.952 -170.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.8 pp -80.45 14.27 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 112.404 0.52 . . . . 74.310000000000002 112.404 -177.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.15 57.49 3.18 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 121.432 -0.413 . . . . 53.240000000000002 112.984 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.631 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 62.1 tttm -125.8 127.09 45.58 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 120.703 0.287 . . . . 71.439999999999998 111.334 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.501 HD11 HG21 ' A' ' 58' ' ' ILE . 56.0 mt -126.26 152.16 33.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-O 120.903 0.382 . . . . 74.230000000000004 111.469 -175.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -84.02 99.52 10.48 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.274 0.472 . . . . 73.010000000000005 112.274 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.57 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 23.4 mt -70.7 -1.61 11.92 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.041 0.756 . . . . 73.109999999999999 113.041 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 53.3 mtp85 -96.99 -42.03 8.1 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 122.067 -0.396 . . . . 73.129999999999995 111.302 173.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -76.66 -37.39 56.31 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.101 0.408 . . . . 74.129999999999995 112.101 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.419 ' OH ' ' HG3' ' A' ' 84' ' ' GLU . 84.6 m-85 -109.82 14.2 23.3 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.461 0.541 . . . . 73.519999999999996 112.461 -171.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.57 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 59.2 tttp -62.37 132.71 53.51 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 120.999 0.428 . . . . 73.329999999999998 111.613 -177.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 23.0 t90 -69.51 109.52 4.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.235 0.54 . . . . 75.420000000000002 111.568 176.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -115.23 98.09 49.7 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 115.713 -0.676 . . . . 74.109999999999999 110.758 174.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.17 -12.26 33.93 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.629 2.219 . . . . 72.530000000000001 112.473 173.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 66.7 mt -109.68 124.64 51.56 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.12 -0.491 . . . . 73.209999999999994 110.494 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 C--O 1.254 1.302 0 CA-C-O 118.726 -0.654 . . . . 73.319999999999993 111.924 -178.342 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.5 tpt . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.714 0.292 . . . . 73.209999999999994 110.954 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.538 ' HB2' ' HG ' ' A' ' 5' ' ' LEU . 5.6 m-20 -63.88 127.99 33.83 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.604 -0.271 . . . . 63.329999999999998 111.438 178.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.429 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 14.3 mm100 -60.15 -25.9 65.87 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.625 0.25 . . . . 73.120000000000005 110.993 175.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -53.57 -50.66 65.08 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.171 0.51 . . . . 74.439999999999998 110.336 170.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.538 ' HG ' ' HB2' ' A' ' 2' ' ' ASP . 65.0 mt -62.39 -45.76 91.66 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.769 -0.65 . . . . 74.430000000000007 110.788 177.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.4 t -56.7 -43.56 79.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 116.018 -0.537 . . . . 73.409999999999997 111.797 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 30.2 mm-40 -68.27 -52.0 38.82 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.044 0.387 . . . . 63.310000000000002 112.044 -178.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.479 HG23 HG23 ' A' ' 39' ' ' VAL . 32.2 pt -59.6 -41.79 86.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 121.065 -0.254 . . . . 73.120000000000005 111.325 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -63.91 -44.21 93.63 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.124 0.488 . . . . 74.230000000000004 110.71 175.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.423 ' O ' ' NE2' ' A' ' 14' ' ' GLN . . . -56.5 -32.23 64.83 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.914 -0.585 . . . . 74.549999999999997 111.819 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.414 HG21 ' O ' ' A' ' 7' ' ' GLN . 88.3 t -73.35 -47.04 47.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.97 0.414 . . . . 73.349999999999994 111.492 176.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.565 ' HB ' HD11 ' A' ' 52' ' ' LEU . 80.9 mt -58.6 -31.69 44.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 112.888 0.699 . . . . 73.200000000000003 112.888 -175.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -60.7 -11.33 7.1 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 112.663 0.616 . . . . 75.420000000000002 112.663 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.423 ' NE2' ' O ' ' A' ' 10' ' ' ALA . 1.6 mp0 -92.23 -2.17 56.65 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.217 0.451 . . . . 72.239999999999995 112.217 178.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.485 HD12 HD12 ' A' ' 26' ' ' ILE . 53.7 mt -84.75 112.53 43.32 Favored Pre-proline 0 CA--C 1.541 0.634 0 O-C-N 122.221 -0.299 . . . . 64.019999999999996 110.591 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -72.37 165.4 32.79 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.471 2.114 . . . . 74.219999999999999 113.573 -177.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.455 ' HG3' ' OE1' ' A' ' 81' ' ' GLU . 61.5 tttm -59.73 133.35 56.02 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.861 -0.609 . . . . 72.109999999999999 112.08 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.96 -7.91 80.51 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-N 116.239 -0.437 . . . . 73.219999999999999 114.083 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -108.19 155.25 20.66 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 117.335 0.567 . . . . 74.5 112.034 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.5 m -134.17 159.26 42.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 115.965 -0.561 . . . . 74.439999999999998 111.468 178.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 44.6 t -139.24 175.28 9.69 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.948 0.404 . . . . 55.310000000000002 110.783 176.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.4 p -109.28 154.62 22.2 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.835 0.35 . . . . 74.010000000000005 111.551 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.527 ' HE2' ' HG ' ' A' ' 65' ' ' SER . 37.1 m-85 -52.92 -34.78 56.75 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.454 -0.339 . . . . 75.340000000000003 111.461 177.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.09 -51.32 54.07 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.334 -0.46 . . . . 63.219999999999999 112.86 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.429 ' O ' ' HG3' ' A' ' 29' ' ' MET . 41.3 mt-10 -58.93 -47.85 83.58 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.85 0.357 . . . . 73.349999999999994 111.257 178.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.485 HD12 HD12 ' A' ' 15' ' ' ILE . 49.7 mm -60.02 -47.63 91.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 116.42 -0.355 . . . . 73.219999999999999 111.579 178.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.23 -45.72 90.39 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.875 0.369 . . . . 73.299999999999997 111.907 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -61.96 -43.76 98.17 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.759 0.314 . . . . 74.409999999999997 111.453 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.429 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 64.8 mtt -67.06 -34.27 77.31 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.751 0.31 . . . . 75.540000000000006 111.248 178.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.74 -18.31 62.14 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.347 -0.388 . . . . 74.120000000000005 112.009 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.34 14.65 32.35 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 121.423 -0.418 . . . . 73.310000000000002 113.533 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -127.39 72.95 77.65 Favored Pre-proline 0 CA--C 1.541 0.632 0 O-C-N 122.38 -0.482 . . . . 65.450000000000003 111.276 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.21 97.34 0.84 Allowed 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.184 1.923 . . . . 70.230000000000004 112.969 -177.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 142.89 -35.25 1.72 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 120.803 -0.713 . . . . 74.319999999999993 113.258 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -84.06 34.57 0.51 Allowed 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.257 0.465 . . . . 74.310000000000002 112.257 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.77 -39.35 88.45 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.99 0.424 . . . . 72.219999999999999 111.676 -178.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.5 ttt85 -61.15 -29.33 69.72 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 116.363 -0.381 . . . . 75.549999999999997 111.525 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -76.65 -33.39 58.33 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.828 0.347 . . . . 75.439999999999998 110.705 177.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.479 HG23 HG23 ' A' ' 8' ' ' ILE . 47.3 t -58.46 -42.57 84.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 121.346 0.593 . . . . 71.519999999999996 109.706 170.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.97 -37.48 92.74 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 115.532 -0.758 . . . . 71.019999999999996 113.105 175.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -62.12 -44.52 96.46 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.017 0.437 . . . . 73.150000000000006 111.27 176.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.49 -55.21 25.89 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.099 0.476 . . . . 74.109999999999999 111.807 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.5 mt -65.64 -32.71 74.43 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.211 -0.45 . . . . 75.219999999999999 111.648 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.84 -15.77 62.82 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.322 -0.466 . . . . 73.099999999999994 113.18 177.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -89.59 -29.54 18.8 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 122.552 -0.381 . . . . 71.299999999999997 110.802 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 97.5 mt -61.8 112.19 5.74 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-O 120.988 0.423 . . . . 75.040000000000006 111.323 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -93.33 -170.1 0.24 Allowed 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.946 2.43 . . . . 65.530000000000001 114.597 -173.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.433 ' CD ' ' HZ2' ' A' ' 77' ' ' LYS . 10.4 tp10 -62.81 107.16 0.92 Allowed 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.206 -0.906 . . . . 62.219999999999999 111.171 176.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 128.11 -2.43 6.76 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 121.092 -0.575 . . . . 74.439999999999998 113.503 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.4 t -64.24 137.8 58.11 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.24 0.459 . . . . 75.420000000000002 112.24 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -68.9 -43.91 74.29 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.308 0.575 . . . . 75.340000000000003 110.618 175.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.565 HD11 ' HB ' ' A' ' 12' ' ' ILE . 35.9 tp -71.93 125.26 91.62 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.419 -0.809 . . . . 75.219999999999999 110.797 177.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.524 ' HD2' HD13 ' A' ' 52' ' ' LEU . 58.2 Cg_endo -71.98 94.95 0.73 Allowed 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 121.138 1.225 . . . . 75.0 111.757 176.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 60.9 p-90 -81.01 -30.95 34.84 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.754 -0.657 . . . . 74.010000000000005 111.338 -178.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -60.49 -16.82 40.61 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.649 0.611 . . . . 70.129999999999995 112.649 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.444 ' NH2' ' HA ' ' A' ' 17' ' ' LYS . 64.3 mtt-85 -78.3 -11.75 59.96 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.098 0.407 . . . . 75.319999999999993 112.098 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 22.7 t -111.71 120.21 61.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.278 0.561 . . . . 64.439999999999998 111.934 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.703 HD12 HD23 ' A' ' 93' ' ' LEU . 37.0 pt -120.48 -169.89 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 121.268 0.556 . . . . 65.430000000000007 111.731 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.9 p30 -89.78 172.65 8.76 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 121.221 0.534 . . . . 73.450000000000003 112.329 -176.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 63.4 p -72.27 -2.99 21.05 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 116.25 -0.432 . . . . 70.209999999999994 111.968 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -89.02 -12.0 42.61 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.969 0.414 . . . . 75.329999999999998 110.868 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.65 27.05 55.3 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.277 -0.487 . . . . 63.509999999999998 112.814 -177.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.567 ' HB3' ' HZ1' ' A' ' 63' ' ' LYS . 8.4 mtpm? -128.1 163.22 25.08 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.388 0.613 . . . . 75.209999999999994 112.324 -177.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.547 HG22 ' OE1' ' A' ' 74' ' ' GLN . 67.3 mt -71.39 116.4 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 115.428 -0.805 . . . . 73.099999999999994 109.728 170.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.527 ' HG ' ' HE2' ' A' ' 23' ' ' TYR . 67.1 m -75.17 -17.5 60.38 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.02 0.748 . . . . 75.219999999999999 113.02 -173.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 90.9 mt -77.23 176.33 8.86 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.107 0.48 . . . . 74.120000000000005 112.141 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.1 ptmm? -130.6 142.25 50.45 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.394 0.516 . . . . 73.140000000000001 112.394 -174.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 48.9 -124.26 12.26 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-N 115.947 -0.57 . . . . 61.43 114.076 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 19.7 mtm180 -43.3 -53.68 5.07 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.805 0.812 . . . . 73.450000000000003 111.157 177.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.449 ' O ' ' HB2' ' A' ' 73' ' ' ARG . 4.3 m-20 -63.7 -34.1 77.11 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.784 -1.098 . . . . 72.420000000000002 111.507 -176.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.3 tt -63.72 -49.06 74.55 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 109.536 -0.542 . . . . 75.030000000000001 109.536 175.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -63.88 -19.44 65.07 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.841 -0.618 . . . . 55.240000000000002 112.066 177.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.558 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 39.1 mmt180 -66.75 -59.49 3.52 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.034 0.445 . . . . 72.319999999999993 110.927 172.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.547 ' OE1' HG22 ' A' ' 64' ' ' ILE . 50.0 tt0 -58.99 -38.87 80.17 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.939 0.4 . . . . 74.549999999999997 110.225 177.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.513 ' HG3' HG13 ' A' ' 85' ' ' VAL . 81.2 tttt -59.66 -56.72 18.32 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.999 -0.546 . . . . 73.0 112.209 177.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.558 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 20.8 pt20 -54.27 -36.68 63.88 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 120.896 0.379 . . . . 74.310000000000002 111.64 -176.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.433 ' HZ2' ' CD ' ' A' ' 48' ' ' GLU . 72.6 mmtt -67.76 -49.38 62.8 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.945 0.403 . . . . 75.530000000000001 111.231 177.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 74' ' ' GLN . 64.8 mt -58.1 -45.36 87.35 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.241 -0.436 . . . . 73.230000000000004 111.375 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -62.9 -40.77 98.57 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.757 0.313 . . . . 73.25 110.976 177.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.03 -23.69 67.57 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.158 0.504 . . . . 72.319999999999993 111.216 175.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.455 ' OE1' ' HG3' ' A' ' 17' ' ' LYS . 42.1 mm-40 -80.43 -23.15 40.5 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.986 -0.552 . . . . 73.140000000000001 111.556 175.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.55 14.86 52.31 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 116.234 -0.439 . . . . 65.129999999999995 112.487 -174.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 76.9 mt -82.83 130.0 36.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 122.506 0.322 . . . . 71.450000000000003 111.007 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.413 ' HG3' ' OH ' ' A' ' 96' ' ' TYR . 51.6 mt-10 -66.95 92.83 0.24 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.314 0.578 . . . . 74.129999999999995 112.115 -177.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.513 HG13 ' HG3' ' A' ' 75' ' ' LYS . 61.2 t -90.49 113.89 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 115.897 -0.592 . . . . 73.030000000000001 110.91 174.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.515 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 39.6 t -66.23 142.1 57.82 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.502 -0.317 . . . . 74.349999999999994 111.034 174.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -42.37 -42.85 3.33 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.672 0.99 . . . . 65.329999999999998 113.672 -174.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.8 pp -82.33 22.64 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 N-CA-C 112.481 0.548 . . . . 74.019999999999996 112.481 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.24 57.97 7.06 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-N 116.428 -0.351 . . . . 52.240000000000002 113.36 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.515 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 84.2 tttt -132.28 149.91 52.27 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.769 0.319 . . . . 72.549999999999997 111.244 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.54 HD13 HD13 ' A' ' 58' ' ' ILE . 57.1 mt -125.16 150.49 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 120.861 0.362 . . . . 74.219999999999999 111.441 -177.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.9 92.68 7.85 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.804 0.335 . . . . 64.319999999999993 111.065 175.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.703 HD23 HD12 ' A' ' 58' ' ' ILE . 50.7 mt -59.25 -56.1 26.49 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.36 0.504 . . . . 75.109999999999999 112.36 -177.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 41.0 mtm-85 -56.16 -19.62 14.29 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.13 0.419 . . . . 70.049999999999997 112.13 -175.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -95.09 -29.0 14.81 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.491 -0.322 . . . . 72.340000000000003 111.796 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.413 ' OH ' ' HG3' ' A' ' 84' ' ' GLU . 91.8 m-85 -118.05 9.01 12.59 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.66 0.985 . . . . 74.219999999999999 113.66 -175.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.512 ' HG3' ' O ' ' A' ' 93' ' ' LEU . 24.9 mtpp -54.67 133.7 46.91 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 118.489 0.586 . . . . 73.219999999999999 112.142 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 16.2 t90 -57.29 113.09 1.6 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.692 -0.685 . . . . 74.150000000000006 111.636 177.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.415 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 65.7 mt-30 -113.57 92.51 24.16 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 115.537 -0.756 . . . . 71.450000000000003 110.28 177.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -81.08 -5.32 12.88 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.712 2.275 . . . . 73.120000000000005 114.078 -177.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 82.4 mt -123.18 159.63 28.22 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.037 0.384 . . . . 75.439999999999998 112.037 -175.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 . . . . . 0 C--O 1.251 1.152 0 CA-C-O 118.727 -0.654 . . . . 64.209999999999994 110.803 175.092 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 tpt . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 120.593 0.235 . . . . 71.010000000000005 110.861 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.504 ' HB2' ' HG ' ' A' ' 5' ' ' LEU . 5.0 m-20 -64.89 138.99 58.71 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.055 0.391 . . . . 73.099999999999994 112.055 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -58.32 -34.74 70.93 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.901 0.381 . . . . 64.549999999999997 110.314 173.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.433 ' O ' HG12 ' A' ' 8' ' ' ILE . 34.2 t80 -51.95 -49.97 62.13 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.786 -0.643 . . . . 74.209999999999994 111.174 174.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.504 ' HG ' ' HB2' ' A' ' 2' ' ' ASP . 84.3 mt -60.97 -52.11 66.41 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.01 -0.541 . . . . 75.239999999999995 111.064 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 40.0 t -55.85 -45.81 79.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 116.126 -0.488 . . . . 74.200000000000003 111.661 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.414 ' O ' HG21 ' A' ' 11' ' ' VAL . 26.8 mm-40 -63.36 -56.89 12.66 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.161 0.43 . . . . 74.340000000000003 112.161 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.513 ' O ' HG13 ' A' ' 12' ' ' ILE . 34.0 pt -58.44 -45.14 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 121.109 -0.237 . . . . 70.129999999999995 111.567 -178.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -60.64 -45.3 94.59 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.015 0.436 . . . . 72.129999999999995 111.016 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.1 -26.75 64.95 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.17 -0.468 . . . . 73.099999999999994 111.817 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.414 HG21 ' O ' ' A' ' 7' ' ' GLN . 99.2 t -80.99 -43.36 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-O 120.88 0.372 . . . . 73.430000000000007 111.213 176.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.513 HG13 ' O ' ' A' ' 8' ' ' ILE . 81.7 mt -54.91 -36.65 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 112.631 0.604 . . . . 74.430000000000007 112.631 -178.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -55.15 -19.43 7.69 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.895 0.702 . . . . 74.239999999999995 112.895 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -77.12 -23.36 51.77 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.561 0.578 . . . . 74.329999999999998 112.561 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.441 ' O ' ' NH1' ' A' ' 56' ' ' ARG . 38.9 mt -70.56 118.7 67.11 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 122.201 0.2 . . . . 74.239999999999995 111.495 -177.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -79.68 170.32 17.14 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 122.758 2.305 . . . . 61.439999999999998 114.005 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 49.7 tttp -64.02 135.41 56.42 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.992 -0.549 . . . . 74.409999999999997 111.294 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 86.31 2.51 85.37 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.078 -0.582 . . . . 42.32 113.402 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.445 ' HB3' ' HA ' ' A' ' 98' ' ' TRP . 47.0 mmtm -118.23 145.44 45.0 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.103 0.478 . . . . 65.239999999999995 111.739 177.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.435 HG12 HD12 ' A' ' 83' ' ' ILE . 18.7 m -131.46 150.4 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 115.91 -0.586 . . . . 75.439999999999998 111.321 177.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 88.7 p -129.19 164.53 23.21 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.537 -0.302 . . . . 73.099999999999994 110.724 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.6 p -90.22 146.91 23.89 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.836 0.35 . . . . 73.040000000000006 111.62 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -49.57 -37.37 27.11 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.025 0.44 . . . . 74.540000000000006 111.3 176.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.05 -40.19 98.15 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 115.95 -0.568 . . . . 75.310000000000002 113.466 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -69.07 -50.54 47.43 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.983 0.392 . . . . 73.329999999999998 111.603 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.5 mm -59.35 -47.61 89.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 120.841 0.353 . . . . 75.129999999999995 110.965 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.533 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -60.81 -44.78 96.42 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.405 -0.361 . . . . 71.530000000000001 111.591 177.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -54.99 -51.34 66.53 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.977 0.418 . . . . 75.420000000000002 111.731 177.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 67.9 mtm -71.24 -27.3 63.37 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.07 -0.513 . . . . 74.340000000000003 112.049 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.44 -30.81 62.04 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.946 0.403 . . . . 73.099999999999994 111.521 176.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.07 17.04 10.52 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.405 -0.426 . . . . 73.439999999999998 113.243 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.533 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 53.1 m-85 -133.48 61.66 55.19 Favored Pre-proline 0 CA--C 1.549 0.91 0 O-C-N 122.665 -0.315 . . . . 75.239999999999995 111.237 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -52.0 -38.47 69.52 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.022 2.481 . . . . 75.329999999999998 114.307 -173.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.8 -1.32 86.97 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 121.133 -0.555 . . . . 72.239999999999995 113.619 -178.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.48 ' O ' HG22 ' A' ' 39' ' ' VAL . 11.2 m-85 -97.51 10.61 39.34 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.925 0.713 . . . . 73.239999999999995 112.925 -177.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.68 -50.18 34.38 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.565 0.698 . . . . 75.439999999999998 111.083 176.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -52.41 -44.43 65.39 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.299 -0.864 . . . . 74.510000000000005 111.697 172.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.401 ' HD2' ' HA ' ' A' ' 35' ' ' TYR . 99.2 m-70 -72.18 -26.17 61.96 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.381 -0.372 . . . . 74.25 111.725 -177.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.48 HG22 ' O ' ' A' ' 35' ' ' TYR . 58.9 t -62.83 -46.72 95.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 120.894 0.378 . . . . 72.450000000000003 110.295 174.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -57.48 -42.63 94.01 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.102 -0.571 . . . . 65.519999999999996 112.355 174.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -64.17 -37.49 87.66 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.898 0.38 . . . . 74.340000000000003 111.223 175.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.76 -44.26 81.89 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.321 -0.399 . . . . 64.200000000000003 112.065 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 39' ' ' VAL . 61.4 mt -63.61 -29.08 70.38 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.801 0.334 . . . . 71.450000000000003 111.355 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.43 -16.3 49.31 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 121.238 -0.506 . . . . 65.140000000000001 113.29 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -77.19 -21.45 53.91 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.011 0.434 . . . . 73.340000000000003 111.247 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 95.0 mt -89.8 135.75 30.12 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-O 121.058 0.456 . . . . 73.420000000000002 112.163 -175.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -81.88 178.56 6.37 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.83 2.353 . . . . 72.439999999999998 113.539 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.53 ' HB3' ' HG3' ' A' ' 73' ' ' ARG . 1.2 pm0 -86.19 23.46 1.53 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.95 -0.568 . . . . 75.349999999999994 112.211 -177.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -147.29 35.81 1.22 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 121.195 -0.526 . . . . 38.170000000000002 112.693 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 34.6 t -86.52 166.76 15.2 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.47 0.653 . . . . 74.430000000000007 112.759 -176.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -82.23 -10.27 59.19 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.374 -0.83 . . . . 64.120000000000005 111.4 176.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.53 HD13 ' HD2' ' A' ' 53' ' ' PRO . 41.3 tp -109.68 122.56 38.88 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 116.028 -0.533 . . . . 71.540000000000006 110.792 178.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.53 ' HD2' HD13 ' A' ' 52' ' ' LEU . 67.8 Cg_endo -76.1 94.3 1.02 Allowed 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 121.182 1.255 . . . . 62.109999999999999 111.716 175.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 53.3 p-90 -84.46 -33.92 23.54 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.72 -0.673 . . . . 73.420000000000002 111.707 -176.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.449 ' O ' HD21 ' A' ' 78' ' ' LEU . 9.6 p90 -56.73 -19.45 16.83 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.209 0.818 . . . . 71.25 113.209 -178.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.441 ' NH1' ' O ' ' A' ' 15' ' ' ILE . 98.0 mtt180 -73.53 4.9 4.29 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 112.31 0.485 . . . . 75.230000000000004 112.31 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.5 t -122.92 116.44 48.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 CA-C-O 121.22 0.534 . . . . 64.340000000000003 111.303 177.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.495 HG21 HD13 ' A' ' 91' ' ' ILE . 28.9 pt -120.18 -170.81 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 116.329 -0.396 . . . . 71.219999999999999 111.433 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.455 ' HB3' ' OG ' ' A' ' 65' ' ' SER . 32.5 p30 -86.74 169.72 12.39 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.375 0.607 . . . . 72.230000000000004 112.46 -176.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.2 m -63.8 -26.71 68.75 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.835 -0.621 . . . . 70.409999999999997 112.16 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -76.24 -7.59 55.22 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.257 0.466 . . . . 72.030000000000001 112.257 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.55 42.67 13.57 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 121.242 -0.504 . . . . 52.530000000000001 112.627 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.448 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 58.3 mtpt -140.94 171.08 14.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.993 0.425 . . . . 73.329999999999998 110.757 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 59.2 mt -84.56 122.69 38.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 116.407 -0.361 . . . . 73.099999999999994 110.661 176.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.455 ' OG ' ' HB3' ' A' ' 59' ' ' ASN . 58.4 m -81.77 -12.11 58.71 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.234 0.457 . . . . 55.240000000000002 112.234 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.6 mt -80.61 148.57 30.22 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.821 0.343 . . . . 74.319999999999993 110.79 174.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -116.5 157.78 24.66 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.249 0.463 . . . . 73.310000000000002 112.249 -176.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 55.2 -128.11 43.19 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 116.076 -0.511 . . . . 62.340000000000003 113.965 176.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -55.07 -44.64 74.98 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.134 0.492 . . . . 73.019999999999996 111.924 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -60.99 -32.93 72.48 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.965 -0.561 . . . . 72.340000000000003 111.624 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.0 tt -65.79 -53.28 42.38 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.817 0.342 . . . . 72.099999999999994 110.185 176.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -58.71 -34.18 71.03 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.802 0.334 . . . . 60.119999999999997 111.526 177.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.53 ' HG3' ' HB3' ' A' ' 48' ' ' GLU . 39.5 ttm180 -61.15 -56.37 21.56 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.098 0.475 . . . . 75.5 110.998 176.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.402 ' NE2' HG23 ' A' ' 58' ' ' ILE . 48.1 tt0 -63.13 -41.81 99.37 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.062 0.458 . . . . 73.510000000000005 110.951 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 49.0 tttm -55.61 -61.78 2.13 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.864 -0.607 . . . . 74.310000000000002 111.804 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -54.74 -36.85 65.22 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.415 -0.357 . . . . 71.340000000000003 111.553 -175.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.424 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 73.4 mmtt -63.02 -43.87 97.51 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.846 0.355 . . . . 74.340000000000003 111.546 176.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.449 HD21 ' O ' ' A' ' 55' ' ' PHE . 96.2 mt -67.94 -33.55 74.9 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.902 0.382 . . . . 73.329999999999998 111.25 177.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -58.06 -41.97 84.45 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.347 0.594 . . . . 64.120000000000005 109.97 172.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.32 -21.28 66.69 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.692 -0.686 . . . . 72.409999999999997 111.897 177.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 77' ' ' LYS . 7.4 mm-40 -85.31 -10.11 56.83 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.832 0.348 . . . . 75.430000000000007 111.532 177.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.08 25.96 25.3 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.249 -0.5 . . . . 72.129999999999995 112.701 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.435 HD12 HG12 ' A' ' 20' ' ' VAL . 66.3 mt -102.49 146.06 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 120.972 0.415 . . . . 75.409999999999997 111.774 -177.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.746 ' HG3' ' HH ' ' A' ' 96' ' ' TYR . 43.8 mt-10 -88.43 95.47 10.23 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 111.776 0.288 . . . . 73.430000000000007 111.776 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.4 t -95.74 98.33 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-O 121.162 0.506 . . . . 74.340000000000003 110.218 173.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.551 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 50.4 m -56.88 152.52 12.59 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.838 -0.619 . . . . 64.450000000000003 112.333 -178.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -41.31 -36.87 0.88 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 115.037 1.495 . . . . 72.319999999999993 115.037 -171.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.45 HD11 ' HB2' ' A' ' 90' ' ' LYS . 2.9 pp -92.81 13.11 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 112.706 0.632 . . . . 72.230000000000004 112.706 -176.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.92 42.6 7.09 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 121.587 -0.34 . . . . 50.009999999999998 113.439 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.551 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 62.6 tttp -116.45 142.65 46.59 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 122.622 -0.34 . . . . 63.039999999999999 111.46 -177.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.495 HD13 HG21 ' A' ' 58' ' ' ILE . 62.2 mt -129.45 146.7 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 120.928 0.394 . . . . 73.329999999999998 111.607 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.85 97.35 10.15 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.94 0.4 . . . . 62.420000000000002 111.601 177.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.46 HD23 HD13 ' A' ' 58' ' ' ILE . 67.7 mt -60.31 -55.37 34.53 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.01 0.374 . . . . 74.439999999999998 112.01 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 29.6 mtp180 -57.11 -9.29 0.86 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.17 0.804 . . . . 75.209999999999994 113.17 -175.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -105.59 -37.86 6.63 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 111.751 0.278 . . . . 74.010000000000005 111.751 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.746 ' HH ' ' HG3' ' A' ' 84' ' ' GLU . 69.6 m-85 -116.56 13.7 15.36 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.281 0.474 . . . . 70.230000000000004 112.281 -173.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 80.3 tttt -65.63 139.05 58.39 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.097 0.475 . . . . 74.209999999999994 111.46 -178.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.445 ' HA ' ' HB3' ' A' ' 19' ' ' LYS . 17.5 t90 -59.96 111.94 1.68 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.065 0.459 . . . . 75.140000000000001 111.432 178.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -107.25 92.42 8.02 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 116.096 -0.502 . . . . 65.019999999999996 111.001 177.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.73 -31.85 5.02 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.579 2.186 . . . . 72.239999999999995 112.936 177.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 84.3 mt -98.29 111.36 23.73 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.824 0.345 . . . . 63.43 110.98 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 . . . . . 0 C--O 1.253 1.249 0 CA-C-O 118.742 -0.647 . . . . 62.399999999999999 111.723 -176.347 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 120.845 0.355 . . . . 64.150000000000006 111.037 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -69.42 118.35 12.19 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 122.172 -0.33 . . . . 70.120000000000005 111.267 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -52.8 -35.18 56.49 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.319 0.489 . . . . 72.230000000000004 112.319 -177.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -54.32 -49.61 69.3 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.245 0.545 . . . . 72.150000000000006 110.75 176.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 77.8 mt -65.71 -42.59 90.92 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.768 -0.651 . . . . 75.109999999999999 110.919 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 92.2 t -55.28 -46.56 78.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.362 -0.381 . . . . 75.450000000000003 111.559 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.418 ' O ' HG22 ' A' ' 11' ' ' VAL . 27.4 mm-40 -66.98 -56.39 10.36 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.252 0.464 . . . . 74.510000000000005 112.252 -177.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.499 ' O ' HG13 ' A' ' 12' ' ' ILE . 29.9 pt -58.66 -41.85 83.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 O-C-N 122.199 -0.313 . . . . 71.299999999999997 111.722 -178.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.41 ' CD1' HG13 ' A' ' 8' ' ' ILE . 9.0 m-30 -62.34 -43.7 98.2 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.813 0.34 . . . . 73.209999999999994 110.915 177.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.32 -28.34 64.96 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.018 0.437 . . . . 73.400000000000006 111.664 177.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 7' ' ' GLN . 57.6 t -80.66 -41.47 20.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 120.81 0.338 . . . . 72.430000000000007 110.998 176.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 8' ' ' ILE . 83.2 mt -61.23 -42.38 93.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 112.206 0.447 . . . . 75.439999999999998 112.206 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -59.94 -20.69 58.85 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.096 0.406 . . . . 74.310000000000002 112.096 178.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.48 -2.34 55.69 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.007 0.373 . . . . 74.140000000000001 112.007 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.513 HD12 HD11 ' A' ' 26' ' ' ILE . 61.0 mt -84.61 113.82 51.48 Favored Pre-proline 0 CA--C 1.543 0.673 0 O-C-N 122.374 -0.204 . . . . 71.230000000000004 110.472 175.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -69.54 147.66 64.79 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.003 2.468 . . . . 72.140000000000001 113.537 -178.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -52.2 120.02 5.01 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 116.021 -0.536 . . . . 72.120000000000005 111.791 176.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.69 -8.84 40.34 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.118 -0.563 . . . . 65.040000000000006 113.037 -177.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -115.18 152.1 33.23 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.985 0.421 . . . . 65.519999999999996 111.23 176.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.449 HG13 HD11 ' A' ' 83' ' ' ILE . 32.8 m -130.18 159.14 42.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-O 121.168 0.509 . . . . 62.509999999999998 110.962 177.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 45.4 t -138.98 168.44 19.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.997 0.427 . . . . 61.149999999999999 111.131 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.4 p -103.78 148.44 26.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.456 -0.338 . . . . 73.349999999999994 111.343 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -51.72 -33.14 33.12 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.749 0.309 . . . . 74.439999999999998 111.394 175.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.16 -44.26 98.36 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.18 -0.533 . . . . 72.120000000000005 112.691 176.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.463 ' O ' ' HG3' ' A' ' 29' ' ' MET . 41.3 mt-10 -70.79 -49.57 45.14 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.575 0.226 . . . . 73.219999999999999 111.519 178.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.513 HD11 HD12 ' A' ' 15' ' ' ILE . 51.4 mm -56.07 -56.53 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 111.958 0.355 . . . . 70.319999999999993 111.958 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.403 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -58.97 -39.99 83.42 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.095 0.474 . . . . 74.230000000000004 111.305 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -60.82 -42.41 97.63 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.136 -0.484 . . . . 75.430000000000007 111.149 178.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.463 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 66.5 mtt -72.65 -36.26 67.93 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 120.898 0.38 . . . . 74.239999999999995 111.462 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.04 -21.28 65.02 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.981 0.42 . . . . 75.209999999999994 111.517 178.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.73 18.06 28.8 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.319 -0.467 . . . . 63.420000000000002 113.217 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.403 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 88.0 m-85 -123.44 85.94 52.28 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-O 120.783 0.325 . . . . 60.240000000000002 111.282 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.76 135.47 25.91 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.412 2.075 . . . . 73.420000000000002 112.672 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.5 -26.65 8.84 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.28 -0.486 . . . . 43.350000000000001 113.24 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -73.36 3.62 5.7 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 112.423 0.527 . . . . 65.109999999999999 112.423 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.0 -44.43 30.77 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.056 0.455 . . . . 65.340000000000003 112.027 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -63.43 -33.79 76.32 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 116.043 -0.526 . . . . 72.319999999999993 111.821 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -75.09 -34.61 61.77 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.799 0.333 . . . . 71.430000000000007 111.032 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.457 HG11 HD12 ' A' ' 8' ' ' ILE . 51.2 t -59.46 -40.11 80.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 121.118 0.485 . . . . 75.450000000000003 110.18 173.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.94 -41.01 99.19 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 115.92 -0.582 . . . . 54.119999999999997 112.665 174.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -57.98 -49.13 77.88 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.074 0.464 . . . . 74.010000000000005 110.424 174.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.71 -53.9 52.42 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.815 -0.629 . . . . 71.409999999999997 111.54 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.3 mt -62.98 -32.3 73.61 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.9 0.381 . . . . 75.420000000000002 111.03 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.97 -22.81 65.14 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.324 -0.465 . . . . 75.340000000000003 113.306 176.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.504 ' N ' HD21 ' A' ' 45' ' ' ASN . 0.8 OUTLIER -80.17 -20.13 45.52 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.841 0.353 . . . . 74.25 111.223 177.133 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 82.0 mt -76.94 140.66 67.03 Favored Pre-proline 0 CA--C 1.539 0.546 0 N-CA-C 112.255 0.465 . . . . 72.239999999999995 112.255 -178.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -88.48 172.95 4.7 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.941 2.427 . . . . 65.340000000000003 112.648 176.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.33 -31.36 72.49 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.489 -0.323 . . . . 63.229999999999997 111.859 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.02 52.43 4.39 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 120.96 -0.638 . . . . 75.540000000000006 113.101 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.8 t -102.32 142.38 33.63 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.131 0.419 . . . . 72.409999999999997 112.131 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -69.39 -35.76 76.1 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.24 0.543 . . . . 73.439999999999998 110.678 174.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.506 HD13 ' HD2' ' A' ' 53' ' ' PRO . 39.7 tp -80.92 121.49 80.93 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.884 -0.598 . . . . 73.349999999999994 110.733 175.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.506 ' HD2' HD13 ' A' ' 52' ' ' LEU . 60.8 Cg_endo -72.71 94.56 0.78 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 121.269 1.313 . . . . 65.510000000000005 111.725 176.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 55.7 p-90 -84.46 -25.36 28.99 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.201 0.524 . . . . 75.439999999999998 111.922 -177.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.545 ' HA ' ' HG3' ' A' ' 74' ' ' GLN . 29.9 p90 -62.97 -22.6 66.94 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.219 0.822 . . . . 72.340000000000003 113.219 -177.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -75.63 -3.46 34.62 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.455 0.539 . . . . 74.409999999999997 112.455 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.4 t -115.2 114.05 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 120.989 0.423 . . . . 75.239999999999995 111.673 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.631 HD12 HD22 ' A' ' 93' ' ' LEU . 39.1 pt -115.99 -171.09 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 120.942 0.401 . . . . 74.310000000000002 111.807 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 34.7 p30 -83.06 178.01 8.33 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.267 0.556 . . . . 74.010000000000005 112.1 -176.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 57.2 p -81.63 -1.31 46.13 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 116.229 -0.442 . . . . 75.129999999999995 111.98 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -86.94 -21.14 26.43 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.771 0.319 . . . . 65.450000000000003 111.372 177.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.08 22.67 24.63 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 121.257 -0.497 . . . . 72.239999999999995 112.212 -173.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.49 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 55.2 mtpt -129.4 172.77 11.18 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.126 0.488 . . . . 72.219999999999999 111.489 -177.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.66 HD13 HG13 ' A' ' 85' ' ' VAL . 55.3 mt -72.55 144.22 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.224 0.535 . . . . 73.439999999999998 111.329 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.4 p -88.47 -44.04 11.0 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.214 -0.448 . . . . 72.409999999999997 111.465 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.419 HD13 ' HB3' ' A' ' 70' ' ' ASP . 74.9 mt -76.42 159.87 30.06 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.291 0.567 . . . . 74.400000000000006 112.037 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -131.73 165.91 22.68 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.037 -0.529 . . . . 75.129999999999995 111.879 -175.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.04 -138.0 41.37 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-N 116.23 -0.441 . . . . 70.049999999999997 113.13 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 65.1 mtm180 -59.11 -26.59 64.82 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.925 0.393 . . . . 74.329999999999998 111.58 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.419 ' HB3' HD13 ' A' ' 66' ' ' LEU . 13.2 m-20 -73.21 -29.39 62.77 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.393 -0.367 . . . . 74.129999999999995 111.637 177.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.9 tt -62.26 -48.11 81.4 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 109.199 -0.667 . . . . 75.209999999999994 109.199 174.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.93 -43.24 95.05 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.887 -0.597 . . . . 72.200000000000003 111.364 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 64.1 mtt180 -53.69 -57.49 10.64 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 120.805 0.336 . . . . 73.409999999999997 111.314 175.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.545 ' HG3' ' HA ' ' A' ' 55' ' ' PHE . 43.3 tt0 -62.88 -47.12 84.7 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.037 0.446 . . . . 73.040000000000006 111.094 -177.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.434 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 61.6 tttp -58.37 -60.7 3.37 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.967 -0.56 . . . . 75.450000000000003 111.978 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -62.14 -26.27 68.22 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.644 0.609 . . . . 72.319999999999993 112.644 -173.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -64.12 -48.73 74.98 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.207 0.527 . . . . 75.540000000000006 110.715 170.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.528 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 41.1 mt -61.04 -47.21 87.45 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.89 -0.595 . . . . 74.319999999999993 110.994 176.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 57.4 mm-40 -50.08 -39.67 43.18 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.719 -0.673 . . . . 75.349999999999994 111.02 175.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.38 -32.89 74.44 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.138 -0.483 . . . . 72.540000000000006 112.144 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -91.48 0.1 57.55 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 111.875 0.324 . . . . 74.439999999999998 111.875 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.24 5.81 59.15 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.351 -0.452 . . . . 64.010000000000005 113.247 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.528 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 61.4 mt -85.46 102.54 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 121.229 0.537 . . . . 74.239999999999995 110.617 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -78.69 110.62 13.99 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.683 0.623 . . . . 73.129999999999995 112.683 -171.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.66 HG13 HD13 ' A' ' 64' ' ' ILE . 40.3 t -97.41 121.12 47.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 116.096 -0.502 . . . . 73.530000000000001 111.988 -178.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.506 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 30.9 t -59.1 150.7 24.34 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.161 0.43 . . . . 71.230000000000004 112.161 177.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -50.42 -39.86 48.52 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.331 0.863 . . . . 75.549999999999997 113.331 -174.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.8 pp -81.04 18.9 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-O 121.114 0.483 . . . . 75.099999999999994 111.859 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.72 50.25 9.49 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 116.164 -0.471 . . . . 37.18 113.407 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 50.1 tttm -125.25 149.4 48.04 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 122.423 -0.457 . . . . 75.420000000000002 112.073 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.519 HD12 HD13 ' A' ' 58' ' ' ILE . 49.1 mt -123.45 152.93 28.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.235 -0.439 . . . . 75.200000000000003 110.322 174.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -86.68 93.29 9.19 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.816 0.341 . . . . 65.329999999999998 111.141 176.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.631 HD22 HD12 ' A' ' 58' ' ' ILE . 51.0 mt -58.88 -53.96 52.48 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.039 0.385 . . . . 72.219999999999999 112.039 -178.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 21.7 ttp180 -56.18 -19.02 11.84 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-O 121.222 0.534 . . . . 71.519999999999996 111.606 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.449 ' HD3' ' O ' ' A' ' 95' ' ' LYS . 7.8 tmtt? -91.43 -45.13 8.72 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 116.501 -0.318 . . . . 75.439999999999998 110.985 177.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -107.92 10.37 28.48 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.902 0.704 . . . . 73.530000000000001 112.902 -170.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 59.1 tttp -58.9 132.23 53.36 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.413 0.523 . . . . 71.140000000000001 112.413 -172.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 17.0 t90 -58.51 105.56 0.31 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.937 -0.574 . . . . 75.109999999999999 112.181 -179.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -102.89 102.07 25.01 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 115.6 -0.727 . . . . 65.349999999999994 110.434 171.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -73.62 -22.15 18.42 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.378 2.052 . . . . 72.299999999999997 112.871 177.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 92.6 mt -123.11 100.25 6.78 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.488 -0.324 . . . . 71.349999999999994 111.431 -177.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 . . . . . 0 C--O 1.253 1.258 0 CA-C-O 118.743 -0.646 . . . . 72.200000000000003 111.887 -178.63 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.1 tpt . . . . . 0 N--CA 1.488 1.443 0 N-CA-C 110.234 -0.284 . . . . 74.409999999999997 110.234 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.42 ' O ' HG22 ' A' ' 6' ' ' VAL . 15.1 t70 -62.11 140.23 58.42 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.553 0.575 . . . . 73.519999999999996 112.553 -172.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -60.83 -27.72 68.27 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.881 0.697 . . . . 74.329999999999998 112.881 -175.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.419 ' O ' HG12 ' A' ' 8' ' ' ILE . 59.7 t80 -58.74 -51.64 69.1 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.23 0.538 . . . . 72.0 110.086 174.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 70.0 mt -67.47 -46.42 73.04 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.543 -0.753 . . . . 70.129999999999995 111.128 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 2' ' ' ASP . 94.1 t -54.39 -48.82 68.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 116.285 -0.416 . . . . 74.25 112.02 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.418 ' O ' HG21 ' A' ' 11' ' ' VAL . 30.8 mm-40 -68.62 -51.44 42.25 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.747 0.647 . . . . 72.010000000000005 112.747 -177.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.474 HD13 HG13 ' A' ' 39' ' ' VAL . 30.2 pt -58.92 -41.54 83.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 120.751 0.31 . . . . 73.530000000000001 111.368 -178.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -64.01 -44.45 92.55 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.081 0.467 . . . . 74.129999999999995 110.591 174.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.98 -20.4 37.89 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.316 0.487 . . . . 73.239999999999995 112.316 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.418 HG21 ' O ' ' A' ' 7' ' ' GLN . 59.1 t -83.8 -43.95 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 120.978 0.418 . . . . 75.329999999999998 111.03 174.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.537 ' HB ' HD13 ' A' ' 52' ' ' LEU . 72.7 mt -61.02 -30.77 48.3 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 112.655 0.613 . . . . 75.209999999999994 112.655 -177.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -55.64 -18.03 6.96 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 112.8 0.667 . . . . 74.420000000000002 112.8 178.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -91.18 -0.89 57.78 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.239 0.459 . . . . 74.019999999999996 112.239 -178.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.494 HD11 HD11 ' A' ' 26' ' ' ILE . 61.2 mt -87.28 113.54 54.38 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-O 120.417 0.151 . . . . 75.319999999999993 110.905 178.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -77.74 170.31 19.3 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.685 2.257 . . . . 75.030000000000001 113.87 -177.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.2 tttp -61.32 130.52 46.53 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.085 -0.507 . . . . 74.230000000000004 111.247 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.67 2.97 75.0 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.035 -0.603 . . . . 72.209999999999994 113.688 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -120.72 148.33 44.09 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 117.272 0.536 . . . . 75.310000000000002 111.315 176.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.6 m -128.69 157.27 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.224 0.535 . . . . 71.209999999999994 111.898 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.4 m -133.1 163.46 29.2 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.158 -0.474 . . . . 72.409999999999997 110.796 176.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 44.5 p -93.88 149.09 21.54 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.734 0.302 . . . . 65.540000000000006 111.416 178.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.484 ' HE2' ' HG ' ' A' ' 65' ' ' SER . 55.5 m-85 -51.12 -38.81 54.12 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.866 0.365 . . . . 75.099999999999994 111.19 177.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.23 -47.78 89.13 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-N 116.154 -0.475 . . . . 72.510000000000005 112.875 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.46 ' O ' ' HG3' ' A' ' 29' ' ' MET . 46.0 mt-10 -59.63 -55.63 32.01 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.705 0.288 . . . . 72.439999999999998 111.537 178.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.494 HD11 HD11 ' A' ' 15' ' ' ILE . 49.8 mm -53.57 -50.43 49.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 120.956 0.408 . . . . 75.400000000000006 111.784 -178.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.471 ' HB2' HG22 ' A' ' 39' ' ' VAL . . . -64.13 -45.78 87.03 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.889 0.376 . . . . 72.129999999999995 111.802 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.9 tttp -64.49 -35.83 82.2 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.508 -0.314 . . . . 75.319999999999993 111.4 -177.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.46 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 65.9 mtt -68.4 -43.44 77.26 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.054 0.454 . . . . 75.409999999999997 110.769 176.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.54 -23.03 66.77 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.03 -0.532 . . . . 65.329999999999998 111.963 178.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.12 31.7 4.61 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.473 -0.394 . . . . 64.140000000000001 113.414 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -129.73 89.32 46.8 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-O 120.874 0.368 . . . . 73.420000000000002 111.402 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -73.72 125.37 9.95 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.135 2.556 . . . . 72.319999999999993 113.124 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.33 -13.99 66.31 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 121.323 -0.465 . . . . 71.5 113.584 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.424 ' HA ' ' HD2' ' A' ' 38' ' ' HIS . 74.5 m-85 -84.58 10.57 10.72 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.838 0.681 . . . . 74.439999999999998 112.838 -176.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.48 -52.72 20.99 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.719 0.637 . . . . 52.240000000000002 112.719 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -65.69 -26.47 67.79 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.887 0.375 . . . . 73.219999999999999 111.872 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.424 ' HD2' ' HA ' ' A' ' 35' ' ' TYR . 99.5 m-70 -74.83 -32.28 61.9 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.95 0.405 . . . . 73.239999999999995 110.921 177.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.474 HG13 HD13 ' A' ' 8' ' ' ILE . 81.3 t -59.44 -40.46 81.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-O 121.252 0.549 . . . . 74.340000000000003 110.195 170.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -57.93 -41.99 94.55 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.869 -0.605 . . . . 71.310000000000002 112.732 174.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -56.68 -40.16 75.07 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.094 0.473 . . . . 71.25 111.218 175.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.1 -51.72 23.51 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.914 -0.585 . . . . 73.420000000000002 112.179 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.9 mt -60.65 -45.14 95.23 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.2 0.444 . . . . 74.140000000000001 112.2 -176.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.59 -20.93 64.32 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 120.692 -0.766 . . . . 55.229999999999997 113.05 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -83.63 -20.97 32.69 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 120.71 0.291 . . . . 74.010000000000005 111.489 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.413 HD12 ' HB3' ' A' ' 54' ' ' TRP . 94.4 mt -67.05 147.68 99.02 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 111.889 0.329 . . . . 73.430000000000007 111.889 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.53 ' HG2' ' HB3' ' A' ' 50' ' ' SER . 30.1 Cg_endo -63.56 165.54 17.71 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.402 2.068 . . . . 70.129999999999995 112.715 176.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -57.3 -41.14 79.28 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.584 0.587 . . . . 74.420000000000002 112.584 -177.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -128.43 60.27 0.67 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.981 -0.628 . . . . 70.010000000000005 113.744 -177.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.53 ' HB3' ' HG2' ' A' ' 47' ' ' PRO . 24.5 p -76.97 -178.7 5.07 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 122.459 -0.436 . . . . 72.329999999999998 110.878 176.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.681 ' HZ3' ' HB2' ' A' ' 51' ' ' LYS . 5.2 ttmp? -61.04 -28.52 69.12 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.065 0.46 . . . . 75.140000000000001 110.825 174.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.537 HD13 ' HB ' ' A' ' 12' ' ' ILE . 26.0 tp -103.38 130.78 22.92 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 116.017 -0.538 . . . . 73.530000000000001 111.812 -177.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.502 ' HD2' HD12 ' A' ' 52' ' ' LEU . 72.0 Cg_endo -79.42 95.89 1.06 Allowed 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 121.657 1.571 . . . . 70.439999999999998 111.511 170.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.413 ' HB3' HD12 ' A' ' 46' ' ' LEU . 64.8 p-90 -76.51 -28.77 56.53 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.162 -0.472 . . . . 74.319999999999993 112.202 -175.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.479 ' O ' HD21 ' A' ' 78' ' ' LEU . 24.8 p90 -60.7 -19.96 59.89 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.409 0.892 . . . . 73.209999999999994 113.409 -175.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -76.82 6.76 5.59 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.864 0.69 . . . . 70.25 112.864 -176.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 45.1 t -123.62 125.85 72.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 O-C-N 121.929 -0.482 . . . . 63.299999999999997 111.624 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.511 HG23 HD13 ' A' ' 91' ' ' ILE . 32.5 pt -127.35 -169.63 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 121.157 0.503 . . . . 74.230000000000004 111.357 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.413 ' HB3' ' OG ' ' A' ' 65' ' ' SER . 30.9 p30 -87.26 173.97 8.87 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.068 0.461 . . . . 71.200000000000003 111.824 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 33.3 p -84.79 9.74 13.32 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.965 0.412 . . . . 70.329999999999998 111.646 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -93.14 -14.79 26.75 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.003 0.43 . . . . 75.140000000000001 110.542 173.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.38 37.17 18.45 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 121.081 -0.58 . . . . 75.430000000000007 112.161 -174.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -137.35 167.71 21.06 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.645 0.736 . . . . 72.120000000000005 112.379 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.489 ' CG2' HD12 ' A' ' 71' ' ' LEU . 74.9 mt -83.68 108.53 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.109 -0.95 . . . . 74.310000000000002 110.209 172.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.484 ' HG ' ' HE2' ' A' ' 23' ' ' TYR . 71.2 m -69.7 -25.9 64.09 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.73 0.641 . . . . 75.129999999999995 112.73 -175.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.478 HD13 ' HB3' ' A' ' 70' ' ' ASP . 88.6 mt -64.78 124.38 21.82 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.696 0.284 . . . . 74.409999999999997 111.018 178.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -113.05 141.59 46.7 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.14 0.495 . . . . 72.030000000000001 111.211 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 107.88 -136.43 13.44 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.462 -0.655 . . . . 63.020000000000003 111.462 -173.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -81.76 -24.94 35.73 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 117.511 0.656 . . . . 75.439999999999998 110.896 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.478 ' HB3' HD13 ' A' ' 66' ' ' LEU . 7.8 m-20 -62.36 -24.83 67.58 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.121 -0.49 . . . . 72.439999999999998 111.936 176.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.489 HD12 ' CG2' ' A' ' 64' ' ' ILE . 16.2 tp -56.84 -60.65 3.26 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.414 0.626 . . . . 74.349999999999994 110.561 174.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.555 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 18.8 m-20 -67.03 -32.48 73.72 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.605 -0.725 . . . . 74.120000000000005 111.178 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -50.13 -59.01 4.33 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-O 121.3 0.572 . . . . 75.140000000000001 111.204 174.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -62.29 -43.55 98.58 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.007 -0.542 . . . . 64.519999999999996 110.7 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -50.0 -58.24 5.9 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.722 -0.672 . . . . 74.409999999999997 112.306 176.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.555 ' HG3' ' O ' ' A' ' 72' ' ' ASP . 96.0 mt-30 -52.75 -49.19 65.97 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.142 0.496 . . . . 74.25 111.467 -178.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -68.91 -27.06 65.43 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.5 0.556 . . . . 75.109999999999999 112.5 -177.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.479 HD21 ' O ' ' A' ' 55' ' ' PHE . 57.6 mt -77.79 -39.03 45.3 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.169 0.433 . . . . 75.5 112.169 177.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -62.8 -30.69 71.66 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.025 0.441 . . . . 73.219999999999999 110.617 175.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.82 -20.06 66.19 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 116.04 -0.527 . . . . 62.399999999999999 111.483 174.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -86.98 2.67 48.72 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.201 -0.454 . . . . 74.549999999999997 111.443 177.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.2 15.67 71.37 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.092 -0.575 . . . . 74.409999999999997 112.832 -177.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 73.0 mt -92.1 124.5 44.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 120.959 0.409 . . . . 73.519999999999996 111.643 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.504 ' HG2' ' OH ' ' A' ' 96' ' ' TYR . 9.0 pt-20 -72.76 90.84 1.44 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.6 0.714 . . . . 75.209999999999994 111.308 175.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 62.3 t -85.73 112.53 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 116.071 -0.513 . . . . 72.530000000000001 110.477 176.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.542 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 42.1 t -61.26 142.57 56.73 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.757 -0.201 . . . . 74.109999999999999 111.055 178.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -48.52 -38.47 20.37 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.744 1.016 . . . . 73.439999999999998 113.744 -172.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.8 pp -80.32 16.42 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 CA-C-O 121.083 0.468 . . . . 75.25 112.23 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.37 52.31 6.18 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 116.373 -0.376 . . . . 75.420000000000002 113.443 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.542 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 1.3 tmtp? -125.4 136.23 53.22 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.052 0.453 . . . . 72.439999999999998 111.214 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.511 HD13 HG23 ' A' ' 58' ' ' ILE . 69.7 mt -125.59 126.49 70.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 116.018 -0.537 . . . . 75.140000000000001 110.864 178.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.98 98.29 1.26 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 111.973 0.36 . . . . 73.409999999999997 111.973 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.441 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 86.2 mt -53.47 -53.22 54.6 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.337 -0.392 . . . . 65.510000000000005 111.838 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 18.5 ttm180 -56.21 -26.58 51.54 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 112.189 0.44 . . . . 75.219999999999999 112.189 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -89.66 -28.88 19.17 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.137 0.421 . . . . 75.150000000000006 112.137 -177.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.504 ' OH ' ' HG2' ' A' ' 84' ' ' GLU . 70.9 m-85 -124.73 12.76 8.57 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.658 0.614 . . . . 75.239999999999995 112.658 -174.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 63.6 tttp -60.08 131.5 51.02 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.093 0.473 . . . . 74.040000000000006 111.825 -177.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 19.8 t90 -56.15 124.26 17.27 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.954 -0.566 . . . . 74.140000000000001 111.735 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -108.82 88.87 5.78 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 116.035 -0.53 . . . . 74.400000000000006 111.029 176.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.63 -39.08 12.66 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.02 1.814 . . . . 72.219999999999999 111.385 173.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 87.2 mt -133.62 164.11 27.93 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.908 -0.587 . . . . 71.239999999999995 110.848 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 . . . . . 0 C--O 1.253 1.255 0 CA-C-O 118.637 -0.697 . . . . 61.450000000000003 111.67 174.071 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.6 tpt . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 120.793 0.33 . . . . 74.25 110.44 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -66.06 131.7 46.8 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.666 0.617 . . . . 71.400000000000006 112.666 -176.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -57.0 -30.31 64.05 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.22 -0.446 . . . . 74.549999999999997 110.964 175.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -57.69 -52.39 65.62 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.041 0.448 . . . . 75.209999999999994 110.717 174.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.4 mt -63.8 -48.19 77.89 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.964 -0.562 . . . . 74.239999999999995 111.471 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 67.4 t -53.03 -49.52 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 120.931 0.396 . . . . 75.329999999999998 111.703 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.457 ' O ' HG21 ' A' ' 11' ' ' VAL . 28.9 mm-40 -67.28 -53.29 31.19 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.632 0.604 . . . . 74.519999999999996 112.632 -177.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.416 ' O ' HG13 ' A' ' 12' ' ' ILE . 35.9 pt -59.64 -41.62 85.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 O-C-N 122.148 -0.345 . . . . 74.200000000000003 111.468 -178.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 14.8 m-30 -63.69 -43.91 95.23 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.958 0.408 . . . . 75.530000000000001 110.818 177.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.75 -43.18 80.48 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.31 -0.405 . . . . 74.140000000000001 111.366 177.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.457 HG21 ' O ' ' A' ' 7' ' ' GLN . 74.3 t -61.74 -43.2 96.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 121.082 0.468 . . . . 71.510000000000005 110.742 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.456 ' HB ' HD11 ' A' ' 52' ' ' LEU . 72.6 mt -62.77 -37.26 78.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 116.146 -0.479 . . . . 72.140000000000001 111.645 177.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -64.22 -10.43 23.34 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.196 0.443 . . . . 74.530000000000001 112.196 176.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.46 -9.92 42.77 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.65 0.262 . . . . 73.049999999999997 111.667 177.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.414 HD12 HD12 ' A' ' 26' ' ' ILE . 54.9 mt -76.92 114.67 41.54 Favored Pre-proline 0 CA--C 1.543 0.684 0 O-C-N 122.448 -0.157 . . . . 75.420000000000002 110.831 177.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -60.62 150.25 82.95 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 122.734 2.289 . . . . 72.25 113.515 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 67.2 tttm -62.05 95.35 0.06 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.076 0.465 . . . . 75.219999999999999 111.255 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 139.11 -18.64 3.11 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 121.155 -0.545 . . . . 74.219999999999999 113.148 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -103.86 162.4 13.14 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.994 0.426 . . . . 75.010000000000005 111.676 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.7 m -136.29 156.2 35.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 122.932 0.493 . . . . 74.540000000000006 111.561 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 98.4 p -138.13 179.43 6.45 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 120.764 0.316 . . . . 71.219999999999999 111.15 178.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.8 p -110.72 153.12 25.74 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 120.991 0.424 . . . . 74.519999999999996 111.651 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -53.48 -39.91 64.9 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.257 0.466 . . . . 73.299999999999997 112.257 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.16 -40.62 93.96 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.172 -0.537 . . . . 70.019999999999996 113.098 178.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.468 ' HB3' ' HE3' ' A' ' 29' ' ' MET . 47.3 mt-10 -67.29 -51.61 50.73 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 122.493 -0.416 . . . . 74.219999999999999 111.396 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.414 HD12 HD12 ' A' ' 15' ' ' ILE . 50.5 mm -53.85 -51.53 43.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-N 116.141 -0.481 . . . . 74.299999999999997 111.397 178.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.02 -54.18 49.86 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.215 -0.448 . . . . 71.310000000000002 111.961 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.555 ' HB2' ' HZ2' ' A' ' 28' ' ' LYS . 10.7 mtmp? -62.09 -41.48 98.24 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.083 0.401 . . . . 74.420000000000002 112.083 -177.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.468 ' HE3' ' HB3' ' A' ' 25' ' ' GLU . 70.7 mtm -76.63 -10.39 59.35 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 111.995 0.369 . . . . 74.319999999999993 111.995 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.34 -14.39 33.21 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.091 0.472 . . . . 71.310000000000002 110.929 172.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.8 18.31 27.89 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 116.012 -0.54 . . . . 72.129999999999995 113.203 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -125.59 91.11 49.29 Favored Pre-proline 0 CA--C 1.544 0.741 0 O-C-N 122.522 -0.399 . . . . 75.349999999999994 111.397 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.01 137.12 26.03 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.861 2.374 . . . . 70.519999999999996 113.092 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.33 -6.18 52.42 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 121.261 -0.495 . . . . 70.420000000000002 113.968 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.409 ' HA ' ' HD2' ' A' ' 38' ' ' HIS . 61.0 m-85 -84.19 11.26 8.47 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.634 0.605 . . . . 62.240000000000002 112.634 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.25 -47.34 69.16 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.963 0.411 . . . . 74.099999999999994 111.895 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.0 ptt180 -57.86 -40.05 79.24 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.18 -0.464 . . . . 75.510000000000005 111.957 175.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.409 ' HD2' ' HA ' ' A' ' 35' ' ' TYR . 88.9 m-70 -67.84 -39.29 83.86 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.861 0.362 . . . . 73.400000000000006 111.19 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.9 t -59.9 -42.62 89.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.013 0.435 . . . . 73.140000000000001 110.611 174.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.97 -41.56 96.41 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-N 116.078 -0.51 . . . . 54.509999999999998 112.718 176.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -61.65 -47.32 85.91 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 120.835 0.35 . . . . 73.430000000000007 111.085 176.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.6 -54.41 47.22 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.989 0.423 . . . . 54.329999999999998 111.727 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.4 mt -63.91 -32.62 74.21 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.846 0.355 . . . . 74.109999999999999 111.461 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.99 -13.99 62.7 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.439 -0.41 . . . . 73.430000000000007 113.507 178.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.468 ' N ' HD21 ' A' ' 45' ' ' ASN . 0.8 OUTLIER -93.53 -4.08 51.67 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 117.087 0.444 . . . . 63.340000000000003 111.945 177.17 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 94.2 mt -85.88 142.34 36.52 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 112.509 0.559 . . . . 75.209999999999994 112.509 -176.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.78 159.5 48.31 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.54 2.16 . . . . 75.420000000000002 112.27 173.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.59 -35.82 73.02 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.401 0.519 . . . . 73.329999999999998 112.401 -176.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -113.94 53.12 0.61 Allowed Glycine 0 CA--C 1.526 0.75 0 C-N-CA 121.23 -0.51 . . . . 53.009999999999998 112.913 178.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 90.9 p -72.93 -179.14 3.06 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 122.297 -0.531 . . . . 71.409999999999997 111.454 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -84.59 4.5 31.92 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.007 0.432 . . . . 73.230000000000004 111.425 176.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.537 HD13 ' HD2' ' A' ' 53' ' ' PRO . 35.6 tp -127.1 126.08 24.23 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 116.159 -0.473 . . . . 74.340000000000003 110.34 178.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.537 ' HD2' HD13 ' A' ' 52' ' ' LEU . 53.0 Cg_endo -70.1 94.36 0.56 Allowed 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 120.94 1.093 . . . . 62.100000000000001 111.879 176.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 68.1 p-90 -84.88 -29.7 25.02 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.305 0.574 . . . . 75.400000000000006 111.051 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.445 ' O ' HD21 ' A' ' 78' ' ' LEU . 33.6 p90 -61.56 -14.16 27.62 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.008 0.744 . . . . 71.230000000000004 113.008 -177.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 69.6 mtt-85 -85.34 7.95 20.52 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.108 0.41 . . . . 74.239999999999995 112.108 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.6 t -125.13 126.91 71.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 120.98 0.419 . . . . 73.430000000000007 111.521 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.582 HD12 HD23 ' A' ' 93' ' ' LEU . 34.9 pt -130.21 -172.11 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-N 116.444 -0.344 . . . . 64.219999999999999 111.504 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 34.6 p30 -84.96 175.39 9.1 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.217 0.532 . . . . 71.430000000000007 111.988 -178.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.2 p -72.51 -12.42 61.07 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.303 -0.408 . . . . 62.119999999999997 112.053 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -80.34 -16.32 54.83 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.633 0.254 . . . . 73.439999999999998 111.59 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.63 21.6 46.84 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 121.059 -0.591 . . . . 71.120000000000005 112.189 -174.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.499 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 62.1 mttp -118.67 159.64 23.27 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.112 0.482 . . . . 75.230000000000004 111.463 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 58.0 mt -67.23 130.03 32.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.242 -0.435 . . . . 74.510000000000005 110.525 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.6 p -64.78 -53.92 39.41 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.962 0.411 . . . . 63.140000000000001 111.589 -177.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.422 ' HB3' ' HB2' ' A' ' 70' ' ' ASP . 85.6 mt -63.48 150.73 43.09 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.253 0.549 . . . . 73.439999999999998 112.075 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.653 ' HZ3' ' HB2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -122.82 157.31 32.73 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.087 -0.506 . . . . 72.430000000000007 111.497 -176.043 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.96 -129.19 10.54 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.284 -0.484 . . . . 72.329999999999998 113.281 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.43 ' H ' ' HG3' ' A' ' 69' ' ' ARG . 9.0 mtm180 -54.61 -51.22 66.03 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 122.451 1.119 . . . . 74.430000000000007 110.515 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.504 ' HA ' ' HB3' ' A' ' 73' ' ' ARG . 3.6 m-20 -63.45 -18.47 63.79 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.121 -1.4 . . . . 75.129999999999995 112.293 -171.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.1 tt -65.55 -56.07 14.32 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 110.087 -0.338 . . . . 75.219999999999999 110.087 175.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -70.22 -26.3 63.8 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 122.315 -0.241 . . . . 65.340000000000003 111.013 178.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.504 ' HB3' ' HA ' ' A' ' 70' ' ' ASP . 29.4 ttm180 -57.2 -55.19 37.93 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.22 0.533 . . . . 75.439999999999998 110.751 171.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -64.56 -40.62 95.9 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.302 -0.408 . . . . 73.299999999999997 110.789 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.435 ' HG3' ' HB ' ' A' ' 85' ' ' VAL . 60.7 tttp -57.15 -56.94 15.34 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 111.931 0.345 . . . . 74.120000000000005 111.931 177.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -56.57 -34.36 67.05 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.505 0.193 . . . . 72.109999999999999 111.506 -177.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.483 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 75.6 mmtt -59.13 -47.42 85.35 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.165 0.507 . . . . 74.450000000000003 110.99 172.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.474 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 58.2 mt -68.85 -42.08 77.59 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.928 -0.578 . . . . 73.349999999999994 111.984 -178.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -55.1 -39.78 69.7 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.245 0.545 . . . . 70.319999999999993 110.86 176.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.65 -22.96 66.7 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.788 -0.642 . . . . 74.010000000000005 111.827 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 77' ' ' LYS . 4.9 mm-40 -94.33 -1.38 53.94 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 111.985 0.365 . . . . 75.519999999999996 111.985 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.07 19.83 51.84 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 120.851 -0.69 . . . . 74.099999999999994 113.37 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.474 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 65.4 mt -99.77 110.77 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 O-C-N 122.704 -0.291 . . . . 72.540000000000006 110.721 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -73.19 102.83 3.72 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.973 0.416 . . . . 75.140000000000001 111.815 -177.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.435 ' HB ' ' HG3' ' A' ' 75' ' ' LYS . 22.0 t -98.54 126.39 51.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 116.453 -0.34 . . . . 74.5 111.328 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.591 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 42.6 t -72.57 159.04 34.56 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 111.979 0.363 . . . . 65.140000000000001 111.979 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -38.98 -55.76 1.51 Allowed 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 114.748 1.388 . . . . 73.150000000000006 114.748 -171.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 pp -82.45 16.96 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 112.543 0.571 . . . . 73.400000000000006 112.543 -175.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.44 52.57 4.43 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 121.347 -0.454 . . . . 62.100000000000001 113.107 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.591 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 86.7 tttt -116.25 125.54 52.35 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 122.352 -0.499 . . . . 74.549999999999997 111.86 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.519 HD13 HD13 ' A' ' 58' ' ' ILE . 57.4 mt -113.95 138.46 43.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 116.274 -0.421 . . . . 74.329999999999998 111.342 -178.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.48 92.52 4.02 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.011 0.434 . . . . 73.420000000000002 111.071 176.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.582 HD23 HD12 ' A' ' 58' ' ' ILE . 82.0 mt -56.26 -48.95 75.55 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.384 -0.371 . . . . 74.439999999999998 111.732 -178.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -52.85 -22.05 4.97 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.877 0.695 . . . . 73.120000000000005 112.877 -176.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -102.67 -38.84 7.31 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.085 0.402 . . . . 71.140000000000001 112.085 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -101.68 3.83 40.11 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 111.968 0.359 . . . . 74.329999999999998 111.968 -172.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.56 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 57.4 tttp -59.51 141.59 54.47 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.042 0.448 . . . . 75.450000000000003 111.91 -175.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 16.2 t90 -60.75 119.47 8.22 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.258 0.551 . . . . 72.329999999999998 111.414 178.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -118.56 90.8 40.33 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 115.776 -0.647 . . . . 75.310000000000002 111.261 -178.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -81.95 -7.39 12.25 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.778 2.319 . . . . 61.310000000000002 113.341 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 38.5 mt -96.0 8.77 42.81 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.797 0.332 . . . . 74.109999999999999 111.678 -176.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 119.09 -0.481 . . . . 74.140000000000001 111.992 -176.725 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 120.879 0.371 . . . . 73.510000000000005 110.743 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -59.37 153.83 18.13 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.716 0.635 . . . . 73.439999999999998 112.716 -176.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -56.41 -38.33 71.39 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.296 -0.411 . . . . 72.010000000000005 111.499 175.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -49.03 -50.78 34.63 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.121 0.486 . . . . 73.230000000000004 110.787 173.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 61.9 mt -63.7 -48.27 77.77 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.759 -0.655 . . . . 71.519999999999996 111.176 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 63.1 t -57.33 -41.09 77.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 116.32 -0.4 . . . . 61.530000000000001 111.997 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.473 ' O ' HG21 ' A' ' 11' ' ' VAL . 27.9 mm-40 -73.75 -49.57 24.87 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.195 0.443 . . . . 74.319999999999993 112.195 -177.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.446 ' O ' HG13 ' A' ' 12' ' ' ILE . 31.4 pt -59.7 -40.2 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 O-C-N 122.055 -0.403 . . . . 72.25 111.259 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -58.23 -48.11 81.42 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.035 0.445 . . . . 75.299999999999997 110.448 171.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.37 -17.31 42.66 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.041 -0.527 . . . . 73.510000000000005 112.407 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.473 HG21 ' O ' ' A' ' 7' ' ' GLN . 49.9 t -92.41 -50.16 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-O 120.808 0.337 . . . . 74.530000000000001 111.3 175.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.493 HD12 HD23 ' A' ' 52' ' ' LEU . 79.8 mt -57.85 -37.82 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 112.849 0.685 . . . . 75.400000000000006 112.849 -175.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 -58.23 -21.3 47.48 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.402 0.519 . . . . 74.140000000000001 112.402 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -83.28 -6.24 59.4 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.509 0.559 . . . . 65.010000000000005 112.509 -178.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 45.3 mt -78.27 122.9 85.81 Favored Pre-proline 0 CA--C 1.544 0.72 0 O-C-N 122.419 -0.175 . . . . 64.200000000000003 110.655 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -79.88 178.76 6.9 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.801 2.334 . . . . 74.439999999999998 114.176 -175.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.521 ' HE3' ' HA ' ' A' ' 81' ' ' GLU . 49.3 tptt -67.18 122.88 18.79 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.627 -0.715 . . . . 63.140000000000001 111.502 -178.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.535 ' HA2' ' HB3' ' A' ' 81' ' ' GLU . . . 91.12 3.5 69.9 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 114.407 0.523 . . . . 71.430000000000007 114.407 175.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -117.81 146.86 43.55 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 117.575 0.688 . . . . 73.319999999999993 111.648 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.6 m -129.13 157.62 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.172 0.51 . . . . 75.030000000000001 111.747 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 89.3 p -132.43 171.11 14.18 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.236 -0.438 . . . . 74.230000000000004 110.793 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.9 p -103.52 152.03 22.17 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.808 0.337 . . . . 74.140000000000001 111.697 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -49.46 -41.47 40.44 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.442 0.534 . . . . 72.329999999999998 112.442 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.7 -40.99 95.57 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 121.239 -0.505 . . . . 72.340000000000003 113.252 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -66.91 -55.17 15.82 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.64 0.257 . . . . 74.019999999999996 111.073 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.6 mm -54.11 -49.99 57.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.208 0.528 . . . . 63.350000000000001 111.365 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.515 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -59.8 -43.77 94.29 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.062 -0.517 . . . . 55.130000000000003 111.737 179.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -62.35 -45.57 92.6 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.79 0.329 . . . . 75.310000000000002 111.182 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 65.4 mtt -63.15 -37.1 85.88 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.406 -0.361 . . . . 74.120000000000005 111.167 178.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.29 -29.38 67.24 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.935 0.397 . . . . 72.239999999999995 111.673 176.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.48 10.05 27.96 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 116.282 -0.417 . . . . 75.239999999999995 112.935 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.515 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 26.8 m-85 -127.27 63.5 58.23 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 122.451 0.3 . . . . 75.319999999999993 111.152 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.69 -35.7 87.99 Favored 'Trans proline' 0 N--CA 1.483 0.862 0 C-N-CA 122.829 2.353 . . . . 75.530000000000001 114.181 -172.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -82.35 -7.96 86.93 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 121.06 -0.59 . . . . 72.439999999999998 113.59 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.435 ' CD1' ' HB3' ' A' ' 32' ' ' TYR . 23.0 m-85 -86.2 16.14 4.61 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.529 0.566 . . . . 74.129999999999995 112.529 -178.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.09 -43.58 61.09 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.216 0.532 . . . . 74.519999999999996 111.618 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -57.55 -40.25 78.47 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.781 -0.645 . . . . 72.329999999999998 111.855 175.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -75.35 -28.23 59.5 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.651 -0.25 . . . . 72.319999999999993 111.673 -178.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 46.5 t -61.18 -43.85 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 109.814 -0.439 . . . . 53.030000000000001 109.814 173.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.02 -41.94 96.69 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 115.992 -0.549 . . . . 53.030000000000001 112.631 174.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.4 mttp -57.46 -53.83 53.75 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.975 0.417 . . . . 74.150000000000006 111.303 173.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.33 -47.64 78.35 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.165 -0.47 . . . . 73.299999999999997 112.08 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.415 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 79.8 mt -68.1 -41.39 81.88 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.861 0.362 . . . . 74.0 111.496 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.7 -18.79 62.09 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.156 -0.545 . . . . 73.040000000000006 113.374 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -86.06 -4.49 59.18 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 122.606 -0.349 . . . . 72.310000000000002 111.649 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 96.2 mt -92.61 121.53 65.99 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-O 120.761 0.315 . . . . 73.099999999999994 111.653 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.89 160.86 36.83 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.326 2.017 . . . . 75.349999999999994 112.469 177.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -67.13 119.32 11.85 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.287 0.565 . . . . 65.420000000000002 110.962 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 110.89 -2.51 28.74 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 115.983 -0.553 . . . . 62.32 112.673 -173.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 31.0 t -61.85 167.82 3.49 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.165 0.507 . . . . 73.239999999999995 112.162 177.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -66.93 -29.51 69.4 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.737 0.643 . . . . 74.25 112.737 -177.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.535 HD13 ' HD2' ' A' ' 53' ' ' PRO . 25.7 tp -102.46 131.84 22.03 Favored Pre-proline 0 N--CA 1.472 0.639 0 N-CA-C 111.558 0.207 . . . . 72.129999999999995 111.558 -178.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.535 ' HD2' HD13 ' A' ' 52' ' ' LEU . 59.4 Cg_endo -73.62 95.1 0.86 Allowed 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 121.591 1.527 . . . . 71.209999999999994 111.813 171.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.415 ' HB2' ' HB3' ' A' ' 43' ' ' LEU . 55.2 p-90 -81.35 -24.51 37.03 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.225 0.536 . . . . 72.25 112.222 -176.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.44 ' CG ' ' HB3' ' A' ' 77' ' ' LYS . 29.3 p90 -65.24 -17.99 64.94 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.381 0.882 . . . . 71.340000000000003 113.381 -175.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -83.23 7.33 16.58 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.545 0.572 . . . . 74.209999999999994 112.545 -177.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.6 t -123.19 117.93 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 121.029 0.443 . . . . 62.32 111.131 176.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.468 HD13 HD23 ' A' ' 93' ' ' LEU . 42.3 pt -123.21 -170.35 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 121.112 0.482 . . . . 65.209999999999994 111.714 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.7 p30 -86.28 163.48 17.69 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.078 0.466 . . . . 74.420000000000002 111.585 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 88.1 p -79.6 9.43 5.0 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 120.983 0.42 . . . . 55.229999999999997 111.665 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -93.61 -8.74 40.28 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.161 -0.472 . . . . 73.5 111.13 178.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.5 40.59 27.29 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.311 -0.471 . . . . 64.310000000000002 112.821 -177.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.591 ' HG2' ' HG2' ' A' ' 90' ' ' LYS . 53.5 mtpt -137.45 166.78 23.02 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.101 0.477 . . . . 73.530000000000001 111.441 178.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 63.6 mt -67.15 109.88 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.505 -0.554 . . . . 73.409999999999997 109.505 170.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.4 t -57.7 -40.09 78.72 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.143 -0.48 . . . . 74.409999999999997 112.013 -175.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.522 HD11 ' HB3' ' A' ' 70' ' ' ASP . 84.9 mt -76.78 160.15 29.53 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.995 0.426 . . . . 75.140000000000001 111.399 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -130.82 157.51 42.66 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.051 0.453 . . . . 75.439999999999998 111.869 -176.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.48 -130.19 31.51 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.267 -0.492 . . . . 62.130000000000003 113.398 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.427 ' H ' ' HG3' ' A' ' 69' ' ' ARG . 10.2 mtm180 -48.69 -50.93 31.1 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.902 0.858 . . . . 74.439999999999998 110.947 178.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.522 ' HB3' HD11 ' A' ' 66' ' ' LEU . 21.5 m-20 -70.72 -18.85 62.79 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 114.627 -1.17 . . . . 72.340000000000003 112.035 -172.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.0 tt -66.7 -51.07 60.18 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.608 -0.516 . . . . 73.099999999999994 109.608 174.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -61.6 -36.36 80.49 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.08 -0.509 . . . . 73.409999999999997 111.528 175.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.2 mtt180 -56.1 -62.81 1.45 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.51 0.195 . . . . 71.310000000000002 111.473 174.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -58.83 -36.47 74.6 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.714 0.293 . . . . 74.010000000000005 111.086 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.498 ' HG3' HG13 ' A' ' 85' ' ' VAL . 79.2 tttt -52.46 -65.95 0.47 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.991 0.424 . . . . 74.420000000000002 111.62 174.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -63.18 -30.87 71.93 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.084 -0.507 . . . . 75.230000000000004 112.224 -175.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.44 ' HB3' ' CG ' ' A' ' 55' ' ' PHE . 72.3 mmtt -61.02 -45.89 92.98 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.974 0.416 . . . . 74.450000000000003 110.626 174.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.464 HD21 HD12 ' A' ' 83' ' ' ILE . 83.6 mt -72.17 -28.09 63.0 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.397 -0.365 . . . . 73.150000000000006 111.633 177.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 49.7 mt-10 -66.88 -28.06 68.02 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.067 0.46 . . . . 75.439999999999998 110.325 172.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.6 -23.66 59.95 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.165 0.507 . . . . 53.25 110.858 172.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.535 ' HB3' ' HA2' ' A' ' 18' ' ' GLY . 39.7 mm-40 -81.77 -26.25 34.61 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.024 -0.535 . . . . 61.100000000000001 110.989 174.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.85 37.18 4.26 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 116.304 -0.407 . . . . 75.319999999999993 113.057 -178.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.464 HD12 HD21 ' A' ' 78' ' ' LEU . 58.6 mt -105.8 136.98 37.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 112.301 0.482 . . . . 75.230000000000004 112.301 -176.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -67.95 93.7 0.43 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.887 0.375 . . . . 72.120000000000005 111.582 172.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.498 HG13 ' HG3' ' A' ' 75' ' ' LYS . 60.2 t -86.94 107.11 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 110.116 -0.328 . . . . 74.420000000000002 110.116 174.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.549 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 23.8 t -64.83 147.74 52.65 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.637 -0.256 . . . . 72.129999999999995 111.352 -177.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.444 ' HG3' ' N ' ' A' ' 88' ' ' ILE . 12.3 pt-20 -36.31 -55.76 0.8 Allowed 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 115.424 1.638 . . . . 74.310000000000002 115.424 -167.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.444 ' N ' ' HG3' ' A' ' 87' ' ' GLU . 2.8 pp -87.35 10.12 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 112.866 0.691 . . . . 74.450000000000003 112.866 -173.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 97.74 47.98 2.03 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 121.363 -0.446 . . . . 74.019999999999996 113.999 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.591 ' HG2' ' HG2' ' A' ' 63' ' ' LYS . 90.8 mttt -114.77 146.36 41.07 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 122.305 -0.526 . . . . 74.510000000000005 111.515 176.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.418 HD12 HG21 ' A' ' 58' ' ' ILE . 58.3 mt -130.97 138.77 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 115.873 -0.603 . . . . 73.239999999999995 111.137 -177.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.56 93.55 8.83 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.621 -0.263 . . . . 73.340000000000003 111.679 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.468 HD23 HD13 ' A' ' 58' ' ' ILE . 62.2 mt -53.97 -57.18 11.97 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 111.79 0.292 . . . . 74.109999999999999 111.79 177.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 52.9 ttp180 -46.25 -30.65 2.1 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.727 0.639 . . . . 75.049999999999997 112.727 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -90.59 -25.63 20.08 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 112.242 0.46 . . . . 72.400000000000006 112.242 -176.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -127.11 13.08 7.21 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 113.129 0.788 . . . . 75.400000000000006 113.129 -176.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 93' ' ' LEU . 55.2 tttm -64.61 125.98 26.44 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.029 0.443 . . . . 72.209999999999994 111.777 -175.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 22.4 t90 -58.94 113.8 2.26 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.853 0.686 . . . . 74.129999999999995 112.853 -175.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -107.71 92.41 8.73 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 115.909 -0.587 . . . . 63.229999999999997 110.481 172.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -61.35 -34.0 88.0 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.585 2.19 . . . . 75.030000000000001 113.184 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 89.1 mt -125.88 -74.15 0.61 Allowed 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.54 0.209 . . . . 74.420000000000002 111.554 -177.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 . . . . . 0 C--O 1.256 1.401 0 CA-C-O 118.938 -0.553 . . . . 71.349999999999994 111.795 -179.551 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ttt . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.59 0.233 . . . . 74.329999999999998 110.851 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -64.15 141.29 58.82 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 112.742 0.645 . . . . 71.430000000000007 112.742 -175.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -52.72 -39.57 62.18 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.677 0.621 . . . . 74.5 112.677 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -57.74 -48.71 78.84 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.898 0.38 . . . . 74.319999999999993 110.754 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.28 -46.58 89.76 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.034 -0.53 . . . . 74.239999999999995 111.26 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 73.2 t -56.48 -52.31 54.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 116.286 -0.415 . . . . 72.549999999999997 111.62 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -63.98 -49.85 70.87 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.947 0.721 . . . . 64.140000000000001 112.947 -176.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 36.9 pt -60.73 -41.76 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 O-C-N 122.114 -0.366 . . . . 73.450000000000003 111.401 -178.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -66.03 -41.78 90.48 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.747 0.308 . . . . 74.519999999999996 110.998 177.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.04 -37.95 69.93 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.011 0.434 . . . . 71.439999999999998 111.586 177.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 95.9 t -66.85 -41.85 88.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-O 121.015 0.436 . . . . 74.329999999999998 110.982 177.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.534 ' HB ' HD11 ' A' ' 52' ' ' LEU . 73.7 mt -62.5 -37.32 78.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 116.117 -0.492 . . . . 75.120000000000005 111.801 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -57.16 -21.17 30.91 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 122.194 -0.316 . . . . 73.109999999999999 111.717 174.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -87.46 -4.13 59.01 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 112.447 0.536 . . . . 74.209999999999994 112.447 -177.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.511 HD11 HD12 ' A' ' 26' ' ' ILE . 60.0 mt -76.32 122.26 86.44 Favored Pre-proline 0 CA--C 1.542 0.658 0 O-C-N 122.349 -0.219 . . . . 75.340000000000003 110.776 177.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -68.21 169.51 16.61 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.582 2.188 . . . . 74.5 112.782 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -67.24 149.46 50.39 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.035 0.445 . . . . 75.400000000000006 112.015 -177.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.99 -32.78 1.73 Allowed Glycine 0 CA--C 1.529 0.966 0 C-N-CA 121.337 -0.459 . . . . 63.420000000000002 113.839 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -77.75 159.92 28.74 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.447 0.641 . . . . 75.439999999999998 112.562 -177.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.5 m -130.54 156.33 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 115.543 -0.753 . . . . 72.040000000000006 110.621 177.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 51.0 m -133.3 155.95 48.48 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.07 0.462 . . . . 73.040000000000006 111.558 176.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.5 p -94.17 155.05 17.26 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.982 0.42 . . . . 72.219999999999999 111.282 176.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -55.8 -33.91 64.84 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.307 -0.406 . . . . 75.439999999999998 111.823 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.99 -43.47 97.35 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.195 -0.526 . . . . 75.030000000000001 112.832 178.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.49 ' HB3' ' HE2' ' A' ' 29' ' ' MET . 42.3 mt-10 -62.36 -54.68 36.83 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.913 0.387 . . . . 73.319999999999993 111.11 177.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.511 HD12 HD11 ' A' ' 15' ' ' ILE . 50.1 mm -54.79 -49.74 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 116.208 -0.451 . . . . 71.319999999999993 111.464 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.07 -43.53 82.2 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.454 -0.339 . . . . 64.040000000000006 111.596 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.03 -56.1 22.47 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 111.752 0.279 . . . . 71.409999999999997 111.752 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.49 ' HE2' ' HB3' ' A' ' 25' ' ' GLU . 4.4 mpp? -61.53 -25.63 67.41 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.148 0.425 . . . . 65.109999999999999 112.148 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.3 -21.22 53.87 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.042 0.386 . . . . 74.430000000000007 112.042 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.09 21.29 20.98 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.251 -0.499 . . . . 63.030000000000001 113.157 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -134.43 54.04 10.95 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 122.529 0.331 . . . . 73.540000000000006 111.74 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -62.25 132.45 38.86 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 121.983 1.789 . . . . 74.099999999999994 112.237 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.65 -28.38 15.74 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.146 -0.55 . . . . 43.420000000000002 113.008 -176.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -82.77 27.57 0.53 Allowed 'General case' 0 CA--C 1.542 0.662 0 O-C-N 122.452 -0.44 . . . . 72.299999999999997 111.989 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.09 -39.96 76.04 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.399 0.518 . . . . 74.349999999999994 112.399 -177.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -60.4 -32.02 70.93 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.946 0.403 . . . . 75.109999999999999 111.1 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -74.57 -41.05 61.21 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.309 -0.405 . . . . 70.329999999999998 110.791 177.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.2 t -56.2 -42.2 72.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.074 0.464 . . . . 73.25 110.641 175.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.26 -45.34 96.27 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-N 116.064 -0.516 . . . . 64.140000000000001 112.731 175.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -64.47 -33.34 75.66 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.938 0.399 . . . . 74.340000000000003 111.392 177.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.32 -48.12 71.34 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.298 -0.41 . . . . 71.200000000000003 111.435 177.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.1 mt -67.34 -38.96 85.67 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.948 0.404 . . . . 75.409999999999997 111.319 177.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.62 -13.21 50.22 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 121.145 -0.55 . . . . 55.219999999999999 113.142 176.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -93.9 -8.0 41.49 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 120.987 0.422 . . . . 73.230000000000004 111.186 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 70.6 mt -82.22 144.78 51.03 Favored Pre-proline 0 N--CA 1.472 0.634 0 N-CA-C 112.665 0.617 . . . . 73.329999999999998 112.665 -177.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.05 144.24 37.55 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.479 2.12 . . . . 63.130000000000003 111.733 172.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.508 ' HB3' ' HE ' ' A' ' 73' ' ' ARG . 16.6 pt-20 -65.04 -26.37 68.23 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 122.102 -0.374 . . . . 64.010000000000005 111.997 -176.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -88.37 20.96 27.57 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 121.066 -0.588 . . . . 52.450000000000003 113.856 177.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.9 t -73.1 150.29 42.39 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 117.083 0.442 . . . . 71.25 112.173 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -64.56 -46.3 83.39 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.275 0.559 . . . . 74.129999999999995 110.77 175.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.534 HD11 ' HB ' ' A' ' 12' ' ' ILE . 51.8 tp -58.22 117.16 17.91 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 115.602 -0.726 . . . . 75.510000000000005 111.382 175.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.47 ' HD2' HD13 ' A' ' 52' ' ' LEU . 58.9 Cg_endo -72.49 94.52 0.77 Allowed 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 121.465 1.443 . . . . 74.129999999999995 111.992 178.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 67.4 p-90 -82.79 -26.79 31.45 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.372 0.606 . . . . 73.439999999999998 110.964 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.515 ' HA ' ' HG3' ' A' ' 74' ' ' GLN . 29.1 p90 -62.27 -20.39 64.23 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.507 -0.769 . . . . 73.519999999999996 112.909 -176.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 79.9 mtt-85 -79.32 1.72 24.06 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.397 0.518 . . . . 74.310000000000002 112.397 -178.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 21' ' ' SER . 33.5 t -109.57 124.79 66.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 O-C-N 121.892 -0.505 . . . . 75.420000000000002 111.89 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.6 pt -132.91 177.04 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 116.414 -0.357 . . . . 72.519999999999996 111.564 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.429 HD22 ' HB2' ' A' ' 63' ' ' LYS . 36.7 p30 -80.61 177.78 8.78 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.773 0.657 . . . . 73.420000000000002 112.773 -174.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 76.0 p -67.3 -17.7 64.88 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.913 -0.585 . . . . 64.120000000000005 112.494 -177.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -83.58 -10.69 58.09 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.066 0.46 . . . . 72.319999999999993 111.13 177.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.67 49.42 14.32 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.88 -0.676 . . . . 73.400000000000006 111.665 -172.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.429 ' HB2' HD22 ' A' ' 59' ' ' ASN . 96.7 mttt -135.1 158.36 44.55 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.922 0.391 . . . . 70.400000000000006 111.015 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 67.9 mt -72.58 119.39 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.4 -0.364 . . . . 74.140000000000001 110.915 177.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.5 m -65.62 -44.2 87.25 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.804 0.335 . . . . 70.340000000000003 111.881 -178.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 84.7 mt -74.92 117.31 16.63 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.807 0.337 . . . . 74.310000000000002 110.896 178.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -108.78 169.87 8.39 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.847 0.356 . . . . 73.219999999999999 111.702 -177.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.02 -132.06 10.94 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 121.18 -0.533 . . . . 65.319999999999993 111.834 -173.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -81.59 -26.41 34.96 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 122.188 -0.595 . . . . 75.219999999999999 110.93 174.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.494 ' O ' ' HB3' ' A' ' 73' ' ' ARG . 17.6 m-20 -63.89 -17.33 63.09 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.994 0.426 . . . . 71.439999999999998 110.798 174.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.1 tt -65.11 -52.33 56.02 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.094 -0.503 . . . . 73.140000000000001 109.937 173.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.554 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 19.3 m-20 -63.59 -31.89 73.19 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.99 0.424 . . . . 72.140000000000001 111.359 176.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.508 ' HE ' ' HB3' ' A' ' 48' ' ' GLU . 70.8 ttt180 -51.1 -63.84 1.0 Allowed 'General case' 0 CA--C 1.547 0.832 0 CA-C-O 121.236 0.541 . . . . 74.030000000000001 110.897 173.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.515 ' HG3' ' HA ' ' A' ' 55' ' ' PHE . 48.1 tt0 -67.77 -43.64 79.35 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.093 0.473 . . . . 73.319999999999993 110.944 178.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.554 ' HB3' ' HA ' ' A' ' 72' ' ' ASP . 85.0 tttt -48.93 -60.94 2.34 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.702 -0.681 . . . . 73.200000000000003 112.149 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -65.02 -34.36 78.26 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.184 0.438 . . . . 64.200000000000003 112.184 -176.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -60.19 -29.67 68.86 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 120.605 -0.438 . . . . 74.310000000000002 111.373 172.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 80.5 mt -86.43 -34.37 20.15 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.227 -0.442 . . . . 73.430000000000007 111.548 175.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -66.08 -31.89 73.04 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 122.192 -0.317 . . . . 74.010000000000005 111.262 178.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.27 -25.86 62.28 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.222 0.534 . . . . 73.239999999999995 111.187 174.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.424 ' HB2' HG13 ' A' ' 83' ' ' ILE . 14.1 mm-40 -80.05 -26.15 39.84 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.347 0.594 . . . . 64.120000000000005 111.066 176.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 99.88 22.82 11.49 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 115.906 -0.588 . . . . 63.119999999999997 112.29 -172.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.424 HG13 ' HB2' ' A' ' 81' ' ' GLU . 73.1 mt -83.86 125.72 40.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.011 0.434 . . . . 71.430000000000007 111.169 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -72.24 99.07 2.3 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.583 0.706 . . . . 75.140000000000001 112.145 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.415 HG12 ' HG3' ' A' ' 75' ' ' LYS . 44.7 t -100.14 111.15 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 115.994 -0.548 . . . . 74.120000000000005 110.879 178.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.566 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 40.3 t -67.12 158.22 31.71 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.278 -0.419 . . . . 61.520000000000003 111.629 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -43.69 -53.43 5.8 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 114.281 1.215 . . . . 71.239999999999995 114.281 -170.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.8 pp -79.47 12.96 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 112.524 0.565 . . . . 75.219999999999999 112.524 -176.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.51 48.97 5.09 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-N 116.365 -0.38 . . . . 64.209999999999994 112.986 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.566 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 61.3 tttm -116.19 123.46 47.84 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 120.992 0.425 . . . . 74.129999999999995 111.941 -178.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 64.6 mt -116.27 142.92 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 122.769 0.428 . . . . 72.010000000000005 111.33 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.25 101.84 5.6 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 111.896 0.332 . . . . 74.519999999999996 111.896 178.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.4 ' O ' ' N ' ' A' ' 97' ' ' LYS . 57.5 mt -54.54 -62.54 1.59 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.15 0.426 . . . . 74.120000000000005 112.15 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 45.3 mtm180 -49.88 -29.9 9.03 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.311 0.485 . . . . 71.329999999999998 112.311 -176.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -79.94 -35.27 38.01 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.083 -0.508 . . . . 73.420000000000002 111.581 -176.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -115.71 5.98 14.35 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.292 0.479 . . . . 75.019999999999996 112.292 -177.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.4 ' N ' ' O ' ' A' ' 93' ' ' LEU . 55.5 tttm -59.32 133.82 56.44 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.074 0.464 . . . . 75.519999999999996 111.971 -174.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 13.6 t90 -55.2 114.29 1.72 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.995 -0.548 . . . . 64.109999999999999 111.491 178.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -109.45 91.83 10.69 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 116.157 -0.474 . . . . 62.030000000000001 110.44 175.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -77.51 -9.4 17.35 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 122.221 1.947 . . . . 75.430000000000007 112.082 177.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 74.6 mt -89.96 99.06 12.14 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.868 -0.605 . . . . 65.200000000000003 110.832 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 C--O 1.256 1.424 0 CA-C-N 115.905 -0.588 . . . . 72.430000000000007 112.39 -179.378 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.9 tpt . . . . . 0 N--CA 1.486 1.371 0 N-CA-C 110.423 -0.214 . . . . 74.450000000000003 110.423 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -49.47 128.63 17.68 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.248 0.462 . . . . 73.430000000000007 112.248 -177.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.484 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 17.4 mm100 -55.21 -37.47 67.16 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.346 0.498 . . . . 73.239999999999995 112.346 -177.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -55.86 -54.48 44.1 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.231 0.538 . . . . 72.219999999999999 110.603 176.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 68.9 mt -62.74 -44.72 95.46 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.556 -0.747 . . . . 73.120000000000005 111.201 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 85.5 t -57.11 -52.27 58.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 112.078 0.399 . . . . 73.430000000000007 112.078 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 28.6 mm-40 -62.32 -51.08 69.09 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.156 0.428 . . . . 74.540000000000006 112.156 -175.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.526 HD12 HG11 ' A' ' 39' ' ' VAL . 31.4 pt -59.55 -45.69 93.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 111.633 0.235 . . . . 73.140000000000001 111.633 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 19.6 m-30 -63.98 -41.33 97.56 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.132 0.491 . . . . 74.25 110.886 177.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.47 -20.4 63.11 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.87 -0.605 . . . . 64.040000000000006 111.798 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 7' ' ' GLN . 99.2 t -85.71 -41.0 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 120.745 0.307 . . . . 74.319999999999993 111.05 173.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 8' ' ' ILE . 79.3 mt -55.28 -41.23 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 112.664 0.616 . . . . 74.209999999999994 112.664 -177.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -58.38 -12.52 3.9 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 113.424 0.898 . . . . 74.040000000000006 113.424 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -85.64 -7.46 58.81 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 112.079 0.4 . . . . 63.399999999999999 112.079 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 63.8 mt -75.71 119.77 78.62 Favored Pre-proline 0 CA--C 1.542 0.661 0 O-C-N 122.407 -0.183 . . . . 74.010000000000005 110.696 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -76.75 161.1 33.94 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.545 2.164 . . . . 71.409999999999997 113.269 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.457 ' HZ1' ' CD ' ' A' ' 81' ' ' GLU . 45.3 tttp -63.88 107.84 1.32 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.253 -0.431 . . . . 70.140000000000001 111.235 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 128.87 -15.61 5.9 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.923 -0.656 . . . . 72.209999999999994 113.483 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -116.6 163.42 16.12 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.386 0.612 . . . . 64.120000000000005 112.254 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.4 m -135.82 162.75 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-N 115.444 -0.798 . . . . 74.430000000000007 110.895 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.489 ' HG ' HD11 ' A' ' 26' ' ' ILE . 89.0 p -137.36 171.02 15.11 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.747 0.308 . . . . 71.200000000000003 110.613 175.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 40.2 p -107.05 154.03 21.73 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.829 0.347 . . . . 71.439999999999998 111.541 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -50.65 -41.25 55.15 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 116.223 -0.444 . . . . 71.209999999999994 112.074 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -57.66 -41.6 93.81 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 121.23 -0.51 . . . . 74.200000000000003 112.912 178.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.476 ' O ' ' HG3' ' A' ' 29' ' ' MET . 42.2 mt-10 -65.93 -52.63 48.2 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.655 0.264 . . . . 71.319999999999993 111.063 178.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.489 HD11 ' HG ' ' A' ' 21' ' ' SER . 44.4 mm -56.54 -47.33 82.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 120.984 0.421 . . . . 73.349999999999994 111.571 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.84 -45.97 90.13 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.34 -0.391 . . . . 75.530000000000001 111.593 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -61.04 -41.61 96.9 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 111.768 0.284 . . . . 74.0 111.768 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.476 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 64.8 mtt -67.86 -34.76 77.31 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.634 0.254 . . . . 55.210000000000001 111.477 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.69 -27.28 50.72 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.877 0.37 . . . . 73.319999999999993 111.731 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.81 44.99 1.84 Allowed Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.442 -0.409 . . . . 41.009999999999998 113.644 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -137.41 83.09 26.89 Favored Pre-proline 0 CA--C 1.544 0.716 0 O-C-N 122.412 -0.464 . . . . 74.219999999999999 111.576 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.4 126.49 14.31 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 122.791 2.327 . . . . 72.540000000000006 113.024 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.19 -8.71 79.22 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 121.396 -0.431 . . . . 54.520000000000003 113.709 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -94.35 11.13 31.58 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.569 0.581 . . . . 75.230000000000004 112.569 -177.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.81 -47.7 70.6 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.208 0.527 . . . . 52.109999999999999 111.457 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.8 ptt180 -53.44 -38.02 63.13 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.678 -0.692 . . . . 75.030000000000001 112.119 174.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -69.49 -35.89 76.0 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.781 0.324 . . . . 65.040000000000006 111.203 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.526 HG11 HD12 ' A' ' 8' ' ' ILE . 55.5 t -57.42 -39.65 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 121.195 0.521 . . . . 72.400000000000006 110.378 174.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.31 -40.9 99.25 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 116.031 -0.531 . . . . 42.539999999999999 112.528 174.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -58.95 -38.0 78.04 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.031 0.443 . . . . 75.329999999999998 111.089 175.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.95 -55.34 19.74 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.87 -0.605 . . . . 74.310000000000002 111.838 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.0 mt -62.47 -32.27 73.12 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.67 0.271 . . . . 74.310000000000002 111.536 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.72 -21.54 58.34 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 121.192 -0.528 . . . . 75.030000000000001 113.542 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -84.4 -10.56 57.43 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.091 0.472 . . . . 72.430000000000007 110.977 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.422 HD13 HD21 ' A' ' 52' ' ' LEU . 97.5 mt -87.5 139.96 31.79 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 116.361 -0.381 . . . . 73.239999999999995 111.924 -178.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -88.08 173.31 4.95 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.701 2.267 . . . . 71.409999999999997 112.667 175.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.741 ' HB3' ' HD3' ' A' ' 73' ' ' ARG . 9.7 pt-20 -67.48 -12.86 61.31 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.785 0.326 . . . . 73.340000000000003 111.82 177.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -96.78 32.84 6.18 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 121.353 -0.451 . . . . 43.229999999999997 113.445 176.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.8 t -95.45 135.36 37.18 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 122.294 -0.533 . . . . 63.399999999999999 111.507 177.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -70.14 -28.57 65.46 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.923 0.392 . . . . 74.239999999999995 111.185 174.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.519 HD13 ' HD2' ' A' ' 53' ' ' PRO . 48.5 tp -72.78 117.65 61.31 Favored Pre-proline 0 C--O 1.237 0.423 0 CA-C-N 116.219 -0.446 . . . . 75.209999999999994 110.441 176.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.519 ' HD2' HD13 ' A' ' 52' ' ' LEU . 44.5 Cg_endo -67.1 95.32 0.36 Allowed 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 121.562 1.508 . . . . 75.209999999999994 112.496 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 -80.81 -31.54 35.6 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.406 0.622 . . . . 70.25 110.723 177.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.472 ' O ' HD21 ' A' ' 78' ' ' LEU . 20.8 p90 -63.25 -21.89 66.52 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.242 0.83 . . . . 73.400000000000006 113.242 -178.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -84.4 -1.25 55.25 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.6 0.593 . . . . 74.019999999999996 112.6 -177.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.8 t -118.11 106.97 20.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-O 121.342 0.592 . . . . 71.140000000000001 111.58 -178.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.564 HD13 HD22 ' A' ' 93' ' ' LEU . 28.6 pt -112.67 -169.64 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 121.263 0.554 . . . . 75.230000000000004 112.114 -177.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 28.2 p30 -95.23 170.3 9.48 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.545 0.572 . . . . 74.409999999999997 112.545 -175.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 31.1 t -63.62 -17.88 63.35 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 112.46 0.541 . . . . 72.200000000000003 112.46 -178.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -75.75 -14.62 60.33 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.058 0.456 . . . . 60.409999999999997 111.113 177.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.99 43.64 33.06 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.036 -0.602 . . . . 52.119999999999997 111.934 -174.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.405 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 89.7 mttt -133.85 162.45 31.98 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.164 0.507 . . . . 75.540000000000006 111.596 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.405 HG22 ' OE1' ' A' ' 74' ' ' GLN . 66.5 mt -70.13 119.03 15.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 115.759 -0.655 . . . . 72.319999999999993 110.178 172.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.0 m -67.16 -27.75 67.55 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.198 0.444 . . . . 72.239999999999995 112.198 -177.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.521 HD13 ' HB3' ' A' ' 70' ' ' ASP . 77.1 mt -77.33 165.93 23.81 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.144 0.497 . . . . 64.420000000000002 111.727 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -133.68 148.96 51.53 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.066 0.46 . . . . 75.129999999999995 112.084 -171.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.34 -123.82 30.36 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-N 116.081 -0.509 . . . . 73.540000000000006 113.553 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 48.0 mtp180 -64.72 -38.96 92.77 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.175 0.512 . . . . 71.140000000000001 110.924 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.521 ' HB3' HD13 ' A' ' 66' ' ' LEU . 4.3 m-20 -60.49 -30.19 69.55 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.949 -0.568 . . . . 72.319999999999993 111.233 176.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.1 tt -65.74 -59.09 4.26 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.351 -0.386 . . . . 73.420000000000002 110.784 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -69.13 -21.63 64.01 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 122.267 -0.271 . . . . 72.430000000000007 111.468 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.741 ' HD3' ' HB3' ' A' ' 48' ' ' GLU . 35.9 ttm180 -61.91 -52.27 64.75 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.069 0.461 . . . . 63.149999999999999 110.319 172.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.405 ' OE1' HG22 ' A' ' 64' ' ' ILE . 53.5 tt0 -60.63 -39.45 88.28 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.1 -0.5 . . . . 72.140000000000001 110.714 178.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.451 ' HG3' ' HB ' ' A' ' 85' ' ' VAL . 85.5 tttt -57.73 -53.08 62.26 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.081 -0.509 . . . . 71.540000000000006 111.236 176.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -55.75 -39.59 71.38 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.948 0.404 . . . . 70.25 111.441 178.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.446 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 69.0 mmtt -58.59 -48.5 80.73 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.189 -0.46 . . . . 75.540000000000006 111.415 173.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.472 HD21 ' O ' ' A' ' 55' ' ' PHE . 85.6 mt -66.28 -39.87 89.69 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.247 -0.433 . . . . 72.049999999999997 111.934 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 46.2 mt-10 -64.15 -26.64 68.62 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.948 0.404 . . . . 73.340000000000003 110.909 177.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.57 -14.53 60.8 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.234 -0.439 . . . . 74.040000000000006 111.576 174.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.457 ' CD ' ' HZ1' ' A' ' 17' ' ' LYS . 22.5 mm-40 -103.6 10.06 37.11 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 111.855 0.317 . . . . 74.239999999999995 111.855 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.46 30.49 40.49 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 121.066 -0.588 . . . . 63.130000000000003 113.535 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.1 mt -112.04 138.67 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 O-C-N 122.449 -0.442 . . . . 74.510000000000005 111.383 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.517 ' HB2' ' HH ' ' A' ' 96' ' ' TYR . 40.1 mt-10 -100.47 114.33 27.83 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.826 0.346 . . . . 73.329999999999998 110.696 175.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.451 ' HB ' ' HG3' ' A' ' 75' ' ' LYS . 79.7 t -107.63 131.44 57.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 116.398 -0.365 . . . . 73.549999999999997 111.177 -178.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.548 ' OG ' ' HB3' ' A' ' 90' ' ' LYS . 25.6 p -74.32 148.0 41.76 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.88 0.372 . . . . 73.239999999999995 111.412 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.409 ' HG3' ' N ' ' A' ' 88' ' ' ILE . 12.4 pt-20 -42.59 -53.92 4.19 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.891 1.441 . . . . 74.299999999999997 114.891 -166.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.409 ' N ' ' HG3' ' A' ' 87' ' ' GLU . 2.8 pp -73.59 11.92 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 112.868 0.692 . . . . 75.129999999999995 112.868 -175.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.43 50.79 4.36 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 121.426 -0.416 . . . . 71.349999999999994 113.127 177.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.562 ' HD3' ' N ' ' A' ' 91' ' ' ILE . 6.6 tmtm? -122.88 138.58 54.62 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 122.446 -0.443 . . . . 71.5 110.488 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.562 ' N ' ' HD3' ' A' ' 90' ' ' LYS . 66.6 mt -121.2 132.34 70.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 120.883 0.373 . . . . 62.530000000000001 111.463 -178.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.86 93.51 2.66 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.899 0.38 . . . . 71.129999999999995 111.454 177.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.564 HD22 HD13 ' A' ' 58' ' ' ILE . 63.4 mt -51.99 -49.58 63.02 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.024 0.75 . . . . 73.340000000000003 113.024 -176.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -49.87 -44.52 49.82 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 121.256 0.55 . . . . 75.329999999999998 111.829 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -76.29 -34.25 59.08 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.718 -0.673 . . . . 73.310000000000002 112.367 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.517 ' HH ' ' HB2' ' A' ' 84' ' ' GLU . 78.8 m-85 -112.28 14.63 20.51 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.273 0.471 . . . . 73.040000000000006 112.273 -172.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 61.9 tttp -65.02 130.05 41.94 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.095 0.474 . . . . 74.530000000000001 111.943 -177.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 19.7 t90 -62.51 113.73 3.12 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.979 -0.555 . . . . 73.230000000000004 111.195 175.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -113.33 92.64 23.41 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 116.4 -0.364 . . . . 74.109999999999999 110.524 176.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.6 -22.83 74.4 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.731 2.288 . . . . 74.209999999999994 112.938 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 71.5 mt -79.71 94.73 5.79 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.449 -0.341 . . . . 65.120000000000005 110.436 176.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 C--O 1.255 1.359 0 CA-C-O 118.549 -0.738 . . . . 75.549999999999997 111.555 -179.684 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.531 ' HE1' ' HA ' ' A' ' 6' ' ' VAL . 24.5 ptt? . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 120.81 0.338 . . . . 72.439999999999998 111.313 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -65.82 141.84 58.15 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.342 -0.39 . . . . 74.209999999999994 112.043 -176.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 62.3 mm-40 -53.61 -32.39 50.93 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.618 0.599 . . . . 73.510000000000005 112.618 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.406 ' O ' HG12 ' A' ' 8' ' ' ILE . 73.0 t80 -55.61 -48.9 74.15 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.247 0.546 . . . . 73.400000000000006 109.993 173.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 72.2 mt -67.07 -46.91 72.89 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.523 -0.762 . . . . 74.310000000000002 111.162 178.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.531 ' HA ' ' HE1' ' A' ' 1' ' ' MET . 85.3 t -52.38 -50.24 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.8 0.334 . . . . 75.129999999999995 111.847 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 26.3 mm-40 -63.71 -52.7 59.35 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.157 0.428 . . . . 75.430000000000007 112.157 -177.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.424 ' O ' HG13 ' A' ' 12' ' ' ILE . 31.6 pt -65.32 -45.67 92.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 O-C-N 122.315 -0.241 . . . . 73.319999999999993 111.647 -178.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.402 ' CD1' HG13 ' A' ' 8' ' ' ILE . 14.2 m-30 -61.1 -43.28 99.13 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.755 0.312 . . . . 74.209999999999994 111.069 178.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.74 -43.08 65.49 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.439 -0.346 . . . . 75.0 111.383 177.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.419 HG21 ' O ' ' A' ' 7' ' ' GLN . 61.4 t -64.36 -42.4 95.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 121.142 0.496 . . . . 73.340000000000003 111.182 177.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.5 ' HB ' HD11 ' A' ' 52' ' ' LEU . 73.7 mt -62.85 -32.59 56.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 116.016 -0.538 . . . . 72.430000000000007 112.086 -178.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 72.3 m-70 -60.58 -22.25 63.51 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.299 0.481 . . . . 75.150000000000006 112.299 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -77.31 -14.07 59.81 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.256 0.465 . . . . 75.030000000000001 112.256 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.511 HD13 HD12 ' A' ' 26' ' ' ILE . 51.4 mt -75.08 113.76 28.3 Favored Pre-proline 0 CA--C 1.542 0.662 0 O-C-N 122.455 -0.153 . . . . 74.310000000000002 111.122 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -69.89 175.23 8.49 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.016 2.477 . . . . 74.010000000000005 113.751 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -67.81 140.13 56.61 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.92 -0.582 . . . . 75.329999999999998 111.768 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.76 17.25 71.04 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.188 -0.529 . . . . 70.230000000000004 113.378 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -118.3 141.18 48.79 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.688 0.28 . . . . 75.109999999999999 110.579 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.9 m -122.52 146.47 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.433 0.635 . . . . 65.140000000000001 112.284 -177.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.4 t -134.51 178.28 7.11 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.692 -0.685 . . . . 73.349999999999994 110.217 175.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 72.7 p -115.05 150.57 35.69 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.079 0.466 . . . . 70.25 111.835 -177.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -51.8 -36.6 48.41 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.086 -0.506 . . . . 75.010000000000005 112.163 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.62 -51.0 60.47 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 121.014 -0.612 . . . . 71.010000000000005 113.039 178.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -55.65 -48.14 75.49 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.0 0.429 . . . . 73.109999999999999 111.135 179.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.511 HD12 HD13 ' A' ' 15' ' ' ILE . 49.9 mm -61.42 -54.17 38.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 116.115 -0.493 . . . . 72.109999999999999 111.746 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.56 -48.66 78.72 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.227 0.454 . . . . 75.219999999999999 112.227 -178.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -60.24 -43.1 96.38 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.677 0.275 . . . . 74.230000000000004 111.589 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 77.7 mtm -73.35 -21.78 60.46 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 111.901 0.334 . . . . 75.219999999999999 111.901 178.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.58 -28.41 33.82 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.961 0.41 . . . . 73.030000000000001 111.186 174.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.94 29.09 5.06 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.298 -0.477 . . . . 74.340000000000003 113.468 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -134.43 79.93 53.13 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-O 120.893 0.378 . . . . 74.540000000000006 111.169 178.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.01 126.89 14.38 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.364 2.043 . . . . 74.319999999999993 112.614 -178.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.38 -22.85 36.47 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.175 -0.535 . . . . 73.140000000000001 113.274 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -78.61 12.19 2.17 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.36 0.504 . . . . 74.200000000000003 112.36 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.05 -44.37 61.09 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.021 0.438 . . . . 73.319999999999993 111.777 177.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 30.7 ptt-85 -58.37 -39.66 80.18 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 116.24 -0.436 . . . . 74.400000000000006 111.922 177.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -70.77 -34.53 71.91 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.662 0.268 . . . . 64.340000000000003 111.015 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.5 t -57.94 -43.39 84.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 CA-C-O 121.13 0.49 . . . . 74.230000000000004 110.267 172.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.47 -38.65 95.17 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-N 115.838 -0.619 . . . . 62.240000000000002 112.905 175.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -62.17 -47.27 85.25 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.982 0.42 . . . . 71.439999999999998 110.873 175.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.93 -45.65 89.88 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.017 -0.538 . . . . 72.540000000000006 111.668 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.562 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 58.2 mt -68.64 -38.49 80.53 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.908 0.385 . . . . 74.530000000000001 111.352 178.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.7 -15.76 66.97 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.268 -0.491 . . . . 70.209999999999994 113.081 176.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -76.6 -23.11 53.43 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.174 0.511 . . . . 74.349999999999994 110.52 175.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 82.6 mt -81.27 143.84 52.91 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 115.956 -0.566 . . . . 72.129999999999995 111.966 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -86.52 -176.7 2.11 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.708 2.272 . . . . 71.409999999999997 112.587 174.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.06 -23.58 64.06 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 122.131 -0.356 . . . . 74.040000000000006 111.937 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -90.02 39.39 3.11 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.534 -0.365 . . . . 74.230000000000004 113.43 177.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.0 t -93.03 140.08 29.85 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 122.437 -0.449 . . . . 73.140000000000001 111.404 177.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -72.42 -42.28 65.25 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.227 0.537 . . . . 75.230000000000004 110.29 175.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.5 HD11 ' HB ' ' A' ' 12' ' ' ILE . 33.3 tp -67.01 118.79 58.89 Favored Pre-proline 0 CA--C 1.535 0.404 0 CA-C-N 115.616 -0.72 . . . . 71.200000000000003 110.707 173.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.69 94.64 0.53 Allowed 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 121.392 1.394 . . . . 64.030000000000001 111.972 177.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.562 ' HB2' ' HB3' ' A' ' 43' ' ' LEU . 58.4 p-90 -84.96 -33.39 22.65 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.565 0.698 . . . . 74.310000000000002 111.0 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -59.91 -20.55 57.98 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.296 -0.865 . . . . 74.409999999999997 112.911 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.409 ' NH1' ' O ' ' A' ' 15' ' ' ILE . 95.8 mtt180 -79.98 -1.14 38.25 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.426 0.528 . . . . 75.120000000000005 112.426 -178.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.3 t -117.01 118.24 58.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 121.038 0.447 . . . . 74.530000000000001 111.744 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.527 HG21 HD13 ' A' ' 91' ' ' ILE . 35.6 pt -127.58 -169.87 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 116.347 -0.388 . . . . 74.540000000000006 111.521 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 32.1 p30 -84.44 163.64 19.35 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 120.94 0.4 . . . . 73.540000000000006 111.857 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 69.2 m -66.02 -15.44 63.03 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.573 0.583 . . . . 65.200000000000003 112.573 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -77.32 -12.59 59.97 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.741 0.305 . . . . 75.439999999999998 111.473 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.26 37.08 12.94 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 121.225 -0.512 . . . . 74.099999999999994 112.621 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.656 ' HZ3' ' HB3' ' A' ' 63' ' ' LYS . 10.0 mtpm? -138.96 162.28 35.28 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.3 0.572 . . . . 74.120000000000005 111.91 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.492 HG22 ' OE1' ' A' ' 74' ' ' GLN . 70.7 mt -69.28 139.71 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 115.725 -0.67 . . . . 75.209999999999994 110.886 175.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 89.1 p -90.18 -50.37 6.03 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.155 0.503 . . . . 73.420000000000002 111.345 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 83.9 mt -64.08 142.92 58.24 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.816 -0.629 . . . . 73.420000000000002 111.951 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -118.06 171.59 7.99 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.004 0.431 . . . . 75.120000000000005 111.234 177.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.78 -138.96 20.9 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.884 -0.674 . . . . 51.340000000000003 112.33 -176.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -74.97 -26.08 59.32 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.086 0.47 . . . . 73.150000000000006 111.474 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.65 -28.04 69.63 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.914 0.388 . . . . 74.129999999999995 111.284 176.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.1 tt -63.35 -60.97 2.68 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.273 -0.421 . . . . 63.420000000000002 110.625 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -64.15 -28.49 69.8 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 122.324 -0.235 . . . . 61.039999999999999 111.234 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -58.53 -53.74 54.88 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.902 0.382 . . . . 74.040000000000006 111.534 176.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.492 ' OE1' HG22 ' A' ' 64' ' ' ILE . 53.9 tt0 -59.38 -40.63 87.16 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.974 0.416 . . . . 75.310000000000002 110.884 177.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -60.13 -53.86 52.71 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.177 -0.465 . . . . 74.400000000000006 112.075 177.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -53.55 -42.46 67.52 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.15 0.5 . . . . 63.310000000000002 111.821 -178.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -59.61 -48.71 80.6 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.024 -0.534 . . . . 75.120000000000005 111.597 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.486 HD23 HD11 ' A' ' 83' ' ' ILE . 89.8 mt -67.69 -43.23 80.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.175 -0.466 . . . . 75.430000000000007 111.581 -177.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -57.03 -42.18 79.94 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.942 0.401 . . . . 64.329999999999998 110.861 175.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.34 -33.97 71.79 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.271 -0.422 . . . . 71.349999999999994 111.414 176.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -86.94 5.74 35.62 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.808 0.337 . . . . 74.209999999999994 111.678 178.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.01 30.89 16.06 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 114.238 0.455 . . . . 63.020000000000003 114.238 174.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.486 HD11 HD23 ' A' ' 78' ' ' LEU . 69.4 mt -104.43 124.77 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 117.129 0.464 . . . . 74.310000000000002 111.723 178.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.8 103.18 4.26 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.503 0.668 . . . . 73.510000000000005 111.601 177.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.2 t -95.78 117.13 39.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.309 -0.405 . . . . 75.420000000000002 111.099 178.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.565 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 41.4 t -67.87 151.15 47.61 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.938 0.399 . . . . 75.219999999999999 112.056 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -40.16 -56.55 1.89 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.322 1.231 . . . . 74.209999999999994 114.322 -171.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.406 ' CD1' ' HB2' ' A' ' 90' ' ' LYS . 2.8 pp -80.15 22.92 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 N-CA-C 112.961 0.726 . . . . 71.319999999999993 112.961 -174.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.06 46.97 11.99 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.17 -0.538 . . . . 74.329999999999998 112.925 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.565 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 1.4 tmtp? -116.74 133.15 56.36 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.91 0.386 . . . . 73.530000000000001 110.765 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.527 HD13 HG21 ' A' ' 58' ' ' ILE . 60.2 mt -121.29 142.4 37.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 120.978 0.418 . . . . 74.209999999999994 111.356 -176.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.58 94.87 4.42 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.98 0.419 . . . . 72.200000000000003 112.039 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.613 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 39.3 mt -63.0 -13.31 33.64 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 116.077 -0.51 . . . . 73.420000000000002 112.334 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -90.27 -48.76 6.94 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.076 0.465 . . . . 75.409999999999997 111.59 175.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.99 -22.65 65.9 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.768 0.655 . . . . 73.409999999999997 112.768 -175.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -128.28 15.11 6.69 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.293 0.479 . . . . 53.310000000000002 112.293 -176.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.613 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 85.0 tttt -56.29 128.98 38.44 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.478 0.547 . . . . 73.319999999999993 112.478 -175.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 16.5 t90 -57.3 114.87 2.37 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.105 -0.498 . . . . 75.340000000000003 111.351 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -105.07 96.42 11.05 Favored Pre-proline 0 CA--C 1.543 0.694 0 CA-C-N 116.209 -0.45 . . . . 74.420000000000002 110.217 174.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -68.55 -0.91 6.56 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.16 2.574 . . . . 71.230000000000004 113.98 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 85.1 mt 63.39 74.04 0.43 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.34 0.59 . . . . 75.329999999999998 111.518 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 . . . . . 0 C--O 1.251 1.168 0 CA-C-O 118.001 -1.0 . . . . 74.010000000000005 111.494 179.944 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 tpt . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 120.727 0.299 . . . . 74.109999999999999 110.991 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.03 129.8 31.85 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.483 0.549 . . . . 60.350000000000001 112.483 -176.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -57.87 -28.12 63.87 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.814 0.34 . . . . 74.129999999999995 111.149 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -57.15 -50.67 72.09 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.0 0.429 . . . . 72.319999999999993 110.651 173.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 76.9 mt -64.57 -44.7 89.88 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.857 -0.61 . . . . 74.420000000000002 110.902 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.0 t -57.1 -49.48 79.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 116.113 -0.494 . . . . 64.030000000000001 111.648 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.423 ' O ' HG21 ' A' ' 11' ' ' VAL . 32.3 mm-40 -62.65 -52.7 62.31 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.527 0.566 . . . . 73.510000000000005 112.527 -178.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.494 HD12 HG11 ' A' ' 39' ' ' VAL . 25.3 pt -60.73 -44.2 96.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 111.757 0.28 . . . . 75.430000000000007 111.757 -177.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.9 m-30 -63.16 -43.61 97.8 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.175 0.512 . . . . 74.530000000000001 110.797 177.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.91 -30.38 61.51 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.007 -0.542 . . . . 62.119999999999997 111.959 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.423 HG21 ' O ' ' A' ' 7' ' ' GLN . 59.4 t -75.87 -41.77 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 121.017 0.437 . . . . 72.239999999999995 111.459 176.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 8' ' ' ILE . 71.2 mt -57.22 -34.93 46.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 112.214 0.45 . . . . 72.109999999999999 112.214 -177.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -59.2 -9.41 2.12 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 113.658 0.984 . . . . 75.030000000000001 113.658 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -92.9 -2.36 55.91 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 112.563 0.579 . . . . 72.239999999999995 112.563 178.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 50.1 mt -84.49 119.03 72.49 Favored Pre-proline 0 CA--C 1.543 0.71 0 O-C-N 122.331 -0.231 . . . . 53.240000000000002 111.188 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -77.94 171.1 17.8 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.392 2.728 . . . . 73.5 113.498 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -67.81 133.84 49.91 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.25 0.548 . . . . 72.219999999999999 111.885 -178.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.38 7.21 82.94 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 116.09 -0.505 . . . . 71.129999999999995 113.439 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -123.77 145.52 48.97 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.941 0.4 . . . . 72.010000000000005 111.119 178.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.406 HG11 ' HA ' ' A' ' 56' ' ' ARG . 34.2 m -133.2 154.99 40.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-O 120.979 0.419 . . . . 74.010000000000005 111.341 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 92.1 p -133.56 170.68 15.17 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.094 0.473 . . . . 75.109999999999999 111.036 177.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.2 p -98.72 152.31 19.81 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.102 0.477 . . . . 73.420000000000002 111.82 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -55.06 -33.5 62.78 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.145 -0.48 . . . . 75.239999999999995 112.139 178.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -60.68 -38.18 94.7 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 120.988 -0.625 . . . . 73.109999999999999 112.772 177.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.421 ' O ' ' HG3' ' A' ' 29' ' ' MET . 42.2 mt-10 -71.2 -51.32 25.42 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.852 0.358 . . . . 73.519999999999996 111.309 178.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.2 mm -58.29 -49.83 80.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-N 116.338 -0.392 . . . . 74.409999999999997 111.827 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.58 -41.6 90.59 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.848 0.356 . . . . 72.340000000000003 111.596 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.574 ' HZ3' ' HB2' ' A' ' 28' ' ' LYS . 4.6 ttmp? -60.01 -47.59 85.2 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.952 0.406 . . . . 75.120000000000005 111.03 178.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.421 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 62.0 mtt -67.22 -29.96 69.75 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.151 -0.477 . . . . 73.409999999999997 111.442 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.67 -20.49 53.63 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.131 0.419 . . . . 63.210000000000001 112.131 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.89 28.35 10.19 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.204 -0.522 . . . . 55.520000000000003 113.455 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -130.9 78.89 72.71 Favored Pre-proline 0 N--CA 1.47 0.552 0 O-C-N 122.48 -0.424 . . . . 72.239999999999995 110.89 177.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -66.71 115.08 3.38 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.666 2.244 . . . . 72.530000000000001 113.073 -176.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.93 -15.58 40.26 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.029 -0.605 . . . . 52.200000000000003 113.624 178.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.416 ' O ' HG23 ' A' ' 39' ' ' VAL . 34.0 m-85 -81.35 18.09 1.21 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.649 0.611 . . . . 62.119999999999997 112.649 -178.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.86 -54.59 18.5 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.31 0.485 . . . . 74.409999999999997 112.31 -178.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.438 ' O ' ' HG3' ' A' ' 41' ' ' LYS . 33.1 ttm180 -57.74 -38.81 75.98 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.026 0.441 . . . . 75.120000000000005 111.614 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.604 ' HA ' ' HE3' ' A' ' 41' ' ' LYS . 81.6 m-70 -68.39 -32.5 72.61 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.282 -0.417 . . . . 73.310000000000002 111.704 -177.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.494 HG11 HD12 ' A' ' 8' ' ' ILE . 56.9 t -60.57 -40.91 85.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 121.156 0.503 . . . . 64.219999999999999 109.886 171.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.82 -44.94 95.45 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 115.947 -0.569 . . . . 55.299999999999997 112.804 176.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.604 ' HE3' ' HA ' ' A' ' 38' ' ' HIS . 8.5 mtmp? -63.04 -22.23 66.71 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.992 0.425 . . . . 74.540000000000006 111.3 178.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.33 -45.88 17.06 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.432 -0.349 . . . . 73.430000000000007 111.442 176.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 66.7 mt -65.51 -35.15 80.03 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 111.976 0.362 . . . . 74.329999999999998 111.976 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.4 -20.81 38.62 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 121.248 -0.501 . . . . 75.439999999999998 113.834 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -81.83 -21.19 37.75 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.804 0.335 . . . . 72.310000000000002 111.832 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 78.7 mt -67.56 142.64 96.36 Favored Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 112.018 0.377 . . . . 73.140000000000001 112.018 -178.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.72 -175.73 2.83 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.681 2.254 . . . . 74.530000000000001 113.202 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -76.19 -38.45 56.55 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.989 -0.551 . . . . 75.219999999999999 110.635 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -95.72 57.69 1.58 Allowed Glycine 0 CA--C 1.528 0.852 0 CA-C-N 116.018 -0.537 . . . . 72.329999999999998 113.729 -178.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.2 t -102.37 159.29 15.55 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 122.32 -0.518 . . . . 63.219999999999999 111.303 173.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -85.85 -15.58 41.42 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.221 0.534 . . . . 74.040000000000006 110.527 176.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.448 HD13 ' HD2' ' A' ' 53' ' ' PRO . 55.9 tp -93.35 116.3 66.28 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 115.908 -0.587 . . . . 73.109999999999999 110.829 178.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.448 ' HD2' HD13 ' A' ' 52' ' ' LEU . 61.6 Cg_endo -74.04 94.4 0.89 Allowed 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 121.251 1.301 . . . . 74.219999999999999 112.299 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 54.9 p-90 -80.11 -30.33 39.11 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.372 0.606 . . . . 72.430000000000007 111.318 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -59.93 -22.63 62.68 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.617 -0.72 . . . . 74.340000000000003 112.876 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.406 ' HA ' HG11 ' A' ' 20' ' ' VAL . 97.8 mtt180 -79.61 -0.94 35.8 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.584 0.587 . . . . 73.430000000000007 112.584 -177.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.9 t -118.63 109.59 27.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.062 0.458 . . . . 65.319999999999993 110.892 178.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.525 HD12 HD23 ' A' ' 93' ' ' LEU . 32.9 pt -114.98 -172.48 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 116.221 -0.445 . . . . 75.049999999999997 111.983 -176.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 32.1 p30 -81.32 165.71 21.14 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.207 0.527 . . . . 73.530000000000001 112.08 -176.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 80.4 p -70.61 -2.73 15.23 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.809 0.67 . . . . 75.519999999999996 112.809 -175.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -94.16 -9.37 36.63 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.042 0.386 . . . . 74.450000000000003 112.042 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.3 44.33 13.71 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 120.667 -0.778 . . . . 64.310000000000002 112.393 -176.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -133.46 172.29 12.91 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 122.753 0.421 . . . . 73.040000000000006 110.588 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.543 HD12 HG13 ' A' ' 85' ' ' VAL . 66.7 mt -67.7 118.73 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 109.938 -0.393 . . . . 74.299999999999997 109.938 173.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.6 p -71.07 -33.58 70.37 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.414 0.524 . . . . 74.129999999999995 112.414 -172.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.504 HD13 ' HB3' ' A' ' 70' ' ' ASP . 85.7 mt -79.85 -174.61 4.48 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.119 0.485 . . . . 75.150000000000006 111.755 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -147.25 161.7 40.42 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.884 0.373 . . . . 75.0 111.758 -176.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 60.45 -134.94 49.98 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.173 -0.537 . . . . 73.439999999999998 112.969 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 49.9 mtp180 -62.51 -33.5 75.0 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.112 0.482 . . . . 75.25 110.95 178.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.504 ' HB3' HD13 ' A' ' 66' ' ' LEU . 7.8 m-20 -62.38 -30.27 71.07 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.218 -0.446 . . . . 73.129999999999995 111.458 176.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.443 ' HG ' HG23 ' A' ' 64' ' ' ILE . 10.2 tt -59.66 -54.98 40.16 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.011 0.434 . . . . 74.340000000000003 110.662 177.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -71.58 -21.78 61.82 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 111.812 0.301 . . . . 72.420000000000002 111.812 177.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.494 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 15.0 ttp180 -66.55 -50.35 63.43 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.385 0.612 . . . . 74.400000000000006 110.408 174.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -63.38 -42.18 98.82 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.896 -0.593 . . . . 73.409999999999997 110.597 175.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.403 ' HG3' HG13 ' A' ' 85' ' ' VAL . 33.0 ttpt -60.81 -50.15 74.63 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.023 -0.535 . . . . 74.420000000000002 111.941 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 19.9 pt20 -60.29 -38.0 82.25 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.964 0.411 . . . . 54.420000000000002 111.354 -177.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -63.93 -34.01 77.01 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 120.887 0.375 . . . . 74.549999999999997 111.129 174.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.9 mt -78.56 -30.05 46.63 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.282 -0.417 . . . . 73.099999999999994 111.98 178.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -68.82 -28.06 66.41 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 121.964 -0.46 . . . . 70.329999999999998 110.408 174.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.41 -23.79 65.59 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.262 0.553 . . . . 73.019999999999996 110.798 171.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -81.94 -9.04 59.7 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.818 -0.628 . . . . 70.209999999999994 111.319 175.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.61 21.87 55.07 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.39 -0.433 . . . . 72.099999999999994 112.891 -177.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 64.6 mt -89.63 127.79 42.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 121.023 0.439 . . . . 75.010000000000005 112.102 -177.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -78.5 97.2 5.64 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.054 0.454 . . . . 73.25 111.012 176.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.543 HG13 HD12 ' A' ' 64' ' ' ILE . 41.2 t -94.89 119.58 43.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.714 0.292 . . . . 73.049999999999997 110.811 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.534 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 49.7 m -61.14 141.31 57.55 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 110.388 -0.227 . . . . 62.240000000000002 110.388 177.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -54.36 -32.96 58.1 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 113.379 0.881 . . . . 74.109999999999999 113.379 -170.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.8 pp -75.22 -2.83 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 112.244 0.461 . . . . 73.329999999999998 112.244 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.28 43.46 2.77 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 116.212 -0.449 . . . . 60.439999999999998 113.966 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.534 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 61.3 tttm -115.35 131.14 57.02 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 117.62 0.71 . . . . 70.109999999999999 112.018 -178.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.466 HD13 HG23 ' A' ' 58' ' ' ILE . 56.6 mt -119.12 115.58 48.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.976 -0.556 . . . . 74.219999999999999 110.89 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.31 93.61 0.23 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.475 0.546 . . . . 72.129999999999995 112.475 -177.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.568 ' O ' ' HG3' ' A' ' 97' ' ' LYS . 76.1 mt -56.33 -46.31 79.97 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.609 -0.269 . . . . 74.129999999999995 111.255 177.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 63.8 mtp180 -51.05 -19.93 1.24 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.415 0.524 . . . . 73.109999999999999 112.415 -177.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -106.22 -36.7 6.8 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 111.922 0.341 . . . . 74.439999999999998 111.922 176.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -105.49 13.76 29.63 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.636 0.976 . . . . 74.299999999999997 113.636 -172.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.568 ' HG3' ' O ' ' A' ' 93' ' ' LEU . 41.8 mtpt -56.14 138.77 49.2 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.553 0.575 . . . . 72.409999999999997 112.553 178.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 14.9 t90 -69.14 115.02 7.94 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.007 -0.542 . . . . 74.329999999999998 110.692 173.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -102.74 96.05 7.11 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-N 116.075 -0.511 . . . . 74.230000000000004 111.166 176.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.589 ' HB2' ' HG2' ' A' ' 102' ' ' GLU . 62.9 Cg_endo -71.92 -9.52 24.83 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.628 2.219 . . . . 70.5 112.762 175.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 93.8 mt 60.79 24.42 14.33 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.604 0.594 . . . . 74.310000000000002 112.604 175.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.589 ' HG2' ' HB2' ' A' ' 100' ' ' PRO . 7.6 pt-20 . . . . . 0 C--O 1.255 1.346 0 CA-C-O 119.192 -0.432 . . . . 75.340000000000003 111.972 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 tpt . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 120.68 0.276 . . . . 71.340000000000003 110.673 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.463 ' O ' HG22 ' A' ' 6' ' ' VAL . 12.2 t70 -60.37 133.56 56.21 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 112.09 0.404 . . . . 74.329999999999998 112.09 -176.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -56.81 -40.12 75.42 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.632 0.604 . . . . 73.150000000000006 112.632 -178.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -58.1 -47.79 82.15 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.18 0.514 . . . . 72.200000000000003 110.477 177.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 85.9 mt -61.07 -47.14 87.71 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.724 -0.671 . . . . 73.239999999999995 110.801 177.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.463 HG22 ' O ' ' A' ' 2' ' ' ASP . 94.1 t -53.91 -50.13 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.173 -0.467 . . . . 74.239999999999995 111.648 178.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.441 ' O ' HG22 ' A' ' 11' ' ' VAL . 27.8 mm-40 -64.67 -50.21 67.92 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.375 0.509 . . . . 73.019999999999996 112.375 -176.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.464 ' O ' HG13 ' A' ' 12' ' ' ILE . 38.5 pt -64.93 -44.15 96.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 121.019 -0.272 . . . . 72.099999999999994 111.554 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.8 m-30 -65.19 -42.51 93.52 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.813 0.339 . . . . 75.099999999999994 111.133 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.85 -40.1 69.29 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.454 -0.339 . . . . 73.230000000000004 111.67 178.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 7' ' ' GLN . 86.9 t -67.59 -41.63 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 120.917 0.389 . . . . 65.409999999999997 111.297 178.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.537 ' HB ' HD13 ' A' ' 52' ' ' LEU . 80.4 mt -59.17 -32.25 47.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 116.405 -0.361 . . . . 73.420000000000002 111.819 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -61.15 -18.51 58.46 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.131 0.419 . . . . 75.219999999999999 112.131 176.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -83.3 -9.17 59.25 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.531 0.567 . . . . 73.310000000000002 112.531 178.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.476 HD13 HD12 ' A' ' 26' ' ' ILE . 54.8 mt -74.46 116.27 51.46 Favored Pre-proline 0 CA--C 1.542 0.669 0 O-C-N 122.203 -0.311 . . . . 74.420000000000002 111.055 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -64.29 157.55 53.58 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.114 2.543 . . . . 74.120000000000005 113.514 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -65.54 120.77 13.5 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.21 -0.45 . . . . 74.299999999999997 111.495 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.34 17.07 56.27 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 120.988 -0.625 . . . . 73.099999999999994 113.22 -176.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -121.11 149.93 42.0 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 122.621 -0.341 . . . . 73.230000000000004 111.22 175.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.6 m -128.08 145.38 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 121.535 0.683 . . . . 75.310000000000002 111.795 -178.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.537 ' HG ' HD12 ' A' ' 26' ' ' ILE . 94.8 p -128.98 177.82 6.84 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.871 -0.604 . . . . 73.310000000000002 110.555 175.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.4 p -111.6 154.77 24.37 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.811 0.338 . . . . 70.120000000000005 111.376 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.408 ' HB2' ' HB3' ' A' ' 36' ' ' ALA . 74.8 m-85 -54.72 -40.12 68.92 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.852 0.358 . . . . 75.120000000000005 111.446 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -57.73 -44.7 94.02 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.268 -0.491 . . . . 73.310000000000002 113.043 177.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.434 ' O ' ' HG3' ' A' ' 29' ' ' MET . 49.8 mt-10 -63.27 -54.0 44.05 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.731 0.3 . . . . 73.329999999999998 111.181 178.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.537 HD12 ' HG ' ' A' ' 21' ' ' SER . 46.4 mm -54.3 -53.1 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 120.818 0.342 . . . . 74.209999999999994 111.72 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.99 -46.72 82.06 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.422 -0.354 . . . . 64.340000000000003 111.674 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -60.99 -42.95 99.41 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.781 0.324 . . . . 73.310000000000002 111.584 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.434 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 64.6 mtt -68.39 -30.67 69.64 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.043 0.449 . . . . 75.109999999999999 111.236 178.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.06 -19.65 59.9 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.197 -0.456 . . . . 71.400000000000006 111.914 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.24 15.18 24.21 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.137 -0.554 . . . . 71.230000000000004 113.014 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.424 ' HB3' ' CD1' ' A' ' 35' ' ' TYR . 69.5 m-85 -128.37 63.94 65.6 Favored Pre-proline 0 CA--C 1.548 0.873 0 O-C-N 122.55 -0.382 . . . . 70.030000000000001 111.54 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -61.72 110.94 1.05 Allowed 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.484 2.123 . . . . 71.299999999999997 112.568 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 123.64 -24.76 6.37 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 121.238 -0.506 . . . . 72.340000000000003 112.922 -177.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.451 ' O ' HG23 ' A' ' 39' ' ' VAL . 58.2 m-85 -79.96 30.54 0.26 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.242 0.46 . . . . 74.310000000000002 112.242 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.408 ' HB3' ' HB2' ' A' ' 23' ' ' TYR . . . -55.24 -64.88 0.7 Allowed 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.452 0.538 . . . . 74.109999999999999 112.452 -177.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -54.7 -31.69 58.41 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.361 0.504 . . . . 74.420000000000002 112.361 177.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 78.1 m-70 -65.63 -40.27 92.37 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.749 0.309 . . . . 71.129999999999995 111.11 178.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 35' ' ' TYR . 67.9 t -57.14 -45.18 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.097 0.475 . . . . 72.140000000000001 110.243 173.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -57.8 -42.98 94.81 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 116.037 -0.529 . . . . 74.129999999999995 112.714 175.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.595 ' HB3' ' HZ3' ' A' ' 41' ' ' LYS . 9.5 mtpm? -62.15 -33.02 73.71 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.071 0.462 . . . . 75.230000000000004 111.154 176.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.0 -42.78 66.03 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.202 -0.454 . . . . 61.140000000000001 111.449 177.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 39' ' ' VAL . 90.0 mt -62.38 -33.32 74.51 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.907 0.384 . . . . 74.439999999999998 111.483 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.62 -12.39 46.63 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 121.405 -0.426 . . . . 74.310000000000002 113.458 176.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -85.8 -15.81 40.82 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.135 0.493 . . . . 52.399999999999999 110.953 177.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.476 HD13 HD22 ' A' ' 52' ' ' LEU . 90.8 mt -81.68 148.12 60.9 Favored Pre-proline 0 N--CA 1.47 0.563 0 N-CA-C 112.42 0.526 . . . . 74.129999999999995 112.42 -177.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.52 163.2 32.33 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.39 2.06 . . . . 70.439999999999998 112.125 173.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.525 ' HG2' ' HE ' ' A' ' 73' ' ' ARG . 42.2 mt-10 -57.02 -52.88 63.5 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 111.984 0.364 . . . . 52.0 111.984 -178.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -93.62 54.61 2.34 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.039 -0.601 . . . . 73.340000000000003 113.294 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.7 t -79.6 156.39 27.7 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.866 0.365 . . . . 73.409999999999997 111.556 178.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -67.12 -26.54 66.74 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.389 0.614 . . . . 63.340000000000003 110.313 174.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.537 HD13 ' HB ' ' A' ' 12' ' ' ILE . 55.3 tp -92.78 117.75 67.68 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 115.5 -0.773 . . . . 74.129999999999995 110.802 176.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.535 ' HD2' HD12 ' A' ' 52' ' ' LEU . 56.8 Cg_endo -71.77 96.58 0.77 Allowed 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 121.639 1.56 . . . . 72.310000000000002 112.47 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 60.9 p-90 -80.52 -25.25 38.81 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.34 0.591 . . . . 72.239999999999995 112.153 -178.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -68.65 -12.71 61.71 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.625 0.972 . . . . 75.239999999999995 113.625 -174.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -87.06 1.55 52.56 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.6 0.593 . . . . 75.219999999999999 112.6 -175.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.8 t -109.75 108.83 26.35 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 CA-C-O 121.266 0.555 . . . . 73.129999999999995 111.659 -178.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.509 HD11 HD22 ' A' ' 93' ' ' LEU . 18.2 pt -113.6 -170.81 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-N 116.093 -0.503 . . . . 75.420000000000002 111.964 -178.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.7 p30 -90.19 175.41 7.15 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.022 0.439 . . . . 73.329999999999998 111.991 -177.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 87.6 p -64.26 -22.58 67.0 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.376 0.509 . . . . 74.140000000000001 112.376 -176.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -82.27 -12.76 57.84 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.851 0.357 . . . . 75.0 111.546 -179.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.64 30.6 20.91 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.163 -0.541 . . . . 54.350000000000001 112.804 -177.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.422 ' HE3' HD11 ' A' ' 88' ' ' ILE . 56.6 mtpt -125.6 163.28 23.09 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.11 0.481 . . . . 75.430000000000007 111.864 -177.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 52.7 mt -75.95 130.38 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 116.09 -0.504 . . . . 75.510000000000005 111.685 -177.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.3 m -80.26 -30.5 38.42 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.393 -0.367 . . . . 74.230000000000004 111.756 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.415 HD11 ' HB2' ' A' ' 74' ' ' GLN . 75.3 mt -72.1 151.99 42.66 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.123 0.487 . . . . 72.409999999999997 111.564 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -129.33 153.32 47.96 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.191 -0.458 . . . . 73.340000000000003 111.89 -174.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 62.27 -129.06 42.7 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 121.283 -0.484 . . . . 71.200000000000003 113.415 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -66.03 -30.14 70.62 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.816 0.341 . . . . 74.540000000000006 111.781 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.524 ' HA ' ' HD3' ' A' ' 73' ' ' ARG . 9.6 m-20 -68.92 -31.03 69.63 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.888 0.375 . . . . 74.209999999999994 111.237 177.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.7 tt -61.32 -42.01 97.97 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 109.524 -0.547 . . . . 61.149999999999999 109.524 173.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -59.3 -43.5 92.6 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.984 -0.553 . . . . 74.439999999999998 111.173 176.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.525 ' HE ' ' HG2' ' A' ' 48' ' ' GLU . 79.9 mtp180 -50.62 -56.14 13.15 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.332 0.587 . . . . 74.129999999999995 111.338 176.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.415 ' HB2' HD11 ' A' ' 66' ' ' LEU . 43.7 tt0 -65.87 -42.63 90.11 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.069 -0.514 . . . . 74.129999999999995 111.065 -177.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -61.61 -50.63 71.79 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.14 0.422 . . . . 73.510000000000005 112.14 -178.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -58.46 -39.05 78.84 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.757 0.313 . . . . 73.019999999999996 111.294 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -62.92 -43.75 97.93 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 120.809 0.338 . . . . 75.030000000000001 111.36 176.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 75.8 mt -66.42 -48.78 68.94 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.291 -0.413 . . . . 74.519999999999996 111.683 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -54.55 -31.48 56.58 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.116 0.484 . . . . 55.240000000000002 111.327 176.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.46 -26.76 64.74 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.636 0.606 . . . . 63.409999999999997 112.636 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -102.44 9.03 39.92 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.417 0.525 . . . . 74.140000000000001 112.417 -176.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.92 41.98 7.37 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 120.938 -0.648 . . . . 75.400000000000006 113.644 176.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 68.2 mt -117.21 128.5 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 O-C-N 122.648 -0.325 . . . . 72.129999999999995 111.052 177.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -78.64 103.36 8.53 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.732 0.301 . . . . 72.230000000000004 111.424 177.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.9 t -90.62 105.21 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 120.826 0.346 . . . . 75.329999999999998 110.985 175.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.509 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 50.0 m -56.61 144.35 32.32 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.475 -0.33 . . . . 43.25 110.997 177.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.486 ' HG3' ' N ' ' A' ' 88' ' ' ILE . 12.3 pt-20 -43.2 -44.19 5.06 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 113.867 1.062 . . . . 70.099999999999994 113.867 -171.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.486 ' N ' ' HG3' ' A' ' 87' ' ' GLU . 2.6 pp -78.72 9.69 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 112.625 0.602 . . . . 73.299999999999997 112.625 -176.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.87 55.67 2.91 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 116.292 -0.413 . . . . 65.200000000000003 113.084 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.509 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 49.1 tttm -127.61 150.1 49.88 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.166 0.508 . . . . 73.140000000000001 112.256 177.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.504 HD12 HD12 ' A' ' 58' ' ' ILE . 50.2 mt -124.15 156.8 31.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-N 115.695 -0.684 . . . . 74.319999999999993 110.228 176.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.427 ' HB2' ' HB3' ' A' ' 95' ' ' LYS . . . -85.37 102.65 13.59 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.028 0.442 . . . . 74.239999999999995 111.796 178.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.644 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 40.2 mt -71.07 -8.32 52.55 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.241 0.83 . . . . 74.209999999999994 113.241 -177.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -97.58 -11.06 24.09 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.337 0.589 . . . . 73.319999999999993 111.015 174.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.427 ' HB3' ' HB2' ' A' ' 92' ' ' ALA . 27.8 tptp -106.31 -35.39 7.17 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.672 0.619 . . . . 70.030000000000001 112.672 -172.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -127.52 15.02 7.11 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.15 0.426 . . . . 74.150000000000006 112.15 -175.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.644 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 63.9 tttp -60.14 135.25 57.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.732 0.301 . . . . 70.120000000000005 111.727 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 17.7 t90 -65.6 96.86 0.28 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.024 0.44 . . . . 73.329999999999998 110.983 176.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -98.66 99.8 8.28 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 116.032 -0.531 . . . . 73.040000000000006 110.885 173.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.35 -4.47 11.87 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.685 2.256 . . . . 75.109999999999999 112.969 176.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 90.4 mt 63.12 21.27 12.77 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.054 0.542 . . . . 75.430000000000007 112.444 175.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 . . . . . 0 C--O 1.255 1.368 0 CA-C-O 118.399 -0.81 . . . . 71.200000000000003 111.736 178.476 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.9 tpt . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 120.616 0.246 . . . . 75.519999999999996 110.515 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -60.36 138.63 57.94 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.579 0.585 . . . . 75.019999999999996 112.579 -175.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 74.3 mm-40 -56.28 -27.83 56.63 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.472 -0.331 . . . . 74.349999999999994 111.569 176.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.434 ' O ' HG12 ' A' ' 8' ' ' ILE . 90.7 t80 -54.96 -52.22 63.72 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.211 0.529 . . . . 72.349999999999994 110.027 172.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 58.0 mt -65.56 -49.79 67.56 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.373 -0.831 . . . . 74.299999999999997 110.988 178.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 85.3 t -53.64 -50.99 47.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 116.119 -0.491 . . . . 73.540000000000006 111.979 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -62.37 -54.95 32.97 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.295 0.48 . . . . 75.510000000000005 112.295 -177.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.512 HD11 HG11 ' A' ' 39' ' ' VAL . 31.4 pt -61.43 -42.98 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 120.641 0.258 . . . . 63.210000000000001 111.693 -177.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.412 ' HA ' HD12 ' A' ' 12' ' ' ILE . 17.6 m-30 -62.58 -43.75 98.03 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.962 0.411 . . . . 65.319999999999993 111.265 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.85 -41.99 68.06 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.131 -0.486 . . . . 74.340000000000003 111.432 178.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 55.2 t -66.95 -36.51 77.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 121.047 0.451 . . . . 74.230000000000004 111.362 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 8' ' ' ILE . 83.3 mt -61.12 -36.01 69.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 116.306 -0.406 . . . . 74.420000000000002 112.054 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -60.06 -22.38 62.63 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 112.324 0.49 . . . . 73.329999999999998 112.324 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -78.73 -5.7 53.9 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 112.792 0.664 . . . . 71.120000000000005 112.792 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.426 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 58.9 mt -76.53 122.02 85.9 Favored Pre-proline 0 CA--C 1.545 0.783 0 O-C-N 122.243 -0.286 . . . . 74.25 111.324 178.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 15' ' ' ILE . 6.3 Cg_exo -75.28 151.28 38.11 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.861 2.374 . . . . 72.049999999999997 112.681 177.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -58.18 110.37 0.93 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.477 0.656 . . . . 74.409999999999997 111.721 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.428 ' H ' ' NH1' ' A' ' 56' ' ' ARG . . . 131.55 -30.17 3.32 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.568 -0.742 . . . . 71.150000000000006 112.387 178.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -93.81 159.83 15.02 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.438 0.637 . . . . 75.219999999999999 112.328 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.1 m -130.35 148.22 33.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 115.214 -0.903 . . . . 71.5 110.353 174.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 95.4 p -119.37 159.88 23.35 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.951 0.405 . . . . 73.099999999999994 110.996 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 72.0 p -102.79 148.92 25.01 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.731 0.3 . . . . 62.210000000000001 111.371 176.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.412 ' HB2' ' HB1' ' A' ' 36' ' ' ALA . 53.5 m-85 -50.76 -39.77 53.19 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 111.909 0.337 . . . . 74.099999999999994 111.909 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.75 -33.99 80.3 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 121.275 -0.488 . . . . 72.319999999999993 113.213 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.422 ' HG3' ' OG1' ' A' ' 22' ' ' THR . 47.1 mt-10 -74.12 -54.48 7.71 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.785 0.326 . . . . 51.43 111.258 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.7 mm -56.4 -53.46 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 116.215 -0.448 . . . . 74.010000000000005 111.386 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.403 ' HB1' HG22 ' A' ' 39' ' ' VAL . . . -57.64 -51.88 67.71 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.874 0.369 . . . . 72.209999999999994 111.717 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.633 ' HB2' ' HZ2' ' A' ' 28' ' ' LYS . 4.2 ttmp? -57.6 -48.76 78.5 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.883 0.373 . . . . 74.340000000000003 111.337 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 74.5 mtm -74.01 -8.3 55.6 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.173 0.434 . . . . 65.329999999999998 112.173 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.86 -9.27 26.67 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.892 0.377 . . . . 75.549999999999997 111.079 172.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.05 37.47 5.16 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 116.038 -0.528 . . . . 75.030000000000001 113.693 178.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -138.58 90.57 12.79 Favored Pre-proline 0 CA--C 1.542 0.639 0 O-C-N 122.564 -0.374 . . . . 72.109999999999999 111.268 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.59 127.86 9.88 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.478 2.118 . . . . 74.329999999999998 113.3 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.84 8.38 87.73 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 121.099 -0.572 . . . . 74.109999999999999 114.195 178.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -101.3 22.61 12.21 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 117.382 0.591 . . . . 74.129999999999995 111.974 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.412 ' HB1' ' HB2' ' A' ' 23' ' ' TYR . . . -56.47 -52.0 66.35 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.103 0.477 . . . . 72.310000000000002 111.855 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -55.96 -32.76 64.16 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.096 -0.502 . . . . 74.140000000000001 111.748 177.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.403 ' HA ' ' HD2' ' A' ' 41' ' ' LYS . 98.6 m-70 -74.79 -32.26 61.96 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.687 0.28 . . . . 73.230000000000004 111.463 -178.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.512 HG11 HD11 ' A' ' 8' ' ' ILE . 58.4 t -61.21 -40.31 85.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 121.138 0.494 . . . . 73.209999999999994 110.292 172.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.61 -37.81 94.0 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 121.133 -0.556 . . . . 72.319999999999993 112.484 173.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.403 ' HD2' ' HA ' ' A' ' 38' ' ' HIS . 66.1 mttm -61.27 -40.02 92.56 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.878 0.37 . . . . 64.430000000000007 111.006 174.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.48 -50.92 69.5 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.066 -0.515 . . . . 73.109999999999999 111.579 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.5 mt -63.42 -36.97 85.48 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.901 0.382 . . . . 74.400000000000006 111.309 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.98 -6.58 45.99 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 121.353 -0.451 . . . . 71.019999999999996 113.681 178.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -100.21 -6.5 25.99 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 120.98 0.419 . . . . 73.510000000000005 111.038 177.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 91.5 mt -79.52 152.23 75.32 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 112.542 0.571 . . . . 74.310000000000002 112.542 -176.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.516 ' HD2' ' HB2' ' A' ' 50' ' ' SER . 22.2 Cg_exo -64.04 148.31 91.51 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.644 2.229 . . . . 73.510000000000005 112.464 173.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -62.98 -12.17 23.88 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-O 121.08 0.466 . . . . 74.340000000000003 111.757 -178.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -135.97 47.71 0.96 Allowed Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.312 -0.47 . . . . 41.350000000000001 113.233 175.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.516 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 43.0 t -74.83 165.84 24.59 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.991 0.424 . . . . 73.5 112.071 176.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -74.02 -19.37 60.66 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.237 -0.438 . . . . 73.319999999999993 111.532 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.535 HD13 ' HD2' ' A' ' 53' ' ' PRO . 30.1 tp -89.45 126.4 58.45 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.281 -0.418 . . . . 75.049999999999997 111.144 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.535 ' HD2' HD13 ' A' ' 52' ' ' LEU . 60.1 Cg_endo -73.42 95.69 0.87 Allowed 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 121.379 1.386 . . . . 72.049999999999997 111.908 174.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 66.1 p-90 -80.5 -31.68 37.15 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.282 0.563 . . . . 72.430000000000007 111.187 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -60.5 -18.68 53.37 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.419 0.896 . . . . 72.0 113.419 -176.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.428 ' NH1' ' H ' ' A' ' 18' ' ' GLY . 90.1 mtt-85 -86.75 11.64 12.64 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.955 0.724 . . . . 72.319999999999993 112.955 -177.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.2 t -125.93 109.72 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-O 121.407 0.622 . . . . 72.230000000000004 111.742 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.497 HD13 HD13 ' A' ' 91' ' ' ILE . 18.9 pt -114.16 -174.56 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 CA-C-N 115.827 -0.624 . . . . 73.439999999999998 111.328 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 34.2 p30 -87.22 171.38 10.69 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.647 -0.658 . . . . 73.439999999999998 111.871 -177.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 71.1 p -65.07 -14.8 61.36 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 112.68 0.622 . . . . 63.020000000000003 112.68 -174.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -75.0 -30.19 61.09 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.127 0.489 . . . . 64.030000000000001 111.297 175.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.49 11.97 34.35 Favored Glycine 0 CA--C 1.521 0.467 0 CA-C-N 115.691 -0.686 . . . . 72.400000000000006 111.676 -170.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.47 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 97.7 mttt -103.22 155.71 18.24 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.338 0.59 . . . . 73.209999999999994 112.19 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 63.6 mt -73.21 129.02 36.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 115.748 -0.66 . . . . 73.010000000000005 110.527 174.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.5 t -67.87 -38.7 83.42 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 120.83 0.348 . . . . 70.400000000000006 111.798 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 84.4 mt -74.25 143.37 45.11 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.856 0.36 . . . . 73.450000000000003 111.169 178.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -125.37 161.72 26.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.132 0.492 . . . . 74.530000000000001 111.336 -177.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 77.54 -138.95 22.41 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.111 -0.566 . . . . 73.439999999999998 112.518 -176.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 68.9 mtm180 -61.36 -38.23 86.23 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.26 0.552 . . . . 72.219999999999999 111.515 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -61.73 -26.78 68.27 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 116.101 -0.5 . . . . 73.129999999999995 111.61 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.6 tt -65.7 -61.37 2.12 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.503 -0.317 . . . . 64.340000000000003 111.098 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.477 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 3.3 p30 -64.75 -24.5 67.58 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.785 0.326 . . . . 64.209999999999994 111.467 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -60.53 -52.45 65.13 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.974 0.416 . . . . 74.230000000000004 110.688 173.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -62.63 -38.93 92.15 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.25 0.547 . . . . 74.439999999999998 110.579 176.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.542 ' HG3' ' HB ' ' A' ' 85' ' ' VAL . 48.0 tttp -52.18 -56.38 14.99 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.601 -0.727 . . . . 73.409999999999997 111.729 174.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -61.88 -35.76 79.27 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 111.969 0.359 . . . . 73.019999999999996 111.969 -178.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -59.59 -45.33 92.22 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.02 0.438 . . . . 75.329999999999998 111.219 175.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.6 mt -71.79 -45.47 61.47 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.13 -0.486 . . . . 75.230000000000004 112.177 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.507 ' CD ' ' HZ2' ' A' ' 75' ' ' LYS . 47.6 mt-10 -68.7 -26.31 65.22 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 122.17 -0.331 . . . . 75.400000000000006 111.786 -178.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.77 -23.71 67.33 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.313 0.577 . . . . 52.310000000000002 110.966 172.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -87.42 -10.84 50.88 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.782 -0.644 . . . . 73.230000000000004 111.462 176.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 108.27 19.29 9.02 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 121.341 -0.457 . . . . 54.009999999999998 114.022 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 57.1 mt -99.98 159.19 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 O-C-N 122.187 -0.596 . . . . 73.019999999999996 111.498 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.422 ' HG3' ' HH ' ' A' ' 96' ' ' TYR . 42.5 mt-10 -105.52 117.71 34.72 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 122.209 -0.307 . . . . 71.420000000000002 110.988 177.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.542 ' HB ' ' HG3' ' A' ' 75' ' ' LYS . 39.2 t -119.94 114.22 43.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.793 0.33 . . . . 65.109999999999999 111.391 178.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.0 m -62.84 141.9 58.46 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 122.386 -0.196 . . . . 53.009999999999998 110.627 176.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -47.06 -42.08 17.99 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.626 0.973 . . . . 71.040000000000006 113.626 -172.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 pp -74.66 8.52 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 112.553 0.575 . . . . 75.400000000000006 112.553 -178.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.92 51.52 3.77 Favored Glycine 0 CA--C 1.524 0.594 0 CA-C-N 116.305 -0.407 . . . . 51.310000000000002 113.706 176.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -128.96 137.3 51.3 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.145 0.498 . . . . 75.230000000000004 111.641 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.497 HD13 HD13 ' A' ' 58' ' ' ILE . 52.0 mt -127.62 141.66 45.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 115.716 -0.675 . . . . 73.400000000000006 110.382 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.19 93.5 4.59 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 122.215 -0.303 . . . . 71.030000000000001 111.654 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.485 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 94.2 mt -55.42 -53.21 59.09 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.667 0.27 . . . . 73.450000000000003 111.56 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -51.37 -15.22 0.37 Allowed 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 113.264 0.838 . . . . 74.239999999999995 113.264 -177.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.5 ' HE3' ' CE2' ' A' ' 96' ' ' TYR . 38.1 ttpt -113.13 -26.64 8.35 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 121.562 -0.711 . . . . 74.430000000000007 112.511 177.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.5 ' CE2' ' HE3' ' A' ' 95' ' ' LYS . 85.4 m-85 -117.92 11.31 13.42 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.361 0.504 . . . . 70.219999999999999 112.361 -176.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 57.2 tttm -65.55 134.68 53.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.085 0.469 . . . . 72.439999999999998 111.733 -176.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 22.5 t90 -66.36 96.51 0.36 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.185 0.516 . . . . 72.219999999999999 111.517 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.421 ' OE1' ' NZ ' ' A' ' 97' ' ' LYS . 14.8 mm100 -105.73 93.68 7.73 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 115.804 -0.634 . . . . 75.510000000000005 110.608 173.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -69.78 7.52 0.98 Allowed 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 122.839 2.359 . . . . 73.549999999999997 113.45 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 73.5 mt -119.14 140.8 49.54 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 122.502 0.321 . . . . 74.540000000000006 111.02 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 C--O 1.251 1.166 0 CA-C-O 118.829 -0.605 . . . . 73.230000000000004 111.733 178.021 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptm . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.72 0.295 . . . . 65.230000000000004 110.742 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -64.88 149.17 50.03 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.412 -0.358 . . . . 63.219999999999999 111.93 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 52.8 tp60 -58.68 -31.45 68.21 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.887 0.375 . . . . 73.349999999999994 110.781 177.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -54.22 -50.27 67.54 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.256 -0.429 . . . . 75.299999999999997 110.688 171.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 76.7 mt -62.16 -46.54 88.51 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.747 -0.66 . . . . 75.450000000000003 111.24 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.9 t -56.7 -49.43 78.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.915 0.388 . . . . 75.439999999999998 111.66 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.422 ' O ' HG21 ' A' ' 11' ' ' VAL . 27.6 mm-40 -60.61 -55.99 26.68 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.349 0.5 . . . . 72.409999999999997 112.349 -178.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.509 ' O ' HG13 ' A' ' 12' ' ' ILE . 26.5 pt -59.37 -45.14 93.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 111.86 0.319 . . . . 70.209999999999994 111.86 -177.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -64.55 -41.93 96.02 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.983 0.421 . . . . 73.409999999999997 111.175 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.27 -37.56 69.98 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.247 -0.433 . . . . 71.239999999999995 111.317 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.422 HG21 ' O ' ' A' ' 7' ' ' GLN . 63.1 t -69.57 -36.98 73.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 121.095 0.474 . . . . 74.310000000000002 111.234 178.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 8' ' ' ILE . 75.1 mt -62.18 -34.25 62.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 116.122 -0.49 . . . . 75.030000000000001 112.168 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -60.82 -12.16 9.96 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 112.921 0.712 . . . . 73.030000000000001 112.921 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -87.52 -5.36 58.82 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 112.827 0.677 . . . . 63.340000000000003 112.827 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 56.2 mt -76.72 115.6 49.44 Favored Pre-proline 0 CA--C 1.546 0.802 0 O-C-N 122.101 -0.375 . . . . 73.420000000000002 111.448 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -67.82 159.34 53.25 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.909 2.406 . . . . 74.340000000000003 113.496 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -66.94 97.02 0.46 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.853 -0.612 . . . . 73.530000000000001 111.395 -176.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 136.23 -22.19 3.42 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 121.222 -0.513 . . . . 71.409999999999997 113.045 176.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -98.42 164.73 12.16 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.144 0.497 . . . . 74.299999999999997 111.996 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.6 m -135.79 157.47 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.732 -0.667 . . . . 73.25 110.607 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.436 ' HG ' HD12 ' A' ' 26' ' ' ILE . 98.0 p -130.35 172.71 11.55 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.043 0.449 . . . . 75.400000000000006 110.965 178.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 46.4 p -108.26 152.39 24.68 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.91 0.386 . . . . 61.329999999999998 111.325 177.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.457 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 67.5 m-85 -55.32 -34.22 64.0 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.287 0.477 . . . . 75.129999999999995 112.287 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.3 -48.93 83.55 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.915 -0.66 . . . . 70.450000000000003 112.426 176.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -59.32 -52.45 65.6 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.849 0.357 . . . . 72.340000000000003 111.52 178.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.436 HD12 ' HG ' ' A' ' 21' ' ' SER . 48.2 mm -59.61 -50.27 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 111.954 0.353 . . . . 72.310000000000002 111.954 -178.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . -58.67 -50.41 73.96 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.047 0.388 . . . . 74.230000000000004 112.047 -178.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -62.45 -44.05 97.34 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.647 0.26 . . . . 75.219999999999999 111.622 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 74.7 mtm -69.17 -24.14 64.03 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.591 0.234 . . . . 73.109999999999999 111.623 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.82 -20.98 44.82 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.026 0.441 . . . . 74.430000000000007 111.229 174.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.96 16.62 20.96 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 121.405 -0.426 . . . . 74.120000000000005 113.645 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.407 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 69.7 m-85 -126.93 89.33 52.33 Favored Pre-proline 0 CA--C 1.542 0.651 0 O-C-N 122.54 -0.388 . . . . 75.019999999999996 111.938 -177.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.24 141.85 40.25 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 122.437 2.091 . . . . 75.140000000000001 112.414 177.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.65 -37.17 2.46 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 121.003 -0.617 . . . . 73.019999999999996 113.637 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -63.8 -2.81 1.97 Allowed 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.744 0.646 . . . . 74.340000000000003 112.744 -178.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.457 ' HB1' ' HB3' ' A' ' 23' ' ' TYR . . . -48.02 -42.44 28.19 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.693 0.627 . . . . 71.150000000000006 112.693 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -59.05 -36.12 74.5 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.236 0.458 . . . . 72.150000000000006 112.236 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -72.65 -33.52 66.64 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.788 0.328 . . . . 74.409999999999997 110.755 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.496 HG11 HD11 ' A' ' 8' ' ' ILE . 60.6 t -58.02 -45.97 88.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 116.195 -0.457 . . . . 73.439999999999998 110.573 174.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.32 -45.4 96.2 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 121.15 -0.548 . . . . 64.430000000000007 113.0 176.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -64.79 -28.48 69.6 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.817 0.341 . . . . 72.329999999999998 111.261 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.65 -48.5 47.32 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.87 0.367 . . . . 71.219999999999999 111.077 174.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.551 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 44.6 mt -64.06 -40.0 95.31 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.864 0.364 . . . . 54.350000000000001 111.298 178.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.529 ' HA2' HD12 ' A' ' 66' ' ' LEU . . . -65.01 -13.85 58.06 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.155 -0.545 . . . . 64.420000000000002 112.924 176.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -86.79 -16.42 36.31 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 120.977 0.418 . . . . 72.540000000000006 110.962 177.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 95.7 mt -77.73 149.17 77.28 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 116.344 -0.389 . . . . 75.420000000000002 111.918 -178.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -77.2 165.93 27.16 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.537 2.158 . . . . 64.5 112.702 176.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.534 ' HB3' ' HD3' ' A' ' 73' ' ' ARG . 11.3 pt-20 -84.02 25.35 0.83 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.044 0.387 . . . . 64.450000000000003 112.044 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -141.87 19.59 2.54 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 121.195 -0.526 . . . . 63.229999999999997 113.482 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 56.4 p -81.11 155.75 26.11 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 117.085 0.442 . . . . 72.549999999999997 111.629 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -69.85 -21.35 63.36 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.325 0.583 . . . . 74.420000000000002 111.413 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.451 HD11 ' HD2' ' A' ' 53' ' ' PRO . 48.5 tp -87.42 116.3 65.65 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 115.882 -0.599 . . . . 74.310000000000002 111.388 178.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.451 ' HD2' HD11 ' A' ' 52' ' ' LEU . 64.2 Cg_endo -74.44 95.1 0.92 Allowed 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 121.419 1.413 . . . . 74.439999999999998 112.02 177.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.551 ' HB2' ' HB3' ' A' ' 43' ' ' LEU . 64.1 p-90 -83.78 -26.73 29.38 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.113 -0.494 . . . . 74.540000000000006 111.665 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -62.43 -12.98 24.9 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 113.102 0.779 . . . . 74.519999999999996 113.102 -178.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.472 HH22 ' HB3' ' A' ' 81' ' ' GLU . 80.4 mtt-85 -86.21 -13.23 47.53 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.846 0.684 . . . . 72.530000000000001 112.846 -178.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.7 t -102.74 99.81 9.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 120.97 0.414 . . . . 74.519999999999996 110.806 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.526 ' HA ' ' OG ' ' A' ' 65' ' ' SER . 44.8 pt -104.29 -170.23 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 121.303 0.573 . . . . 74.150000000000006 111.787 -178.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.1 p30 -89.38 158.96 17.56 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.199 0.523 . . . . 74.209999999999994 111.928 -177.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.7 p -66.01 -3.85 6.1 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.143 0.423 . . . . 63.520000000000003 112.143 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -86.55 -1.88 58.01 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 122.647 0.379 . . . . 64.409999999999997 111.896 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.78 31.88 67.17 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.147 -0.549 . . . . 72.519999999999996 112.69 -178.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -133.04 173.32 11.55 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.114 0.483 . . . . 74.349999999999994 111.324 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.58 HD11 HG13 ' A' ' 85' ' ' VAL . 38.1 mt -65.53 146.65 13.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 116.029 -0.532 . . . . 74.329999999999998 112.015 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.526 ' OG ' ' HA ' ' A' ' 58' ' ' ILE . 14.8 m -70.22 -47.86 59.58 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.002 -0.545 . . . . 75.209999999999994 111.91 -176.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.529 HD12 ' HA2' ' A' ' 44' ' ' GLY . 86.8 mt -103.54 158.2 16.53 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.084 -0.507 . . . . 63.229999999999997 111.794 -176.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.467 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 53.4 mtpt -120.24 163.66 17.44 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.02 0.438 . . . . 71.230000000000004 111.48 -178.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 77.53 -139.35 22.95 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 121.069 -0.586 . . . . 62.520000000000003 112.831 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -63.9 -34.95 79.11 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.206 0.526 . . . . 73.430000000000007 110.952 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -61.38 -27.77 68.76 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.764 -0.653 . . . . 73.329999999999998 111.195 177.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.467 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 10.1 tt -67.07 -48.31 68.64 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.103 -0.499 . . . . 72.140000000000001 110.663 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.582 ' HA ' ' HD3' ' A' ' 75' ' ' LYS . 11.9 m-20 -65.05 -34.22 77.9 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.68 0.276 . . . . 61.409999999999997 111.417 176.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.534 ' HD3' ' HB3' ' A' ' 48' ' ' GLU . 38.8 ttm180 -56.82 -50.71 71.55 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.108 0.48 . . . . 71.430000000000007 110.684 174.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.463 ' OE1' HG22 ' A' ' 64' ' ' ILE . 45.6 tt0 -66.84 -34.5 77.94 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.17 -0.468 . . . . 54.020000000000003 111.108 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.582 ' HD3' ' HA ' ' A' ' 72' ' ' ASP . 47.2 mtpt -55.7 -62.75 1.48 Allowed 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 120.963 0.411 . . . . 71.230000000000004 111.434 173.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -53.58 -37.57 63.08 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.795 -0.639 . . . . 74.329999999999998 112.053 -175.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -61.28 -53.51 55.83 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.027 0.442 . . . . 74.439999999999998 111.592 175.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.7 mt -65.26 -40.97 94.64 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.357 -0.383 . . . . 72.219999999999999 111.525 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -55.54 -44.63 76.93 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.152 0.501 . . . . 74.340000000000003 111.043 174.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.71 -31.86 71.13 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.008 -0.542 . . . . 70.430000000000007 111.278 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.472 ' HB3' HH22 ' A' ' 56' ' ' ARG . 14.1 mm-40 -87.65 9.85 20.02 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.562 0.578 . . . . 65.040000000000006 112.562 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.27 4.3 83.92 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.398 -0.43 . . . . 74.230000000000004 113.813 175.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 67.0 mt -87.39 132.79 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 O-C-N 122.6 -0.353 . . . . 71.099999999999994 111.171 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -87.99 101.01 13.35 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.918 0.39 . . . . 52.43 111.424 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.58 HG13 HD11 ' A' ' 64' ' ' ILE . 48.8 t -89.87 120.58 38.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 120.844 0.354 . . . . 74.140000000000001 110.731 176.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.571 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 36.5 m -68.18 146.2 53.62 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.595 -0.275 . . . . 74.450000000000003 111.1 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -41.22 -51.96 3.44 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 115.246 1.573 . . . . 53.420000000000002 115.246 -169.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 pp -75.01 -5.7 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 112.924 0.713 . . . . 73.519999999999996 112.924 -175.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 105.99 46.93 1.13 Allowed Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.29 -0.481 . . . . 73.319999999999993 113.171 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.571 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 48.5 tttm -116.81 139.65 50.35 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.829 0.347 . . . . 73.120000000000005 111.916 -178.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.445 HD13 HG21 ' A' ' 58' ' ' ILE . 65.8 mt -131.11 126.36 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 116.267 -0.424 . . . . 72.25 111.216 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.22 95.88 1.04 Allowed 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 111.958 0.355 . . . . 54.350000000000001 111.958 179.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.434 HD23 HD12 ' A' ' 58' ' ' ILE . 70.7 mt -56.24 -51.1 69.34 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 111.918 0.34 . . . . 73.230000000000004 111.918 179.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -61.71 -9.29 6.02 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.193 0.442 . . . . 75.349999999999994 112.193 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -107.92 -22.11 12.56 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 122.507 0.323 . . . . 73.140000000000001 111.608 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -127.92 13.67 6.82 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.241 0.46 . . . . 64.129999999999995 112.241 -177.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -62.99 131.41 48.55 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.535 0.568 . . . . 71.340000000000003 112.535 -175.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 20.4 t90 -72.64 109.82 6.55 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.101 -0.499 . . . . 71.329999999999998 111.024 174.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.424 ' HA ' ' HD2' ' A' ' 100' ' ' PRO . 20.8 mm-40 -108.72 93.7 12.69 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 115.982 -0.554 . . . . 72.019999999999996 110.735 176.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 99' ' ' GLN . 22.5 Cg_endo -60.59 -31.26 92.02 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.971 2.447 . . . . 71.430000000000007 112.857 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 99' ' ' GLN . 65.7 mt 61.39 25.73 15.64 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.202 0.445 . . . . 74.109999999999999 112.202 177.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 . . . . . 0 C--O 1.256 1.4 0 CA-C-O 118.704 -0.665 . . . . 74.299999999999997 111.283 178.631 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.4 tpt . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 120.823 0.344 . . . . 65.239999999999995 111.069 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -71.2 131.67 43.86 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.408 -0.36 . . . . 63.530000000000001 111.896 -177.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.411 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 26.4 mm-40 -60.19 -27.6 67.29 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.595 0.236 . . . . 64.030000000000001 111.363 176.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -52.59 -49.13 65.62 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.237 0.541 . . . . 72.430000000000007 110.222 172.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 73.1 mt -66.61 -47.54 72.36 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.485 -0.78 . . . . 64.150000000000006 111.055 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.7 t -55.19 -44.92 76.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.324 -0.398 . . . . 71.450000000000003 111.589 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 31.8 mm-40 -66.58 -52.28 47.14 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.208 0.447 . . . . 75.239999999999995 112.208 -178.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.425 ' O ' HG13 ' A' ' 12' ' ' ILE . 31.8 pt -60.73 -41.62 89.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 O-C-N 122.146 -0.346 . . . . 64.540000000000006 111.47 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 17.6 m-30 -61.72 -46.56 89.12 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.068 0.461 . . . . 74.420000000000002 110.705 176.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.28 -39.55 64.01 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.109 -0.496 . . . . 72.230000000000004 111.448 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 7' ' ' GLN . 92.1 t -65.25 -43.2 95.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 120.776 0.322 . . . . 75.340000000000003 111.476 178.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.532 ' HB ' HD12 ' A' ' 52' ' ' LEU . 72.8 mt -56.84 -33.97 42.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 120.927 0.394 . . . . 74.310000000000002 111.763 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -59.4 -16.94 26.36 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 113.22 0.822 . . . . 74.230000000000004 113.22 178.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.408 ' HB3' ' HZ2' ' A' ' 98' ' ' TRP . 2.0 mp0 -80.97 -11.7 59.52 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.375 0.509 . . . . 73.239999999999995 112.375 177.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.47 HD12 HD11 ' A' ' 26' ' ' ILE . 51.0 mt -75.33 115.3 44.0 Favored Pre-proline 0 N--CA 1.472 0.626 0 O-C-N 122.311 -0.243 . . . . 74.430000000000007 111.086 178.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -66.95 169.29 15.17 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.778 2.319 . . . . 72.319999999999993 113.523 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -70.06 115.65 9.51 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.822 -0.626 . . . . 74.010000000000005 110.891 -178.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.32 19.25 21.55 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 120.97 -0.633 . . . . 71.340000000000003 113.643 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -127.11 152.45 47.29 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 117.169 0.485 . . . . 73.010000000000005 111.347 176.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.6 m -128.04 150.04 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 121.136 0.493 . . . . 73.519999999999996 111.731 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.7 t -138.75 175.0 9.93 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.362 -0.381 . . . . 52.210000000000001 111.091 175.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 67.6 p -104.88 150.78 24.57 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.907 0.384 . . . . 75.510000000000005 111.988 -177.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -52.54 -36.68 56.12 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.27 -0.423 . . . . 63.210000000000001 111.659 178.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -60.96 -48.25 87.23 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 116.086 -0.506 . . . . 55.340000000000003 112.789 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.4 ' O ' ' HG3' ' A' ' 29' ' ' MET . 45.1 mt-10 -61.14 -51.95 66.93 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.848 0.356 . . . . 65.409999999999997 111.107 178.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.47 HD11 HD12 ' A' ' 15' ' ' ILE . 49.4 mm -53.14 -53.31 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 121.131 0.491 . . . . 75.230000000000004 111.622 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.62 -44.63 96.11 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.157 0.504 . . . . 63.409999999999997 111.322 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.4 ttpp -62.46 -33.99 75.93 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.168 -0.469 . . . . 73.329999999999998 111.531 -178.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.4 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 67.2 mtt -72.99 -41.33 64.43 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.984 0.421 . . . . 73.099999999999994 111.161 175.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.73 -24.81 67.05 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.236 -0.438 . . . . 61.210000000000001 112.171 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.42 24.55 6.14 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.286 -0.483 . . . . 62.100000000000001 113.254 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -135.65 66.07 62.64 Favored Pre-proline 0 CA--C 1.543 0.674 0 O-C-N 122.665 -0.315 . . . . 75.319999999999993 111.57 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -61.91 138.28 72.78 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.588 2.192 . . . . 73.25 112.757 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.33 -27.8 9.96 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.274 -0.488 . . . . 54.009999999999998 113.127 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -79.88 22.94 0.47 Allowed 'General case' 0 N--CA 1.473 0.715 0 O-C-N 122.214 -0.58 . . . . 73.319999999999993 112.542 -177.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.93 -37.86 69.52 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.414 0.524 . . . . 74.329999999999998 112.414 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -58.82 -38.22 78.17 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.825 0.345 . . . . 70.140000000000001 111.782 178.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -69.74 -35.02 74.63 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.537 -0.301 . . . . 73.439999999999998 111.124 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.403 HG11 HD11 ' A' ' 8' ' ' ILE . 46.6 t -59.67 -44.5 93.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.002 0.43 . . . . 74.540000000000006 110.655 175.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.68 -40.58 98.71 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 121.169 -0.539 . . . . 74.120000000000005 112.718 176.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -67.0 -27.89 67.8 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.982 0.42 . . . . 74.430000000000007 111.157 175.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.89 -53.61 12.64 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.308 -0.406 . . . . 70.540000000000006 111.625 177.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.1 mt -61.13 -39.46 90.1 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.501 -0.318 . . . . 73.530000000000001 111.558 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.45 -15.91 57.73 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 120.88 -0.676 . . . . 54.509999999999998 113.507 178.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -103.41 10.78 37.17 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 122.622 -0.34 . . . . 73.349999999999994 111.804 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 57.9 mt -86.12 155.89 57.65 Favored Pre-proline 0 N--CA 1.47 0.568 0 CA-C-O 120.999 0.428 . . . . 75.230000000000004 112.031 177.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.447 ' HG2' ' HB2' ' A' ' 50' ' ' SER . 55.2 Cg_endo -70.29 153.16 66.75 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.266 1.977 . . . . 70.140000000000001 111.819 172.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -49.28 -70.8 0.08 Allowed 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 121.239 0.542 . . . . 64.340000000000003 111.372 -176.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -91.53 59.46 2.96 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 121.201 -0.523 . . . . 70.140000000000001 113.364 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.447 ' HB2' ' HG2' ' A' ' 47' ' ' PRO . 40.2 t -70.25 165.41 22.27 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.028 0.442 . . . . 70.239999999999995 111.621 176.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -67.09 -24.73 65.98 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.234 0.54 . . . . 74.510000000000005 110.545 174.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.532 HD12 ' HB ' ' A' ' 12' ' ' ILE . 28.0 tp -90.37 126.8 55.37 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 115.722 -0.672 . . . . 73.239999999999995 111.747 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.526 ' HD2' HD11 ' A' ' 52' ' ' LEU . 74.0 Cg_endo -76.24 94.99 1.02 Allowed 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 121.574 1.516 . . . . 75.5 111.553 170.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 60.4 p-90 -83.71 -26.98 29.31 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.352 0.596 . . . . 54.200000000000003 111.678 -177.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -62.66 -13.95 37.99 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.571 0.952 . . . . 73.099999999999994 113.571 -177.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -86.36 3.57 43.0 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 112.541 0.571 . . . . 74.219999999999999 112.541 -178.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.8 t -116.62 123.23 71.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 121.194 0.521 . . . . 75.25 111.795 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.504 HG21 HD13 ' A' ' 91' ' ' ILE . 21.1 pt -126.97 -172.65 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 116.068 -0.514 . . . . 64.239999999999995 111.269 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.6 p30 -90.29 172.64 8.63 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.899 -0.501 . . . . 74.230000000000004 112.126 -177.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 43.9 m -63.32 -16.57 60.8 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 112.587 0.588 . . . . 72.109999999999999 112.587 -176.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -88.38 -2.71 58.75 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.809 0.338 . . . . 73.109999999999999 111.662 -178.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.63 40.75 58.5 Favored Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.977 -0.63 . . . . 64.230000000000004 112.358 -175.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -130.76 155.11 47.2 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.101 0.477 . . . . 73.519999999999996 111.387 -177.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.544 HG21 ' OE1' ' A' ' 74' ' ' GLN . 65.5 mt -77.2 130.78 35.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 116.252 -0.431 . . . . 74.439999999999998 110.966 176.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.9 m -73.17 -41.17 64.18 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 112.101 0.408 . . . . 74.519999999999996 112.101 -179.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.504 HD13 ' HB3' ' A' ' 70' ' ' ASP . 93.8 mt -73.15 146.15 45.85 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.453 -0.34 . . . . 74.299999999999997 110.789 178.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -116.2 157.09 25.39 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.17 0.509 . . . . 74.340000000000003 112.121 -176.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.6 -124.14 30.57 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 115.858 -0.61 . . . . 74.510000000000005 114.007 177.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.5 mtp180 -61.27 -46.96 88.19 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.948 0.404 . . . . 75.340000000000003 111.972 -177.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.504 ' HB3' HD13 ' A' ' 66' ' ' LEU . 15.1 m-20 -63.08 -29.59 70.93 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.85 0.357 . . . . 71.129999999999995 111.174 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.8 tt -63.88 -53.44 50.49 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.312 -0.404 . . . . 75.040000000000006 110.463 175.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -62.27 -30.2 70.96 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.303 -0.408 . . . . 64.430000000000007 111.22 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.542 ' O ' ' HG2' ' A' ' 77' ' ' LYS . 43.5 ttm180 -58.94 -60.38 3.96 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.743 0.306 . . . . 74.200000000000003 110.946 174.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.544 ' OE1' HG21 ' A' ' 64' ' ' ILE . 43.3 tt0 -55.73 -43.3 76.45 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.086 0.47 . . . . 75.409999999999997 110.962 177.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.412 ' HG3' ' HB ' ' A' ' 85' ' ' VAL . 31.5 tttm -55.07 -56.54 18.7 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.728 -0.669 . . . . 71.129999999999995 111.837 176.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -59.14 -37.97 78.54 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.154 0.427 . . . . 64.099999999999994 112.154 -178.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.542 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 75.0 mmtt -58.8 -46.46 87.52 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.934 0.397 . . . . 74.439999999999998 110.942 176.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.479 HD22 HD13 ' A' ' 83' ' ' ILE . 95.8 mt -71.26 -35.33 71.35 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.198 -0.455 . . . . 74.209999999999994 111.628 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -54.6 -41.16 69.61 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.075 0.464 . . . . 62.240000000000002 110.741 173.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.61 -8.18 39.6 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.419 0.526 . . . . 71.400000000000006 112.419 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -107.64 4.45 25.86 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.969 0.414 . . . . 63.32 111.47 177.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.67 5.17 63.25 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.285 -0.483 . . . . 52.109999999999999 113.926 177.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.479 HD13 HD22 ' A' ' 78' ' ' LEU . 66.4 mt -82.64 133.13 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 O-C-N 122.242 -0.563 . . . . 75.430000000000007 111.435 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -92.36 97.64 10.99 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.891 0.377 . . . . 72.299999999999997 111.455 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.412 ' HB ' ' HG3' ' A' ' 75' ' ' LYS . 44.8 t -91.22 124.53 43.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 120.883 0.373 . . . . 75.349999999999994 111.49 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.548 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 42.7 t -67.63 144.56 55.47 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 111.635 0.235 . . . . 75.230000000000004 111.635 177.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -41.94 -48.25 4.47 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.081 1.141 . . . . 75.450000000000003 114.081 -173.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.8 pp -80.74 16.11 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 112.87 0.693 . . . . 73.439999999999998 112.87 -175.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.82 51.59 4.73 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 121.414 -0.422 . . . . 64.150000000000006 113.51 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.548 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 60.4 tttm -125.72 132.17 52.41 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 122.532 -0.393 . . . . 75.129999999999995 111.256 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.504 HD13 HG21 ' A' ' 58' ' ' ILE . 61.0 mt -124.09 134.41 66.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 120.934 0.397 . . . . 75.400000000000006 111.475 -177.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.8 100.22 1.14 Allowed 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 111.947 0.351 . . . . 73.230000000000004 111.947 178.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 39.4 mt -59.06 -62.27 2.01 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.355 0.502 . . . . 73.329999999999998 112.355 -178.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -50.19 -34.46 22.78 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 112.314 0.487 . . . . 73.209999999999994 112.314 -175.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -73.71 -47.29 40.56 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 112.32 0.489 . . . . 73.430000000000007 112.32 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -102.41 14.1 32.85 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 120.973 0.416 . . . . 73.200000000000003 111.528 -177.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -55.02 114.09 1.61 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.905 -0.589 . . . . 75.549999999999997 111.894 -175.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.408 ' HZ2' ' HB3' ' A' ' 14' ' ' GLN . 21.4 t90 -56.45 121.28 9.25 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.101 0.778 . . . . 65.150000000000006 113.101 -177.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.436 ' O ' ' HG3' ' A' ' 99' ' ' GLN . 12.9 pt20 -127.16 109.98 21.55 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 115.662 -0.699 . . . . 74.450000000000003 109.924 167.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.0 -7.02 17.98 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.152 1.901 . . . . 75.230000000000004 112.27 174.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 64.2 mt -120.51 111.68 18.0 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.121 -0.491 . . . . 74.099999999999994 111.381 -175.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 . . . . . 0 C--O 1.251 1.169 0 CA-C-O 118.814 -0.612 . . . . 65.140000000000001 111.171 174.495 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.8 tpt . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.638 0.256 . . . . 74.519999999999996 110.968 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.459 ' O ' HG22 ' A' ' 6' ' ' VAL . 5.8 m-20 -57.25 130.25 45.37 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.088 0.403 . . . . 74.140000000000001 112.088 -179.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -57.66 -31.73 66.6 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.395 -0.366 . . . . 74.310000000000002 111.767 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.405 ' O ' HG12 ' A' ' 8' ' ' ILE . 53.2 t80 -54.83 -52.41 62.81 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.309 0.576 . . . . 72.140000000000001 110.49 172.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 72.5 mt -64.53 -45.32 87.7 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.629 -0.714 . . . . 70.120000000000005 111.17 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 2' ' ' ASP . 58.6 t -55.37 -51.49 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 120.931 0.396 . . . . 63.43 111.697 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -65.27 -50.81 64.32 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 112.539 0.57 . . . . 74.519999999999996 112.539 -176.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.456 ' O ' HG13 ' A' ' 12' ' ' ILE . 32.6 pt -62.16 -45.55 98.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 O-C-N 122.192 -0.317 . . . . 75.420000000000002 111.58 -178.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 19.5 m-30 -62.31 -43.37 98.98 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.081 0.467 . . . . 74.140000000000001 110.91 177.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.03 -48.15 67.83 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.927 -0.579 . . . . 61.32 111.413 178.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 78.0 t -62.87 -41.84 94.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 120.795 0.331 . . . . 75.120000000000005 111.502 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 8' ' ' ILE . 81.5 mt -57.4 -35.86 50.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 112.06 0.393 . . . . 71.340000000000003 112.06 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -56.72 -15.17 4.1 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.15 0.796 . . . . 71.5 113.15 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -86.79 -11.19 51.73 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.699 0.629 . . . . 72.109999999999999 112.699 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.474 HD12 HD12 ' A' ' 26' ' ' ILE . 52.1 mt -73.32 111.64 12.6 Favored Pre-proline 0 CA--C 1.543 0.679 0 O-C-N 122.245 -0.284 . . . . 73.329999999999998 110.677 178.021 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -81.57 178.05 6.99 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.635 2.223 . . . . 71.140000000000001 113.736 -175.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.4 tptt -58.56 140.92 53.49 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.842 -0.617 . . . . 75.349999999999994 111.482 -178.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.611 ' H ' ' NH2' ' A' ' 56' ' ' ARG . . . 82.45 -32.53 2.84 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 116.176 -0.465 . . . . 71.239999999999995 114.142 179.281 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -85.67 158.3 20.1 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.019 0.748 . . . . 74.439999999999998 113.019 -175.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.8 m -139.97 166.84 19.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 115.636 -0.711 . . . . 75.219999999999999 110.734 177.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.8 t -149.28 -178.66 6.52 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.448 -0.342 . . . . 72.430000000000007 110.314 176.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 72.3 p -112.53 158.7 19.61 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.391 0.515 . . . . 73.140000000000001 112.391 -177.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -54.34 -41.82 69.52 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.203 -0.453 . . . . 72.420000000000002 110.903 176.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.12 -47.5 89.46 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.911 -0.586 . . . . 75.409999999999997 113.094 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -55.9 -53.48 56.25 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.925 0.363 . . . . 75.420000000000002 111.389 177.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.474 HD12 HD12 ' A' ' 15' ' ' ILE . 49.3 mm -58.72 -49.62 82.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 120.834 0.35 . . . . 72.439999999999998 111.491 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.51 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -57.89 -49.04 78.09 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 120.995 0.426 . . . . 73.5 112.05 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.734 ' HB3' ' HZ2' ' A' ' 28' ' ' LYS . 9.4 mtpm? -62.71 -39.43 94.02 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.438 -0.346 . . . . 73.540000000000006 111.825 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 72.5 mtm -79.48 -16.07 56.68 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.649 0.261 . . . . 72.310000000000002 111.657 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -85.85 -30.62 22.79 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.028 0.442 . . . . 74.109999999999999 111.363 174.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.41 12.23 10.96 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.286 -0.483 . . . . 54.119999999999997 113.448 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.51 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 71.1 m-85 -130.35 67.53 80.15 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 117.011 0.405 . . . . 73.439999999999998 111.062 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.48 -49.24 16.72 Favored 'Trans proline' 0 N--CA 1.482 0.819 0 C-N-CA 122.842 2.362 . . . . 72.430000000000007 114.096 -174.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -81.38 41.82 2.7 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.105 -0.569 . . . . 72.239999999999995 113.897 -177.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -141.26 21.42 2.24 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.668 0.618 . . . . 75.209999999999994 112.668 -178.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.35 -51.51 64.54 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.076 0.398 . . . . 63.229999999999997 112.076 -177.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -55.11 -36.89 66.2 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.873 0.368 . . . . 75.329999999999998 111.968 176.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -72.39 -37.45 68.72 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.553 -0.294 . . . . 73.040000000000006 111.367 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.445 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 99.7 t -56.85 -47.2 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 120.874 0.369 . . . . 64.430000000000007 110.7 175.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.26 -46.69 92.54 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.281 -0.485 . . . . 70.420000000000002 113.069 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.34 -36.63 82.81 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.984 0.421 . . . . 74.010000000000005 111.337 177.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.29 -40.39 95.86 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.978 0.418 . . . . 75.5 111.265 175.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.479 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 89.9 mt -69.75 -38.83 76.94 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.271 -0.422 . . . . 72.219999999999999 111.338 178.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.05 -13.55 48.97 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 121.285 -0.483 . . . . 72.430000000000007 113.337 178.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -90.59 -12.38 37.18 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 122.556 -0.379 . . . . 72.049999999999997 111.445 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 88.8 mt -66.43 133.58 94.4 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 112.116 0.413 . . . . 62.140000000000001 112.116 -178.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.95 161.33 39.08 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.661 2.241 . . . . 73.109999999999999 113.725 -177.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -61.96 -12.99 21.16 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.331 -0.85 . . . . 70.400000000000006 112.556 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -107.77 18.27 34.82 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 121.139 -0.553 . . . . 75.549999999999997 113.949 -179.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 41.6 t -79.79 152.96 29.48 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 117.413 0.606 . . . . 72.230000000000004 111.583 177.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -101.2 6.55 43.09 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.222 0.534 . . . . 73.239999999999995 110.938 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.508 HD11 ' HD2' ' A' ' 53' ' ' PRO . 56.4 tp -95.16 115.26 65.25 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 116.125 -0.488 . . . . 74.349999999999994 110.681 176.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.508 ' HD2' HD11 ' A' ' 52' ' ' LEU . 63.7 Cg_endo -73.66 95.0 0.86 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 121.39 1.394 . . . . 65.420000000000002 112.059 178.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.479 ' HB2' ' HB3' ' A' ' 43' ' ' LEU . 68.5 p-90 -89.07 -26.24 21.49 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.171 0.51 . . . . 75.450000000000003 111.426 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.439 ' O ' HD21 ' A' ' 78' ' ' LEU . 35.8 p90 -58.48 -21.79 52.78 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.007 -0.542 . . . . 74.150000000000006 112.299 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.611 ' NH2' ' H ' ' A' ' 18' ' ' GLY . 88.0 mtt-85 -81.31 5.78 16.23 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.086 0.402 . . . . 63.130000000000003 112.086 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 18.6 t -115.31 111.44 35.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-O 121.228 0.537 . . . . 72.109999999999999 111.195 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.533 HD13 HD12 ' A' ' 91' ' ' ILE . 20.2 pt -117.79 -169.06 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 122.835 0.454 . . . . 74.040000000000006 111.047 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -92.12 167.35 12.13 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.57 -0.706 . . . . 63.229999999999997 111.764 -178.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 80.8 p -59.13 -18.76 38.72 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 112.644 0.609 . . . . 51.350000000000001 112.644 -176.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -85.94 4.6 36.84 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.786 0.327 . . . . 74.230000000000004 111.702 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.03 38.21 88.31 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 121.122 -0.561 . . . . 61.420000000000002 112.426 -177.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.485 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 54.5 mtpt -131.55 156.9 44.94 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.511 0.672 . . . . 74.420000000000002 112.009 -176.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.545 HG21 ' OE1' ' A' ' 74' ' ' GLN . 68.4 mt -78.59 104.28 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 115.575 -0.739 . . . . 73.319999999999993 110.047 173.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.2 t -63.38 -25.37 68.26 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.398 -0.365 . . . . 74.340000000000003 111.845 -176.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 83.1 mt -74.99 145.17 42.72 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.354 -0.384 . . . . 72.430000000000007 110.873 177.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.426 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -133.86 171.41 14.21 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.16 0.505 . . . . 74.420000000000002 112.0 -175.128 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.5 -121.75 24.83 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.918 -0.658 . . . . 62.420000000000002 112.663 -177.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 69' ' ' ARG . 35.3 mtt180 -71.6 -33.88 69.38 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.019 0.438 . . . . 74.450000000000003 111.277 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.424 ' O ' ' HB3' ' A' ' 73' ' ' ARG . 25.4 m-20 -73.32 -18.19 61.22 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 111.959 0.355 . . . . 70.519999999999996 111.959 -178.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.426 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 6.8 tt -66.11 -55.03 18.49 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.949 -0.389 . . . . 75.099999999999994 109.949 177.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.543 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 19.8 m-20 -67.45 -26.16 66.25 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.766 0.317 . . . . 72.019999999999996 111.304 176.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.424 ' HB3' ' O ' ' A' ' 70' ' ' ASP . 76.0 ttt180 -53.31 -62.5 1.61 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.203 0.525 . . . . 73.510000000000005 110.493 173.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.545 ' OE1' HG21 ' A' ' 64' ' ' ILE . 48.6 tt0 -67.1 -46.71 73.4 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.202 -0.454 . . . . 74.219999999999999 111.356 177.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.543 ' HB3' ' HA ' ' A' ' 72' ' ' ASP . 47.1 tttm -51.97 -50.36 61.4 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.616 0.598 . . . . 70.5 112.616 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -71.0 -30.88 67.24 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 111.904 0.335 . . . . 74.120000000000005 111.904 -176.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -64.75 -35.08 79.91 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.07 0.462 . . . . 73.120000000000005 110.873 171.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.439 HD21 ' O ' ' A' ' 55' ' ' PHE . 57.8 mt -70.15 -47.36 61.99 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.185 -0.461 . . . . 71.340000000000003 111.286 175.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -57.88 -31.22 66.51 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.193 -0.458 . . . . 74.049999999999997 111.389 176.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.55 -34.07 70.62 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.836 0.351 . . . . 74.420000000000002 111.32 173.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -88.09 -11.81 45.99 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 111.813 0.301 . . . . 75.109999999999999 111.813 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.77 54.76 3.15 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.285 -0.484 . . . . 71.519999999999996 113.029 -178.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.506 HD13 HH12 ' A' ' 56' ' ' ARG . 68.3 mt -116.2 137.06 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 122.605 0.362 . . . . 75.310000000000002 111.223 -179.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.46 ' HG3' ' OH ' ' A' ' 96' ' ' TYR . 66.9 mt-10 -66.71 92.98 0.23 Allowed 'General case' 0 N--CA 1.471 0.588 0 O-C-N 122.012 -0.43 . . . . 61.520000000000003 111.868 -179.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.41 HG13 ' HG3' ' A' ' 75' ' ' LYS . 42.9 t -89.99 102.79 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 120.815 0.341 . . . . 74.420000000000002 110.722 173.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.569 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 69.9 m -64.46 163.46 13.31 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.317 0.488 . . . . 71.129999999999995 112.317 -178.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -35.04 -58.09 0.54 Allowed 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 115.247 1.573 . . . . 75.340000000000003 115.247 -169.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.429 HD13 ' HE3' ' A' ' 63' ' ' LYS . 2.6 pp -92.82 23.06 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 112.505 0.557 . . . . 75.319999999999993 112.505 -174.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.71 47.8 7.03 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 121.266 -0.492 . . . . 74.219999999999999 112.604 -176.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.569 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 49.3 tttm -111.8 131.88 55.04 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 122.432 -0.452 . . . . 74.519999999999996 111.452 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.533 HD12 HD13 ' A' ' 58' ' ' ILE . 53.5 mt -116.46 135.87 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 120.921 0.391 . . . . 75.120000000000005 111.699 -176.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.99 93.92 1.42 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.948 0.404 . . . . 70.109999999999999 111.453 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.47 HD22 HD12 ' A' ' 58' ' ' ILE . 66.6 mt -54.24 -56.85 14.31 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.384 0.513 . . . . 74.140000000000001 112.384 -178.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -53.05 -28.21 23.54 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.522 0.564 . . . . 74.349999999999994 112.522 -177.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -84.52 -33.09 23.58 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.033 0.383 . . . . 74.120000000000005 112.033 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.46 ' OH ' ' HG3' ' A' ' 84' ' ' GLU . 80.3 m-85 -117.59 6.92 12.52 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.84 0.682 . . . . 73.420000000000002 112.84 -173.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 61.5 tttp -63.31 128.8 37.51 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.159 0.504 . . . . 75.099999999999994 112.209 -173.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 15.7 t90 -69.72 116.81 10.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.761 -0.654 . . . . 75.450000000000003 110.798 175.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -114.38 92.04 26.37 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 116.476 -0.329 . . . . 71.450000000000003 111.187 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.72 -32.7 46.5 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.514 2.143 . . . . 73.420000000000002 112.043 174.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 81.2 mt -77.39 118.05 19.47 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.879 -0.6 . . . . 75.530000000000001 110.655 176.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 C--O 1.252 1.228 0 N-CA-C 112.115 0.413 . . . . 74.420000000000002 112.115 -176.453 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.9 tpt . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 120.876 0.37 . . . . 63.509999999999998 110.975 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -74.5 155.11 38.32 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.737 0.643 . . . . 75.439999999999998 112.737 -175.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.58 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 22.2 mm-40 -53.74 -40.04 65.83 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.063 -0.517 . . . . 74.25 111.38 175.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.413 ' O ' HG12 ' A' ' 8' ' ' ILE . 64.5 t80 -50.42 -53.38 29.9 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.131 0.491 . . . . 74.540000000000006 111.105 177.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 59.5 mt -61.61 -46.55 89.34 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.748 -0.66 . . . . 65.049999999999997 111.182 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.4 t -60.44 -44.86 97.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 116.137 -0.483 . . . . 62.119999999999997 111.896 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.58 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 24.4 mm-40 -68.51 -52.1 35.89 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.014 0.376 . . . . 75.530000000000001 112.014 -176.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.506 ' O ' HG13 ' A' ' 12' ' ' ILE . 30.9 pt -58.16 -43.42 85.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 121.055 -0.258 . . . . 73.349999999999994 111.306 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.5 m-30 -63.34 -46.76 85.08 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.036 0.446 . . . . 74.329999999999998 110.671 175.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.35 -44.67 65.32 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.926 -0.579 . . . . 75.219999999999999 111.661 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.426 HG21 ' O ' ' A' ' 7' ' ' GLN . 99.7 t -63.48 -43.78 98.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 120.825 0.345 . . . . 74.200000000000003 111.4 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.53 ' HB ' HD11 ' A' ' 52' ' ' LEU . 72.6 mt -58.63 -32.09 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 112.161 0.43 . . . . 74.530000000000001 112.161 -178.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -60.55 -10.24 4.83 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.064 0.764 . . . . 70.329999999999998 113.064 178.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -92.86 -2.52 55.81 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 112.564 0.579 . . . . 71.230000000000004 112.564 178.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 55.3 mt -81.5 114.1 47.05 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-O 120.653 0.263 . . . . 73.430000000000007 111.176 179.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.55 171.47 13.04 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.926 2.417 . . . . 70.430000000000007 113.054 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 44.9 tttp -66.68 133.04 49.42 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.064 0.459 . . . . 70.209999999999994 111.25 -178.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.464 ' H ' ' NH2' ' A' ' 56' ' ' ARG . . . 95.19 -25.14 25.63 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 121.319 -0.467 . . . . 64.299999999999997 113.184 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -86.72 157.31 19.67 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.587 0.588 . . . . 71.010000000000005 112.587 -177.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.3 m -140.51 153.98 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.621 -0.718 . . . . 71.150000000000006 110.722 176.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.5 t -135.07 179.98 5.98 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 122.189 -0.319 . . . . 70.519999999999996 110.726 176.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.2 p -110.9 155.52 22.51 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.09 0.471 . . . . 72.25 112.14 -176.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -54.3 -34.87 61.88 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.197 -0.456 . . . . 73.519999999999996 111.978 177.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.98 -49.9 60.5 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.095 -0.574 . . . . 75.540000000000006 112.752 177.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -56.39 -53.84 52.63 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.0 0.428 . . . . 74.409999999999997 111.364 177.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.5 mm -56.63 -48.23 80.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-N 116.12 -0.491 . . . . 74.549999999999997 111.729 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . -60.12 -49.39 77.81 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 120.88 0.371 . . . . 74.430000000000007 111.971 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -60.63 -36.63 79.1 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.9 0.381 . . . . 72.519999999999996 111.878 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.445 ' HE3' ' CZ3' ' A' ' 98' ' ' TRP . 73.6 mtm -84.81 -9.71 57.89 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.746 0.308 . . . . 65.219999999999999 111.773 179.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.3 -11.5 32.3 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.933 0.396 . . . . 71.230000000000004 111.356 173.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.13 21.68 37.87 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 121.312 -0.47 . . . . 72.120000000000005 113.482 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.438 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 97.2 m-85 -133.59 77.78 63.71 Favored Pre-proline 0 CA--C 1.543 0.699 0 O-C-N 122.522 -0.399 . . . . 74.510000000000005 111.916 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.52 135.71 24.71 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.305 2.004 . . . . 75.219999999999999 112.712 178.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.63 -1.87 76.2 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 121.238 -0.506 . . . . 70.420000000000002 113.738 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -99.88 23.21 10.04 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 117.258 0.529 . . . . 70.0 112.29 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.65 -48.4 58.3 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.723 0.638 . . . . 72.030000000000001 112.723 -177.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.0 ttp180 -68.08 -32.42 72.73 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.738 0.304 . . . . 75.400000000000006 111.711 -178.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -67.99 -35.98 79.24 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.848 0.356 . . . . 74.109999999999999 110.993 178.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.45 HG21 HG22 ' A' ' 8' ' ' ILE . 47.1 t -60.01 -42.84 91.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 121.393 0.615 . . . . 74.129999999999995 109.851 172.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.31 -37.93 92.61 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 115.681 -0.69 . . . . 62.240000000000002 112.781 174.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -58.19 -50.76 72.39 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.139 0.495 . . . . 74.109999999999999 110.602 174.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.29 -46.75 82.85 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.66 -0.7 . . . . 73.340000000000003 112.125 -177.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 62.2 mt -65.17 -39.26 92.69 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.794 0.331 . . . . 75.340000000000003 111.596 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.7 -25.19 65.22 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 120.805 -0.712 . . . . 72.340000000000003 113.249 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -87.3 5.58 37.66 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 120.877 0.37 . . . . 72.430000000000007 111.84 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 97.0 mt -94.48 155.71 39.34 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-O 120.664 0.268 . . . . 75.430000000000007 111.084 176.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.9 160.47 46.82 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.241 1.961 . . . . 74.329999999999998 112.367 174.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -53.83 -41.46 67.4 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.174 0.435 . . . . 74.140000000000001 112.174 -174.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -124.77 65.51 0.54 Allowed Glycine 0 CA--C 1.526 0.735 0 C-N-CA 121.334 -0.46 . . . . 72.109999999999999 112.577 178.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.8 t -69.72 163.96 24.55 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.206 0.447 . . . . 63.039999999999999 112.206 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -60.38 -30.61 69.68 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.384 0.611 . . . . 74.25 110.259 173.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.533 HD13 ' HD2' ' A' ' 53' ' ' PRO . 48.5 tp -86.36 121.93 72.29 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 115.592 -0.731 . . . . 74.129999999999995 110.456 173.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.533 ' HD2' HD13 ' A' ' 52' ' ' LEU . 58.1 Cg_endo -72.95 94.9 0.81 Allowed 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 121.12 1.213 . . . . 72.540000000000006 111.745 177.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 69.2 p-90 -79.67 -31.28 41.36 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.978 -0.555 . . . . 75.120000000000005 111.605 -177.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -62.81 -11.01 15.1 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.726 0.639 . . . . 75.299999999999997 112.726 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.66 HH12 HD11 ' A' ' 83' ' ' ILE . 71.9 mtt-85 -90.2 9.33 28.9 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.142 0.423 . . . . 73.200000000000003 112.142 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.3 t -124.69 105.87 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.038 0.447 . . . . 73.239999999999995 111.004 176.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.496 HD13 HD13 ' A' ' 91' ' ' ILE . 22.3 pt -115.41 -170.19 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 121.069 0.461 . . . . 60.25 112.013 -176.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -88.1 169.99 11.46 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.896 0.379 . . . . 74.109999999999999 111.852 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 33.4 t -63.27 -24.51 67.9 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.494 0.553 . . . . 52.340000000000003 112.494 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -72.68 -10.34 59.68 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.73 0.3 . . . . 70.439999999999998 111.803 178.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.11 44.18 24.06 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.84 -0.695 . . . . 72.530000000000001 111.878 -175.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.427 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 99.6 mttt -135.93 159.54 41.37 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.936 0.398 . . . . 70.439999999999998 111.286 -178.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 61.5 mt -62.26 132.83 28.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.115 -0.493 . . . . 74.420000000000002 110.888 177.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.5 p -76.18 -47.68 23.28 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.866 0.365 . . . . 60.350000000000001 111.29 -178.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.575 ' HB3' ' HB3' ' A' ' 70' ' ' ASP . 76.6 mt -67.36 156.8 35.59 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.081 0.467 . . . . 63.25 111.584 178.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.458 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 13.7 ptmm? -131.83 162.36 30.77 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.18 0.437 . . . . 70.200000000000003 112.18 -172.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 61.97 -131.07 45.59 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 116.255 -0.43 . . . . 60.210000000000001 113.243 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 -54.18 -41.62 68.76 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.264 0.554 . . . . 74.219999999999999 111.35 175.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.575 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 2.1 m-20 -66.12 -27.69 68.24 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.78 -0.645 . . . . 74.019999999999996 111.99 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.458 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 7.3 tt -64.0 -53.47 49.59 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.949 0.404 . . . . 73.299999999999997 110.053 176.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.432 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 67.7 m-20 -63.51 -29.82 71.03 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.246 -0.434 . . . . 61.109999999999999 111.25 177.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.41 ' HB3' ' O ' ' A' ' 70' ' ' ASP . 34.5 ttm180 -56.9 -58.24 8.99 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.111 -0.495 . . . . 75.200000000000003 111.247 174.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.437 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 49.5 tt0 -63.56 -40.75 97.79 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.983 0.421 . . . . 72.409999999999997 110.417 177.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.432 ' HB3' ' HA ' ' A' ' 72' ' ' ASP . 84.2 tttt -48.99 -52.95 22.04 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.77 -0.65 . . . . 75.349999999999994 112.075 176.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -63.07 -39.13 93.8 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.059 0.392 . . . . 71.540000000000006 112.059 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 75.0 mmtt -64.35 -36.37 83.9 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.122 0.487 . . . . 75.310000000000002 111.004 177.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.504 HD11 HD11 ' A' ' 91' ' ' ILE . 73.4 mt -69.48 -52.38 27.15 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.093 -0.503 . . . . 73.329999999999998 111.414 178.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -52.78 -45.03 66.95 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.968 0.413 . . . . 63.109999999999999 111.529 177.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.69 -16.47 57.41 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.285 0.476 . . . . 62.350000000000001 112.285 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.547 ' HB3' HH22 ' A' ' 56' ' ' ARG . 28.2 mm-40 -104.57 13.15 32.17 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.025 0.38 . . . . 64.420000000000002 112.025 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.91 6.79 88.67 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.156 -0.545 . . . . 74.5 113.539 178.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.66 HD11 HH12 ' A' ' 56' ' ' ARG . 57.5 mt -88.39 149.51 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 O-C-N 122.475 -0.427 . . . . 72.200000000000003 110.656 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.433 ' HG2' ' CE2' ' A' ' 96' ' ' TYR . 12.4 pt-20 -97.83 130.31 44.75 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.191 0.52 . . . . 63.399999999999999 111.548 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.4 HG22 ' HA ' ' A' ' 75' ' ' LYS . 45.4 t -110.42 100.85 11.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 116.186 -0.461 . . . . 75.5 110.951 174.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.558 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 47.0 m -58.82 153.7 16.51 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.331 -0.395 . . . . 63.530000000000001 110.788 176.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.462 ' HG3' ' N ' ' A' ' 88' ' ' ILE . 10.8 pt-20 -40.46 -46.79 2.51 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 114.663 1.357 . . . . 73.400000000000006 114.663 -167.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.462 ' N ' ' HG3' ' A' ' 87' ' ' GLU . 2.6 pp -90.13 21.29 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-O 121.192 0.52 . . . . 75.200000000000003 112.197 -176.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.61 51.74 7.02 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 116.04 -0.527 . . . . 73.129999999999995 113.391 -178.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.558 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 62.2 tttp -118.7 135.98 54.19 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 117.34 0.57 . . . . 71.5 112.42 179.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.504 HD11 HD11 ' A' ' 78' ' ' LEU . 52.7 mt -113.93 138.24 44.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 123.028 0.531 . . . . 72.340000000000003 110.968 178.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.26 92.92 1.42 Allowed 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.851 0.357 . . . . 73.25 111.568 177.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.492 HD23 HD12 ' A' ' 58' ' ' ILE . 45.3 mt -53.23 -60.47 3.25 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.517 0.562 . . . . 73.530000000000001 112.517 -178.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -62.36 1.23 0.36 Allowed 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.192 0.812 . . . . 73.219999999999999 113.192 -172.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.419 ' HD2' ' CE2' ' A' ' 96' ' ' TYR . 9.1 tmtm? -112.9 -34.71 5.67 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 122.104 -0.373 . . . . 75.209999999999994 110.954 173.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.433 ' CE2' ' HG2' ' A' ' 84' ' ' GLU . 97.6 m-85 -108.85 5.79 24.83 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.364 0.505 . . . . 75.239999999999995 112.364 -177.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 50.9 tttm -63.31 133.13 53.64 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.144 0.497 . . . . 74.049999999999997 111.759 -174.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.445 ' CZ3' ' HE3' ' A' ' 29' ' ' MET . 16.0 t90 -57.28 125.12 21.34 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.046 -0.525 . . . . 71.109999999999999 111.827 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -107.24 90.39 5.61 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 116.061 -0.518 . . . . 74.549999999999997 110.918 177.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.61 -19.77 41.66 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.636 2.224 . . . . 73.319999999999993 112.595 178.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 85.0 mt -107.02 -175.5 2.81 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.354 -0.385 . . . . 70.219999999999999 110.974 178.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 . . . . . 0 C--O 1.254 1.331 0 CA-C-N 116.38 -0.373 . . . . 72.019999999999996 111.58 178.956 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 120.646 0.26 . . . . 72.310000000000002 111.231 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -61.56 156.39 19.8 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.609 0.596 . . . . 75.040000000000006 112.609 -175.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -52.03 -37.69 54.39 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.928 -0.578 . . . . 64.340000000000003 112.244 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -53.66 -49.25 68.34 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.22 0.533 . . . . 75.239999999999995 110.607 177.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 77.8 mt -67.21 -45.75 75.93 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.601 -0.727 . . . . 72.310000000000002 111.218 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.9 t -55.79 -47.58 79.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.027 0.441 . . . . 74.129999999999995 111.655 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -67.16 -51.29 55.56 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.335 0.494 . . . . 74.310000000000002 112.335 -177.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.466 ' O ' HG13 ' A' ' 12' ' ' ILE . 33.5 pt -60.79 -42.72 93.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 O-C-N 122.154 -0.341 . . . . 73.310000000000002 111.576 -177.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -62.85 -43.83 97.76 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.061 0.458 . . . . 73.5 110.941 177.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.97 -39.64 66.15 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.983 -0.553 . . . . 61.130000000000003 111.725 177.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 67.6 t -69.68 -39.49 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 120.966 0.412 . . . . 72.439999999999998 111.521 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.504 ' HB ' HD11 ' A' ' 52' ' ' LEU . 82.8 mt -59.3 -33.87 52.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 116.21 -0.45 . . . . 75.439999999999998 111.955 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 83.0 m-70 -55.37 -25.28 34.31 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 113.171 0.804 . . . . 75.019999999999996 113.171 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -80.7 1.51 29.84 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.071 0.767 . . . . 73.450000000000003 113.071 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 57.2 mt -83.34 111.44 31.23 Favored Pre-proline 0 CA--C 1.543 0.676 0 O-C-N 121.961 -0.462 . . . . 73.409999999999997 110.943 177.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.85 157.72 57.49 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.675 2.25 . . . . 72.310000000000002 113.312 -176.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.8 tttp -62.67 94.81 0.07 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.218 0.532 . . . . 73.099999999999994 111.734 -177.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.423 ' H ' ' CZ ' ' A' ' 56' ' ' ARG . . . 142.94 -28.74 2.12 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-N 116.054 -0.521 . . . . 50.130000000000003 112.473 178.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -95.66 165.49 12.29 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.273 0.558 . . . . 73.140000000000001 112.067 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.7 m -141.43 159.68 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.677 -0.692 . . . . 73.310000000000002 110.482 176.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 94.1 p -138.35 -179.37 5.76 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.817 0.341 . . . . 61.329999999999998 111.023 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 51.2 p -106.21 155.91 18.99 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.855 0.36 . . . . 71.319999999999993 111.971 -179.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -54.91 -38.59 67.82 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.944 0.402 . . . . 74.019999999999996 110.945 177.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.26 -52.75 51.41 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-N 115.788 -0.642 . . . . 54.140000000000001 113.18 178.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -56.37 -48.3 77.13 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.905 0.383 . . . . 73.409999999999997 111.513 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.6 mm -58.75 -49.29 83.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 116.292 -0.413 . . . . 61.450000000000003 111.258 178.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.458 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -59.93 -45.28 93.09 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.965 0.412 . . . . 72.510000000000005 111.973 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.554 ' HZ1' ' HB3' ' A' ' 28' ' ' LYS . 9.4 mtpm? -57.79 -52.53 65.07 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.788 0.328 . . . . 75.25 111.408 178.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.49 ' HE3' ' CZ3' ' A' ' 98' ' ' TRP . 72.7 mtm -66.65 -28.18 68.27 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.399 -0.364 . . . . 74.439999999999998 111.879 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.72 -30.44 64.18 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.027 0.442 . . . . 62.350000000000001 111.417 176.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.71 13.15 19.33 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.333 -0.46 . . . . 71.209999999999994 113.057 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.458 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 76.3 m-85 -127.74 66.78 71.59 Favored Pre-proline 0 CA--C 1.543 0.679 0 O-C-N 122.61 -0.347 . . . . 63.210000000000001 111.714 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.71 144.73 60.86 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.224 1.95 . . . . 74.420000000000002 112.41 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.77 -11.78 65.56 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 121.032 -0.604 . . . . 71.310000000000002 113.523 -177.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -99.4 19.16 16.07 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 122.394 -0.474 . . . . 74.030000000000001 111.757 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.26 -42.92 66.99 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.263 0.468 . . . . 74.319999999999993 112.263 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -57.0 -37.51 71.75 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.009 0.374 . . . . 74.319999999999993 112.009 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -72.43 -31.9 65.87 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 120.653 0.264 . . . . 74.439999999999998 111.296 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.1 t -56.7 -51.78 62.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 120.887 0.375 . . . . 72.439999999999998 110.335 173.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -57.48 -42.41 93.88 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 121.219 -0.515 . . . . 43.329999999999998 113.039 176.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.758 ' HB3' ' HZ3' ' A' ' 41' ' ' LYS . 8.9 mtpm? -60.22 -34.54 73.81 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.795 0.331 . . . . 75.439999999999998 111.753 178.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.9 -41.75 59.13 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.324 -0.398 . . . . 55.229999999999997 111.475 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 86.2 mt -65.66 -42.15 91.71 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.316 -0.402 . . . . 75.219999999999999 111.908 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.28 -26.84 51.56 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 121.195 -0.526 . . . . 72.230000000000004 113.542 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -78.94 -20.15 50.0 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 122.584 -0.362 . . . . 70.049999999999997 111.751 -178.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 81.5 mt -68.03 147.17 98.43 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-O 120.851 0.357 . . . . 73.510000000000005 111.601 -179.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -84.13 177.53 5.88 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.693 2.262 . . . . 74.420000000000002 112.971 178.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.447 ' OE1' ' HD2' ' A' ' 73' ' ' ARG . 1.4 mp0 -71.72 -37.21 70.65 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.983 0.42 . . . . 71.140000000000001 111.156 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -94.38 43.54 2.35 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 121.371 -0.442 . . . . 71.420000000000002 113.344 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.0 t -84.19 159.75 20.97 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.99 0.424 . . . . 74.209999999999994 111.472 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -81.91 -12.91 58.19 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.435 0.635 . . . . 75.409999999999997 110.726 178.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.527 HD13 ' HD2' ' A' ' 53' ' ' PRO . 33.0 tp -107.05 126.05 31.09 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 115.735 -0.666 . . . . 75.549999999999997 110.983 179.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.527 ' HD2' HD13 ' A' ' 52' ' ' LEU . 57.0 Cg_endo -72.94 94.53 0.8 Allowed 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 121.205 1.27 . . . . 72.120000000000005 111.637 174.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 69.2 p-90 -86.66 -17.69 33.15 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.291 0.567 . . . . 73.549999999999997 111.673 -177.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.476 ' O ' HD21 ' A' ' 78' ' ' LEU . 37.4 p90 -73.88 -5.72 42.76 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.985 0.735 . . . . 62.350000000000001 112.985 -176.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.466 HH12 HD11 ' A' ' 83' ' ' ILE . 87.1 mtt-85 -99.24 12.92 34.83 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.771 0.656 . . . . 74.219999999999999 112.771 -177.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.4 t -123.11 112.76 35.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 121.263 0.554 . . . . 72.430000000000007 111.214 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.549 HD11 HD23 ' A' ' 93' ' ' LEU . 27.4 pt -122.04 -169.98 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-N 116.087 -0.506 . . . . 72.400000000000006 111.386 -178.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 32.9 p30 -85.22 167.75 15.39 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.83 -0.544 . . . . 73.510000000000005 112.048 -177.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.482 ' HA ' HG21 ' A' ' 22' ' ' THR . 50.3 p -66.3 -10.71 45.22 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.941 0.719 . . . . 74.140000000000001 112.941 -177.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -96.33 11.32 35.14 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.762 0.315 . . . . 54.210000000000001 111.628 179.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.33 39.0 87.89 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 116.438 -0.346 . . . . 72.510000000000005 113.53 176.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.451 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 56.4 mttp -139.45 157.97 44.93 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.208 0.528 . . . . 73.230000000000004 111.6 -178.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.419 HG21 ' OE1' ' A' ' 74' ' ' GLN . 59.2 mt -73.26 117.57 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.806 -0.634 . . . . 75.040000000000006 110.903 177.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.3 t -69.19 -33.01 72.69 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.06 0.457 . . . . 71.310000000000002 110.99 178.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.53 HD13 ' HB3' ' A' ' 70' ' ' ASP . 66.6 mt -65.08 148.28 51.95 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.162 -0.472 . . . . 71.219999999999999 111.118 177.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -130.25 149.38 51.97 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.965 0.412 . . . . 75.129999999999995 112.098 -176.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.15 -120.37 7.81 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-N 116.263 -0.426 . . . . 72.099999999999994 113.451 178.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -65.03 -46.19 82.34 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.943 0.402 . . . . 74.209999999999994 111.653 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.53 ' HB3' HD13 ' A' ' 66' ' ' LEU . 67.6 m-20 -59.38 -36.08 75.12 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.552 -0.294 . . . . 74.230000000000004 111.568 177.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.9 tt -62.99 -54.99 29.76 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.963 -0.384 . . . . 75.209999999999994 109.963 177.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -58.98 -32.88 70.05 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.134 0.492 . . . . 73.349999999999994 111.312 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.447 ' HD2' ' OE1' ' A' ' 48' ' ' GLU . 11.2 ttp180 -67.84 -51.95 42.55 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.005 -0.543 . . . . 64.239999999999995 111.572 -178.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.419 ' OE1' HG21 ' A' ' 64' ' ' ILE . 34.2 tt0 -62.87 -47.28 84.02 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.181 0.515 . . . . 74.439999999999998 110.216 174.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.0 tttt -47.77 -55.17 10.21 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.206 -0.906 . . . . 71.409999999999997 112.576 175.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -56.41 -42.7 78.43 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.087 0.403 . . . . 62.039999999999999 112.087 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -62.57 -42.02 99.3 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.093 0.473 . . . . 74.439999999999998 111.517 177.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.476 HD21 ' O ' ' A' ' 55' ' ' PHE . 81.2 mt -64.19 -44.1 93.05 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.204 -0.453 . . . . 73.140000000000001 111.767 178.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -55.48 -42.42 74.34 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.923 0.392 . . . . 75.109999999999999 111.111 176.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.93 -33.76 73.66 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.056 0.455 . . . . 71.230000000000004 111.833 177.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.418 ' HB3' HH22 ' A' ' 56' ' ' ARG . 8.2 mm-40 -83.6 1.72 40.83 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.377 -0.374 . . . . 72.430000000000007 111.952 -179.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.84 9.93 70.46 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 121.379 -0.439 . . . . 62.43 113.949 177.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.466 HD11 HH12 ' A' ' 56' ' ' ARG . 67.0 mt -89.15 136.18 24.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 117.023 0.411 . . . . 65.400000000000006 111.405 -178.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' A' ' 84' ' ' GLU . 9.2 pt-20 -76.44 114.66 15.39 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.143 0.497 . . . . 75.540000000000006 111.79 178.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.8 t -101.54 105.05 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 120.965 0.412 . . . . 74.209999999999994 110.666 172.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.616 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 25.2 t -69.48 157.96 36.11 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.423 -0.353 . . . . 73.430000000000007 111.77 178.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -37.55 -56.55 1.02 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.638 1.347 . . . . 71.129999999999995 114.638 -168.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.409 HD12 ' HB2' ' A' ' 90' ' ' LYS . 2.7 pp -86.54 18.27 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 112.69 0.626 . . . . 71.439999999999998 112.69 -174.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.2 44.83 7.85 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.113 -0.565 . . . . 36.710000000000001 112.518 -177.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.616 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 0.6 OUTLIER -105.52 128.15 53.42 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 122.539 -0.389 . . . . 72.109999999999999 110.389 -179.602 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.504 HD13 HD12 ' A' ' 58' ' ' ILE . 62.3 mt -116.53 139.67 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.899 0.381 . . . . 71.340000000000003 111.118 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.58 92.61 4.08 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.925 0.393 . . . . 71.209999999999994 111.786 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.587 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 57.4 mt -59.79 -44.19 94.05 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.733 0.302 . . . . 71.420000000000002 111.251 178.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 80.9 mtt-85 -56.48 -12.52 1.76 Allowed 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 112.173 0.434 . . . . 75.120000000000005 112.173 -177.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -109.92 -42.37 4.25 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 120.964 0.411 . . . . 73.519999999999996 111.814 176.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -101.7 6.46 41.87 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.149 0.425 . . . . 75.519999999999996 112.149 -171.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.587 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 78.0 tttt -61.56 129.35 40.7 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.143 0.497 . . . . 71.310000000000002 111.914 -175.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.49 ' CZ3' ' HE3' ' A' ' 29' ' ' MET . 21.2 t90 -71.03 116.96 11.93 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.978 -0.555 . . . . 73.129999999999995 111.991 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -124.65 92.66 47.51 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 115.971 -0.559 . . . . 65.340000000000003 110.58 175.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -79.36 34.12 0.51 Allowed 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 122.959 2.44 . . . . 74.239999999999995 113.797 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 96.8 mt -132.55 97.57 4.12 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.528 0.566 . . . . 72.549999999999997 112.528 -176.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 . . . . . 0 C--O 1.251 1.153 0 CA-C-O 118.678 -0.677 . . . . 44.439999999999998 110.997 172.646 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 tpt . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 120.891 0.376 . . . . 71.549999999999997 110.897 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -75.86 150.53 37.6 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.744 0.646 . . . . 74.430000000000007 112.744 -174.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -51.19 -31.74 21.22 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.625 -0.716 . . . . 64.299999999999997 112.318 178.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -57.61 -55.54 33.48 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.848 0.356 . . . . 75.439999999999998 110.727 177.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 77.0 mt -59.97 -45.19 93.49 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.964 -0.562 . . . . 75.25 111.218 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 62.0 t -57.14 -52.62 53.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 116.178 -0.465 . . . . 74.230000000000004 112.053 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.408 ' O ' HG22 ' A' ' 11' ' ' VAL . 28.7 mm-40 -67.58 -44.71 77.5 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.727 0.64 . . . . 73.430000000000007 112.727 -175.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.424 ' O ' HG13 ' A' ' 12' ' ' ILE . 36.8 pt -63.33 -43.43 98.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 120.909 -0.316 . . . . 73.219999999999999 111.281 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -62.87 -44.98 94.65 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.943 0.401 . . . . 75.349999999999994 110.978 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.52 -37.22 62.6 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.08 -0.509 . . . . 71.439999999999998 111.793 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 7' ' ' GLN . 96.0 t -70.21 -42.65 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-O 120.929 0.395 . . . . 73.200000000000003 111.513 178.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.524 ' HB ' HD11 ' A' ' 52' ' ' LEU . 79.9 mt -59.19 -30.57 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 112.28 0.474 . . . . 75.129999999999995 112.28 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -60.85 -12.52 11.22 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 112.966 0.728 . . . . 75.140000000000001 112.966 178.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -90.77 -3.5 57.38 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.481 0.549 . . . . 75.200000000000003 112.481 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.413 HD11 HG21 ' A' ' 12' ' ' ILE . 56.0 mt -84.3 113.79 50.65 Favored Pre-proline 0 CA--C 1.544 0.741 0 O-C-N 122.184 -0.322 . . . . 70.140000000000001 111.44 -179.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -70.5 163.78 37.64 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.961 2.44 . . . . 74.200000000000003 113.843 -177.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.35 120.85 12.99 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.944 -0.571 . . . . 74.420000000000002 111.639 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.33 14.09 46.02 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.092 -0.575 . . . . 75.209999999999994 113.442 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -126.03 148.3 49.34 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.889 0.376 . . . . 72.150000000000006 111.18 176.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.0 m -125.32 149.11 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-O 121.122 0.487 . . . . 71.519999999999996 111.613 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 97.8 p -128.67 167.03 17.8 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.106 -0.497 . . . . 73.010000000000005 110.83 177.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.5 p -103.79 147.45 27.27 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.763 0.316 . . . . 74.239999999999995 111.378 177.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -52.16 -36.52 51.82 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.751 0.31 . . . . 74.219999999999999 111.766 178.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -57.35 -43.82 93.68 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 121.129 -0.558 . . . . 73.329999999999998 112.779 177.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.492 ' O ' ' HG3' ' A' ' 29' ' ' MET . 41.7 mt-10 -65.11 -54.13 34.63 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.78 0.324 . . . . 73.450000000000003 111.112 177.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.8 mm -54.62 -51.12 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.3 -0.409 . . . . 73.239999999999995 111.889 -178.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.49 -46.19 84.0 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.945 0.402 . . . . 61.32 111.748 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -61.19 -48.38 81.82 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.781 0.324 . . . . 75.239999999999995 111.511 178.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.492 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 61.0 mtt -63.37 -30.1 71.29 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.096 0.474 . . . . 71.0 111.522 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.01 -19.57 58.55 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.158 -0.474 . . . . 74.209999999999994 111.858 178.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.57 23.26 12.49 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.191 -0.528 . . . . 74.519999999999996 113.154 -178.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -132.78 62.82 64.63 Favored Pre-proline 0 CA--C 1.542 0.648 0 O-C-N 122.48 -0.423 . . . . 75.200000000000003 111.064 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -62.5 119.82 7.09 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.27 1.98 . . . . 73.030000000000001 112.731 -177.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.44 -6.58 49.79 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.036 -0.602 . . . . 72.420000000000002 113.589 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -97.98 20.74 11.71 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 117.332 0.566 . . . . 74.209999999999994 111.375 177.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.8 -39.43 68.46 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.806 0.669 . . . . 74.040000000000006 112.806 -177.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -58.8 -34.89 72.01 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 120.924 0.392 . . . . 73.340000000000003 111.714 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -77.94 -28.25 49.51 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.687 -0.233 . . . . 65.230000000000004 111.408 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.3 t -59.66 -42.63 89.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.238 0.542 . . . . 74.239999999999995 110.12 172.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -62.7 -42.31 99.71 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 115.771 -0.65 . . . . 53.219999999999999 112.789 175.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -60.66 -41.82 95.78 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.049 0.452 . . . . 72.329999999999998 111.134 176.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.52 -54.47 45.07 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.177 -0.465 . . . . 55.219999999999999 111.418 178.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.471 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 80.6 mt -61.88 -38.53 88.66 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.932 0.396 . . . . 74.109999999999999 111.589 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.29 -17.77 70.65 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.339 -0.458 . . . . 73.420000000000002 113.396 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -101.07 2.84 40.79 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 122.416 -0.461 . . . . 73.230000000000004 111.391 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 69.9 mt -78.54 155.54 78.64 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-O 120.809 0.338 . . . . 73.450000000000003 111.321 176.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.518 ' HG2' ' HB2' ' A' ' 50' ' ' SER . 20.5 Cg_endo -61.02 140.76 91.7 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.116 1.877 . . . . 75.209999999999994 112.083 174.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.642 ' HG3' ' HD3' ' A' ' 73' ' ' ARG . 33.0 tt0 -43.52 -39.35 3.35 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.696 0.628 . . . . 73.400000000000006 112.696 -174.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -123.24 55.64 0.68 Allowed Glycine 0 CA--C 1.529 0.942 0 C-N-CA 121.098 -0.572 . . . . 74.340000000000003 113.491 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.518 ' HB2' ' HG2' ' A' ' 47' ' ' PRO . 37.8 t -63.5 168.2 4.86 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.427 0.632 . . . . 74.120000000000005 112.641 177.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -65.47 -32.66 74.39 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.309 0.576 . . . . 75.239999999999995 110.181 173.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.527 HD13 ' HD2' ' A' ' 53' ' ' PRO . 30.7 tp -84.48 127.04 67.49 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 115.641 -0.709 . . . . 75.319999999999993 110.894 177.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.527 ' HD2' HD13 ' A' ' 52' ' ' LEU . 61.5 Cg_endo -73.67 95.65 0.89 Allowed 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 121.396 1.398 . . . . 65.129999999999995 111.656 174.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.471 ' HB2' ' HB3' ' A' ' 43' ' ' LEU . 65.2 p-90 -79.52 -31.55 42.17 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.188 0.518 . . . . 74.340000000000003 111.891 -176.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.411 ' O ' HD21 ' A' ' 78' ' ' LEU . 27.3 p90 -63.6 -19.87 65.2 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.244 0.831 . . . . 71.230000000000004 113.244 -176.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.404 ' NH1' ' O ' ' A' ' 15' ' ' ILE . 98.5 mtt180 -77.76 2.07 18.14 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.497 0.554 . . . . 75.439999999999998 112.497 -177.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.4 t -122.22 125.62 73.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 O-C-N 121.9 -0.5 . . . . 74.430000000000007 111.426 179.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.633 HD12 HD22 ' A' ' 93' ' ' LEU . 33.8 pt -125.46 -171.39 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 120.978 0.418 . . . . 75.299999999999997 111.646 -179.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.8 p30 -73.03 171.65 12.48 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.243 0.544 . . . . 74.120000000000005 112.23 -179.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 46.6 p -79.69 8.52 6.46 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.074 0.464 . . . . 65.109999999999999 112.128 -179.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -95.64 -46.44 6.62 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.358 0.599 . . . . 74.140000000000001 110.944 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 121.33 32.38 1.06 Allowed Glycine 0 CA--C 1.522 0.475 0 CA-C-N 115.766 -0.652 . . . . 54.32 112.159 -175.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -138.67 163.14 32.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.092 0.472 . . . . 74.140000000000001 111.387 -177.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.48 HG21 ' OE1' ' A' ' 74' ' ' GLN . 65.3 mt -67.81 122.08 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 115.968 -0.56 . . . . 54.409999999999997 110.605 175.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.5 m -63.89 -41.83 97.61 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.166 0.508 . . . . 65.099999999999994 111.464 -178.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.484 HD13 ' HB3' ' A' ' 70' ' ' ASP . 86.6 mt -74.15 161.33 30.1 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.788 -0.642 . . . . 75.109999999999999 111.813 -178.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -130.18 177.11 7.55 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.8 0.333 . . . . 72.340000000000003 111.429 -178.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 57.38 -126.55 42.46 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 121.36 -0.447 . . . . 70.319999999999993 113.106 178.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 38.7 mtp180 -74.54 -32.13 62.35 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.171 0.51 . . . . 74.129999999999995 110.714 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.484 ' HB3' HD13 ' A' ' 66' ' ' LEU . 2.6 m-20 -60.02 -32.47 70.91 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.892 -0.595 . . . . 62.520000000000003 110.676 177.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.9 tt -63.28 -57.05 11.71 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.027 -0.533 . . . . 64.340000000000003 110.212 176.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -55.58 -36.87 67.35 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.902 0.382 . . . . 74.129999999999995 111.462 176.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.642 ' HD3' ' HG3' ' A' ' 48' ' ' GLU . 39.8 ttm180 -59.22 -58.87 6.71 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 116.383 -0.371 . . . . 73.219999999999999 111.65 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.48 ' OE1' HG21 ' A' ' 64' ' ' ILE . 53.6 tt0 -61.66 -41.01 96.94 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.708 0.289 . . . . 73.099999999999994 111.132 177.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -54.88 -58.67 6.66 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.259 -0.428 . . . . 75.439999999999998 111.72 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -52.9 -45.65 67.64 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.079 0.4 . . . . 75.310000000000002 112.079 -178.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -61.46 -30.53 70.65 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.853 0.359 . . . . 75.430000000000007 111.936 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.411 HD21 ' O ' ' A' ' 55' ' ' PHE . 94.8 mt -78.0 -42.08 33.84 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.046 0.45 . . . . 74.519999999999996 111.13 174.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -57.4 -39.4 76.02 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.913 0.387 . . . . 64.430000000000007 111.057 177.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.23 -24.39 63.13 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.119 -0.491 . . . . 73.430000000000007 111.929 178.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -95.38 -1.37 51.22 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 111.831 0.308 . . . . 73.510000000000005 111.831 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.24 12.89 44.05 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.512 -0.375 . . . . 75.340000000000003 113.689 177.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.418 ' HA ' ' CE1' ' A' ' 96' ' ' TYR . 66.6 mt -88.59 109.57 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 122.477 -0.425 . . . . 72.0 111.547 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -73.39 100.66 3.26 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.982 0.42 . . . . 75.329999999999998 111.465 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 58.2 t -92.41 130.45 41.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 120.901 0.381 . . . . 62.329999999999998 111.593 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.58 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 31.0 t -69.73 155.99 39.68 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.515 -0.311 . . . . 75.540000000000006 111.573 177.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.494 ' HG3' HG21 ' A' ' 88' ' ' ILE . 15.3 pt-20 -46.05 -49.84 15.85 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.034 1.124 . . . . 74.140000000000001 114.034 -169.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.494 HG21 ' HG3' ' A' ' 87' ' ' GLU . 2.9 pp -81.34 13.85 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 121.216 0.531 . . . . 74.420000000000002 112.326 -176.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.57 50.03 5.19 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 121.335 -0.459 . . . . 73.400000000000006 112.894 -178.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.58 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 14.4 tmtt? -117.27 129.63 56.03 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 122.326 -0.514 . . . . 73.540000000000006 111.197 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.495 HD12 HD13 ' A' ' 58' ' ' ILE . 60.6 mt -116.35 148.26 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.173 -0.467 . . . . 73.430000000000007 111.462 -177.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.32 99.96 8.16 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.886 0.374 . . . . 72.120000000000005 111.682 177.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.633 HD22 HD12 ' A' ' 58' ' ' ILE . 25.3 mt -69.64 -1.35 8.7 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.112 0.782 . . . . 74.150000000000006 113.112 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -98.05 -52.7 3.61 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.074 0.464 . . . . 74.150000000000006 111.181 173.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -69.28 -29.75 67.7 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.224 -0.444 . . . . 74.140000000000001 112.101 -177.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.418 ' CE1' ' HA ' ' A' ' 83' ' ' ILE . 90.5 m-85 -114.09 13.65 18.15 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 111.796 0.295 . . . . 75.409999999999997 111.796 -176.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.543 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 83.8 tttt -60.85 131.38 50.51 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 111.827 0.306 . . . . 74.530000000000001 111.827 -176.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 19.2 t90 -58.64 105.59 0.32 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.641 0.734 . . . . 74.5 111.151 176.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -113.45 95.29 35.5 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 115.348 -0.842 . . . . 74.0 110.723 177.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.39 1.86 5.71 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.511 2.141 . . . . 71.150000000000006 112.524 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 38.4 mt -99.24 -40.23 8.05 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.295 -0.411 . . . . 72.400000000000006 111.251 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 . . . . . 0 C--O 1.257 1.457 0 CA-C-O 118.855 -0.593 . . . . 72.450000000000003 111.772 -175.984 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.457 ' O ' HG23 ' A' ' 6' ' ' VAL . 3.8 m-20 . . . . . 0 N--CA 1.469 0.504 0 N-CA-C 112.42 0.526 . . . . 70.510000000000005 112.42 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.527 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 6.4 tp-100 -52.97 -44.27 67.03 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.416 -0.357 . . . . 73.140000000000001 111.655 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -54.74 -50.72 67.7 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.095 0.474 . . . . 72.510000000000005 111.069 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.1 mt -61.11 -42.24 98.17 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.942 -0.572 . . . . 60.149999999999999 111.322 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 2' ' ' ASP . 64.8 t -59.51 -41.58 85.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.007 0.432 . . . . 74.120000000000005 111.35 177.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.527 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 15.0 mm100 -66.29 -54.31 26.4 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.345 -0.388 . . . . 73.439999999999998 111.896 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.497 HG21 HG22 ' A' ' 39' ' ' VAL . 37.2 pt -63.31 -43.86 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 111.746 0.276 . . . . 64.340000000000003 111.746 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 12.5 m-30 -60.67 -45.23 94.92 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.742 0.306 . . . . 75.150000000000006 111.147 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.432 ' O ' ' NE2' ' A' ' 14' ' ' GLN . . . -52.36 -43.86 64.9 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.365 -0.379 . . . . 72.209999999999994 111.226 177.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 93.5 t -64.46 -47.14 90.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.339 -0.391 . . . . 61.509999999999998 111.356 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 8' ' ' ILE . 79.7 mt -55.69 -33.98 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 116.084 -0.507 . . . . 60.109999999999999 112.303 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 74.9 m-70 -61.21 -16.15 41.97 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 112.702 0.63 . . . . 71.030000000000001 112.702 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.432 ' NE2' ' O ' ' A' ' 10' ' ' ALA . 1.0 OUTLIER -82.88 -7.3 59.67 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.073 0.397 . . . . 70.200000000000003 112.073 177.925 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.434 HG21 ' HB3' ' A' ' 56' ' ' ARG . 56.1 mt -80.46 116.48 62.15 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 122.421 -0.174 . . . . 72.230000000000004 111.203 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -69.94 170.2 17.35 Favored 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 123.062 2.508 . . . . 72.25 113.764 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.9 tttp -65.79 121.0 14.03 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.078 -0.51 . . . . 55.020000000000003 111.362 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.27 17.59 45.91 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 121.017 -0.611 . . . . 73.510000000000005 113.901 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -119.94 146.28 45.96 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 117.103 0.451 . . . . 71.299999999999997 111.389 176.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 56' ' ' ARG . 34.6 m -130.0 140.24 49.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.142 0.496 . . . . 44.210000000000001 111.307 177.27 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 83.9 p -122.47 170.27 10.14 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.842 0.354 . . . . 74.25 111.1 177.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 44.4 p -95.83 147.5 23.58 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.005 0.431 . . . . 65.150000000000006 111.487 178.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -52.91 -32.9 47.85 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 116.289 -0.414 . . . . 71.430000000000007 111.993 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.78 -44.02 95.37 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 121.094 -0.574 . . . . 73.409999999999997 112.965 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 29' ' ' MET . 46.7 mt-10 -64.59 -44.9 89.18 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.811 0.338 . . . . 73.140000000000001 111.347 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.408 HD11 HD11 ' A' ' 15' ' ' ILE . 47.2 mm -60.58 -50.01 82.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 120.809 0.338 . . . . 62.409999999999997 111.307 177.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.5 -43.84 84.49 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.96 0.41 . . . . 71.230000000000004 111.517 177.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -59.21 -48.2 82.49 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.174 -0.466 . . . . 63.439999999999998 111.298 178.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.431 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 63.1 mtt -65.95 -28.75 69.15 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.878 0.371 . . . . 72.129999999999995 111.621 178.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.35 -20.55 51.1 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.928 0.394 . . . . 65.439999999999998 111.573 177.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.87 22.41 28.22 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.199 -0.524 . . . . 41.240000000000002 113.459 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -124.94 81.82 61.89 Favored Pre-proline 0 CA--C 1.543 0.68 0 O-C-N 122.393 -0.474 . . . . 74.430000000000007 111.79 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.62 131.72 37.03 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.732 2.288 . . . . 64.239999999999995 112.658 177.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.95 -8.46 79.77 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.014 -0.613 . . . . 63.439999999999998 113.649 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -89.68 22.6 2.99 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.482 0.549 . . . . 63.530000000000001 112.482 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.36 -57.58 11.24 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.012 0.434 . . . . 72.310000000000002 112.167 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 46.6 ttp180 -58.66 -32.3 68.97 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.008 0.433 . . . . 71.450000000000003 111.552 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.587 ' HA ' ' HE2' ' A' ' 41' ' ' LYS . 76.7 m80 -65.2 -41.28 94.67 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.35 -0.386 . . . . 53.340000000000003 111.284 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.497 HG22 HG21 ' A' ' 8' ' ' ILE . 53.6 t -58.43 -37.95 67.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.264 0.554 . . . . 64.230000000000004 110.171 172.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.79 -37.66 95.01 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 115.808 -0.633 . . . . 33.109999999999999 112.999 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.587 ' HE2' ' HA ' ' A' ' 38' ' ' HIS . 41.1 mtmt -62.75 -47.27 84.26 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.006 0.431 . . . . 74.209999999999994 110.476 176.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.07 -51.42 66.41 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.869 -0.605 . . . . 72.409999999999997 111.921 -178.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.5 mt -63.56 -43.35 97.31 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.297 -0.41 . . . . 72.420000000000002 111.459 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.11 -22.72 72.69 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 120.853 -0.689 . . . . 61.509999999999998 112.884 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -79.85 -21.08 44.56 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.995 0.426 . . . . 73.319999999999993 111.277 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 91.6 mt -75.77 155.39 85.08 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 116.444 -0.344 . . . . 53.530000000000001 111.897 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.57 164.87 19.51 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.46 2.107 . . . . 64.219999999999999 112.192 174.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.503 ' HA ' ' HE ' ' A' ' 73' ' ' ARG . 0.8 OUTLIER -64.91 -26.57 68.37 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.211 0.448 . . . . 74.150000000000006 112.211 -175.203 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -131.88 64.38 0.61 Allowed Glycine 0 CA--C 1.528 0.857 0 C-N-CA 121.094 -0.574 . . . . 71.310000000000002 113.325 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.6 t -79.72 172.77 13.34 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.182 0.515 . . . . 72.420000000000002 111.772 178.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? -67.79 -28.94 68.03 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.17 -0.468 . . . . 61.520000000000003 110.78 174.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.529 HD12 ' HD2' ' A' ' 53' ' ' PRO . 33.0 tp -86.71 124.8 68.74 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 116.017 -0.538 . . . . 63.5 111.02 177.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.529 ' HD2' HD12 ' A' ' 52' ' ' LEU . 38.0 Cg_endo -67.19 95.08 0.36 Allowed 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 121.285 1.324 . . . . 52.509999999999998 111.386 173.115 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.417 ' HH2' ' HG2' ' A' ' 73' ' ' ARG . 65.9 p-90 -82.51 -30.49 29.78 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.685 -0.689 . . . . 74.430000000000007 111.716 -177.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.462 ' O ' HD21 ' A' ' 78' ' ' LEU . 11.9 p90 -67.32 -11.53 57.85 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.335 0.865 . . . . 74.5 113.335 -175.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.459 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 94.2 mtt180 -86.27 8.08 22.73 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.024 0.75 . . . . 72.519999999999996 113.024 -174.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 20.9 t -127.86 116.23 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 O-C-N 121.81 -0.556 . . . . 64.239999999999995 111.652 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.457 HG21 HD12 ' A' ' 91' ' ' ILE . 28.0 pt -118.98 -174.52 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 116.472 -0.331 . . . . 75.040000000000006 111.376 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 35.4 p30 -83.78 168.75 15.89 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.139 0.495 . . . . 74.409999999999997 111.906 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.1 t -67.93 -9.24 43.5 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.234 -0.439 . . . . 61.450000000000003 111.951 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -88.14 0.69 55.73 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.619 -0.264 . . . . 73.5 111.53 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.41 42.59 89.36 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 121.015 -0.612 . . . . 41.200000000000003 112.396 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -141.15 157.32 45.44 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.096 0.474 . . . . 74.010000000000005 111.378 -176.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 63.8 mt -73.34 128.07 35.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 116.258 -0.428 . . . . 72.340000000000003 111.001 177.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.9 p -74.29 -31.04 62.35 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 120.973 0.416 . . . . 71.430000000000007 111.408 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.47 HD13 ' HB3' ' A' ' 70' ' ' ASP . 92.5 mt -74.91 152.51 38.85 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.171 -0.468 . . . . 53.329999999999998 111.09 177.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -129.45 171.4 12.59 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.017 0.436 . . . . 72.109999999999999 111.973 -176.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 57.58 -128.75 48.23 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 116.24 -0.436 . . . . 64.540000000000006 113.327 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -61.71 -39.41 91.4 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 122.586 -0.361 . . . . 74.219999999999999 111.339 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.47 ' HB3' HD13 ' A' ' 66' ' ' LEU . 19.7 m-20 -65.43 -25.9 67.73 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.026 0.38 . . . . 62.420000000000002 112.026 -178.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.8 tt -64.11 -55.92 18.55 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.881 -0.414 . . . . 71.239999999999995 109.881 174.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.579 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 33.0 t70 -65.99 -27.04 67.84 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.997 0.427 . . . . 73.040000000000006 111.219 177.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.503 ' HE ' ' HA ' ' A' ' 48' ' ' GLU . 51.9 ttt180 -57.44 -55.11 39.06 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.245 0.545 . . . . 72.409999999999997 110.878 173.276 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -64.84 -41.95 95.31 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.129 0.49 . . . . 74.049999999999997 110.562 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.579 ' HB3' ' HA ' ' A' ' 72' ' ' ASP . 32.0 tttm -54.81 -55.14 33.35 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.67 -0.696 . . . . 71.109999999999999 112.37 178.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -58.74 -36.96 75.17 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.932 0.396 . . . . 61.350000000000001 111.499 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.485 ' HE2' ' O ' ' A' ' 48' ' ' GLU . 45.3 mmtm -64.16 -42.44 96.74 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.923 0.392 . . . . 64.439999999999998 111.224 174.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.512 HD22 HD12 ' A' ' 83' ' ' ILE . 95.9 mt -68.99 -31.89 71.05 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.916 0.389 . . . . 73.549999999999997 111.631 178.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 46.6 mt-10 -65.81 -30.54 71.19 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.886 0.374 . . . . 72.109999999999999 110.516 175.082 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.26 -11.86 60.16 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.321 0.581 . . . . 74.010000000000005 111.12 173.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -97.82 -11.31 23.44 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.917 -0.583 . . . . 62.329999999999998 111.137 176.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.91 50.4 5.22 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.494 -0.384 . . . . 74.200000000000003 113.098 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.512 HD12 HD22 ' A' ' 78' ' ' LEU . 71.4 mt -119.97 129.54 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 O-C-N 122.682 -0.305 . . . . 70.420000000000002 111.248 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -75.64 91.52 2.88 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.347 0.594 . . . . 74.0 111.438 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.2 t -96.68 121.1 46.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.624 -0.716 . . . . 73.040000000000006 110.837 177.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.595 ' OG ' ' HB3' ' A' ' 90' ' ' LYS . 6.3 p -72.91 151.27 41.98 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 122.331 -0.23 . . . . 71.099999999999994 110.644 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -42.36 -44.7 4.03 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.584 1.327 . . . . 53.109999999999999 114.584 -173.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.482 HD11 ' HB2' ' A' ' 90' ' ' LYS . 2.9 pp -81.1 9.53 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 112.461 0.541 . . . . 61.340000000000003 112.461 -176.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.57 45.59 5.75 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 121.622 -0.323 . . . . 54.420000000000002 113.624 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.595 ' HB3' ' OG ' ' A' ' 86' ' ' SER . 1.2 tmtp? -114.35 132.84 56.06 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-O 121.009 0.433 . . . . 74.409999999999997 111.425 -178.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.457 HD12 HG21 ' A' ' 58' ' ' ILE . 60.0 mt -127.08 138.8 53.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 116.152 -0.476 . . . . 64.549999999999997 111.426 -178.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.29 93.93 6.01 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.947 0.403 . . . . 71.040000000000006 111.838 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.552 ' O ' ' HG3' ' A' ' 97' ' ' LYS . 38.5 mt -53.79 -52.33 60.62 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.09 0.404 . . . . 75.109999999999999 112.09 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -52.82 -14.07 0.5 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.296 0.85 . . . . 73.400000000000006 113.296 -174.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -112.98 -33.91 5.9 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 122.03 -0.419 . . . . 74.400000000000006 112.068 175.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -99.33 0.32 42.67 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.808 1.04 . . . . 63.119999999999997 113.808 -173.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 93' ' ' LEU . 33.0 mtpt -57.18 138.18 54.94 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.213 0.53 . . . . 74.340000000000003 112.22 -178.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 16.3 t90 -64.96 105.26 0.99 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.692 -0.686 . . . . 60.5 111.268 175.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -112.09 99.53 46.29 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 116.1 -0.5 . . . . 74.400000000000006 110.653 175.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 CA--C 1.548 1.188 0 C-N-CA 122.948 2.432 . . . . 71.25 113.596 178.24 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 . . . . . 0 CA--C 1.536 0.43 0 CA-C-O 120.877 0.37 . . . . 55.409999999999997 111.354 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.566 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 52.5 tp60 -60.49 -33.21 72.28 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.385 -0.37 . . . . 63.130000000000003 111.236 -178.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -51.49 -49.69 61.34 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.265 0.555 . . . . 73.040000000000006 110.906 175.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.7 mt -61.67 -45.0 95.9 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.695 -0.684 . . . . 72.140000000000001 111.016 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.1 t -56.45 -41.11 71.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 120.958 0.409 . . . . 61.219999999999999 111.349 177.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 13.6 mm100 -65.33 -58.94 4.66 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.316 -0.402 . . . . 74.519999999999996 111.758 -178.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.457 HG21 HG22 ' A' ' 39' ' ' VAL . 33.4 pt -61.02 -42.41 92.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 111.751 0.278 . . . . 72.200000000000003 111.751 -178.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -58.53 -49.78 76.17 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.794 0.331 . . . . 64.239999999999995 111.106 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.2 -39.94 67.12 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.326 -0.397 . . . . 70.299999999999997 111.916 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 7' ' ' GLN . 78.6 t -66.65 -42.5 89.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.058 0.456 . . . . 74.530000000000001 111.243 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.557 ' HB ' HD11 ' A' ' 52' ' ' LEU . 80.5 mt -61.85 -31.87 52.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 116.202 -0.453 . . . . 45.210000000000001 112.014 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -62.15 -15.44 45.92 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.312 0.486 . . . . 74.099999999999994 112.312 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -86.74 -5.85 59.0 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.471 0.545 . . . . 70.420000000000002 112.471 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.487 HD11 HD11 ' A' ' 26' ' ' ILE . 58.0 mt -81.21 117.96 70.32 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-O 120.677 0.275 . . . . 62.109999999999999 111.5 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.6 160.03 38.58 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.5 2.133 . . . . 72.209999999999994 113.082 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -62.9 131.03 47.37 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.318 -0.401 . . . . 53.140000000000001 111.359 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.89 2.04 61.3 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 120.88 -0.676 . . . . 73.030000000000001 113.55 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -122.13 148.31 45.06 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.075 0.464 . . . . 65.230000000000004 111.62 176.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.6 m -125.4 147.53 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-O 121.309 0.576 . . . . 64.0 111.374 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 44.4 t -123.2 174.51 7.23 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.199 -0.455 . . . . 73.239999999999995 110.355 175.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 67.6 p -105.82 147.44 28.66 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.598 0.237 . . . . 71.329999999999998 111.408 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -50.55 -36.75 35.86 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.129 0.49 . . . . 71.540000000000006 110.697 175.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.47 -48.0 85.24 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 115.735 -0.666 . . . . 52.439999999999998 113.243 177.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.438 ' O ' ' HG3' ' A' ' 29' ' ' MET . 44.3 mt-10 -64.81 -48.41 74.52 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 117.073 0.437 . . . . 74.200000000000003 111.893 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.487 HD11 HD11 ' A' ' 15' ' ' ILE . 49.0 mm -55.53 -49.4 73.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 121.085 0.469 . . . . 74.120000000000005 111.052 177.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.504 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -62.99 -42.76 99.93 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.213 -0.449 . . . . 35.299999999999997 111.488 177.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -59.82 -42.56 93.76 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.985 0.421 . . . . 73.129999999999995 111.431 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.438 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 66.0 mtt -70.07 -34.87 73.74 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.0 0.429 . . . . 64.150000000000006 111.044 178.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.28 -30.68 66.57 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.132 -0.485 . . . . 74.219999999999999 111.672 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.39 13.73 14.41 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.512 -0.375 . . . . 74.540000000000006 113.355 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.542 ' HB3' ' HB2' ' A' ' 35' ' ' TYR . 52.2 m-85 -128.55 63.1 63.37 Favored Pre-proline 0 CA--C 1.548 0.898 0 O-C-N 122.556 -0.379 . . . . 73.450000000000003 111.766 -178.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -55.96 -43.08 60.26 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.646 2.23 . . . . 60.25 113.408 -175.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.04 -22.66 78.73 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.186 -0.53 . . . . 70.329999999999998 113.116 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.542 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 90.2 m-85 -86.23 6.67 28.5 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 111.962 0.356 . . . . 74.340000000000003 111.962 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.47 -36.18 32.44 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.244 0.545 . . . . 44.210000000000001 111.407 177.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.472 ' O ' ' HG3' ' A' ' 41' ' ' LYS . 14.8 ptp180 -55.41 -43.55 75.37 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.848 -0.615 . . . . 74.219999999999999 111.416 175.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -72.55 -30.3 64.32 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.334 -0.394 . . . . 73.540000000000006 111.443 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.457 HG22 HG21 ' A' ' 8' ' ' ILE . 58.5 t -57.74 -52.28 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 120.899 0.38 . . . . 63.420000000000002 110.569 175.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.16 -37.72 93.33 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.081 -0.58 . . . . 63.509999999999998 113.039 176.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 37' ' ' ARG . 28.2 mtpp -65.05 -44.14 89.99 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 122.515 -0.403 . . . . 65.450000000000003 111.192 177.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.47 -52.36 61.7 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.437 -0.347 . . . . 75.129999999999995 111.788 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.433 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 88.9 mt -56.92 -34.46 67.99 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.873 0.368 . . . . 72.310000000000002 111.592 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.98 -8.15 33.81 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 121.397 -0.43 . . . . 73.329999999999998 114.077 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -93.41 -12.63 29.39 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 117.379 0.589 . . . . 54.299999999999997 112.108 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.556 HD12 ' HB3' ' A' ' 54' ' ' TRP . 94.1 mt -74.02 143.68 81.11 Favored Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 112.189 0.441 . . . . 75.230000000000004 112.189 -175.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.25 177.51 6.52 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 122.898 2.398 . . . . 74.140000000000001 114.094 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -57.79 -45.66 85.7 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.542 -0.754 . . . . 73.209999999999994 111.736 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -114.75 56.17 0.51 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.3 -0.476 . . . . 34.229999999999997 112.897 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.4 t -66.9 159.35 28.53 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.266 0.469 . . . . 73.310000000000002 112.266 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -71.44 -11.18 60.75 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.168 0.508 . . . . 71.420000000000002 111.148 175.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.557 HD11 ' HB ' ' A' ' 12' ' ' ILE . 42.0 tp -117.59 124.26 29.07 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 115.849 -0.614 . . . . 75.420000000000002 110.713 177.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.536 ' HD2' HD12 ' A' ' 52' ' ' LEU . 58.6 Cg_endo -72.3 95.26 0.76 Allowed 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 121.364 1.376 . . . . 71.349999999999994 112.115 176.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.556 ' HB3' HD12 ' A' ' 46' ' ' LEU . 65.7 p-90 -83.5 -32.43 25.96 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.176 0.513 . . . . 74.310000000000002 111.89 -177.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -56.7 -24.81 51.74 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.227 0.825 . . . . 65.120000000000005 113.227 -177.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -77.85 2.43 17.28 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.444 0.535 . . . . 72.340000000000003 112.444 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 18.8 t -115.59 107.87 23.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.239 0.542 . . . . 52.329999999999998 111.479 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.518 HG21 HD12 ' A' ' 91' ' ' ILE . 33.7 pt -108.89 -169.73 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 116.164 -0.471 . . . . 65.549999999999997 111.339 178.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.59 ' HB3' ' OG ' ' A' ' 65' ' ' SER . 30.9 p30 -93.44 171.79 8.68 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.737 0.643 . . . . 64.340000000000003 112.737 -175.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 48.2 t -72.03 -8.08 52.47 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.88 -0.6 . . . . 73.400000000000006 111.712 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -84.59 -6.37 59.36 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.496 -0.32 . . . . 74.0 111.502 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.05 31.94 54.08 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 121.006 -0.616 . . . . 45.240000000000002 112.084 -174.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.489 ' HB3' ' NZ ' ' A' ' 63' ' ' LYS . 9.5 mtpm? -139.93 173.27 11.69 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.534 0.683 . . . . 53.340000000000003 112.02 -176.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.483 HG23 ' OE1' ' A' ' 74' ' ' GLN . 73.8 mt -86.45 116.12 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.415 -0.812 . . . . 53.329999999999998 110.469 173.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.59 ' OG ' ' HB3' ' A' ' 59' ' ' ASN . 58.0 m -71.62 -31.92 67.43 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.055 0.391 . . . . 71.109999999999999 112.055 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 81.9 mt -72.56 121.94 20.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.038 0.447 . . . . 63.539999999999999 111.594 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -115.16 159.56 20.77 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.02 0.438 . . . . 54.240000000000002 111.042 177.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.36 -141.59 15.65 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.95 -0.643 . . . . 71.439999999999998 111.689 -172.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 69' ' ' ARG . 67.7 mtt-85 -72.45 -22.69 61.05 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 117.624 0.712 . . . . 73.150000000000006 110.782 177.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.562 ' HA ' ' HD2' ' A' ' 73' ' ' ARG . 23.3 m-20 -67.72 -23.3 65.26 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.017 -0.538 . . . . 64.099999999999994 111.561 177.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.4 tt -67.22 -56.07 11.43 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.87 0.366 . . . . 73.150000000000006 110.452 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.19 -27.79 68.94 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.536 -0.302 . . . . 73.239999999999995 111.802 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.562 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 97.5 mtt180 -57.33 -62.02 2.06 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.906 0.384 . . . . 50.409999999999997 111.223 172.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.483 ' OE1' HG23 ' A' ' 64' ' ' ILE . 55.5 tt0 -63.88 -40.69 97.11 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.315 -0.402 . . . . 73.219999999999999 111.584 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.455 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 58.9 tttm -57.58 -61.91 2.16 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 111.917 0.34 . . . . 74.329999999999998 111.917 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -57.59 -37.93 74.02 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 111.959 0.355 . . . . 73.450000000000003 111.959 -176.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -55.4 -49.34 72.6 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.023 0.44 . . . . 73.510000000000005 111.533 176.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.8 mt -70.02 -40.16 75.38 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.052 0.454 . . . . 71.540000000000006 111.265 -177.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 45.0 mt-10 -61.76 -35.21 77.44 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.996 0.427 . . . . 71.549999999999997 110.767 176.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.26 -31.99 71.8 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.294 -0.412 . . . . 43.149999999999999 111.486 176.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -81.49 -9.95 59.59 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.67 0.271 . . . . 71.030000000000001 111.679 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.86 27.28 8.45 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 121.346 -0.454 . . . . 72.010000000000005 113.386 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 68.4 mt -98.34 130.78 46.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 120.91 0.386 . . . . 71.150000000000006 111.83 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.414 ' HG3' ' OH ' ' A' ' 96' ' ' TYR . 45.0 mt-10 -67.62 118.6 11.12 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.447 -0.342 . . . . 70.310000000000002 111.243 175.033 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.9 t -128.57 109.5 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 120.785 0.326 . . . . 74.349999999999994 110.85 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.653 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 40.9 m -61.7 147.05 47.26 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.524 -0.307 . . . . 74.239999999999995 111.184 177.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.419 ' HG3' HG23 ' A' ' 88' ' ' ILE . 15.3 pt-20 -45.38 -44.65 12.04 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.952 1.093 . . . . 75.329999999999998 113.952 -170.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.419 HG23 ' HG3' ' A' ' 87' ' ' GLU . 2.8 pp -80.45 14.27 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 112.404 0.52 . . . . 74.310000000000002 112.404 -177.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.15 57.49 3.18 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 121.432 -0.413 . . . . 53.240000000000002 112.984 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.653 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 62.1 tttm -125.8 127.09 45.58 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 120.703 0.287 . . . . 71.439999999999998 111.334 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.518 HD12 HG21 ' A' ' 58' ' ' ILE . 56.0 mt -126.26 152.16 33.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-O 120.903 0.382 . . . . 74.230000000000004 111.469 -175.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -84.02 99.52 10.48 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.274 0.472 . . . . 73.010000000000005 112.274 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.568 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 23.4 mt -70.7 -1.61 11.92 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.041 0.756 . . . . 60.119999999999997 113.041 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 53.3 mtp85 -96.99 -42.03 8.1 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 122.067 -0.396 . . . . 73.129999999999995 111.302 173.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -76.66 -37.39 56.31 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.101 0.408 . . . . 74.129999999999995 112.101 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.414 ' OH ' ' HG3' ' A' ' 84' ' ' GLU . 84.6 m-85 -109.82 14.2 23.3 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.461 0.541 . . . . 73.519999999999996 112.461 -171.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.568 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 59.2 tttp -62.37 132.71 53.51 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 120.999 0.428 . . . . 64.140000000000001 111.613 -177.317 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 23.0 t90 -69.51 109.52 4.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.235 0.54 . . . . 72.099999999999994 111.568 176.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -115.23 98.09 49.7 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 115.713 -0.676 . . . . 53.509999999999998 110.758 174.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo . . . . . 0 CA--C 1.541 0.86 0 C-N-CA 122.629 2.219 . . . . 65.450000000000003 112.473 173.455 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.558 ' HB2' ' HG ' ' A' ' 5' ' ' LEU . 5.6 m-20 . . . . . 0 CA--C 1.536 0.437 0 CA-C-O 120.648 0.261 . . . . 62.119999999999997 111.438 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.437 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 14.3 mm100 -60.15 -25.9 65.87 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.625 0.25 . . . . 63.310000000000002 110.993 175.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -53.57 -50.66 65.08 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.171 0.51 . . . . 74.439999999999998 110.336 170.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.558 ' HG ' ' HB2' ' A' ' 2' ' ' ASP . 65.0 mt -62.39 -45.76 91.66 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.769 -0.65 . . . . 74.430000000000007 110.788 177.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.4 t -56.7 -43.56 79.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 116.018 -0.537 . . . . 65.439999999999998 111.797 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 30.2 mm-40 -68.27 -52.0 38.82 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.044 0.387 . . . . 63.310000000000002 112.044 -178.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.485 HG21 HG22 ' A' ' 39' ' ' VAL . 32.2 pt -59.6 -41.79 86.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 121.065 -0.254 . . . . 73.120000000000005 111.325 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -63.91 -44.21 93.63 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.124 0.488 . . . . 51.109999999999999 110.71 175.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.423 ' O ' ' NE2' ' A' ' 14' ' ' GLN . . . -56.5 -32.23 64.83 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.914 -0.585 . . . . 73.030000000000001 111.819 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 7' ' ' GLN . 88.3 t -73.35 -47.04 47.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.97 0.414 . . . . 60.43 111.492 176.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.592 ' HB ' HD11 ' A' ' 52' ' ' LEU . 80.9 mt -58.6 -31.69 44.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 112.888 0.699 . . . . 73.200000000000003 112.888 -175.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -60.7 -11.33 7.1 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 112.663 0.616 . . . . 75.420000000000002 112.663 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.423 ' NE2' ' O ' ' A' ' 10' ' ' ALA . 1.6 mp0 -92.23 -2.17 56.65 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.217 0.451 . . . . 72.120000000000005 112.217 178.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.511 HD11 HD11 ' A' ' 26' ' ' ILE . 53.7 mt -84.75 112.53 43.32 Favored Pre-proline 0 CA--C 1.541 0.634 0 O-C-N 122.221 -0.299 . . . . 64.019999999999996 110.591 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -72.37 165.4 32.79 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.471 2.114 . . . . 74.219999999999999 113.573 -177.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.472 ' HG3' ' OE1' ' A' ' 81' ' ' GLU . 61.5 tttm -59.73 133.35 56.02 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.861 -0.609 . . . . 72.109999999999999 112.08 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.96 -7.91 80.51 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-N 116.239 -0.437 . . . . 73.219999999999999 114.083 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -108.19 155.25 20.66 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 117.335 0.567 . . . . 74.5 112.034 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.5 m -134.17 159.26 42.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 115.965 -0.561 . . . . 74.439999999999998 111.468 178.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 44.6 t -139.24 175.28 9.69 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.948 0.404 . . . . 33.350000000000001 110.783 176.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.4 p -109.28 154.62 22.2 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.835 0.35 . . . . 64.219999999999999 111.551 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -52.92 -34.78 56.75 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.454 -0.339 . . . . 75.340000000000003 111.461 177.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.09 -51.32 54.07 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.334 -0.46 . . . . 63.219999999999999 112.86 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 29' ' ' MET . 41.3 mt-10 -58.93 -47.85 83.58 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.85 0.357 . . . . 73.349999999999994 111.257 178.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.511 HD11 HD11 ' A' ' 15' ' ' ILE . 49.7 mm -60.02 -47.63 91.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 116.42 -0.355 . . . . 70.150000000000006 111.579 178.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.23 -45.72 90.39 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.875 0.369 . . . . 73.299999999999997 111.907 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -61.96 -43.76 98.17 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.759 0.314 . . . . 74.409999999999997 111.453 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.425 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 64.8 mtt -67.06 -34.27 77.31 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.751 0.31 . . . . 75.540000000000006 111.248 178.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.74 -18.31 62.14 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.347 -0.388 . . . . 72.140000000000001 112.009 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.34 14.65 32.35 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 121.423 -0.418 . . . . 73.310000000000002 113.533 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -127.39 72.95 77.65 Favored Pre-proline 0 CA--C 1.541 0.632 0 O-C-N 122.38 -0.482 . . . . 62.530000000000001 111.276 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.21 97.34 0.84 Allowed 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.184 1.923 . . . . 65.219999999999999 112.969 -177.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 142.89 -35.25 1.72 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 120.803 -0.713 . . . . 74.319999999999993 113.258 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -84.06 34.57 0.51 Allowed 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.257 0.465 . . . . 74.310000000000002 112.257 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.77 -39.35 88.45 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.99 0.424 . . . . 72.219999999999999 111.676 -178.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.5 ttt85 -61.15 -29.33 69.72 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 116.363 -0.381 . . . . 75.549999999999997 111.525 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -76.65 -33.39 58.33 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.828 0.347 . . . . 75.439999999999998 110.705 177.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.485 HG22 HG21 ' A' ' 8' ' ' ILE . 47.3 t -58.46 -42.57 84.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 121.346 0.593 . . . . 61.109999999999999 109.706 170.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.97 -37.48 92.74 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 115.532 -0.758 . . . . 71.019999999999996 113.105 175.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -62.12 -44.52 96.46 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.017 0.437 . . . . 71.530000000000001 111.27 176.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.49 -55.21 25.89 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.099 0.476 . . . . 64.239999999999995 111.807 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.5 mt -65.64 -32.71 74.43 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.211 -0.45 . . . . 72.530000000000001 111.648 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.84 -15.77 62.82 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.322 -0.466 . . . . 73.099999999999994 113.18 177.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -89.59 -29.54 18.8 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 122.552 -0.381 . . . . 71.299999999999997 110.802 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 97.5 mt -61.8 112.19 5.74 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-O 120.988 0.423 . . . . 75.040000000000006 111.323 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -93.33 -170.1 0.24 Allowed 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.946 2.43 . . . . 65.530000000000001 114.597 -173.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -62.81 107.16 0.92 Allowed 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.206 -0.906 . . . . 62.219999999999999 111.171 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 128.11 -2.43 6.76 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 121.092 -0.575 . . . . 74.439999999999998 113.503 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.4 t -64.24 137.8 58.11 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.24 0.459 . . . . 75.420000000000002 112.24 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -68.9 -43.91 74.29 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.308 0.575 . . . . 75.340000000000003 110.618 175.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.592 HD11 ' HB ' ' A' ' 12' ' ' ILE . 35.9 tp -71.93 125.26 91.62 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.419 -0.809 . . . . 74.439999999999998 110.797 177.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.567 ' HD2' HD12 ' A' ' 52' ' ' LEU . 58.2 Cg_endo -71.98 94.95 0.73 Allowed 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 121.138 1.225 . . . . 75.0 111.757 176.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 60.9 p-90 -81.01 -30.95 34.84 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.754 -0.657 . . . . 71.329999999999998 111.338 -178.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -60.49 -16.82 40.61 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.649 0.611 . . . . 61.0 112.649 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.446 ' NH2' ' HA ' ' A' ' 17' ' ' LYS . 64.3 mtt-85 -78.3 -11.75 59.96 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.098 0.407 . . . . 75.319999999999993 112.098 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 22.7 t -111.71 120.21 61.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.278 0.561 . . . . 64.439999999999998 111.934 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.722 HD11 HD21 ' A' ' 93' ' ' LEU . 37.0 pt -120.48 -169.89 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 121.268 0.556 . . . . 63.130000000000003 111.731 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.9 p30 -89.78 172.65 8.76 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 121.221 0.534 . . . . 62.140000000000001 112.329 -176.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 63.4 p -72.27 -2.99 21.05 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 116.25 -0.432 . . . . 70.209999999999994 111.968 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -89.02 -12.0 42.61 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.969 0.414 . . . . 75.329999999999998 110.868 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.65 27.05 55.3 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.277 -0.487 . . . . 63.509999999999998 112.814 -177.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.522 ' HB3' ' NZ ' ' A' ' 63' ' ' LYS . 8.4 mtpm? -128.1 163.22 25.08 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.388 0.613 . . . . 70.239999999999995 112.324 -177.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.568 HG23 ' OE1' ' A' ' 74' ' ' GLN . 67.3 mt -71.39 116.4 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 115.428 -0.805 . . . . 73.099999999999994 109.728 170.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.1 m -75.17 -17.5 60.38 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.02 0.748 . . . . 75.219999999999999 113.02 -173.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 90.9 mt -77.23 176.33 8.86 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.107 0.48 . . . . 54.130000000000003 112.141 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.1 ptmm? -130.6 142.25 50.45 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.394 0.516 . . . . 73.140000000000001 112.394 -174.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 48.9 -124.26 12.26 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-N 115.947 -0.57 . . . . 61.43 114.076 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.463 ' HG3' ' H ' ' A' ' 69' ' ' ARG . 19.7 mtm180 -43.3 -53.68 5.07 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.805 0.812 . . . . 72.219999999999999 111.157 177.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.45 ' O ' ' HB2' ' A' ' 73' ' ' ARG . 4.3 m-20 -63.7 -34.1 77.11 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.784 -1.098 . . . . 72.420000000000002 111.507 -176.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.3 tt -63.72 -49.06 74.55 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 109.536 -0.542 . . . . 75.030000000000001 109.536 175.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.43 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 3.2 m-20 -63.88 -19.44 65.07 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.841 -0.618 . . . . 55.240000000000002 112.066 177.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.58 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 39.1 mmt180 -66.75 -59.49 3.52 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.034 0.445 . . . . 72.319999999999993 110.927 172.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.568 ' OE1' HG23 ' A' ' 64' ' ' ILE . 50.0 tt0 -58.99 -38.87 80.17 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.939 0.4 . . . . 74.109999999999999 110.225 177.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.514 ' HG3' HG11 ' A' ' 85' ' ' VAL . 81.2 tttt -59.66 -56.72 18.32 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.999 -0.546 . . . . 65.430000000000007 112.209 177.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.58 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 20.8 pt20 -54.27 -36.68 63.88 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 120.896 0.379 . . . . 74.310000000000002 111.64 -176.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -67.76 -49.38 62.8 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.945 0.403 . . . . 75.530000000000001 111.231 177.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 74' ' ' GLN . 64.8 mt -58.1 -45.36 87.35 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.241 -0.436 . . . . 73.219999999999999 111.375 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -62.9 -40.77 98.57 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.757 0.313 . . . . 73.25 110.976 177.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.03 -23.69 67.57 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.158 0.504 . . . . 62.039999999999999 111.216 175.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.472 ' OE1' ' HG3' ' A' ' 17' ' ' LYS . 42.1 mm-40 -80.43 -23.15 40.5 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.986 -0.552 . . . . 71.140000000000001 111.556 175.214 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.55 14.86 52.31 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 116.234 -0.439 . . . . 65.129999999999995 112.487 -174.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 76.9 mt -82.83 130.0 36.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 122.506 0.322 . . . . 63.509999999999998 111.007 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.412 ' HG3' ' OH ' ' A' ' 96' ' ' TYR . 51.6 mt-10 -66.95 92.83 0.24 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.314 0.578 . . . . 74.129999999999995 112.115 -177.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.514 HG11 ' HG3' ' A' ' 75' ' ' LYS . 61.2 t -90.49 113.89 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 115.897 -0.592 . . . . 73.030000000000001 110.91 174.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.542 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 39.6 t -66.23 142.1 57.82 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.502 -0.317 . . . . 74.349999999999994 111.034 174.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -42.37 -42.85 3.33 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.672 0.99 . . . . 65.329999999999998 113.672 -174.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.419 ' H ' HG13 ' A' ' 88' ' ' ILE . 2.8 pp -82.33 22.64 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 N-CA-C 112.481 0.548 . . . . 74.019999999999996 112.481 -178.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.24 57.97 7.06 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-N 116.428 -0.351 . . . . 52.240000000000002 113.36 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.542 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 84.2 tttt -132.28 149.91 52.27 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.769 0.319 . . . . 72.549999999999997 111.244 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.56 HD12 HD13 ' A' ' 58' ' ' ILE . 57.1 mt -125.16 150.49 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 120.861 0.362 . . . . 74.219999999999999 111.441 -177.041 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.9 92.68 7.85 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.804 0.335 . . . . 64.319999999999993 111.065 175.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.722 HD21 HD11 ' A' ' 58' ' ' ILE . 50.7 mt -59.25 -56.1 26.49 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.36 0.504 . . . . 75.109999999999999 112.36 -177.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 41.0 mtm-85 -56.16 -19.62 14.29 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.13 0.419 . . . . 70.010000000000005 112.13 -175.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -95.09 -29.0 14.81 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.491 -0.322 . . . . 51.32 111.796 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.412 ' OH ' ' HG3' ' A' ' 84' ' ' GLU . 91.8 m-85 -118.05 9.01 12.59 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.66 0.985 . . . . 74.219999999999999 113.66 -175.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.518 ' HG3' ' O ' ' A' ' 93' ' ' LEU . 24.9 mtpp -54.67 133.7 46.91 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 118.489 0.586 . . . . 71.329999999999998 112.142 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.409 ' HZ2' ' HB3' ' A' ' 14' ' ' GLN . 16.2 t90 -57.29 113.09 1.6 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.692 -0.685 . . . . 52.520000000000003 111.636 177.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 65.7 mt-30 -113.57 92.51 24.16 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 115.537 -0.756 . . . . 71.450000000000003 110.28 177.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo . . . . . 0 CA--C 1.54 0.82 0 C-N-CA 122.712 2.275 . . . . 70.5 114.078 -177.184 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.515 ' HB2' ' HG ' ' A' ' 5' ' ' LEU . 5.0 m-20 . . . . . 0 CA--C 1.543 0.709 0 N-CA-C 112.055 0.391 . . . . 73.099999999999994 112.055 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -58.32 -34.74 70.93 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.901 0.381 . . . . 64.299999999999997 110.314 173.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.435 ' O ' HG12 ' A' ' 8' ' ' ILE . 34.2 t80 -51.95 -49.97 62.13 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.786 -0.643 . . . . 74.209999999999994 111.174 174.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.515 ' HG ' ' HB2' ' A' ' 2' ' ' ASP . 84.3 mt -60.97 -52.11 66.41 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.01 -0.541 . . . . 75.239999999999995 111.064 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 40.0 t -55.85 -45.81 79.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 116.126 -0.488 . . . . 55.32 111.661 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.429 ' O ' HG23 ' A' ' 11' ' ' VAL . 26.8 mm-40 -63.36 -56.89 12.66 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.161 0.43 . . . . 73.299999999999997 112.161 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.514 ' O ' HG13 ' A' ' 12' ' ' ILE . 34.0 pt -58.44 -45.14 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 121.109 -0.237 . . . . 62.329999999999998 111.567 -178.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.402 ' N ' HG13 ' A' ' 8' ' ' ILE . 21.1 m-30 -60.64 -45.3 94.59 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.015 0.436 . . . . 71.120000000000005 111.016 178.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.1 -26.75 64.95 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.17 -0.468 . . . . 73.099999999999994 111.817 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 7' ' ' GLN . 99.2 t -80.99 -43.36 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-O 120.88 0.372 . . . . 73.430000000000007 111.213 176.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 8' ' ' ILE . 81.7 mt -54.91 -36.65 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 112.631 0.604 . . . . 73.409999999999997 112.631 -178.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -55.15 -19.43 7.69 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.895 0.702 . . . . 74.239999999999995 112.895 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -77.12 -23.36 51.77 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.561 0.578 . . . . 72.319999999999993 112.561 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.441 ' O ' ' NH1' ' A' ' 56' ' ' ARG . 38.9 mt -70.56 118.7 67.11 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 122.201 0.2 . . . . 74.239999999999995 111.495 -177.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -79.68 170.32 17.14 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 122.758 2.305 . . . . 61.439999999999998 114.005 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 49.7 tttp -64.02 135.41 56.42 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.992 -0.549 . . . . 64.140000000000001 111.294 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.438 ' H ' ' HB3' ' A' ' 81' ' ' GLU . . . 86.31 2.51 85.37 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.078 -0.582 . . . . 32.140000000000001 113.402 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.441 ' HB3' ' HA ' ' A' ' 98' ' ' TRP . 47.0 mmtm -118.23 145.44 45.0 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.103 0.478 . . . . 63.340000000000003 111.739 177.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.435 HG13 HD13 ' A' ' 83' ' ' ILE . 18.7 m -131.46 150.4 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 115.91 -0.586 . . . . 61.140000000000001 111.321 177.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 88.7 p -129.19 164.53 23.21 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.537 -0.302 . . . . 73.099999999999994 110.724 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.6 p -90.22 146.91 23.89 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.836 0.35 . . . . 73.040000000000006 111.62 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -49.57 -37.37 27.11 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.025 0.44 . . . . 71.150000000000006 111.3 176.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.05 -40.19 98.15 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 115.95 -0.568 . . . . 73.230000000000004 113.466 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -69.07 -50.54 47.43 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.983 0.392 . . . . 73.329999999999998 111.603 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.5 mm -59.35 -47.61 89.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 120.841 0.353 . . . . 75.129999999999995 110.965 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.546 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -60.81 -44.78 96.42 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.405 -0.361 . . . . 71.530000000000001 111.591 177.254 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -54.99 -51.34 66.53 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.977 0.418 . . . . 75.420000000000002 111.731 177.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 67.9 mtm -71.24 -27.3 63.37 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.07 -0.513 . . . . 74.340000000000003 112.049 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.44 -30.81 62.04 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.946 0.403 . . . . 73.099999999999994 111.521 176.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.07 17.04 10.52 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.405 -0.426 . . . . 73.439999999999998 113.243 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.546 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 53.1 m-85 -133.48 61.66 55.19 Favored Pre-proline 0 CA--C 1.549 0.91 0 O-C-N 122.665 -0.315 . . . . 75.239999999999995 111.237 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -52.0 -38.47 69.52 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.022 2.481 . . . . 75.329999999999998 114.307 -173.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.8 -1.32 86.97 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 121.133 -0.555 . . . . 72.239999999999995 113.619 -178.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.491 ' O ' HG23 ' A' ' 39' ' ' VAL . 11.2 m-85 -97.51 10.61 39.34 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.925 0.713 . . . . 73.239999999999995 112.925 -177.05 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.68 -50.18 34.38 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.565 0.698 . . . . 74.340000000000003 111.083 176.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -52.41 -44.43 65.39 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.299 -0.864 . . . . 74.510000000000005 111.697 172.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 67.8 m80 -72.18 -26.17 61.96 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.381 -0.372 . . . . 74.25 111.725 -177.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 35' ' ' TYR . 58.9 t -62.83 -46.72 95.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 120.894 0.378 . . . . 63.109999999999999 110.295 174.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -57.48 -42.63 94.01 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.102 -0.571 . . . . 65.519999999999996 112.355 174.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -64.17 -37.49 87.66 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.898 0.38 . . . . 72.310000000000002 111.223 175.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.76 -44.26 81.89 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.321 -0.399 . . . . 64.200000000000003 112.065 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 39' ' ' VAL . 61.4 mt -63.61 -29.08 70.38 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.801 0.334 . . . . 71.450000000000003 111.355 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.43 -16.3 49.31 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 121.238 -0.506 . . . . 61.409999999999997 113.29 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -77.19 -21.45 53.91 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.011 0.434 . . . . 73.340000000000003 111.247 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 95.0 mt -89.8 135.75 30.12 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-O 121.058 0.456 . . . . 73.420000000000002 112.163 -175.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -81.88 178.56 6.37 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.83 2.353 . . . . 72.439999999999998 113.539 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.553 ' HB3' ' HG3' ' A' ' 73' ' ' ARG . 1.2 pm0 -86.19 23.46 1.53 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.95 -0.568 . . . . 75.349999999999994 112.211 -177.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -147.29 35.81 1.22 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 121.195 -0.526 . . . . 34.509999999999998 112.693 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 34.6 t -86.52 166.76 15.2 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.47 0.653 . . . . 74.430000000000007 112.759 -176.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -82.23 -10.27 59.19 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.374 -0.83 . . . . 64.120000000000005 111.4 176.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.537 HD12 ' HD2' ' A' ' 53' ' ' PRO . 41.3 tp -109.68 122.56 38.88 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 116.028 -0.533 . . . . 71.540000000000006 110.792 178.049 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.537 ' HD2' HD12 ' A' ' 52' ' ' LEU . 67.8 Cg_endo -76.1 94.3 1.02 Allowed 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 121.182 1.255 . . . . 62.109999999999999 111.716 175.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.412 ' HB2' HD22 ' A' ' 43' ' ' LEU . 53.3 p-90 -84.46 -33.92 23.54 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.72 -0.673 . . . . 73.420000000000002 111.707 -176.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.455 ' O ' HD21 ' A' ' 78' ' ' LEU . 9.6 p90 -56.73 -19.45 16.83 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.209 0.818 . . . . 71.25 113.209 -178.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.441 ' NH1' ' O ' ' A' ' 15' ' ' ILE . 98.0 mtt180 -73.53 4.9 4.29 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 112.31 0.485 . . . . 65.230000000000004 112.31 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.5 t -122.92 116.44 48.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 CA-C-O 121.22 0.534 . . . . 64.340000000000003 111.303 177.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.515 HG21 HD12 ' A' ' 91' ' ' ILE . 28.9 pt -120.18 -170.81 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 116.329 -0.396 . . . . 63.0 111.433 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.462 ' HB3' ' OG ' ' A' ' 65' ' ' SER . 32.5 p30 -86.74 169.72 12.39 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.375 0.607 . . . . 44.530000000000001 112.46 -176.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.2 m -63.8 -26.71 68.75 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.835 -0.621 . . . . 64.310000000000002 112.16 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -76.24 -7.59 55.22 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.257 0.466 . . . . 61.119999999999997 112.257 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.55 42.67 13.57 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 121.242 -0.504 . . . . 52.530000000000001 112.627 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.452 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 58.3 mtpt -140.94 171.08 14.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.993 0.425 . . . . 73.329999999999998 110.757 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 59.2 mt -84.56 122.69 38.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 116.407 -0.361 . . . . 71.549999999999997 110.661 176.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.462 ' OG ' ' HB3' ' A' ' 59' ' ' ASN . 58.4 m -81.77 -12.11 58.71 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.234 0.457 . . . . 55.240000000000002 112.234 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.6 mt -80.61 148.57 30.22 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.821 0.343 . . . . 74.319999999999993 110.79 174.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -116.5 157.78 24.66 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.249 0.463 . . . . 71.409999999999997 112.249 -176.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 55.2 -128.11 43.19 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 116.076 -0.511 . . . . 62.340000000000003 113.965 176.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -55.07 -44.64 74.98 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.134 0.492 . . . . 61.219999999999999 111.924 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -60.99 -32.93 72.48 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.965 -0.561 . . . . 72.340000000000003 111.624 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.0 tt -65.79 -53.28 42.38 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.817 0.342 . . . . 72.019999999999996 110.185 176.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -58.71 -34.18 71.03 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.802 0.334 . . . . 60.119999999999997 111.526 177.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.553 ' HG3' ' HB3' ' A' ' 48' ' ' GLU . 39.5 ttm180 -61.15 -56.37 21.56 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.098 0.475 . . . . 75.5 110.998 176.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -63.13 -41.81 99.37 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.062 0.458 . . . . 73.510000000000005 110.951 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.4 ' HG3' HG11 ' A' ' 85' ' ' VAL . 49.0 tttm -55.61 -61.78 2.13 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.864 -0.607 . . . . 61.450000000000003 111.804 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -54.74 -36.85 65.22 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.415 -0.357 . . . . 64.420000000000002 111.553 -175.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.439 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 73.4 mmtt -63.02 -43.87 97.51 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.846 0.355 . . . . 65.540000000000006 111.546 176.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.455 HD21 ' O ' ' A' ' 55' ' ' PHE . 96.2 mt -67.94 -33.55 74.9 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.902 0.382 . . . . 73.299999999999997 111.25 177.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -58.06 -41.97 84.45 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.347 0.594 . . . . 44.210000000000001 109.97 172.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.32 -21.28 66.69 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.692 -0.686 . . . . 72.310000000000002 111.897 177.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 77' ' ' LYS . 7.4 mm-40 -85.31 -10.11 56.83 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.832 0.348 . . . . 74.439999999999998 111.532 177.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.08 25.96 25.3 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.249 -0.5 . . . . 72.129999999999995 112.701 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.435 HD13 HG13 ' A' ' 20' ' ' VAL . 66.3 mt -102.49 146.06 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 120.972 0.415 . . . . 62.520000000000003 111.774 -177.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -88.43 95.47 10.23 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 111.776 0.288 . . . . 61.530000000000001 111.776 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.4 HG11 ' HG3' ' A' ' 75' ' ' LYS . 22.4 t -95.74 98.33 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-O 121.162 0.506 . . . . 74.340000000000003 110.218 173.049 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.569 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 50.4 m -56.88 152.52 12.59 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.838 -0.619 . . . . 64.010000000000005 112.333 -178.061 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.423 ' HG3' HG23 ' A' ' 88' ' ' ILE . 12.3 pt-20 -41.31 -36.87 0.88 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 115.037 1.495 . . . . 72.319999999999993 115.037 -171.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.452 HD11 ' HB2' ' A' ' 90' ' ' LYS . 2.9 pp -92.81 13.11 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 112.706 0.632 . . . . 64.209999999999994 112.706 -176.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.92 42.6 7.09 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 121.587 -0.34 . . . . 25.530000000000001 113.439 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.569 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 62.6 tttp -116.45 142.65 46.59 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 122.622 -0.34 . . . . 63.039999999999999 111.46 -177.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.515 HD12 HG21 ' A' ' 58' ' ' ILE . 62.2 mt -129.45 146.7 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 120.928 0.394 . . . . 61.130000000000003 111.607 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.85 97.35 10.15 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.94 0.4 . . . . 51.409999999999997 111.601 177.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.496 HD21 HD11 ' A' ' 58' ' ' ILE . 67.7 mt -60.31 -55.37 34.53 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.01 0.374 . . . . 61.43 112.01 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 29.6 mtp180 -57.11 -9.29 0.86 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.17 0.804 . . . . 73.209999999999994 113.17 -175.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -105.59 -37.86 6.63 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 111.751 0.278 . . . . 72.5 111.751 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -116.56 13.7 15.36 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.281 0.474 . . . . 70.230000000000004 112.281 -173.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 80.3 tttt -65.63 139.05 58.39 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.097 0.475 . . . . 63.509999999999998 111.46 -178.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.441 ' HA ' ' HB3' ' A' ' 19' ' ' LYS . 17.5 t90 -59.96 111.94 1.68 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.065 0.459 . . . . 75.140000000000001 111.432 178.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -107.25 92.42 8.02 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 116.096 -0.502 . . . . 65.019999999999996 111.001 177.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo . . . . . 0 CA--C 1.542 0.879 0 C-N-CA 122.579 2.186 . . . . 62.439999999999998 112.936 177.823 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 . . . . . 0 CA--C 1.539 0.551 0 CA-C-O 120.717 0.294 . . . . 70.120000000000005 111.267 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -52.8 -35.18 56.49 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.319 0.489 . . . . 65.540000000000006 112.319 -177.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -54.32 -49.61 69.3 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.245 0.545 . . . . 71.439999999999998 110.75 176.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 77.8 mt -65.71 -42.59 90.92 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.768 -0.651 . . . . 73.0 110.919 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 92.2 t -55.28 -46.56 78.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.362 -0.381 . . . . 62.229999999999997 111.559 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.427 ' O ' HG23 ' A' ' 11' ' ' VAL . 27.4 mm-40 -66.98 -56.39 10.36 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.252 0.464 . . . . 74.209999999999994 112.252 -177.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.502 ' O ' HG13 ' A' ' 12' ' ' ILE . 29.9 pt -58.66 -41.85 83.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 O-C-N 122.199 -0.313 . . . . 71.299999999999997 111.722 -178.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.414 ' CD1' HG13 ' A' ' 8' ' ' ILE . 9.0 m-30 -62.34 -43.7 98.2 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.813 0.34 . . . . 63.32 110.915 177.115 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.32 -28.34 64.96 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.018 0.437 . . . . 73.400000000000006 111.664 177.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 7' ' ' GLN . 57.6 t -80.66 -41.47 20.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 120.81 0.338 . . . . 72.430000000000007 110.998 176.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 8' ' ' ILE . 83.2 mt -61.23 -42.38 93.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 112.206 0.447 . . . . 75.439999999999998 112.206 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -59.94 -20.69 58.85 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.096 0.406 . . . . 74.310000000000002 112.096 178.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -83.48 -2.34 55.69 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.007 0.373 . . . . 71.140000000000001 112.007 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.566 HD11 HD11 ' A' ' 26' ' ' ILE . 61.0 mt -84.61 113.82 51.48 Favored Pre-proline 0 CA--C 1.543 0.673 0 O-C-N 122.374 -0.204 . . . . 71.230000000000004 110.472 175.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 15' ' ' ILE . 15.1 Cg_exo -69.54 147.66 64.79 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.003 2.468 . . . . 64.019999999999996 113.537 -178.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -52.2 120.02 5.01 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 116.021 -0.536 . . . . 72.120000000000005 111.791 176.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.69 -8.84 40.34 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.118 -0.563 . . . . 65.040000000000006 113.037 -177.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -115.18 152.1 33.23 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.985 0.421 . . . . 64.140000000000001 111.23 176.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.449 HG13 HD13 ' A' ' 83' ' ' ILE . 32.8 m -130.18 159.14 42.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-O 121.168 0.509 . . . . 53.350000000000001 110.962 177.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 45.4 t -138.98 168.44 19.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.997 0.427 . . . . 61.149999999999999 111.131 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.4 p -103.78 148.44 26.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.456 -0.338 . . . . 73.349999999999994 111.343 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.402 ' HE1' HD12 ' A' ' 43' ' ' LEU . 73.3 m-85 -51.72 -33.14 33.12 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.749 0.309 . . . . 74.439999999999998 111.394 175.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.16 -44.26 98.36 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.18 -0.533 . . . . 72.120000000000005 112.691 176.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.459 ' O ' ' HG3' ' A' ' 29' ' ' MET . 41.3 mt-10 -70.79 -49.57 45.14 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.575 0.226 . . . . 73.219999999999999 111.519 178.123 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.566 HD11 HD11 ' A' ' 15' ' ' ILE . 51.4 mm -56.07 -56.53 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 111.958 0.355 . . . . 70.319999999999993 111.958 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.435 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -58.97 -39.99 83.42 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.095 0.474 . . . . 73.200000000000003 111.305 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -60.82 -42.41 97.63 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.136 -0.484 . . . . 72.299999999999997 111.149 178.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.459 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 66.5 mtt -72.65 -36.26 67.93 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 120.898 0.38 . . . . 72.219999999999999 111.462 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.04 -21.28 65.02 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.981 0.42 . . . . 75.209999999999994 111.517 178.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.73 18.06 28.8 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.319 -0.467 . . . . 63.420000000000002 113.217 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.435 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 88.0 m-85 -123.44 85.94 52.28 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-O 120.783 0.325 . . . . 60.240000000000002 111.282 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.76 135.47 25.91 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.412 2.075 . . . . 73.420000000000002 112.672 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.5 -26.65 8.84 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.28 -0.486 . . . . 43.350000000000001 113.24 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -73.36 3.62 5.7 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 112.423 0.527 . . . . 65.109999999999999 112.423 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.0 -44.43 30.77 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.056 0.455 . . . . 45.520000000000003 112.027 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -63.43 -33.79 76.32 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 116.043 -0.526 . . . . 72.319999999999993 111.821 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -75.09 -34.61 61.77 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.799 0.333 . . . . 71.430000000000007 111.032 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.444 HG13 HD12 ' A' ' 8' ' ' ILE . 51.2 t -59.46 -40.11 80.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 121.118 0.485 . . . . 61.43 110.18 173.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.94 -41.01 99.19 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 115.92 -0.582 . . . . 54.119999999999997 112.665 174.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -57.98 -49.13 77.88 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.074 0.464 . . . . 74.010000000000005 110.424 174.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.71 -53.9 52.42 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.815 -0.629 . . . . 71.409999999999997 111.54 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.402 HD12 ' HE1' ' A' ' 23' ' ' TYR . 40.3 mt -62.98 -32.3 73.61 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.9 0.381 . . . . 75.420000000000002 111.03 178.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.97 -22.81 65.14 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.324 -0.465 . . . . 75.340000000000003 113.306 176.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -80.17 -20.13 45.52 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.841 0.353 . . . . 74.25 111.223 177.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 82.0 mt -76.94 140.66 67.03 Favored Pre-proline 0 CA--C 1.539 0.546 0 N-CA-C 112.255 0.465 . . . . 52.119999999999997 112.255 -178.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -88.48 172.95 4.7 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.941 2.427 . . . . 64.209999999999994 112.648 176.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.33 -31.36 72.49 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.489 -0.323 . . . . 54.119999999999997 111.859 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.02 52.43 4.39 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 120.96 -0.638 . . . . 75.540000000000006 113.101 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.8 t -102.32 142.38 33.63 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.131 0.419 . . . . 72.409999999999997 112.131 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -69.39 -35.76 76.1 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.24 0.543 . . . . 73.439999999999998 110.678 174.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.527 HD12 ' HD2' ' A' ' 53' ' ' PRO . 39.7 tp -80.92 121.49 80.93 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.884 -0.598 . . . . 73.349999999999994 110.733 175.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.527 ' HD2' HD12 ' A' ' 52' ' ' LEU . 60.8 Cg_endo -72.71 94.56 0.78 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 121.269 1.313 . . . . 65.510000000000005 111.725 176.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 55.7 p-90 -84.46 -25.36 28.99 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.201 0.524 . . . . 75.439999999999998 111.922 -177.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.548 ' HA ' ' HG3' ' A' ' 74' ' ' GLN . 29.9 p90 -62.97 -22.6 66.94 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.219 0.822 . . . . 72.340000000000003 113.219 -177.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -75.63 -3.46 34.62 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.455 0.539 . . . . 74.329999999999998 112.455 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.4 t -115.2 114.05 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 120.989 0.423 . . . . 65.420000000000002 111.673 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.629 HD11 HD21 ' A' ' 93' ' ' LEU . 39.1 pt -115.99 -171.09 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 120.942 0.401 . . . . 71.209999999999994 111.807 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 34.7 p30 -83.06 178.01 8.33 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.267 0.556 . . . . 74.010000000000005 112.1 -176.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 57.2 p -81.63 -1.31 46.13 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 116.229 -0.442 . . . . 75.129999999999995 111.98 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -86.94 -21.14 26.43 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.771 0.319 . . . . 65.450000000000003 111.372 177.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.08 22.67 24.63 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 121.257 -0.497 . . . . 72.239999999999995 112.212 -173.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.495 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 55.2 mtpt -129.4 172.77 11.18 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.126 0.488 . . . . 63.329999999999998 111.489 -177.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.687 HD11 HG11 ' A' ' 85' ' ' VAL . 55.3 mt -72.55 144.22 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.224 0.535 . . . . 72.299999999999997 111.329 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.4 p -88.47 -44.04 11.0 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.214 -0.448 . . . . 72.409999999999997 111.465 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.43 HD13 ' HB3' ' A' ' 70' ' ' ASP . 74.9 mt -76.42 159.87 30.06 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.291 0.567 . . . . 70.25 112.037 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -131.73 165.91 22.68 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.037 -0.529 . . . . 74.200000000000003 111.879 -175.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.04 -138.0 41.37 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-N 116.23 -0.441 . . . . 52.299999999999997 113.13 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 65.1 mtm180 -59.11 -26.59 64.82 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.925 0.393 . . . . 62.119999999999997 111.58 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.43 ' HB3' HD13 ' A' ' 66' ' ' LEU . 13.2 m-20 -73.21 -29.39 62.77 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.393 -0.367 . . . . 74.129999999999995 111.637 177.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.9 tt -62.26 -48.11 81.4 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 109.199 -0.667 . . . . 70.200000000000003 109.199 174.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.93 -43.24 95.05 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.887 -0.597 . . . . 72.200000000000003 111.364 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 73' ' ' ARG . 64.1 mtt180 -53.69 -57.49 10.64 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 120.805 0.336 . . . . 73.409999999999997 111.314 175.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.548 ' HG3' ' HA ' ' A' ' 55' ' ' PHE . 43.3 tt0 -62.88 -47.12 84.7 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.037 0.446 . . . . 65.420000000000002 111.094 -177.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.446 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 61.6 tttp -58.37 -60.7 3.37 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.967 -0.56 . . . . 61.210000000000001 111.978 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -62.14 -26.27 68.22 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.644 0.609 . . . . 63.130000000000003 112.644 -173.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -64.12 -48.73 74.98 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.207 0.527 . . . . 74.140000000000001 110.715 170.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.548 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 41.1 mt -61.04 -47.21 87.45 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.89 -0.595 . . . . 70.209999999999994 110.994 176.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 57.4 mm-40 -50.08 -39.67 43.18 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.719 -0.673 . . . . 75.349999999999994 111.02 175.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.38 -32.89 74.44 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.138 -0.483 . . . . 72.540000000000006 112.144 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -91.48 0.1 57.55 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 111.875 0.324 . . . . 74.439999999999998 111.875 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.24 5.81 59.15 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.351 -0.452 . . . . 64.010000000000005 113.247 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.548 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 61.4 mt -85.46 102.54 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 121.229 0.537 . . . . 71.200000000000003 110.617 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -78.69 110.62 13.99 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.683 0.623 . . . . 73.129999999999995 112.683 -171.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.687 HG11 HD11 ' A' ' 64' ' ' ILE . 40.3 t -97.41 121.12 47.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 116.096 -0.502 . . . . 73.530000000000001 111.988 -178.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.531 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 30.9 t -59.1 150.7 24.34 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.161 0.43 . . . . 71.230000000000004 112.161 177.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -50.42 -39.86 48.52 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.331 0.863 . . . . 75.549999999999997 113.331 -174.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.415 ' H ' HG13 ' A' ' 88' ' ' ILE . 2.8 pp -81.04 18.9 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-O 121.114 0.483 . . . . 74.319999999999993 111.859 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.72 50.25 9.49 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 116.164 -0.471 . . . . 32.119999999999997 113.407 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.531 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 50.1 tttm -125.25 149.4 48.04 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 122.423 -0.457 . . . . 72.510000000000005 112.073 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.57 HD12 HG21 ' A' ' 58' ' ' ILE . 49.1 mt -123.45 152.93 28.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.235 -0.439 . . . . 54.030000000000001 110.322 174.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -86.68 93.29 9.19 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.816 0.341 . . . . 63.100000000000001 111.141 176.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.629 HD21 HD11 ' A' ' 58' ' ' ILE . 51.0 mt -58.88 -53.96 52.48 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.039 0.385 . . . . 71.120000000000005 112.039 -178.064 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 21.7 ttp180 -56.18 -19.02 11.84 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-O 121.222 0.534 . . . . 54.210000000000001 111.606 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.465 ' HD3' ' O ' ' A' ' 95' ' ' LYS . 7.8 tmtt? -91.43 -45.13 8.72 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 116.501 -0.318 . . . . 63.0 110.985 177.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -107.92 10.37 28.48 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.902 0.704 . . . . 73.530000000000001 112.902 -170.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 59.1 tttp -58.9 132.23 53.36 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.413 0.523 . . . . 42.020000000000003 112.413 -172.083 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 17.0 t90 -58.51 105.56 0.31 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.937 -0.574 . . . . 75.109999999999999 112.181 -179.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -102.89 102.07 25.01 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 115.6 -0.727 . . . . 65.349999999999994 110.434 171.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo . . . . . 0 CA--C 1.54 0.777 0 C-N-CA 122.378 2.052 . . . . 50.039999999999999 112.871 177.798 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.434 ' O ' HG23 ' A' ' 6' ' ' VAL . 15.1 t70 . . . . . 0 CA--C 1.543 0.682 0 N-CA-C 112.553 0.575 . . . . 73.519999999999996 112.553 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -60.83 -27.72 68.27 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.881 0.697 . . . . 74.239999999999995 112.881 -175.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.414 ' O ' HG12 ' A' ' 8' ' ' ILE . 59.7 t80 -58.74 -51.64 69.1 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.23 0.538 . . . . 64.340000000000003 110.086 174.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 70.0 mt -67.47 -46.42 73.04 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.543 -0.753 . . . . 63.530000000000001 111.128 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 2' ' ' ASP . 94.1 t -54.39 -48.82 68.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 116.285 -0.416 . . . . 74.25 112.02 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.43 ' O ' HG23 ' A' ' 11' ' ' VAL . 30.8 mm-40 -68.62 -51.44 42.25 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.747 0.647 . . . . 72.010000000000005 112.747 -177.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.494 HD12 HG13 ' A' ' 39' ' ' VAL . 30.2 pt -58.92 -41.54 83.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 120.751 0.31 . . . . 61.310000000000002 111.368 -178.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -64.01 -44.45 92.55 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.081 0.467 . . . . 71.329999999999998 110.591 174.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.98 -20.4 37.89 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.316 0.487 . . . . 73.239999999999995 112.316 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 7' ' ' GLN . 59.1 t -83.8 -43.95 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 120.978 0.418 . . . . 65.340000000000003 111.03 174.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.571 ' HB ' HD11 ' A' ' 52' ' ' LEU . 72.7 mt -61.02 -30.77 48.3 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 112.655 0.613 . . . . 75.209999999999994 112.655 -177.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -55.64 -18.03 6.96 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 112.8 0.667 . . . . 60.039999999999999 112.8 178.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -91.18 -0.89 57.78 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.239 0.459 . . . . 74.019999999999996 112.239 -178.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.526 HD11 HD11 ' A' ' 26' ' ' ILE . 61.2 mt -87.28 113.54 54.38 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-O 120.417 0.151 . . . . 74.329999999999998 110.905 178.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -77.74 170.31 19.3 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.685 2.257 . . . . 75.030000000000001 113.87 -177.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.2 tttp -61.32 130.52 46.53 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.085 -0.507 . . . . 73.310000000000002 111.247 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.67 2.97 75.0 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.035 -0.603 . . . . 54.329999999999998 113.688 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -120.72 148.33 44.09 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 117.272 0.536 . . . . 63.509999999999998 111.315 176.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.6 m -128.69 157.27 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.224 0.535 . . . . 71.209999999999994 111.898 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.4 m -133.1 163.46 29.2 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.158 -0.474 . . . . 42.210000000000001 110.796 176.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 44.5 p -93.88 149.09 21.54 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.734 0.302 . . . . 62.0 111.416 178.094 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -51.12 -38.81 54.12 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.866 0.365 . . . . 75.099999999999994 111.19 177.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.23 -47.78 89.13 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-N 116.154 -0.475 . . . . 72.510000000000005 112.875 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.455 ' O ' ' HG3' ' A' ' 29' ' ' MET . 46.0 mt-10 -59.63 -55.63 32.01 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.705 0.288 . . . . 55.100000000000001 111.537 178.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.526 HD11 HD11 ' A' ' 15' ' ' ILE . 49.8 mm -53.57 -50.43 49.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 120.956 0.408 . . . . 75.400000000000006 111.784 -178.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.473 ' HB2' HG21 ' A' ' 39' ' ' VAL . . . -64.13 -45.78 87.03 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.889 0.376 . . . . 71.409999999999997 111.802 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.9 tttp -64.49 -35.83 82.2 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.508 -0.314 . . . . 75.319999999999993 111.4 -177.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.455 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 65.9 mtt -68.4 -43.44 77.26 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.054 0.454 . . . . 63.530000000000001 110.769 176.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.54 -23.03 66.77 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.03 -0.532 . . . . 65.329999999999998 111.963 178.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.12 31.7 4.61 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.473 -0.394 . . . . 60.539999999999999 113.414 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -129.73 89.32 46.8 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-O 120.874 0.368 . . . . 71.409999999999997 111.402 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -73.72 125.37 9.95 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.135 2.556 . . . . 63.140000000000001 113.124 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.33 -13.99 66.31 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 121.323 -0.465 . . . . 71.5 113.584 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.428 ' HA ' ' HD2' ' A' ' 38' ' ' HIS . 74.5 m-85 -84.58 10.57 10.72 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.838 0.681 . . . . 73.530000000000001 112.838 -176.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.48 -52.72 20.99 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.719 0.637 . . . . 52.240000000000002 112.719 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -65.69 -26.47 67.79 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.887 0.375 . . . . 73.219999999999999 111.872 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.428 ' HD2' ' HA ' ' A' ' 35' ' ' TYR . 99.5 m-70 -74.83 -32.28 61.9 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.95 0.405 . . . . 73.239999999999995 110.921 177.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.494 HG13 HD12 ' A' ' 8' ' ' ILE . 81.3 t -59.44 -40.46 81.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-O 121.252 0.549 . . . . 62.43 110.195 170.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -57.93 -41.99 94.55 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.869 -0.605 . . . . 71.310000000000002 112.732 174.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -56.68 -40.16 75.07 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.094 0.473 . . . . 71.219999999999999 111.218 175.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.1 -51.72 23.51 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.914 -0.585 . . . . 73.420000000000002 112.179 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.9 mt -60.65 -45.14 95.23 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.2 0.444 . . . . 64.450000000000003 112.2 -176.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.59 -20.93 64.32 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 120.692 -0.766 . . . . 55.229999999999997 113.05 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -83.63 -20.97 32.69 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 120.71 0.291 . . . . 74.010000000000005 111.489 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.454 HD12 ' HB3' ' A' ' 54' ' ' TRP . 94.4 mt -67.05 147.68 99.02 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 111.889 0.329 . . . . 73.430000000000007 111.889 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.548 ' HG2' ' HB3' ' A' ' 50' ' ' SER . 30.1 Cg_endo -63.56 165.54 17.71 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.402 2.068 . . . . 53.229999999999997 112.715 176.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.405 ' HG2' ' HE ' ' A' ' 73' ' ' ARG . 45.7 mt-10 -57.3 -41.14 79.28 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.584 0.587 . . . . 74.420000000000002 112.584 -177.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -128.43 60.27 0.67 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.981 -0.628 . . . . 70.010000000000005 113.744 -177.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.548 ' HB3' ' HG2' ' A' ' 47' ' ' PRO . 24.5 p -76.97 -178.7 5.07 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 122.459 -0.436 . . . . 72.329999999999998 110.878 176.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.429 ' HB2' ' NZ ' ' A' ' 51' ' ' LYS . 5.2 ttmp? -61.04 -28.52 69.12 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.065 0.46 . . . . 75.140000000000001 110.825 174.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.571 HD11 ' HB ' ' A' ' 12' ' ' ILE . 26.0 tp -103.38 130.78 22.92 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 116.017 -0.538 . . . . 73.530000000000001 111.812 -177.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.534 ' HD2' HD12 ' A' ' 52' ' ' LEU . 72.0 Cg_endo -79.42 95.89 1.06 Allowed 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 121.657 1.571 . . . . 70.439999999999998 111.511 170.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.454 ' HB3' HD12 ' A' ' 46' ' ' LEU . 64.8 p-90 -76.51 -28.77 56.53 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.162 -0.472 . . . . 74.319999999999993 112.202 -175.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.491 ' O ' HD21 ' A' ' 78' ' ' LEU . 24.8 p90 -60.7 -19.96 59.89 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.409 0.892 . . . . 62.32 113.409 -175.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -76.82 6.76 5.59 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.864 0.69 . . . . 54.219999999999999 112.864 -176.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 45.1 t -123.62 125.85 72.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 O-C-N 121.929 -0.482 . . . . 54.310000000000002 111.624 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.541 HG21 HD12 ' A' ' 91' ' ' ILE . 32.5 pt -127.35 -169.63 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 121.157 0.503 . . . . 74.230000000000004 111.357 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.414 ' HB3' ' OG ' ' A' ' 65' ' ' SER . 30.9 p30 -87.26 173.97 8.87 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.068 0.461 . . . . 64.030000000000001 111.824 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 33.3 p -84.79 9.74 13.32 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.965 0.412 . . . . 61.520000000000003 111.646 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -93.14 -14.79 26.75 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.003 0.43 . . . . 72.519999999999996 110.542 173.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.38 37.17 18.45 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 121.081 -0.58 . . . . 75.430000000000007 112.161 -174.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -137.35 167.71 21.06 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.645 0.736 . . . . 62.219999999999999 112.379 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.516 ' CG2' HD12 ' A' ' 71' ' ' LEU . 74.9 mt -83.68 108.53 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.109 -0.95 . . . . 54.119999999999997 110.209 172.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.414 ' OG ' ' HB3' ' A' ' 59' ' ' ASN . 71.2 m -69.7 -25.9 64.09 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.73 0.641 . . . . 54.130000000000003 112.73 -175.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.499 HD13 ' HB3' ' A' ' 70' ' ' ASP . 88.6 mt -64.78 124.38 21.82 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.696 0.284 . . . . 73.230000000000004 111.018 178.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -113.05 141.59 46.7 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.14 0.495 . . . . 63.140000000000001 111.211 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 107.88 -136.43 13.44 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.462 -0.655 . . . . 63.020000000000003 111.462 -173.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -81.76 -24.94 35.73 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 117.511 0.656 . . . . 64.099999999999994 110.896 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.499 ' HB3' HD13 ' A' ' 66' ' ' LEU . 7.8 m-20 -62.36 -24.83 67.58 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.121 -0.49 . . . . 72.439999999999998 111.936 176.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.516 HD12 ' CG2' ' A' ' 64' ' ' ILE . 16.2 tp -56.84 -60.65 3.26 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.414 0.626 . . . . 74.120000000000005 110.561 174.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.554 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 18.8 m-20 -67.03 -32.48 73.72 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.605 -0.725 . . . . 74.120000000000005 111.178 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.405 ' HE ' ' HG2' ' A' ' 48' ' ' GLU . 57.7 ttt180 -50.13 -59.01 4.33 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-O 121.3 0.572 . . . . 63.100000000000001 111.204 174.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -62.29 -43.55 98.58 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.007 -0.542 . . . . 63.439999999999998 110.7 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.43 ' HB3' ' HA ' ' A' ' 72' ' ' ASP . 76.4 tttt -50.0 -58.24 5.9 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.722 -0.672 . . . . 73.099999999999994 112.306 176.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.554 ' HG3' ' O ' ' A' ' 72' ' ' ASP . 96.0 mt-30 -52.75 -49.19 65.97 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.142 0.496 . . . . 74.25 111.467 -178.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -68.91 -27.06 65.43 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.5 0.556 . . . . 72.409999999999997 112.5 -177.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.495 HD13 HD11 ' A' ' 91' ' ' ILE . 57.6 mt -77.79 -39.03 45.3 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.169 0.433 . . . . 75.5 112.169 177.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -62.8 -30.69 71.66 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.025 0.441 . . . . 73.219999999999999 110.617 175.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.82 -20.06 66.19 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 116.04 -0.527 . . . . 40.340000000000003 111.483 174.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -86.98 2.67 48.72 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.201 -0.454 . . . . 73.25 111.443 177.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.2 15.67 71.37 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.092 -0.575 . . . . 74.409999999999997 112.832 -177.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 73.0 mt -92.1 124.5 44.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 120.959 0.409 . . . . 73.519999999999996 111.643 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.507 ' HG2' ' OH ' ' A' ' 96' ' ' TYR . 9.0 pt-20 -72.76 90.84 1.44 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.6 0.714 . . . . 70.010000000000005 111.308 175.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 62.3 t -85.73 112.53 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 116.071 -0.513 . . . . 51.100000000000001 110.477 176.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.571 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 42.1 t -61.26 142.57 56.73 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.757 -0.201 . . . . 73.319999999999993 111.055 178.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -48.52 -38.47 20.37 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.744 1.016 . . . . 73.439999999999998 113.744 -172.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.426 ' H ' HG13 ' A' ' 88' ' ' ILE . 2.8 pp -80.32 16.42 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 CA-C-O 121.083 0.468 . . . . 74.420000000000002 112.23 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.37 52.31 6.18 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 116.373 -0.376 . . . . 75.420000000000002 113.443 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.571 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 1.3 tmtp? -125.4 136.23 53.22 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.052 0.453 . . . . 72.439999999999998 111.214 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.541 HD12 HG21 ' A' ' 58' ' ' ILE . 69.7 mt -125.59 126.49 70.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 116.018 -0.537 . . . . 72.230000000000004 110.864 178.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.98 98.29 1.26 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 111.973 0.36 . . . . 73.409999999999997 111.973 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.453 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 86.2 mt -53.47 -53.22 54.6 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.337 -0.392 . . . . 64.209999999999994 111.838 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 18.5 ttm180 -56.21 -26.58 51.54 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 112.189 0.44 . . . . 75.219999999999999 112.189 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -89.66 -28.88 19.17 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.137 0.421 . . . . 70.219999999999999 112.137 -177.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.507 ' OH ' ' HG2' ' A' ' 84' ' ' GLU . 70.9 m-85 -124.73 12.76 8.57 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.658 0.614 . . . . 75.120000000000005 112.658 -174.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 63.6 tttp -60.08 131.5 51.02 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.093 0.473 . . . . 74.040000000000006 111.825 -177.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 19.8 t90 -56.15 124.26 17.27 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.954 -0.566 . . . . 74.140000000000001 111.735 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -108.82 88.87 5.78 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 116.035 -0.53 . . . . 74.0 111.029 176.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo . . . . . 0 CA--C 1.536 0.583 0 C-N-CA 122.02 1.814 . . . . 72.219999999999999 111.385 173.874 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 CA--C 1.539 0.547 0 N-CA-C 112.666 0.617 . . . . 71.400000000000006 112.666 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -57.0 -30.31 64.05 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.22 -0.446 . . . . 74.549999999999997 110.964 175.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -57.69 -52.39 65.62 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.041 0.448 . . . . 51.119999999999997 110.717 174.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.4 mt -63.8 -48.19 77.89 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.964 -0.562 . . . . 71.219999999999999 111.471 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 67.4 t -53.03 -49.52 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 120.931 0.396 . . . . 64.239999999999995 111.703 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.467 ' O ' HG23 ' A' ' 11' ' ' VAL . 28.9 mm-40 -67.28 -53.29 31.19 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.632 0.604 . . . . 74.519999999999996 112.632 -177.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.41 ' O ' HG13 ' A' ' 12' ' ' ILE . 35.9 pt -59.64 -41.62 85.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 O-C-N 122.148 -0.345 . . . . 45.420000000000002 111.468 -178.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.401 ' CD1' HG13 ' A' ' 8' ' ' ILE . 14.8 m-30 -63.69 -43.91 95.23 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.958 0.408 . . . . 74.329999999999998 110.818 177.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.75 -43.18 80.48 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.31 -0.405 . . . . 74.140000000000001 111.366 177.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 7' ' ' GLN . 74.3 t -61.74 -43.2 96.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 121.082 0.468 . . . . 70.329999999999998 110.742 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.473 ' HB ' HD11 ' A' ' 52' ' ' LEU . 72.6 mt -62.77 -37.26 78.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 116.146 -0.479 . . . . 71.040000000000006 111.645 177.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -64.22 -10.43 23.34 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.196 0.443 . . . . 74.530000000000001 112.196 176.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.46 -9.92 42.77 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.65 0.262 . . . . 73.049999999999997 111.667 177.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.427 HD11 HD11 ' A' ' 26' ' ' ILE . 54.9 mt -76.92 114.67 41.54 Favored Pre-proline 0 CA--C 1.543 0.684 0 O-C-N 122.448 -0.157 . . . . 75.420000000000002 110.831 177.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -60.62 150.25 82.95 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 122.734 2.289 . . . . 72.25 113.515 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 67.2 tttm -62.05 95.35 0.06 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.076 0.465 . . . . 64.140000000000001 111.255 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 139.11 -18.64 3.11 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 121.155 -0.545 . . . . 73.209999999999994 113.148 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -103.86 162.4 13.14 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.994 0.426 . . . . 71.200000000000003 111.676 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.7 m -136.29 156.2 35.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 122.932 0.493 . . . . 74.329999999999998 111.561 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 98.4 p -138.13 179.43 6.45 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 120.764 0.316 . . . . 71.219999999999999 111.15 178.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.8 p -110.72 153.12 25.74 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 120.991 0.424 . . . . 74.519999999999996 111.651 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.401 ' CE1' ' HA2' ' A' ' 40' ' ' GLY . 90.0 m-85 -53.48 -39.91 64.9 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.257 0.466 . . . . 73.299999999999997 112.257 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.16 -40.62 93.96 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.172 -0.537 . . . . 41.229999999999997 113.098 178.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -67.29 -51.61 50.73 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 122.493 -0.416 . . . . 71.400000000000006 111.396 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.427 HD11 HD11 ' A' ' 15' ' ' ILE . 50.5 mm -53.85 -51.53 43.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-N 116.141 -0.481 . . . . 73.209999999999994 111.397 178.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.02 -54.18 49.86 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.215 -0.448 . . . . 34.240000000000002 111.961 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.7 mtmp? -62.09 -41.48 98.24 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.083 0.401 . . . . 74.010000000000005 112.083 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 70.7 mtm -76.63 -10.39 59.35 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 111.995 0.369 . . . . 72.409999999999997 111.995 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.34 -14.39 33.21 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.091 0.472 . . . . 51.049999999999997 110.929 172.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.8 18.31 27.89 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 116.012 -0.54 . . . . 23.510000000000002 113.203 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -125.59 91.11 49.29 Favored Pre-proline 0 CA--C 1.544 0.741 0 O-C-N 122.522 -0.399 . . . . 75.349999999999994 111.397 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.01 137.12 26.03 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.861 2.374 . . . . 64.040000000000006 113.092 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.33 -6.18 52.42 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 121.261 -0.495 . . . . 70.420000000000002 113.968 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.401 ' O ' HG23 ' A' ' 39' ' ' VAL . 61.0 m-85 -84.19 11.26 8.47 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.634 0.605 . . . . 62.240000000000002 112.634 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.25 -47.34 69.16 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.963 0.411 . . . . 74.099999999999994 111.895 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.0 ptt180 -57.86 -40.05 79.24 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.18 -0.464 . . . . 71.150000000000006 111.957 175.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -67.84 -39.29 83.86 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.861 0.362 . . . . 73.400000000000006 111.19 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 35' ' ' TYR . 58.9 t -59.9 -42.62 89.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.013 0.435 . . . . 64.299999999999997 110.611 174.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.401 ' HA2' ' CE1' ' A' ' 23' ' ' TYR . . . -58.97 -41.56 96.41 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-N 116.078 -0.51 . . . . 54.509999999999998 112.718 176.05 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -61.65 -47.32 85.91 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 120.835 0.35 . . . . 64.510000000000005 111.085 176.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.6 -54.41 47.22 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.989 0.423 . . . . 45.43 111.727 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.4 mt -63.91 -32.62 74.21 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.846 0.355 . . . . 74.109999999999999 111.461 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.99 -13.99 62.7 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.439 -0.41 . . . . 73.430000000000007 113.507 178.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -93.53 -4.08 51.67 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 117.087 0.444 . . . . 63.140000000000001 111.945 177.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 94.2 mt -85.88 142.34 36.52 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 112.509 0.559 . . . . 71.400000000000006 112.509 -176.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.78 159.5 48.31 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.54 2.16 . . . . 73.439999999999998 112.27 173.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.59 -35.82 73.02 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.401 0.519 . . . . 63.100000000000001 112.401 -176.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -113.94 53.12 0.61 Allowed Glycine 0 CA--C 1.526 0.75 0 C-N-CA 121.23 -0.51 . . . . 45.32 112.913 178.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 90.9 p -72.93 -179.14 3.06 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 122.297 -0.531 . . . . 70.349999999999994 111.454 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -84.59 4.5 31.92 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.007 0.432 . . . . 73.230000000000004 111.425 176.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.554 HD12 ' HD2' ' A' ' 53' ' ' PRO . 35.6 tp -127.1 126.08 24.23 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 116.159 -0.473 . . . . 74.340000000000003 110.34 178.168 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.554 ' HD2' HD12 ' A' ' 52' ' ' LEU . 53.0 Cg_endo -70.1 94.36 0.56 Allowed 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 120.94 1.093 . . . . 62.100000000000001 111.879 176.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 68.1 p-90 -84.88 -29.7 25.02 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.305 0.574 . . . . 73.530000000000001 111.051 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.454 ' O ' HD21 ' A' ' 78' ' ' LEU . 33.6 p90 -61.56 -14.16 27.62 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.008 0.744 . . . . 71.230000000000004 113.008 -177.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 69.6 mtt-85 -85.34 7.95 20.52 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.108 0.41 . . . . 74.239999999999995 112.108 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.6 t -125.13 126.91 71.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 120.98 0.419 . . . . 53.109999999999999 111.521 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.609 HD11 HD21 ' A' ' 93' ' ' LEU . 34.9 pt -130.21 -172.11 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-N 116.444 -0.344 . . . . 64.040000000000006 111.504 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.421 HD21 ' HB2' ' A' ' 63' ' ' LYS . 34.6 p30 -84.96 175.39 9.1 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.217 0.532 . . . . 55.329999999999998 111.988 -178.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.2 p -72.51 -12.42 61.07 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.303 -0.408 . . . . 62.030000000000001 112.053 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -80.34 -16.32 54.83 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.633 0.254 . . . . 73.439999999999998 111.59 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.63 21.6 46.84 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 121.059 -0.591 . . . . 71.120000000000005 112.189 -174.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.505 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 62.1 mttp -118.67 159.64 23.27 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.112 0.482 . . . . 75.230000000000004 111.463 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 58.0 mt -67.23 130.03 32.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.242 -0.435 . . . . 71.239999999999995 110.525 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.6 p -64.78 -53.92 39.41 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.962 0.411 . . . . 63.140000000000001 111.589 -177.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.487 HD13 ' HB3' ' A' ' 70' ' ' ASP . 85.6 mt -63.48 150.73 43.09 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.253 0.549 . . . . 73.439999999999998 112.075 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.82 157.31 32.73 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.087 -0.506 . . . . 72.430000000000007 111.497 -176.043 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.96 -129.19 10.54 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.284 -0.484 . . . . 72.329999999999998 113.281 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.417 ' H ' ' HG3' ' A' ' 69' ' ' ARG . 9.0 mtm180 -54.61 -51.22 66.03 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 122.451 1.119 . . . . 74.430000000000007 110.515 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.571 ' HA ' ' HB3' ' A' ' 73' ' ' ARG . 3.6 m-20 -63.45 -18.47 63.79 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.121 -1.4 . . . . 75.129999999999995 112.293 -171.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.1 tt -65.55 -56.07 14.32 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 110.087 -0.338 . . . . 75.219999999999999 110.087 175.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -70.22 -26.3 63.8 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 122.315 -0.241 . . . . 65.340000000000003 111.013 178.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.571 ' HB3' ' HA ' ' A' ' 70' ' ' ASP . 29.4 ttm180 -57.2 -55.19 37.93 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.22 0.533 . . . . 74.400000000000006 110.751 171.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -64.56 -40.62 95.9 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.302 -0.408 . . . . 73.299999999999997 110.789 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.446 ' HG3' ' HB ' ' A' ' 85' ' ' VAL . 60.7 tttp -57.15 -56.94 15.34 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 111.931 0.345 . . . . 71.230000000000004 111.931 177.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -56.57 -34.36 67.05 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.505 0.193 . . . . 72.109999999999999 111.506 -177.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.5 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 75.6 mmtt -59.13 -47.42 85.35 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.165 0.507 . . . . 73.439999999999998 110.99 172.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.496 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 58.2 mt -68.85 -42.08 77.59 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.928 -0.578 . . . . 73.349999999999994 111.984 -178.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -55.1 -39.78 69.7 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.245 0.545 . . . . 70.319999999999993 110.86 176.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.65 -22.96 66.7 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.788 -0.642 . . . . 72.150000000000006 111.827 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 77' ' ' LYS . 4.9 mm-40 -94.33 -1.38 53.94 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 111.985 0.365 . . . . 73.5 111.985 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.07 19.83 51.84 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 120.851 -0.69 . . . . 74.099999999999994 113.37 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.496 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 65.4 mt -99.77 110.77 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 O-C-N 122.704 -0.291 . . . . 70.409999999999997 110.721 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -73.19 102.83 3.72 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.973 0.416 . . . . 75.140000000000001 111.815 -177.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.446 ' HB ' ' HG3' ' A' ' 75' ' ' LYS . 22.0 t -98.54 126.39 51.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 116.453 -0.34 . . . . 74.25 111.328 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.619 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 42.6 t -72.57 159.04 34.56 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 111.979 0.363 . . . . 65.140000000000001 111.979 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -38.98 -55.76 1.51 Allowed 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 114.748 1.388 . . . . 62.530000000000001 114.748 -171.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 pp -82.45 16.96 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 112.543 0.571 . . . . 53.420000000000002 112.543 -175.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.44 52.57 4.43 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 121.347 -0.454 . . . . 62.100000000000001 113.107 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.619 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 86.7 tttt -116.25 125.54 52.35 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 122.352 -0.499 . . . . 74.329999999999998 111.86 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.527 HD12 HD13 ' A' ' 58' ' ' ILE . 57.4 mt -113.95 138.46 43.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 116.274 -0.421 . . . . 74.030000000000001 111.342 -178.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.48 92.52 4.02 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.011 0.434 . . . . 53.32 111.071 176.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.609 HD21 HD11 ' A' ' 58' ' ' ILE . 82.0 mt -56.26 -48.95 75.55 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.384 -0.371 . . . . 65.200000000000003 111.732 -178.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -52.85 -22.05 4.97 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.877 0.695 . . . . 73.120000000000005 112.877 -176.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -102.67 -38.84 7.31 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.085 0.402 . . . . 64.140000000000001 112.085 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -101.68 3.83 40.11 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 111.968 0.359 . . . . 72.120000000000005 111.968 -172.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 57.4 tttp -59.51 141.59 54.47 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.042 0.448 . . . . 71.420000000000002 111.91 -175.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 16.2 t90 -60.75 119.47 8.22 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.258 0.551 . . . . 72.329999999999998 111.414 178.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -118.56 90.8 40.33 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 115.776 -0.647 . . . . 74.519999999999996 111.261 -178.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo . . . . . 0 CA--C 1.54 0.795 0 C-N-CA 122.778 2.319 . . . . 61.310000000000002 113.341 178.912 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 CA--C 1.54 0.561 0 N-CA-C 112.716 0.635 . . . . 73.439999999999998 112.716 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -56.41 -38.33 71.39 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.296 -0.411 . . . . 72.010000000000005 111.499 175.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -49.03 -50.78 34.63 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.121 0.486 . . . . 73.230000000000004 110.787 173.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 61.9 mt -63.7 -48.27 77.77 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.759 -0.655 . . . . 71.519999999999996 111.176 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 63.1 t -57.33 -41.09 77.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 116.32 -0.4 . . . . 61.530000000000001 111.997 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.49 ' O ' HG23 ' A' ' 11' ' ' VAL . 27.9 mm-40 -73.75 -49.57 24.87 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.195 0.443 . . . . 74.319999999999993 112.195 -177.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.44 ' O ' HG13 ' A' ' 12' ' ' ILE . 31.4 pt -59.7 -40.2 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 O-C-N 122.055 -0.403 . . . . 53.299999999999997 111.259 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -58.23 -48.11 81.42 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.035 0.445 . . . . 64.150000000000006 110.448 171.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.37 -17.31 42.66 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.041 -0.527 . . . . 73.510000000000005 112.407 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 7' ' ' GLN . 49.9 t -92.41 -50.16 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-O 120.808 0.337 . . . . 71.310000000000002 111.3 175.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.501 HD12 HD21 ' A' ' 52' ' ' LEU . 79.8 mt -57.85 -37.82 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 112.849 0.685 . . . . 74.150000000000006 112.849 -175.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 -58.23 -21.3 47.48 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.402 0.519 . . . . 74.140000000000001 112.402 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -83.28 -6.24 59.4 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.509 0.559 . . . . 64.349999999999994 112.509 -178.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 45.3 mt -78.27 122.9 85.81 Favored Pre-proline 0 CA--C 1.544 0.72 0 O-C-N 122.419 -0.175 . . . . 64.200000000000003 110.655 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -79.88 178.76 6.9 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.801 2.334 . . . . 65.340000000000003 114.176 -175.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.53 ' HE3' ' HA ' ' A' ' 81' ' ' GLU . 49.3 tptt -67.18 122.88 18.79 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.627 -0.715 . . . . 61.200000000000003 111.502 -178.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.549 ' HA2' ' HB3' ' A' ' 81' ' ' GLU . . . 91.12 3.5 69.9 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 114.407 0.523 . . . . 71.430000000000007 114.407 175.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -117.81 146.86 43.55 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 117.575 0.688 . . . . 73.319999999999993 111.648 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.6 m -129.13 157.62 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.172 0.51 . . . . 73.439999999999998 111.747 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 89.3 p -132.43 171.11 14.18 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.236 -0.438 . . . . 74.230000000000004 110.793 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.9 p -103.52 152.03 22.17 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.808 0.337 . . . . 74.140000000000001 111.697 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -49.46 -41.47 40.44 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.442 0.534 . . . . 72.329999999999998 112.442 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.7 -40.99 95.57 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 121.239 -0.505 . . . . 72.340000000000003 113.252 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -66.91 -55.17 15.82 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.64 0.257 . . . . 73.140000000000001 111.073 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.6 mm -54.11 -49.99 57.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.208 0.528 . . . . 53.409999999999997 111.365 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.53 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -59.8 -43.77 94.29 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.062 -0.517 . . . . 55.130000000000003 111.737 179.082 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -62.35 -45.57 92.6 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.79 0.329 . . . . 75.310000000000002 111.182 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 65.4 mtt -63.15 -37.1 85.88 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.406 -0.361 . . . . 74.120000000000005 111.167 178.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.29 -29.38 67.24 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.935 0.397 . . . . 62.109999999999999 111.673 176.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.48 10.05 27.96 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 116.282 -0.417 . . . . 75.239999999999995 112.935 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.53 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 26.8 m-85 -127.27 63.5 58.23 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 122.451 0.3 . . . . 70.299999999999997 111.152 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.69 -35.7 87.99 Favored 'Trans proline' 0 N--CA 1.483 0.862 0 C-N-CA 122.829 2.353 . . . . 63.329999999999998 114.181 -172.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -82.35 -7.96 86.93 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 121.06 -0.59 . . . . 72.439999999999998 113.59 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.448 ' CD1' ' HB3' ' A' ' 32' ' ' TYR . 23.0 m-85 -86.2 16.14 4.61 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.529 0.566 . . . . 72.340000000000003 112.529 -178.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.09 -43.58 61.09 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.216 0.532 . . . . 74.519999999999996 111.618 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -57.55 -40.25 78.47 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.781 -0.645 . . . . 72.329999999999998 111.855 175.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -75.35 -28.23 59.5 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.651 -0.25 . . . . 72.319999999999993 111.673 -178.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 35' ' ' TYR . 46.5 t -61.18 -43.85 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 109.814 -0.439 . . . . 53.030000000000001 109.814 173.154 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.02 -41.94 96.69 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 115.992 -0.549 . . . . 53.030000000000001 112.631 174.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.4 mttp -57.46 -53.83 53.75 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.975 0.417 . . . . 74.150000000000006 111.303 173.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.33 -47.64 78.35 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.165 -0.47 . . . . 73.299999999999997 112.08 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.437 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 79.8 mt -68.1 -41.39 81.88 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.861 0.362 . . . . 74.0 111.496 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.7 -18.79 62.09 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.156 -0.545 . . . . 73.040000000000006 113.374 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -86.06 -4.49 59.18 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 122.606 -0.349 . . . . 72.310000000000002 111.649 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 96.2 mt -92.61 121.53 65.99 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-O 120.761 0.315 . . . . 73.099999999999994 111.653 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.89 160.86 36.83 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.326 2.017 . . . . 63.310000000000002 112.469 177.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -67.13 119.32 11.85 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.287 0.565 . . . . 64.230000000000004 110.962 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 110.89 -2.51 28.74 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 115.983 -0.553 . . . . 62.32 112.673 -173.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 31.0 t -61.85 167.82 3.49 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.165 0.507 . . . . 62.299999999999997 112.162 177.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -66.93 -29.51 69.4 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.737 0.643 . . . . 53.229999999999997 112.737 -177.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.555 HD12 ' HD2' ' A' ' 53' ' ' PRO . 25.7 tp -102.46 131.84 22.03 Favored Pre-proline 0 N--CA 1.472 0.639 0 N-CA-C 111.558 0.207 . . . . 51.340000000000003 111.558 -178.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.555 ' HD2' HD12 ' A' ' 52' ' ' LEU . 59.4 Cg_endo -73.62 95.1 0.86 Allowed 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 121.591 1.527 . . . . 71.209999999999994 111.813 171.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.437 ' HB2' ' HB3' ' A' ' 43' ' ' LEU . 55.2 p-90 -81.35 -24.51 37.03 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.225 0.536 . . . . 71.5 112.222 -176.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.451 ' CG ' ' HB3' ' A' ' 77' ' ' LYS . 29.3 p90 -65.24 -17.99 64.94 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.381 0.882 . . . . 65.430000000000007 113.381 -175.162 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -83.23 7.33 16.58 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.545 0.572 . . . . 74.150000000000006 112.545 -177.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.6 t -123.19 117.93 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 121.029 0.443 . . . . 62.32 111.131 176.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.495 HD11 HD21 ' A' ' 93' ' ' LEU . 42.3 pt -123.21 -170.35 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 121.112 0.482 . . . . 65.209999999999994 111.714 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.7 p30 -86.28 163.48 17.69 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.078 0.466 . . . . 61.399999999999999 111.585 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 88.1 p -79.6 9.43 5.0 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 120.983 0.42 . . . . 55.229999999999997 111.665 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -93.61 -8.74 40.28 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.161 -0.472 . . . . 73.5 111.13 178.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.5 40.59 27.29 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.311 -0.471 . . . . 21.510000000000002 112.821 -177.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.627 ' HG2' ' HG2' ' A' ' 90' ' ' LYS . 53.5 mtpt -137.45 166.78 23.02 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.101 0.477 . . . . 73.530000000000001 111.441 178.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 63.6 mt -67.15 109.88 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.505 -0.554 . . . . 73.409999999999997 109.505 170.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.4 t -57.7 -40.09 78.72 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.143 -0.48 . . . . 74.409999999999997 112.013 -175.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.595 HD13 ' HB3' ' A' ' 70' ' ' ASP . 84.9 mt -76.78 160.15 29.53 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.995 0.426 . . . . 75.140000000000001 111.399 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -130.82 157.51 42.66 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.051 0.453 . . . . 75.439999999999998 111.869 -176.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.48 -130.19 31.51 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.267 -0.492 . . . . 62.130000000000003 113.398 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.418 ' H ' ' HG3' ' A' ' 69' ' ' ARG . 10.2 mtm180 -48.69 -50.93 31.1 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.902 0.858 . . . . 74.439999999999998 110.947 178.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.595 ' HB3' HD13 ' A' ' 66' ' ' LEU . 21.5 m-20 -70.72 -18.85 62.79 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 114.627 -1.17 . . . . 72.340000000000003 112.035 -172.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.0 tt -66.7 -51.07 60.18 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.608 -0.516 . . . . 73.099999999999994 109.608 174.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -61.6 -36.36 80.49 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.08 -0.509 . . . . 61.439999999999998 111.528 175.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.2 mtt180 -56.1 -62.81 1.45 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.51 0.195 . . . . 61.399999999999999 111.473 174.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.413 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 52.5 tt0 -58.83 -36.47 74.6 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.714 0.293 . . . . 74.010000000000005 111.086 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.497 ' HG3' HG11 ' A' ' 85' ' ' VAL . 79.2 tttt -52.46 -65.95 0.47 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.991 0.424 . . . . 74.109999999999999 111.62 174.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -63.18 -30.87 71.93 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.084 -0.507 . . . . 75.230000000000004 112.224 -175.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.451 ' HB3' ' CG ' ' A' ' 55' ' ' PHE . 72.3 mmtt -61.02 -45.89 92.98 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.974 0.416 . . . . 54.409999999999997 110.626 174.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.474 HD22 HD12 ' A' ' 83' ' ' ILE . 83.6 mt -72.17 -28.09 63.0 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.397 -0.365 . . . . 73.150000000000006 111.633 177.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.495 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 49.7 mt-10 -66.88 -28.06 68.02 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.067 0.46 . . . . 74.109999999999999 110.325 172.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.6 -23.66 59.95 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.165 0.507 . . . . 40.549999999999997 110.858 172.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.549 ' HB3' ' HA2' ' A' ' 18' ' ' GLY . 39.7 mm-40 -81.77 -26.25 34.61 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.024 -0.535 . . . . 61.100000000000001 110.989 174.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.85 37.18 4.26 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 116.304 -0.407 . . . . 75.319999999999993 113.057 -178.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.474 HD12 HD22 ' A' ' 78' ' ' LEU . 58.6 mt -105.8 136.98 37.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 112.301 0.482 . . . . 75.129999999999995 112.301 -176.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -67.95 93.7 0.43 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.887 0.375 . . . . 72.120000000000005 111.582 172.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.497 HG11 ' HG3' ' A' ' 75' ' ' LYS . 60.2 t -86.94 107.11 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 110.116 -0.328 . . . . 74.420000000000002 110.116 174.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.574 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 23.8 t -64.83 147.74 52.65 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.637 -0.256 . . . . 71.430000000000007 111.352 -177.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.453 ' HG3' ' N ' ' A' ' 88' ' ' ILE . 12.3 pt-20 -36.31 -55.76 0.8 Allowed 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 115.424 1.638 . . . . 64.439999999999998 115.424 -167.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.453 ' N ' ' HG3' ' A' ' 87' ' ' GLU . 2.8 pp -87.35 10.12 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 112.866 0.691 . . . . 74.450000000000003 112.866 -173.104 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 97.74 47.98 2.03 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 121.363 -0.446 . . . . 74.019999999999996 113.999 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.627 ' HG2' ' HG2' ' A' ' 63' ' ' LYS . 90.8 mttt -114.77 146.36 41.07 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 122.305 -0.526 . . . . 74.510000000000005 111.515 176.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.444 HD12 HG21 ' A' ' 58' ' ' ILE . 58.3 mt -130.97 138.77 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 115.873 -0.603 . . . . 73.150000000000006 111.137 -177.052 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.56 93.55 8.83 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.621 -0.263 . . . . 73.340000000000003 111.679 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.495 HD21 HD11 ' A' ' 58' ' ' ILE . 62.2 mt -53.97 -57.18 11.97 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 111.79 0.292 . . . . 72.319999999999993 111.79 177.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 52.9 ttp180 -46.25 -30.65 2.1 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.727 0.639 . . . . 64.409999999999997 112.727 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -90.59 -25.63 20.08 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 112.242 0.46 . . . . 72.400000000000006 112.242 -176.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -127.11 13.08 7.21 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 113.129 0.788 . . . . 75.400000000000006 113.129 -176.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 93' ' ' LEU . 55.2 tttm -64.61 125.98 26.44 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.029 0.443 . . . . 65.120000000000005 111.777 -175.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 22.4 t90 -58.94 113.8 2.26 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.853 0.686 . . . . 71.239999999999995 112.853 -175.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -107.71 92.41 8.73 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 115.909 -0.587 . . . . 63.229999999999997 110.481 172.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo . . . . . 0 CA--C 1.54 0.808 0 C-N-CA 122.585 2.19 . . . . 75.030000000000001 113.184 179.885 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.5 t70 . . . . . 0 CA--C 1.546 0.823 0 N-CA-C 112.742 0.645 . . . . 44.240000000000002 112.742 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -52.72 -39.57 62.18 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.677 0.621 . . . . 74.5 112.677 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -57.74 -48.71 78.84 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.898 0.38 . . . . 64.129999999999995 110.754 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.28 -46.58 89.76 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.034 -0.53 . . . . 54.329999999999998 111.26 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 73.2 t -56.48 -52.31 54.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 116.286 -0.415 . . . . 72.329999999999998 111.62 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -63.98 -49.85 70.87 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.947 0.721 . . . . 53.310000000000002 112.947 -176.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 36.9 pt -60.73 -41.76 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 O-C-N 122.114 -0.366 . . . . 65.25 111.401 -178.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -66.03 -41.78 90.48 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.747 0.308 . . . . 74.519999999999996 110.998 177.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.04 -37.95 69.93 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.011 0.434 . . . . 61.439999999999998 111.586 177.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 95.9 t -66.85 -41.85 88.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-O 121.015 0.436 . . . . 73.129999999999995 110.982 177.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.557 ' HB ' HD11 ' A' ' 52' ' ' LEU . 73.7 mt -62.5 -37.32 78.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 116.117 -0.492 . . . . 75.120000000000005 111.801 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -57.16 -21.17 30.91 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 122.194 -0.316 . . . . 70.019999999999996 111.717 174.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -87.46 -4.13 59.01 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 112.447 0.536 . . . . 74.209999999999994 112.447 -177.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.547 HD11 HD11 ' A' ' 26' ' ' ILE . 60.0 mt -76.32 122.26 86.44 Favored Pre-proline 0 CA--C 1.542 0.658 0 O-C-N 122.349 -0.219 . . . . 64.319999999999993 110.776 177.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -68.21 169.51 16.61 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.582 2.188 . . . . 74.5 112.782 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -67.24 149.46 50.39 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.035 0.445 . . . . 73.439999999999998 112.015 -177.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.99 -32.78 1.73 Allowed Glycine 0 CA--C 1.529 0.966 0 C-N-CA 121.337 -0.459 . . . . 52.299999999999997 113.839 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -77.75 159.92 28.74 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.447 0.641 . . . . 71.5 112.562 -177.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.5 m -130.54 156.33 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 115.543 -0.753 . . . . 54.420000000000002 110.621 177.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 51.0 m -133.3 155.95 48.48 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.07 0.462 . . . . 73.040000000000006 111.558 176.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.5 p -94.17 155.05 17.26 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.982 0.42 . . . . 72.219999999999999 111.282 176.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -55.8 -33.91 64.84 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.307 -0.406 . . . . 75.239999999999995 111.823 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.99 -43.47 97.35 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.195 -0.526 . . . . 75.030000000000001 112.832 178.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -62.36 -54.68 36.83 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.913 0.387 . . . . 73.319999999999993 111.11 177.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.547 HD11 HD11 ' A' ' 15' ' ' ILE . 50.1 mm -54.79 -49.74 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 116.208 -0.451 . . . . 71.319999999999993 111.464 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.07 -43.53 82.2 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.454 -0.339 . . . . 45.299999999999997 111.596 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.03 -56.1 22.47 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 111.752 0.279 . . . . 71.409999999999997 111.752 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -61.53 -25.63 67.41 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.148 0.425 . . . . 65.109999999999999 112.148 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.3 -21.22 53.87 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.042 0.386 . . . . 74.430000000000007 112.042 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.09 21.29 20.98 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.251 -0.499 . . . . 63.030000000000001 113.157 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -134.43 54.04 10.95 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 122.529 0.331 . . . . 73.540000000000006 111.74 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -62.25 132.45 38.86 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 121.983 1.789 . . . . 52.549999999999997 112.237 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.65 -28.38 15.74 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.146 -0.55 . . . . 43.420000000000002 113.008 -176.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -82.77 27.57 0.53 Allowed 'General case' 0 CA--C 1.542 0.662 0 O-C-N 122.452 -0.44 . . . . 72.299999999999997 111.989 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.09 -39.96 76.04 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.399 0.518 . . . . 74.349999999999994 112.399 -177.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -60.4 -32.02 70.93 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.946 0.403 . . . . 64.420000000000002 111.1 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -74.57 -41.05 61.21 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.309 -0.405 . . . . 70.329999999999998 110.791 177.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.2 t -56.2 -42.2 72.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.074 0.464 . . . . 63.32 110.641 175.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.26 -45.34 96.27 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-N 116.064 -0.516 . . . . 52.009999999999998 112.731 175.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -64.47 -33.34 75.66 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.938 0.399 . . . . 64.430000000000007 111.392 177.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.32 -48.12 71.34 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.298 -0.41 . . . . 71.200000000000003 111.435 177.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.1 mt -67.34 -38.96 85.67 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.948 0.404 . . . . 75.349999999999994 111.319 177.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.62 -13.21 50.22 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 121.145 -0.55 . . . . 51.32 113.142 176.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -93.9 -8.0 41.49 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 120.987 0.422 . . . . 73.230000000000004 111.186 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 70.6 mt -82.22 144.78 51.03 Favored Pre-proline 0 N--CA 1.472 0.634 0 N-CA-C 112.665 0.617 . . . . 71.219999999999999 112.665 -177.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.05 144.24 37.55 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.479 2.12 . . . . 63.130000000000003 111.733 172.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.548 ' HB3' ' HE ' ' A' ' 73' ' ' ARG . 16.6 pt-20 -65.04 -26.37 68.23 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 122.102 -0.374 . . . . 55.229999999999997 111.997 -176.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -88.37 20.96 27.57 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 121.066 -0.588 . . . . 52.450000000000003 113.856 177.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.9 t -73.1 150.29 42.39 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 117.083 0.442 . . . . 63.329999999999998 112.173 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -64.56 -46.3 83.39 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.275 0.559 . . . . 72.340000000000003 110.77 175.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.557 HD11 ' HB ' ' A' ' 12' ' ' ILE . 51.8 tp -58.22 117.16 17.91 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 115.602 -0.726 . . . . 61.43 111.382 175.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.49 ' HD2' HD12 ' A' ' 52' ' ' LEU . 58.9 Cg_endo -72.49 94.52 0.77 Allowed 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 121.465 1.443 . . . . 63.100000000000001 111.992 178.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 67.4 p-90 -82.79 -26.79 31.45 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.372 0.606 . . . . 73.439999999999998 110.964 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.523 ' HA ' ' HG3' ' A' ' 74' ' ' GLN . 29.1 p90 -62.27 -20.39 64.23 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.507 -0.769 . . . . 73.519999999999996 112.909 -176.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 79.9 mtt-85 -79.32 1.72 24.06 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.397 0.518 . . . . 70.120000000000005 112.397 -178.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 21' ' ' SER . 33.5 t -109.57 124.79 66.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 O-C-N 121.892 -0.505 . . . . 75.420000000000002 111.89 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.6 pt -132.91 177.04 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 116.414 -0.357 . . . . 71.420000000000002 111.564 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.454 HD21 ' HB2' ' A' ' 63' ' ' LYS . 36.7 p30 -80.61 177.78 8.78 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.773 0.657 . . . . 73.420000000000002 112.773 -174.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 76.0 p -67.3 -17.7 64.88 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.913 -0.585 . . . . 64.120000000000005 112.494 -177.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -83.58 -10.69 58.09 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.066 0.46 . . . . 72.319999999999993 111.13 177.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.67 49.42 14.32 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.88 -0.676 . . . . 73.400000000000006 111.665 -172.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.454 ' HB2' HD21 ' A' ' 59' ' ' ASN . 96.7 mttt -135.1 158.36 44.55 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.922 0.391 . . . . 63.240000000000002 111.015 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 67.9 mt -72.58 119.39 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.4 -0.364 . . . . 65.319999999999993 110.915 177.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.5 m -65.62 -44.2 87.25 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.804 0.335 . . . . 70.340000000000003 111.881 -178.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.436 ' HB3' ' HB3' ' A' ' 70' ' ' ASP . 84.7 mt -74.92 117.31 16.63 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.807 0.337 . . . . 71.230000000000004 110.896 178.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -108.78 169.87 8.39 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.847 0.356 . . . . 64.230000000000004 111.702 -177.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.02 -132.06 10.94 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 121.18 -0.533 . . . . 41.109999999999999 111.834 -173.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -81.59 -26.41 34.96 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 122.188 -0.595 . . . . 72.319999999999993 110.93 174.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.503 ' O ' ' HB3' ' A' ' 73' ' ' ARG . 17.6 m-20 -63.89 -17.33 63.09 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.994 0.426 . . . . 71.439999999999998 110.798 174.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.1 tt -65.11 -52.33 56.02 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.094 -0.503 . . . . 72.129999999999995 109.937 173.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.582 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 19.3 m-20 -63.59 -31.89 73.19 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.99 0.424 . . . . 64.040000000000006 111.359 176.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.548 ' HE ' ' HB3' ' A' ' 48' ' ' GLU . 70.8 ttt180 -51.1 -63.84 1.0 Allowed 'General case' 0 CA--C 1.547 0.832 0 CA-C-O 121.236 0.541 . . . . 74.030000000000001 110.897 173.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.523 ' HG3' ' HA ' ' A' ' 55' ' ' PHE . 48.1 tt0 -67.77 -43.64 79.35 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.093 0.473 . . . . 73.319999999999993 110.944 178.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.582 ' HB3' ' HA ' ' A' ' 72' ' ' ASP . 85.0 tttt -48.93 -60.94 2.34 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.702 -0.681 . . . . 73.200000000000003 112.149 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -65.02 -34.36 78.26 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.184 0.438 . . . . 63.399999999999999 112.184 -176.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -60.19 -29.67 68.86 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 120.605 -0.438 . . . . 74.310000000000002 111.373 172.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 80.5 mt -86.43 -34.37 20.15 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.227 -0.442 . . . . 73.430000000000007 111.548 175.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 35.7 mt-10 -66.08 -31.89 73.04 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 122.192 -0.317 . . . . 74.010000000000005 111.262 178.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.27 -25.86 62.28 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.222 0.534 . . . . 73.239999999999995 111.187 174.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.435 ' HB2' HG13 ' A' ' 83' ' ' ILE . 14.1 mm-40 -80.05 -26.15 39.84 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.347 0.594 . . . . 64.120000000000005 111.066 176.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 99.88 22.82 11.49 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 115.906 -0.588 . . . . 63.119999999999997 112.29 -172.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.435 HG13 ' HB2' ' A' ' 81' ' ' GLU . 73.1 mt -83.86 125.72 40.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.011 0.434 . . . . 65.319999999999993 111.169 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.408 ' HG2' ' CE2' ' A' ' 96' ' ' TYR . 11.6 pt-20 -72.24 99.07 2.3 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.583 0.706 . . . . 75.140000000000001 112.145 -177.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.429 HG11 ' HG3' ' A' ' 75' ' ' LYS . 44.7 t -100.14 111.15 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 115.994 -0.548 . . . . 74.120000000000005 110.879 178.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.587 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 40.3 t -67.12 158.22 31.71 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.278 -0.419 . . . . 61.140000000000001 111.629 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -43.69 -53.43 5.8 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 114.281 1.215 . . . . 71.239999999999995 114.281 -170.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.445 HD11 ' HB2' ' A' ' 90' ' ' LYS . 2.8 pp -79.47 12.96 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 112.524 0.565 . . . . 75.219999999999999 112.524 -176.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.51 48.97 5.09 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-N 116.365 -0.38 . . . . 64.209999999999994 112.986 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.587 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 61.3 tttm -116.19 123.46 47.84 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 120.992 0.425 . . . . 74.109999999999999 111.941 -178.078 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 64.6 mt -116.27 142.92 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 122.769 0.428 . . . . 63.200000000000003 111.33 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.25 101.84 5.6 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 111.896 0.332 . . . . 44.299999999999997 111.896 178.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.4 ' O ' ' N ' ' A' ' 97' ' ' LYS . 57.5 mt -54.54 -62.54 1.59 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.15 0.426 . . . . 54.140000000000001 112.15 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 45.3 mtm180 -49.88 -29.9 9.03 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.311 0.485 . . . . 71.329999999999998 112.311 -176.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -79.94 -35.27 38.01 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.083 -0.508 . . . . 73.420000000000002 111.581 -176.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.408 ' CE2' ' HG2' ' A' ' 84' ' ' GLU . 98.8 m-85 -115.71 5.98 14.35 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.292 0.479 . . . . 74.409999999999997 112.292 -177.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.4 ' N ' ' O ' ' A' ' 93' ' ' LEU . 55.5 tttm -59.32 133.82 56.44 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.074 0.464 . . . . 65.530000000000001 111.971 -174.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 13.6 t90 -55.2 114.29 1.72 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.995 -0.548 . . . . 64.109999999999999 111.491 178.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -109.45 91.83 10.69 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 116.157 -0.474 . . . . 60.439999999999998 110.44 175.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo . . . . . 0 CA--C 1.537 0.628 0 C-N-CA 122.221 1.947 . . . . 75.430000000000007 112.082 177.963 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.416 ' O ' HG23 ' A' ' 6' ' ' VAL . 3.9 m-20 . . . . . 0 N--CA 1.475 0.777 0 N-CA-C 112.248 0.462 . . . . 73.430000000000007 112.248 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.494 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 90.7 mm-40 -55.21 -37.47 67.16 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.346 0.498 . . . . 61.240000000000002 112.346 -177.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -55.86 -54.48 44.1 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.231 0.538 . . . . 72.219999999999999 110.603 176.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 68.9 mt -62.74 -44.72 95.46 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.556 -0.747 . . . . 54.130000000000003 111.201 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 2' ' ' ASP . 85.5 t -57.11 -52.27 58.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 112.078 0.399 . . . . 61.109999999999999 112.078 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 28.6 mm-40 -62.32 -51.08 69.09 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.156 0.428 . . . . 72.409999999999997 112.156 -175.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.54 HD12 HG13 ' A' ' 39' ' ' VAL . 31.4 pt -59.55 -45.69 93.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 111.633 0.235 . . . . 73.140000000000001 111.633 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 19.6 m-30 -63.98 -41.33 97.56 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.132 0.491 . . . . 62.25 110.886 177.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.47 -20.4 63.11 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.87 -0.605 . . . . 30.100000000000001 111.798 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 7' ' ' GLN . 99.2 t -85.71 -41.0 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 120.745 0.307 . . . . 65.430000000000007 111.05 173.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 8' ' ' ILE . 79.3 mt -55.28 -41.23 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 112.664 0.616 . . . . 72.319999999999993 112.664 -177.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -58.38 -12.52 3.9 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 113.424 0.898 . . . . 74.040000000000006 113.424 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -85.64 -7.46 58.81 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 112.079 0.4 . . . . 63.210000000000001 112.079 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 63.8 mt -75.71 119.77 78.62 Favored Pre-proline 0 CA--C 1.542 0.661 0 O-C-N 122.407 -0.183 . . . . 74.010000000000005 110.696 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -76.75 161.1 33.94 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.545 2.164 . . . . 51.43 113.269 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 45.3 tttp -63.88 107.84 1.32 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.253 -0.431 . . . . 64.329999999999998 111.235 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 128.87 -15.61 5.9 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.923 -0.656 . . . . 72.209999999999994 113.483 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -116.6 163.42 16.12 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.386 0.612 . . . . 61.299999999999997 112.254 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.4 m -135.82 162.75 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-N 115.444 -0.798 . . . . 74.430000000000007 110.895 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 89.0 p -137.36 171.02 15.11 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.747 0.308 . . . . 42.539999999999999 110.613 175.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 40.2 p -107.05 154.03 21.73 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.829 0.347 . . . . 71.439999999999998 111.541 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.433 ' HE1' HD12 ' A' ' 43' ' ' LEU . 54.2 m-85 -50.65 -41.25 55.15 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 116.223 -0.444 . . . . 71.209999999999994 112.074 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -57.66 -41.6 93.81 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 121.23 -0.51 . . . . 74.200000000000003 112.912 178.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 29' ' ' MET . 42.2 mt-10 -65.93 -52.63 48.2 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.655 0.264 . . . . 71.310000000000002 111.063 178.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 44.4 mm -56.54 -47.33 82.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 120.984 0.421 . . . . 73.349999999999994 111.571 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.84 -45.97 90.13 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.34 -0.391 . . . . 75.530000000000001 111.593 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -61.04 -41.61 96.9 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 111.768 0.284 . . . . 73.030000000000001 111.768 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.477 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 64.8 mtt -67.86 -34.76 77.31 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.634 0.254 . . . . 43.409999999999997 111.477 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.69 -27.28 50.72 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.877 0.37 . . . . 73.319999999999993 111.731 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.81 44.99 1.84 Allowed Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.442 -0.409 . . . . 41.009999999999998 113.644 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -137.41 83.09 26.89 Favored Pre-proline 0 CA--C 1.544 0.716 0 O-C-N 122.412 -0.464 . . . . 74.219999999999999 111.576 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.4 126.49 14.31 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 122.791 2.327 . . . . 72.540000000000006 113.024 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.19 -8.71 79.22 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 121.396 -0.431 . . . . 54.520000000000003 113.709 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -94.35 11.13 31.58 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.569 0.581 . . . . 70.439999999999998 112.569 -177.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.81 -47.7 70.6 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.208 0.527 . . . . 52.109999999999999 111.457 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.8 ptt180 -53.44 -38.02 63.13 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.678 -0.692 . . . . 75.030000000000001 112.119 174.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -69.49 -35.89 76.0 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.781 0.324 . . . . 65.040000000000006 111.203 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.54 HG13 HD12 ' A' ' 8' ' ' ILE . 55.5 t -57.42 -39.65 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 121.195 0.521 . . . . 72.400000000000006 110.378 174.046 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.31 -40.9 99.25 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 116.031 -0.531 . . . . 42.119999999999997 112.528 174.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -58.95 -38.0 78.04 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.031 0.443 . . . . 74.530000000000001 111.089 175.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.95 -55.34 19.74 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.87 -0.605 . . . . 71.129999999999995 111.838 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.433 HD12 ' HE1' ' A' ' 23' ' ' TYR . 68.0 mt -62.47 -32.27 73.12 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.67 0.271 . . . . 61.539999999999999 111.536 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.72 -21.54 58.34 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 121.192 -0.528 . . . . 75.030000000000001 113.542 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -84.4 -10.56 57.43 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.091 0.472 . . . . 62.539999999999999 110.977 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.452 HD11 HD23 ' A' ' 52' ' ' LEU . 97.5 mt -87.5 139.96 31.79 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 116.361 -0.381 . . . . 73.239999999999995 111.924 -178.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -88.08 173.31 4.95 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.701 2.267 . . . . 60.210000000000001 112.667 175.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.767 ' HB3' ' HD3' ' A' ' 73' ' ' ARG . 9.7 pt-20 -67.48 -12.86 61.31 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.785 0.326 . . . . 73.340000000000003 111.82 177.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -96.78 32.84 6.18 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 121.353 -0.451 . . . . 43.229999999999997 113.445 176.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.8 t -95.45 135.36 37.18 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 122.294 -0.533 . . . . 52.200000000000003 111.507 177.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -70.14 -28.57 65.46 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.923 0.392 . . . . 52.200000000000003 111.185 174.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.526 HD12 ' HD2' ' A' ' 53' ' ' PRO . 48.5 tp -72.78 117.65 61.31 Favored Pre-proline 0 C--O 1.237 0.423 0 CA-C-N 116.219 -0.446 . . . . 73.310000000000002 110.441 176.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.526 ' HD2' HD12 ' A' ' 52' ' ' LEU . 44.5 Cg_endo -67.1 95.32 0.36 Allowed 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 121.562 1.508 . . . . 75.209999999999994 112.496 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 -80.81 -31.54 35.6 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.406 0.622 . . . . 70.25 110.723 177.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.481 ' O ' HD21 ' A' ' 78' ' ' LEU . 20.8 p90 -63.25 -21.89 66.52 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.242 0.83 . . . . 72.25 113.242 -178.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -84.4 -1.25 55.25 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.6 0.593 . . . . 71.230000000000004 112.6 -177.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.8 t -118.11 106.97 20.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-O 121.342 0.592 . . . . 71.140000000000001 111.58 -178.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.567 HD11 HD21 ' A' ' 93' ' ' LEU . 28.6 pt -112.67 -169.64 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 121.263 0.554 . . . . 63.119999999999997 112.114 -177.006 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 28.2 p30 -95.23 170.3 9.48 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.545 0.572 . . . . 52.0 112.545 -175.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 31.1 t -63.62 -17.88 63.35 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 112.46 0.541 . . . . 72.200000000000003 112.46 -178.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -75.75 -14.62 60.33 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.058 0.456 . . . . 60.409999999999997 111.113 177.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.99 43.64 33.06 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.036 -0.602 . . . . 52.119999999999997 111.934 -174.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.409 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 89.7 mttt -133.85 162.45 31.98 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.164 0.507 . . . . 74.549999999999997 111.596 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.415 HG23 ' OE1' ' A' ' 74' ' ' GLN . 66.5 mt -70.13 119.03 15.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 115.759 -0.655 . . . . 72.319999999999993 110.178 172.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.0 m -67.16 -27.75 67.55 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.198 0.444 . . . . 72.109999999999999 112.198 -177.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.533 HD13 ' HB3' ' A' ' 70' ' ' ASP . 77.1 mt -77.33 165.93 23.81 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.144 0.497 . . . . 64.420000000000002 111.727 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -133.68 148.96 51.53 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.066 0.46 . . . . 72.319999999999993 112.084 -171.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.34 -123.82 30.36 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-N 116.081 -0.509 . . . . 73.540000000000006 113.553 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 48.0 mtp180 -64.72 -38.96 92.77 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.175 0.512 . . . . 63.229999999999997 110.924 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.533 ' HB3' HD13 ' A' ' 66' ' ' LEU . 4.3 m-20 -60.49 -30.19 69.55 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.949 -0.568 . . . . 72.319999999999993 111.233 176.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.1 tt -65.74 -59.09 4.26 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.351 -0.386 . . . . 73.219999999999999 110.784 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -69.13 -21.63 64.01 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 122.267 -0.271 . . . . 72.430000000000007 111.468 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.767 ' HD3' ' HB3' ' A' ' 48' ' ' GLU . 35.9 ttm180 -61.91 -52.27 64.75 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.069 0.461 . . . . 61.549999999999997 110.319 172.026 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.415 ' OE1' HG23 ' A' ' 64' ' ' ILE . 53.5 tt0 -60.63 -39.45 88.28 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.1 -0.5 . . . . 72.140000000000001 110.714 178.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.464 ' HG3' ' HB ' ' A' ' 85' ' ' VAL . 85.5 tttt -57.73 -53.08 62.26 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.081 -0.509 . . . . 62.43 111.236 176.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -55.75 -39.59 71.38 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.948 0.404 . . . . 70.25 111.441 178.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.457 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 69.0 mmtt -58.59 -48.5 80.73 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.189 -0.46 . . . . 75.540000000000006 111.415 173.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.481 HD21 ' O ' ' A' ' 55' ' ' PHE . 85.6 mt -66.28 -39.87 89.69 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.247 -0.433 . . . . 72.049999999999997 111.934 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 46.2 mt-10 -64.15 -26.64 68.62 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.948 0.404 . . . . 73.340000000000003 110.909 177.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.57 -14.53 60.8 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.234 -0.439 . . . . 52.140000000000001 111.576 174.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 77' ' ' LYS . 22.5 mm-40 -103.6 10.06 37.11 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 111.855 0.317 . . . . 74.239999999999995 111.855 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.46 30.49 40.49 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 121.066 -0.588 . . . . 51.520000000000003 113.535 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.1 mt -112.04 138.67 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 O-C-N 122.449 -0.442 . . . . 74.129999999999995 111.383 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.476 ' HB2' ' OH ' ' A' ' 96' ' ' TYR . 40.1 mt-10 -100.47 114.33 27.83 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.826 0.346 . . . . 73.329999999999998 110.696 175.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.464 ' HB ' ' HG3' ' A' ' 75' ' ' LYS . 79.7 t -107.63 131.44 57.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 116.398 -0.365 . . . . 73.239999999999995 111.177 -178.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.562 ' OG ' ' HB3' ' A' ' 90' ' ' LYS . 25.6 p -74.32 148.0 41.76 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.88 0.372 . . . . 62.439999999999998 111.412 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.417 ' HG3' ' N ' ' A' ' 88' ' ' ILE . 12.4 pt-20 -42.59 -53.92 4.19 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.891 1.441 . . . . 74.299999999999997 114.891 -166.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.417 ' N ' ' HG3' ' A' ' 87' ' ' GLU . 2.8 pp -73.59 11.92 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 112.868 0.692 . . . . 75.129999999999995 112.868 -175.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.43 50.79 4.36 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 121.426 -0.416 . . . . 71.349999999999994 113.127 177.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.574 ' HD3' ' N ' ' A' ' 91' ' ' ILE . 6.6 tmtm? -122.88 138.58 54.62 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 122.446 -0.443 . . . . 64.510000000000005 110.488 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.574 ' N ' ' HD3' ' A' ' 90' ' ' LYS . 66.6 mt -121.2 132.34 70.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 120.883 0.373 . . . . 62.530000000000001 111.463 -178.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.86 93.51 2.66 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.899 0.38 . . . . 71.129999999999995 111.454 177.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.567 HD21 HD11 ' A' ' 58' ' ' ILE . 63.4 mt -51.99 -49.58 63.02 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.024 0.75 . . . . 71.120000000000005 113.024 -176.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -49.87 -44.52 49.82 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 121.256 0.55 . . . . 75.329999999999998 111.829 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -76.29 -34.25 59.08 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.718 -0.673 . . . . 63.310000000000002 112.367 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.476 ' OH ' ' HB2' ' A' ' 84' ' ' GLU . 78.8 m-85 -112.28 14.63 20.51 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.273 0.471 . . . . 73.010000000000005 112.273 -172.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 61.9 tttp -65.02 130.05 41.94 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.095 0.474 . . . . 44.450000000000003 111.943 -177.004 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 19.7 t90 -62.51 113.73 3.12 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.979 -0.555 . . . . 73.230000000000004 111.195 175.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -113.33 92.64 23.41 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 116.4 -0.364 . . . . 71.549999999999997 110.524 176.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo . . . . . 0 C--N 1.354 0.855 0 C-N-CA 122.731 2.288 . . . . 72.420000000000002 112.938 -179.0 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 . . . . . 0 CA--C 1.542 0.64 0 N-CA-C 112.043 0.386 . . . . 74.209999999999994 112.043 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.435 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 62.3 mm-40 -53.61 -32.39 50.93 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.618 0.599 . . . . 42.340000000000003 112.618 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.405 ' O ' HG12 ' A' ' 8' ' ' ILE . 73.0 t80 -55.61 -48.9 74.15 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.247 0.546 . . . . 63.25 109.993 173.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 72.2 mt -67.07 -46.91 72.89 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.523 -0.762 . . . . 74.310000000000002 111.162 178.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 85.3 t -52.38 -50.24 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.8 0.334 . . . . 75.129999999999995 111.847 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.435 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 26.3 mm-40 -63.71 -52.7 59.35 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.157 0.428 . . . . 62.210000000000001 112.157 -177.514 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.419 ' O ' HG13 ' A' ' 12' ' ' ILE . 31.6 pt -65.32 -45.67 92.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 O-C-N 122.315 -0.241 . . . . 72.030000000000001 111.647 -178.168 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.405 ' CD1' HG13 ' A' ' 8' ' ' ILE . 14.2 m-30 -61.1 -43.28 99.13 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.755 0.312 . . . . 71.299999999999997 111.069 178.149 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.74 -43.08 65.49 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.439 -0.346 . . . . 75.0 111.383 177.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 7' ' ' GLN . 61.4 t -64.36 -42.4 95.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 121.142 0.496 . . . . 63.219999999999999 111.182 177.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.517 ' HB ' HD11 ' A' ' 52' ' ' LEU . 73.7 mt -62.85 -32.59 56.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 116.016 -0.538 . . . . 72.430000000000007 112.086 -178.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 72.3 m-70 -60.58 -22.25 63.51 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.299 0.481 . . . . 75.150000000000006 112.299 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -77.31 -14.07 59.81 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.256 0.465 . . . . 75.030000000000001 112.256 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.515 HD11 HD11 ' A' ' 26' ' ' ILE . 51.4 mt -75.08 113.76 28.3 Favored Pre-proline 0 CA--C 1.542 0.662 0 O-C-N 122.455 -0.153 . . . . 71.099999999999994 111.122 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -69.89 175.23 8.49 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.016 2.477 . . . . 72.219999999999999 113.751 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -67.81 140.13 56.61 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.92 -0.582 . . . . 64.129999999999995 111.768 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.76 17.25 71.04 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.188 -0.529 . . . . 70.230000000000004 113.378 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -118.3 141.18 48.79 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.688 0.28 . . . . 71.430000000000007 110.579 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.9 m -122.52 146.47 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.433 0.635 . . . . 63.329999999999998 112.284 -177.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.4 t -134.51 178.28 7.11 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.692 -0.685 . . . . 61.340000000000003 110.217 175.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 72.7 p -115.05 150.57 35.69 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.079 0.466 . . . . 70.25 111.835 -177.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.407 ' HE1' HD12 ' A' ' 43' ' ' LEU . 70.9 m-85 -51.8 -36.6 48.41 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.086 -0.506 . . . . 75.010000000000005 112.163 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.62 -51.0 60.47 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 121.014 -0.612 . . . . 71.010000000000005 113.039 178.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.415 ' O ' ' HE2' ' A' ' 29' ' ' MET . 47.1 mt-10 -55.65 -48.14 75.49 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.0 0.429 . . . . 73.109999999999999 111.135 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.515 HD11 HD11 ' A' ' 15' ' ' ILE . 49.9 mm -61.42 -54.17 38.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 116.115 -0.493 . . . . 65.450000000000003 111.746 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.56 -48.66 78.72 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.227 0.454 . . . . 44.450000000000003 112.227 -178.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -60.24 -43.1 96.38 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.677 0.275 . . . . 74.230000000000004 111.589 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.415 ' HE2' ' O ' ' A' ' 25' ' ' GLU . 77.7 mtm -73.35 -21.78 60.46 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 111.901 0.334 . . . . 75.219999999999999 111.901 178.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.58 -28.41 33.82 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.961 0.41 . . . . 73.030000000000001 111.186 174.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.94 29.09 5.06 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.298 -0.477 . . . . 74.340000000000003 113.468 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -134.43 79.93 53.13 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-O 120.893 0.378 . . . . 74.540000000000006 111.169 178.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.01 126.89 14.38 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.364 2.043 . . . . 74.319999999999993 112.614 -178.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.38 -22.85 36.47 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.175 -0.535 . . . . 73.140000000000001 113.274 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -78.61 12.19 2.17 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.36 0.504 . . . . 72.510000000000005 112.36 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.05 -44.37 61.09 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.021 0.438 . . . . 63.109999999999999 111.777 177.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 30.7 ptt-85 -58.37 -39.66 80.18 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 116.24 -0.436 . . . . 74.400000000000006 111.922 177.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -70.77 -34.53 71.91 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.662 0.268 . . . . 64.340000000000003 111.015 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.5 t -57.94 -43.39 84.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 CA-C-O 121.13 0.49 . . . . 72.109999999999999 110.267 172.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.47 -38.65 95.17 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-N 115.838 -0.619 . . . . 54.119999999999997 112.905 175.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -62.17 -47.27 85.25 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.982 0.42 . . . . 71.439999999999998 110.873 175.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.93 -45.65 89.88 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.017 -0.538 . . . . 65.049999999999997 111.668 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.588 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 58.2 mt -68.64 -38.49 80.53 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.908 0.385 . . . . 60.240000000000002 111.352 178.066 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.7 -15.76 66.97 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.268 -0.491 . . . . 70.209999999999994 113.081 176.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -76.6 -23.11 53.43 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.174 0.511 . . . . 74.349999999999994 110.52 175.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 82.6 mt -81.27 143.84 52.91 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 115.956 -0.566 . . . . 72.129999999999995 111.966 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -86.52 -176.7 2.11 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.708 2.272 . . . . 60.119999999999997 112.587 174.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.404 ' HG3' ' H ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -69.06 -23.58 64.06 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 122.131 -0.356 . . . . 74.040000000000006 111.937 178.662 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -90.02 39.39 3.11 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.534 -0.365 . . . . 74.230000000000004 113.43 177.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.0 t -93.03 140.08 29.85 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 122.437 -0.449 . . . . 64.430000000000007 111.404 177.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -72.42 -42.28 65.25 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.227 0.537 . . . . 75.230000000000004 110.29 175.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.517 HD11 ' HB ' ' A' ' 12' ' ' ILE . 33.3 tp -67.01 118.79 58.89 Favored Pre-proline 0 CA--C 1.535 0.404 0 CA-C-N 115.616 -0.72 . . . . 53.229999999999997 110.707 173.505 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.69 94.64 0.53 Allowed 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 121.392 1.394 . . . . 40.399999999999999 111.972 177.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.588 ' HB2' ' HB3' ' A' ' 43' ' ' LEU . 58.4 p-90 -84.96 -33.39 22.65 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.565 0.698 . . . . 74.310000000000002 111.0 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -59.91 -20.55 57.98 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.296 -0.865 . . . . 73.310000000000002 112.911 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.409 ' NH1' ' O ' ' A' ' 15' ' ' ILE . 95.8 mtt180 -79.98 -1.14 38.25 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.426 0.528 . . . . 74.230000000000004 112.426 -178.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.3 t -117.01 118.24 58.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 121.038 0.447 . . . . 74.530000000000001 111.744 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.558 HG21 HD12 ' A' ' 91' ' ' ILE . 35.6 pt -127.58 -169.87 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 116.347 -0.388 . . . . 74.540000000000006 111.521 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 32.1 p30 -84.44 163.64 19.35 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 120.94 0.4 . . . . 73.540000000000006 111.857 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 69.2 m -66.02 -15.44 63.03 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.573 0.583 . . . . 65.200000000000003 112.573 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -77.32 -12.59 59.97 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.741 0.305 . . . . 72.319999999999993 111.473 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.26 37.08 12.94 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 121.225 -0.512 . . . . 74.099999999999994 112.621 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -138.96 162.28 35.28 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.3 0.572 . . . . 70.120000000000005 111.91 -179.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.499 HG23 ' OE1' ' A' ' 74' ' ' GLN . 70.7 mt -69.28 139.71 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 115.725 -0.67 . . . . 63.329999999999998 110.886 175.097 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 89.1 p -90.18 -50.37 6.03 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.155 0.503 . . . . 73.420000000000002 111.345 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 83.9 mt -64.08 142.92 58.24 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.816 -0.629 . . . . 73.420000000000002 111.951 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -118.06 171.59 7.99 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.004 0.431 . . . . 71.310000000000002 111.234 177.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.78 -138.96 20.9 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.884 -0.674 . . . . 51.340000000000003 112.33 -176.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -74.97 -26.08 59.32 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.086 0.47 . . . . 73.150000000000006 111.474 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.65 -28.04 69.63 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.914 0.388 . . . . 74.129999999999995 111.284 176.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.1 tt -63.35 -60.97 2.68 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.273 -0.421 . . . . 63.420000000000002 110.625 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.405 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 3.9 p30 -64.15 -28.49 69.8 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 122.324 -0.235 . . . . 42.140000000000001 111.234 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -58.53 -53.74 54.88 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.902 0.382 . . . . 72.450000000000003 111.534 176.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.499 ' OE1' HG23 ' A' ' 64' ' ' ILE . 53.9 tt0 -59.38 -40.63 87.16 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.974 0.416 . . . . 75.310000000000002 110.884 177.066 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -60.13 -53.86 52.71 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.177 -0.465 . . . . 73.049999999999997 112.075 177.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' A' ' 72' ' ' ASP . 27.4 mm-40 -53.55 -42.46 67.52 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.15 0.5 . . . . 45.140000000000001 111.821 -178.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -59.61 -48.71 80.6 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.024 -0.534 . . . . 54.140000000000001 111.597 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.512 HD22 HD12 ' A' ' 83' ' ' ILE . 89.8 mt -67.69 -43.23 80.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.175 -0.466 . . . . 75.430000000000007 111.581 -177.015 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -57.03 -42.18 79.94 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.942 0.401 . . . . 64.329999999999998 110.861 175.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.34 -33.97 71.79 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.271 -0.422 . . . . 71.129999999999995 111.414 176.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -86.94 5.74 35.62 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.808 0.337 . . . . 74.209999999999994 111.678 178.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.01 30.89 16.06 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 114.238 0.455 . . . . 63.020000000000003 114.238 174.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.512 HD12 HD22 ' A' ' 78' ' ' LEU . 69.4 mt -104.43 124.77 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 117.129 0.464 . . . . 73.319999999999993 111.723 178.305 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.8 103.18 4.26 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.503 0.668 . . . . 71.099999999999994 111.601 177.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.2 t -95.78 117.13 39.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.309 -0.405 . . . . 75.420000000000002 111.099 178.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.587 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 41.4 t -67.87 151.15 47.61 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.938 0.399 . . . . 75.219999999999999 112.056 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -40.16 -56.55 1.89 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.322 1.231 . . . . 74.209999999999994 114.322 -171.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.431 ' H ' HG13 ' A' ' 88' ' ' ILE . 2.8 pp -80.15 22.92 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 N-CA-C 112.961 0.726 . . . . 61.030000000000001 112.961 -174.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.06 46.97 11.99 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.17 -0.538 . . . . 74.329999999999998 112.925 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.587 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 1.4 tmtp? -116.74 133.15 56.36 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.91 0.386 . . . . 73.530000000000001 110.765 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.558 HD12 HG21 ' A' ' 58' ' ' ILE . 60.2 mt -121.29 142.4 37.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 120.978 0.418 . . . . 63.350000000000001 111.356 -176.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.58 94.87 4.42 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.98 0.419 . . . . 42.240000000000002 112.039 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.614 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 39.3 mt -63.0 -13.31 33.64 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 116.077 -0.51 . . . . 65.120000000000005 112.334 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -90.27 -48.76 6.94 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.076 0.465 . . . . 75.409999999999997 111.59 175.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.99 -22.65 65.9 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.768 0.655 . . . . 64.409999999999997 112.768 -175.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -128.28 15.11 6.69 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.293 0.479 . . . . 53.310000000000002 112.293 -176.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.614 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 85.0 tttt -56.29 128.98 38.44 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.478 0.547 . . . . 73.319999999999993 112.478 -175.047 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 16.5 t90 -57.3 114.87 2.37 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.105 -0.498 . . . . 75.340000000000003 111.351 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -105.07 96.42 11.05 Favored Pre-proline 0 CA--C 1.543 0.694 0 CA-C-N 116.209 -0.45 . . . . 74.420000000000002 110.217 174.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo . . . . . 0 CA--C 1.54 0.814 0 C-N-CA 123.16 2.574 . . . . 70.230000000000004 113.98 -178.715 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.47 0.532 0 N-CA-C 112.483 0.549 . . . . 60.350000000000001 112.483 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -57.87 -28.12 63.87 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.814 0.34 . . . . 72.120000000000005 111.149 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -57.15 -50.67 72.09 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.0 0.429 . . . . 72.319999999999993 110.651 173.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 76.9 mt -64.57 -44.7 89.88 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.857 -0.61 . . . . 73.140000000000001 110.902 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.0 t -57.1 -49.48 79.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 116.113 -0.494 . . . . 64.030000000000001 111.648 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.433 ' O ' HG23 ' A' ' 11' ' ' VAL . 32.3 mm-40 -62.65 -52.7 62.31 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.527 0.566 . . . . 73.510000000000005 112.527 -178.063 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.504 HD12 HG13 ' A' ' 39' ' ' VAL . 25.3 pt -60.73 -44.2 96.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 111.757 0.28 . . . . 72.140000000000001 111.757 -177.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.9 m-30 -63.16 -43.61 97.8 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.175 0.512 . . . . 74.530000000000001 110.797 177.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.91 -30.38 61.51 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.007 -0.542 . . . . 62.119999999999997 111.959 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 7' ' ' GLN . 59.4 t -75.87 -41.77 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 121.017 0.437 . . . . 63.119999999999997 111.459 176.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 8' ' ' ILE . 71.2 mt -57.22 -34.93 46.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 112.214 0.45 . . . . 72.109999999999999 112.214 -177.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -59.2 -9.41 2.12 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 113.658 0.984 . . . . 74.340000000000003 113.658 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -92.9 -2.36 55.91 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 112.563 0.579 . . . . 64.109999999999999 112.563 178.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.409 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 50.1 mt -84.49 119.03 72.49 Favored Pre-proline 0 CA--C 1.543 0.71 0 O-C-N 122.331 -0.231 . . . . 53.229999999999997 111.188 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 15' ' ' ILE . 3.7 Cg_exo -77.94 171.1 17.8 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.392 2.728 . . . . 73.5 113.498 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -67.81 133.84 49.91 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.25 0.548 . . . . 72.219999999999999 111.885 -178.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.404 ' HA2' ' HB3' ' A' ' 81' ' ' GLU . . . 85.38 7.21 82.94 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 116.09 -0.505 . . . . 71.129999999999995 113.439 178.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -123.77 145.52 48.97 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.941 0.4 . . . . 72.010000000000005 111.119 178.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.415 HG12 ' HA ' ' A' ' 56' ' ' ARG . 34.2 m -133.2 154.99 40.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-O 120.979 0.419 . . . . 73.25 111.341 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 92.1 p -133.56 170.68 15.17 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.094 0.473 . . . . 75.109999999999999 111.036 177.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.2 p -98.72 152.31 19.81 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.102 0.477 . . . . 73.420000000000002 111.82 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.441 ' HE1' HD12 ' A' ' 43' ' ' LEU . 64.2 m-85 -55.06 -33.5 62.78 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.145 -0.48 . . . . 75.239999999999995 112.139 178.143 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -60.68 -38.18 94.7 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 120.988 -0.625 . . . . 73.109999999999999 112.772 177.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.421 ' O ' ' HG3' ' A' ' 29' ' ' MET . 42.2 mt-10 -71.2 -51.32 25.42 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.852 0.358 . . . . 71.010000000000005 111.309 178.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.2 mm -58.29 -49.83 80.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-N 116.338 -0.392 . . . . 70.239999999999995 111.827 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.58 -41.6 90.59 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.848 0.356 . . . . 72.340000000000003 111.596 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.6 ttmp? -60.01 -47.59 85.2 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.952 0.406 . . . . 74.409999999999997 111.03 178.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.421 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 62.0 mtt -67.22 -29.96 69.75 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.151 -0.477 . . . . 73.010000000000005 111.442 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.67 -20.49 53.63 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.131 0.419 . . . . 63.210000000000001 112.131 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.89 28.35 10.19 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.204 -0.522 . . . . 55.520000000000003 113.455 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -130.9 78.89 72.71 Favored Pre-proline 0 N--CA 1.47 0.552 0 O-C-N 122.48 -0.424 . . . . 72.219999999999999 110.89 177.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -66.71 115.08 3.38 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.666 2.244 . . . . 72.530000000000001 113.073 -176.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.93 -15.58 40.26 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.029 -0.605 . . . . 52.200000000000003 113.624 178.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.429 ' O ' HG23 ' A' ' 39' ' ' VAL . 34.0 m-85 -81.35 18.09 1.21 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.649 0.611 . . . . 55.329999999999998 112.649 -178.375 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.86 -54.59 18.5 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.31 0.485 . . . . 61.299999999999997 112.31 -178.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.449 ' O ' ' HG3' ' A' ' 41' ' ' LYS . 33.1 ttm180 -57.74 -38.81 75.98 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.026 0.441 . . . . 75.120000000000005 111.614 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.609 ' HA ' ' HE3' ' A' ' 41' ' ' LYS . 81.6 m-70 -68.39 -32.5 72.61 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.282 -0.417 . . . . 73.310000000000002 111.704 -177.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.504 HG13 HD12 ' A' ' 8' ' ' ILE . 56.9 t -60.57 -40.91 85.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 121.156 0.503 . . . . 41.210000000000001 109.886 171.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.82 -44.94 95.45 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 115.947 -0.569 . . . . 55.299999999999997 112.804 176.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.609 ' HE3' ' HA ' ' A' ' 38' ' ' HIS . 8.5 mtmp? -63.04 -22.23 66.71 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.992 0.425 . . . . 71.140000000000001 111.3 178.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.33 -45.88 17.06 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.432 -0.349 . . . . 73.430000000000007 111.442 176.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.441 HD12 ' HE1' ' A' ' 23' ' ' TYR . 66.7 mt -65.51 -35.15 80.03 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 111.976 0.362 . . . . 74.329999999999998 111.976 -179.048 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.4 -20.81 38.62 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 121.248 -0.501 . . . . 75.439999999999998 113.834 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -81.83 -21.19 37.75 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.804 0.335 . . . . 72.310000000000002 111.832 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 78.7 mt -67.56 142.64 96.36 Favored Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 112.018 0.377 . . . . 64.319999999999993 112.018 -178.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.72 -175.73 2.83 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.681 2.254 . . . . 65.349999999999994 113.202 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -76.19 -38.45 56.55 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.989 -0.551 . . . . 65.310000000000002 110.635 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -95.72 57.69 1.58 Allowed Glycine 0 CA--C 1.528 0.852 0 CA-C-N 116.018 -0.537 . . . . 72.329999999999998 113.729 -178.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.2 t -102.37 159.29 15.55 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 122.32 -0.518 . . . . 63.219999999999999 111.303 173.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -85.85 -15.58 41.42 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.221 0.534 . . . . 71.239999999999995 110.527 176.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.463 HD12 ' HD2' ' A' ' 53' ' ' PRO . 55.9 tp -93.35 116.3 66.28 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 115.908 -0.587 . . . . 73.109999999999999 110.829 178.129 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.463 ' HD2' HD12 ' A' ' 52' ' ' LEU . 61.6 Cg_endo -74.04 94.4 0.89 Allowed 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 121.251 1.301 . . . . 63.109999999999999 112.299 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.409 ' HB2' ' HB3' ' A' ' 43' ' ' LEU . 54.9 p-90 -80.11 -30.33 39.11 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.372 0.606 . . . . 71.530000000000001 111.318 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -59.93 -22.63 62.68 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.617 -0.72 . . . . 74.340000000000003 112.876 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.415 ' HA ' HG12 ' A' ' 20' ' ' VAL . 97.8 mtt180 -79.61 -0.94 35.8 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.584 0.587 . . . . 73.430000000000007 112.584 -177.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.9 t -118.63 109.59 27.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.062 0.458 . . . . 65.319999999999993 110.892 178.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.528 HD11 HD21 ' A' ' 93' ' ' LEU . 32.9 pt -114.98 -172.48 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 116.221 -0.445 . . . . 72.0 111.983 -176.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.411 HD21 ' HB2' ' A' ' 63' ' ' LYS . 32.1 p30 -81.32 165.71 21.14 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.207 0.527 . . . . 71.519999999999996 112.08 -176.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 80.4 p -70.61 -2.73 15.23 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.809 0.67 . . . . 75.519999999999996 112.809 -175.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -94.16 -9.37 36.63 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.042 0.386 . . . . 74.450000000000003 112.042 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.3 44.33 13.71 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 120.667 -0.778 . . . . 62.450000000000003 112.393 -176.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.411 ' HB2' HD21 ' A' ' 59' ' ' ASN . 98.6 mttt -133.46 172.29 12.91 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 122.753 0.421 . . . . 73.040000000000006 110.588 179.01 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.556 HD11 HG11 ' A' ' 85' ' ' VAL . 66.7 mt -67.7 118.73 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 109.938 -0.393 . . . . 63.539999999999999 109.938 173.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.6 p -71.07 -33.58 70.37 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.414 0.524 . . . . 73.129999999999995 112.414 -172.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.572 HD13 ' HB3' ' A' ' 70' ' ' ASP . 85.7 mt -79.85 -174.61 4.48 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.119 0.485 . . . . 75.129999999999995 111.755 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -147.25 161.7 40.42 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.884 0.373 . . . . 64.129999999999995 111.758 -176.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 60.45 -134.94 49.98 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.173 -0.537 . . . . 73.439999999999998 112.969 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 49.9 mtp180 -62.51 -33.5 75.0 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.112 0.482 . . . . 75.25 110.95 178.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.572 ' HB3' HD13 ' A' ' 66' ' ' LEU . 7.8 m-20 -62.38 -30.27 71.07 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.218 -0.446 . . . . 73.129999999999995 111.458 176.289 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.479 ' HG ' HG21 ' A' ' 64' ' ' ILE . 10.2 tt -59.66 -54.98 40.16 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.011 0.434 . . . . 43.32 110.662 177.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -71.58 -21.78 61.82 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 111.812 0.301 . . . . 50.329999999999998 111.812 177.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.514 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 15.0 ttp180 -66.55 -50.35 63.43 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.385 0.612 . . . . 74.400000000000006 110.408 174.392 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.416 ' HB2' HD12 ' A' ' 66' ' ' LEU . 63.9 tt0 -63.38 -42.18 98.82 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.896 -0.593 . . . . 73.409999999999997 110.597 175.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.422 ' HG3' HG11 ' A' ' 85' ' ' VAL . 33.0 ttpt -60.81 -50.15 74.63 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.023 -0.535 . . . . 61.030000000000001 111.941 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.514 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 19.9 pt20 -60.29 -38.0 82.25 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.964 0.411 . . . . 54.420000000000002 111.354 -177.1 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -63.93 -34.01 77.01 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 120.887 0.375 . . . . 74.549999999999997 111.129 174.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.43 HD22 HD12 ' A' ' 83' ' ' ILE . 96.9 mt -78.56 -30.05 46.63 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.282 -0.417 . . . . 73.099999999999994 111.98 178.321 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -68.82 -28.06 66.41 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 121.964 -0.46 . . . . 70.329999999999998 110.408 174.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.41 -23.79 65.59 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.262 0.553 . . . . 61.340000000000003 110.798 171.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.404 ' HB3' ' HA2' ' A' ' 18' ' ' GLY . 15.4 mm-40 -81.94 -9.04 59.7 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.818 -0.628 . . . . 70.209999999999994 111.319 175.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.61 21.87 55.07 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.39 -0.433 . . . . 72.099999999999994 112.891 -177.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.43 HD12 HD22 ' A' ' 78' ' ' LEU . 64.6 mt -89.63 127.79 42.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 121.023 0.439 . . . . 75.010000000000005 112.102 -177.196 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -78.5 97.2 5.64 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.054 0.454 . . . . 73.150000000000006 111.012 176.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.556 HG11 HD11 ' A' ' 64' ' ' ILE . 41.2 t -94.89 119.58 43.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.714 0.292 . . . . 73.049999999999997 110.811 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.55 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 49.7 m -61.14 141.31 57.55 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 110.388 -0.227 . . . . 62.240000000000002 110.388 177.032 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -54.36 -32.96 58.1 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 113.379 0.881 . . . . 73.409999999999997 113.379 -170.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.417 HD11 ' HB2' ' A' ' 90' ' ' LYS . 2.8 pp -75.22 -2.83 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 112.244 0.461 . . . . 71.040000000000006 112.244 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.28 43.46 2.77 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 116.212 -0.449 . . . . 60.439999999999998 113.966 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.55 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 61.3 tttm -115.35 131.14 57.02 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 117.62 0.71 . . . . 60.310000000000002 112.018 -178.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.49 HD12 HG21 ' A' ' 58' ' ' ILE . 56.6 mt -119.12 115.58 48.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.976 -0.556 . . . . 74.219999999999999 110.89 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.31 93.61 0.23 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.475 0.546 . . . . 64.200000000000003 112.475 -177.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.572 ' O ' ' HG3' ' A' ' 97' ' ' LYS . 76.1 mt -56.33 -46.31 79.97 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.609 -0.269 . . . . 74.129999999999995 111.255 177.263 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 63.8 mtp180 -51.05 -19.93 1.24 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.415 0.524 . . . . 71.150000000000006 112.415 -177.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -106.22 -36.7 6.8 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 111.922 0.341 . . . . 74.439999999999998 111.922 176.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -105.49 13.76 29.63 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.636 0.976 . . . . 72.420000000000002 113.636 -172.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.572 ' HG3' ' O ' ' A' ' 93' ' ' LEU . 41.8 mtpt -56.14 138.77 49.2 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.553 0.575 . . . . 70.340000000000003 112.553 178.178 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 14.9 t90 -69.14 115.02 7.94 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.007 -0.542 . . . . 74.329999999999998 110.692 173.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -102.74 96.05 7.11 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-N 116.075 -0.511 . . . . 74.230000000000004 111.166 176.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo . . . . . 0 CA--C 1.542 0.904 0 C-N-CA 122.628 2.219 . . . . 53.43 112.762 175.74 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.483 ' O ' HG23 ' A' ' 6' ' ' VAL . 12.2 t70 . . . . . 0 CA--C 1.544 0.74 0 N-CA-C 112.09 0.404 . . . . 72.319999999999993 112.09 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -56.81 -40.12 75.42 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.632 0.604 . . . . 63.509999999999998 112.632 -178.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -58.1 -47.79 82.15 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.18 0.514 . . . . 72.200000000000003 110.477 177.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 85.9 mt -61.07 -47.14 87.71 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.724 -0.671 . . . . 50.020000000000003 110.801 177.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 2' ' ' ASP . 94.1 t -53.91 -50.13 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.173 -0.467 . . . . 74.239999999999995 111.648 178.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.453 ' O ' HG23 ' A' ' 11' ' ' VAL . 27.8 mm-40 -64.67 -50.21 67.92 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.375 0.509 . . . . 73.019999999999996 112.375 -176.015 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.459 ' O ' HG13 ' A' ' 12' ' ' ILE . 38.5 pt -64.93 -44.15 96.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 121.019 -0.272 . . . . 63.210000000000001 111.554 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.415 ' N ' HG13 ' A' ' 8' ' ' ILE . 21.8 m-30 -65.19 -42.51 93.52 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.813 0.339 . . . . 74.040000000000006 111.133 178.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.85 -40.1 69.29 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.454 -0.339 . . . . 63.340000000000003 111.67 178.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 7' ' ' GLN . 86.9 t -67.59 -41.63 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 120.917 0.389 . . . . 65.409999999999997 111.297 178.273 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.557 ' HB ' HD11 ' A' ' 52' ' ' LEU . 80.4 mt -59.17 -32.25 47.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 116.405 -0.361 . . . . 73.420000000000002 111.819 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.511 ' CE1' HD13 ' A' ' 52' ' ' LEU . 44.5 m80 -61.15 -18.51 58.46 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.131 0.419 . . . . 75.219999999999999 112.131 176.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -83.3 -9.17 59.25 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.531 0.567 . . . . 73.310000000000002 112.531 178.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.498 HD11 HD11 ' A' ' 26' ' ' ILE . 54.8 mt -74.46 116.27 51.46 Favored Pre-proline 0 CA--C 1.542 0.669 0 O-C-N 122.203 -0.311 . . . . 54.439999999999998 111.055 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -64.29 157.55 53.58 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.114 2.543 . . . . 65.219999999999999 113.514 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -65.54 120.77 13.5 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.21 -0.45 . . . . 74.299999999999997 111.495 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.34 17.07 56.27 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 120.988 -0.625 . . . . 73.099999999999994 113.22 -176.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -121.11 149.93 42.0 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 122.621 -0.341 . . . . 42.329999999999998 111.22 175.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.425 HG11 HD13 ' A' ' 91' ' ' ILE . 33.6 m -128.08 145.38 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 121.535 0.683 . . . . 73.209999999999994 111.795 -178.435 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 94.8 p -128.98 177.82 6.84 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.871 -0.604 . . . . 73.310000000000002 110.555 175.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.4 p -111.6 154.77 24.37 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.811 0.338 . . . . 62.009999999999998 111.376 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.432 ' HB2' ' HB1' ' A' ' 36' ' ' ALA . 74.8 m-85 -54.72 -40.12 68.92 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.852 0.358 . . . . 71.319999999999993 111.446 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -57.73 -44.7 94.02 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.268 -0.491 . . . . 72.099999999999994 113.043 177.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' A' ' 29' ' ' MET . 49.8 mt-10 -63.27 -54.0 44.05 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.731 0.3 . . . . 73.329999999999998 111.181 178.176 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.498 HD11 HD11 ' A' ' 15' ' ' ILE . 46.4 mm -54.3 -53.1 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 120.818 0.342 . . . . 72.5 111.72 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.99 -46.72 82.06 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.422 -0.354 . . . . 64.340000000000003 111.674 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -60.99 -42.95 99.41 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.781 0.324 . . . . 50.420000000000002 111.584 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.43 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 64.6 mtt -68.39 -30.67 69.64 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.043 0.449 . . . . 54.340000000000003 111.236 178.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.06 -19.65 59.9 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.197 -0.456 . . . . 71.400000000000006 111.914 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.24 15.18 24.21 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.137 -0.554 . . . . 61.340000000000003 113.014 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.434 ' HB3' ' CD1' ' A' ' 35' ' ' TYR . 69.5 m-85 -128.37 63.94 65.6 Favored Pre-proline 0 CA--C 1.548 0.873 0 O-C-N 122.55 -0.382 . . . . 70.030000000000001 111.54 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -61.72 110.94 1.05 Allowed 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.484 2.123 . . . . 60.299999999999997 112.568 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 123.64 -24.76 6.37 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 121.238 -0.506 . . . . 62.149999999999999 112.922 -177.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.461 ' O ' HG23 ' A' ' 39' ' ' VAL . 58.2 m-85 -79.96 30.54 0.26 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.242 0.46 . . . . 74.310000000000002 112.242 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.432 ' HB1' ' HB2' ' A' ' 23' ' ' TYR . . . -55.24 -64.88 0.7 Allowed 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.452 0.538 . . . . 74.109999999999999 112.452 -177.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -54.7 -31.69 58.41 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.361 0.504 . . . . 74.420000000000002 112.361 177.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -65.63 -40.27 92.37 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.749 0.309 . . . . 70.200000000000003 111.11 178.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 35' ' ' TYR . 67.9 t -57.14 -45.18 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.097 0.475 . . . . 62.439999999999998 110.243 173.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -57.8 -42.98 94.81 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 116.037 -0.529 . . . . 31.530000000000001 112.714 175.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -62.15 -33.02 73.71 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.071 0.462 . . . . 70.319999999999993 111.154 176.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.0 -42.78 66.03 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.202 -0.454 . . . . 61.140000000000001 111.449 177.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 39' ' ' VAL . 90.0 mt -62.38 -33.32 74.51 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.907 0.384 . . . . 74.439999999999998 111.483 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.62 -12.39 46.63 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 121.405 -0.426 . . . . 74.310000000000002 113.458 176.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -85.8 -15.81 40.82 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.135 0.493 . . . . 52.399999999999999 110.953 177.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.521 HD11 HD23 ' A' ' 52' ' ' LEU . 90.8 mt -81.68 148.12 60.9 Favored Pre-proline 0 N--CA 1.47 0.563 0 N-CA-C 112.42 0.526 . . . . 74.129999999999995 112.42 -177.083 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.52 163.2 32.33 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.39 2.06 . . . . 70.439999999999998 112.125 173.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.562 ' HG2' ' HE ' ' A' ' 73' ' ' ARG . 42.2 mt-10 -57.02 -52.88 63.5 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 111.984 0.364 . . . . 51.200000000000003 111.984 -178.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -93.62 54.61 2.34 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.039 -0.601 . . . . 73.340000000000003 113.294 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.7 t -79.6 156.39 27.7 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.866 0.365 . . . . 73.409999999999997 111.556 178.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -67.12 -26.54 66.74 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.389 0.614 . . . . 63.340000000000003 110.313 174.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.557 HD11 ' HB ' ' A' ' 12' ' ' ILE . 55.3 tp -92.78 117.75 67.68 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 115.5 -0.773 . . . . 74.129999999999995 110.802 176.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.547 ' HD2' HD12 ' A' ' 52' ' ' LEU . 56.8 Cg_endo -71.77 96.58 0.77 Allowed 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 121.639 1.56 . . . . 61.140000000000001 112.47 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 60.9 p-90 -80.52 -25.25 38.81 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.34 0.591 . . . . 65.530000000000001 112.153 -178.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -68.65 -12.71 61.71 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.625 0.972 . . . . 54.539999999999999 113.625 -174.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -87.06 1.55 52.56 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.6 0.593 . . . . 75.219999999999999 112.6 -175.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.8 t -109.75 108.83 26.35 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 CA-C-O 121.266 0.555 . . . . 41.420000000000002 111.659 -178.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.535 HD13 HD12 ' A' ' 91' ' ' ILE . 18.2 pt -113.6 -170.81 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-N 116.093 -0.503 . . . . 73.099999999999994 111.964 -178.065 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.7 p30 -90.19 175.41 7.15 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.022 0.439 . . . . 73.329999999999998 111.991 -177.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 87.6 p -64.26 -22.58 67.0 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.376 0.509 . . . . 74.140000000000001 112.376 -176.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -82.27 -12.76 57.84 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.851 0.357 . . . . 75.0 111.546 -179.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.64 30.6 20.91 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.163 -0.541 . . . . 54.350000000000001 112.804 -177.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.408 ' HE3' HD13 ' A' ' 88' ' ' ILE . 56.6 mtpt -125.6 163.28 23.09 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.11 0.481 . . . . 75.239999999999995 111.864 -177.2 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 52.7 mt -75.95 130.38 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 116.09 -0.504 . . . . 41.109999999999999 111.685 -177.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.3 m -80.26 -30.5 38.42 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.393 -0.367 . . . . 73.219999999999999 111.756 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.438 HD12 ' HB2' ' A' ' 74' ' ' GLN . 75.3 mt -72.1 151.99 42.66 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.123 0.487 . . . . 62.119999999999997 111.564 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -129.33 153.32 47.96 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.191 -0.458 . . . . 73.340000000000003 111.89 -174.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 62.27 -129.06 42.7 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 121.283 -0.484 . . . . 71.200000000000003 113.415 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -66.03 -30.14 70.62 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.816 0.341 . . . . 74.010000000000005 111.781 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.54 ' HA ' ' HD3' ' A' ' 73' ' ' ARG . 9.6 m-20 -68.92 -31.03 69.63 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.888 0.375 . . . . 74.209999999999994 111.237 177.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.7 tt -61.32 -42.01 97.97 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 109.524 -0.547 . . . . 44.350000000000001 109.524 173.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -59.3 -43.5 92.6 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.984 -0.553 . . . . 74.400000000000006 111.173 176.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.562 ' HE ' ' HG2' ' A' ' 48' ' ' GLU . 79.9 mtp180 -50.62 -56.14 13.15 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.332 0.587 . . . . 74.129999999999995 111.338 176.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.438 ' HB2' HD12 ' A' ' 66' ' ' LEU . 43.7 tt0 -65.87 -42.63 90.11 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.069 -0.514 . . . . 74.129999999999995 111.065 -177.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -61.61 -50.63 71.79 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.14 0.422 . . . . 73.439999999999998 112.14 -178.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.401 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 13.7 pt20 -58.46 -39.05 78.84 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.757 0.313 . . . . 73.019999999999996 111.294 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -62.92 -43.75 97.93 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 120.809 0.338 . . . . 75.030000000000001 111.36 176.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 75.8 mt -66.42 -48.78 68.94 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.291 -0.413 . . . . 74.519999999999996 111.683 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -54.55 -31.48 56.58 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.116 0.484 . . . . 54.149999999999999 111.327 176.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.46 -26.76 64.74 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.636 0.606 . . . . 63.409999999999997 112.636 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -102.44 9.03 39.92 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.417 0.525 . . . . 74.140000000000001 112.417 -176.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.92 41.98 7.37 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 120.938 -0.648 . . . . 61.32 113.644 176.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 68.2 mt -117.21 128.5 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 O-C-N 122.648 -0.325 . . . . 71.209999999999994 111.052 177.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -78.64 103.36 8.53 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.732 0.301 . . . . 71.040000000000006 111.424 177.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.9 t -90.62 105.21 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 120.826 0.346 . . . . 75.329999999999998 110.985 175.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.523 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 50.0 m -56.61 144.35 32.32 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.475 -0.33 . . . . 43.009999999999998 110.997 177.584 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.497 ' HG3' ' N ' ' A' ' 88' ' ' ILE . 12.3 pt-20 -43.2 -44.19 5.06 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 113.867 1.062 . . . . 61.450000000000003 113.867 -171.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.497 ' N ' ' HG3' ' A' ' 87' ' ' GLU . 2.6 pp -78.72 9.69 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 112.625 0.602 . . . . 73.299999999999997 112.625 -176.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.87 55.67 2.91 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 116.292 -0.413 . . . . 44.109999999999999 113.084 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.523 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 49.1 tttm -127.61 150.1 49.88 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.166 0.508 . . . . 65.310000000000002 112.256 177.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.535 HD12 HD13 ' A' ' 58' ' ' ILE . 50.2 mt -124.15 156.8 31.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-N 115.695 -0.684 . . . . 63.310000000000002 110.228 176.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.42 ' HB3' ' HB3' ' A' ' 95' ' ' LYS . . . -85.37 102.65 13.59 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.028 0.442 . . . . 74.239999999999995 111.796 178.319 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.656 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 40.2 mt -71.07 -8.32 52.55 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.241 0.83 . . . . 63.539999999999999 113.241 -177.075 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -97.58 -11.06 24.09 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.337 0.589 . . . . 72.230000000000004 111.015 174.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.42 ' HB3' ' HB3' ' A' ' 92' ' ' ALA . 27.8 tptp -106.31 -35.39 7.17 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.672 0.619 . . . . 70.030000000000001 112.672 -172.176 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -127.52 15.02 7.11 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.15 0.426 . . . . 74.150000000000006 112.15 -175.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.656 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 63.9 tttp -60.14 135.25 57.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.732 0.301 . . . . 63.539999999999999 111.727 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 17.7 t90 -65.6 96.86 0.28 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.024 0.44 . . . . 65.150000000000006 110.983 176.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -98.66 99.8 8.28 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 116.032 -0.531 . . . . 52.420000000000002 110.885 173.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo . . . . . 0 CA--C 1.544 0.979 0 C-N-CA 122.685 2.256 . . . . 75.109999999999999 112.969 176.387 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 . . . . . 0 CA--C 1.54 0.578 0 N-CA-C 112.579 0.585 . . . . 75.019999999999996 112.579 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.4 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 74.3 mm-40 -56.28 -27.83 56.63 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.472 -0.331 . . . . 73.319999999999993 111.569 176.055 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.431 ' O ' HG12 ' A' ' 8' ' ' ILE . 90.7 t80 -54.96 -52.22 63.72 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.211 0.529 . . . . 72.349999999999994 110.027 172.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 58.0 mt -65.56 -49.79 67.56 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.373 -0.831 . . . . 74.299999999999997 110.988 178.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 85.3 t -53.64 -50.99 47.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 116.119 -0.491 . . . . 73.540000000000006 111.979 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 31.4 mm-40 -62.37 -54.95 32.97 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.295 0.48 . . . . 72.099999999999994 112.295 -177.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.537 HD12 HG13 ' A' ' 39' ' ' VAL . 31.4 pt -61.43 -42.98 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 120.641 0.258 . . . . 35.340000000000003 111.693 -177.201 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.434 ' HA ' HD12 ' A' ' 12' ' ' ILE . 17.6 m-30 -62.58 -43.75 98.03 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.962 0.411 . . . . 53.219999999999999 111.265 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.85 -41.99 68.06 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.131 -0.486 . . . . 73.150000000000006 111.432 178.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 55.2 t -66.95 -36.51 77.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 121.047 0.451 . . . . 74.230000000000004 111.362 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 8' ' ' ILE . 83.3 mt -61.12 -36.01 69.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 116.306 -0.406 . . . . 74.420000000000002 112.054 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -60.06 -22.38 62.63 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 112.324 0.49 . . . . 73.329999999999998 112.324 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -78.73 -5.7 53.9 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 112.792 0.664 . . . . 71.120000000000005 112.792 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.431 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 58.9 mt -76.53 122.02 85.9 Favored Pre-proline 0 CA--C 1.545 0.783 0 O-C-N 122.243 -0.286 . . . . 74.25 111.324 178.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 15' ' ' ILE . 6.3 Cg_exo -75.28 151.28 38.11 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.861 2.374 . . . . 63.43 112.681 177.311 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -58.18 110.37 0.93 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.477 0.656 . . . . 74.409999999999997 111.721 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.501 ' H ' ' NH1' ' A' ' 56' ' ' ARG . . . 131.55 -30.17 3.32 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.568 -0.742 . . . . 52.329999999999998 112.387 178.158 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -93.81 159.83 15.02 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.438 0.637 . . . . 75.219999999999999 112.328 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.1 m -130.35 148.22 33.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 115.214 -0.903 . . . . 71.109999999999999 110.353 174.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 95.4 p -119.37 159.88 23.35 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.951 0.405 . . . . 72.439999999999998 110.996 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 72.0 p -102.79 148.92 25.01 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.731 0.3 . . . . 62.210000000000001 111.371 176.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.43 ' HB2' ' HB1' ' A' ' 36' ' ' ALA . 53.5 m-85 -50.76 -39.77 53.19 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 111.909 0.337 . . . . 65.140000000000001 111.909 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.75 -33.99 80.3 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 121.275 -0.488 . . . . 72.319999999999993 113.213 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.418 ' HG3' ' OG1' ' A' ' 22' ' ' THR . 47.1 mt-10 -74.12 -54.48 7.71 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.785 0.326 . . . . 42.340000000000003 111.258 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.7 mm -56.4 -53.46 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 116.215 -0.448 . . . . 74.010000000000005 111.386 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.412 ' HB2' HG21 ' A' ' 39' ' ' VAL . . . -57.64 -51.88 67.71 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.874 0.369 . . . . 72.140000000000001 111.717 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -57.6 -48.76 78.5 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.883 0.373 . . . . 74.340000000000003 111.337 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 74.5 mtm -74.01 -8.3 55.6 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.173 0.434 . . . . 65.329999999999998 112.173 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.86 -9.27 26.67 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.892 0.377 . . . . 75.549999999999997 111.079 172.031 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.05 37.47 5.16 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 116.038 -0.528 . . . . 75.030000000000001 113.693 178.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -138.58 90.57 12.79 Favored Pre-proline 0 CA--C 1.542 0.639 0 O-C-N 122.564 -0.374 . . . . 72.109999999999999 111.268 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.59 127.86 9.88 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.478 2.118 . . . . 74.019999999999996 113.3 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.84 8.38 87.73 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 121.099 -0.572 . . . . 74.109999999999999 114.195 178.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -101.3 22.61 12.21 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 117.382 0.591 . . . . 74.129999999999995 111.974 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.43 ' HB1' ' HB2' ' A' ' 23' ' ' TYR . . . -56.47 -52.0 66.35 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.103 0.477 . . . . 42.549999999999997 111.855 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -55.96 -32.76 64.16 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.096 -0.502 . . . . 74.140000000000001 111.748 177.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.404 ' HA ' ' HD2' ' A' ' 41' ' ' LYS . 98.6 m-70 -74.79 -32.26 61.96 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.687 0.28 . . . . 73.230000000000004 111.463 -178.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.537 HG13 HD12 ' A' ' 8' ' ' ILE . 58.4 t -61.21 -40.31 85.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 121.138 0.494 . . . . 73.209999999999994 110.292 172.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.61 -37.81 94.0 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 121.133 -0.556 . . . . 72.319999999999993 112.484 173.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.404 ' HD2' ' HA ' ' A' ' 38' ' ' HIS . 66.1 mttm -61.27 -40.02 92.56 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.878 0.37 . . . . 54.43 111.006 174.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.48 -50.92 69.5 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.066 -0.515 . . . . 62.240000000000002 111.579 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.5 mt -63.42 -36.97 85.48 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.901 0.382 . . . . 74.400000000000006 111.309 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.98 -6.58 45.99 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 121.353 -0.451 . . . . 71.019999999999996 113.681 178.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -100.21 -6.5 25.99 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 120.98 0.419 . . . . 73.510000000000005 111.038 177.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 91.5 mt -79.52 152.23 75.32 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 112.542 0.571 . . . . 63.439999999999998 112.542 -176.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.516 ' HD2' ' HB2' ' A' ' 50' ' ' SER . 22.2 Cg_exo -64.04 148.31 91.51 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.644 2.229 . . . . 73.510000000000005 112.464 173.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -62.98 -12.17 23.88 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-O 121.08 0.466 . . . . 74.340000000000003 111.757 -178.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -135.97 47.71 0.96 Allowed Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.312 -0.47 . . . . 41.350000000000001 113.233 175.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.516 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 43.0 t -74.83 165.84 24.59 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.991 0.424 . . . . 63.43 112.071 176.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -74.02 -19.37 60.66 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.237 -0.438 . . . . 73.109999999999999 111.532 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.549 HD12 ' HD2' ' A' ' 53' ' ' PRO . 30.1 tp -89.45 126.4 58.45 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.281 -0.418 . . . . 72.010000000000005 111.144 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.549 ' HD2' HD12 ' A' ' 52' ' ' LEU . 60.1 Cg_endo -73.42 95.69 0.87 Allowed 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 121.379 1.386 . . . . 72.049999999999997 111.908 174.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 66.1 p-90 -80.5 -31.68 37.15 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.282 0.563 . . . . 72.430000000000007 111.187 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -60.5 -18.68 53.37 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.419 0.896 . . . . 72.0 113.419 -176.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.501 ' NH1' ' H ' ' A' ' 18' ' ' GLY . 90.1 mtt-85 -86.75 11.64 12.64 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.955 0.724 . . . . 71.010000000000005 112.955 -177.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.2 t -125.93 109.72 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-O 121.407 0.622 . . . . 72.230000000000004 111.742 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.513 HD13 HD12 ' A' ' 91' ' ' ILE . 18.9 pt -114.16 -174.56 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 CA-C-N 115.827 -0.624 . . . . 72.310000000000002 111.328 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.408 HD21 ' HB2' ' A' ' 63' ' ' LYS . 34.2 p30 -87.22 171.38 10.69 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.647 -0.658 . . . . 73.439999999999998 111.871 -177.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 71.1 p -65.07 -14.8 61.36 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 112.68 0.622 . . . . 63.020000000000003 112.68 -174.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -75.0 -30.19 61.09 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.127 0.489 . . . . 64.030000000000001 111.297 175.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.49 11.97 34.35 Favored Glycine 0 CA--C 1.521 0.467 0 CA-C-N 115.691 -0.686 . . . . 72.400000000000006 111.676 -170.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.471 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 97.7 mttt -103.22 155.71 18.24 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.338 0.59 . . . . 71.409999999999997 112.19 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 63.6 mt -73.21 129.02 36.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 115.748 -0.66 . . . . 55.229999999999997 110.527 174.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.5 t -67.87 -38.7 83.42 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 120.83 0.348 . . . . 70.400000000000006 111.798 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.416 HD13 ' HB3' ' A' ' 70' ' ' ASP . 84.4 mt -74.25 143.37 45.11 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.856 0.36 . . . . 73.450000000000003 111.169 178.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -125.37 161.72 26.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.132 0.492 . . . . 74.230000000000004 111.336 -177.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 77.54 -138.95 22.41 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.111 -0.566 . . . . 73.439999999999998 112.518 -176.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 68.9 mtm180 -61.36 -38.23 86.23 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.26 0.552 . . . . 72.120000000000005 111.515 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.416 ' HB3' HD13 ' A' ' 66' ' ' LEU . 4.5 m-20 -61.73 -26.78 68.27 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 116.101 -0.5 . . . . 73.129999999999995 111.61 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.6 tt -65.7 -61.37 2.12 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.503 -0.317 . . . . 63.049999999999997 111.098 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.505 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 3.3 p30 -64.75 -24.5 67.58 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.785 0.326 . . . . 64.209999999999994 111.467 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -60.53 -52.45 65.13 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.974 0.416 . . . . 72.0 110.688 173.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -62.63 -38.93 92.15 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.25 0.547 . . . . 72.040000000000006 110.579 176.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.559 ' HG3' ' HB ' ' A' ' 85' ' ' VAL . 48.0 tttp -52.18 -56.38 14.99 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.601 -0.727 . . . . 73.310000000000002 111.729 174.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -61.88 -35.76 79.27 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 111.969 0.359 . . . . 73.019999999999996 111.969 -178.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -59.59 -45.33 92.22 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.02 0.438 . . . . 75.329999999999998 111.219 175.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.6 mt -71.79 -45.47 61.47 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.13 -0.486 . . . . 73.239999999999995 112.177 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -68.7 -26.31 65.22 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 122.17 -0.331 . . . . 71.140000000000001 111.786 -178.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.77 -23.71 67.33 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.313 0.577 . . . . 52.310000000000002 110.966 172.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -87.42 -10.84 50.88 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.782 -0.644 . . . . 71.340000000000003 111.462 176.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 108.27 19.29 9.02 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 121.341 -0.457 . . . . 54.009999999999998 114.022 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 57.1 mt -99.98 159.19 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 O-C-N 122.187 -0.596 . . . . 62.25 111.498 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -105.52 117.71 34.72 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 122.209 -0.307 . . . . 71.420000000000002 110.988 177.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.559 ' HB ' ' HG3' ' A' ' 75' ' ' LYS . 39.2 t -119.94 114.22 43.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.793 0.33 . . . . 55.049999999999997 111.391 178.231 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.0 m -62.84 141.9 58.46 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 122.386 -0.196 . . . . 53.009999999999998 110.627 176.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -47.06 -42.08 17.99 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.626 0.973 . . . . 64.409999999999997 113.626 -172.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.417 HG13 ' H ' ' A' ' 88' ' ' ILE . 2.7 pp -74.66 8.52 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 112.553 0.575 . . . . 75.400000000000006 112.553 -178.426 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.92 51.52 3.77 Favored Glycine 0 CA--C 1.524 0.594 0 CA-C-N 116.305 -0.407 . . . . 51.310000000000002 113.706 176.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -128.96 137.3 51.3 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.145 0.498 . . . . 52.030000000000001 111.641 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.513 HD12 HD13 ' A' ' 58' ' ' ILE . 52.0 mt -127.62 141.66 45.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 115.716 -0.675 . . . . 70.530000000000001 110.382 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.19 93.5 4.59 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 122.215 -0.303 . . . . 71.030000000000001 111.654 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.499 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 94.2 mt -55.42 -53.21 59.09 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.667 0.27 . . . . 73.450000000000003 111.56 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -51.37 -15.22 0.37 Allowed 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 113.264 0.838 . . . . 73.409999999999997 113.264 -177.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.518 ' HE3' ' CE2' ' A' ' 96' ' ' TYR . 38.1 ttpt -113.13 -26.64 8.35 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 121.562 -0.711 . . . . 74.430000000000007 112.511 177.125 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.518 ' CE2' ' HE3' ' A' ' 95' ' ' LYS . 85.4 m-85 -117.92 11.31 13.42 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.361 0.504 . . . . 70.219999999999999 112.361 -176.239 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 57.2 tttm -65.55 134.68 53.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.085 0.469 . . . . 72.439999999999998 111.733 -176.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 22.5 t90 -66.36 96.51 0.36 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.185 0.516 . . . . 71.030000000000001 111.517 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -105.73 93.68 7.73 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 115.804 -0.634 . . . . 71.409999999999997 110.608 173.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo . . . . . 0 CA--C 1.544 0.984 0 C-N-CA 122.839 2.359 . . . . 73.549999999999997 113.45 179.591 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 CA--C 1.541 0.599 0 N-CA-C 111.93 0.344 . . . . 63.219999999999999 111.93 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 52.8 tp60 -58.68 -31.45 68.21 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.887 0.375 . . . . 73.349999999999994 110.781 177.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -54.22 -50.27 67.54 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.256 -0.429 . . . . 75.299999999999997 110.688 171.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 76.7 mt -62.16 -46.54 88.51 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.747 -0.66 . . . . 74.349999999999994 111.24 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.9 t -56.7 -49.43 78.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.915 0.388 . . . . 75.439999999999998 111.66 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.435 ' O ' HG23 ' A' ' 11' ' ' VAL . 27.6 mm-40 -60.61 -55.99 26.68 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.349 0.5 . . . . 72.409999999999997 112.349 -178.172 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.511 ' O ' HG13 ' A' ' 12' ' ' ILE . 26.5 pt -59.37 -45.14 93.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 111.86 0.319 . . . . 70.209999999999994 111.86 -177.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -64.55 -41.93 96.02 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.983 0.421 . . . . 73.409999999999997 111.175 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.27 -37.56 69.98 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.247 -0.433 . . . . 71.239999999999995 111.317 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 7' ' ' GLN . 63.1 t -69.57 -36.98 73.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 121.095 0.474 . . . . 63.439999999999998 111.234 178.073 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 8' ' ' ILE . 75.1 mt -62.18 -34.25 62.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 116.122 -0.49 . . . . 72.129999999999995 112.168 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -60.82 -12.16 9.96 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 112.921 0.712 . . . . 70.420000000000002 112.921 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -87.52 -5.36 58.82 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 112.827 0.677 . . . . 63.340000000000003 112.827 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 56.2 mt -76.72 115.6 49.44 Favored Pre-proline 0 CA--C 1.546 0.802 0 O-C-N 122.101 -0.375 . . . . 63.399999999999999 111.448 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -67.82 159.34 53.25 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.909 2.406 . . . . 64.109999999999999 113.496 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -66.94 97.02 0.46 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.853 -0.612 . . . . 73.510000000000005 111.395 -176.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.476 ' H ' ' NH1' ' A' ' 56' ' ' ARG . . . 136.23 -22.19 3.42 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 121.222 -0.513 . . . . 70.549999999999997 113.045 176.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -98.42 164.73 12.16 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.144 0.497 . . . . 62.229999999999997 111.996 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.6 m -135.79 157.47 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.732 -0.667 . . . . 73.25 110.607 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 98.0 p -130.35 172.71 11.55 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.043 0.449 . . . . 75.400000000000006 110.965 178.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 46.4 p -108.26 152.39 24.68 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.91 0.386 . . . . 31.25 111.325 177.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.49 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 67.5 m-85 -55.32 -34.22 64.0 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.287 0.477 . . . . 75.109999999999999 112.287 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.3 -48.93 83.55 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.915 -0.66 . . . . 70.450000000000003 112.426 176.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -59.32 -52.45 65.6 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.849 0.357 . . . . 72.340000000000003 111.52 178.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.2 mm -59.61 -50.27 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 111.954 0.353 . . . . 64.530000000000001 111.954 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.449 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -58.67 -50.41 73.96 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.047 0.388 . . . . 74.129999999999995 112.047 -178.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -62.45 -44.05 97.34 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.647 0.26 . . . . 75.219999999999999 111.622 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 74.7 mtm -69.17 -24.14 64.03 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.591 0.234 . . . . 42.340000000000003 111.623 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.82 -20.98 44.82 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.026 0.441 . . . . 74.430000000000007 111.229 174.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.96 16.62 20.96 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 121.405 -0.426 . . . . 64.519999999999996 113.645 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.449 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 69.7 m-85 -126.93 89.33 52.33 Favored Pre-proline 0 CA--C 1.542 0.651 0 O-C-N 122.54 -0.388 . . . . 75.019999999999996 111.938 -177.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.24 141.85 40.25 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 122.437 2.091 . . . . 74.099999999999994 112.414 177.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.65 -37.17 2.46 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 121.003 -0.617 . . . . 73.019999999999996 113.637 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -63.8 -2.81 1.97 Allowed 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.744 0.646 . . . . 74.340000000000003 112.744 -178.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.49 ' HB1' ' HB3' ' A' ' 23' ' ' TYR . . . -48.02 -42.44 28.19 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.693 0.627 . . . . 34.25 112.693 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -59.05 -36.12 74.5 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.236 0.458 . . . . 72.150000000000006 112.236 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -72.65 -33.52 66.64 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.788 0.328 . . . . 74.409999999999997 110.755 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.489 HG13 HD12 ' A' ' 8' ' ' ILE . 60.6 t -58.02 -45.97 88.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 116.195 -0.457 . . . . 73.439999999999998 110.573 174.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.32 -45.4 96.2 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 121.15 -0.548 . . . . 64.430000000000007 113.0 176.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -64.79 -28.48 69.6 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.817 0.341 . . . . 64.209999999999994 111.261 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.65 -48.5 47.32 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.87 0.367 . . . . 71.219999999999999 111.077 174.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.561 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 44.6 mt -64.06 -40.0 95.31 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.864 0.364 . . . . 54.32 111.298 178.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.553 ' HA2' HD11 ' A' ' 66' ' ' LEU . . . -65.01 -13.85 58.06 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.155 -0.545 . . . . 55.140000000000001 112.924 176.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -86.79 -16.42 36.31 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 120.977 0.418 . . . . 72.540000000000006 110.962 177.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 95.7 mt -77.73 149.17 77.28 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 116.344 -0.389 . . . . 63.219999999999999 111.918 -178.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -77.2 165.93 27.16 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.537 2.158 . . . . 60.219999999999999 112.702 176.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.53 ' HB3' ' HD3' ' A' ' 73' ' ' ARG . 11.3 pt-20 -84.02 25.35 0.83 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.044 0.387 . . . . 64.450000000000003 112.044 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -141.87 19.59 2.54 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 121.195 -0.526 . . . . 50.229999999999997 113.482 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 56.4 p -81.11 155.75 26.11 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 117.085 0.442 . . . . 72.549999999999997 111.629 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -69.85 -21.35 63.36 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.325 0.583 . . . . 74.420000000000002 111.413 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.468 HD12 ' HD2' ' A' ' 53' ' ' PRO . 48.5 tp -87.42 116.3 65.65 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 115.882 -0.599 . . . . 74.310000000000002 111.388 178.072 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.468 ' HD2' HD12 ' A' ' 52' ' ' LEU . 64.2 Cg_endo -74.44 95.1 0.92 Allowed 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 121.419 1.413 . . . . 64.340000000000003 112.02 177.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.561 ' HB2' ' HB3' ' A' ' 43' ' ' LEU . 64.1 p-90 -83.78 -26.73 29.38 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.113 -0.494 . . . . 74.540000000000006 111.665 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -62.43 -12.98 24.9 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 113.102 0.779 . . . . 74.519999999999996 113.102 -178.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.486 HH22 ' HB3' ' A' ' 81' ' ' GLU . 80.4 mtt-85 -86.21 -13.23 47.53 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.846 0.684 . . . . 72.420000000000002 112.846 -178.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.7 t -102.74 99.81 9.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 120.97 0.414 . . . . 55.509999999999998 110.806 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.537 ' HA ' ' OG ' ' A' ' 65' ' ' SER . 44.8 pt -104.29 -170.23 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 121.303 0.573 . . . . 74.150000000000006 111.787 -178.148 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.1 p30 -89.38 158.96 17.56 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.199 0.523 . . . . 74.209999999999994 111.928 -177.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.7 p -66.01 -3.85 6.1 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.143 0.423 . . . . 60.32 112.143 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -86.55 -1.88 58.01 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 122.647 0.379 . . . . 63.43 111.896 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.78 31.88 67.17 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.147 -0.549 . . . . 42.310000000000002 112.69 -178.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -133.04 173.32 11.55 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.114 0.483 . . . . 74.010000000000005 111.324 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.611 HD11 HG11 ' A' ' 85' ' ' VAL . 38.1 mt -65.53 146.65 13.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 116.029 -0.532 . . . . 74.209999999999994 112.015 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.537 ' OG ' ' HA ' ' A' ' 58' ' ' ILE . 14.8 m -70.22 -47.86 59.58 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.002 -0.545 . . . . 75.209999999999994 111.91 -176.614 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.553 HD11 ' HA2' ' A' ' 44' ' ' GLY . 86.8 mt -103.54 158.2 16.53 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.084 -0.507 . . . . 54.350000000000001 111.794 -176.087 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.491 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 53.4 mtpt -120.24 163.66 17.44 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.02 0.438 . . . . 71.230000000000004 111.48 -178.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 77.53 -139.35 22.95 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 121.069 -0.586 . . . . 62.520000000000003 112.831 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -63.9 -34.95 79.11 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.206 0.526 . . . . 72.129999999999995 110.952 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -61.38 -27.77 68.76 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.764 -0.653 . . . . 72.030000000000001 111.195 177.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.491 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 10.1 tt -67.07 -48.31 68.64 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.103 -0.499 . . . . 72.140000000000001 110.663 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.58 ' HA ' ' HD3' ' A' ' 75' ' ' LYS . 11.9 m-20 -65.05 -34.22 77.9 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.68 0.276 . . . . 61.409999999999997 111.417 176.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.53 ' HD3' ' HB3' ' A' ' 48' ' ' GLU . 38.8 ttm180 -56.82 -50.71 71.55 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.108 0.48 . . . . 62.420000000000002 110.684 174.246 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.487 ' OE1' HG23 ' A' ' 64' ' ' ILE . 45.6 tt0 -66.84 -34.5 77.94 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.17 -0.468 . . . . 54.020000000000003 111.108 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.58 ' HD3' ' HA ' ' A' ' 72' ' ' ASP . 47.2 mtpt -55.7 -62.75 1.48 Allowed 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 120.963 0.411 . . . . 63.229999999999997 111.434 173.057 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -53.58 -37.57 63.08 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.795 -0.639 . . . . 74.329999999999998 112.053 -175.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -61.28 -53.51 55.83 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.027 0.442 . . . . 73.239999999999995 111.592 175.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.7 mt -65.26 -40.97 94.64 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.357 -0.383 . . . . 72.219999999999999 111.525 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -55.54 -44.63 76.93 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.152 0.501 . . . . 74.340000000000003 111.043 174.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.71 -31.86 71.13 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.008 -0.542 . . . . 70.430000000000007 111.278 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.486 ' HB3' HH22 ' A' ' 56' ' ' ARG . 14.1 mm-40 -87.65 9.85 20.02 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.562 0.578 . . . . 65.040000000000006 112.562 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.27 4.3 83.92 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.398 -0.43 . . . . 70.129999999999995 113.813 175.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 67.0 mt -87.39 132.79 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 O-C-N 122.6 -0.353 . . . . 71.099999999999994 111.171 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -87.99 101.01 13.35 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.918 0.39 . . . . 52.43 111.424 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.611 HG11 HD11 ' A' ' 64' ' ' ILE . 48.8 t -89.87 120.58 38.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 120.844 0.354 . . . . 74.140000000000001 110.731 176.005 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.589 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 36.5 m -68.18 146.2 53.62 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.595 -0.275 . . . . 74.450000000000003 111.1 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -41.22 -51.96 3.44 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 115.246 1.573 . . . . 53.229999999999997 115.246 -169.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 pp -75.01 -5.7 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 112.924 0.713 . . . . 73.519999999999996 112.924 -175.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 105.99 46.93 1.13 Allowed Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.29 -0.481 . . . . 73.319999999999993 113.171 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.589 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 48.5 tttm -116.81 139.65 50.35 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.829 0.347 . . . . 73.120000000000005 111.916 -178.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.464 HD12 HG21 ' A' ' 58' ' ' ILE . 65.8 mt -131.11 126.36 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 116.267 -0.424 . . . . 71.049999999999997 111.216 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.22 95.88 1.04 Allowed 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 111.958 0.355 . . . . 50.439999999999998 111.958 179.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.485 HD21 HD11 ' A' ' 58' ' ' ILE . 70.7 mt -56.24 -51.1 69.34 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 111.918 0.34 . . . . 73.230000000000004 111.918 179.243 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -61.71 -9.29 6.02 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.193 0.442 . . . . 63.020000000000003 112.193 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -107.92 -22.11 12.56 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 122.507 0.323 . . . . 73.040000000000006 111.608 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -127.92 13.67 6.82 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.241 0.46 . . . . 64.129999999999995 112.241 -177.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 65.1 tttp -62.99 131.41 48.55 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.535 0.568 . . . . 71.340000000000003 112.535 -175.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 20.4 t90 -72.64 109.82 6.55 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.101 -0.499 . . . . 71.329999999999998 111.024 174.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.445 ' HA ' ' HD2' ' A' ' 100' ' ' PRO . 20.8 mm-40 -108.72 93.7 12.69 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 115.982 -0.554 . . . . 64.120000000000005 110.735 176.261 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 99' ' ' GLN . 22.5 Cg_endo . . . . . 0 C--N 1.352 0.736 0 C-N-CA 122.971 2.447 . . . . 71.430000000000007 112.857 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 . . . . . 0 CA--C 1.54 0.558 0 N-CA-C 111.896 0.332 . . . . 63.530000000000001 111.896 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.422 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 15.1 mm100 -60.19 -27.6 67.29 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.595 0.236 . . . . 64.030000000000001 111.363 176.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -52.59 -49.13 65.62 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.237 0.541 . . . . 72.219999999999999 110.222 172.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 73.1 mt -66.61 -47.54 72.36 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.485 -0.78 . . . . 51.100000000000001 111.055 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.7 t -55.19 -44.92 76.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.324 -0.398 . . . . 71.450000000000003 111.589 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 31.8 mm-40 -66.58 -52.28 47.14 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.208 0.447 . . . . 75.239999999999995 112.208 -178.557 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.423 ' O ' HG13 ' A' ' 12' ' ' ILE . 31.8 pt -60.73 -41.62 89.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 O-C-N 122.146 -0.346 . . . . 54.340000000000003 111.47 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 17.6 m-30 -61.72 -46.56 89.12 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.068 0.461 . . . . 74.420000000000002 110.705 176.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.28 -39.55 64.01 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.109 -0.496 . . . . 72.230000000000004 111.448 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 7' ' ' GLN . 92.1 t -65.25 -43.2 95.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 120.776 0.322 . . . . 74.530000000000001 111.476 178.209 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.551 ' HB ' HD11 ' A' ' 52' ' ' LEU . 72.8 mt -56.84 -33.97 42.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 120.927 0.394 . . . . 74.310000000000002 111.763 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -59.4 -16.94 26.36 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 113.22 0.822 . . . . 74.230000000000004 113.22 178.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.437 ' HB3' ' HZ2' ' A' ' 98' ' ' TRP . 2.0 mp0 -80.97 -11.7 59.52 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.375 0.509 . . . . 71.530000000000001 112.375 177.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.495 HD11 HD11 ' A' ' 26' ' ' ILE . 51.0 mt -75.33 115.3 44.0 Favored Pre-proline 0 N--CA 1.472 0.626 0 O-C-N 122.311 -0.243 . . . . 74.430000000000007 111.086 178.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 15' ' ' ILE . 19.6 Cg_exo -66.95 169.29 15.17 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.778 2.319 . . . . 72.319999999999993 113.523 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -70.06 115.65 9.51 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.822 -0.626 . . . . 74.010000000000005 110.891 -178.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.32 19.25 21.55 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 120.97 -0.633 . . . . 71.340000000000003 113.643 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -127.11 152.45 47.29 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 117.169 0.485 . . . . 73.010000000000005 111.347 176.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.6 m -128.04 150.04 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 121.136 0.493 . . . . 73.519999999999996 111.731 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.7 t -138.75 175.0 9.93 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.362 -0.381 . . . . 51.450000000000003 111.091 175.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 67.6 p -104.88 150.78 24.57 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.907 0.384 . . . . 75.510000000000005 111.988 -177.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.42 ' HE1' HD12 ' A' ' 43' ' ' LEU . 68.9 m-85 -52.54 -36.68 56.12 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.27 -0.423 . . . . 63.210000000000001 111.659 178.167 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -60.96 -48.25 87.23 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 116.086 -0.506 . . . . 55.109999999999999 112.789 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -61.14 -51.95 66.93 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.848 0.356 . . . . 65.409999999999997 111.107 178.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.495 HD11 HD11 ' A' ' 15' ' ' ILE . 49.4 mm -53.14 -53.31 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 121.131 0.491 . . . . 72.109999999999999 111.622 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.62 -44.63 96.11 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.157 0.504 . . . . 62.229999999999997 111.322 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.4 ttpp -62.46 -33.99 75.93 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.168 -0.469 . . . . 73.329999999999998 111.531 -178.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 67.2 mtt -72.99 -41.33 64.43 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.984 0.421 . . . . 73.099999999999994 111.161 175.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.73 -24.81 67.05 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.236 -0.438 . . . . 51.340000000000003 112.171 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.42 24.55 6.14 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.286 -0.483 . . . . 51.310000000000002 113.254 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -135.65 66.07 62.64 Favored Pre-proline 0 CA--C 1.543 0.674 0 O-C-N 122.665 -0.315 . . . . 74.5 111.57 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -61.91 138.28 72.78 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.588 2.192 . . . . 64.040000000000006 112.757 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.33 -27.8 9.96 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.274 -0.488 . . . . 54.009999999999998 113.127 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -79.88 22.94 0.47 Allowed 'General case' 0 N--CA 1.473 0.715 0 O-C-N 122.214 -0.58 . . . . 64.349999999999994 112.542 -177.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.93 -37.86 69.52 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.414 0.524 . . . . 74.329999999999998 112.414 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -58.82 -38.22 78.17 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.825 0.345 . . . . 70.140000000000001 111.782 178.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -69.74 -35.02 74.63 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.537 -0.301 . . . . 73.439999999999998 111.124 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.418 HG13 HD12 ' A' ' 8' ' ' ILE . 46.6 t -59.67 -44.5 93.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.002 0.43 . . . . 52.520000000000003 110.655 175.242 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.68 -40.58 98.71 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 121.169 -0.539 . . . . 74.120000000000005 112.718 176.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -67.0 -27.89 67.8 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.982 0.42 . . . . 74.329999999999998 111.157 175.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.89 -53.61 12.64 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.308 -0.406 . . . . 70.540000000000006 111.625 177.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.42 HD12 ' HE1' ' A' ' 23' ' ' TYR . 61.1 mt -61.13 -39.46 90.1 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.501 -0.318 . . . . 73.530000000000001 111.558 -179.287 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.45 -15.91 57.73 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 120.88 -0.676 . . . . 54.509999999999998 113.507 178.026 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -103.41 10.78 37.17 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 122.622 -0.34 . . . . 64.349999999999994 111.804 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 57.9 mt -86.12 155.89 57.65 Favored Pre-proline 0 N--CA 1.47 0.568 0 CA-C-O 120.999 0.428 . . . . 75.230000000000004 112.031 177.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.436 ' HG2' ' HB2' ' A' ' 50' ' ' SER . 55.2 Cg_endo -70.29 153.16 66.75 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.266 1.977 . . . . 70.140000000000001 111.819 172.288 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -49.28 -70.8 0.08 Allowed 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 121.239 0.542 . . . . 64.340000000000003 111.372 -176.261 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -91.53 59.46 2.96 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 121.201 -0.523 . . . . 70.140000000000001 113.364 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.436 ' HB2' ' HG2' ' A' ' 47' ' ' PRO . 40.2 t -70.25 165.41 22.27 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.028 0.442 . . . . 63.409999999999997 111.621 176.119 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -67.09 -24.73 65.98 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.234 0.54 . . . . 63.039999999999999 110.545 174.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.551 HD11 ' HB ' ' A' ' 12' ' ' ILE . 28.0 tp -90.37 126.8 55.37 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 115.722 -0.672 . . . . 73.239999999999995 111.747 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.534 ' HD2' HD12 ' A' ' 52' ' ' LEU . 74.0 Cg_endo -76.24 94.99 1.02 Allowed 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 121.574 1.516 . . . . 71.230000000000004 111.553 170.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 60.4 p-90 -83.71 -26.98 29.31 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.352 0.596 . . . . 54.109999999999999 111.678 -177.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -62.66 -13.95 37.99 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.571 0.952 . . . . 73.099999999999994 113.571 -177.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -86.36 3.57 43.0 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 112.541 0.571 . . . . 74.219999999999999 112.541 -178.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.8 t -116.62 123.23 71.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 121.194 0.521 . . . . 73.420000000000002 111.795 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.549 HG21 HD12 ' A' ' 91' ' ' ILE . 21.1 pt -126.97 -172.65 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 116.068 -0.514 . . . . 52.340000000000003 111.269 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.6 p30 -90.29 172.64 8.63 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.899 -0.501 . . . . 73.099999999999994 112.126 -177.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 43.9 m -63.32 -16.57 60.8 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 112.587 0.588 . . . . 72.109999999999999 112.587 -176.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -88.38 -2.71 58.75 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.809 0.338 . . . . 73.109999999999999 111.662 -178.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.63 40.75 58.5 Favored Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.977 -0.63 . . . . 64.230000000000004 112.358 -175.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -130.76 155.11 47.2 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.101 0.477 . . . . 71.0 111.387 -177.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.552 HG23 ' OE1' ' A' ' 74' ' ' GLN . 65.5 mt -77.2 130.78 35.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 116.252 -0.431 . . . . 74.439999999999998 110.966 176.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.9 m -73.17 -41.17 64.18 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 112.101 0.408 . . . . 74.519999999999996 112.101 -179.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.541 HD13 ' HB3' ' A' ' 70' ' ' ASP . 93.8 mt -73.15 146.15 45.85 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.453 -0.34 . . . . 74.299999999999997 110.789 178.42 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -116.2 157.09 25.39 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.17 0.509 . . . . 73.349999999999994 112.121 -176.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.6 -124.14 30.57 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 115.858 -0.61 . . . . 74.510000000000005 114.007 177.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.5 mtp180 -61.27 -46.96 88.19 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.948 0.404 . . . . 74.319999999999993 111.972 -177.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.541 ' HB3' HD13 ' A' ' 66' ' ' LEU . 15.1 m-20 -63.08 -29.59 70.93 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.85 0.357 . . . . 61.539999999999999 111.174 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.8 tt -63.88 -53.44 50.49 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.312 -0.404 . . . . 75.040000000000006 110.463 175.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -62.27 -30.2 70.96 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.303 -0.408 . . . . 64.430000000000007 111.22 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.557 ' O ' ' HG2' ' A' ' 77' ' ' LYS . 43.5 ttm180 -58.94 -60.38 3.96 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.743 0.306 . . . . 74.200000000000003 110.946 174.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.552 ' OE1' HG23 ' A' ' 64' ' ' ILE . 43.3 tt0 -55.73 -43.3 76.45 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.086 0.47 . . . . 71.150000000000006 110.962 177.525 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.415 ' HG3' ' HB ' ' A' ' 85' ' ' VAL . 31.5 tttm -55.07 -56.54 18.7 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.728 -0.669 . . . . 70.239999999999995 111.837 176.103 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -59.14 -37.97 78.54 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.154 0.427 . . . . 61.450000000000003 112.154 -178.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.557 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 75.0 mmtt -58.8 -46.46 87.52 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.934 0.397 . . . . 74.439999999999998 110.942 176.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.504 HD22 HD12 ' A' ' 83' ' ' ILE . 95.8 mt -71.26 -35.33 71.35 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.198 -0.455 . . . . 70.25 111.628 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -54.6 -41.16 69.61 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.075 0.464 . . . . 60.520000000000003 110.741 173.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.61 -8.18 39.6 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.419 0.526 . . . . 71.400000000000006 112.419 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -107.64 4.45 25.86 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.969 0.414 . . . . 63.030000000000001 111.47 177.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.67 5.17 63.25 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.285 -0.483 . . . . 52.109999999999999 113.926 177.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.504 HD12 HD22 ' A' ' 78' ' ' LEU . 66.4 mt -82.64 133.13 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 O-C-N 122.242 -0.563 . . . . 75.430000000000007 111.435 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -92.36 97.64 10.99 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.891 0.377 . . . . 72.299999999999997 111.455 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.415 ' HB ' ' HG3' ' A' ' 75' ' ' LYS . 44.8 t -91.22 124.53 43.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 120.883 0.373 . . . . 75.349999999999994 111.49 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.56 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 42.7 t -67.63 144.56 55.47 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 111.635 0.235 . . . . 62.32 111.635 177.421 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -41.94 -48.25 4.47 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.081 1.141 . . . . 75.450000000000003 114.081 -173.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.403 ' H ' HG13 ' A' ' 88' ' ' ILE . 2.8 pp -80.74 16.11 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 112.87 0.693 . . . . 73.439999999999998 112.87 -175.446 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.82 51.59 4.73 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 121.414 -0.422 . . . . 64.150000000000006 113.51 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.56 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 60.4 tttm -125.72 132.17 52.41 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 122.532 -0.393 . . . . 71.209999999999994 111.256 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.549 HD12 HG21 ' A' ' 58' ' ' ILE . 61.0 mt -124.09 134.41 66.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 120.934 0.397 . . . . 62.100000000000001 111.475 -177.54 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.8 100.22 1.14 Allowed 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 111.947 0.351 . . . . 65.439999999999998 111.947 178.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 39.4 mt -59.06 -62.27 2.01 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.355 0.502 . . . . 73.329999999999998 112.355 -178.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -50.19 -34.46 22.78 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 112.314 0.487 . . . . 73.209999999999994 112.314 -175.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -73.71 -47.29 40.56 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 112.32 0.489 . . . . 53.530000000000001 112.32 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -102.41 14.1 32.85 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 120.973 0.416 . . . . 73.200000000000003 111.528 -177.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -55.02 114.09 1.61 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.905 -0.589 . . . . 72.329999999999998 111.894 -175.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.437 ' HZ2' ' HB3' ' A' ' 14' ' ' GLN . 21.4 t90 -56.45 121.28 9.25 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.101 0.778 . . . . 65.150000000000006 113.101 -177.195 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.447 ' O ' ' HG3' ' A' ' 99' ' ' GLN . 12.9 pt20 -127.16 109.98 21.55 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 115.662 -0.699 . . . . 73.140000000000001 109.924 167.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo . . . . . 0 CA--C 1.538 0.686 0 C-N-CA 122.152 1.901 . . . . 63.299999999999997 112.27 174.945 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.47 ' O ' HG23 ' A' ' 6' ' ' VAL . 5.8 m-20 . . . . . 0 N--CA 1.472 0.626 0 N-CA-C 112.088 0.403 . . . . 74.140000000000001 112.088 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -57.66 -31.73 66.6 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.395 -0.366 . . . . 63.299999999999997 111.767 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.406 ' O ' HG12 ' A' ' 8' ' ' ILE . 53.2 t80 -54.83 -52.41 62.81 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.309 0.576 . . . . 72.140000000000001 110.49 172.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 72.5 mt -64.53 -45.32 87.7 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.629 -0.714 . . . . 70.120000000000005 111.17 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 2' ' ' ASP . 58.6 t -55.37 -51.49 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 120.931 0.396 . . . . 63.43 111.697 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.409 ' O ' HG23 ' A' ' 11' ' ' VAL . 28.3 mm-40 -65.27 -50.81 64.32 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 112.539 0.57 . . . . 65.109999999999999 112.539 -176.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.45 ' O ' HG13 ' A' ' 12' ' ' ILE . 32.6 pt -62.16 -45.55 98.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 O-C-N 122.192 -0.317 . . . . 62.329999999999998 111.58 -178.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.405 ' N ' HG13 ' A' ' 8' ' ' ILE . 19.5 m-30 -62.31 -43.37 98.98 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.081 0.467 . . . . 72.430000000000007 110.91 177.101 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.03 -48.15 67.83 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.927 -0.579 . . . . 61.32 111.413 178.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 7' ' ' GLN . 78.0 t -62.87 -41.84 94.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 120.795 0.331 . . . . 75.120000000000005 111.502 -179.231 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 8' ' ' ILE . 81.5 mt -57.4 -35.86 50.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 112.06 0.393 . . . . 71.340000000000003 112.06 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -56.72 -15.17 4.1 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.15 0.796 . . . . 71.5 113.15 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -86.79 -11.19 51.73 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.699 0.629 . . . . 72.109999999999999 112.699 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.494 HD11 HD11 ' A' ' 26' ' ' ILE . 52.1 mt -73.32 111.64 12.6 Favored Pre-proline 0 CA--C 1.543 0.679 0 O-C-N 122.245 -0.284 . . . . 71.129999999999995 110.677 178.021 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -81.57 178.05 6.99 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.635 2.223 . . . . 63.439999999999998 113.736 -175.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.4 tptt -58.56 140.92 53.49 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.842 -0.617 . . . . 75.349999999999994 111.482 -178.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.661 ' H ' ' NH2' ' A' ' 56' ' ' ARG . . . 82.45 -32.53 2.84 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 116.176 -0.465 . . . . 52.25 114.142 179.281 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -85.67 158.3 20.1 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.019 0.748 . . . . 73.040000000000006 113.019 -175.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.8 m -139.97 166.84 19.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 115.636 -0.711 . . . . 51.329999999999998 110.734 177.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.8 t -149.28 -178.66 6.52 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.448 -0.342 . . . . 72.430000000000007 110.314 176.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 72.3 p -112.53 158.7 19.61 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.391 0.515 . . . . 72.140000000000001 112.391 -177.211 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -54.34 -41.82 69.52 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.203 -0.453 . . . . 72.420000000000002 110.903 176.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.12 -47.5 89.46 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.911 -0.586 . . . . 75.409999999999997 113.094 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.432 ' O ' ' HE2' ' A' ' 29' ' ' MET . 34.5 mt-10 -55.9 -53.48 56.25 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.925 0.363 . . . . 71.400000000000006 111.389 177.006 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.494 HD11 HD11 ' A' ' 15' ' ' ILE . 49.3 mm -58.72 -49.62 82.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 120.834 0.35 . . . . 70.430000000000007 111.491 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.523 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -57.89 -49.04 78.09 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 120.995 0.426 . . . . 73.5 112.05 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.458 ' NZ ' ' HB3' ' A' ' 28' ' ' LYS . 9.4 mtpm? -62.71 -39.43 94.02 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.438 -0.346 . . . . 73.540000000000006 111.825 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.432 ' HE2' ' O ' ' A' ' 25' ' ' GLU . 72.5 mtm -79.48 -16.07 56.68 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.649 0.261 . . . . 72.129999999999995 111.657 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -85.85 -30.62 22.79 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.028 0.442 . . . . 74.109999999999999 111.363 174.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.41 12.23 10.96 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.286 -0.483 . . . . 42.039999999999999 113.448 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.523 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 71.1 m-85 -130.35 67.53 80.15 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 117.011 0.405 . . . . 73.439999999999998 111.062 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.48 -49.24 16.72 Favored 'Trans proline' 0 N--CA 1.482 0.819 0 C-N-CA 122.842 2.362 . . . . 65.120000000000005 114.096 -174.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -81.38 41.82 2.7 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.105 -0.569 . . . . 72.239999999999995 113.897 -177.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.41 ' O ' HG23 ' A' ' 39' ' ' VAL . 77.0 m-85 -141.26 21.42 2.24 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.668 0.618 . . . . 65.450000000000003 112.668 -178.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.35 -51.51 64.54 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.076 0.398 . . . . 63.229999999999997 112.076 -177.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -55.11 -36.89 66.2 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.873 0.368 . . . . 70.439999999999998 111.968 176.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -72.39 -37.45 68.72 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.553 -0.294 . . . . 72.129999999999995 111.367 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.457 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 99.7 t -56.85 -47.2 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 120.874 0.369 . . . . 64.230000000000004 110.7 175.236 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.26 -46.69 92.54 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.281 -0.485 . . . . 70.420000000000002 113.069 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.34 -36.63 82.81 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.984 0.421 . . . . 74.010000000000005 111.337 177.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.29 -40.39 95.86 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.978 0.418 . . . . 75.5 111.265 175.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.484 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 89.9 mt -69.75 -38.83 76.94 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.271 -0.422 . . . . 51.109999999999999 111.338 178.118 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.05 -13.55 48.97 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 121.285 -0.483 . . . . 72.430000000000007 113.337 178.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -90.59 -12.38 37.18 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 122.556 -0.379 . . . . 55.130000000000003 111.445 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 88.8 mt -66.43 133.58 94.4 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 112.116 0.413 . . . . 62.140000000000001 112.116 -178.03 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.95 161.33 39.08 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.661 2.241 . . . . 73.109999999999999 113.725 -177.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -61.96 -12.99 21.16 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.331 -0.85 . . . . 70.400000000000006 112.556 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -107.77 18.27 34.82 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 121.139 -0.553 . . . . 75.549999999999997 113.949 -179.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 41.6 t -79.79 152.96 29.48 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 117.413 0.606 . . . . 72.230000000000004 111.583 177.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -101.2 6.55 43.09 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.222 0.534 . . . . 55.329999999999998 110.938 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.517 HD12 ' HD2' ' A' ' 53' ' ' PRO . 56.4 tp -95.16 115.26 65.25 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 116.125 -0.488 . . . . 74.349999999999994 110.681 176.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.517 ' HD2' HD12 ' A' ' 52' ' ' LEU . 63.7 Cg_endo -73.66 95.0 0.86 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 121.39 1.394 . . . . 65.420000000000002 112.059 178.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.484 ' HB2' ' HB3' ' A' ' 43' ' ' LEU . 68.5 p-90 -89.07 -26.24 21.49 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.171 0.51 . . . . 75.450000000000003 111.426 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.442 ' O ' HD21 ' A' ' 78' ' ' LEU . 35.8 p90 -58.48 -21.79 52.78 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.007 -0.542 . . . . 65.239999999999995 112.299 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.661 ' NH2' ' H ' ' A' ' 18' ' ' GLY . 88.0 mtt-85 -81.31 5.78 16.23 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.086 0.402 . . . . 45.43 112.086 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 18.6 t -115.31 111.44 35.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-O 121.228 0.537 . . . . 64.349999999999994 111.195 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.586 HG21 HD12 ' A' ' 91' ' ' ILE . 20.2 pt -117.79 -169.06 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 122.835 0.454 . . . . 54.340000000000003 111.047 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -92.12 167.35 12.13 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.57 -0.706 . . . . 63.229999999999997 111.764 -178.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 80.8 p -59.13 -18.76 38.72 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 112.644 0.609 . . . . 42.130000000000003 112.644 -176.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -85.94 4.6 36.84 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.786 0.327 . . . . 74.230000000000004 111.702 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.03 38.21 88.31 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 121.122 -0.561 . . . . 20.239999999999998 112.426 -177.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.486 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 54.5 mtpt -131.55 156.9 44.94 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.511 0.672 . . . . 71.140000000000001 112.009 -176.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.551 HG23 ' OE1' ' A' ' 74' ' ' GLN . 68.4 mt -78.59 104.28 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 115.575 -0.739 . . . . 73.319999999999993 110.047 173.644 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.2 t -63.38 -25.37 68.26 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.398 -0.365 . . . . 50.32 111.845 -176.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.418 HD13 ' HB3' ' A' ' 70' ' ' ASP . 83.1 mt -74.99 145.17 42.72 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.354 -0.384 . . . . 72.219999999999999 110.873 177.072 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.45 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -133.86 171.41 14.21 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.16 0.505 . . . . 74.420000000000002 112.0 -175.128 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.5 -121.75 24.83 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.918 -0.658 . . . . 61.240000000000002 112.663 -177.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 69' ' ' ARG . 35.3 mtt180 -71.6 -33.88 69.38 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.019 0.438 . . . . 54.009999999999998 111.277 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 73' ' ' ARG . 25.4 m-20 -73.32 -18.19 61.22 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 111.959 0.355 . . . . 70.519999999999996 111.959 -178.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.45 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 6.8 tt -66.11 -55.03 18.49 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.949 -0.389 . . . . 75.099999999999994 109.949 177.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.559 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 19.8 m-20 -67.45 -26.16 66.25 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.766 0.317 . . . . 72.019999999999996 111.304 176.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.434 ' HB3' ' O ' ' A' ' 70' ' ' ASP . 76.0 ttt180 -53.31 -62.5 1.61 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.203 0.525 . . . . 73.510000000000005 110.493 173.06 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.551 ' OE1' HG23 ' A' ' 64' ' ' ILE . 48.6 tt0 -67.1 -46.71 73.4 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.202 -0.454 . . . . 62.130000000000003 111.356 177.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.559 ' HB3' ' HA ' ' A' ' 72' ' ' ASP . 47.1 tttm -51.97 -50.36 61.4 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.616 0.598 . . . . 70.5 112.616 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -71.0 -30.88 67.24 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 111.904 0.335 . . . . 74.120000000000005 111.904 -176.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -64.75 -35.08 79.91 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.07 0.462 . . . . 73.120000000000005 110.873 171.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.524 HD13 HD11 ' A' ' 91' ' ' ILE . 57.8 mt -70.15 -47.36 61.99 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.185 -0.461 . . . . 71.219999999999999 111.286 175.147 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -57.88 -31.22 66.51 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.193 -0.458 . . . . 52.210000000000001 111.389 176.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.55 -34.07 70.62 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.836 0.351 . . . . 74.340000000000003 111.32 173.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -88.09 -11.81 45.99 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 111.813 0.301 . . . . 63.420000000000002 111.813 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.77 54.76 3.15 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.285 -0.484 . . . . 71.519999999999996 113.029 -178.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.535 HD11 HH12 ' A' ' 56' ' ' ARG . 68.3 mt -116.2 137.06 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 122.605 0.362 . . . . 72.329999999999998 111.223 -179.155 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.461 ' HG3' ' OH ' ' A' ' 96' ' ' TYR . 66.9 mt-10 -66.71 92.98 0.23 Allowed 'General case' 0 N--CA 1.471 0.588 0 O-C-N 122.012 -0.43 . . . . 61.520000000000003 111.868 -179.324 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.42 HG11 ' HG3' ' A' ' 75' ' ' LYS . 42.9 t -89.99 102.79 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 120.815 0.341 . . . . 45.0 110.722 173.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.596 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 69.9 m -64.46 163.46 13.31 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.317 0.488 . . . . 53.310000000000002 112.317 -178.529 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -35.04 -58.09 0.54 Allowed 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 115.247 1.573 . . . . 54.32 115.247 -169.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.461 HD13 ' HE3' ' A' ' 63' ' ' LYS . 2.6 pp -92.82 23.06 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 112.505 0.557 . . . . 75.319999999999993 112.505 -174.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.71 47.8 7.03 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 121.266 -0.492 . . . . 74.219999999999999 112.604 -176.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.596 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 49.3 tttm -111.8 131.88 55.04 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 122.432 -0.452 . . . . 65.030000000000001 111.452 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.586 HD12 HG21 ' A' ' 58' ' ' ILE . 53.5 mt -116.46 135.87 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 120.921 0.391 . . . . 75.120000000000005 111.699 -176.365 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.99 93.92 1.42 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.948 0.404 . . . . 70.109999999999999 111.453 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.463 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 66.6 mt -54.24 -56.85 14.31 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.384 0.513 . . . . 74.140000000000001 112.384 -178.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -53.05 -28.21 23.54 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.522 0.564 . . . . 73.140000000000001 112.522 -177.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -84.52 -33.09 23.58 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.033 0.383 . . . . 64.239999999999995 112.033 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.461 ' OH ' ' HG3' ' A' ' 84' ' ' GLU . 80.3 m-85 -117.59 6.92 12.52 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.84 0.682 . . . . 73.420000000000002 112.84 -173.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 61.5 tttp -63.31 128.8 37.51 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.159 0.504 . . . . 74.400000000000006 112.209 -173.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 15.7 t90 -69.72 116.81 10.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.761 -0.654 . . . . 74.230000000000004 110.798 175.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.413 ' HA ' ' HD2' ' A' ' 100' ' ' PRO . 77.1 mt-30 -114.38 92.04 26.37 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 116.476 -0.329 . . . . 71.450000000000003 111.187 178.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 99' ' ' GLN . 36.7 Cg_endo . . . . . 0 CA--C 1.538 0.683 0 C-N-CA 122.514 2.143 . . . . 73.420000000000002 112.043 174.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 112.737 0.643 . . . . 74.329999999999998 112.737 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.591 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 22.2 mm-40 -53.74 -40.04 65.83 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.063 -0.517 . . . . 72.319999999999993 111.38 175.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.416 ' O ' HG12 ' A' ' 8' ' ' ILE . 64.5 t80 -50.42 -53.38 29.9 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.131 0.491 . . . . 61.420000000000002 111.105 177.124 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 59.5 mt -61.61 -46.55 89.34 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.748 -0.66 . . . . 65.049999999999997 111.182 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.4 t -60.44 -44.86 97.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 116.137 -0.483 . . . . 62.119999999999997 111.896 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.591 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 24.4 mm-40 -68.51 -52.1 35.89 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.014 0.376 . . . . 75.530000000000001 112.014 -176.022 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.499 ' O ' HG13 ' A' ' 12' ' ' ILE . 30.9 pt -58.16 -43.42 85.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 121.055 -0.258 . . . . 52.509999999999998 111.306 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.5 m-30 -63.34 -46.76 85.08 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.036 0.446 . . . . 74.329999999999998 110.671 175.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.35 -44.67 65.32 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.926 -0.579 . . . . 75.219999999999999 111.661 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 7' ' ' GLN . 99.7 t -63.48 -43.78 98.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 120.825 0.345 . . . . 74.010000000000005 111.4 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.551 ' HB ' HD11 ' A' ' 52' ' ' LEU . 72.6 mt -58.63 -32.09 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 112.161 0.43 . . . . 74.530000000000001 112.161 -178.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -60.55 -10.24 4.83 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.064 0.764 . . . . 60.32 113.064 178.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -92.86 -2.52 55.81 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 112.564 0.579 . . . . 71.230000000000004 112.564 178.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.412 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 55.3 mt -81.5 114.1 47.05 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-O 120.653 0.263 . . . . 64.450000000000003 111.176 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 15' ' ' ILE . 16.7 Cg_exo -68.55 171.47 13.04 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.926 2.417 . . . . 53.0 113.054 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 44.9 tttp -66.68 133.04 49.42 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.064 0.459 . . . . 64.319999999999993 111.25 -178.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.505 ' H ' ' NH2' ' A' ' 56' ' ' ARG . . . 95.19 -25.14 25.63 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 121.319 -0.467 . . . . 24.34 113.184 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -86.72 157.31 19.67 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.587 0.588 . . . . 71.010000000000005 112.587 -177.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.3 m -140.51 153.98 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.621 -0.718 . . . . 71.030000000000001 110.722 176.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.5 t -135.07 179.98 5.98 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 122.189 -0.319 . . . . 55.210000000000001 110.726 176.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.2 p -110.9 155.52 22.51 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.09 0.471 . . . . 72.25 112.14 -176.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -54.3 -34.87 61.88 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.197 -0.456 . . . . 73.519999999999996 111.978 177.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.98 -49.9 60.5 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.095 -0.574 . . . . 41.240000000000002 112.752 177.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -56.39 -53.84 52.63 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.0 0.428 . . . . 72.450000000000003 111.364 177.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.5 mm -56.63 -48.23 80.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-N 116.12 -0.491 . . . . 74.549999999999997 111.729 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.467 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -60.12 -49.39 77.81 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 120.88 0.371 . . . . 74.430000000000007 111.971 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -60.63 -36.63 79.1 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.9 0.381 . . . . 61.210000000000001 111.878 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 73.6 mtm -84.81 -9.71 57.89 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.746 0.308 . . . . 65.219999999999999 111.773 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.3 -11.5 32.3 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.933 0.396 . . . . 71.230000000000004 111.356 173.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.13 21.68 37.87 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 121.312 -0.47 . . . . 72.120000000000005 113.482 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.467 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 97.2 m-85 -133.59 77.78 63.71 Favored Pre-proline 0 CA--C 1.543 0.699 0 O-C-N 122.522 -0.399 . . . . 74.510000000000005 111.916 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.52 135.71 24.71 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.305 2.004 . . . . 73.230000000000004 112.712 178.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.63 -1.87 76.2 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 121.238 -0.506 . . . . 63.310000000000002 113.738 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -99.88 23.21 10.04 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 117.258 0.529 . . . . 70.0 112.29 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.65 -48.4 58.3 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.723 0.638 . . . . 34.409999999999997 112.723 -177.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.0 ttp180 -68.08 -32.42 72.73 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.738 0.304 . . . . 75.400000000000006 111.711 -178.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -67.99 -35.98 79.24 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.848 0.356 . . . . 64.0 110.993 178.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.451 HG22 HG21 ' A' ' 8' ' ' ILE . 47.1 t -60.01 -42.84 91.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 121.393 0.615 . . . . 74.129999999999995 109.851 172.432 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.31 -37.93 92.61 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 115.681 -0.69 . . . . 62.240000000000002 112.781 174.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -58.19 -50.76 72.39 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.139 0.495 . . . . 74.109999999999999 110.602 174.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.29 -46.75 82.85 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.66 -0.7 . . . . 73.340000000000003 112.125 -177.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 62.2 mt -65.17 -39.26 92.69 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.794 0.331 . . . . 75.340000000000003 111.596 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.7 -25.19 65.22 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 120.805 -0.712 . . . . 72.340000000000003 113.249 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -87.3 5.58 37.66 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 120.877 0.37 . . . . 63.420000000000002 111.84 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 97.0 mt -94.48 155.71 39.34 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-O 120.664 0.268 . . . . 64.099999999999994 111.084 176.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.9 160.47 46.82 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.241 1.961 . . . . 55.450000000000003 112.367 174.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -53.83 -41.46 67.4 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.174 0.435 . . . . 74.140000000000001 112.174 -174.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -124.77 65.51 0.54 Allowed Glycine 0 CA--C 1.526 0.735 0 C-N-CA 121.334 -0.46 . . . . 72.109999999999999 112.577 178.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.8 t -69.72 163.96 24.55 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.206 0.447 . . . . 63.039999999999999 112.206 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -60.38 -30.61 69.68 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.384 0.611 . . . . 74.25 110.259 173.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.553 HD12 ' HD2' ' A' ' 53' ' ' PRO . 48.5 tp -86.36 121.93 72.29 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 115.592 -0.731 . . . . 70.310000000000002 110.456 173.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.553 ' HD2' HD12 ' A' ' 52' ' ' LEU . 58.1 Cg_endo -72.95 94.9 0.81 Allowed 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 121.12 1.213 . . . . 72.540000000000006 111.745 177.17 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 69.2 p-90 -79.67 -31.28 41.36 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.978 -0.555 . . . . 71.439999999999998 111.605 -177.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.412 ' O ' HD21 ' A' ' 78' ' ' LEU . 31.7 p90 -62.81 -11.01 15.1 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.726 0.639 . . . . 72.340000000000003 112.726 -179.315 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.659 HH12 HD11 ' A' ' 83' ' ' ILE . 71.9 mtt-85 -90.2 9.33 28.9 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.142 0.423 . . . . 70.129999999999995 112.142 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.3 t -124.69 105.87 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.038 0.447 . . . . 71.530000000000001 111.004 176.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.488 HD13 HD12 ' A' ' 91' ' ' ILE . 22.3 pt -115.41 -170.19 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 121.069 0.461 . . . . 60.25 112.013 -176.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -88.1 169.99 11.46 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.896 0.379 . . . . 74.109999999999999 111.852 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 33.4 t -63.27 -24.51 67.9 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.494 0.553 . . . . 52.340000000000003 112.494 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 -72.68 -10.34 59.68 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.73 0.3 . . . . 55.340000000000003 111.803 178.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.11 44.18 24.06 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.84 -0.695 . . . . 72.530000000000001 111.878 -175.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.428 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 99.6 mttt -135.93 159.54 41.37 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.936 0.398 . . . . 70.439999999999998 111.286 -178.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 61.5 mt -62.26 132.83 28.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.115 -0.493 . . . . 71.540000000000006 110.888 177.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.5 p -76.18 -47.68 23.28 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.866 0.365 . . . . 53.140000000000001 111.29 -178.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.607 ' HB3' ' HB3' ' A' ' 70' ' ' ASP . 76.6 mt -67.36 156.8 35.59 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.081 0.467 . . . . 54.420000000000002 111.584 178.51 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.494 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 13.7 ptmm? -131.83 162.36 30.77 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.18 0.437 . . . . 65.549999999999997 112.18 -172.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 61.97 -131.07 45.59 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 116.255 -0.43 . . . . 60.210000000000001 113.243 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 -54.18 -41.62 68.76 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.264 0.554 . . . . 71.439999999999998 111.35 175.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.607 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 2.1 m-20 -66.12 -27.69 68.24 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.78 -0.645 . . . . 74.019999999999996 111.99 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.494 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 7.3 tt -64.0 -53.47 49.59 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.949 0.404 . . . . 73.299999999999997 110.053 176.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.453 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 67.7 m-20 -63.51 -29.82 71.03 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.246 -0.434 . . . . 61.109999999999999 111.25 177.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.419 ' O ' ' HG2' ' A' ' 77' ' ' LYS . 34.5 ttm180 -56.9 -58.24 8.99 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.111 -0.495 . . . . 75.200000000000003 111.247 174.447 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.448 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 49.5 tt0 -63.56 -40.75 97.79 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.983 0.421 . . . . 72.409999999999997 110.417 177.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.453 ' HB3' ' HA ' ' A' ' 72' ' ' ASP . 84.2 tttt -48.99 -52.95 22.04 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.77 -0.65 . . . . 75.349999999999994 112.075 176.392 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -63.07 -39.13 93.8 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.059 0.392 . . . . 45.240000000000002 112.059 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 75.0 mmtt -64.35 -36.37 83.9 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.122 0.487 . . . . 74.329999999999998 111.004 177.34 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.587 HD13 HD11 ' A' ' 91' ' ' ILE . 73.4 mt -69.48 -52.38 27.15 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.093 -0.503 . . . . 44.340000000000003 111.414 178.507 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -52.78 -45.03 66.95 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.968 0.413 . . . . 63.109999999999999 111.529 177.087 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.69 -16.47 57.41 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.285 0.476 . . . . 62.350000000000001 112.285 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.555 ' HB3' HH22 ' A' ' 56' ' ' ARG . 28.2 mm-40 -104.57 13.15 32.17 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.025 0.38 . . . . 63.25 112.025 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.91 6.79 88.67 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.156 -0.545 . . . . 74.5 113.539 178.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.659 HD11 HH12 ' A' ' 56' ' ' ARG . 57.5 mt -88.39 149.51 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 O-C-N 122.475 -0.427 . . . . 70.329999999999998 110.656 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.437 ' HG2' ' CE2' ' A' ' 96' ' ' TYR . 12.4 pt-20 -97.83 130.31 44.75 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.191 0.52 . . . . 45.509999999999998 111.548 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.426 HG21 ' HA ' ' A' ' 75' ' ' LYS . 45.4 t -110.42 100.85 11.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 116.186 -0.461 . . . . 74.150000000000006 110.951 174.154 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.578 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 47.0 m -58.82 153.7 16.51 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.331 -0.395 . . . . 63.530000000000001 110.788 176.174 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.473 ' HG3' ' N ' ' A' ' 88' ' ' ILE . 10.8 pt-20 -40.46 -46.79 2.51 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 114.663 1.357 . . . . 63.119999999999997 114.663 -167.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.473 ' N ' ' HG3' ' A' ' 87' ' ' GLU . 2.6 pp -90.13 21.29 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-O 121.192 0.52 . . . . 75.200000000000003 112.197 -176.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.61 51.74 7.02 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 116.04 -0.527 . . . . 73.129999999999995 113.391 -178.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.578 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 62.2 tttp -118.7 135.98 54.19 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 117.34 0.57 . . . . 71.5 112.42 179.509 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.587 HD11 HD13 ' A' ' 78' ' ' LEU . 52.7 mt -113.93 138.24 44.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 123.028 0.531 . . . . 72.340000000000003 110.968 178.486 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.26 92.92 1.42 Allowed 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.851 0.357 . . . . 54.130000000000003 111.568 177.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.488 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 45.3 mt -53.23 -60.47 3.25 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.517 0.562 . . . . 73.530000000000001 112.517 -178.24 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -62.36 1.23 0.36 Allowed 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.192 0.812 . . . . 73.219999999999999 113.192 -172.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.438 ' HD2' ' CE2' ' A' ' 96' ' ' TYR . 9.1 tmtm? -112.9 -34.71 5.67 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 122.104 -0.373 . . . . 75.209999999999994 110.954 173.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.438 ' CE2' ' HD2' ' A' ' 95' ' ' LYS . 97.6 m-85 -108.85 5.79 24.83 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.364 0.505 . . . . 45.140000000000001 112.364 -177.248 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 50.9 tttm -63.31 133.13 53.64 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.144 0.497 . . . . 74.049999999999997 111.759 -174.554 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 16.0 t90 -57.28 125.12 21.34 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.046 -0.525 . . . . 63.109999999999999 111.827 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -107.24 90.39 5.61 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 116.061 -0.518 . . . . 74.549999999999997 110.918 177.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 CA--C 1.539 0.728 0 C-N-CA 122.636 2.224 . . . . 71.5 112.595 178.201 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 37.9 t70 . . . . . 0 CA--C 1.542 0.643 0 N-CA-C 112.609 0.596 . . . . 75.040000000000006 112.609 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -52.03 -37.69 54.39 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.928 -0.578 . . . . 64.340000000000003 112.244 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -53.66 -49.25 68.34 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.22 0.533 . . . . 75.239999999999995 110.607 177.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 77.8 mt -67.21 -45.75 75.93 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.601 -0.727 . . . . 71.25 111.218 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.9 t -55.79 -47.58 79.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.027 0.441 . . . . 74.120000000000005 111.655 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -67.16 -51.29 55.56 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.335 0.494 . . . . 65.230000000000004 112.335 -177.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.462 ' O ' HG13 ' A' ' 12' ' ' ILE . 33.5 pt -60.79 -42.72 93.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 O-C-N 122.154 -0.341 . . . . 62.0 111.576 -177.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -62.85 -43.83 97.76 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.061 0.458 . . . . 73.5 110.941 177.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.97 -39.64 66.15 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.983 -0.553 . . . . 44.539999999999999 111.725 177.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 67.6 t -69.68 -39.49 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 120.966 0.412 . . . . 55.219999999999999 111.521 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.523 ' HB ' HD11 ' A' ' 52' ' ' LEU . 82.8 mt -59.3 -33.87 52.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 116.21 -0.45 . . . . 32.229999999999997 111.955 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 83.0 m-70 -55.37 -25.28 34.31 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 113.171 0.804 . . . . 75.019999999999996 113.171 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -80.7 1.51 29.84 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.071 0.767 . . . . 73.450000000000003 113.071 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 57.2 mt -83.34 111.44 31.23 Favored Pre-proline 0 CA--C 1.543 0.676 0 O-C-N 121.961 -0.462 . . . . 73.230000000000004 110.943 177.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.85 157.72 57.49 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.675 2.25 . . . . 72.310000000000002 113.312 -176.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.8 tttp -62.67 94.81 0.07 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.218 0.532 . . . . 73.099999999999994 111.734 -177.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.465 ' H ' ' CZ ' ' A' ' 56' ' ' ARG . . . 142.94 -28.74 2.12 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-N 116.054 -0.521 . . . . 50.130000000000003 112.473 178.105 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -95.66 165.49 12.29 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.273 0.558 . . . . 61.399999999999999 112.067 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.7 m -141.43 159.68 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.677 -0.692 . . . . 72.329999999999998 110.482 176.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 94.1 p -138.35 -179.37 5.76 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.817 0.341 . . . . 61.329999999999998 111.023 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 51.2 p -106.21 155.91 18.99 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.855 0.36 . . . . 65.129999999999995 111.971 -179.546 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.403 ' HB2' ' HB1' ' A' ' 36' ' ' ALA . 52.7 m-85 -54.91 -38.59 67.82 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.944 0.402 . . . . 72.310000000000002 110.945 177.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.26 -52.75 51.41 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-N 115.788 -0.642 . . . . 42.100000000000001 113.18 178.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -56.37 -48.3 77.13 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.905 0.383 . . . . 72.519999999999996 111.513 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.6 mm -58.75 -49.29 83.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 116.292 -0.413 . . . . 55.25 111.258 178.244 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.473 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -59.93 -45.28 93.09 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.965 0.412 . . . . 63.32 111.973 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -57.79 -52.53 65.07 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.788 0.328 . . . . 74.530000000000001 111.408 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 72.7 mtm -66.65 -28.18 68.27 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.399 -0.364 . . . . 71.530000000000001 111.879 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.72 -30.44 64.18 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.027 0.442 . . . . 62.350000000000001 111.417 176.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.71 13.15 19.33 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.333 -0.46 . . . . 71.209999999999994 113.057 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.473 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 76.3 m-85 -127.74 66.78 71.59 Favored Pre-proline 0 CA--C 1.543 0.679 0 O-C-N 122.61 -0.347 . . . . 63.109999999999999 111.714 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.71 144.73 60.86 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.224 1.95 . . . . 71.340000000000003 112.41 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.77 -11.78 65.56 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 121.032 -0.604 . . . . 71.310000000000002 113.523 -177.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -99.4 19.16 16.07 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 122.394 -0.474 . . . . 62.409999999999997 111.757 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.403 ' HB1' ' HB2' ' A' ' 23' ' ' TYR . . . -53.26 -42.92 66.99 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.263 0.468 . . . . 72.430000000000007 112.263 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -57.0 -37.51 71.75 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.009 0.374 . . . . 74.319999999999993 112.009 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -72.43 -31.9 65.87 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 120.653 0.264 . . . . 74.439999999999998 111.296 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.406 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 61.1 t -56.7 -51.78 62.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 120.887 0.375 . . . . 71.120000000000005 110.335 173.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -57.48 -42.41 93.88 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 121.219 -0.515 . . . . 32.329999999999998 113.039 176.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.518 ' HB3' ' NZ ' ' A' ' 41' ' ' LYS . 8.9 mtpm? -60.22 -34.54 73.81 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.795 0.331 . . . . 75.439999999999998 111.753 178.443 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.9 -41.75 59.13 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.324 -0.398 . . . . 33.229999999999997 111.475 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 39' ' ' VAL . 86.2 mt -65.66 -42.15 91.71 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.316 -0.402 . . . . 75.219999999999999 111.908 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.28 -26.84 51.56 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 121.195 -0.526 . . . . 72.230000000000004 113.542 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -78.94 -20.15 50.0 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 122.584 -0.362 . . . . 70.049999999999997 111.751 -178.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 81.5 mt -68.03 147.17 98.43 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-O 120.851 0.357 . . . . 73.510000000000005 111.601 -179.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -84.13 177.53 5.88 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.693 2.262 . . . . 54.439999999999998 112.971 178.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.463 ' OE1' ' HD2' ' A' ' 73' ' ' ARG . 1.4 mp0 -71.72 -37.21 70.65 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.983 0.42 . . . . 44.109999999999999 111.156 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -94.38 43.54 2.35 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 121.371 -0.442 . . . . 71.420000000000002 113.344 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.0 t -84.19 159.75 20.97 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.99 0.424 . . . . 74.209999999999994 111.472 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 51' ' ' LYS . 37.1 ttmt -81.91 -12.91 58.19 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.435 0.635 . . . . 73.439999999999998 110.726 178.049 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.537 HD12 ' HD2' ' A' ' 53' ' ' PRO . 33.0 tp -107.05 126.05 31.09 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 115.735 -0.666 . . . . 61.240000000000002 110.983 179.028 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.537 ' HD2' HD12 ' A' ' 52' ' ' LEU . 57.0 Cg_endo -72.94 94.53 0.8 Allowed 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 121.205 1.27 . . . . 72.120000000000005 111.637 174.166 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 69.2 p-90 -86.66 -17.69 33.15 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.291 0.567 . . . . 73.549999999999997 111.673 -177.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.491 ' O ' HD21 ' A' ' 78' ' ' LEU . 37.4 p90 -73.88 -5.72 42.76 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.985 0.735 . . . . 62.350000000000001 112.985 -176.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.485 HH12 HD11 ' A' ' 83' ' ' ILE . 87.1 mtt-85 -99.24 12.92 34.83 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.771 0.656 . . . . 74.219999999999999 112.771 -177.129 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.4 t -123.11 112.76 35.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 121.263 0.554 . . . . 72.409999999999997 111.214 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.545 HD13 HD12 ' A' ' 91' ' ' ILE . 27.4 pt -122.04 -169.98 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-N 116.087 -0.506 . . . . 61.119999999999997 111.386 -178.236 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.412 HD21 ' HB2' ' A' ' 63' ' ' LYS . 32.9 p30 -85.22 167.75 15.39 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.83 -0.544 . . . . 73.319999999999993 112.048 -177.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.478 ' HA ' HG21 ' A' ' 22' ' ' THR . 50.3 p -66.3 -10.71 45.22 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.941 0.719 . . . . 74.140000000000001 112.941 -177.601 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -96.33 11.32 35.14 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.762 0.315 . . . . 51.439999999999998 111.628 179.071 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.33 39.0 87.89 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 116.438 -0.346 . . . . 72.510000000000005 113.53 176.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.457 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 56.4 mttp -139.45 157.97 44.93 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.208 0.528 . . . . 65.530000000000001 111.6 -178.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.435 HG23 ' OE1' ' A' ' 74' ' ' GLN . 59.2 mt -73.26 117.57 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.806 -0.634 . . . . 73.439999999999998 110.903 177.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.3 t -69.19 -33.01 72.69 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.06 0.457 . . . . 64.239999999999995 110.99 178.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.553 HD13 ' HB3' ' A' ' 70' ' ' ASP . 66.6 mt -65.08 148.28 51.95 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.162 -0.472 . . . . 71.219999999999999 111.118 177.731 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -130.25 149.38 51.97 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.965 0.412 . . . . 72.519999999999996 112.098 -176.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.15 -120.37 7.81 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-N 116.263 -0.426 . . . . 53.130000000000003 113.451 178.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -65.03 -46.19 82.34 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.943 0.402 . . . . 74.209999999999994 111.653 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.553 ' HB3' HD13 ' A' ' 66' ' ' LEU . 67.6 m-20 -59.38 -36.08 75.12 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.552 -0.294 . . . . 74.230000000000004 111.568 177.588 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.9 tt -62.99 -54.99 29.76 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.963 -0.384 . . . . 72.0 109.963 177.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -58.98 -32.88 70.05 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.134 0.492 . . . . 73.349999999999994 111.312 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.463 ' HD2' ' OE1' ' A' ' 48' ' ' GLU . 11.2 ttp180 -67.84 -51.95 42.55 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.005 -0.543 . . . . 64.239999999999995 111.572 -178.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.451 HE21 ' HA ' ' A' ' 55' ' ' PHE . 34.2 tt0 -62.87 -47.28 84.02 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.181 0.515 . . . . 72.340000000000003 110.216 174.486 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.0 tttt -47.77 -55.17 10.21 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.206 -0.906 . . . . 50.439999999999998 112.576 175.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -56.41 -42.7 78.43 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.087 0.403 . . . . 55.25 112.087 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -62.57 -42.02 99.3 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.093 0.473 . . . . 74.439999999999998 111.517 177.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.491 HD21 ' O ' ' A' ' 55' ' ' PHE . 81.2 mt -64.19 -44.1 93.05 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.204 -0.453 . . . . 63.539999999999999 111.767 178.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -55.48 -42.42 74.34 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.923 0.392 . . . . 70.549999999999997 111.111 176.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.93 -33.76 73.66 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.056 0.455 . . . . 71.230000000000004 111.833 177.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.437 ' HB3' HH22 ' A' ' 56' ' ' ARG . 8.2 mm-40 -83.6 1.72 40.83 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.377 -0.374 . . . . 72.409999999999997 111.952 -179.28 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.84 9.93 70.46 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 121.379 -0.439 . . . . 60.119999999999997 113.949 177.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.485 HD11 HH12 ' A' ' 56' ' ' ARG . 67.0 mt -89.15 136.18 24.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 117.023 0.411 . . . . 62.409999999999997 111.405 -178.066 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.465 ' O ' ' HG3' ' A' ' 84' ' ' GLU . 9.2 pt-20 -76.44 114.66 15.39 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.143 0.497 . . . . 62.310000000000002 111.79 178.267 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.8 t -101.54 105.05 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 120.965 0.412 . . . . 74.209999999999994 110.666 172.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.642 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 25.2 t -69.48 157.96 36.11 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.423 -0.353 . . . . 70.5 111.77 178.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -37.55 -56.55 1.02 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.638 1.347 . . . . 71.129999999999995 114.638 -168.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.445 HD11 ' HB2' ' A' ' 90' ' ' LYS . 2.7 pp -86.54 18.27 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 112.69 0.626 . . . . 71.129999999999995 112.69 -174.559 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.2 44.83 7.85 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.113 -0.565 . . . . 35.310000000000002 112.518 -177.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.642 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 0.6 OUTLIER -105.52 128.15 53.42 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 122.539 -0.389 . . . . 60.329999999999998 110.389 -179.602 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.545 HD12 HD13 ' A' ' 58' ' ' ILE . 62.3 mt -116.53 139.67 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.899 0.381 . . . . 43.240000000000002 111.118 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.58 92.61 4.08 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.925 0.393 . . . . 43.549999999999997 111.786 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.598 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 57.4 mt -59.79 -44.19 94.05 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.733 0.302 . . . . 71.420000000000002 111.251 178.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 80.9 mtt-85 -56.48 -12.52 1.76 Allowed 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 112.173 0.434 . . . . 74.099999999999994 112.173 -177.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -109.92 -42.37 4.25 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 120.964 0.411 . . . . 73.519999999999996 111.814 176.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -101.7 6.46 41.87 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.149 0.425 . . . . 72.219999999999999 112.149 -171.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.598 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 78.0 tttt -61.56 129.35 40.7 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.143 0.497 . . . . 71.310000000000002 111.914 -175.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 21.2 t90 -71.03 116.96 11.93 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.978 -0.555 . . . . 72.099999999999994 111.991 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -124.65 92.66 47.51 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 115.971 -0.559 . . . . 51.119999999999997 110.58 175.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo . . . . . 0 CA--C 1.545 1.06 0 C-N-CA 122.959 2.44 . . . . 73.319999999999993 113.797 -177.94 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 . . . . . 0 CA--C 1.539 0.527 0 N-CA-C 112.744 0.646 . . . . 63.100000000000001 112.744 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -51.19 -31.74 21.22 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.625 -0.716 . . . . 63.439999999999998 112.318 178.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -57.61 -55.54 33.48 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.848 0.356 . . . . 75.439999999999998 110.727 177.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 77.0 mt -59.97 -45.19 93.49 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.964 -0.562 . . . . 75.25 111.218 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 62.0 t -57.14 -52.62 53.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 116.178 -0.465 . . . . 55.539999999999999 112.053 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.426 ' O ' HG23 ' A' ' 11' ' ' VAL . 28.7 mm-40 -67.58 -44.71 77.5 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.727 0.64 . . . . 73.430000000000007 112.727 -175.143 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.42 ' O ' HG13 ' A' ' 12' ' ' ILE . 36.8 pt -63.33 -43.43 98.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 120.909 -0.316 . . . . 73.129999999999995 111.281 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -62.87 -44.98 94.65 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.943 0.401 . . . . 75.349999999999994 110.978 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.52 -37.22 62.6 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.08 -0.509 . . . . 71.439999999999998 111.793 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 7' ' ' GLN . 96.0 t -70.21 -42.65 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-O 120.929 0.395 . . . . 63.329999999999998 111.513 178.327 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.545 ' HB ' HD11 ' A' ' 52' ' ' LEU . 79.9 mt -59.19 -30.57 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 112.28 0.474 . . . . 74.340000000000003 112.28 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -60.85 -12.52 11.22 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 112.966 0.728 . . . . 75.140000000000001 112.966 178.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -90.77 -3.5 57.38 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.481 0.549 . . . . 72.420000000000002 112.481 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.404 HD12 HG23 ' A' ' 12' ' ' ILE . 56.0 mt -84.3 113.79 50.65 Favored Pre-proline 0 CA--C 1.544 0.741 0 O-C-N 122.184 -0.322 . . . . 70.140000000000001 111.44 -179.077 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -70.5 163.78 37.64 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.961 2.44 . . . . 72.200000000000003 113.843 -177.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.35 120.85 12.99 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.944 -0.571 . . . . 74.420000000000002 111.639 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.33 14.09 46.02 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.092 -0.575 . . . . 75.209999999999994 113.442 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -126.03 148.3 49.34 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.889 0.376 . . . . 70.340000000000003 111.18 176.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.0 m -125.32 149.11 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-O 121.122 0.487 . . . . 71.519999999999996 111.613 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 97.8 p -128.67 167.03 17.8 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.106 -0.497 . . . . 64.129999999999995 110.83 177.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.5 p -103.79 147.45 27.27 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.763 0.316 . . . . 74.239999999999995 111.378 177.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -52.16 -36.52 51.82 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.751 0.31 . . . . 74.219999999999999 111.766 178.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -57.35 -43.82 93.68 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 121.129 -0.558 . . . . 73.329999999999998 112.779 177.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' A' ' 29' ' ' MET . 41.7 mt-10 -65.11 -54.13 34.63 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.78 0.324 . . . . 73.450000000000003 111.112 177.427 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.8 mm -54.62 -51.12 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.3 -0.409 . . . . 72.150000000000006 111.889 -178.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.49 -46.19 84.0 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.945 0.402 . . . . 61.32 111.748 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -61.19 -48.38 81.82 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.781 0.324 . . . . 72.329999999999998 111.511 178.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.489 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 61.0 mtt -63.37 -30.1 71.29 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.096 0.474 . . . . 71.0 111.522 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.01 -19.57 58.55 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.158 -0.474 . . . . 74.209999999999994 111.858 178.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.57 23.26 12.49 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.191 -0.528 . . . . 72.329999999999998 113.154 -178.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -132.78 62.82 64.63 Favored Pre-proline 0 CA--C 1.542 0.648 0 O-C-N 122.48 -0.423 . . . . 75.200000000000003 111.064 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -62.5 119.82 7.09 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.27 1.98 . . . . 73.030000000000001 112.731 -177.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.44 -6.58 49.79 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.036 -0.602 . . . . 72.420000000000002 113.589 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -97.98 20.74 11.71 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 117.332 0.566 . . . . 63.119999999999997 111.375 177.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.8 -39.43 68.46 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.806 0.669 . . . . 74.040000000000006 112.806 -177.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -58.8 -34.89 72.01 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 120.924 0.392 . . . . 73.340000000000003 111.714 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -77.94 -28.25 49.51 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.687 -0.233 . . . . 65.230000000000004 111.408 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.3 t -59.66 -42.63 89.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.238 0.542 . . . . 71.150000000000006 110.12 172.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -62.7 -42.31 99.71 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 115.771 -0.65 . . . . 51.350000000000001 112.789 175.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -60.66 -41.82 95.78 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.049 0.452 . . . . 72.329999999999998 111.134 176.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.52 -54.47 45.07 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.177 -0.465 . . . . 55.219999999999999 111.418 178.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.49 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 80.6 mt -61.88 -38.53 88.66 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.932 0.396 . . . . 71.549999999999997 111.589 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.29 -17.77 70.65 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.339 -0.458 . . . . 72.109999999999999 113.396 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -101.07 2.84 40.79 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 122.416 -0.461 . . . . 73.230000000000004 111.391 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 69.9 mt -78.54 155.54 78.64 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-O 120.809 0.338 . . . . 61.200000000000003 111.321 176.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.509 ' HG2' ' HB2' ' A' ' 50' ' ' SER . 20.5 Cg_endo -61.02 140.76 91.7 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.116 1.877 . . . . 75.209999999999994 112.083 174.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.645 ' HG3' ' HD3' ' A' ' 73' ' ' ARG . 33.0 tt0 -43.52 -39.35 3.35 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.696 0.628 . . . . 71.310000000000002 112.696 -174.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -123.24 55.64 0.68 Allowed Glycine 0 CA--C 1.529 0.942 0 C-N-CA 121.098 -0.572 . . . . 74.340000000000003 113.491 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.509 ' HB2' ' HG2' ' A' ' 47' ' ' PRO . 37.8 t -63.5 168.2 4.86 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.427 0.632 . . . . 74.120000000000005 112.641 177.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -65.47 -32.66 74.39 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.309 0.576 . . . . 73.299999999999997 110.181 173.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.554 HD12 ' HD2' ' A' ' 53' ' ' PRO . 30.7 tp -84.48 127.04 67.49 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 115.641 -0.709 . . . . 64.409999999999997 110.894 177.375 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.554 ' HD2' HD12 ' A' ' 52' ' ' LEU . 61.5 Cg_endo -73.67 95.65 0.89 Allowed 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 121.396 1.398 . . . . 65.129999999999995 111.656 174.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.49 ' HB2' ' HB3' ' A' ' 43' ' ' LEU . 65.2 p-90 -79.52 -31.55 42.17 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.188 0.518 . . . . 74.340000000000003 111.891 -176.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.417 ' O ' HD21 ' A' ' 78' ' ' LEU . 27.3 p90 -63.6 -19.87 65.2 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.244 0.831 . . . . 71.230000000000004 113.244 -176.004 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.404 ' NH1' ' O ' ' A' ' 15' ' ' ILE . 98.5 mtt180 -77.76 2.07 18.14 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.497 0.554 . . . . 73.299999999999997 112.497 -177.257 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.4 t -122.22 125.62 73.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 O-C-N 121.9 -0.5 . . . . 62.439999999999998 111.426 179.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.625 HD11 HD21 ' A' ' 93' ' ' LEU . 33.8 pt -125.46 -171.39 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 120.978 0.418 . . . . 62.439999999999998 111.646 -179.111 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.429 HD21 ' HB2' ' A' ' 63' ' ' LYS . 33.8 p30 -73.03 171.65 12.48 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.243 0.544 . . . . 61.329999999999998 112.23 -179.063 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 46.6 p -79.69 8.52 6.46 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.074 0.464 . . . . 65.109999999999999 112.128 -179.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -95.64 -46.44 6.62 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.358 0.599 . . . . 74.140000000000001 110.944 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 121.33 32.38 1.06 Allowed Glycine 0 CA--C 1.522 0.475 0 CA-C-N 115.766 -0.652 . . . . 42.149999999999999 112.159 -175.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.429 ' HB2' HD21 ' A' ' 59' ' ' ASN . 98.4 mttt -138.67 163.14 32.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.092 0.472 . . . . 35.409999999999997 111.387 -177.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.506 HG23 ' OE1' ' A' ' 74' ' ' GLN . 65.3 mt -67.81 122.08 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 115.968 -0.56 . . . . 53.109999999999999 110.605 175.549 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.5 m -63.89 -41.83 97.61 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.166 0.508 . . . . 65.099999999999994 111.464 -178.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.513 HD13 ' HB3' ' A' ' 70' ' ' ASP . 86.6 mt -74.15 161.33 30.1 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.788 -0.642 . . . . 74.120000000000005 111.813 -178.198 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -130.18 177.11 7.55 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.8 0.333 . . . . 44.439999999999998 111.429 -178.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 57.38 -126.55 42.46 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 121.36 -0.447 . . . . 42.520000000000003 113.106 178.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 38.7 mtp180 -74.54 -32.13 62.35 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.171 0.51 . . . . 74.129999999999995 110.714 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.513 ' HB3' HD13 ' A' ' 66' ' ' LEU . 2.6 m-20 -60.02 -32.47 70.91 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.892 -0.595 . . . . 62.520000000000003 110.676 177.111 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.9 tt -63.28 -57.05 11.71 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.027 -0.533 . . . . 62.030000000000001 110.212 176.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -55.58 -36.87 67.35 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.902 0.382 . . . . 74.129999999999995 111.462 176.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.645 ' HD3' ' HG3' ' A' ' 48' ' ' GLU . 39.8 ttm180 -59.22 -58.87 6.71 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 116.383 -0.371 . . . . 71.519999999999996 111.65 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.506 ' OE1' HG23 ' A' ' 64' ' ' ILE . 53.6 tt0 -61.66 -41.01 96.94 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.708 0.289 . . . . 73.099999999999994 111.132 177.347 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -54.88 -58.67 6.66 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.259 -0.428 . . . . 74.129999999999995 111.72 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -52.9 -45.65 67.64 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.079 0.4 . . . . 64.0 112.079 -178.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -61.46 -30.53 70.65 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.853 0.359 . . . . 75.430000000000007 111.936 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.417 HD21 ' O ' ' A' ' 55' ' ' PHE . 94.8 mt -78.0 -42.08 33.84 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.046 0.45 . . . . 62.219999999999999 111.13 174.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -57.4 -39.4 76.02 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.913 0.387 . . . . 64.129999999999995 111.057 177.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.23 -24.39 63.13 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.119 -0.491 . . . . 73.430000000000007 111.929 178.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -95.38 -1.37 51.22 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 111.831 0.308 . . . . 73.510000000000005 111.831 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.24 12.89 44.05 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.512 -0.375 . . . . 75.340000000000003 113.689 177.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.418 ' HA ' ' CE1' ' A' ' 96' ' ' TYR . 66.6 mt -88.59 109.57 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 122.477 -0.425 . . . . 72.0 111.547 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -73.39 100.66 3.26 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.982 0.42 . . . . 75.329999999999998 111.465 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 58.2 t -92.41 130.45 41.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 120.901 0.381 . . . . 61.229999999999997 111.593 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.603 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 31.0 t -69.73 155.99 39.68 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.515 -0.311 . . . . 63.25 111.573 177.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.502 ' HG3' HG23 ' A' ' 88' ' ' ILE . 15.3 pt-20 -46.05 -49.84 15.85 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.034 1.124 . . . . 73.540000000000006 114.034 -169.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.502 HG23 ' HG3' ' A' ' 87' ' ' GLU . 2.9 pp -81.34 13.85 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 121.216 0.531 . . . . 74.420000000000002 112.326 -176.081 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.57 50.03 5.19 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 121.335 -0.459 . . . . 73.400000000000006 112.894 -178.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.603 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 14.4 tmtt? -117.27 129.63 56.03 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 122.326 -0.514 . . . . 65.430000000000007 111.197 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.507 HD12 HD13 ' A' ' 58' ' ' ILE . 60.6 mt -116.35 148.26 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.173 -0.467 . . . . 72.200000000000003 111.462 -177.238 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.32 99.96 8.16 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.886 0.374 . . . . 61.299999999999997 111.682 177.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.625 HD21 HD11 ' A' ' 58' ' ' ILE . 25.3 mt -69.64 -1.35 8.7 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.112 0.782 . . . . 74.150000000000006 113.112 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -98.05 -52.7 3.61 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.074 0.464 . . . . 74.150000000000006 111.181 173.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -69.28 -29.75 67.7 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.224 -0.444 . . . . 64.319999999999993 112.101 -177.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.418 ' CE1' ' HA ' ' A' ' 83' ' ' ILE . 90.5 m-85 -114.09 13.65 18.15 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 111.796 0.295 . . . . 62.119999999999997 111.796 -176.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.539 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 83.8 tttt -60.85 131.38 50.51 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 111.827 0.306 . . . . 73.209999999999994 111.827 -176.118 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 19.2 t90 -58.64 105.59 0.32 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.641 0.734 . . . . 74.5 111.151 176.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -113.45 95.29 35.5 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 115.348 -0.842 . . . . 73.420000000000002 110.723 177.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo . . . . . 0 CA--C 1.538 0.717 0 C-N-CA 122.511 2.141 . . . . 71.099999999999994 112.524 179.05 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.8 tpt . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 120.565 0.221 . . . . 73.25 110.952 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.457 ' O ' HG23 ' A' ' 6' ' ' VAL . 3.8 m-20 -55.8 129.14 38.2 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.42 0.526 . . . . 70.510000000000005 112.42 -177.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.527 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 6.4 tp-100 -52.97 -44.27 67.03 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.416 -0.357 . . . . 73.140000000000001 111.655 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -54.74 -50.72 67.7 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.095 0.474 . . . . 72.510000000000005 111.069 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.1 mt -61.11 -42.24 98.17 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.942 -0.572 . . . . 60.149999999999999 111.322 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 2' ' ' ASP . 64.8 t -59.51 -41.58 85.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.007 0.432 . . . . 74.120000000000005 111.35 177.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.527 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 15.0 mm100 -66.29 -54.31 26.4 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.345 -0.388 . . . . 73.439999999999998 111.896 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.497 HG21 HG22 ' A' ' 39' ' ' VAL . 37.2 pt -63.31 -43.86 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 111.746 0.276 . . . . 64.340000000000003 111.746 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 12.5 m-30 -60.67 -45.23 94.92 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.742 0.306 . . . . 75.150000000000006 111.147 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.432 ' O ' ' NE2' ' A' ' 14' ' ' GLN . . . -52.36 -43.86 64.9 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.365 -0.379 . . . . 72.209999999999994 111.226 177.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 93.5 t -64.46 -47.14 90.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.339 -0.391 . . . . 61.509999999999998 111.356 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 8' ' ' ILE . 79.7 mt -55.69 -33.98 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 116.084 -0.507 . . . . 60.109999999999999 112.303 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 74.9 m-70 -61.21 -16.15 41.97 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 112.702 0.63 . . . . 71.030000000000001 112.702 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.432 ' NE2' ' O ' ' A' ' 10' ' ' ALA . 1.0 OUTLIER -82.88 -7.3 59.67 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.073 0.397 . . . . 70.200000000000003 112.073 177.925 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.434 HG21 ' HB3' ' A' ' 56' ' ' ARG . 56.1 mt -80.46 116.48 62.15 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 122.421 -0.174 . . . . 72.230000000000004 111.203 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -69.94 170.2 17.35 Favored 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 123.062 2.508 . . . . 72.25 113.764 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.9 tttp -65.79 121.0 14.03 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.078 -0.51 . . . . 55.020000000000003 111.362 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.27 17.59 45.91 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 121.017 -0.611 . . . . 73.510000000000005 113.901 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -119.94 146.28 45.96 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 117.103 0.451 . . . . 71.299999999999997 111.389 176.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 56' ' ' ARG . 34.6 m -130.0 140.24 49.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.142 0.496 . . . . 44.210000000000001 111.307 177.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 83.9 p -122.47 170.27 10.14 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.842 0.354 . . . . 74.25 111.1 177.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 44.4 p -95.83 147.5 23.58 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.005 0.431 . . . . 65.150000000000006 111.487 178.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -52.91 -32.9 47.85 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 116.289 -0.414 . . . . 71.430000000000007 111.993 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.78 -44.02 95.37 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 121.094 -0.574 . . . . 73.409999999999997 112.965 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 29' ' ' MET . 46.7 mt-10 -64.59 -44.9 89.18 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.811 0.338 . . . . 73.140000000000001 111.347 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.408 HD11 HD11 ' A' ' 15' ' ' ILE . 47.2 mm -60.58 -50.01 82.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 120.809 0.338 . . . . 62.409999999999997 111.307 177.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.5 -43.84 84.49 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.96 0.41 . . . . 71.230000000000004 111.517 177.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -59.21 -48.2 82.49 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.174 -0.466 . . . . 63.439999999999998 111.298 178.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.431 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 63.1 mtt -65.95 -28.75 69.15 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.878 0.371 . . . . 72.129999999999995 111.621 178.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.35 -20.55 51.1 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.928 0.394 . . . . 65.439999999999998 111.573 177.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.87 22.41 28.22 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.199 -0.524 . . . . 41.240000000000002 113.459 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -124.94 81.82 61.89 Favored Pre-proline 0 CA--C 1.543 0.68 0 O-C-N 122.393 -0.474 . . . . 74.430000000000007 111.79 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.62 131.72 37.03 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.732 2.288 . . . . 64.239999999999995 112.658 177.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.95 -8.46 79.77 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.014 -0.613 . . . . 63.439999999999998 113.649 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -89.68 22.6 2.99 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.482 0.549 . . . . 63.530000000000001 112.482 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.36 -57.58 11.24 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.012 0.434 . . . . 72.310000000000002 112.167 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 46.6 ttp180 -58.66 -32.3 68.97 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.008 0.433 . . . . 71.450000000000003 111.552 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.587 ' HA ' ' HE2' ' A' ' 41' ' ' LYS . 76.7 m80 -65.2 -41.28 94.67 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.35 -0.386 . . . . 53.340000000000003 111.284 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.497 HG22 HG21 ' A' ' 8' ' ' ILE . 53.6 t -58.43 -37.95 67.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.264 0.554 . . . . 64.230000000000004 110.171 172.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.79 -37.66 95.01 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 115.808 -0.633 . . . . 33.109999999999999 112.999 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.587 ' HE2' ' HA ' ' A' ' 38' ' ' HIS . 41.1 mtmt -62.75 -47.27 84.26 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.006 0.431 . . . . 74.209999999999994 110.476 176.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.07 -51.42 66.41 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.869 -0.605 . . . . 72.409999999999997 111.921 -178.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.5 mt -63.56 -43.35 97.31 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.297 -0.41 . . . . 72.420000000000002 111.459 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.11 -22.72 72.69 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 120.853 -0.689 . . . . 61.509999999999998 112.884 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -79.85 -21.08 44.56 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.995 0.426 . . . . 73.319999999999993 111.277 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 91.6 mt -75.77 155.39 85.08 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 116.444 -0.344 . . . . 53.530000000000001 111.897 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.57 164.87 19.51 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.46 2.107 . . . . 64.219999999999999 112.192 174.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.503 ' HA ' ' HE ' ' A' ' 73' ' ' ARG . 0.8 OUTLIER -64.91 -26.57 68.37 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.211 0.448 . . . . 74.150000000000006 112.211 -175.203 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -131.88 64.38 0.61 Allowed Glycine 0 CA--C 1.528 0.857 0 C-N-CA 121.094 -0.574 . . . . 71.310000000000002 113.325 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.6 t -79.72 172.77 13.34 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.182 0.515 . . . . 72.420000000000002 111.772 178.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? -67.79 -28.94 68.03 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.17 -0.468 . . . . 61.520000000000003 110.78 174.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.529 HD12 ' HD2' ' A' ' 53' ' ' PRO . 33.0 tp -86.71 124.8 68.74 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 116.017 -0.538 . . . . 63.5 111.02 177.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.529 ' HD2' HD12 ' A' ' 52' ' ' LEU . 38.0 Cg_endo -67.19 95.08 0.36 Allowed 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 121.285 1.324 . . . . 52.509999999999998 111.386 173.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.417 ' HH2' ' HG2' ' A' ' 73' ' ' ARG . 65.9 p-90 -82.51 -30.49 29.78 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.685 -0.689 . . . . 74.430000000000007 111.716 -177.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.462 ' O ' HD21 ' A' ' 78' ' ' LEU . 11.9 p90 -67.32 -11.53 57.85 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.335 0.865 . . . . 74.5 113.335 -175.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.459 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 94.2 mtt180 -86.27 8.08 22.73 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.024 0.75 . . . . 72.519999999999996 113.024 -174.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 20.9 t -127.86 116.23 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 O-C-N 121.81 -0.556 . . . . 64.239999999999995 111.652 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.457 HG21 HD12 ' A' ' 91' ' ' ILE . 28.0 pt -118.98 -174.52 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 116.472 -0.331 . . . . 75.040000000000006 111.376 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 35.4 p30 -83.78 168.75 15.89 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.139 0.495 . . . . 74.409999999999997 111.906 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.1 t -67.93 -9.24 43.5 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.234 -0.439 . . . . 61.450000000000003 111.951 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -88.14 0.69 55.73 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.619 -0.264 . . . . 73.5 111.53 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.41 42.59 89.36 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 121.015 -0.612 . . . . 41.200000000000003 112.396 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -141.15 157.32 45.44 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.096 0.474 . . . . 74.010000000000005 111.378 -176.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 63.8 mt -73.34 128.07 35.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 116.258 -0.428 . . . . 72.340000000000003 111.001 177.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.9 p -74.29 -31.04 62.35 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 120.973 0.416 . . . . 71.430000000000007 111.408 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.47 HD13 ' HB3' ' A' ' 70' ' ' ASP . 92.5 mt -74.91 152.51 38.85 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.171 -0.468 . . . . 53.329999999999998 111.09 177.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -129.45 171.4 12.59 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.017 0.436 . . . . 72.109999999999999 111.973 -176.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 57.58 -128.75 48.23 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 116.24 -0.436 . . . . 64.540000000000006 113.327 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -61.71 -39.41 91.4 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 122.586 -0.361 . . . . 74.219999999999999 111.339 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.47 ' HB3' HD13 ' A' ' 66' ' ' LEU . 19.7 m-20 -65.43 -25.9 67.73 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.026 0.38 . . . . 62.420000000000002 112.026 -178.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.8 tt -64.11 -55.92 18.55 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.881 -0.414 . . . . 71.239999999999995 109.881 174.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.579 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 33.0 t70 -65.99 -27.04 67.84 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.997 0.427 . . . . 73.040000000000006 111.219 177.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.503 ' HE ' ' HA ' ' A' ' 48' ' ' GLU . 51.9 ttt180 -57.44 -55.11 39.06 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.245 0.545 . . . . 72.409999999999997 110.878 173.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -64.84 -41.95 95.31 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.129 0.49 . . . . 74.049999999999997 110.562 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.579 ' HB3' ' HA ' ' A' ' 72' ' ' ASP . 32.0 tttm -54.81 -55.14 33.35 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.67 -0.696 . . . . 71.109999999999999 112.37 178.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -58.74 -36.96 75.17 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.932 0.396 . . . . 61.350000000000001 111.499 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.485 ' HE2' ' O ' ' A' ' 48' ' ' GLU . 45.3 mmtm -64.16 -42.44 96.74 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.923 0.392 . . . . 64.439999999999998 111.224 174.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.512 HD22 HD12 ' A' ' 83' ' ' ILE . 95.9 mt -68.99 -31.89 71.05 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.916 0.389 . . . . 73.549999999999997 111.631 178.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 46.6 mt-10 -65.81 -30.54 71.19 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.886 0.374 . . . . 72.109999999999999 110.516 175.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.26 -11.86 60.16 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.321 0.581 . . . . 74.010000000000005 111.12 173.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -97.82 -11.31 23.44 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.917 -0.583 . . . . 62.329999999999998 111.137 176.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.91 50.4 5.22 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.494 -0.384 . . . . 74.200000000000003 113.098 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.512 HD12 HD22 ' A' ' 78' ' ' LEU . 71.4 mt -119.97 129.54 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 O-C-N 122.682 -0.305 . . . . 70.420000000000002 111.248 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -75.64 91.52 2.88 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.347 0.594 . . . . 74.0 111.438 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.2 t -96.68 121.1 46.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.624 -0.716 . . . . 73.040000000000006 110.837 177.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.595 ' OG ' ' HB3' ' A' ' 90' ' ' LYS . 6.3 p -72.91 151.27 41.98 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 122.331 -0.23 . . . . 71.099999999999994 110.644 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -42.36 -44.7 4.03 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.584 1.327 . . . . 53.109999999999999 114.584 -173.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.482 HD11 ' HB2' ' A' ' 90' ' ' LYS . 2.9 pp -81.1 9.53 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 112.461 0.541 . . . . 61.340000000000003 112.461 -176.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.57 45.59 5.75 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 121.622 -0.323 . . . . 54.420000000000002 113.624 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.595 ' HB3' ' OG ' ' A' ' 86' ' ' SER . 1.2 tmtp? -114.35 132.84 56.06 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-O 121.009 0.433 . . . . 74.409999999999997 111.425 -178.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.457 HD12 HG21 ' A' ' 58' ' ' ILE . 60.0 mt -127.08 138.8 53.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 116.152 -0.476 . . . . 64.549999999999997 111.426 -178.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.29 93.93 6.01 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.947 0.403 . . . . 71.040000000000006 111.838 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.552 ' O ' ' HG3' ' A' ' 97' ' ' LYS . 38.5 mt -53.79 -52.33 60.62 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.09 0.404 . . . . 75.109999999999999 112.09 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -52.82 -14.07 0.5 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.296 0.85 . . . . 73.400000000000006 113.296 -174.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -112.98 -33.91 5.9 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 122.03 -0.419 . . . . 74.400000000000006 112.068 175.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -99.33 0.32 42.67 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.808 1.04 . . . . 63.119999999999997 113.808 -173.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 93' ' ' LEU . 33.0 mtpt -57.18 138.18 54.94 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.213 0.53 . . . . 74.340000000000003 112.22 -178.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 16.3 t90 -64.96 105.26 0.99 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.692 -0.686 . . . . 60.5 111.268 175.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -112.09 99.53 46.29 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 116.1 -0.5 . . . . 74.400000000000006 110.653 175.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.25 32.22 0.17 Allowed 'Trans proline' 0 CA--C 1.548 1.188 0 C-N-CA 122.948 2.432 . . . . 71.25 113.596 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 59.7 mt -103.78 -1.76 27.42 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.959 0.409 . . . . 75.239999999999995 111.069 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 . . . . . 0 C--O 1.253 1.253 0 N-CA-C 112.055 0.391 . . . . 74.329999999999998 112.055 -179.213 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ttt . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 120.617 0.246 . . . . 73.140000000000001 111.187 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -71.09 134.17 46.83 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.877 0.37 . . . . 55.409999999999997 111.354 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.566 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 52.5 tp60 -60.49 -33.21 72.28 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.385 -0.37 . . . . 63.130000000000003 111.236 -178.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -51.49 -49.69 61.34 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.265 0.555 . . . . 73.040000000000006 110.906 175.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.7 mt -61.67 -45.0 95.9 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.695 -0.684 . . . . 72.140000000000001 111.016 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.1 t -56.45 -41.11 71.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 120.958 0.409 . . . . 61.219999999999999 111.349 177.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 13.6 mm100 -65.33 -58.94 4.66 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.316 -0.402 . . . . 74.519999999999996 111.758 -178.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.457 HG21 HG22 ' A' ' 39' ' ' VAL . 33.4 pt -61.02 -42.41 92.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 111.751 0.278 . . . . 72.200000000000003 111.751 -178.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -58.53 -49.78 76.17 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.794 0.331 . . . . 64.239999999999995 111.106 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.2 -39.94 67.12 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.326 -0.397 . . . . 70.299999999999997 111.916 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 7' ' ' GLN . 78.6 t -66.65 -42.5 89.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.058 0.456 . . . . 74.530000000000001 111.243 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.557 ' HB ' HD11 ' A' ' 52' ' ' LEU . 80.5 mt -61.85 -31.87 52.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 116.202 -0.453 . . . . 45.210000000000001 112.014 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -62.15 -15.44 45.92 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.312 0.486 . . . . 74.099999999999994 112.312 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -86.74 -5.85 59.0 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.471 0.545 . . . . 70.420000000000002 112.471 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.487 HD11 HD11 ' A' ' 26' ' ' ILE . 58.0 mt -81.21 117.96 70.32 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-O 120.677 0.275 . . . . 62.109999999999999 111.5 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.6 160.03 38.58 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.5 2.133 . . . . 72.209999999999994 113.082 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -62.9 131.03 47.37 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.318 -0.401 . . . . 53.140000000000001 111.359 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.89 2.04 61.3 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 120.88 -0.676 . . . . 73.030000000000001 113.55 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -122.13 148.31 45.06 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.075 0.464 . . . . 65.230000000000004 111.62 176.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.6 m -125.4 147.53 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-O 121.309 0.576 . . . . 64.0 111.374 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 44.4 t -123.2 174.51 7.23 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.199 -0.455 . . . . 73.239999999999995 110.355 175.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 67.6 p -105.82 147.44 28.66 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.598 0.237 . . . . 71.329999999999998 111.408 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -50.55 -36.75 35.86 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.129 0.49 . . . . 71.540000000000006 110.697 175.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.47 -48.0 85.24 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 115.735 -0.666 . . . . 52.439999999999998 113.243 177.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.438 ' O ' ' HG3' ' A' ' 29' ' ' MET . 44.3 mt-10 -64.81 -48.41 74.52 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 117.073 0.437 . . . . 74.200000000000003 111.893 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.487 HD11 HD11 ' A' ' 15' ' ' ILE . 49.0 mm -55.53 -49.4 73.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 121.085 0.469 . . . . 74.120000000000005 111.052 177.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.504 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -62.99 -42.76 99.93 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.213 -0.449 . . . . 35.299999999999997 111.488 177.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -59.82 -42.56 93.76 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.985 0.421 . . . . 73.129999999999995 111.431 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.438 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 66.0 mtt -70.07 -34.87 73.74 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.0 0.429 . . . . 64.150000000000006 111.044 178.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.28 -30.68 66.57 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.132 -0.485 . . . . 74.219999999999999 111.672 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.39 13.73 14.41 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.512 -0.375 . . . . 74.540000000000006 113.355 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.542 ' HB3' ' HB2' ' A' ' 35' ' ' TYR . 52.2 m-85 -128.55 63.1 63.37 Favored Pre-proline 0 CA--C 1.548 0.898 0 O-C-N 122.556 -0.379 . . . . 73.450000000000003 111.766 -178.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -55.96 -43.08 60.26 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.646 2.23 . . . . 60.25 113.408 -175.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.04 -22.66 78.73 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.186 -0.53 . . . . 70.329999999999998 113.116 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.542 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 90.2 m-85 -86.23 6.67 28.5 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 111.962 0.356 . . . . 74.340000000000003 111.962 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.47 -36.18 32.44 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.244 0.545 . . . . 44.210000000000001 111.407 177.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.472 ' O ' ' HG3' ' A' ' 41' ' ' LYS . 14.8 ptp180 -55.41 -43.55 75.37 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.848 -0.615 . . . . 74.219999999999999 111.416 175.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -72.55 -30.3 64.32 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.334 -0.394 . . . . 73.540000000000006 111.443 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.457 HG22 HG21 ' A' ' 8' ' ' ILE . 58.5 t -57.74 -52.28 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 120.899 0.38 . . . . 63.420000000000002 110.569 175.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.16 -37.72 93.33 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.081 -0.58 . . . . 63.509999999999998 113.039 176.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 37' ' ' ARG . 28.2 mtpp -65.05 -44.14 89.99 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 122.515 -0.403 . . . . 65.450000000000003 111.192 177.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.47 -52.36 61.7 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.437 -0.347 . . . . 75.129999999999995 111.788 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.433 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 88.9 mt -56.92 -34.46 67.99 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.873 0.368 . . . . 72.310000000000002 111.592 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.98 -8.15 33.81 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 121.397 -0.43 . . . . 73.329999999999998 114.077 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -93.41 -12.63 29.39 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 117.379 0.589 . . . . 54.299999999999997 112.108 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.556 HD12 ' HB3' ' A' ' 54' ' ' TRP . 94.1 mt -74.02 143.68 81.11 Favored Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 112.189 0.441 . . . . 75.230000000000004 112.189 -175.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.25 177.51 6.52 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 122.898 2.398 . . . . 74.140000000000001 114.094 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -57.79 -45.66 85.7 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.542 -0.754 . . . . 73.209999999999994 111.736 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -114.75 56.17 0.51 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.3 -0.476 . . . . 34.229999999999997 112.897 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.4 t -66.9 159.35 28.53 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.266 0.469 . . . . 73.310000000000002 112.266 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -71.44 -11.18 60.75 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.168 0.508 . . . . 71.420000000000002 111.148 175.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.557 HD11 ' HB ' ' A' ' 12' ' ' ILE . 42.0 tp -117.59 124.26 29.07 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 115.849 -0.614 . . . . 75.420000000000002 110.713 177.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.536 ' HD2' HD12 ' A' ' 52' ' ' LEU . 58.6 Cg_endo -72.3 95.26 0.76 Allowed 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 121.364 1.376 . . . . 71.349999999999994 112.115 176.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.556 ' HB3' HD12 ' A' ' 46' ' ' LEU . 65.7 p-90 -83.5 -32.43 25.96 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.176 0.513 . . . . 74.310000000000002 111.89 -177.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -56.7 -24.81 51.74 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.227 0.825 . . . . 65.120000000000005 113.227 -177.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -77.85 2.43 17.28 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.444 0.535 . . . . 72.340000000000003 112.444 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 18.8 t -115.59 107.87 23.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.239 0.542 . . . . 52.329999999999998 111.479 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.518 HG21 HD12 ' A' ' 91' ' ' ILE . 33.7 pt -108.89 -169.73 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 116.164 -0.471 . . . . 65.549999999999997 111.339 178.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.59 ' HB3' ' OG ' ' A' ' 65' ' ' SER . 30.9 p30 -93.44 171.79 8.68 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.737 0.643 . . . . 64.340000000000003 112.737 -175.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 48.2 t -72.03 -8.08 52.47 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.88 -0.6 . . . . 73.400000000000006 111.712 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -84.59 -6.37 59.36 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.496 -0.32 . . . . 74.0 111.502 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.05 31.94 54.08 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 121.006 -0.616 . . . . 45.240000000000002 112.084 -174.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.489 ' HB3' ' NZ ' ' A' ' 63' ' ' LYS . 9.5 mtpm? -139.93 173.27 11.69 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.534 0.683 . . . . 53.340000000000003 112.02 -176.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.483 HG23 ' OE1' ' A' ' 74' ' ' GLN . 73.8 mt -86.45 116.12 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.415 -0.812 . . . . 53.329999999999998 110.469 173.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.59 ' OG ' ' HB3' ' A' ' 59' ' ' ASN . 58.0 m -71.62 -31.92 67.43 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.055 0.391 . . . . 71.109999999999999 112.055 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 81.9 mt -72.56 121.94 20.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.038 0.447 . . . . 63.539999999999999 111.594 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -115.16 159.56 20.77 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.02 0.438 . . . . 54.240000000000002 111.042 177.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.36 -141.59 15.65 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.95 -0.643 . . . . 71.439999999999998 111.689 -172.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 69' ' ' ARG . 67.7 mtt-85 -72.45 -22.69 61.05 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 117.624 0.712 . . . . 73.150000000000006 110.782 177.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.562 ' HA ' ' HD2' ' A' ' 73' ' ' ARG . 23.3 m-20 -67.72 -23.3 65.26 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.017 -0.538 . . . . 64.099999999999994 111.561 177.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.4 tt -67.22 -56.07 11.43 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.87 0.366 . . . . 73.150000000000006 110.452 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.19 -27.79 68.94 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.536 -0.302 . . . . 73.239999999999995 111.802 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.562 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 97.5 mtt180 -57.33 -62.02 2.06 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.906 0.384 . . . . 50.409999999999997 111.223 172.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.483 ' OE1' HG23 ' A' ' 64' ' ' ILE . 55.5 tt0 -63.88 -40.69 97.11 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.315 -0.402 . . . . 73.219999999999999 111.584 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.455 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 58.9 tttm -57.58 -61.91 2.16 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 111.917 0.34 . . . . 74.329999999999998 111.917 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -57.59 -37.93 74.02 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 111.959 0.355 . . . . 73.450000000000003 111.959 -176.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -55.4 -49.34 72.6 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.023 0.44 . . . . 73.510000000000005 111.533 176.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.8 mt -70.02 -40.16 75.38 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.052 0.454 . . . . 71.540000000000006 111.265 -177.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 45.0 mt-10 -61.76 -35.21 77.44 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.996 0.427 . . . . 71.549999999999997 110.767 176.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.26 -31.99 71.8 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.294 -0.412 . . . . 43.149999999999999 111.486 176.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -81.49 -9.95 59.59 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.67 0.271 . . . . 71.030000000000001 111.679 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.86 27.28 8.45 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 121.346 -0.454 . . . . 72.010000000000005 113.386 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 68.4 mt -98.34 130.78 46.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 120.91 0.386 . . . . 71.150000000000006 111.83 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.414 ' HG3' ' OH ' ' A' ' 96' ' ' TYR . 45.0 mt-10 -67.62 118.6 11.12 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.447 -0.342 . . . . 70.310000000000002 111.243 175.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.9 t -128.57 109.5 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 120.785 0.326 . . . . 74.349999999999994 110.85 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.653 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 40.9 m -61.7 147.05 47.26 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.524 -0.307 . . . . 74.239999999999995 111.184 177.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.419 ' HG3' HG23 ' A' ' 88' ' ' ILE . 15.3 pt-20 -45.38 -44.65 12.04 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.952 1.093 . . . . 75.329999999999998 113.952 -170.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.419 HG23 ' HG3' ' A' ' 87' ' ' GLU . 2.8 pp -80.45 14.27 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 112.404 0.52 . . . . 74.310000000000002 112.404 -177.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.15 57.49 3.18 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 121.432 -0.413 . . . . 53.240000000000002 112.984 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.653 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 62.1 tttm -125.8 127.09 45.58 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 120.703 0.287 . . . . 71.439999999999998 111.334 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.518 HD12 HG21 ' A' ' 58' ' ' ILE . 56.0 mt -126.26 152.16 33.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-O 120.903 0.382 . . . . 74.230000000000004 111.469 -175.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -84.02 99.52 10.48 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.274 0.472 . . . . 73.010000000000005 112.274 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.568 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 23.4 mt -70.7 -1.61 11.92 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.041 0.756 . . . . 60.119999999999997 113.041 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 53.3 mtp85 -96.99 -42.03 8.1 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 122.067 -0.396 . . . . 73.129999999999995 111.302 173.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -76.66 -37.39 56.31 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.101 0.408 . . . . 74.129999999999995 112.101 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.414 ' OH ' ' HG3' ' A' ' 84' ' ' GLU . 84.6 m-85 -109.82 14.2 23.3 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.461 0.541 . . . . 73.519999999999996 112.461 -171.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.568 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 59.2 tttp -62.37 132.71 53.51 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 120.999 0.428 . . . . 64.140000000000001 111.613 -177.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 23.0 t90 -69.51 109.52 4.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.235 0.54 . . . . 72.099999999999994 111.568 176.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -115.23 98.09 49.7 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 115.713 -0.676 . . . . 53.509999999999998 110.758 174.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.17 -12.26 33.93 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.629 2.219 . . . . 65.450000000000003 112.473 173.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 66.7 mt -109.68 124.64 51.56 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.12 -0.491 . . . . 71.510000000000005 110.494 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 C--O 1.254 1.302 0 CA-C-O 118.726 -0.654 . . . . 54.420000000000002 111.924 -178.342 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.5 tpt . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.714 0.292 . . . . 73.209999999999994 110.954 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.558 ' HB2' ' HG ' ' A' ' 5' ' ' LEU . 5.6 m-20 -63.88 127.99 33.83 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.604 -0.271 . . . . 62.119999999999997 111.438 178.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.437 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 14.3 mm100 -60.15 -25.9 65.87 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.625 0.25 . . . . 63.310000000000002 110.993 175.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -53.57 -50.66 65.08 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.171 0.51 . . . . 74.439999999999998 110.336 170.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.558 ' HG ' ' HB2' ' A' ' 2' ' ' ASP . 65.0 mt -62.39 -45.76 91.66 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.769 -0.65 . . . . 74.430000000000007 110.788 177.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.4 t -56.7 -43.56 79.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 116.018 -0.537 . . . . 65.439999999999998 111.797 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 30.2 mm-40 -68.27 -52.0 38.82 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.044 0.387 . . . . 63.310000000000002 112.044 -178.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.485 HG21 HG22 ' A' ' 39' ' ' VAL . 32.2 pt -59.6 -41.79 86.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 121.065 -0.254 . . . . 73.120000000000005 111.325 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -63.91 -44.21 93.63 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.124 0.488 . . . . 51.109999999999999 110.71 175.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.423 ' O ' ' NE2' ' A' ' 14' ' ' GLN . . . -56.5 -32.23 64.83 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.914 -0.585 . . . . 73.030000000000001 111.819 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 7' ' ' GLN . 88.3 t -73.35 -47.04 47.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.97 0.414 . . . . 60.43 111.492 176.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.592 ' HB ' HD11 ' A' ' 52' ' ' LEU . 80.9 mt -58.6 -31.69 44.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 112.888 0.699 . . . . 73.200000000000003 112.888 -175.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -60.7 -11.33 7.1 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 112.663 0.616 . . . . 75.420000000000002 112.663 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.423 ' NE2' ' O ' ' A' ' 10' ' ' ALA . 1.6 mp0 -92.23 -2.17 56.65 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.217 0.451 . . . . 72.120000000000005 112.217 178.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.511 HD11 HD11 ' A' ' 26' ' ' ILE . 53.7 mt -84.75 112.53 43.32 Favored Pre-proline 0 CA--C 1.541 0.634 0 O-C-N 122.221 -0.299 . . . . 64.019999999999996 110.591 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -72.37 165.4 32.79 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.471 2.114 . . . . 74.219999999999999 113.573 -177.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.472 ' HG3' ' OE1' ' A' ' 81' ' ' GLU . 61.5 tttm -59.73 133.35 56.02 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.861 -0.609 . . . . 72.109999999999999 112.08 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.96 -7.91 80.51 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-N 116.239 -0.437 . . . . 73.219999999999999 114.083 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -108.19 155.25 20.66 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 117.335 0.567 . . . . 74.5 112.034 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.5 m -134.17 159.26 42.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 115.965 -0.561 . . . . 74.439999999999998 111.468 178.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 44.6 t -139.24 175.28 9.69 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.948 0.404 . . . . 33.350000000000001 110.783 176.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.4 p -109.28 154.62 22.2 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.835 0.35 . . . . 64.219999999999999 111.551 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -52.92 -34.78 56.75 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.454 -0.339 . . . . 75.340000000000003 111.461 177.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.09 -51.32 54.07 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.334 -0.46 . . . . 63.219999999999999 112.86 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 29' ' ' MET . 41.3 mt-10 -58.93 -47.85 83.58 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.85 0.357 . . . . 73.349999999999994 111.257 178.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.511 HD11 HD11 ' A' ' 15' ' ' ILE . 49.7 mm -60.02 -47.63 91.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 116.42 -0.355 . . . . 70.150000000000006 111.579 178.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.23 -45.72 90.39 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.875 0.369 . . . . 73.299999999999997 111.907 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -61.96 -43.76 98.17 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.759 0.314 . . . . 74.409999999999997 111.453 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.425 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 64.8 mtt -67.06 -34.27 77.31 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.751 0.31 . . . . 75.540000000000006 111.248 178.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.74 -18.31 62.14 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.347 -0.388 . . . . 72.140000000000001 112.009 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.34 14.65 32.35 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 121.423 -0.418 . . . . 73.310000000000002 113.533 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -127.39 72.95 77.65 Favored Pre-proline 0 CA--C 1.541 0.632 0 O-C-N 122.38 -0.482 . . . . 62.530000000000001 111.276 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.21 97.34 0.84 Allowed 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.184 1.923 . . . . 65.219999999999999 112.969 -177.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 142.89 -35.25 1.72 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 120.803 -0.713 . . . . 74.319999999999993 113.258 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -84.06 34.57 0.51 Allowed 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.257 0.465 . . . . 74.310000000000002 112.257 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.77 -39.35 88.45 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.99 0.424 . . . . 72.219999999999999 111.676 -178.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.5 ttt85 -61.15 -29.33 69.72 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 116.363 -0.381 . . . . 75.549999999999997 111.525 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -76.65 -33.39 58.33 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.828 0.347 . . . . 75.439999999999998 110.705 177.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.485 HG22 HG21 ' A' ' 8' ' ' ILE . 47.3 t -58.46 -42.57 84.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 121.346 0.593 . . . . 61.109999999999999 109.706 170.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.97 -37.48 92.74 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 115.532 -0.758 . . . . 71.019999999999996 113.105 175.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -62.12 -44.52 96.46 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.017 0.437 . . . . 71.530000000000001 111.27 176.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.49 -55.21 25.89 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.099 0.476 . . . . 64.239999999999995 111.807 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.5 mt -65.64 -32.71 74.43 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.211 -0.45 . . . . 72.530000000000001 111.648 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.84 -15.77 62.82 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.322 -0.466 . . . . 73.099999999999994 113.18 177.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -89.59 -29.54 18.8 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 122.552 -0.381 . . . . 71.299999999999997 110.802 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 97.5 mt -61.8 112.19 5.74 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-O 120.988 0.423 . . . . 75.040000000000006 111.323 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -93.33 -170.1 0.24 Allowed 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.946 2.43 . . . . 65.530000000000001 114.597 -173.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -62.81 107.16 0.92 Allowed 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.206 -0.906 . . . . 62.219999999999999 111.171 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 128.11 -2.43 6.76 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 121.092 -0.575 . . . . 74.439999999999998 113.503 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.4 t -64.24 137.8 58.11 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.24 0.459 . . . . 75.420000000000002 112.24 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -68.9 -43.91 74.29 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.308 0.575 . . . . 75.340000000000003 110.618 175.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.592 HD11 ' HB ' ' A' ' 12' ' ' ILE . 35.9 tp -71.93 125.26 91.62 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.419 -0.809 . . . . 74.439999999999998 110.797 177.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.567 ' HD2' HD12 ' A' ' 52' ' ' LEU . 58.2 Cg_endo -71.98 94.95 0.73 Allowed 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 121.138 1.225 . . . . 75.0 111.757 176.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 60.9 p-90 -81.01 -30.95 34.84 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.754 -0.657 . . . . 71.329999999999998 111.338 -178.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -60.49 -16.82 40.61 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.649 0.611 . . . . 61.0 112.649 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.446 ' NH2' ' HA ' ' A' ' 17' ' ' LYS . 64.3 mtt-85 -78.3 -11.75 59.96 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.098 0.407 . . . . 75.319999999999993 112.098 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 22.7 t -111.71 120.21 61.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.278 0.561 . . . . 64.439999999999998 111.934 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.722 HD11 HD21 ' A' ' 93' ' ' LEU . 37.0 pt -120.48 -169.89 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 121.268 0.556 . . . . 63.130000000000003 111.731 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.9 p30 -89.78 172.65 8.76 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 121.221 0.534 . . . . 62.140000000000001 112.329 -176.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 63.4 p -72.27 -2.99 21.05 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 116.25 -0.432 . . . . 70.209999999999994 111.968 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -89.02 -12.0 42.61 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.969 0.414 . . . . 75.329999999999998 110.868 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.65 27.05 55.3 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.277 -0.487 . . . . 63.509999999999998 112.814 -177.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.522 ' HB3' ' NZ ' ' A' ' 63' ' ' LYS . 8.4 mtpm? -128.1 163.22 25.08 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.388 0.613 . . . . 70.239999999999995 112.324 -177.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.568 HG23 ' OE1' ' A' ' 74' ' ' GLN . 67.3 mt -71.39 116.4 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 115.428 -0.805 . . . . 73.099999999999994 109.728 170.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.1 m -75.17 -17.5 60.38 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.02 0.748 . . . . 75.219999999999999 113.02 -173.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 90.9 mt -77.23 176.33 8.86 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.107 0.48 . . . . 54.130000000000003 112.141 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.1 ptmm? -130.6 142.25 50.45 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.394 0.516 . . . . 73.140000000000001 112.394 -174.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 48.9 -124.26 12.26 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-N 115.947 -0.57 . . . . 61.43 114.076 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.463 ' HG3' ' H ' ' A' ' 69' ' ' ARG . 19.7 mtm180 -43.3 -53.68 5.07 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.805 0.812 . . . . 72.219999999999999 111.157 177.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.45 ' O ' ' HB2' ' A' ' 73' ' ' ARG . 4.3 m-20 -63.7 -34.1 77.11 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.784 -1.098 . . . . 72.420000000000002 111.507 -176.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.3 tt -63.72 -49.06 74.55 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 109.536 -0.542 . . . . 75.030000000000001 109.536 175.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.43 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 3.2 m-20 -63.88 -19.44 65.07 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.841 -0.618 . . . . 55.240000000000002 112.066 177.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.58 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 39.1 mmt180 -66.75 -59.49 3.52 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.034 0.445 . . . . 72.319999999999993 110.927 172.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.568 ' OE1' HG23 ' A' ' 64' ' ' ILE . 50.0 tt0 -58.99 -38.87 80.17 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.939 0.4 . . . . 74.109999999999999 110.225 177.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.514 ' HG3' HG11 ' A' ' 85' ' ' VAL . 81.2 tttt -59.66 -56.72 18.32 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.999 -0.546 . . . . 65.430000000000007 112.209 177.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.58 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 20.8 pt20 -54.27 -36.68 63.88 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 120.896 0.379 . . . . 74.310000000000002 111.64 -176.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -67.76 -49.38 62.8 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.945 0.403 . . . . 75.530000000000001 111.231 177.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 74' ' ' GLN . 64.8 mt -58.1 -45.36 87.35 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.241 -0.436 . . . . 73.219999999999999 111.375 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -62.9 -40.77 98.57 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.757 0.313 . . . . 73.25 110.976 177.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.03 -23.69 67.57 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.158 0.504 . . . . 62.039999999999999 111.216 175.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.472 ' OE1' ' HG3' ' A' ' 17' ' ' LYS . 42.1 mm-40 -80.43 -23.15 40.5 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.986 -0.552 . . . . 71.140000000000001 111.556 175.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.55 14.86 52.31 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 116.234 -0.439 . . . . 65.129999999999995 112.487 -174.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 76.9 mt -82.83 130.0 36.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 122.506 0.322 . . . . 63.509999999999998 111.007 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.412 ' HG3' ' OH ' ' A' ' 96' ' ' TYR . 51.6 mt-10 -66.95 92.83 0.24 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.314 0.578 . . . . 74.129999999999995 112.115 -177.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.514 HG11 ' HG3' ' A' ' 75' ' ' LYS . 61.2 t -90.49 113.89 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 115.897 -0.592 . . . . 73.030000000000001 110.91 174.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.542 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 39.6 t -66.23 142.1 57.82 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.502 -0.317 . . . . 74.349999999999994 111.034 174.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -42.37 -42.85 3.33 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.672 0.99 . . . . 65.329999999999998 113.672 -174.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.419 ' H ' HG13 ' A' ' 88' ' ' ILE . 2.8 pp -82.33 22.64 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 N-CA-C 112.481 0.548 . . . . 74.019999999999996 112.481 -178.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.24 57.97 7.06 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-N 116.428 -0.351 . . . . 52.240000000000002 113.36 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.542 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 84.2 tttt -132.28 149.91 52.27 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.769 0.319 . . . . 72.549999999999997 111.244 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.56 HD12 HD13 ' A' ' 58' ' ' ILE . 57.1 mt -125.16 150.49 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 120.861 0.362 . . . . 74.219999999999999 111.441 -177.041 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.9 92.68 7.85 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.804 0.335 . . . . 64.319999999999993 111.065 175.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.722 HD21 HD11 ' A' ' 58' ' ' ILE . 50.7 mt -59.25 -56.1 26.49 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.36 0.504 . . . . 75.109999999999999 112.36 -177.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 41.0 mtm-85 -56.16 -19.62 14.29 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.13 0.419 . . . . 70.010000000000005 112.13 -175.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -95.09 -29.0 14.81 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.491 -0.322 . . . . 51.32 111.796 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.412 ' OH ' ' HG3' ' A' ' 84' ' ' GLU . 91.8 m-85 -118.05 9.01 12.59 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.66 0.985 . . . . 74.219999999999999 113.66 -175.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.518 ' HG3' ' O ' ' A' ' 93' ' ' LEU . 24.9 mtpp -54.67 133.7 46.91 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 118.489 0.586 . . . . 71.329999999999998 112.142 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.409 ' HZ2' ' HB3' ' A' ' 14' ' ' GLN . 16.2 t90 -57.29 113.09 1.6 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.692 -0.685 . . . . 52.520000000000003 111.636 177.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 65.7 mt-30 -113.57 92.51 24.16 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 115.537 -0.756 . . . . 71.450000000000003 110.28 177.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -81.08 -5.32 12.88 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.712 2.275 . . . . 70.5 114.078 -177.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 82.4 mt -123.18 159.63 28.22 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.037 0.384 . . . . 75.439999999999998 112.037 -175.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 . . . . . 0 C--O 1.251 1.152 0 CA-C-O 118.727 -0.654 . . . . 51.32 110.803 175.092 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 tpt . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 120.593 0.235 . . . . 71.010000000000005 110.861 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.515 ' HB2' ' HG ' ' A' ' 5' ' ' LEU . 5.0 m-20 -64.89 138.99 58.71 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.055 0.391 . . . . 73.099999999999994 112.055 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -58.32 -34.74 70.93 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.901 0.381 . . . . 64.299999999999997 110.314 173.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.435 ' O ' HG12 ' A' ' 8' ' ' ILE . 34.2 t80 -51.95 -49.97 62.13 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.786 -0.643 . . . . 74.209999999999994 111.174 174.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.515 ' HG ' ' HB2' ' A' ' 2' ' ' ASP . 84.3 mt -60.97 -52.11 66.41 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.01 -0.541 . . . . 75.239999999999995 111.064 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 40.0 t -55.85 -45.81 79.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 116.126 -0.488 . . . . 55.32 111.661 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.429 ' O ' HG23 ' A' ' 11' ' ' VAL . 26.8 mm-40 -63.36 -56.89 12.66 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.161 0.43 . . . . 73.299999999999997 112.161 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.514 ' O ' HG13 ' A' ' 12' ' ' ILE . 34.0 pt -58.44 -45.14 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 121.109 -0.237 . . . . 62.329999999999998 111.567 -178.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.402 ' N ' HG13 ' A' ' 8' ' ' ILE . 21.1 m-30 -60.64 -45.3 94.59 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.015 0.436 . . . . 71.120000000000005 111.016 178.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.1 -26.75 64.95 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.17 -0.468 . . . . 73.099999999999994 111.817 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 7' ' ' GLN . 99.2 t -80.99 -43.36 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-O 120.88 0.372 . . . . 73.430000000000007 111.213 176.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 8' ' ' ILE . 81.7 mt -54.91 -36.65 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 112.631 0.604 . . . . 73.409999999999997 112.631 -178.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -55.15 -19.43 7.69 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.895 0.702 . . . . 74.239999999999995 112.895 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -77.12 -23.36 51.77 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.561 0.578 . . . . 72.319999999999993 112.561 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.441 ' O ' ' NH1' ' A' ' 56' ' ' ARG . 38.9 mt -70.56 118.7 67.11 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 122.201 0.2 . . . . 74.239999999999995 111.495 -177.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -79.68 170.32 17.14 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 122.758 2.305 . . . . 61.439999999999998 114.005 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 49.7 tttp -64.02 135.41 56.42 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.992 -0.549 . . . . 64.140000000000001 111.294 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.438 ' H ' ' HB3' ' A' ' 81' ' ' GLU . . . 86.31 2.51 85.37 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.078 -0.582 . . . . 32.140000000000001 113.402 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.441 ' HB3' ' HA ' ' A' ' 98' ' ' TRP . 47.0 mmtm -118.23 145.44 45.0 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.103 0.478 . . . . 63.340000000000003 111.739 177.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.435 HG13 HD13 ' A' ' 83' ' ' ILE . 18.7 m -131.46 150.4 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 115.91 -0.586 . . . . 61.140000000000001 111.321 177.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 88.7 p -129.19 164.53 23.21 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.537 -0.302 . . . . 73.099999999999994 110.724 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.6 p -90.22 146.91 23.89 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.836 0.35 . . . . 73.040000000000006 111.62 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -49.57 -37.37 27.11 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.025 0.44 . . . . 71.150000000000006 111.3 176.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.05 -40.19 98.15 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 115.95 -0.568 . . . . 73.230000000000004 113.466 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -69.07 -50.54 47.43 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.983 0.392 . . . . 73.329999999999998 111.603 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.5 mm -59.35 -47.61 89.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 120.841 0.353 . . . . 75.129999999999995 110.965 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.546 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -60.81 -44.78 96.42 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.405 -0.361 . . . . 71.530000000000001 111.591 177.254 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -54.99 -51.34 66.53 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.977 0.418 . . . . 75.420000000000002 111.731 177.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 67.9 mtm -71.24 -27.3 63.37 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.07 -0.513 . . . . 74.340000000000003 112.049 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.44 -30.81 62.04 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.946 0.403 . . . . 73.099999999999994 111.521 176.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.07 17.04 10.52 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.405 -0.426 . . . . 73.439999999999998 113.243 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.546 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 53.1 m-85 -133.48 61.66 55.19 Favored Pre-proline 0 CA--C 1.549 0.91 0 O-C-N 122.665 -0.315 . . . . 75.239999999999995 111.237 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -52.0 -38.47 69.52 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.022 2.481 . . . . 75.329999999999998 114.307 -173.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.8 -1.32 86.97 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 121.133 -0.555 . . . . 72.239999999999995 113.619 -178.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.491 ' O ' HG23 ' A' ' 39' ' ' VAL . 11.2 m-85 -97.51 10.61 39.34 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.925 0.713 . . . . 73.239999999999995 112.925 -177.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.68 -50.18 34.38 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.565 0.698 . . . . 74.340000000000003 111.083 176.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -52.41 -44.43 65.39 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.299 -0.864 . . . . 74.510000000000005 111.697 172.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 67.8 m80 -72.18 -26.17 61.96 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.381 -0.372 . . . . 74.25 111.725 -177.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 35' ' ' TYR . 58.9 t -62.83 -46.72 95.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 120.894 0.378 . . . . 63.109999999999999 110.295 174.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -57.48 -42.63 94.01 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.102 -0.571 . . . . 65.519999999999996 112.355 174.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -64.17 -37.49 87.66 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.898 0.38 . . . . 72.310000000000002 111.223 175.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.76 -44.26 81.89 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.321 -0.399 . . . . 64.200000000000003 112.065 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 39' ' ' VAL . 61.4 mt -63.61 -29.08 70.38 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.801 0.334 . . . . 71.450000000000003 111.355 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.43 -16.3 49.31 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 121.238 -0.506 . . . . 61.409999999999997 113.29 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -77.19 -21.45 53.91 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.011 0.434 . . . . 73.340000000000003 111.247 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 95.0 mt -89.8 135.75 30.12 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-O 121.058 0.456 . . . . 73.420000000000002 112.163 -175.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -81.88 178.56 6.37 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.83 2.353 . . . . 72.439999999999998 113.539 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.553 ' HB3' ' HG3' ' A' ' 73' ' ' ARG . 1.2 pm0 -86.19 23.46 1.53 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.95 -0.568 . . . . 75.349999999999994 112.211 -177.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -147.29 35.81 1.22 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 121.195 -0.526 . . . . 34.509999999999998 112.693 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 34.6 t -86.52 166.76 15.2 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.47 0.653 . . . . 74.430000000000007 112.759 -176.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -82.23 -10.27 59.19 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.374 -0.83 . . . . 64.120000000000005 111.4 176.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.537 HD12 ' HD2' ' A' ' 53' ' ' PRO . 41.3 tp -109.68 122.56 38.88 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 116.028 -0.533 . . . . 71.540000000000006 110.792 178.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.537 ' HD2' HD12 ' A' ' 52' ' ' LEU . 67.8 Cg_endo -76.1 94.3 1.02 Allowed 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 121.182 1.255 . . . . 62.109999999999999 111.716 175.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.412 ' HB2' HD22 ' A' ' 43' ' ' LEU . 53.3 p-90 -84.46 -33.92 23.54 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.72 -0.673 . . . . 73.420000000000002 111.707 -176.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.455 ' O ' HD21 ' A' ' 78' ' ' LEU . 9.6 p90 -56.73 -19.45 16.83 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.209 0.818 . . . . 71.25 113.209 -178.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.441 ' NH1' ' O ' ' A' ' 15' ' ' ILE . 98.0 mtt180 -73.53 4.9 4.29 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 112.31 0.485 . . . . 65.230000000000004 112.31 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.5 t -122.92 116.44 48.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 CA-C-O 121.22 0.534 . . . . 64.340000000000003 111.303 177.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.515 HG21 HD12 ' A' ' 91' ' ' ILE . 28.9 pt -120.18 -170.81 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 116.329 -0.396 . . . . 63.0 111.433 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.462 ' HB3' ' OG ' ' A' ' 65' ' ' SER . 32.5 p30 -86.74 169.72 12.39 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.375 0.607 . . . . 44.530000000000001 112.46 -176.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.2 m -63.8 -26.71 68.75 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.835 -0.621 . . . . 64.310000000000002 112.16 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -76.24 -7.59 55.22 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.257 0.466 . . . . 61.119999999999997 112.257 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.55 42.67 13.57 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 121.242 -0.504 . . . . 52.530000000000001 112.627 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.452 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 58.3 mtpt -140.94 171.08 14.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.993 0.425 . . . . 73.329999999999998 110.757 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 59.2 mt -84.56 122.69 38.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 116.407 -0.361 . . . . 71.549999999999997 110.661 176.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.462 ' OG ' ' HB3' ' A' ' 59' ' ' ASN . 58.4 m -81.77 -12.11 58.71 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.234 0.457 . . . . 55.240000000000002 112.234 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.6 mt -80.61 148.57 30.22 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.821 0.343 . . . . 74.319999999999993 110.79 174.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -116.5 157.78 24.66 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.249 0.463 . . . . 71.409999999999997 112.249 -176.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 55.2 -128.11 43.19 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 116.076 -0.511 . . . . 62.340000000000003 113.965 176.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -55.07 -44.64 74.98 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.134 0.492 . . . . 61.219999999999999 111.924 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -60.99 -32.93 72.48 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.965 -0.561 . . . . 72.340000000000003 111.624 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.0 tt -65.79 -53.28 42.38 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.817 0.342 . . . . 72.019999999999996 110.185 176.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -58.71 -34.18 71.03 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.802 0.334 . . . . 60.119999999999997 111.526 177.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.553 ' HG3' ' HB3' ' A' ' 48' ' ' GLU . 39.5 ttm180 -61.15 -56.37 21.56 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.098 0.475 . . . . 75.5 110.998 176.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -63.13 -41.81 99.37 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.062 0.458 . . . . 73.510000000000005 110.951 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.4 ' HG3' HG11 ' A' ' 85' ' ' VAL . 49.0 tttm -55.61 -61.78 2.13 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.864 -0.607 . . . . 61.450000000000003 111.804 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -54.74 -36.85 65.22 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.415 -0.357 . . . . 64.420000000000002 111.553 -175.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.439 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 73.4 mmtt -63.02 -43.87 97.51 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.846 0.355 . . . . 65.540000000000006 111.546 176.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.455 HD21 ' O ' ' A' ' 55' ' ' PHE . 96.2 mt -67.94 -33.55 74.9 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.902 0.382 . . . . 73.299999999999997 111.25 177.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -58.06 -41.97 84.45 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.347 0.594 . . . . 44.210000000000001 109.97 172.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.32 -21.28 66.69 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.692 -0.686 . . . . 72.310000000000002 111.897 177.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 77' ' ' LYS . 7.4 mm-40 -85.31 -10.11 56.83 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.832 0.348 . . . . 74.439999999999998 111.532 177.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.08 25.96 25.3 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.249 -0.5 . . . . 72.129999999999995 112.701 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.435 HD13 HG13 ' A' ' 20' ' ' VAL . 66.3 mt -102.49 146.06 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 120.972 0.415 . . . . 62.520000000000003 111.774 -177.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -88.43 95.47 10.23 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 111.776 0.288 . . . . 61.530000000000001 111.776 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.4 HG11 ' HG3' ' A' ' 75' ' ' LYS . 22.4 t -95.74 98.33 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-O 121.162 0.506 . . . . 74.340000000000003 110.218 173.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.569 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 50.4 m -56.88 152.52 12.59 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.838 -0.619 . . . . 64.010000000000005 112.333 -178.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.423 ' HG3' HG23 ' A' ' 88' ' ' ILE . 12.3 pt-20 -41.31 -36.87 0.88 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 115.037 1.495 . . . . 72.319999999999993 115.037 -171.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.452 HD11 ' HB2' ' A' ' 90' ' ' LYS . 2.9 pp -92.81 13.11 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 112.706 0.632 . . . . 64.209999999999994 112.706 -176.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.92 42.6 7.09 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 121.587 -0.34 . . . . 25.530000000000001 113.439 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.569 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 62.6 tttp -116.45 142.65 46.59 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 122.622 -0.34 . . . . 63.039999999999999 111.46 -177.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.515 HD12 HG21 ' A' ' 58' ' ' ILE . 62.2 mt -129.45 146.7 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 120.928 0.394 . . . . 61.130000000000003 111.607 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.85 97.35 10.15 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.94 0.4 . . . . 51.409999999999997 111.601 177.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.496 HD21 HD11 ' A' ' 58' ' ' ILE . 67.7 mt -60.31 -55.37 34.53 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.01 0.374 . . . . 61.43 112.01 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 29.6 mtp180 -57.11 -9.29 0.86 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.17 0.804 . . . . 73.209999999999994 113.17 -175.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -105.59 -37.86 6.63 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 111.751 0.278 . . . . 72.5 111.751 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -116.56 13.7 15.36 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.281 0.474 . . . . 70.230000000000004 112.281 -173.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 80.3 tttt -65.63 139.05 58.39 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.097 0.475 . . . . 63.509999999999998 111.46 -178.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.441 ' HA ' ' HB3' ' A' ' 19' ' ' LYS . 17.5 t90 -59.96 111.94 1.68 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.065 0.459 . . . . 75.140000000000001 111.432 178.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -107.25 92.42 8.02 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 116.096 -0.502 . . . . 65.019999999999996 111.001 177.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.73 -31.85 5.02 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.579 2.186 . . . . 62.439999999999998 112.936 177.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 84.3 mt -98.29 111.36 23.73 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.824 0.345 . . . . 63.43 110.98 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 . . . . . 0 C--O 1.253 1.249 0 CA-C-O 118.742 -0.647 . . . . 62.399999999999999 111.723 -176.347 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 120.845 0.355 . . . . 63.240000000000002 111.037 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -69.42 118.35 12.19 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 122.172 -0.33 . . . . 70.120000000000005 111.267 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -52.8 -35.18 56.49 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.319 0.489 . . . . 65.540000000000006 112.319 -177.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -54.32 -49.61 69.3 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.245 0.545 . . . . 71.439999999999998 110.75 176.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 77.8 mt -65.71 -42.59 90.92 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.768 -0.651 . . . . 73.0 110.919 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 92.2 t -55.28 -46.56 78.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.362 -0.381 . . . . 62.229999999999997 111.559 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.427 ' O ' HG23 ' A' ' 11' ' ' VAL . 27.4 mm-40 -66.98 -56.39 10.36 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.252 0.464 . . . . 74.209999999999994 112.252 -177.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.502 ' O ' HG13 ' A' ' 12' ' ' ILE . 29.9 pt -58.66 -41.85 83.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 O-C-N 122.199 -0.313 . . . . 71.299999999999997 111.722 -178.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.414 ' CD1' HG13 ' A' ' 8' ' ' ILE . 9.0 m-30 -62.34 -43.7 98.2 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.813 0.34 . . . . 63.32 110.915 177.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.32 -28.34 64.96 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.018 0.437 . . . . 73.400000000000006 111.664 177.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 7' ' ' GLN . 57.6 t -80.66 -41.47 20.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 120.81 0.338 . . . . 72.430000000000007 110.998 176.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 8' ' ' ILE . 83.2 mt -61.23 -42.38 93.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 112.206 0.447 . . . . 75.439999999999998 112.206 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -59.94 -20.69 58.85 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.096 0.406 . . . . 74.310000000000002 112.096 178.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -83.48 -2.34 55.69 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.007 0.373 . . . . 71.140000000000001 112.007 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.566 HD11 HD11 ' A' ' 26' ' ' ILE . 61.0 mt -84.61 113.82 51.48 Favored Pre-proline 0 CA--C 1.543 0.673 0 O-C-N 122.374 -0.204 . . . . 71.230000000000004 110.472 175.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 15' ' ' ILE . 15.1 Cg_exo -69.54 147.66 64.79 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.003 2.468 . . . . 64.019999999999996 113.537 -178.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -52.2 120.02 5.01 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 116.021 -0.536 . . . . 72.120000000000005 111.791 176.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.69 -8.84 40.34 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.118 -0.563 . . . . 65.040000000000006 113.037 -177.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -115.18 152.1 33.23 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.985 0.421 . . . . 64.140000000000001 111.23 176.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.449 HG13 HD13 ' A' ' 83' ' ' ILE . 32.8 m -130.18 159.14 42.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-O 121.168 0.509 . . . . 53.350000000000001 110.962 177.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 45.4 t -138.98 168.44 19.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.997 0.427 . . . . 61.149999999999999 111.131 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.4 p -103.78 148.44 26.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.456 -0.338 . . . . 73.349999999999994 111.343 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.402 ' HE1' HD12 ' A' ' 43' ' ' LEU . 73.3 m-85 -51.72 -33.14 33.12 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.749 0.309 . . . . 74.439999999999998 111.394 175.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.16 -44.26 98.36 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.18 -0.533 . . . . 72.120000000000005 112.691 176.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.459 ' O ' ' HG3' ' A' ' 29' ' ' MET . 41.3 mt-10 -70.79 -49.57 45.14 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.575 0.226 . . . . 73.219999999999999 111.519 178.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.566 HD11 HD11 ' A' ' 15' ' ' ILE . 51.4 mm -56.07 -56.53 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 111.958 0.355 . . . . 70.319999999999993 111.958 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.435 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -58.97 -39.99 83.42 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.095 0.474 . . . . 73.200000000000003 111.305 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -60.82 -42.41 97.63 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.136 -0.484 . . . . 72.299999999999997 111.149 178.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.459 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 66.5 mtt -72.65 -36.26 67.93 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 120.898 0.38 . . . . 72.219999999999999 111.462 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.04 -21.28 65.02 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.981 0.42 . . . . 75.209999999999994 111.517 178.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.73 18.06 28.8 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.319 -0.467 . . . . 63.420000000000002 113.217 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.435 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 88.0 m-85 -123.44 85.94 52.28 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-O 120.783 0.325 . . . . 60.240000000000002 111.282 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.76 135.47 25.91 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.412 2.075 . . . . 73.420000000000002 112.672 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.5 -26.65 8.84 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.28 -0.486 . . . . 43.350000000000001 113.24 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -73.36 3.62 5.7 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 112.423 0.527 . . . . 65.109999999999999 112.423 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.0 -44.43 30.77 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.056 0.455 . . . . 45.520000000000003 112.027 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -63.43 -33.79 76.32 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 116.043 -0.526 . . . . 72.319999999999993 111.821 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -75.09 -34.61 61.77 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.799 0.333 . . . . 71.430000000000007 111.032 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.444 HG13 HD12 ' A' ' 8' ' ' ILE . 51.2 t -59.46 -40.11 80.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 121.118 0.485 . . . . 61.43 110.18 173.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.94 -41.01 99.19 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 115.92 -0.582 . . . . 54.119999999999997 112.665 174.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -57.98 -49.13 77.88 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.074 0.464 . . . . 74.010000000000005 110.424 174.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.71 -53.9 52.42 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.815 -0.629 . . . . 71.409999999999997 111.54 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.402 HD12 ' HE1' ' A' ' 23' ' ' TYR . 40.3 mt -62.98 -32.3 73.61 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.9 0.381 . . . . 75.420000000000002 111.03 178.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.97 -22.81 65.14 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.324 -0.465 . . . . 75.340000000000003 113.306 176.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -80.17 -20.13 45.52 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.841 0.353 . . . . 74.25 111.223 177.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 82.0 mt -76.94 140.66 67.03 Favored Pre-proline 0 CA--C 1.539 0.546 0 N-CA-C 112.255 0.465 . . . . 52.119999999999997 112.255 -178.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -88.48 172.95 4.7 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.941 2.427 . . . . 64.209999999999994 112.648 176.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.33 -31.36 72.49 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.489 -0.323 . . . . 54.119999999999997 111.859 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.02 52.43 4.39 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 120.96 -0.638 . . . . 75.540000000000006 113.101 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.8 t -102.32 142.38 33.63 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.131 0.419 . . . . 72.409999999999997 112.131 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -69.39 -35.76 76.1 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.24 0.543 . . . . 73.439999999999998 110.678 174.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.527 HD12 ' HD2' ' A' ' 53' ' ' PRO . 39.7 tp -80.92 121.49 80.93 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.884 -0.598 . . . . 73.349999999999994 110.733 175.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.527 ' HD2' HD12 ' A' ' 52' ' ' LEU . 60.8 Cg_endo -72.71 94.56 0.78 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 121.269 1.313 . . . . 65.510000000000005 111.725 176.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 55.7 p-90 -84.46 -25.36 28.99 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.201 0.524 . . . . 75.439999999999998 111.922 -177.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.548 ' HA ' ' HG3' ' A' ' 74' ' ' GLN . 29.9 p90 -62.97 -22.6 66.94 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.219 0.822 . . . . 72.340000000000003 113.219 -177.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -75.63 -3.46 34.62 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.455 0.539 . . . . 74.329999999999998 112.455 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.4 t -115.2 114.05 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 120.989 0.423 . . . . 65.420000000000002 111.673 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.629 HD11 HD21 ' A' ' 93' ' ' LEU . 39.1 pt -115.99 -171.09 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 120.942 0.401 . . . . 71.209999999999994 111.807 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 34.7 p30 -83.06 178.01 8.33 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.267 0.556 . . . . 74.010000000000005 112.1 -176.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 57.2 p -81.63 -1.31 46.13 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 116.229 -0.442 . . . . 75.129999999999995 111.98 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -86.94 -21.14 26.43 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.771 0.319 . . . . 65.450000000000003 111.372 177.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.08 22.67 24.63 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 121.257 -0.497 . . . . 72.239999999999995 112.212 -173.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.495 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 55.2 mtpt -129.4 172.77 11.18 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.126 0.488 . . . . 63.329999999999998 111.489 -177.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.687 HD11 HG11 ' A' ' 85' ' ' VAL . 55.3 mt -72.55 144.22 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.224 0.535 . . . . 72.299999999999997 111.329 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.4 p -88.47 -44.04 11.0 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.214 -0.448 . . . . 72.409999999999997 111.465 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.43 HD13 ' HB3' ' A' ' 70' ' ' ASP . 74.9 mt -76.42 159.87 30.06 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.291 0.567 . . . . 70.25 112.037 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -131.73 165.91 22.68 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.037 -0.529 . . . . 74.200000000000003 111.879 -175.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.04 -138.0 41.37 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-N 116.23 -0.441 . . . . 52.299999999999997 113.13 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 65.1 mtm180 -59.11 -26.59 64.82 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.925 0.393 . . . . 62.119999999999997 111.58 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.43 ' HB3' HD13 ' A' ' 66' ' ' LEU . 13.2 m-20 -73.21 -29.39 62.77 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.393 -0.367 . . . . 74.129999999999995 111.637 177.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.9 tt -62.26 -48.11 81.4 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 109.199 -0.667 . . . . 70.200000000000003 109.199 174.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.93 -43.24 95.05 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.887 -0.597 . . . . 72.200000000000003 111.364 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 73' ' ' ARG . 64.1 mtt180 -53.69 -57.49 10.64 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 120.805 0.336 . . . . 73.409999999999997 111.314 175.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.548 ' HG3' ' HA ' ' A' ' 55' ' ' PHE . 43.3 tt0 -62.88 -47.12 84.7 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.037 0.446 . . . . 65.420000000000002 111.094 -177.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.446 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 61.6 tttp -58.37 -60.7 3.37 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.967 -0.56 . . . . 61.210000000000001 111.978 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -62.14 -26.27 68.22 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.644 0.609 . . . . 63.130000000000003 112.644 -173.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -64.12 -48.73 74.98 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.207 0.527 . . . . 74.140000000000001 110.715 170.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.548 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 41.1 mt -61.04 -47.21 87.45 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.89 -0.595 . . . . 70.209999999999994 110.994 176.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 57.4 mm-40 -50.08 -39.67 43.18 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.719 -0.673 . . . . 75.349999999999994 111.02 175.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.38 -32.89 74.44 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.138 -0.483 . . . . 72.540000000000006 112.144 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -91.48 0.1 57.55 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 111.875 0.324 . . . . 74.439999999999998 111.875 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.24 5.81 59.15 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.351 -0.452 . . . . 64.010000000000005 113.247 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.548 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 61.4 mt -85.46 102.54 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 121.229 0.537 . . . . 71.200000000000003 110.617 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -78.69 110.62 13.99 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.683 0.623 . . . . 73.129999999999995 112.683 -171.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.687 HG11 HD11 ' A' ' 64' ' ' ILE . 40.3 t -97.41 121.12 47.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 116.096 -0.502 . . . . 73.530000000000001 111.988 -178.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.531 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 30.9 t -59.1 150.7 24.34 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.161 0.43 . . . . 71.230000000000004 112.161 177.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -50.42 -39.86 48.52 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.331 0.863 . . . . 75.549999999999997 113.331 -174.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.415 ' H ' HG13 ' A' ' 88' ' ' ILE . 2.8 pp -81.04 18.9 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-O 121.114 0.483 . . . . 74.319999999999993 111.859 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.72 50.25 9.49 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 116.164 -0.471 . . . . 32.119999999999997 113.407 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.531 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 50.1 tttm -125.25 149.4 48.04 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 122.423 -0.457 . . . . 72.510000000000005 112.073 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.57 HD12 HG21 ' A' ' 58' ' ' ILE . 49.1 mt -123.45 152.93 28.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.235 -0.439 . . . . 54.030000000000001 110.322 174.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -86.68 93.29 9.19 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.816 0.341 . . . . 63.100000000000001 111.141 176.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.629 HD21 HD11 ' A' ' 58' ' ' ILE . 51.0 mt -58.88 -53.96 52.48 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.039 0.385 . . . . 71.120000000000005 112.039 -178.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 21.7 ttp180 -56.18 -19.02 11.84 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-O 121.222 0.534 . . . . 54.210000000000001 111.606 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.465 ' HD3' ' O ' ' A' ' 95' ' ' LYS . 7.8 tmtt? -91.43 -45.13 8.72 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 116.501 -0.318 . . . . 63.0 110.985 177.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -107.92 10.37 28.48 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.902 0.704 . . . . 73.530000000000001 112.902 -170.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 59.1 tttp -58.9 132.23 53.36 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.413 0.523 . . . . 42.020000000000003 112.413 -172.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 17.0 t90 -58.51 105.56 0.31 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.937 -0.574 . . . . 75.109999999999999 112.181 -179.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -102.89 102.07 25.01 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 115.6 -0.727 . . . . 65.349999999999994 110.434 171.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -73.62 -22.15 18.42 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.378 2.052 . . . . 50.039999999999999 112.871 177.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 92.6 mt -123.11 100.25 6.78 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.488 -0.324 . . . . 43.32 111.431 -177.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 . . . . . 0 C--O 1.253 1.258 0 CA-C-O 118.743 -0.646 . . . . 62.229999999999997 111.887 -178.63 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.1 tpt . . . . . 0 N--CA 1.488 1.443 0 N-CA-C 110.234 -0.284 . . . . 74.409999999999997 110.234 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.434 ' O ' HG23 ' A' ' 6' ' ' VAL . 15.1 t70 -62.11 140.23 58.42 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.553 0.575 . . . . 73.519999999999996 112.553 -172.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -60.83 -27.72 68.27 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.881 0.697 . . . . 74.239999999999995 112.881 -175.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.414 ' O ' HG12 ' A' ' 8' ' ' ILE . 59.7 t80 -58.74 -51.64 69.1 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.23 0.538 . . . . 64.340000000000003 110.086 174.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 70.0 mt -67.47 -46.42 73.04 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.543 -0.753 . . . . 63.530000000000001 111.128 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 2' ' ' ASP . 94.1 t -54.39 -48.82 68.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 116.285 -0.416 . . . . 74.25 112.02 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.43 ' O ' HG23 ' A' ' 11' ' ' VAL . 30.8 mm-40 -68.62 -51.44 42.25 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.747 0.647 . . . . 72.010000000000005 112.747 -177.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.494 HD12 HG13 ' A' ' 39' ' ' VAL . 30.2 pt -58.92 -41.54 83.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 120.751 0.31 . . . . 61.310000000000002 111.368 -178.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -64.01 -44.45 92.55 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.081 0.467 . . . . 71.329999999999998 110.591 174.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.98 -20.4 37.89 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.316 0.487 . . . . 73.239999999999995 112.316 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 7' ' ' GLN . 59.1 t -83.8 -43.95 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 120.978 0.418 . . . . 65.340000000000003 111.03 174.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.571 ' HB ' HD11 ' A' ' 52' ' ' LEU . 72.7 mt -61.02 -30.77 48.3 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 112.655 0.613 . . . . 75.209999999999994 112.655 -177.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -55.64 -18.03 6.96 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 112.8 0.667 . . . . 60.039999999999999 112.8 178.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -91.18 -0.89 57.78 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.239 0.459 . . . . 74.019999999999996 112.239 -178.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.526 HD11 HD11 ' A' ' 26' ' ' ILE . 61.2 mt -87.28 113.54 54.38 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-O 120.417 0.151 . . . . 74.329999999999998 110.905 178.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -77.74 170.31 19.3 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.685 2.257 . . . . 75.030000000000001 113.87 -177.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.2 tttp -61.32 130.52 46.53 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.085 -0.507 . . . . 73.310000000000002 111.247 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.67 2.97 75.0 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.035 -0.603 . . . . 54.329999999999998 113.688 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -120.72 148.33 44.09 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 117.272 0.536 . . . . 63.509999999999998 111.315 176.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.6 m -128.69 157.27 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.224 0.535 . . . . 71.209999999999994 111.898 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.4 m -133.1 163.46 29.2 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.158 -0.474 . . . . 42.210000000000001 110.796 176.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 44.5 p -93.88 149.09 21.54 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.734 0.302 . . . . 62.0 111.416 178.094 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -51.12 -38.81 54.12 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.866 0.365 . . . . 75.099999999999994 111.19 177.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.23 -47.78 89.13 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-N 116.154 -0.475 . . . . 72.510000000000005 112.875 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.455 ' O ' ' HG3' ' A' ' 29' ' ' MET . 46.0 mt-10 -59.63 -55.63 32.01 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.705 0.288 . . . . 55.100000000000001 111.537 178.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.526 HD11 HD11 ' A' ' 15' ' ' ILE . 49.8 mm -53.57 -50.43 49.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 120.956 0.408 . . . . 75.400000000000006 111.784 -178.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.473 ' HB2' HG21 ' A' ' 39' ' ' VAL . . . -64.13 -45.78 87.03 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.889 0.376 . . . . 71.409999999999997 111.802 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.9 tttp -64.49 -35.83 82.2 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.508 -0.314 . . . . 75.319999999999993 111.4 -177.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.455 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 65.9 mtt -68.4 -43.44 77.26 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.054 0.454 . . . . 63.530000000000001 110.769 176.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.54 -23.03 66.77 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.03 -0.532 . . . . 65.329999999999998 111.963 178.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.12 31.7 4.61 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.473 -0.394 . . . . 60.539999999999999 113.414 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -129.73 89.32 46.8 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-O 120.874 0.368 . . . . 71.409999999999997 111.402 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -73.72 125.37 9.95 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.135 2.556 . . . . 63.140000000000001 113.124 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.33 -13.99 66.31 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 121.323 -0.465 . . . . 71.5 113.584 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.428 ' HA ' ' HD2' ' A' ' 38' ' ' HIS . 74.5 m-85 -84.58 10.57 10.72 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.838 0.681 . . . . 73.530000000000001 112.838 -176.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.48 -52.72 20.99 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.719 0.637 . . . . 52.240000000000002 112.719 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -65.69 -26.47 67.79 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.887 0.375 . . . . 73.219999999999999 111.872 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.428 ' HD2' ' HA ' ' A' ' 35' ' ' TYR . 99.5 m-70 -74.83 -32.28 61.9 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.95 0.405 . . . . 73.239999999999995 110.921 177.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.494 HG13 HD12 ' A' ' 8' ' ' ILE . 81.3 t -59.44 -40.46 81.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-O 121.252 0.549 . . . . 62.43 110.195 170.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -57.93 -41.99 94.55 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.869 -0.605 . . . . 71.310000000000002 112.732 174.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -56.68 -40.16 75.07 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.094 0.473 . . . . 71.219999999999999 111.218 175.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.1 -51.72 23.51 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.914 -0.585 . . . . 73.420000000000002 112.179 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.9 mt -60.65 -45.14 95.23 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.2 0.444 . . . . 64.450000000000003 112.2 -176.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.59 -20.93 64.32 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 120.692 -0.766 . . . . 55.229999999999997 113.05 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -83.63 -20.97 32.69 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 120.71 0.291 . . . . 74.010000000000005 111.489 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.454 HD12 ' HB3' ' A' ' 54' ' ' TRP . 94.4 mt -67.05 147.68 99.02 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 111.889 0.329 . . . . 73.430000000000007 111.889 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.548 ' HG2' ' HB3' ' A' ' 50' ' ' SER . 30.1 Cg_endo -63.56 165.54 17.71 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.402 2.068 . . . . 53.229999999999997 112.715 176.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.405 ' HG2' ' HE ' ' A' ' 73' ' ' ARG . 45.7 mt-10 -57.3 -41.14 79.28 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.584 0.587 . . . . 74.420000000000002 112.584 -177.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -128.43 60.27 0.67 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.981 -0.628 . . . . 70.010000000000005 113.744 -177.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.548 ' HB3' ' HG2' ' A' ' 47' ' ' PRO . 24.5 p -76.97 -178.7 5.07 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 122.459 -0.436 . . . . 72.329999999999998 110.878 176.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.429 ' HB2' ' NZ ' ' A' ' 51' ' ' LYS . 5.2 ttmp? -61.04 -28.52 69.12 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.065 0.46 . . . . 75.140000000000001 110.825 174.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.571 HD11 ' HB ' ' A' ' 12' ' ' ILE . 26.0 tp -103.38 130.78 22.92 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 116.017 -0.538 . . . . 73.530000000000001 111.812 -177.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.534 ' HD2' HD12 ' A' ' 52' ' ' LEU . 72.0 Cg_endo -79.42 95.89 1.06 Allowed 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 121.657 1.571 . . . . 70.439999999999998 111.511 170.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.454 ' HB3' HD12 ' A' ' 46' ' ' LEU . 64.8 p-90 -76.51 -28.77 56.53 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.162 -0.472 . . . . 74.319999999999993 112.202 -175.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.491 ' O ' HD21 ' A' ' 78' ' ' LEU . 24.8 p90 -60.7 -19.96 59.89 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.409 0.892 . . . . 62.32 113.409 -175.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -76.82 6.76 5.59 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.864 0.69 . . . . 54.219999999999999 112.864 -176.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 45.1 t -123.62 125.85 72.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 O-C-N 121.929 -0.482 . . . . 54.310000000000002 111.624 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.541 HG21 HD12 ' A' ' 91' ' ' ILE . 32.5 pt -127.35 -169.63 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 121.157 0.503 . . . . 74.230000000000004 111.357 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.414 ' HB3' ' OG ' ' A' ' 65' ' ' SER . 30.9 p30 -87.26 173.97 8.87 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.068 0.461 . . . . 64.030000000000001 111.824 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 33.3 p -84.79 9.74 13.32 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.965 0.412 . . . . 61.520000000000003 111.646 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -93.14 -14.79 26.75 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.003 0.43 . . . . 72.519999999999996 110.542 173.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.38 37.17 18.45 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 121.081 -0.58 . . . . 75.430000000000007 112.161 -174.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -137.35 167.71 21.06 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.645 0.736 . . . . 62.219999999999999 112.379 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.516 ' CG2' HD12 ' A' ' 71' ' ' LEU . 74.9 mt -83.68 108.53 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.109 -0.95 . . . . 54.119999999999997 110.209 172.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.414 ' OG ' ' HB3' ' A' ' 59' ' ' ASN . 71.2 m -69.7 -25.9 64.09 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.73 0.641 . . . . 54.130000000000003 112.73 -175.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.499 HD13 ' HB3' ' A' ' 70' ' ' ASP . 88.6 mt -64.78 124.38 21.82 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.696 0.284 . . . . 73.230000000000004 111.018 178.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -113.05 141.59 46.7 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.14 0.495 . . . . 63.140000000000001 111.211 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 107.88 -136.43 13.44 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.462 -0.655 . . . . 63.020000000000003 111.462 -173.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -81.76 -24.94 35.73 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 117.511 0.656 . . . . 64.099999999999994 110.896 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.499 ' HB3' HD13 ' A' ' 66' ' ' LEU . 7.8 m-20 -62.36 -24.83 67.58 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.121 -0.49 . . . . 72.439999999999998 111.936 176.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.516 HD12 ' CG2' ' A' ' 64' ' ' ILE . 16.2 tp -56.84 -60.65 3.26 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.414 0.626 . . . . 74.120000000000005 110.561 174.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.554 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 18.8 m-20 -67.03 -32.48 73.72 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.605 -0.725 . . . . 74.120000000000005 111.178 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.405 ' HE ' ' HG2' ' A' ' 48' ' ' GLU . 57.7 ttt180 -50.13 -59.01 4.33 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-O 121.3 0.572 . . . . 63.100000000000001 111.204 174.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -62.29 -43.55 98.58 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.007 -0.542 . . . . 63.439999999999998 110.7 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.43 ' HB3' ' HA ' ' A' ' 72' ' ' ASP . 76.4 tttt -50.0 -58.24 5.9 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.722 -0.672 . . . . 73.099999999999994 112.306 176.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.554 ' HG3' ' O ' ' A' ' 72' ' ' ASP . 96.0 mt-30 -52.75 -49.19 65.97 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.142 0.496 . . . . 74.25 111.467 -178.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -68.91 -27.06 65.43 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.5 0.556 . . . . 72.409999999999997 112.5 -177.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.495 HD13 HD11 ' A' ' 91' ' ' ILE . 57.6 mt -77.79 -39.03 45.3 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.169 0.433 . . . . 75.5 112.169 177.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -62.8 -30.69 71.66 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.025 0.441 . . . . 73.219999999999999 110.617 175.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.82 -20.06 66.19 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 116.04 -0.527 . . . . 40.340000000000003 111.483 174.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -86.98 2.67 48.72 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.201 -0.454 . . . . 73.25 111.443 177.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.2 15.67 71.37 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.092 -0.575 . . . . 74.409999999999997 112.832 -177.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 73.0 mt -92.1 124.5 44.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 120.959 0.409 . . . . 73.519999999999996 111.643 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.507 ' HG2' ' OH ' ' A' ' 96' ' ' TYR . 9.0 pt-20 -72.76 90.84 1.44 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.6 0.714 . . . . 70.010000000000005 111.308 175.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 62.3 t -85.73 112.53 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 116.071 -0.513 . . . . 51.100000000000001 110.477 176.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.571 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 42.1 t -61.26 142.57 56.73 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.757 -0.201 . . . . 73.319999999999993 111.055 178.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -48.52 -38.47 20.37 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.744 1.016 . . . . 73.439999999999998 113.744 -172.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.426 ' H ' HG13 ' A' ' 88' ' ' ILE . 2.8 pp -80.32 16.42 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 CA-C-O 121.083 0.468 . . . . 74.420000000000002 112.23 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.37 52.31 6.18 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 116.373 -0.376 . . . . 75.420000000000002 113.443 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.571 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 1.3 tmtp? -125.4 136.23 53.22 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.052 0.453 . . . . 72.439999999999998 111.214 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.541 HD12 HG21 ' A' ' 58' ' ' ILE . 69.7 mt -125.59 126.49 70.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 116.018 -0.537 . . . . 72.230000000000004 110.864 178.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.98 98.29 1.26 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 111.973 0.36 . . . . 73.409999999999997 111.973 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.453 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 86.2 mt -53.47 -53.22 54.6 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.337 -0.392 . . . . 64.209999999999994 111.838 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 18.5 ttm180 -56.21 -26.58 51.54 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 112.189 0.44 . . . . 75.219999999999999 112.189 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -89.66 -28.88 19.17 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.137 0.421 . . . . 70.219999999999999 112.137 -177.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.507 ' OH ' ' HG2' ' A' ' 84' ' ' GLU . 70.9 m-85 -124.73 12.76 8.57 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.658 0.614 . . . . 75.120000000000005 112.658 -174.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 63.6 tttp -60.08 131.5 51.02 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.093 0.473 . . . . 74.040000000000006 111.825 -177.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 19.8 t90 -56.15 124.26 17.27 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.954 -0.566 . . . . 74.140000000000001 111.735 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -108.82 88.87 5.78 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 116.035 -0.53 . . . . 74.0 111.029 176.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.63 -39.08 12.66 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.02 1.814 . . . . 72.219999999999999 111.385 173.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 87.2 mt -133.62 164.11 27.93 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.908 -0.587 . . . . 61.439999999999998 110.848 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 . . . . . 0 C--O 1.253 1.255 0 CA-C-O 118.637 -0.697 . . . . 55.549999999999997 111.67 174.071 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.6 tpt . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 120.793 0.33 . . . . 62.32 110.44 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -66.06 131.7 46.8 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.666 0.617 . . . . 71.400000000000006 112.666 -176.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -57.0 -30.31 64.05 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.22 -0.446 . . . . 74.549999999999997 110.964 175.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -57.69 -52.39 65.62 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.041 0.448 . . . . 51.119999999999997 110.717 174.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.4 mt -63.8 -48.19 77.89 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.964 -0.562 . . . . 71.219999999999999 111.471 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 67.4 t -53.03 -49.52 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 120.931 0.396 . . . . 64.239999999999995 111.703 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.467 ' O ' HG23 ' A' ' 11' ' ' VAL . 28.9 mm-40 -67.28 -53.29 31.19 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.632 0.604 . . . . 74.519999999999996 112.632 -177.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.41 ' O ' HG13 ' A' ' 12' ' ' ILE . 35.9 pt -59.64 -41.62 85.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 O-C-N 122.148 -0.345 . . . . 45.420000000000002 111.468 -178.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.401 ' CD1' HG13 ' A' ' 8' ' ' ILE . 14.8 m-30 -63.69 -43.91 95.23 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.958 0.408 . . . . 74.329999999999998 110.818 177.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.75 -43.18 80.48 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.31 -0.405 . . . . 74.140000000000001 111.366 177.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 7' ' ' GLN . 74.3 t -61.74 -43.2 96.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 121.082 0.468 . . . . 70.329999999999998 110.742 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.473 ' HB ' HD11 ' A' ' 52' ' ' LEU . 72.6 mt -62.77 -37.26 78.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 116.146 -0.479 . . . . 71.040000000000006 111.645 177.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -64.22 -10.43 23.34 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.196 0.443 . . . . 74.530000000000001 112.196 176.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.46 -9.92 42.77 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.65 0.262 . . . . 73.049999999999997 111.667 177.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.427 HD11 HD11 ' A' ' 26' ' ' ILE . 54.9 mt -76.92 114.67 41.54 Favored Pre-proline 0 CA--C 1.543 0.684 0 O-C-N 122.448 -0.157 . . . . 75.420000000000002 110.831 177.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -60.62 150.25 82.95 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 122.734 2.289 . . . . 72.25 113.515 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 67.2 tttm -62.05 95.35 0.06 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.076 0.465 . . . . 64.140000000000001 111.255 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 139.11 -18.64 3.11 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 121.155 -0.545 . . . . 73.209999999999994 113.148 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -103.86 162.4 13.14 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.994 0.426 . . . . 71.200000000000003 111.676 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.7 m -136.29 156.2 35.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 122.932 0.493 . . . . 74.329999999999998 111.561 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 98.4 p -138.13 179.43 6.45 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 120.764 0.316 . . . . 71.219999999999999 111.15 178.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.8 p -110.72 153.12 25.74 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 120.991 0.424 . . . . 74.519999999999996 111.651 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.401 ' CE1' ' HA2' ' A' ' 40' ' ' GLY . 90.0 m-85 -53.48 -39.91 64.9 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.257 0.466 . . . . 73.299999999999997 112.257 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.16 -40.62 93.96 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.172 -0.537 . . . . 41.229999999999997 113.098 178.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -67.29 -51.61 50.73 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 122.493 -0.416 . . . . 71.400000000000006 111.396 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.427 HD11 HD11 ' A' ' 15' ' ' ILE . 50.5 mm -53.85 -51.53 43.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-N 116.141 -0.481 . . . . 73.209999999999994 111.397 178.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.02 -54.18 49.86 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.215 -0.448 . . . . 34.240000000000002 111.961 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.7 mtmp? -62.09 -41.48 98.24 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.083 0.401 . . . . 74.010000000000005 112.083 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 70.7 mtm -76.63 -10.39 59.35 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 111.995 0.369 . . . . 72.409999999999997 111.995 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.34 -14.39 33.21 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.091 0.472 . . . . 51.049999999999997 110.929 172.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.8 18.31 27.89 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 116.012 -0.54 . . . . 23.510000000000002 113.203 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -125.59 91.11 49.29 Favored Pre-proline 0 CA--C 1.544 0.741 0 O-C-N 122.522 -0.399 . . . . 75.349999999999994 111.397 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.01 137.12 26.03 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.861 2.374 . . . . 64.040000000000006 113.092 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.33 -6.18 52.42 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 121.261 -0.495 . . . . 70.420000000000002 113.968 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.401 ' O ' HG23 ' A' ' 39' ' ' VAL . 61.0 m-85 -84.19 11.26 8.47 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.634 0.605 . . . . 62.240000000000002 112.634 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.25 -47.34 69.16 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.963 0.411 . . . . 74.099999999999994 111.895 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.0 ptt180 -57.86 -40.05 79.24 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.18 -0.464 . . . . 71.150000000000006 111.957 175.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -67.84 -39.29 83.86 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.861 0.362 . . . . 73.400000000000006 111.19 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 35' ' ' TYR . 58.9 t -59.9 -42.62 89.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.013 0.435 . . . . 64.299999999999997 110.611 174.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.401 ' HA2' ' CE1' ' A' ' 23' ' ' TYR . . . -58.97 -41.56 96.41 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-N 116.078 -0.51 . . . . 54.509999999999998 112.718 176.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -61.65 -47.32 85.91 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 120.835 0.35 . . . . 64.510000000000005 111.085 176.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.6 -54.41 47.22 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.989 0.423 . . . . 45.43 111.727 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.4 mt -63.91 -32.62 74.21 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.846 0.355 . . . . 74.109999999999999 111.461 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.99 -13.99 62.7 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.439 -0.41 . . . . 73.430000000000007 113.507 178.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -93.53 -4.08 51.67 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 117.087 0.444 . . . . 63.140000000000001 111.945 177.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 94.2 mt -85.88 142.34 36.52 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 112.509 0.559 . . . . 71.400000000000006 112.509 -176.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.78 159.5 48.31 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.54 2.16 . . . . 73.439999999999998 112.27 173.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.59 -35.82 73.02 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.401 0.519 . . . . 63.100000000000001 112.401 -176.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -113.94 53.12 0.61 Allowed Glycine 0 CA--C 1.526 0.75 0 C-N-CA 121.23 -0.51 . . . . 45.32 112.913 178.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 90.9 p -72.93 -179.14 3.06 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 122.297 -0.531 . . . . 70.349999999999994 111.454 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -84.59 4.5 31.92 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.007 0.432 . . . . 73.230000000000004 111.425 176.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.554 HD12 ' HD2' ' A' ' 53' ' ' PRO . 35.6 tp -127.1 126.08 24.23 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 116.159 -0.473 . . . . 74.340000000000003 110.34 178.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.554 ' HD2' HD12 ' A' ' 52' ' ' LEU . 53.0 Cg_endo -70.1 94.36 0.56 Allowed 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 120.94 1.093 . . . . 62.100000000000001 111.879 176.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 68.1 p-90 -84.88 -29.7 25.02 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.305 0.574 . . . . 73.530000000000001 111.051 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.454 ' O ' HD21 ' A' ' 78' ' ' LEU . 33.6 p90 -61.56 -14.16 27.62 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.008 0.744 . . . . 71.230000000000004 113.008 -177.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 69.6 mtt-85 -85.34 7.95 20.52 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.108 0.41 . . . . 74.239999999999995 112.108 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.6 t -125.13 126.91 71.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 120.98 0.419 . . . . 53.109999999999999 111.521 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.609 HD11 HD21 ' A' ' 93' ' ' LEU . 34.9 pt -130.21 -172.11 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-N 116.444 -0.344 . . . . 64.040000000000006 111.504 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.421 HD21 ' HB2' ' A' ' 63' ' ' LYS . 34.6 p30 -84.96 175.39 9.1 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.217 0.532 . . . . 55.329999999999998 111.988 -178.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.2 p -72.51 -12.42 61.07 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.303 -0.408 . . . . 62.030000000000001 112.053 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -80.34 -16.32 54.83 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.633 0.254 . . . . 73.439999999999998 111.59 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.63 21.6 46.84 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 121.059 -0.591 . . . . 71.120000000000005 112.189 -174.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.505 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 62.1 mttp -118.67 159.64 23.27 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.112 0.482 . . . . 75.230000000000004 111.463 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 58.0 mt -67.23 130.03 32.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.242 -0.435 . . . . 71.239999999999995 110.525 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.6 p -64.78 -53.92 39.41 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.962 0.411 . . . . 63.140000000000001 111.589 -177.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.487 HD13 ' HB3' ' A' ' 70' ' ' ASP . 85.6 mt -63.48 150.73 43.09 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.253 0.549 . . . . 73.439999999999998 112.075 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.82 157.31 32.73 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.087 -0.506 . . . . 72.430000000000007 111.497 -176.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.96 -129.19 10.54 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.284 -0.484 . . . . 72.329999999999998 113.281 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.417 ' H ' ' HG3' ' A' ' 69' ' ' ARG . 9.0 mtm180 -54.61 -51.22 66.03 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 122.451 1.119 . . . . 74.430000000000007 110.515 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.571 ' HA ' ' HB3' ' A' ' 73' ' ' ARG . 3.6 m-20 -63.45 -18.47 63.79 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.121 -1.4 . . . . 75.129999999999995 112.293 -171.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.1 tt -65.55 -56.07 14.32 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 110.087 -0.338 . . . . 75.219999999999999 110.087 175.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -70.22 -26.3 63.8 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 122.315 -0.241 . . . . 65.340000000000003 111.013 178.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.571 ' HB3' ' HA ' ' A' ' 70' ' ' ASP . 29.4 ttm180 -57.2 -55.19 37.93 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.22 0.533 . . . . 74.400000000000006 110.751 171.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -64.56 -40.62 95.9 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.302 -0.408 . . . . 73.299999999999997 110.789 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.446 ' HG3' ' HB ' ' A' ' 85' ' ' VAL . 60.7 tttp -57.15 -56.94 15.34 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 111.931 0.345 . . . . 71.230000000000004 111.931 177.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -56.57 -34.36 67.05 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.505 0.193 . . . . 72.109999999999999 111.506 -177.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.5 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 75.6 mmtt -59.13 -47.42 85.35 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.165 0.507 . . . . 73.439999999999998 110.99 172.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.496 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 58.2 mt -68.85 -42.08 77.59 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.928 -0.578 . . . . 73.349999999999994 111.984 -178.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -55.1 -39.78 69.7 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.245 0.545 . . . . 70.319999999999993 110.86 176.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.65 -22.96 66.7 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.788 -0.642 . . . . 72.150000000000006 111.827 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 77' ' ' LYS . 4.9 mm-40 -94.33 -1.38 53.94 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 111.985 0.365 . . . . 73.5 111.985 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.07 19.83 51.84 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 120.851 -0.69 . . . . 74.099999999999994 113.37 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.496 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 65.4 mt -99.77 110.77 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 O-C-N 122.704 -0.291 . . . . 70.409999999999997 110.721 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -73.19 102.83 3.72 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.973 0.416 . . . . 75.140000000000001 111.815 -177.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.446 ' HB ' ' HG3' ' A' ' 75' ' ' LYS . 22.0 t -98.54 126.39 51.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 116.453 -0.34 . . . . 74.25 111.328 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.619 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 42.6 t -72.57 159.04 34.56 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 111.979 0.363 . . . . 65.140000000000001 111.979 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -38.98 -55.76 1.51 Allowed 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 114.748 1.388 . . . . 62.530000000000001 114.748 -171.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 pp -82.45 16.96 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 112.543 0.571 . . . . 53.420000000000002 112.543 -175.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.44 52.57 4.43 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 121.347 -0.454 . . . . 62.100000000000001 113.107 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.619 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 86.7 tttt -116.25 125.54 52.35 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 122.352 -0.499 . . . . 74.329999999999998 111.86 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.527 HD12 HD13 ' A' ' 58' ' ' ILE . 57.4 mt -113.95 138.46 43.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 116.274 -0.421 . . . . 74.030000000000001 111.342 -178.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.48 92.52 4.02 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.011 0.434 . . . . 53.32 111.071 176.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.609 HD21 HD11 ' A' ' 58' ' ' ILE . 82.0 mt -56.26 -48.95 75.55 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.384 -0.371 . . . . 65.200000000000003 111.732 -178.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -52.85 -22.05 4.97 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.877 0.695 . . . . 73.120000000000005 112.877 -176.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -102.67 -38.84 7.31 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.085 0.402 . . . . 64.140000000000001 112.085 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -101.68 3.83 40.11 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 111.968 0.359 . . . . 72.120000000000005 111.968 -172.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 57.4 tttp -59.51 141.59 54.47 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.042 0.448 . . . . 71.420000000000002 111.91 -175.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 16.2 t90 -60.75 119.47 8.22 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.258 0.551 . . . . 72.329999999999998 111.414 178.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -118.56 90.8 40.33 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 115.776 -0.647 . . . . 74.519999999999996 111.261 -178.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -81.95 -7.39 12.25 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.778 2.319 . . . . 61.310000000000002 113.341 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 38.5 mt -96.0 8.77 42.81 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.797 0.332 . . . . 72.219999999999999 111.678 -176.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 119.09 -0.481 . . . . 74.140000000000001 111.992 -176.725 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 120.879 0.371 . . . . 73.510000000000005 110.743 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -59.37 153.83 18.13 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.716 0.635 . . . . 73.439999999999998 112.716 -176.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -56.41 -38.33 71.39 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.296 -0.411 . . . . 72.010000000000005 111.499 175.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -49.03 -50.78 34.63 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.121 0.486 . . . . 73.230000000000004 110.787 173.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 61.9 mt -63.7 -48.27 77.77 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.759 -0.655 . . . . 71.519999999999996 111.176 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 63.1 t -57.33 -41.09 77.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 116.32 -0.4 . . . . 61.530000000000001 111.997 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.49 ' O ' HG23 ' A' ' 11' ' ' VAL . 27.9 mm-40 -73.75 -49.57 24.87 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.195 0.443 . . . . 74.319999999999993 112.195 -177.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.44 ' O ' HG13 ' A' ' 12' ' ' ILE . 31.4 pt -59.7 -40.2 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 O-C-N 122.055 -0.403 . . . . 53.299999999999997 111.259 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -58.23 -48.11 81.42 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.035 0.445 . . . . 64.150000000000006 110.448 171.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.37 -17.31 42.66 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.041 -0.527 . . . . 73.510000000000005 112.407 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 7' ' ' GLN . 49.9 t -92.41 -50.16 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-O 120.808 0.337 . . . . 71.310000000000002 111.3 175.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.501 HD12 HD21 ' A' ' 52' ' ' LEU . 79.8 mt -57.85 -37.82 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 112.849 0.685 . . . . 74.150000000000006 112.849 -175.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 -58.23 -21.3 47.48 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.402 0.519 . . . . 74.140000000000001 112.402 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -83.28 -6.24 59.4 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.509 0.559 . . . . 64.349999999999994 112.509 -178.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 45.3 mt -78.27 122.9 85.81 Favored Pre-proline 0 CA--C 1.544 0.72 0 O-C-N 122.419 -0.175 . . . . 64.200000000000003 110.655 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -79.88 178.76 6.9 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.801 2.334 . . . . 65.340000000000003 114.176 -175.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.53 ' HE3' ' HA ' ' A' ' 81' ' ' GLU . 49.3 tptt -67.18 122.88 18.79 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.627 -0.715 . . . . 61.200000000000003 111.502 -178.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.549 ' HA2' ' HB3' ' A' ' 81' ' ' GLU . . . 91.12 3.5 69.9 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 114.407 0.523 . . . . 71.430000000000007 114.407 175.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -117.81 146.86 43.55 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 117.575 0.688 . . . . 73.319999999999993 111.648 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.6 m -129.13 157.62 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.172 0.51 . . . . 73.439999999999998 111.747 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 89.3 p -132.43 171.11 14.18 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.236 -0.438 . . . . 74.230000000000004 110.793 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.9 p -103.52 152.03 22.17 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.808 0.337 . . . . 74.140000000000001 111.697 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -49.46 -41.47 40.44 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.442 0.534 . . . . 72.329999999999998 112.442 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.7 -40.99 95.57 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 121.239 -0.505 . . . . 72.340000000000003 113.252 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -66.91 -55.17 15.82 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.64 0.257 . . . . 73.140000000000001 111.073 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.6 mm -54.11 -49.99 57.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.208 0.528 . . . . 53.409999999999997 111.365 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.53 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -59.8 -43.77 94.29 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.062 -0.517 . . . . 55.130000000000003 111.737 179.082 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -62.35 -45.57 92.6 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.79 0.329 . . . . 75.310000000000002 111.182 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 65.4 mtt -63.15 -37.1 85.88 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.406 -0.361 . . . . 74.120000000000005 111.167 178.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.29 -29.38 67.24 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.935 0.397 . . . . 62.109999999999999 111.673 176.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.48 10.05 27.96 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 116.282 -0.417 . . . . 75.239999999999995 112.935 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.53 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 26.8 m-85 -127.27 63.5 58.23 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 122.451 0.3 . . . . 70.299999999999997 111.152 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.69 -35.7 87.99 Favored 'Trans proline' 0 N--CA 1.483 0.862 0 C-N-CA 122.829 2.353 . . . . 63.329999999999998 114.181 -172.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -82.35 -7.96 86.93 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 121.06 -0.59 . . . . 72.439999999999998 113.59 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.448 ' CD1' ' HB3' ' A' ' 32' ' ' TYR . 23.0 m-85 -86.2 16.14 4.61 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.529 0.566 . . . . 72.340000000000003 112.529 -178.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.09 -43.58 61.09 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.216 0.532 . . . . 74.519999999999996 111.618 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -57.55 -40.25 78.47 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.781 -0.645 . . . . 72.329999999999998 111.855 175.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -75.35 -28.23 59.5 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.651 -0.25 . . . . 72.319999999999993 111.673 -178.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 35' ' ' TYR . 46.5 t -61.18 -43.85 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 109.814 -0.439 . . . . 53.030000000000001 109.814 173.154 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.02 -41.94 96.69 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 115.992 -0.549 . . . . 53.030000000000001 112.631 174.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.4 mttp -57.46 -53.83 53.75 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.975 0.417 . . . . 74.150000000000006 111.303 173.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.33 -47.64 78.35 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.165 -0.47 . . . . 73.299999999999997 112.08 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.437 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 79.8 mt -68.1 -41.39 81.88 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.861 0.362 . . . . 74.0 111.496 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.7 -18.79 62.09 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.156 -0.545 . . . . 73.040000000000006 113.374 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -86.06 -4.49 59.18 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 122.606 -0.349 . . . . 72.310000000000002 111.649 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 96.2 mt -92.61 121.53 65.99 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-O 120.761 0.315 . . . . 73.099999999999994 111.653 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.89 160.86 36.83 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.326 2.017 . . . . 63.310000000000002 112.469 177.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -67.13 119.32 11.85 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.287 0.565 . . . . 64.230000000000004 110.962 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 110.89 -2.51 28.74 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 115.983 -0.553 . . . . 62.32 112.673 -173.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 31.0 t -61.85 167.82 3.49 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.165 0.507 . . . . 62.299999999999997 112.162 177.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -66.93 -29.51 69.4 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.737 0.643 . . . . 53.229999999999997 112.737 -177.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.555 HD12 ' HD2' ' A' ' 53' ' ' PRO . 25.7 tp -102.46 131.84 22.03 Favored Pre-proline 0 N--CA 1.472 0.639 0 N-CA-C 111.558 0.207 . . . . 51.340000000000003 111.558 -178.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.555 ' HD2' HD12 ' A' ' 52' ' ' LEU . 59.4 Cg_endo -73.62 95.1 0.86 Allowed 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 121.591 1.527 . . . . 71.209999999999994 111.813 171.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.437 ' HB2' ' HB3' ' A' ' 43' ' ' LEU . 55.2 p-90 -81.35 -24.51 37.03 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.225 0.536 . . . . 71.5 112.222 -176.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.451 ' CG ' ' HB3' ' A' ' 77' ' ' LYS . 29.3 p90 -65.24 -17.99 64.94 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.381 0.882 . . . . 65.430000000000007 113.381 -175.162 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -83.23 7.33 16.58 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.545 0.572 . . . . 74.150000000000006 112.545 -177.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.6 t -123.19 117.93 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 121.029 0.443 . . . . 62.32 111.131 176.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.495 HD11 HD21 ' A' ' 93' ' ' LEU . 42.3 pt -123.21 -170.35 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 121.112 0.482 . . . . 65.209999999999994 111.714 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.7 p30 -86.28 163.48 17.69 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.078 0.466 . . . . 61.399999999999999 111.585 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 88.1 p -79.6 9.43 5.0 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 120.983 0.42 . . . . 55.229999999999997 111.665 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -93.61 -8.74 40.28 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.161 -0.472 . . . . 73.5 111.13 178.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.5 40.59 27.29 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.311 -0.471 . . . . 21.510000000000002 112.821 -177.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.627 ' HG2' ' HG2' ' A' ' 90' ' ' LYS . 53.5 mtpt -137.45 166.78 23.02 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.101 0.477 . . . . 73.530000000000001 111.441 178.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 63.6 mt -67.15 109.88 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.505 -0.554 . . . . 73.409999999999997 109.505 170.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.4 t -57.7 -40.09 78.72 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.143 -0.48 . . . . 74.409999999999997 112.013 -175.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.595 HD13 ' HB3' ' A' ' 70' ' ' ASP . 84.9 mt -76.78 160.15 29.53 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.995 0.426 . . . . 75.140000000000001 111.399 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -130.82 157.51 42.66 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.051 0.453 . . . . 75.439999999999998 111.869 -176.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.48 -130.19 31.51 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.267 -0.492 . . . . 62.130000000000003 113.398 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.418 ' H ' ' HG3' ' A' ' 69' ' ' ARG . 10.2 mtm180 -48.69 -50.93 31.1 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.902 0.858 . . . . 74.439999999999998 110.947 178.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.595 ' HB3' HD13 ' A' ' 66' ' ' LEU . 21.5 m-20 -70.72 -18.85 62.79 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 114.627 -1.17 . . . . 72.340000000000003 112.035 -172.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.0 tt -66.7 -51.07 60.18 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.608 -0.516 . . . . 73.099999999999994 109.608 174.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -61.6 -36.36 80.49 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.08 -0.509 . . . . 61.439999999999998 111.528 175.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.2 mtt180 -56.1 -62.81 1.45 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.51 0.195 . . . . 61.399999999999999 111.473 174.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.413 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 52.5 tt0 -58.83 -36.47 74.6 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.714 0.293 . . . . 74.010000000000005 111.086 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.497 ' HG3' HG11 ' A' ' 85' ' ' VAL . 79.2 tttt -52.46 -65.95 0.47 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.991 0.424 . . . . 74.109999999999999 111.62 174.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -63.18 -30.87 71.93 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.084 -0.507 . . . . 75.230000000000004 112.224 -175.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.451 ' HB3' ' CG ' ' A' ' 55' ' ' PHE . 72.3 mmtt -61.02 -45.89 92.98 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.974 0.416 . . . . 54.409999999999997 110.626 174.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.474 HD22 HD12 ' A' ' 83' ' ' ILE . 83.6 mt -72.17 -28.09 63.0 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.397 -0.365 . . . . 73.150000000000006 111.633 177.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.495 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 49.7 mt-10 -66.88 -28.06 68.02 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.067 0.46 . . . . 74.109999999999999 110.325 172.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.6 -23.66 59.95 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.165 0.507 . . . . 40.549999999999997 110.858 172.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.549 ' HB3' ' HA2' ' A' ' 18' ' ' GLY . 39.7 mm-40 -81.77 -26.25 34.61 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.024 -0.535 . . . . 61.100000000000001 110.989 174.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.85 37.18 4.26 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 116.304 -0.407 . . . . 75.319999999999993 113.057 -178.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.474 HD12 HD22 ' A' ' 78' ' ' LEU . 58.6 mt -105.8 136.98 37.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 112.301 0.482 . . . . 75.129999999999995 112.301 -176.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -67.95 93.7 0.43 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.887 0.375 . . . . 72.120000000000005 111.582 172.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.497 HG11 ' HG3' ' A' ' 75' ' ' LYS . 60.2 t -86.94 107.11 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 110.116 -0.328 . . . . 74.420000000000002 110.116 174.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.574 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 23.8 t -64.83 147.74 52.65 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.637 -0.256 . . . . 71.430000000000007 111.352 -177.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.453 ' HG3' ' N ' ' A' ' 88' ' ' ILE . 12.3 pt-20 -36.31 -55.76 0.8 Allowed 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 115.424 1.638 . . . . 64.439999999999998 115.424 -167.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.453 ' N ' ' HG3' ' A' ' 87' ' ' GLU . 2.8 pp -87.35 10.12 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 112.866 0.691 . . . . 74.450000000000003 112.866 -173.104 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 97.74 47.98 2.03 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 121.363 -0.446 . . . . 74.019999999999996 113.999 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.627 ' HG2' ' HG2' ' A' ' 63' ' ' LYS . 90.8 mttt -114.77 146.36 41.07 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 122.305 -0.526 . . . . 74.510000000000005 111.515 176.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.444 HD12 HG21 ' A' ' 58' ' ' ILE . 58.3 mt -130.97 138.77 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 115.873 -0.603 . . . . 73.150000000000006 111.137 -177.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.56 93.55 8.83 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.621 -0.263 . . . . 73.340000000000003 111.679 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.495 HD21 HD11 ' A' ' 58' ' ' ILE . 62.2 mt -53.97 -57.18 11.97 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 111.79 0.292 . . . . 72.319999999999993 111.79 177.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 52.9 ttp180 -46.25 -30.65 2.1 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.727 0.639 . . . . 64.409999999999997 112.727 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -90.59 -25.63 20.08 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 112.242 0.46 . . . . 72.400000000000006 112.242 -176.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -127.11 13.08 7.21 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 113.129 0.788 . . . . 75.400000000000006 113.129 -176.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 93' ' ' LEU . 55.2 tttm -64.61 125.98 26.44 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.029 0.443 . . . . 65.120000000000005 111.777 -175.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 22.4 t90 -58.94 113.8 2.26 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.853 0.686 . . . . 71.239999999999995 112.853 -175.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -107.71 92.41 8.73 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 115.909 -0.587 . . . . 63.229999999999997 110.481 172.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -61.35 -34.0 88.0 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.585 2.19 . . . . 75.030000000000001 113.184 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 89.1 mt -125.88 -74.15 0.61 Allowed 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.54 0.209 . . . . 60.219999999999999 111.554 -177.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 . . . . . 0 C--O 1.256 1.401 0 CA-C-O 118.938 -0.553 . . . . 71.349999999999994 111.795 -179.551 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ttt . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.59 0.233 . . . . 61.020000000000003 110.851 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -64.15 141.29 58.82 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 112.742 0.645 . . . . 44.240000000000002 112.742 -175.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -52.72 -39.57 62.18 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.677 0.621 . . . . 74.5 112.677 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -57.74 -48.71 78.84 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.898 0.38 . . . . 64.129999999999995 110.754 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.28 -46.58 89.76 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.034 -0.53 . . . . 54.329999999999998 111.26 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 73.2 t -56.48 -52.31 54.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 116.286 -0.415 . . . . 72.329999999999998 111.62 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -63.98 -49.85 70.87 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.947 0.721 . . . . 53.310000000000002 112.947 -176.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 36.9 pt -60.73 -41.76 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 O-C-N 122.114 -0.366 . . . . 65.25 111.401 -178.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -66.03 -41.78 90.48 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.747 0.308 . . . . 74.519999999999996 110.998 177.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.04 -37.95 69.93 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.011 0.434 . . . . 61.439999999999998 111.586 177.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 95.9 t -66.85 -41.85 88.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-O 121.015 0.436 . . . . 73.129999999999995 110.982 177.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.557 ' HB ' HD11 ' A' ' 52' ' ' LEU . 73.7 mt -62.5 -37.32 78.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 116.117 -0.492 . . . . 75.120000000000005 111.801 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -57.16 -21.17 30.91 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 122.194 -0.316 . . . . 70.019999999999996 111.717 174.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -87.46 -4.13 59.01 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 112.447 0.536 . . . . 74.209999999999994 112.447 -177.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.547 HD11 HD11 ' A' ' 26' ' ' ILE . 60.0 mt -76.32 122.26 86.44 Favored Pre-proline 0 CA--C 1.542 0.658 0 O-C-N 122.349 -0.219 . . . . 64.319999999999993 110.776 177.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -68.21 169.51 16.61 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.582 2.188 . . . . 74.5 112.782 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -67.24 149.46 50.39 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.035 0.445 . . . . 73.439999999999998 112.015 -177.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.99 -32.78 1.73 Allowed Glycine 0 CA--C 1.529 0.966 0 C-N-CA 121.337 -0.459 . . . . 52.299999999999997 113.839 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -77.75 159.92 28.74 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.447 0.641 . . . . 71.5 112.562 -177.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.5 m -130.54 156.33 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 115.543 -0.753 . . . . 54.420000000000002 110.621 177.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 51.0 m -133.3 155.95 48.48 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.07 0.462 . . . . 73.040000000000006 111.558 176.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.5 p -94.17 155.05 17.26 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.982 0.42 . . . . 72.219999999999999 111.282 176.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -55.8 -33.91 64.84 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.307 -0.406 . . . . 75.239999999999995 111.823 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.99 -43.47 97.35 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.195 -0.526 . . . . 75.030000000000001 112.832 178.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -62.36 -54.68 36.83 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.913 0.387 . . . . 73.319999999999993 111.11 177.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.547 HD11 HD11 ' A' ' 15' ' ' ILE . 50.1 mm -54.79 -49.74 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 116.208 -0.451 . . . . 71.319999999999993 111.464 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.07 -43.53 82.2 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.454 -0.339 . . . . 45.299999999999997 111.596 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.03 -56.1 22.47 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 111.752 0.279 . . . . 71.409999999999997 111.752 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -61.53 -25.63 67.41 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.148 0.425 . . . . 65.109999999999999 112.148 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.3 -21.22 53.87 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.042 0.386 . . . . 74.430000000000007 112.042 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.09 21.29 20.98 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.251 -0.499 . . . . 63.030000000000001 113.157 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -134.43 54.04 10.95 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 122.529 0.331 . . . . 73.540000000000006 111.74 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -62.25 132.45 38.86 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 121.983 1.789 . . . . 52.549999999999997 112.237 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.65 -28.38 15.74 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.146 -0.55 . . . . 43.420000000000002 113.008 -176.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -82.77 27.57 0.53 Allowed 'General case' 0 CA--C 1.542 0.662 0 O-C-N 122.452 -0.44 . . . . 72.299999999999997 111.989 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.09 -39.96 76.04 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.399 0.518 . . . . 74.349999999999994 112.399 -177.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -60.4 -32.02 70.93 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.946 0.403 . . . . 64.420000000000002 111.1 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -74.57 -41.05 61.21 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.309 -0.405 . . . . 70.329999999999998 110.791 177.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.2 t -56.2 -42.2 72.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.074 0.464 . . . . 63.32 110.641 175.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.26 -45.34 96.27 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-N 116.064 -0.516 . . . . 52.009999999999998 112.731 175.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -64.47 -33.34 75.66 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.938 0.399 . . . . 64.430000000000007 111.392 177.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.32 -48.12 71.34 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.298 -0.41 . . . . 71.200000000000003 111.435 177.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.1 mt -67.34 -38.96 85.67 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.948 0.404 . . . . 75.349999999999994 111.319 177.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.62 -13.21 50.22 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 121.145 -0.55 . . . . 51.32 113.142 176.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -93.9 -8.0 41.49 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 120.987 0.422 . . . . 73.230000000000004 111.186 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 70.6 mt -82.22 144.78 51.03 Favored Pre-proline 0 N--CA 1.472 0.634 0 N-CA-C 112.665 0.617 . . . . 71.219999999999999 112.665 -177.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.05 144.24 37.55 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.479 2.12 . . . . 63.130000000000003 111.733 172.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.548 ' HB3' ' HE ' ' A' ' 73' ' ' ARG . 16.6 pt-20 -65.04 -26.37 68.23 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 122.102 -0.374 . . . . 55.229999999999997 111.997 -176.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -88.37 20.96 27.57 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 121.066 -0.588 . . . . 52.450000000000003 113.856 177.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.9 t -73.1 150.29 42.39 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 117.083 0.442 . . . . 63.329999999999998 112.173 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -64.56 -46.3 83.39 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.275 0.559 . . . . 72.340000000000003 110.77 175.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.557 HD11 ' HB ' ' A' ' 12' ' ' ILE . 51.8 tp -58.22 117.16 17.91 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 115.602 -0.726 . . . . 61.43 111.382 175.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.49 ' HD2' HD12 ' A' ' 52' ' ' LEU . 58.9 Cg_endo -72.49 94.52 0.77 Allowed 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 121.465 1.443 . . . . 63.100000000000001 111.992 178.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 67.4 p-90 -82.79 -26.79 31.45 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.372 0.606 . . . . 73.439999999999998 110.964 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.523 ' HA ' ' HG3' ' A' ' 74' ' ' GLN . 29.1 p90 -62.27 -20.39 64.23 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.507 -0.769 . . . . 73.519999999999996 112.909 -176.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 79.9 mtt-85 -79.32 1.72 24.06 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.397 0.518 . . . . 70.120000000000005 112.397 -178.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 21' ' ' SER . 33.5 t -109.57 124.79 66.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 O-C-N 121.892 -0.505 . . . . 75.420000000000002 111.89 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.6 pt -132.91 177.04 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 116.414 -0.357 . . . . 71.420000000000002 111.564 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.454 HD21 ' HB2' ' A' ' 63' ' ' LYS . 36.7 p30 -80.61 177.78 8.78 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.773 0.657 . . . . 73.420000000000002 112.773 -174.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 76.0 p -67.3 -17.7 64.88 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.913 -0.585 . . . . 64.120000000000005 112.494 -177.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -83.58 -10.69 58.09 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.066 0.46 . . . . 72.319999999999993 111.13 177.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.67 49.42 14.32 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.88 -0.676 . . . . 73.400000000000006 111.665 -172.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.454 ' HB2' HD21 ' A' ' 59' ' ' ASN . 96.7 mttt -135.1 158.36 44.55 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.922 0.391 . . . . 63.240000000000002 111.015 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 67.9 mt -72.58 119.39 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.4 -0.364 . . . . 65.319999999999993 110.915 177.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.5 m -65.62 -44.2 87.25 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.804 0.335 . . . . 70.340000000000003 111.881 -178.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.436 ' HB3' ' HB3' ' A' ' 70' ' ' ASP . 84.7 mt -74.92 117.31 16.63 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.807 0.337 . . . . 71.230000000000004 110.896 178.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -108.78 169.87 8.39 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.847 0.356 . . . . 64.230000000000004 111.702 -177.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.02 -132.06 10.94 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 121.18 -0.533 . . . . 41.109999999999999 111.834 -173.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -81.59 -26.41 34.96 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 122.188 -0.595 . . . . 72.319999999999993 110.93 174.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.503 ' O ' ' HB3' ' A' ' 73' ' ' ARG . 17.6 m-20 -63.89 -17.33 63.09 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.994 0.426 . . . . 71.439999999999998 110.798 174.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.1 tt -65.11 -52.33 56.02 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.094 -0.503 . . . . 72.129999999999995 109.937 173.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.582 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 19.3 m-20 -63.59 -31.89 73.19 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.99 0.424 . . . . 64.040000000000006 111.359 176.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.548 ' HE ' ' HB3' ' A' ' 48' ' ' GLU . 70.8 ttt180 -51.1 -63.84 1.0 Allowed 'General case' 0 CA--C 1.547 0.832 0 CA-C-O 121.236 0.541 . . . . 74.030000000000001 110.897 173.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.523 ' HG3' ' HA ' ' A' ' 55' ' ' PHE . 48.1 tt0 -67.77 -43.64 79.35 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.093 0.473 . . . . 73.319999999999993 110.944 178.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.582 ' HB3' ' HA ' ' A' ' 72' ' ' ASP . 85.0 tttt -48.93 -60.94 2.34 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.702 -0.681 . . . . 73.200000000000003 112.149 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -65.02 -34.36 78.26 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.184 0.438 . . . . 63.399999999999999 112.184 -176.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -60.19 -29.67 68.86 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 120.605 -0.438 . . . . 74.310000000000002 111.373 172.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 80.5 mt -86.43 -34.37 20.15 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.227 -0.442 . . . . 73.430000000000007 111.548 175.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 35.7 mt-10 -66.08 -31.89 73.04 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 122.192 -0.317 . . . . 74.010000000000005 111.262 178.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.27 -25.86 62.28 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.222 0.534 . . . . 73.239999999999995 111.187 174.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.435 ' HB2' HG13 ' A' ' 83' ' ' ILE . 14.1 mm-40 -80.05 -26.15 39.84 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.347 0.594 . . . . 64.120000000000005 111.066 176.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 99.88 22.82 11.49 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 115.906 -0.588 . . . . 63.119999999999997 112.29 -172.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.435 HG13 ' HB2' ' A' ' 81' ' ' GLU . 73.1 mt -83.86 125.72 40.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.011 0.434 . . . . 65.319999999999993 111.169 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.408 ' HG2' ' CE2' ' A' ' 96' ' ' TYR . 11.6 pt-20 -72.24 99.07 2.3 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.583 0.706 . . . . 75.140000000000001 112.145 -177.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.429 HG11 ' HG3' ' A' ' 75' ' ' LYS . 44.7 t -100.14 111.15 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 115.994 -0.548 . . . . 74.120000000000005 110.879 178.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.587 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 40.3 t -67.12 158.22 31.71 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.278 -0.419 . . . . 61.140000000000001 111.629 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -43.69 -53.43 5.8 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 114.281 1.215 . . . . 71.239999999999995 114.281 -170.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.445 HD11 ' HB2' ' A' ' 90' ' ' LYS . 2.8 pp -79.47 12.96 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 112.524 0.565 . . . . 75.219999999999999 112.524 -176.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.51 48.97 5.09 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-N 116.365 -0.38 . . . . 64.209999999999994 112.986 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.587 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 61.3 tttm -116.19 123.46 47.84 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 120.992 0.425 . . . . 74.109999999999999 111.941 -178.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 64.6 mt -116.27 142.92 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 122.769 0.428 . . . . 63.200000000000003 111.33 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.25 101.84 5.6 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 111.896 0.332 . . . . 44.299999999999997 111.896 178.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.4 ' O ' ' N ' ' A' ' 97' ' ' LYS . 57.5 mt -54.54 -62.54 1.59 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.15 0.426 . . . . 54.140000000000001 112.15 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 45.3 mtm180 -49.88 -29.9 9.03 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.311 0.485 . . . . 71.329999999999998 112.311 -176.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -79.94 -35.27 38.01 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.083 -0.508 . . . . 73.420000000000002 111.581 -176.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.408 ' CE2' ' HG2' ' A' ' 84' ' ' GLU . 98.8 m-85 -115.71 5.98 14.35 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.292 0.479 . . . . 74.409999999999997 112.292 -177.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.4 ' N ' ' O ' ' A' ' 93' ' ' LEU . 55.5 tttm -59.32 133.82 56.44 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.074 0.464 . . . . 65.530000000000001 111.971 -174.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 13.6 t90 -55.2 114.29 1.72 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.995 -0.548 . . . . 64.109999999999999 111.491 178.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -109.45 91.83 10.69 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 116.157 -0.474 . . . . 60.439999999999998 110.44 175.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -77.51 -9.4 17.35 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 122.221 1.947 . . . . 75.430000000000007 112.082 177.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 74.6 mt -89.96 99.06 12.14 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.868 -0.605 . . . . 65.200000000000003 110.832 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 C--O 1.256 1.424 0 CA-C-N 115.905 -0.588 . . . . 72.329999999999998 112.39 -179.378 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.9 tpt . . . . . 0 N--CA 1.486 1.371 0 N-CA-C 110.423 -0.214 . . . . 74.430000000000007 110.423 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.416 ' O ' HG23 ' A' ' 6' ' ' VAL . 3.9 m-20 -49.47 128.63 17.68 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.248 0.462 . . . . 73.430000000000007 112.248 -177.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.494 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 90.7 mm-40 -55.21 -37.47 67.16 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.346 0.498 . . . . 61.240000000000002 112.346 -177.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -55.86 -54.48 44.1 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.231 0.538 . . . . 72.219999999999999 110.603 176.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 68.9 mt -62.74 -44.72 95.46 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.556 -0.747 . . . . 54.130000000000003 111.201 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 2' ' ' ASP . 85.5 t -57.11 -52.27 58.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 112.078 0.399 . . . . 61.109999999999999 112.078 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 28.6 mm-40 -62.32 -51.08 69.09 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.156 0.428 . . . . 72.409999999999997 112.156 -175.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.54 HD12 HG13 ' A' ' 39' ' ' VAL . 31.4 pt -59.55 -45.69 93.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 111.633 0.235 . . . . 73.140000000000001 111.633 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 19.6 m-30 -63.98 -41.33 97.56 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.132 0.491 . . . . 62.25 110.886 177.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.47 -20.4 63.11 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.87 -0.605 . . . . 30.100000000000001 111.798 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 7' ' ' GLN . 99.2 t -85.71 -41.0 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 120.745 0.307 . . . . 65.430000000000007 111.05 173.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 8' ' ' ILE . 79.3 mt -55.28 -41.23 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 112.664 0.616 . . . . 72.319999999999993 112.664 -177.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -58.38 -12.52 3.9 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 113.424 0.898 . . . . 74.040000000000006 113.424 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -85.64 -7.46 58.81 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 112.079 0.4 . . . . 63.210000000000001 112.079 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 63.8 mt -75.71 119.77 78.62 Favored Pre-proline 0 CA--C 1.542 0.661 0 O-C-N 122.407 -0.183 . . . . 74.010000000000005 110.696 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -76.75 161.1 33.94 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.545 2.164 . . . . 51.43 113.269 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 45.3 tttp -63.88 107.84 1.32 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.253 -0.431 . . . . 64.329999999999998 111.235 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 128.87 -15.61 5.9 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.923 -0.656 . . . . 72.209999999999994 113.483 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -116.6 163.42 16.12 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.386 0.612 . . . . 61.299999999999997 112.254 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.4 m -135.82 162.75 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-N 115.444 -0.798 . . . . 74.430000000000007 110.895 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 89.0 p -137.36 171.02 15.11 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.747 0.308 . . . . 42.539999999999999 110.613 175.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 40.2 p -107.05 154.03 21.73 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.829 0.347 . . . . 71.439999999999998 111.541 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.433 ' HE1' HD12 ' A' ' 43' ' ' LEU . 54.2 m-85 -50.65 -41.25 55.15 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 116.223 -0.444 . . . . 71.209999999999994 112.074 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -57.66 -41.6 93.81 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 121.23 -0.51 . . . . 74.200000000000003 112.912 178.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 29' ' ' MET . 42.2 mt-10 -65.93 -52.63 48.2 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.655 0.264 . . . . 71.310000000000002 111.063 178.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 44.4 mm -56.54 -47.33 82.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 120.984 0.421 . . . . 73.349999999999994 111.571 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.84 -45.97 90.13 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.34 -0.391 . . . . 75.530000000000001 111.593 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -61.04 -41.61 96.9 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 111.768 0.284 . . . . 73.030000000000001 111.768 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.477 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 64.8 mtt -67.86 -34.76 77.31 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.634 0.254 . . . . 43.409999999999997 111.477 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.69 -27.28 50.72 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.877 0.37 . . . . 73.319999999999993 111.731 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.81 44.99 1.84 Allowed Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.442 -0.409 . . . . 41.009999999999998 113.644 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -137.41 83.09 26.89 Favored Pre-proline 0 CA--C 1.544 0.716 0 O-C-N 122.412 -0.464 . . . . 74.219999999999999 111.576 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.4 126.49 14.31 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 122.791 2.327 . . . . 72.540000000000006 113.024 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.19 -8.71 79.22 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 121.396 -0.431 . . . . 54.520000000000003 113.709 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -94.35 11.13 31.58 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.569 0.581 . . . . 70.439999999999998 112.569 -177.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.81 -47.7 70.6 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.208 0.527 . . . . 52.109999999999999 111.457 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.8 ptt180 -53.44 -38.02 63.13 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.678 -0.692 . . . . 75.030000000000001 112.119 174.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -69.49 -35.89 76.0 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.781 0.324 . . . . 65.040000000000006 111.203 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.54 HG13 HD12 ' A' ' 8' ' ' ILE . 55.5 t -57.42 -39.65 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 121.195 0.521 . . . . 72.400000000000006 110.378 174.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.31 -40.9 99.25 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 116.031 -0.531 . . . . 42.119999999999997 112.528 174.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -58.95 -38.0 78.04 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.031 0.443 . . . . 74.530000000000001 111.089 175.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.95 -55.34 19.74 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.87 -0.605 . . . . 71.129999999999995 111.838 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.433 HD12 ' HE1' ' A' ' 23' ' ' TYR . 68.0 mt -62.47 -32.27 73.12 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.67 0.271 . . . . 61.539999999999999 111.536 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.72 -21.54 58.34 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 121.192 -0.528 . . . . 75.030000000000001 113.542 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -84.4 -10.56 57.43 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.091 0.472 . . . . 62.539999999999999 110.977 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.452 HD11 HD23 ' A' ' 52' ' ' LEU . 97.5 mt -87.5 139.96 31.79 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 116.361 -0.381 . . . . 73.239999999999995 111.924 -178.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -88.08 173.31 4.95 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.701 2.267 . . . . 60.210000000000001 112.667 175.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.767 ' HB3' ' HD3' ' A' ' 73' ' ' ARG . 9.7 pt-20 -67.48 -12.86 61.31 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.785 0.326 . . . . 73.340000000000003 111.82 177.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -96.78 32.84 6.18 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 121.353 -0.451 . . . . 43.229999999999997 113.445 176.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.8 t -95.45 135.36 37.18 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 122.294 -0.533 . . . . 52.200000000000003 111.507 177.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -70.14 -28.57 65.46 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.923 0.392 . . . . 52.200000000000003 111.185 174.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.526 HD12 ' HD2' ' A' ' 53' ' ' PRO . 48.5 tp -72.78 117.65 61.31 Favored Pre-proline 0 C--O 1.237 0.423 0 CA-C-N 116.219 -0.446 . . . . 73.310000000000002 110.441 176.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.526 ' HD2' HD12 ' A' ' 52' ' ' LEU . 44.5 Cg_endo -67.1 95.32 0.36 Allowed 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 121.562 1.508 . . . . 75.209999999999994 112.496 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 -80.81 -31.54 35.6 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.406 0.622 . . . . 70.25 110.723 177.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.481 ' O ' HD21 ' A' ' 78' ' ' LEU . 20.8 p90 -63.25 -21.89 66.52 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.242 0.83 . . . . 72.25 113.242 -178.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -84.4 -1.25 55.25 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.6 0.593 . . . . 71.230000000000004 112.6 -177.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.8 t -118.11 106.97 20.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-O 121.342 0.592 . . . . 71.140000000000001 111.58 -178.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.567 HD11 HD21 ' A' ' 93' ' ' LEU . 28.6 pt -112.67 -169.64 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 121.263 0.554 . . . . 63.119999999999997 112.114 -177.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 28.2 p30 -95.23 170.3 9.48 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.545 0.572 . . . . 52.0 112.545 -175.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 31.1 t -63.62 -17.88 63.35 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 112.46 0.541 . . . . 72.200000000000003 112.46 -178.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -75.75 -14.62 60.33 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.058 0.456 . . . . 60.409999999999997 111.113 177.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.99 43.64 33.06 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.036 -0.602 . . . . 52.119999999999997 111.934 -174.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.409 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 89.7 mttt -133.85 162.45 31.98 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.164 0.507 . . . . 74.549999999999997 111.596 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.415 HG23 ' OE1' ' A' ' 74' ' ' GLN . 66.5 mt -70.13 119.03 15.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 115.759 -0.655 . . . . 72.319999999999993 110.178 172.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.0 m -67.16 -27.75 67.55 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.198 0.444 . . . . 72.109999999999999 112.198 -177.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.533 HD13 ' HB3' ' A' ' 70' ' ' ASP . 77.1 mt -77.33 165.93 23.81 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.144 0.497 . . . . 64.420000000000002 111.727 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -133.68 148.96 51.53 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.066 0.46 . . . . 72.319999999999993 112.084 -171.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.34 -123.82 30.36 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-N 116.081 -0.509 . . . . 73.540000000000006 113.553 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 48.0 mtp180 -64.72 -38.96 92.77 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.175 0.512 . . . . 63.229999999999997 110.924 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.533 ' HB3' HD13 ' A' ' 66' ' ' LEU . 4.3 m-20 -60.49 -30.19 69.55 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.949 -0.568 . . . . 72.319999999999993 111.233 176.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.1 tt -65.74 -59.09 4.26 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.351 -0.386 . . . . 73.219999999999999 110.784 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -69.13 -21.63 64.01 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 122.267 -0.271 . . . . 72.430000000000007 111.468 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.767 ' HD3' ' HB3' ' A' ' 48' ' ' GLU . 35.9 ttm180 -61.91 -52.27 64.75 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.069 0.461 . . . . 61.549999999999997 110.319 172.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.415 ' OE1' HG23 ' A' ' 64' ' ' ILE . 53.5 tt0 -60.63 -39.45 88.28 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.1 -0.5 . . . . 72.140000000000001 110.714 178.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.464 ' HG3' ' HB ' ' A' ' 85' ' ' VAL . 85.5 tttt -57.73 -53.08 62.26 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.081 -0.509 . . . . 62.43 111.236 176.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -55.75 -39.59 71.38 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.948 0.404 . . . . 70.25 111.441 178.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.457 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 69.0 mmtt -58.59 -48.5 80.73 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.189 -0.46 . . . . 75.540000000000006 111.415 173.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.481 HD21 ' O ' ' A' ' 55' ' ' PHE . 85.6 mt -66.28 -39.87 89.69 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.247 -0.433 . . . . 72.049999999999997 111.934 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 46.2 mt-10 -64.15 -26.64 68.62 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.948 0.404 . . . . 73.340000000000003 110.909 177.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.57 -14.53 60.8 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.234 -0.439 . . . . 52.140000000000001 111.576 174.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 77' ' ' LYS . 22.5 mm-40 -103.6 10.06 37.11 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 111.855 0.317 . . . . 74.239999999999995 111.855 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.46 30.49 40.49 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 121.066 -0.588 . . . . 51.520000000000003 113.535 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.1 mt -112.04 138.67 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 O-C-N 122.449 -0.442 . . . . 74.129999999999995 111.383 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.476 ' HB2' ' OH ' ' A' ' 96' ' ' TYR . 40.1 mt-10 -100.47 114.33 27.83 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.826 0.346 . . . . 73.329999999999998 110.696 175.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.464 ' HB ' ' HG3' ' A' ' 75' ' ' LYS . 79.7 t -107.63 131.44 57.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 116.398 -0.365 . . . . 73.239999999999995 111.177 -178.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.562 ' OG ' ' HB3' ' A' ' 90' ' ' LYS . 25.6 p -74.32 148.0 41.76 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.88 0.372 . . . . 62.439999999999998 111.412 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.417 ' HG3' ' N ' ' A' ' 88' ' ' ILE . 12.4 pt-20 -42.59 -53.92 4.19 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.891 1.441 . . . . 74.299999999999997 114.891 -166.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.417 ' N ' ' HG3' ' A' ' 87' ' ' GLU . 2.8 pp -73.59 11.92 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 112.868 0.692 . . . . 75.129999999999995 112.868 -175.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.43 50.79 4.36 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 121.426 -0.416 . . . . 71.349999999999994 113.127 177.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.574 ' HD3' ' N ' ' A' ' 91' ' ' ILE . 6.6 tmtm? -122.88 138.58 54.62 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 122.446 -0.443 . . . . 64.510000000000005 110.488 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.574 ' N ' ' HD3' ' A' ' 90' ' ' LYS . 66.6 mt -121.2 132.34 70.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 120.883 0.373 . . . . 62.530000000000001 111.463 -178.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.86 93.51 2.66 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.899 0.38 . . . . 71.129999999999995 111.454 177.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.567 HD21 HD11 ' A' ' 58' ' ' ILE . 63.4 mt -51.99 -49.58 63.02 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.024 0.75 . . . . 71.120000000000005 113.024 -176.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -49.87 -44.52 49.82 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 121.256 0.55 . . . . 75.329999999999998 111.829 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -76.29 -34.25 59.08 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.718 -0.673 . . . . 63.310000000000002 112.367 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.476 ' OH ' ' HB2' ' A' ' 84' ' ' GLU . 78.8 m-85 -112.28 14.63 20.51 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.273 0.471 . . . . 73.010000000000005 112.273 -172.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 61.9 tttp -65.02 130.05 41.94 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.095 0.474 . . . . 44.450000000000003 111.943 -177.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 19.7 t90 -62.51 113.73 3.12 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.979 -0.555 . . . . 73.230000000000004 111.195 175.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -113.33 92.64 23.41 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 116.4 -0.364 . . . . 71.549999999999997 110.524 176.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.6 -22.83 74.4 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.731 2.288 . . . . 72.420000000000002 112.938 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 71.5 mt -79.71 94.73 5.79 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.449 -0.341 . . . . 65.120000000000005 110.436 176.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 C--O 1.255 1.359 0 CA-C-O 118.549 -0.738 . . . . 75.239999999999995 111.555 -179.684 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 120.81 0.338 . . . . 72.439999999999998 111.313 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -65.82 141.84 58.15 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.342 -0.39 . . . . 74.209999999999994 112.043 -176.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.435 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 62.3 mm-40 -53.61 -32.39 50.93 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.618 0.599 . . . . 42.340000000000003 112.618 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.405 ' O ' HG12 ' A' ' 8' ' ' ILE . 73.0 t80 -55.61 -48.9 74.15 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.247 0.546 . . . . 63.25 109.993 173.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 72.2 mt -67.07 -46.91 72.89 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.523 -0.762 . . . . 74.310000000000002 111.162 178.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 85.3 t -52.38 -50.24 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.8 0.334 . . . . 75.129999999999995 111.847 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.435 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 26.3 mm-40 -63.71 -52.7 59.35 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.157 0.428 . . . . 62.210000000000001 112.157 -177.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.419 ' O ' HG13 ' A' ' 12' ' ' ILE . 31.6 pt -65.32 -45.67 92.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 O-C-N 122.315 -0.241 . . . . 72.030000000000001 111.647 -178.168 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.405 ' CD1' HG13 ' A' ' 8' ' ' ILE . 14.2 m-30 -61.1 -43.28 99.13 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.755 0.312 . . . . 71.299999999999997 111.069 178.149 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.74 -43.08 65.49 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.439 -0.346 . . . . 75.0 111.383 177.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 7' ' ' GLN . 61.4 t -64.36 -42.4 95.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 121.142 0.496 . . . . 63.219999999999999 111.182 177.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.517 ' HB ' HD11 ' A' ' 52' ' ' LEU . 73.7 mt -62.85 -32.59 56.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 116.016 -0.538 . . . . 72.430000000000007 112.086 -178.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 72.3 m-70 -60.58 -22.25 63.51 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.299 0.481 . . . . 75.150000000000006 112.299 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -77.31 -14.07 59.81 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.256 0.465 . . . . 75.030000000000001 112.256 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.515 HD11 HD11 ' A' ' 26' ' ' ILE . 51.4 mt -75.08 113.76 28.3 Favored Pre-proline 0 CA--C 1.542 0.662 0 O-C-N 122.455 -0.153 . . . . 71.099999999999994 111.122 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -69.89 175.23 8.49 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.016 2.477 . . . . 72.219999999999999 113.751 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -67.81 140.13 56.61 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.92 -0.582 . . . . 64.129999999999995 111.768 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.76 17.25 71.04 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.188 -0.529 . . . . 70.230000000000004 113.378 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -118.3 141.18 48.79 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.688 0.28 . . . . 71.430000000000007 110.579 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.9 m -122.52 146.47 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.433 0.635 . . . . 63.329999999999998 112.284 -177.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.4 t -134.51 178.28 7.11 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.692 -0.685 . . . . 61.340000000000003 110.217 175.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 72.7 p -115.05 150.57 35.69 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.079 0.466 . . . . 70.25 111.835 -177.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.407 ' HE1' HD12 ' A' ' 43' ' ' LEU . 70.9 m-85 -51.8 -36.6 48.41 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.086 -0.506 . . . . 75.010000000000005 112.163 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.62 -51.0 60.47 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 121.014 -0.612 . . . . 71.010000000000005 113.039 178.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.415 ' O ' ' HE2' ' A' ' 29' ' ' MET . 47.1 mt-10 -55.65 -48.14 75.49 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.0 0.429 . . . . 73.109999999999999 111.135 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.515 HD11 HD11 ' A' ' 15' ' ' ILE . 49.9 mm -61.42 -54.17 38.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 116.115 -0.493 . . . . 65.450000000000003 111.746 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.56 -48.66 78.72 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.227 0.454 . . . . 44.450000000000003 112.227 -178.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -60.24 -43.1 96.38 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.677 0.275 . . . . 74.230000000000004 111.589 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.415 ' HE2' ' O ' ' A' ' 25' ' ' GLU . 77.7 mtm -73.35 -21.78 60.46 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 111.901 0.334 . . . . 75.219999999999999 111.901 178.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.58 -28.41 33.82 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.961 0.41 . . . . 73.030000000000001 111.186 174.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.94 29.09 5.06 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.298 -0.477 . . . . 74.340000000000003 113.468 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -134.43 79.93 53.13 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-O 120.893 0.378 . . . . 74.540000000000006 111.169 178.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.01 126.89 14.38 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.364 2.043 . . . . 74.319999999999993 112.614 -178.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.38 -22.85 36.47 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.175 -0.535 . . . . 73.140000000000001 113.274 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -78.61 12.19 2.17 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.36 0.504 . . . . 72.510000000000005 112.36 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.05 -44.37 61.09 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.021 0.438 . . . . 63.109999999999999 111.777 177.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 30.7 ptt-85 -58.37 -39.66 80.18 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 116.24 -0.436 . . . . 74.400000000000006 111.922 177.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -70.77 -34.53 71.91 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.662 0.268 . . . . 64.340000000000003 111.015 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.5 t -57.94 -43.39 84.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 CA-C-O 121.13 0.49 . . . . 72.109999999999999 110.267 172.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.47 -38.65 95.17 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-N 115.838 -0.619 . . . . 54.119999999999997 112.905 175.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -62.17 -47.27 85.25 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.982 0.42 . . . . 71.439999999999998 110.873 175.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.93 -45.65 89.88 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.017 -0.538 . . . . 65.049999999999997 111.668 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.588 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 58.2 mt -68.64 -38.49 80.53 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.908 0.385 . . . . 60.240000000000002 111.352 178.066 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.7 -15.76 66.97 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.268 -0.491 . . . . 70.209999999999994 113.081 176.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -76.6 -23.11 53.43 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.174 0.511 . . . . 74.349999999999994 110.52 175.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 82.6 mt -81.27 143.84 52.91 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 115.956 -0.566 . . . . 72.129999999999995 111.966 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -86.52 -176.7 2.11 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.708 2.272 . . . . 60.119999999999997 112.587 174.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.404 ' HG3' ' H ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -69.06 -23.58 64.06 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 122.131 -0.356 . . . . 74.040000000000006 111.937 178.662 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -90.02 39.39 3.11 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.534 -0.365 . . . . 74.230000000000004 113.43 177.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.0 t -93.03 140.08 29.85 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 122.437 -0.449 . . . . 64.430000000000007 111.404 177.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -72.42 -42.28 65.25 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.227 0.537 . . . . 75.230000000000004 110.29 175.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.517 HD11 ' HB ' ' A' ' 12' ' ' ILE . 33.3 tp -67.01 118.79 58.89 Favored Pre-proline 0 CA--C 1.535 0.404 0 CA-C-N 115.616 -0.72 . . . . 53.229999999999997 110.707 173.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.69 94.64 0.53 Allowed 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 121.392 1.394 . . . . 40.399999999999999 111.972 177.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.588 ' HB2' ' HB3' ' A' ' 43' ' ' LEU . 58.4 p-90 -84.96 -33.39 22.65 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.565 0.698 . . . . 74.310000000000002 111.0 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -59.91 -20.55 57.98 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.296 -0.865 . . . . 73.310000000000002 112.911 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.409 ' NH1' ' O ' ' A' ' 15' ' ' ILE . 95.8 mtt180 -79.98 -1.14 38.25 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.426 0.528 . . . . 74.230000000000004 112.426 -178.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.3 t -117.01 118.24 58.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 121.038 0.447 . . . . 74.530000000000001 111.744 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.558 HG21 HD12 ' A' ' 91' ' ' ILE . 35.6 pt -127.58 -169.87 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 116.347 -0.388 . . . . 74.540000000000006 111.521 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 32.1 p30 -84.44 163.64 19.35 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 120.94 0.4 . . . . 73.540000000000006 111.857 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 69.2 m -66.02 -15.44 63.03 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.573 0.583 . . . . 65.200000000000003 112.573 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -77.32 -12.59 59.97 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.741 0.305 . . . . 72.319999999999993 111.473 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.26 37.08 12.94 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 121.225 -0.512 . . . . 74.099999999999994 112.621 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -138.96 162.28 35.28 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.3 0.572 . . . . 70.120000000000005 111.91 -179.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.499 HG23 ' OE1' ' A' ' 74' ' ' GLN . 70.7 mt -69.28 139.71 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 115.725 -0.67 . . . . 63.329999999999998 110.886 175.097 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 89.1 p -90.18 -50.37 6.03 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.155 0.503 . . . . 73.420000000000002 111.345 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 83.9 mt -64.08 142.92 58.24 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.816 -0.629 . . . . 73.420000000000002 111.951 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -118.06 171.59 7.99 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.004 0.431 . . . . 71.310000000000002 111.234 177.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.78 -138.96 20.9 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.884 -0.674 . . . . 51.340000000000003 112.33 -176.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -74.97 -26.08 59.32 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.086 0.47 . . . . 73.150000000000006 111.474 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.65 -28.04 69.63 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.914 0.388 . . . . 74.129999999999995 111.284 176.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.1 tt -63.35 -60.97 2.68 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.273 -0.421 . . . . 63.420000000000002 110.625 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.405 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 3.9 p30 -64.15 -28.49 69.8 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 122.324 -0.235 . . . . 42.140000000000001 111.234 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -58.53 -53.74 54.88 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.902 0.382 . . . . 72.450000000000003 111.534 176.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.499 ' OE1' HG23 ' A' ' 64' ' ' ILE . 53.9 tt0 -59.38 -40.63 87.16 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.974 0.416 . . . . 75.310000000000002 110.884 177.066 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -60.13 -53.86 52.71 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.177 -0.465 . . . . 73.049999999999997 112.075 177.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' A' ' 72' ' ' ASP . 27.4 mm-40 -53.55 -42.46 67.52 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.15 0.5 . . . . 45.140000000000001 111.821 -178.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -59.61 -48.71 80.6 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.024 -0.534 . . . . 54.140000000000001 111.597 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.512 HD22 HD12 ' A' ' 83' ' ' ILE . 89.8 mt -67.69 -43.23 80.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.175 -0.466 . . . . 75.430000000000007 111.581 -177.015 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -57.03 -42.18 79.94 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.942 0.401 . . . . 64.329999999999998 110.861 175.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.34 -33.97 71.79 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.271 -0.422 . . . . 71.129999999999995 111.414 176.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -86.94 5.74 35.62 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.808 0.337 . . . . 74.209999999999994 111.678 178.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.01 30.89 16.06 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 114.238 0.455 . . . . 63.020000000000003 114.238 174.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.512 HD12 HD22 ' A' ' 78' ' ' LEU . 69.4 mt -104.43 124.77 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 117.129 0.464 . . . . 73.319999999999993 111.723 178.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.8 103.18 4.26 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.503 0.668 . . . . 71.099999999999994 111.601 177.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.2 t -95.78 117.13 39.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.309 -0.405 . . . . 75.420000000000002 111.099 178.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.587 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 41.4 t -67.87 151.15 47.61 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.938 0.399 . . . . 75.219999999999999 112.056 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -40.16 -56.55 1.89 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.322 1.231 . . . . 74.209999999999994 114.322 -171.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.431 ' H ' HG13 ' A' ' 88' ' ' ILE . 2.8 pp -80.15 22.92 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 N-CA-C 112.961 0.726 . . . . 61.030000000000001 112.961 -174.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.06 46.97 11.99 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.17 -0.538 . . . . 74.329999999999998 112.925 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.587 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 1.4 tmtp? -116.74 133.15 56.36 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.91 0.386 . . . . 73.530000000000001 110.765 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.558 HD12 HG21 ' A' ' 58' ' ' ILE . 60.2 mt -121.29 142.4 37.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 120.978 0.418 . . . . 63.350000000000001 111.356 -176.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.58 94.87 4.42 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.98 0.419 . . . . 42.240000000000002 112.039 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.614 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 39.3 mt -63.0 -13.31 33.64 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 116.077 -0.51 . . . . 65.120000000000005 112.334 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -90.27 -48.76 6.94 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.076 0.465 . . . . 75.409999999999997 111.59 175.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.99 -22.65 65.9 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.768 0.655 . . . . 64.409999999999997 112.768 -175.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -128.28 15.11 6.69 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.293 0.479 . . . . 53.310000000000002 112.293 -176.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.614 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 85.0 tttt -56.29 128.98 38.44 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.478 0.547 . . . . 73.319999999999993 112.478 -175.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 16.5 t90 -57.3 114.87 2.37 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.105 -0.498 . . . . 75.340000000000003 111.351 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -105.07 96.42 11.05 Favored Pre-proline 0 CA--C 1.543 0.694 0 CA-C-N 116.209 -0.45 . . . . 74.420000000000002 110.217 174.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -68.55 -0.91 6.56 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.16 2.574 . . . . 70.230000000000004 113.98 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 85.1 mt 63.39 74.04 0.43 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.34 0.59 . . . . 73.510000000000005 111.518 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 . . . . . 0 C--O 1.251 1.168 0 CA-C-O 118.001 -1.0 . . . . 74.010000000000005 111.494 179.944 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 tpt . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 120.727 0.299 . . . . 72.420000000000002 110.991 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.03 129.8 31.85 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.483 0.549 . . . . 60.350000000000001 112.483 -176.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -57.87 -28.12 63.87 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.814 0.34 . . . . 72.120000000000005 111.149 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -57.15 -50.67 72.09 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.0 0.429 . . . . 72.319999999999993 110.651 173.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 76.9 mt -64.57 -44.7 89.88 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.857 -0.61 . . . . 73.140000000000001 110.902 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.0 t -57.1 -49.48 79.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 116.113 -0.494 . . . . 64.030000000000001 111.648 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.433 ' O ' HG23 ' A' ' 11' ' ' VAL . 32.3 mm-40 -62.65 -52.7 62.31 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.527 0.566 . . . . 73.510000000000005 112.527 -178.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.504 HD12 HG13 ' A' ' 39' ' ' VAL . 25.3 pt -60.73 -44.2 96.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 111.757 0.28 . . . . 72.140000000000001 111.757 -177.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.9 m-30 -63.16 -43.61 97.8 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.175 0.512 . . . . 74.530000000000001 110.797 177.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.91 -30.38 61.51 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.007 -0.542 . . . . 62.119999999999997 111.959 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 7' ' ' GLN . 59.4 t -75.87 -41.77 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 121.017 0.437 . . . . 63.119999999999997 111.459 176.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 8' ' ' ILE . 71.2 mt -57.22 -34.93 46.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 112.214 0.45 . . . . 72.109999999999999 112.214 -177.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -59.2 -9.41 2.12 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 113.658 0.984 . . . . 74.340000000000003 113.658 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -92.9 -2.36 55.91 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 112.563 0.579 . . . . 64.109999999999999 112.563 178.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.409 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 50.1 mt -84.49 119.03 72.49 Favored Pre-proline 0 CA--C 1.543 0.71 0 O-C-N 122.331 -0.231 . . . . 53.229999999999997 111.188 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 15' ' ' ILE . 3.7 Cg_exo -77.94 171.1 17.8 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.392 2.728 . . . . 73.5 113.498 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -67.81 133.84 49.91 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.25 0.548 . . . . 72.219999999999999 111.885 -178.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.404 ' HA2' ' HB3' ' A' ' 81' ' ' GLU . . . 85.38 7.21 82.94 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 116.09 -0.505 . . . . 71.129999999999995 113.439 178.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -123.77 145.52 48.97 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.941 0.4 . . . . 72.010000000000005 111.119 178.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.415 HG12 ' HA ' ' A' ' 56' ' ' ARG . 34.2 m -133.2 154.99 40.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-O 120.979 0.419 . . . . 73.25 111.341 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 92.1 p -133.56 170.68 15.17 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.094 0.473 . . . . 75.109999999999999 111.036 177.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.2 p -98.72 152.31 19.81 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.102 0.477 . . . . 73.420000000000002 111.82 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.441 ' HE1' HD12 ' A' ' 43' ' ' LEU . 64.2 m-85 -55.06 -33.5 62.78 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.145 -0.48 . . . . 75.239999999999995 112.139 178.143 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -60.68 -38.18 94.7 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 120.988 -0.625 . . . . 73.109999999999999 112.772 177.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.421 ' O ' ' HG3' ' A' ' 29' ' ' MET . 42.2 mt-10 -71.2 -51.32 25.42 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.852 0.358 . . . . 71.010000000000005 111.309 178.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.2 mm -58.29 -49.83 80.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-N 116.338 -0.392 . . . . 70.239999999999995 111.827 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.58 -41.6 90.59 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.848 0.356 . . . . 72.340000000000003 111.596 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.6 ttmp? -60.01 -47.59 85.2 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.952 0.406 . . . . 74.409999999999997 111.03 178.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.421 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 62.0 mtt -67.22 -29.96 69.75 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.151 -0.477 . . . . 73.010000000000005 111.442 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.67 -20.49 53.63 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.131 0.419 . . . . 63.210000000000001 112.131 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.89 28.35 10.19 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.204 -0.522 . . . . 55.520000000000003 113.455 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -130.9 78.89 72.71 Favored Pre-proline 0 N--CA 1.47 0.552 0 O-C-N 122.48 -0.424 . . . . 72.219999999999999 110.89 177.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -66.71 115.08 3.38 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.666 2.244 . . . . 72.530000000000001 113.073 -176.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.93 -15.58 40.26 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.029 -0.605 . . . . 52.200000000000003 113.624 178.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.429 ' O ' HG23 ' A' ' 39' ' ' VAL . 34.0 m-85 -81.35 18.09 1.21 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.649 0.611 . . . . 55.329999999999998 112.649 -178.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.86 -54.59 18.5 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.31 0.485 . . . . 61.299999999999997 112.31 -178.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.449 ' O ' ' HG3' ' A' ' 41' ' ' LYS . 33.1 ttm180 -57.74 -38.81 75.98 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.026 0.441 . . . . 75.120000000000005 111.614 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.609 ' HA ' ' HE3' ' A' ' 41' ' ' LYS . 81.6 m-70 -68.39 -32.5 72.61 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.282 -0.417 . . . . 73.310000000000002 111.704 -177.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.504 HG13 HD12 ' A' ' 8' ' ' ILE . 56.9 t -60.57 -40.91 85.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 121.156 0.503 . . . . 41.210000000000001 109.886 171.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.82 -44.94 95.45 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 115.947 -0.569 . . . . 55.299999999999997 112.804 176.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.609 ' HE3' ' HA ' ' A' ' 38' ' ' HIS . 8.5 mtmp? -63.04 -22.23 66.71 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.992 0.425 . . . . 71.140000000000001 111.3 178.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.33 -45.88 17.06 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.432 -0.349 . . . . 73.430000000000007 111.442 176.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.441 HD12 ' HE1' ' A' ' 23' ' ' TYR . 66.7 mt -65.51 -35.15 80.03 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 111.976 0.362 . . . . 74.329999999999998 111.976 -179.048 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.4 -20.81 38.62 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 121.248 -0.501 . . . . 75.439999999999998 113.834 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -81.83 -21.19 37.75 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.804 0.335 . . . . 72.310000000000002 111.832 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 78.7 mt -67.56 142.64 96.36 Favored Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 112.018 0.377 . . . . 64.319999999999993 112.018 -178.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.72 -175.73 2.83 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.681 2.254 . . . . 65.349999999999994 113.202 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -76.19 -38.45 56.55 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.989 -0.551 . . . . 65.310000000000002 110.635 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -95.72 57.69 1.58 Allowed Glycine 0 CA--C 1.528 0.852 0 CA-C-N 116.018 -0.537 . . . . 72.329999999999998 113.729 -178.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.2 t -102.37 159.29 15.55 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 122.32 -0.518 . . . . 63.219999999999999 111.303 173.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -85.85 -15.58 41.42 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.221 0.534 . . . . 71.239999999999995 110.527 176.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.463 HD12 ' HD2' ' A' ' 53' ' ' PRO . 55.9 tp -93.35 116.3 66.28 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 115.908 -0.587 . . . . 73.109999999999999 110.829 178.129 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.463 ' HD2' HD12 ' A' ' 52' ' ' LEU . 61.6 Cg_endo -74.04 94.4 0.89 Allowed 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 121.251 1.301 . . . . 63.109999999999999 112.299 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.409 ' HB2' ' HB3' ' A' ' 43' ' ' LEU . 54.9 p-90 -80.11 -30.33 39.11 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.372 0.606 . . . . 71.530000000000001 111.318 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -59.93 -22.63 62.68 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.617 -0.72 . . . . 74.340000000000003 112.876 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.415 ' HA ' HG12 ' A' ' 20' ' ' VAL . 97.8 mtt180 -79.61 -0.94 35.8 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.584 0.587 . . . . 73.430000000000007 112.584 -177.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.9 t -118.63 109.59 27.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.062 0.458 . . . . 65.319999999999993 110.892 178.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.528 HD11 HD21 ' A' ' 93' ' ' LEU . 32.9 pt -114.98 -172.48 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 116.221 -0.445 . . . . 72.0 111.983 -176.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.411 HD21 ' HB2' ' A' ' 63' ' ' LYS . 32.1 p30 -81.32 165.71 21.14 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.207 0.527 . . . . 71.519999999999996 112.08 -176.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 80.4 p -70.61 -2.73 15.23 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.809 0.67 . . . . 75.519999999999996 112.809 -175.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -94.16 -9.37 36.63 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.042 0.386 . . . . 74.450000000000003 112.042 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.3 44.33 13.71 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 120.667 -0.778 . . . . 62.450000000000003 112.393 -176.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.411 ' HB2' HD21 ' A' ' 59' ' ' ASN . 98.6 mttt -133.46 172.29 12.91 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 122.753 0.421 . . . . 73.040000000000006 110.588 179.01 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.556 HD11 HG11 ' A' ' 85' ' ' VAL . 66.7 mt -67.7 118.73 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 109.938 -0.393 . . . . 63.539999999999999 109.938 173.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.6 p -71.07 -33.58 70.37 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.414 0.524 . . . . 73.129999999999995 112.414 -172.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.572 HD13 ' HB3' ' A' ' 70' ' ' ASP . 85.7 mt -79.85 -174.61 4.48 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.119 0.485 . . . . 75.129999999999995 111.755 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -147.25 161.7 40.42 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.884 0.373 . . . . 64.129999999999995 111.758 -176.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 60.45 -134.94 49.98 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.173 -0.537 . . . . 73.439999999999998 112.969 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 49.9 mtp180 -62.51 -33.5 75.0 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.112 0.482 . . . . 75.25 110.95 178.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.572 ' HB3' HD13 ' A' ' 66' ' ' LEU . 7.8 m-20 -62.38 -30.27 71.07 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.218 -0.446 . . . . 73.129999999999995 111.458 176.289 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.479 ' HG ' HG21 ' A' ' 64' ' ' ILE . 10.2 tt -59.66 -54.98 40.16 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.011 0.434 . . . . 43.32 110.662 177.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -71.58 -21.78 61.82 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 111.812 0.301 . . . . 50.329999999999998 111.812 177.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.514 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 15.0 ttp180 -66.55 -50.35 63.43 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.385 0.612 . . . . 74.400000000000006 110.408 174.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.416 ' HB2' HD12 ' A' ' 66' ' ' LEU . 63.9 tt0 -63.38 -42.18 98.82 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.896 -0.593 . . . . 73.409999999999997 110.597 175.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.422 ' HG3' HG11 ' A' ' 85' ' ' VAL . 33.0 ttpt -60.81 -50.15 74.63 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.023 -0.535 . . . . 61.030000000000001 111.941 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.514 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 19.9 pt20 -60.29 -38.0 82.25 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.964 0.411 . . . . 54.420000000000002 111.354 -177.1 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -63.93 -34.01 77.01 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 120.887 0.375 . . . . 74.549999999999997 111.129 174.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.43 HD22 HD12 ' A' ' 83' ' ' ILE . 96.9 mt -78.56 -30.05 46.63 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.282 -0.417 . . . . 73.099999999999994 111.98 178.321 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -68.82 -28.06 66.41 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 121.964 -0.46 . . . . 70.329999999999998 110.408 174.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.41 -23.79 65.59 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.262 0.553 . . . . 61.340000000000003 110.798 171.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.404 ' HB3' ' HA2' ' A' ' 18' ' ' GLY . 15.4 mm-40 -81.94 -9.04 59.7 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.818 -0.628 . . . . 70.209999999999994 111.319 175.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.61 21.87 55.07 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.39 -0.433 . . . . 72.099999999999994 112.891 -177.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.43 HD12 HD22 ' A' ' 78' ' ' LEU . 64.6 mt -89.63 127.79 42.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 121.023 0.439 . . . . 75.010000000000005 112.102 -177.196 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -78.5 97.2 5.64 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.054 0.454 . . . . 73.150000000000006 111.012 176.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.556 HG11 HD11 ' A' ' 64' ' ' ILE . 41.2 t -94.89 119.58 43.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.714 0.292 . . . . 73.049999999999997 110.811 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.55 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 49.7 m -61.14 141.31 57.55 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 110.388 -0.227 . . . . 62.240000000000002 110.388 177.032 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -54.36 -32.96 58.1 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 113.379 0.881 . . . . 73.409999999999997 113.379 -170.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.417 HD11 ' HB2' ' A' ' 90' ' ' LYS . 2.8 pp -75.22 -2.83 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 112.244 0.461 . . . . 71.040000000000006 112.244 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.28 43.46 2.77 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 116.212 -0.449 . . . . 60.439999999999998 113.966 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.55 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 61.3 tttm -115.35 131.14 57.02 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 117.62 0.71 . . . . 60.310000000000002 112.018 -178.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.49 HD12 HG21 ' A' ' 58' ' ' ILE . 56.6 mt -119.12 115.58 48.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.976 -0.556 . . . . 74.219999999999999 110.89 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.31 93.61 0.23 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.475 0.546 . . . . 64.200000000000003 112.475 -177.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.572 ' O ' ' HG3' ' A' ' 97' ' ' LYS . 76.1 mt -56.33 -46.31 79.97 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.609 -0.269 . . . . 74.129999999999995 111.255 177.263 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 63.8 mtp180 -51.05 -19.93 1.24 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.415 0.524 . . . . 71.150000000000006 112.415 -177.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -106.22 -36.7 6.8 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 111.922 0.341 . . . . 74.439999999999998 111.922 176.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -105.49 13.76 29.63 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.636 0.976 . . . . 72.420000000000002 113.636 -172.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.572 ' HG3' ' O ' ' A' ' 93' ' ' LEU . 41.8 mtpt -56.14 138.77 49.2 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.553 0.575 . . . . 70.340000000000003 112.553 178.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 14.9 t90 -69.14 115.02 7.94 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.007 -0.542 . . . . 74.329999999999998 110.692 173.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -102.74 96.05 7.11 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-N 116.075 -0.511 . . . . 74.230000000000004 111.166 176.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.588 ' HB2' ' HG2' ' A' ' 102' ' ' GLU . 62.9 Cg_endo -71.92 -9.52 24.83 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.628 2.219 . . . . 53.43 112.762 175.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 93.8 mt 60.79 24.42 14.33 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.604 0.594 . . . . 73.319999999999993 112.604 175.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.588 ' HG2' ' HB2' ' A' ' 100' ' ' PRO . 7.6 pt-20 . . . . . 0 C--O 1.255 1.346 0 CA-C-O 119.192 -0.432 . . . . 75.109999999999999 111.972 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 tpt . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 120.68 0.276 . . . . 54.149999999999999 110.673 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.483 ' O ' HG23 ' A' ' 6' ' ' VAL . 12.2 t70 -60.37 133.56 56.21 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 112.09 0.404 . . . . 72.319999999999993 112.09 -176.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -56.81 -40.12 75.42 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.632 0.604 . . . . 63.509999999999998 112.632 -178.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -58.1 -47.79 82.15 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.18 0.514 . . . . 72.200000000000003 110.477 177.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 85.9 mt -61.07 -47.14 87.71 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.724 -0.671 . . . . 50.020000000000003 110.801 177.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 2' ' ' ASP . 94.1 t -53.91 -50.13 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.173 -0.467 . . . . 74.239999999999995 111.648 178.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.453 ' O ' HG23 ' A' ' 11' ' ' VAL . 27.8 mm-40 -64.67 -50.21 67.92 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.375 0.509 . . . . 73.019999999999996 112.375 -176.015 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.459 ' O ' HG13 ' A' ' 12' ' ' ILE . 38.5 pt -64.93 -44.15 96.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 121.019 -0.272 . . . . 63.210000000000001 111.554 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.415 ' N ' HG13 ' A' ' 8' ' ' ILE . 21.8 m-30 -65.19 -42.51 93.52 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.813 0.339 . . . . 74.040000000000006 111.133 178.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.85 -40.1 69.29 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.454 -0.339 . . . . 63.340000000000003 111.67 178.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 7' ' ' GLN . 86.9 t -67.59 -41.63 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 120.917 0.389 . . . . 65.409999999999997 111.297 178.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.557 ' HB ' HD11 ' A' ' 52' ' ' LEU . 80.4 mt -59.17 -32.25 47.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 116.405 -0.361 . . . . 73.420000000000002 111.819 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.511 ' CE1' HD13 ' A' ' 52' ' ' LEU . 44.5 m80 -61.15 -18.51 58.46 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.131 0.419 . . . . 75.219999999999999 112.131 176.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -83.3 -9.17 59.25 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.531 0.567 . . . . 73.310000000000002 112.531 178.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.498 HD11 HD11 ' A' ' 26' ' ' ILE . 54.8 mt -74.46 116.27 51.46 Favored Pre-proline 0 CA--C 1.542 0.669 0 O-C-N 122.203 -0.311 . . . . 54.439999999999998 111.055 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -64.29 157.55 53.58 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.114 2.543 . . . . 65.219999999999999 113.514 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -65.54 120.77 13.5 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.21 -0.45 . . . . 74.299999999999997 111.495 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.34 17.07 56.27 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 120.988 -0.625 . . . . 73.099999999999994 113.22 -176.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -121.11 149.93 42.0 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 122.621 -0.341 . . . . 42.329999999999998 111.22 175.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.425 HG11 HD13 ' A' ' 91' ' ' ILE . 33.6 m -128.08 145.38 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 121.535 0.683 . . . . 73.209999999999994 111.795 -178.435 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 94.8 p -128.98 177.82 6.84 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.871 -0.604 . . . . 73.310000000000002 110.555 175.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.4 p -111.6 154.77 24.37 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.811 0.338 . . . . 62.009999999999998 111.376 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.432 ' HB2' ' HB1' ' A' ' 36' ' ' ALA . 74.8 m-85 -54.72 -40.12 68.92 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.852 0.358 . . . . 71.319999999999993 111.446 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -57.73 -44.7 94.02 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.268 -0.491 . . . . 72.099999999999994 113.043 177.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' A' ' 29' ' ' MET . 49.8 mt-10 -63.27 -54.0 44.05 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.731 0.3 . . . . 73.329999999999998 111.181 178.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.498 HD11 HD11 ' A' ' 15' ' ' ILE . 46.4 mm -54.3 -53.1 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 120.818 0.342 . . . . 72.5 111.72 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.99 -46.72 82.06 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.422 -0.354 . . . . 64.340000000000003 111.674 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -60.99 -42.95 99.41 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.781 0.324 . . . . 50.420000000000002 111.584 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.43 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 64.6 mtt -68.39 -30.67 69.64 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.043 0.449 . . . . 54.340000000000003 111.236 178.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.06 -19.65 59.9 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.197 -0.456 . . . . 71.400000000000006 111.914 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.24 15.18 24.21 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.137 -0.554 . . . . 61.340000000000003 113.014 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.434 ' HB3' ' CD1' ' A' ' 35' ' ' TYR . 69.5 m-85 -128.37 63.94 65.6 Favored Pre-proline 0 CA--C 1.548 0.873 0 O-C-N 122.55 -0.382 . . . . 70.030000000000001 111.54 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -61.72 110.94 1.05 Allowed 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.484 2.123 . . . . 60.299999999999997 112.568 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 123.64 -24.76 6.37 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 121.238 -0.506 . . . . 62.149999999999999 112.922 -177.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.461 ' O ' HG23 ' A' ' 39' ' ' VAL . 58.2 m-85 -79.96 30.54 0.26 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.242 0.46 . . . . 74.310000000000002 112.242 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.432 ' HB1' ' HB2' ' A' ' 23' ' ' TYR . . . -55.24 -64.88 0.7 Allowed 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.452 0.538 . . . . 74.109999999999999 112.452 -177.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -54.7 -31.69 58.41 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.361 0.504 . . . . 74.420000000000002 112.361 177.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -65.63 -40.27 92.37 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.749 0.309 . . . . 70.200000000000003 111.11 178.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 35' ' ' TYR . 67.9 t -57.14 -45.18 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.097 0.475 . . . . 62.439999999999998 110.243 173.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -57.8 -42.98 94.81 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 116.037 -0.529 . . . . 31.530000000000001 112.714 175.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -62.15 -33.02 73.71 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.071 0.462 . . . . 70.319999999999993 111.154 176.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.0 -42.78 66.03 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.202 -0.454 . . . . 61.140000000000001 111.449 177.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 39' ' ' VAL . 90.0 mt -62.38 -33.32 74.51 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.907 0.384 . . . . 74.439999999999998 111.483 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.62 -12.39 46.63 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 121.405 -0.426 . . . . 74.310000000000002 113.458 176.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -85.8 -15.81 40.82 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.135 0.493 . . . . 52.399999999999999 110.953 177.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.521 HD11 HD23 ' A' ' 52' ' ' LEU . 90.8 mt -81.68 148.12 60.9 Favored Pre-proline 0 N--CA 1.47 0.563 0 N-CA-C 112.42 0.526 . . . . 74.129999999999995 112.42 -177.083 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.52 163.2 32.33 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.39 2.06 . . . . 70.439999999999998 112.125 173.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.562 ' HG2' ' HE ' ' A' ' 73' ' ' ARG . 42.2 mt-10 -57.02 -52.88 63.5 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 111.984 0.364 . . . . 51.200000000000003 111.984 -178.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -93.62 54.61 2.34 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.039 -0.601 . . . . 73.340000000000003 113.294 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.7 t -79.6 156.39 27.7 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.866 0.365 . . . . 73.409999999999997 111.556 178.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -67.12 -26.54 66.74 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.389 0.614 . . . . 63.340000000000003 110.313 174.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.557 HD11 ' HB ' ' A' ' 12' ' ' ILE . 55.3 tp -92.78 117.75 67.68 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 115.5 -0.773 . . . . 74.129999999999995 110.802 176.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.547 ' HD2' HD12 ' A' ' 52' ' ' LEU . 56.8 Cg_endo -71.77 96.58 0.77 Allowed 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 121.639 1.56 . . . . 61.140000000000001 112.47 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 60.9 p-90 -80.52 -25.25 38.81 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.34 0.591 . . . . 65.530000000000001 112.153 -178.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -68.65 -12.71 61.71 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.625 0.972 . . . . 54.539999999999999 113.625 -174.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -87.06 1.55 52.56 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.6 0.593 . . . . 75.219999999999999 112.6 -175.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.8 t -109.75 108.83 26.35 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 CA-C-O 121.266 0.555 . . . . 41.420000000000002 111.659 -178.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.535 HD13 HD12 ' A' ' 91' ' ' ILE . 18.2 pt -113.6 -170.81 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-N 116.093 -0.503 . . . . 73.099999999999994 111.964 -178.065 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.7 p30 -90.19 175.41 7.15 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.022 0.439 . . . . 73.329999999999998 111.991 -177.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 87.6 p -64.26 -22.58 67.0 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.376 0.509 . . . . 74.140000000000001 112.376 -176.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -82.27 -12.76 57.84 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.851 0.357 . . . . 75.0 111.546 -179.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.64 30.6 20.91 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.163 -0.541 . . . . 54.350000000000001 112.804 -177.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.408 ' HE3' HD13 ' A' ' 88' ' ' ILE . 56.6 mtpt -125.6 163.28 23.09 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.11 0.481 . . . . 75.239999999999995 111.864 -177.2 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 52.7 mt -75.95 130.38 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 116.09 -0.504 . . . . 41.109999999999999 111.685 -177.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.3 m -80.26 -30.5 38.42 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.393 -0.367 . . . . 73.219999999999999 111.756 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.438 HD12 ' HB2' ' A' ' 74' ' ' GLN . 75.3 mt -72.1 151.99 42.66 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.123 0.487 . . . . 62.119999999999997 111.564 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -129.33 153.32 47.96 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.191 -0.458 . . . . 73.340000000000003 111.89 -174.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 62.27 -129.06 42.7 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 121.283 -0.484 . . . . 71.200000000000003 113.415 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -66.03 -30.14 70.62 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.816 0.341 . . . . 74.010000000000005 111.781 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.54 ' HA ' ' HD3' ' A' ' 73' ' ' ARG . 9.6 m-20 -68.92 -31.03 69.63 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.888 0.375 . . . . 74.209999999999994 111.237 177.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.7 tt -61.32 -42.01 97.97 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 109.524 -0.547 . . . . 44.350000000000001 109.524 173.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -59.3 -43.5 92.6 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.984 -0.553 . . . . 74.400000000000006 111.173 176.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.562 ' HE ' ' HG2' ' A' ' 48' ' ' GLU . 79.9 mtp180 -50.62 -56.14 13.15 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.332 0.587 . . . . 74.129999999999995 111.338 176.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.438 ' HB2' HD12 ' A' ' 66' ' ' LEU . 43.7 tt0 -65.87 -42.63 90.11 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.069 -0.514 . . . . 74.129999999999995 111.065 -177.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -61.61 -50.63 71.79 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.14 0.422 . . . . 73.439999999999998 112.14 -178.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.401 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 13.7 pt20 -58.46 -39.05 78.84 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.757 0.313 . . . . 73.019999999999996 111.294 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -62.92 -43.75 97.93 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 120.809 0.338 . . . . 75.030000000000001 111.36 176.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 75.8 mt -66.42 -48.78 68.94 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.291 -0.413 . . . . 74.519999999999996 111.683 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -54.55 -31.48 56.58 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.116 0.484 . . . . 54.149999999999999 111.327 176.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.46 -26.76 64.74 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.636 0.606 . . . . 63.409999999999997 112.636 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -102.44 9.03 39.92 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.417 0.525 . . . . 74.140000000000001 112.417 -176.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.92 41.98 7.37 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 120.938 -0.648 . . . . 61.32 113.644 176.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 68.2 mt -117.21 128.5 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 O-C-N 122.648 -0.325 . . . . 71.209999999999994 111.052 177.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -78.64 103.36 8.53 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.732 0.301 . . . . 71.040000000000006 111.424 177.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.9 t -90.62 105.21 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 120.826 0.346 . . . . 75.329999999999998 110.985 175.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.523 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 50.0 m -56.61 144.35 32.32 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.475 -0.33 . . . . 43.009999999999998 110.997 177.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.497 ' HG3' ' N ' ' A' ' 88' ' ' ILE . 12.3 pt-20 -43.2 -44.19 5.06 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 113.867 1.062 . . . . 61.450000000000003 113.867 -171.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.497 ' N ' ' HG3' ' A' ' 87' ' ' GLU . 2.6 pp -78.72 9.69 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 112.625 0.602 . . . . 73.299999999999997 112.625 -176.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.87 55.67 2.91 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 116.292 -0.413 . . . . 44.109999999999999 113.084 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.523 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 49.1 tttm -127.61 150.1 49.88 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.166 0.508 . . . . 65.310000000000002 112.256 177.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.535 HD12 HD13 ' A' ' 58' ' ' ILE . 50.2 mt -124.15 156.8 31.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-N 115.695 -0.684 . . . . 63.310000000000002 110.228 176.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.42 ' HB3' ' HB3' ' A' ' 95' ' ' LYS . . . -85.37 102.65 13.59 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.028 0.442 . . . . 74.239999999999995 111.796 178.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.656 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 40.2 mt -71.07 -8.32 52.55 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.241 0.83 . . . . 63.539999999999999 113.241 -177.075 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -97.58 -11.06 24.09 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.337 0.589 . . . . 72.230000000000004 111.015 174.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.42 ' HB3' ' HB3' ' A' ' 92' ' ' ALA . 27.8 tptp -106.31 -35.39 7.17 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.672 0.619 . . . . 70.030000000000001 112.672 -172.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -127.52 15.02 7.11 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.15 0.426 . . . . 74.150000000000006 112.15 -175.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.656 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 63.9 tttp -60.14 135.25 57.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.732 0.301 . . . . 63.539999999999999 111.727 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 17.7 t90 -65.6 96.86 0.28 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.024 0.44 . . . . 65.150000000000006 110.983 176.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -98.66 99.8 8.28 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 116.032 -0.531 . . . . 52.420000000000002 110.885 173.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.35 -4.47 11.87 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.685 2.256 . . . . 75.109999999999999 112.969 176.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 90.4 mt 63.12 21.27 12.77 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.054 0.542 . . . . 75.430000000000007 112.444 175.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 . . . . . 0 C--O 1.255 1.368 0 CA-C-O 118.399 -0.81 . . . . 43.109999999999999 111.736 178.476 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.9 tpt . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 120.616 0.246 . . . . 75.310000000000002 110.515 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -60.36 138.63 57.94 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.579 0.585 . . . . 75.019999999999996 112.579 -175.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.4 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 74.3 mm-40 -56.28 -27.83 56.63 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.472 -0.331 . . . . 73.319999999999993 111.569 176.055 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.431 ' O ' HG12 ' A' ' 8' ' ' ILE . 90.7 t80 -54.96 -52.22 63.72 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.211 0.529 . . . . 72.349999999999994 110.027 172.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 58.0 mt -65.56 -49.79 67.56 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.373 -0.831 . . . . 74.299999999999997 110.988 178.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 85.3 t -53.64 -50.99 47.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 116.119 -0.491 . . . . 73.540000000000006 111.979 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 31.4 mm-40 -62.37 -54.95 32.97 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.295 0.48 . . . . 72.099999999999994 112.295 -177.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.537 HD12 HG13 ' A' ' 39' ' ' VAL . 31.4 pt -61.43 -42.98 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 120.641 0.258 . . . . 35.340000000000003 111.693 -177.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.434 ' HA ' HD12 ' A' ' 12' ' ' ILE . 17.6 m-30 -62.58 -43.75 98.03 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.962 0.411 . . . . 53.219999999999999 111.265 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.85 -41.99 68.06 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.131 -0.486 . . . . 73.150000000000006 111.432 178.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 55.2 t -66.95 -36.51 77.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 121.047 0.451 . . . . 74.230000000000004 111.362 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 8' ' ' ILE . 83.3 mt -61.12 -36.01 69.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 116.306 -0.406 . . . . 74.420000000000002 112.054 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -60.06 -22.38 62.63 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 112.324 0.49 . . . . 73.329999999999998 112.324 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -78.73 -5.7 53.9 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 112.792 0.664 . . . . 71.120000000000005 112.792 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.431 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 58.9 mt -76.53 122.02 85.9 Favored Pre-proline 0 CA--C 1.545 0.783 0 O-C-N 122.243 -0.286 . . . . 74.25 111.324 178.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 15' ' ' ILE . 6.3 Cg_exo -75.28 151.28 38.11 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.861 2.374 . . . . 63.43 112.681 177.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -58.18 110.37 0.93 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.477 0.656 . . . . 74.409999999999997 111.721 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.501 ' H ' ' NH1' ' A' ' 56' ' ' ARG . . . 131.55 -30.17 3.32 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.568 -0.742 . . . . 52.329999999999998 112.387 178.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -93.81 159.83 15.02 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.438 0.637 . . . . 75.219999999999999 112.328 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.1 m -130.35 148.22 33.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 115.214 -0.903 . . . . 71.109999999999999 110.353 174.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 95.4 p -119.37 159.88 23.35 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.951 0.405 . . . . 72.439999999999998 110.996 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 72.0 p -102.79 148.92 25.01 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.731 0.3 . . . . 62.210000000000001 111.371 176.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.43 ' HB2' ' HB1' ' A' ' 36' ' ' ALA . 53.5 m-85 -50.76 -39.77 53.19 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 111.909 0.337 . . . . 65.140000000000001 111.909 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.75 -33.99 80.3 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 121.275 -0.488 . . . . 72.319999999999993 113.213 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.418 ' HG3' ' OG1' ' A' ' 22' ' ' THR . 47.1 mt-10 -74.12 -54.48 7.71 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.785 0.326 . . . . 42.340000000000003 111.258 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.7 mm -56.4 -53.46 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 116.215 -0.448 . . . . 74.010000000000005 111.386 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.412 ' HB2' HG21 ' A' ' 39' ' ' VAL . . . -57.64 -51.88 67.71 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.874 0.369 . . . . 72.140000000000001 111.717 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -57.6 -48.76 78.5 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.883 0.373 . . . . 74.340000000000003 111.337 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 74.5 mtm -74.01 -8.3 55.6 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.173 0.434 . . . . 65.329999999999998 112.173 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.86 -9.27 26.67 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.892 0.377 . . . . 75.549999999999997 111.079 172.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.05 37.47 5.16 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 116.038 -0.528 . . . . 75.030000000000001 113.693 178.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -138.58 90.57 12.79 Favored Pre-proline 0 CA--C 1.542 0.639 0 O-C-N 122.564 -0.374 . . . . 72.109999999999999 111.268 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.59 127.86 9.88 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.478 2.118 . . . . 74.019999999999996 113.3 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.84 8.38 87.73 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 121.099 -0.572 . . . . 74.109999999999999 114.195 178.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -101.3 22.61 12.21 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 117.382 0.591 . . . . 74.129999999999995 111.974 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.43 ' HB1' ' HB2' ' A' ' 23' ' ' TYR . . . -56.47 -52.0 66.35 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.103 0.477 . . . . 42.549999999999997 111.855 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -55.96 -32.76 64.16 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.096 -0.502 . . . . 74.140000000000001 111.748 177.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.404 ' HA ' ' HD2' ' A' ' 41' ' ' LYS . 98.6 m-70 -74.79 -32.26 61.96 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.687 0.28 . . . . 73.230000000000004 111.463 -178.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.537 HG13 HD12 ' A' ' 8' ' ' ILE . 58.4 t -61.21 -40.31 85.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 121.138 0.494 . . . . 73.209999999999994 110.292 172.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.61 -37.81 94.0 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 121.133 -0.556 . . . . 72.319999999999993 112.484 173.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.404 ' HD2' ' HA ' ' A' ' 38' ' ' HIS . 66.1 mttm -61.27 -40.02 92.56 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.878 0.37 . . . . 54.43 111.006 174.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.48 -50.92 69.5 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.066 -0.515 . . . . 62.240000000000002 111.579 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.5 mt -63.42 -36.97 85.48 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.901 0.382 . . . . 74.400000000000006 111.309 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.98 -6.58 45.99 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 121.353 -0.451 . . . . 71.019999999999996 113.681 178.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -100.21 -6.5 25.99 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 120.98 0.419 . . . . 73.510000000000005 111.038 177.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 91.5 mt -79.52 152.23 75.32 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 112.542 0.571 . . . . 63.439999999999998 112.542 -176.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.516 ' HD2' ' HB2' ' A' ' 50' ' ' SER . 22.2 Cg_exo -64.04 148.31 91.51 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.644 2.229 . . . . 73.510000000000005 112.464 173.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -62.98 -12.17 23.88 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-O 121.08 0.466 . . . . 74.340000000000003 111.757 -178.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -135.97 47.71 0.96 Allowed Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.312 -0.47 . . . . 41.350000000000001 113.233 175.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.516 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 43.0 t -74.83 165.84 24.59 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.991 0.424 . . . . 63.43 112.071 176.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -74.02 -19.37 60.66 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.237 -0.438 . . . . 73.109999999999999 111.532 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.549 HD12 ' HD2' ' A' ' 53' ' ' PRO . 30.1 tp -89.45 126.4 58.45 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.281 -0.418 . . . . 72.010000000000005 111.144 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.549 ' HD2' HD12 ' A' ' 52' ' ' LEU . 60.1 Cg_endo -73.42 95.69 0.87 Allowed 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 121.379 1.386 . . . . 72.049999999999997 111.908 174.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 66.1 p-90 -80.5 -31.68 37.15 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.282 0.563 . . . . 72.430000000000007 111.187 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -60.5 -18.68 53.37 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.419 0.896 . . . . 72.0 113.419 -176.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.501 ' NH1' ' H ' ' A' ' 18' ' ' GLY . 90.1 mtt-85 -86.75 11.64 12.64 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.955 0.724 . . . . 71.010000000000005 112.955 -177.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.2 t -125.93 109.72 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-O 121.407 0.622 . . . . 72.230000000000004 111.742 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.513 HD13 HD12 ' A' ' 91' ' ' ILE . 18.9 pt -114.16 -174.56 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 CA-C-N 115.827 -0.624 . . . . 72.310000000000002 111.328 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.408 HD21 ' HB2' ' A' ' 63' ' ' LYS . 34.2 p30 -87.22 171.38 10.69 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.647 -0.658 . . . . 73.439999999999998 111.871 -177.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 71.1 p -65.07 -14.8 61.36 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 112.68 0.622 . . . . 63.020000000000003 112.68 -174.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -75.0 -30.19 61.09 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.127 0.489 . . . . 64.030000000000001 111.297 175.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.49 11.97 34.35 Favored Glycine 0 CA--C 1.521 0.467 0 CA-C-N 115.691 -0.686 . . . . 72.400000000000006 111.676 -170.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.471 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 97.7 mttt -103.22 155.71 18.24 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.338 0.59 . . . . 71.409999999999997 112.19 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 63.6 mt -73.21 129.02 36.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 115.748 -0.66 . . . . 55.229999999999997 110.527 174.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.5 t -67.87 -38.7 83.42 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 120.83 0.348 . . . . 70.400000000000006 111.798 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.416 HD13 ' HB3' ' A' ' 70' ' ' ASP . 84.4 mt -74.25 143.37 45.11 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.856 0.36 . . . . 73.450000000000003 111.169 178.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -125.37 161.72 26.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.132 0.492 . . . . 74.230000000000004 111.336 -177.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 77.54 -138.95 22.41 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.111 -0.566 . . . . 73.439999999999998 112.518 -176.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 68.9 mtm180 -61.36 -38.23 86.23 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.26 0.552 . . . . 72.120000000000005 111.515 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.416 ' HB3' HD13 ' A' ' 66' ' ' LEU . 4.5 m-20 -61.73 -26.78 68.27 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 116.101 -0.5 . . . . 73.129999999999995 111.61 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.6 tt -65.7 -61.37 2.12 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.503 -0.317 . . . . 63.049999999999997 111.098 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.505 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 3.3 p30 -64.75 -24.5 67.58 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.785 0.326 . . . . 64.209999999999994 111.467 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -60.53 -52.45 65.13 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.974 0.416 . . . . 72.0 110.688 173.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -62.63 -38.93 92.15 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.25 0.547 . . . . 72.040000000000006 110.579 176.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.559 ' HG3' ' HB ' ' A' ' 85' ' ' VAL . 48.0 tttp -52.18 -56.38 14.99 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.601 -0.727 . . . . 73.310000000000002 111.729 174.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -61.88 -35.76 79.27 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 111.969 0.359 . . . . 73.019999999999996 111.969 -178.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -59.59 -45.33 92.22 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.02 0.438 . . . . 75.329999999999998 111.219 175.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.6 mt -71.79 -45.47 61.47 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.13 -0.486 . . . . 73.239999999999995 112.177 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -68.7 -26.31 65.22 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 122.17 -0.331 . . . . 71.140000000000001 111.786 -178.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.77 -23.71 67.33 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.313 0.577 . . . . 52.310000000000002 110.966 172.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -87.42 -10.84 50.88 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.782 -0.644 . . . . 71.340000000000003 111.462 176.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 108.27 19.29 9.02 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 121.341 -0.457 . . . . 54.009999999999998 114.022 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 57.1 mt -99.98 159.19 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 O-C-N 122.187 -0.596 . . . . 62.25 111.498 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -105.52 117.71 34.72 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 122.209 -0.307 . . . . 71.420000000000002 110.988 177.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.559 ' HB ' ' HG3' ' A' ' 75' ' ' LYS . 39.2 t -119.94 114.22 43.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.793 0.33 . . . . 55.049999999999997 111.391 178.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.0 m -62.84 141.9 58.46 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 122.386 -0.196 . . . . 53.009999999999998 110.627 176.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -47.06 -42.08 17.99 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.626 0.973 . . . . 64.409999999999997 113.626 -172.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.417 HG13 ' H ' ' A' ' 88' ' ' ILE . 2.7 pp -74.66 8.52 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 112.553 0.575 . . . . 75.400000000000006 112.553 -178.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.92 51.52 3.77 Favored Glycine 0 CA--C 1.524 0.594 0 CA-C-N 116.305 -0.407 . . . . 51.310000000000002 113.706 176.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -128.96 137.3 51.3 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.145 0.498 . . . . 52.030000000000001 111.641 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.513 HD12 HD13 ' A' ' 58' ' ' ILE . 52.0 mt -127.62 141.66 45.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 115.716 -0.675 . . . . 70.530000000000001 110.382 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.19 93.5 4.59 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 122.215 -0.303 . . . . 71.030000000000001 111.654 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.499 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 94.2 mt -55.42 -53.21 59.09 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.667 0.27 . . . . 73.450000000000003 111.56 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -51.37 -15.22 0.37 Allowed 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 113.264 0.838 . . . . 73.409999999999997 113.264 -177.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.518 ' HE3' ' CE2' ' A' ' 96' ' ' TYR . 38.1 ttpt -113.13 -26.64 8.35 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 121.562 -0.711 . . . . 74.430000000000007 112.511 177.125 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.518 ' CE2' ' HE3' ' A' ' 95' ' ' LYS . 85.4 m-85 -117.92 11.31 13.42 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.361 0.504 . . . . 70.219999999999999 112.361 -176.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 57.2 tttm -65.55 134.68 53.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.085 0.469 . . . . 72.439999999999998 111.733 -176.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 22.5 t90 -66.36 96.51 0.36 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.185 0.516 . . . . 71.030000000000001 111.517 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -105.73 93.68 7.73 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 115.804 -0.634 . . . . 71.409999999999997 110.608 173.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -69.78 7.52 0.98 Allowed 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 122.839 2.359 . . . . 73.549999999999997 113.45 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 73.5 mt -119.14 140.8 49.54 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 122.502 0.321 . . . . 74.540000000000006 111.02 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 C--O 1.251 1.166 0 CA-C-O 118.829 -0.605 . . . . 73.230000000000004 111.733 178.021 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptm . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.72 0.295 . . . . 61.020000000000003 110.742 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -64.88 149.17 50.03 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.412 -0.358 . . . . 63.219999999999999 111.93 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 52.8 tp60 -58.68 -31.45 68.21 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.887 0.375 . . . . 73.349999999999994 110.781 177.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -54.22 -50.27 67.54 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.256 -0.429 . . . . 75.299999999999997 110.688 171.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 76.7 mt -62.16 -46.54 88.51 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.747 -0.66 . . . . 74.349999999999994 111.24 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.9 t -56.7 -49.43 78.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.915 0.388 . . . . 75.439999999999998 111.66 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.435 ' O ' HG23 ' A' ' 11' ' ' VAL . 27.6 mm-40 -60.61 -55.99 26.68 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.349 0.5 . . . . 72.409999999999997 112.349 -178.172 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.511 ' O ' HG13 ' A' ' 12' ' ' ILE . 26.5 pt -59.37 -45.14 93.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 111.86 0.319 . . . . 70.209999999999994 111.86 -177.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -64.55 -41.93 96.02 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.983 0.421 . . . . 73.409999999999997 111.175 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.27 -37.56 69.98 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.247 -0.433 . . . . 71.239999999999995 111.317 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 7' ' ' GLN . 63.1 t -69.57 -36.98 73.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 121.095 0.474 . . . . 63.439999999999998 111.234 178.073 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 8' ' ' ILE . 75.1 mt -62.18 -34.25 62.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 116.122 -0.49 . . . . 72.129999999999995 112.168 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -60.82 -12.16 9.96 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 112.921 0.712 . . . . 70.420000000000002 112.921 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -87.52 -5.36 58.82 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 112.827 0.677 . . . . 63.340000000000003 112.827 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 56.2 mt -76.72 115.6 49.44 Favored Pre-proline 0 CA--C 1.546 0.802 0 O-C-N 122.101 -0.375 . . . . 63.399999999999999 111.448 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -67.82 159.34 53.25 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.909 2.406 . . . . 64.109999999999999 113.496 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -66.94 97.02 0.46 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.853 -0.612 . . . . 73.510000000000005 111.395 -176.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.476 ' H ' ' NH1' ' A' ' 56' ' ' ARG . . . 136.23 -22.19 3.42 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 121.222 -0.513 . . . . 70.549999999999997 113.045 176.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -98.42 164.73 12.16 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.144 0.497 . . . . 62.229999999999997 111.996 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.6 m -135.79 157.47 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.732 -0.667 . . . . 73.25 110.607 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 98.0 p -130.35 172.71 11.55 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.043 0.449 . . . . 75.400000000000006 110.965 178.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 46.4 p -108.26 152.39 24.68 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.91 0.386 . . . . 31.25 111.325 177.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.49 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 67.5 m-85 -55.32 -34.22 64.0 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.287 0.477 . . . . 75.109999999999999 112.287 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.3 -48.93 83.55 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.915 -0.66 . . . . 70.450000000000003 112.426 176.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -59.32 -52.45 65.6 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.849 0.357 . . . . 72.340000000000003 111.52 178.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.2 mm -59.61 -50.27 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 111.954 0.353 . . . . 64.530000000000001 111.954 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.449 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -58.67 -50.41 73.96 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.047 0.388 . . . . 74.129999999999995 112.047 -178.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -62.45 -44.05 97.34 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.647 0.26 . . . . 75.219999999999999 111.622 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 74.7 mtm -69.17 -24.14 64.03 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.591 0.234 . . . . 42.340000000000003 111.623 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.82 -20.98 44.82 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.026 0.441 . . . . 74.430000000000007 111.229 174.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.96 16.62 20.96 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 121.405 -0.426 . . . . 64.519999999999996 113.645 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.449 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 69.7 m-85 -126.93 89.33 52.33 Favored Pre-proline 0 CA--C 1.542 0.651 0 O-C-N 122.54 -0.388 . . . . 75.019999999999996 111.938 -177.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.24 141.85 40.25 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 122.437 2.091 . . . . 74.099999999999994 112.414 177.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.65 -37.17 2.46 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 121.003 -0.617 . . . . 73.019999999999996 113.637 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -63.8 -2.81 1.97 Allowed 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.744 0.646 . . . . 74.340000000000003 112.744 -178.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.49 ' HB1' ' HB3' ' A' ' 23' ' ' TYR . . . -48.02 -42.44 28.19 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.693 0.627 . . . . 34.25 112.693 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -59.05 -36.12 74.5 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.236 0.458 . . . . 72.150000000000006 112.236 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -72.65 -33.52 66.64 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.788 0.328 . . . . 74.409999999999997 110.755 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.489 HG13 HD12 ' A' ' 8' ' ' ILE . 60.6 t -58.02 -45.97 88.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 116.195 -0.457 . . . . 73.439999999999998 110.573 174.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.32 -45.4 96.2 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 121.15 -0.548 . . . . 64.430000000000007 113.0 176.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -64.79 -28.48 69.6 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.817 0.341 . . . . 64.209999999999994 111.261 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.65 -48.5 47.32 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.87 0.367 . . . . 71.219999999999999 111.077 174.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.561 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 44.6 mt -64.06 -40.0 95.31 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.864 0.364 . . . . 54.32 111.298 178.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.553 ' HA2' HD11 ' A' ' 66' ' ' LEU . . . -65.01 -13.85 58.06 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.155 -0.545 . . . . 55.140000000000001 112.924 176.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -86.79 -16.42 36.31 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 120.977 0.418 . . . . 72.540000000000006 110.962 177.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 95.7 mt -77.73 149.17 77.28 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 116.344 -0.389 . . . . 63.219999999999999 111.918 -178.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -77.2 165.93 27.16 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.537 2.158 . . . . 60.219999999999999 112.702 176.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.53 ' HB3' ' HD3' ' A' ' 73' ' ' ARG . 11.3 pt-20 -84.02 25.35 0.83 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.044 0.387 . . . . 64.450000000000003 112.044 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -141.87 19.59 2.54 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 121.195 -0.526 . . . . 50.229999999999997 113.482 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 56.4 p -81.11 155.75 26.11 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 117.085 0.442 . . . . 72.549999999999997 111.629 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -69.85 -21.35 63.36 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.325 0.583 . . . . 74.420000000000002 111.413 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.468 HD12 ' HD2' ' A' ' 53' ' ' PRO . 48.5 tp -87.42 116.3 65.65 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 115.882 -0.599 . . . . 74.310000000000002 111.388 178.072 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.468 ' HD2' HD12 ' A' ' 52' ' ' LEU . 64.2 Cg_endo -74.44 95.1 0.92 Allowed 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 121.419 1.413 . . . . 64.340000000000003 112.02 177.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.561 ' HB2' ' HB3' ' A' ' 43' ' ' LEU . 64.1 p-90 -83.78 -26.73 29.38 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.113 -0.494 . . . . 74.540000000000006 111.665 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -62.43 -12.98 24.9 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 113.102 0.779 . . . . 74.519999999999996 113.102 -178.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.486 HH22 ' HB3' ' A' ' 81' ' ' GLU . 80.4 mtt-85 -86.21 -13.23 47.53 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.846 0.684 . . . . 72.420000000000002 112.846 -178.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.7 t -102.74 99.81 9.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 120.97 0.414 . . . . 55.509999999999998 110.806 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.537 ' HA ' ' OG ' ' A' ' 65' ' ' SER . 44.8 pt -104.29 -170.23 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 121.303 0.573 . . . . 74.150000000000006 111.787 -178.148 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.1 p30 -89.38 158.96 17.56 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.199 0.523 . . . . 74.209999999999994 111.928 -177.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.7 p -66.01 -3.85 6.1 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.143 0.423 . . . . 60.32 112.143 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -86.55 -1.88 58.01 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 122.647 0.379 . . . . 63.43 111.896 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.78 31.88 67.17 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.147 -0.549 . . . . 42.310000000000002 112.69 -178.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -133.04 173.32 11.55 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.114 0.483 . . . . 74.010000000000005 111.324 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.611 HD11 HG11 ' A' ' 85' ' ' VAL . 38.1 mt -65.53 146.65 13.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 116.029 -0.532 . . . . 74.209999999999994 112.015 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.537 ' OG ' ' HA ' ' A' ' 58' ' ' ILE . 14.8 m -70.22 -47.86 59.58 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.002 -0.545 . . . . 75.209999999999994 111.91 -176.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.553 HD11 ' HA2' ' A' ' 44' ' ' GLY . 86.8 mt -103.54 158.2 16.53 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.084 -0.507 . . . . 54.350000000000001 111.794 -176.087 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.491 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 53.4 mtpt -120.24 163.66 17.44 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.02 0.438 . . . . 71.230000000000004 111.48 -178.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 77.53 -139.35 22.95 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 121.069 -0.586 . . . . 62.520000000000003 112.831 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -63.9 -34.95 79.11 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.206 0.526 . . . . 72.129999999999995 110.952 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -61.38 -27.77 68.76 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.764 -0.653 . . . . 72.030000000000001 111.195 177.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.491 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 10.1 tt -67.07 -48.31 68.64 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.103 -0.499 . . . . 72.140000000000001 110.663 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.58 ' HA ' ' HD3' ' A' ' 75' ' ' LYS . 11.9 m-20 -65.05 -34.22 77.9 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.68 0.276 . . . . 61.409999999999997 111.417 176.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.53 ' HD3' ' HB3' ' A' ' 48' ' ' GLU . 38.8 ttm180 -56.82 -50.71 71.55 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.108 0.48 . . . . 62.420000000000002 110.684 174.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.487 ' OE1' HG23 ' A' ' 64' ' ' ILE . 45.6 tt0 -66.84 -34.5 77.94 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.17 -0.468 . . . . 54.020000000000003 111.108 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.58 ' HD3' ' HA ' ' A' ' 72' ' ' ASP . 47.2 mtpt -55.7 -62.75 1.48 Allowed 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 120.963 0.411 . . . . 63.229999999999997 111.434 173.057 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -53.58 -37.57 63.08 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.795 -0.639 . . . . 74.329999999999998 112.053 -175.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -61.28 -53.51 55.83 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.027 0.442 . . . . 73.239999999999995 111.592 175.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.7 mt -65.26 -40.97 94.64 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.357 -0.383 . . . . 72.219999999999999 111.525 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -55.54 -44.63 76.93 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.152 0.501 . . . . 74.340000000000003 111.043 174.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.71 -31.86 71.13 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.008 -0.542 . . . . 70.430000000000007 111.278 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.486 ' HB3' HH22 ' A' ' 56' ' ' ARG . 14.1 mm-40 -87.65 9.85 20.02 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.562 0.578 . . . . 65.040000000000006 112.562 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.27 4.3 83.92 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.398 -0.43 . . . . 70.129999999999995 113.813 175.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 67.0 mt -87.39 132.79 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 O-C-N 122.6 -0.353 . . . . 71.099999999999994 111.171 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -87.99 101.01 13.35 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.918 0.39 . . . . 52.43 111.424 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.611 HG11 HD11 ' A' ' 64' ' ' ILE . 48.8 t -89.87 120.58 38.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 120.844 0.354 . . . . 74.140000000000001 110.731 176.005 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.589 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 36.5 m -68.18 146.2 53.62 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.595 -0.275 . . . . 74.450000000000003 111.1 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -41.22 -51.96 3.44 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 115.246 1.573 . . . . 53.229999999999997 115.246 -169.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 pp -75.01 -5.7 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 112.924 0.713 . . . . 73.519999999999996 112.924 -175.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 105.99 46.93 1.13 Allowed Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.29 -0.481 . . . . 73.319999999999993 113.171 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.589 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 48.5 tttm -116.81 139.65 50.35 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.829 0.347 . . . . 73.120000000000005 111.916 -178.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.464 HD12 HG21 ' A' ' 58' ' ' ILE . 65.8 mt -131.11 126.36 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 116.267 -0.424 . . . . 71.049999999999997 111.216 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.22 95.88 1.04 Allowed 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 111.958 0.355 . . . . 50.439999999999998 111.958 179.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.485 HD21 HD11 ' A' ' 58' ' ' ILE . 70.7 mt -56.24 -51.1 69.34 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 111.918 0.34 . . . . 73.230000000000004 111.918 179.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -61.71 -9.29 6.02 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.193 0.442 . . . . 63.020000000000003 112.193 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -107.92 -22.11 12.56 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 122.507 0.323 . . . . 73.040000000000006 111.608 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -127.92 13.67 6.82 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.241 0.46 . . . . 64.129999999999995 112.241 -177.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 65.1 tttp -62.99 131.41 48.55 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.535 0.568 . . . . 71.340000000000003 112.535 -175.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 20.4 t90 -72.64 109.82 6.55 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.101 -0.499 . . . . 71.329999999999998 111.024 174.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.445 ' HA ' ' HD2' ' A' ' 100' ' ' PRO . 20.8 mm-40 -108.72 93.7 12.69 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 115.982 -0.554 . . . . 64.120000000000005 110.735 176.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 99' ' ' GLN . 22.5 Cg_endo -60.59 -31.26 92.02 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.971 2.447 . . . . 71.430000000000007 112.857 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 99' ' ' GLN . 65.7 mt 61.39 25.73 15.64 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.202 0.445 . . . . 73.129999999999995 112.202 177.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 . . . . . 0 C--O 1.256 1.4 0 CA-C-O 118.704 -0.665 . . . . 74.299999999999997 111.283 178.631 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.4 tpt . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 120.823 0.344 . . . . 65.239999999999995 111.069 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -71.2 131.67 43.86 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.408 -0.36 . . . . 63.530000000000001 111.896 -177.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.422 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 15.1 mm100 -60.19 -27.6 67.29 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.595 0.236 . . . . 64.030000000000001 111.363 176.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -52.59 -49.13 65.62 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.237 0.541 . . . . 72.219999999999999 110.222 172.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 73.1 mt -66.61 -47.54 72.36 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.485 -0.78 . . . . 51.100000000000001 111.055 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.7 t -55.19 -44.92 76.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.324 -0.398 . . . . 71.450000000000003 111.589 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 31.8 mm-40 -66.58 -52.28 47.14 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.208 0.447 . . . . 75.239999999999995 112.208 -178.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.423 ' O ' HG13 ' A' ' 12' ' ' ILE . 31.8 pt -60.73 -41.62 89.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 O-C-N 122.146 -0.346 . . . . 54.340000000000003 111.47 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 17.6 m-30 -61.72 -46.56 89.12 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.068 0.461 . . . . 74.420000000000002 110.705 176.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.28 -39.55 64.01 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.109 -0.496 . . . . 72.230000000000004 111.448 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 7' ' ' GLN . 92.1 t -65.25 -43.2 95.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 120.776 0.322 . . . . 74.530000000000001 111.476 178.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.551 ' HB ' HD11 ' A' ' 52' ' ' LEU . 72.8 mt -56.84 -33.97 42.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 120.927 0.394 . . . . 74.310000000000002 111.763 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -59.4 -16.94 26.36 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 113.22 0.822 . . . . 74.230000000000004 113.22 178.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.437 ' HB3' ' HZ2' ' A' ' 98' ' ' TRP . 2.0 mp0 -80.97 -11.7 59.52 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.375 0.509 . . . . 71.530000000000001 112.375 177.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.495 HD11 HD11 ' A' ' 26' ' ' ILE . 51.0 mt -75.33 115.3 44.0 Favored Pre-proline 0 N--CA 1.472 0.626 0 O-C-N 122.311 -0.243 . . . . 74.430000000000007 111.086 178.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 15' ' ' ILE . 19.6 Cg_exo -66.95 169.29 15.17 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.778 2.319 . . . . 72.319999999999993 113.523 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -70.06 115.65 9.51 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.822 -0.626 . . . . 74.010000000000005 110.891 -178.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.32 19.25 21.55 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 120.97 -0.633 . . . . 71.340000000000003 113.643 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -127.11 152.45 47.29 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 117.169 0.485 . . . . 73.010000000000005 111.347 176.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.6 m -128.04 150.04 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 121.136 0.493 . . . . 73.519999999999996 111.731 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.7 t -138.75 175.0 9.93 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.362 -0.381 . . . . 51.450000000000003 111.091 175.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 67.6 p -104.88 150.78 24.57 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.907 0.384 . . . . 75.510000000000005 111.988 -177.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.42 ' HE1' HD12 ' A' ' 43' ' ' LEU . 68.9 m-85 -52.54 -36.68 56.12 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.27 -0.423 . . . . 63.210000000000001 111.659 178.167 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -60.96 -48.25 87.23 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 116.086 -0.506 . . . . 55.109999999999999 112.789 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -61.14 -51.95 66.93 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.848 0.356 . . . . 65.409999999999997 111.107 178.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.495 HD11 HD11 ' A' ' 15' ' ' ILE . 49.4 mm -53.14 -53.31 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 121.131 0.491 . . . . 72.109999999999999 111.622 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.62 -44.63 96.11 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.157 0.504 . . . . 62.229999999999997 111.322 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.4 ttpp -62.46 -33.99 75.93 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.168 -0.469 . . . . 73.329999999999998 111.531 -178.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 67.2 mtt -72.99 -41.33 64.43 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.984 0.421 . . . . 73.099999999999994 111.161 175.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.73 -24.81 67.05 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.236 -0.438 . . . . 51.340000000000003 112.171 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.42 24.55 6.14 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.286 -0.483 . . . . 51.310000000000002 113.254 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -135.65 66.07 62.64 Favored Pre-proline 0 CA--C 1.543 0.674 0 O-C-N 122.665 -0.315 . . . . 74.5 111.57 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -61.91 138.28 72.78 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.588 2.192 . . . . 64.040000000000006 112.757 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.33 -27.8 9.96 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.274 -0.488 . . . . 54.009999999999998 113.127 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -79.88 22.94 0.47 Allowed 'General case' 0 N--CA 1.473 0.715 0 O-C-N 122.214 -0.58 . . . . 64.349999999999994 112.542 -177.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.93 -37.86 69.52 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.414 0.524 . . . . 74.329999999999998 112.414 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -58.82 -38.22 78.17 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.825 0.345 . . . . 70.140000000000001 111.782 178.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -69.74 -35.02 74.63 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.537 -0.301 . . . . 73.439999999999998 111.124 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.418 HG13 HD12 ' A' ' 8' ' ' ILE . 46.6 t -59.67 -44.5 93.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.002 0.43 . . . . 52.520000000000003 110.655 175.242 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.68 -40.58 98.71 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 121.169 -0.539 . . . . 74.120000000000005 112.718 176.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -67.0 -27.89 67.8 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.982 0.42 . . . . 74.329999999999998 111.157 175.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.89 -53.61 12.64 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.308 -0.406 . . . . 70.540000000000006 111.625 177.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.42 HD12 ' HE1' ' A' ' 23' ' ' TYR . 61.1 mt -61.13 -39.46 90.1 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.501 -0.318 . . . . 73.530000000000001 111.558 -179.287 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.45 -15.91 57.73 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 120.88 -0.676 . . . . 54.509999999999998 113.507 178.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -103.41 10.78 37.17 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 122.622 -0.34 . . . . 64.349999999999994 111.804 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 57.9 mt -86.12 155.89 57.65 Favored Pre-proline 0 N--CA 1.47 0.568 0 CA-C-O 120.999 0.428 . . . . 75.230000000000004 112.031 177.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.436 ' HG2' ' HB2' ' A' ' 50' ' ' SER . 55.2 Cg_endo -70.29 153.16 66.75 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.266 1.977 . . . . 70.140000000000001 111.819 172.288 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -49.28 -70.8 0.08 Allowed 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 121.239 0.542 . . . . 64.340000000000003 111.372 -176.261 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -91.53 59.46 2.96 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 121.201 -0.523 . . . . 70.140000000000001 113.364 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.436 ' HB2' ' HG2' ' A' ' 47' ' ' PRO . 40.2 t -70.25 165.41 22.27 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.028 0.442 . . . . 63.409999999999997 111.621 176.119 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -67.09 -24.73 65.98 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.234 0.54 . . . . 63.039999999999999 110.545 174.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.551 HD11 ' HB ' ' A' ' 12' ' ' ILE . 28.0 tp -90.37 126.8 55.37 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 115.722 -0.672 . . . . 73.239999999999995 111.747 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.534 ' HD2' HD12 ' A' ' 52' ' ' LEU . 74.0 Cg_endo -76.24 94.99 1.02 Allowed 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 121.574 1.516 . . . . 71.230000000000004 111.553 170.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 60.4 p-90 -83.71 -26.98 29.31 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.352 0.596 . . . . 54.109999999999999 111.678 -177.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -62.66 -13.95 37.99 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.571 0.952 . . . . 73.099999999999994 113.571 -177.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -86.36 3.57 43.0 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 112.541 0.571 . . . . 74.219999999999999 112.541 -178.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.8 t -116.62 123.23 71.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 121.194 0.521 . . . . 73.420000000000002 111.795 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.549 HG21 HD12 ' A' ' 91' ' ' ILE . 21.1 pt -126.97 -172.65 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 116.068 -0.514 . . . . 52.340000000000003 111.269 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.6 p30 -90.29 172.64 8.63 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.899 -0.501 . . . . 73.099999999999994 112.126 -177.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 43.9 m -63.32 -16.57 60.8 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 112.587 0.588 . . . . 72.109999999999999 112.587 -176.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -88.38 -2.71 58.75 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.809 0.338 . . . . 73.109999999999999 111.662 -178.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.63 40.75 58.5 Favored Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.977 -0.63 . . . . 64.230000000000004 112.358 -175.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -130.76 155.11 47.2 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.101 0.477 . . . . 71.0 111.387 -177.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.552 HG23 ' OE1' ' A' ' 74' ' ' GLN . 65.5 mt -77.2 130.78 35.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 116.252 -0.431 . . . . 74.439999999999998 110.966 176.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.9 m -73.17 -41.17 64.18 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 112.101 0.408 . . . . 74.519999999999996 112.101 -179.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.541 HD13 ' HB3' ' A' ' 70' ' ' ASP . 93.8 mt -73.15 146.15 45.85 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.453 -0.34 . . . . 74.299999999999997 110.789 178.42 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -116.2 157.09 25.39 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.17 0.509 . . . . 73.349999999999994 112.121 -176.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.6 -124.14 30.57 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 115.858 -0.61 . . . . 74.510000000000005 114.007 177.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.5 mtp180 -61.27 -46.96 88.19 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.948 0.404 . . . . 74.319999999999993 111.972 -177.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.541 ' HB3' HD13 ' A' ' 66' ' ' LEU . 15.1 m-20 -63.08 -29.59 70.93 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.85 0.357 . . . . 61.539999999999999 111.174 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.8 tt -63.88 -53.44 50.49 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.312 -0.404 . . . . 75.040000000000006 110.463 175.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -62.27 -30.2 70.96 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.303 -0.408 . . . . 64.430000000000007 111.22 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.557 ' O ' ' HG2' ' A' ' 77' ' ' LYS . 43.5 ttm180 -58.94 -60.38 3.96 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.743 0.306 . . . . 74.200000000000003 110.946 174.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.552 ' OE1' HG23 ' A' ' 64' ' ' ILE . 43.3 tt0 -55.73 -43.3 76.45 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.086 0.47 . . . . 71.150000000000006 110.962 177.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.415 ' HG3' ' HB ' ' A' ' 85' ' ' VAL . 31.5 tttm -55.07 -56.54 18.7 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.728 -0.669 . . . . 70.239999999999995 111.837 176.103 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -59.14 -37.97 78.54 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.154 0.427 . . . . 61.450000000000003 112.154 -178.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.557 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 75.0 mmtt -58.8 -46.46 87.52 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.934 0.397 . . . . 74.439999999999998 110.942 176.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.504 HD22 HD12 ' A' ' 83' ' ' ILE . 95.8 mt -71.26 -35.33 71.35 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.198 -0.455 . . . . 70.25 111.628 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -54.6 -41.16 69.61 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.075 0.464 . . . . 60.520000000000003 110.741 173.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.61 -8.18 39.6 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.419 0.526 . . . . 71.400000000000006 112.419 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -107.64 4.45 25.86 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.969 0.414 . . . . 63.030000000000001 111.47 177.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.67 5.17 63.25 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.285 -0.483 . . . . 52.109999999999999 113.926 177.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.504 HD12 HD22 ' A' ' 78' ' ' LEU . 66.4 mt -82.64 133.13 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 O-C-N 122.242 -0.563 . . . . 75.430000000000007 111.435 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -92.36 97.64 10.99 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.891 0.377 . . . . 72.299999999999997 111.455 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.415 ' HB ' ' HG3' ' A' ' 75' ' ' LYS . 44.8 t -91.22 124.53 43.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 120.883 0.373 . . . . 75.349999999999994 111.49 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.56 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 42.7 t -67.63 144.56 55.47 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 111.635 0.235 . . . . 62.32 111.635 177.421 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -41.94 -48.25 4.47 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.081 1.141 . . . . 75.450000000000003 114.081 -173.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.403 ' H ' HG13 ' A' ' 88' ' ' ILE . 2.8 pp -80.74 16.11 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 112.87 0.693 . . . . 73.439999999999998 112.87 -175.446 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.82 51.59 4.73 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 121.414 -0.422 . . . . 64.150000000000006 113.51 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.56 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 60.4 tttm -125.72 132.17 52.41 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 122.532 -0.393 . . . . 71.209999999999994 111.256 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.549 HD12 HG21 ' A' ' 58' ' ' ILE . 61.0 mt -124.09 134.41 66.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 120.934 0.397 . . . . 62.100000000000001 111.475 -177.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.8 100.22 1.14 Allowed 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 111.947 0.351 . . . . 65.439999999999998 111.947 178.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 39.4 mt -59.06 -62.27 2.01 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.355 0.502 . . . . 73.329999999999998 112.355 -178.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -50.19 -34.46 22.78 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 112.314 0.487 . . . . 73.209999999999994 112.314 -175.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -73.71 -47.29 40.56 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 112.32 0.489 . . . . 53.530000000000001 112.32 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -102.41 14.1 32.85 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 120.973 0.416 . . . . 73.200000000000003 111.528 -177.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -55.02 114.09 1.61 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.905 -0.589 . . . . 72.329999999999998 111.894 -175.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.437 ' HZ2' ' HB3' ' A' ' 14' ' ' GLN . 21.4 t90 -56.45 121.28 9.25 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.101 0.778 . . . . 65.150000000000006 113.101 -177.195 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.447 ' O ' ' HG3' ' A' ' 99' ' ' GLN . 12.9 pt20 -127.16 109.98 21.55 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 115.662 -0.699 . . . . 73.140000000000001 109.924 167.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.0 -7.02 17.98 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.152 1.901 . . . . 63.299999999999997 112.27 174.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 64.2 mt -120.51 111.68 18.0 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.121 -0.491 . . . . 41.409999999999997 111.381 -175.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 . . . . . 0 C--O 1.251 1.169 0 CA-C-O 118.814 -0.612 . . . . 65.140000000000001 111.171 174.495 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.8 tpt . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.638 0.256 . . . . 74.519999999999996 110.968 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.47 ' O ' HG23 ' A' ' 6' ' ' VAL . 5.8 m-20 -57.25 130.25 45.37 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.088 0.403 . . . . 74.140000000000001 112.088 -179.399 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -57.66 -31.73 66.6 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.395 -0.366 . . . . 63.299999999999997 111.767 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.406 ' O ' HG12 ' A' ' 8' ' ' ILE . 53.2 t80 -54.83 -52.41 62.81 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.309 0.576 . . . . 72.140000000000001 110.49 172.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 72.5 mt -64.53 -45.32 87.7 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.629 -0.714 . . . . 70.120000000000005 111.17 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 2' ' ' ASP . 58.6 t -55.37 -51.49 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 120.931 0.396 . . . . 63.43 111.697 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.409 ' O ' HG23 ' A' ' 11' ' ' VAL . 28.3 mm-40 -65.27 -50.81 64.32 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 112.539 0.57 . . . . 65.109999999999999 112.539 -176.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.45 ' O ' HG13 ' A' ' 12' ' ' ILE . 32.6 pt -62.16 -45.55 98.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 O-C-N 122.192 -0.317 . . . . 62.329999999999998 111.58 -178.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.405 ' N ' HG13 ' A' ' 8' ' ' ILE . 19.5 m-30 -62.31 -43.37 98.98 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.081 0.467 . . . . 72.430000000000007 110.91 177.101 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.03 -48.15 67.83 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.927 -0.579 . . . . 61.32 111.413 178.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 7' ' ' GLN . 78.0 t -62.87 -41.84 94.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 120.795 0.331 . . . . 75.120000000000005 111.502 -179.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 8' ' ' ILE . 81.5 mt -57.4 -35.86 50.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 112.06 0.393 . . . . 71.340000000000003 112.06 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -56.72 -15.17 4.1 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.15 0.796 . . . . 71.5 113.15 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -86.79 -11.19 51.73 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.699 0.629 . . . . 72.109999999999999 112.699 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.494 HD11 HD11 ' A' ' 26' ' ' ILE . 52.1 mt -73.32 111.64 12.6 Favored Pre-proline 0 CA--C 1.543 0.679 0 O-C-N 122.245 -0.284 . . . . 71.129999999999995 110.677 178.021 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -81.57 178.05 6.99 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.635 2.223 . . . . 63.439999999999998 113.736 -175.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.4 tptt -58.56 140.92 53.49 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.842 -0.617 . . . . 75.349999999999994 111.482 -178.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.661 ' H ' ' NH2' ' A' ' 56' ' ' ARG . . . 82.45 -32.53 2.84 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 116.176 -0.465 . . . . 52.25 114.142 179.281 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -85.67 158.3 20.1 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.019 0.748 . . . . 73.040000000000006 113.019 -175.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.8 m -139.97 166.84 19.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 115.636 -0.711 . . . . 51.329999999999998 110.734 177.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.8 t -149.28 -178.66 6.52 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.448 -0.342 . . . . 72.430000000000007 110.314 176.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 72.3 p -112.53 158.7 19.61 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.391 0.515 . . . . 72.140000000000001 112.391 -177.211 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -54.34 -41.82 69.52 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.203 -0.453 . . . . 72.420000000000002 110.903 176.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.12 -47.5 89.46 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.911 -0.586 . . . . 75.409999999999997 113.094 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.432 ' O ' ' HE2' ' A' ' 29' ' ' MET . 34.5 mt-10 -55.9 -53.48 56.25 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.925 0.363 . . . . 71.400000000000006 111.389 177.006 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.494 HD11 HD11 ' A' ' 15' ' ' ILE . 49.3 mm -58.72 -49.62 82.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 120.834 0.35 . . . . 70.430000000000007 111.491 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.523 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -57.89 -49.04 78.09 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 120.995 0.426 . . . . 73.5 112.05 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.458 ' NZ ' ' HB3' ' A' ' 28' ' ' LYS . 9.4 mtpm? -62.71 -39.43 94.02 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.438 -0.346 . . . . 73.540000000000006 111.825 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.432 ' HE2' ' O ' ' A' ' 25' ' ' GLU . 72.5 mtm -79.48 -16.07 56.68 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.649 0.261 . . . . 72.129999999999995 111.657 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -85.85 -30.62 22.79 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.028 0.442 . . . . 74.109999999999999 111.363 174.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.41 12.23 10.96 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.286 -0.483 . . . . 42.039999999999999 113.448 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.523 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 71.1 m-85 -130.35 67.53 80.15 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 117.011 0.405 . . . . 73.439999999999998 111.062 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.48 -49.24 16.72 Favored 'Trans proline' 0 N--CA 1.482 0.819 0 C-N-CA 122.842 2.362 . . . . 65.120000000000005 114.096 -174.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -81.38 41.82 2.7 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.105 -0.569 . . . . 72.239999999999995 113.897 -177.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.41 ' O ' HG23 ' A' ' 39' ' ' VAL . 77.0 m-85 -141.26 21.42 2.24 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.668 0.618 . . . . 65.450000000000003 112.668 -178.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.35 -51.51 64.54 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.076 0.398 . . . . 63.229999999999997 112.076 -177.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -55.11 -36.89 66.2 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.873 0.368 . . . . 70.439999999999998 111.968 176.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -72.39 -37.45 68.72 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.553 -0.294 . . . . 72.129999999999995 111.367 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.457 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 99.7 t -56.85 -47.2 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 120.874 0.369 . . . . 64.230000000000004 110.7 175.236 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.26 -46.69 92.54 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.281 -0.485 . . . . 70.420000000000002 113.069 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.34 -36.63 82.81 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.984 0.421 . . . . 74.010000000000005 111.337 177.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.29 -40.39 95.86 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.978 0.418 . . . . 75.5 111.265 175.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.484 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 89.9 mt -69.75 -38.83 76.94 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.271 -0.422 . . . . 51.109999999999999 111.338 178.118 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.05 -13.55 48.97 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 121.285 -0.483 . . . . 72.430000000000007 113.337 178.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -90.59 -12.38 37.18 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 122.556 -0.379 . . . . 55.130000000000003 111.445 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 88.8 mt -66.43 133.58 94.4 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 112.116 0.413 . . . . 62.140000000000001 112.116 -178.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.95 161.33 39.08 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.661 2.241 . . . . 73.109999999999999 113.725 -177.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -61.96 -12.99 21.16 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.331 -0.85 . . . . 70.400000000000006 112.556 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -107.77 18.27 34.82 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 121.139 -0.553 . . . . 75.549999999999997 113.949 -179.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 41.6 t -79.79 152.96 29.48 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 117.413 0.606 . . . . 72.230000000000004 111.583 177.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -101.2 6.55 43.09 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.222 0.534 . . . . 55.329999999999998 110.938 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.517 HD12 ' HD2' ' A' ' 53' ' ' PRO . 56.4 tp -95.16 115.26 65.25 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 116.125 -0.488 . . . . 74.349999999999994 110.681 176.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.517 ' HD2' HD12 ' A' ' 52' ' ' LEU . 63.7 Cg_endo -73.66 95.0 0.86 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 121.39 1.394 . . . . 65.420000000000002 112.059 178.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.484 ' HB2' ' HB3' ' A' ' 43' ' ' LEU . 68.5 p-90 -89.07 -26.24 21.49 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.171 0.51 . . . . 75.450000000000003 111.426 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.442 ' O ' HD21 ' A' ' 78' ' ' LEU . 35.8 p90 -58.48 -21.79 52.78 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.007 -0.542 . . . . 65.239999999999995 112.299 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.661 ' NH2' ' H ' ' A' ' 18' ' ' GLY . 88.0 mtt-85 -81.31 5.78 16.23 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.086 0.402 . . . . 45.43 112.086 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 18.6 t -115.31 111.44 35.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-O 121.228 0.537 . . . . 64.349999999999994 111.195 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.586 HG21 HD12 ' A' ' 91' ' ' ILE . 20.2 pt -117.79 -169.06 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 122.835 0.454 . . . . 54.340000000000003 111.047 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -92.12 167.35 12.13 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.57 -0.706 . . . . 63.229999999999997 111.764 -178.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 80.8 p -59.13 -18.76 38.72 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 112.644 0.609 . . . . 42.130000000000003 112.644 -176.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -85.94 4.6 36.84 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.786 0.327 . . . . 74.230000000000004 111.702 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.03 38.21 88.31 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 121.122 -0.561 . . . . 20.239999999999998 112.426 -177.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.486 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 54.5 mtpt -131.55 156.9 44.94 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.511 0.672 . . . . 71.140000000000001 112.009 -176.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.551 HG23 ' OE1' ' A' ' 74' ' ' GLN . 68.4 mt -78.59 104.28 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 115.575 -0.739 . . . . 73.319999999999993 110.047 173.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.2 t -63.38 -25.37 68.26 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.398 -0.365 . . . . 50.32 111.845 -176.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.418 HD13 ' HB3' ' A' ' 70' ' ' ASP . 83.1 mt -74.99 145.17 42.72 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.354 -0.384 . . . . 72.219999999999999 110.873 177.072 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.45 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -133.86 171.41 14.21 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.16 0.505 . . . . 74.420000000000002 112.0 -175.128 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.5 -121.75 24.83 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.918 -0.658 . . . . 61.240000000000002 112.663 -177.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 69' ' ' ARG . 35.3 mtt180 -71.6 -33.88 69.38 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.019 0.438 . . . . 54.009999999999998 111.277 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 73' ' ' ARG . 25.4 m-20 -73.32 -18.19 61.22 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 111.959 0.355 . . . . 70.519999999999996 111.959 -178.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.45 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 6.8 tt -66.11 -55.03 18.49 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.949 -0.389 . . . . 75.099999999999994 109.949 177.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.559 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 19.8 m-20 -67.45 -26.16 66.25 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.766 0.317 . . . . 72.019999999999996 111.304 176.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.434 ' HB3' ' O ' ' A' ' 70' ' ' ASP . 76.0 ttt180 -53.31 -62.5 1.61 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.203 0.525 . . . . 73.510000000000005 110.493 173.06 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.551 ' OE1' HG23 ' A' ' 64' ' ' ILE . 48.6 tt0 -67.1 -46.71 73.4 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.202 -0.454 . . . . 62.130000000000003 111.356 177.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.559 ' HB3' ' HA ' ' A' ' 72' ' ' ASP . 47.1 tttm -51.97 -50.36 61.4 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.616 0.598 . . . . 70.5 112.616 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -71.0 -30.88 67.24 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 111.904 0.335 . . . . 74.120000000000005 111.904 -176.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -64.75 -35.08 79.91 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.07 0.462 . . . . 73.120000000000005 110.873 171.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.524 HD13 HD11 ' A' ' 91' ' ' ILE . 57.8 mt -70.15 -47.36 61.99 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.185 -0.461 . . . . 71.219999999999999 111.286 175.147 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -57.88 -31.22 66.51 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.193 -0.458 . . . . 52.210000000000001 111.389 176.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.55 -34.07 70.62 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.836 0.351 . . . . 74.340000000000003 111.32 173.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -88.09 -11.81 45.99 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 111.813 0.301 . . . . 63.420000000000002 111.813 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.77 54.76 3.15 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.285 -0.484 . . . . 71.519999999999996 113.029 -178.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.535 HD11 HH12 ' A' ' 56' ' ' ARG . 68.3 mt -116.2 137.06 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 122.605 0.362 . . . . 72.329999999999998 111.223 -179.155 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.461 ' HG3' ' OH ' ' A' ' 96' ' ' TYR . 66.9 mt-10 -66.71 92.98 0.23 Allowed 'General case' 0 N--CA 1.471 0.588 0 O-C-N 122.012 -0.43 . . . . 61.520000000000003 111.868 -179.324 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.42 HG11 ' HG3' ' A' ' 75' ' ' LYS . 42.9 t -89.99 102.79 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 120.815 0.341 . . . . 45.0 110.722 173.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.596 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 69.9 m -64.46 163.46 13.31 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.317 0.488 . . . . 53.310000000000002 112.317 -178.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -35.04 -58.09 0.54 Allowed 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 115.247 1.573 . . . . 54.32 115.247 -169.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.461 HD13 ' HE3' ' A' ' 63' ' ' LYS . 2.6 pp -92.82 23.06 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 112.505 0.557 . . . . 75.319999999999993 112.505 -174.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.71 47.8 7.03 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 121.266 -0.492 . . . . 74.219999999999999 112.604 -176.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.596 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 49.3 tttm -111.8 131.88 55.04 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 122.432 -0.452 . . . . 65.030000000000001 111.452 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.586 HD12 HG21 ' A' ' 58' ' ' ILE . 53.5 mt -116.46 135.87 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 120.921 0.391 . . . . 75.120000000000005 111.699 -176.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.99 93.92 1.42 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.948 0.404 . . . . 70.109999999999999 111.453 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.463 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 66.6 mt -54.24 -56.85 14.31 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.384 0.513 . . . . 74.140000000000001 112.384 -178.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -53.05 -28.21 23.54 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.522 0.564 . . . . 73.140000000000001 112.522 -177.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -84.52 -33.09 23.58 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.033 0.383 . . . . 64.239999999999995 112.033 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.461 ' OH ' ' HG3' ' A' ' 84' ' ' GLU . 80.3 m-85 -117.59 6.92 12.52 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.84 0.682 . . . . 73.420000000000002 112.84 -173.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 61.5 tttp -63.31 128.8 37.51 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.159 0.504 . . . . 74.400000000000006 112.209 -173.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 15.7 t90 -69.72 116.81 10.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.761 -0.654 . . . . 74.230000000000004 110.798 175.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.413 ' HA ' ' HD2' ' A' ' 100' ' ' PRO . 77.1 mt-30 -114.38 92.04 26.37 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 116.476 -0.329 . . . . 71.450000000000003 111.187 178.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 99' ' ' GLN . 36.7 Cg_endo -65.72 -32.7 46.5 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.514 2.143 . . . . 73.420000000000002 112.043 174.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 81.2 mt -77.39 118.05 19.47 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.879 -0.6 . . . . 75.530000000000001 110.655 176.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 C--O 1.252 1.228 0 N-CA-C 112.115 0.413 . . . . 74.349999999999994 112.115 -176.453 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.9 tpt . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 120.876 0.37 . . . . 52.329999999999998 110.975 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -74.5 155.11 38.32 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.737 0.643 . . . . 74.329999999999998 112.737 -175.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.591 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 22.2 mm-40 -53.74 -40.04 65.83 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.063 -0.517 . . . . 72.319999999999993 111.38 175.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.416 ' O ' HG12 ' A' ' 8' ' ' ILE . 64.5 t80 -50.42 -53.38 29.9 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.131 0.491 . . . . 61.420000000000002 111.105 177.124 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 59.5 mt -61.61 -46.55 89.34 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.748 -0.66 . . . . 65.049999999999997 111.182 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.4 t -60.44 -44.86 97.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 116.137 -0.483 . . . . 62.119999999999997 111.896 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.591 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 24.4 mm-40 -68.51 -52.1 35.89 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.014 0.376 . . . . 75.530000000000001 112.014 -176.022 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.499 ' O ' HG13 ' A' ' 12' ' ' ILE . 30.9 pt -58.16 -43.42 85.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 121.055 -0.258 . . . . 52.509999999999998 111.306 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.5 m-30 -63.34 -46.76 85.08 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.036 0.446 . . . . 74.329999999999998 110.671 175.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.35 -44.67 65.32 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.926 -0.579 . . . . 75.219999999999999 111.661 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 7' ' ' GLN . 99.7 t -63.48 -43.78 98.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 120.825 0.345 . . . . 74.010000000000005 111.4 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.551 ' HB ' HD11 ' A' ' 52' ' ' LEU . 72.6 mt -58.63 -32.09 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 112.161 0.43 . . . . 74.530000000000001 112.161 -178.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -60.55 -10.24 4.83 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.064 0.764 . . . . 60.32 113.064 178.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -92.86 -2.52 55.81 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 112.564 0.579 . . . . 71.230000000000004 112.564 178.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.412 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 55.3 mt -81.5 114.1 47.05 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-O 120.653 0.263 . . . . 64.450000000000003 111.176 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 15' ' ' ILE . 16.7 Cg_exo -68.55 171.47 13.04 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.926 2.417 . . . . 53.0 113.054 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 44.9 tttp -66.68 133.04 49.42 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.064 0.459 . . . . 64.319999999999993 111.25 -178.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.505 ' H ' ' NH2' ' A' ' 56' ' ' ARG . . . 95.19 -25.14 25.63 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 121.319 -0.467 . . . . 24.34 113.184 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -86.72 157.31 19.67 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.587 0.588 . . . . 71.010000000000005 112.587 -177.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.3 m -140.51 153.98 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.621 -0.718 . . . . 71.030000000000001 110.722 176.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.5 t -135.07 179.98 5.98 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 122.189 -0.319 . . . . 55.210000000000001 110.726 176.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.2 p -110.9 155.52 22.51 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.09 0.471 . . . . 72.25 112.14 -176.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -54.3 -34.87 61.88 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.197 -0.456 . . . . 73.519999999999996 111.978 177.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.98 -49.9 60.5 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.095 -0.574 . . . . 41.240000000000002 112.752 177.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -56.39 -53.84 52.63 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.0 0.428 . . . . 72.450000000000003 111.364 177.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.5 mm -56.63 -48.23 80.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-N 116.12 -0.491 . . . . 74.549999999999997 111.729 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.467 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -60.12 -49.39 77.81 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 120.88 0.371 . . . . 74.430000000000007 111.971 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -60.63 -36.63 79.1 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.9 0.381 . . . . 61.210000000000001 111.878 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 73.6 mtm -84.81 -9.71 57.89 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.746 0.308 . . . . 65.219999999999999 111.773 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.3 -11.5 32.3 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.933 0.396 . . . . 71.230000000000004 111.356 173.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.13 21.68 37.87 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 121.312 -0.47 . . . . 72.120000000000005 113.482 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.467 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 97.2 m-85 -133.59 77.78 63.71 Favored Pre-proline 0 CA--C 1.543 0.699 0 O-C-N 122.522 -0.399 . . . . 74.510000000000005 111.916 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.52 135.71 24.71 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.305 2.004 . . . . 73.230000000000004 112.712 178.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.63 -1.87 76.2 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 121.238 -0.506 . . . . 63.310000000000002 113.738 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -99.88 23.21 10.04 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 117.258 0.529 . . . . 70.0 112.29 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.65 -48.4 58.3 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.723 0.638 . . . . 34.409999999999997 112.723 -177.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.0 ttp180 -68.08 -32.42 72.73 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.738 0.304 . . . . 75.400000000000006 111.711 -178.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -67.99 -35.98 79.24 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.848 0.356 . . . . 64.0 110.993 178.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.451 HG22 HG21 ' A' ' 8' ' ' ILE . 47.1 t -60.01 -42.84 91.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 121.393 0.615 . . . . 74.129999999999995 109.851 172.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.31 -37.93 92.61 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 115.681 -0.69 . . . . 62.240000000000002 112.781 174.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -58.19 -50.76 72.39 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.139 0.495 . . . . 74.109999999999999 110.602 174.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.29 -46.75 82.85 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.66 -0.7 . . . . 73.340000000000003 112.125 -177.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 62.2 mt -65.17 -39.26 92.69 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.794 0.331 . . . . 75.340000000000003 111.596 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.7 -25.19 65.22 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 120.805 -0.712 . . . . 72.340000000000003 113.249 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -87.3 5.58 37.66 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 120.877 0.37 . . . . 63.420000000000002 111.84 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 97.0 mt -94.48 155.71 39.34 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-O 120.664 0.268 . . . . 64.099999999999994 111.084 176.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.9 160.47 46.82 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.241 1.961 . . . . 55.450000000000003 112.367 174.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -53.83 -41.46 67.4 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.174 0.435 . . . . 74.140000000000001 112.174 -174.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -124.77 65.51 0.54 Allowed Glycine 0 CA--C 1.526 0.735 0 C-N-CA 121.334 -0.46 . . . . 72.109999999999999 112.577 178.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.8 t -69.72 163.96 24.55 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.206 0.447 . . . . 63.039999999999999 112.206 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -60.38 -30.61 69.68 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.384 0.611 . . . . 74.25 110.259 173.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.553 HD12 ' HD2' ' A' ' 53' ' ' PRO . 48.5 tp -86.36 121.93 72.29 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 115.592 -0.731 . . . . 70.310000000000002 110.456 173.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.553 ' HD2' HD12 ' A' ' 52' ' ' LEU . 58.1 Cg_endo -72.95 94.9 0.81 Allowed 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 121.12 1.213 . . . . 72.540000000000006 111.745 177.17 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 69.2 p-90 -79.67 -31.28 41.36 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.978 -0.555 . . . . 71.439999999999998 111.605 -177.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.412 ' O ' HD21 ' A' ' 78' ' ' LEU . 31.7 p90 -62.81 -11.01 15.1 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.726 0.639 . . . . 72.340000000000003 112.726 -179.315 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.659 HH12 HD11 ' A' ' 83' ' ' ILE . 71.9 mtt-85 -90.2 9.33 28.9 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.142 0.423 . . . . 70.129999999999995 112.142 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.3 t -124.69 105.87 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.038 0.447 . . . . 71.530000000000001 111.004 176.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.488 HD13 HD12 ' A' ' 91' ' ' ILE . 22.3 pt -115.41 -170.19 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 121.069 0.461 . . . . 60.25 112.013 -176.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -88.1 169.99 11.46 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.896 0.379 . . . . 74.109999999999999 111.852 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 33.4 t -63.27 -24.51 67.9 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.494 0.553 . . . . 52.340000000000003 112.494 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 -72.68 -10.34 59.68 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.73 0.3 . . . . 55.340000000000003 111.803 178.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.11 44.18 24.06 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.84 -0.695 . . . . 72.530000000000001 111.878 -175.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.428 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 99.6 mttt -135.93 159.54 41.37 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.936 0.398 . . . . 70.439999999999998 111.286 -178.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 61.5 mt -62.26 132.83 28.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.115 -0.493 . . . . 71.540000000000006 110.888 177.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.5 p -76.18 -47.68 23.28 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.866 0.365 . . . . 53.140000000000001 111.29 -178.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.607 ' HB3' ' HB3' ' A' ' 70' ' ' ASP . 76.6 mt -67.36 156.8 35.59 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.081 0.467 . . . . 54.420000000000002 111.584 178.51 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.494 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 13.7 ptmm? -131.83 162.36 30.77 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.18 0.437 . . . . 65.549999999999997 112.18 -172.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 61.97 -131.07 45.59 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 116.255 -0.43 . . . . 60.210000000000001 113.243 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 -54.18 -41.62 68.76 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.264 0.554 . . . . 71.439999999999998 111.35 175.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.607 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 2.1 m-20 -66.12 -27.69 68.24 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.78 -0.645 . . . . 74.019999999999996 111.99 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.494 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 7.3 tt -64.0 -53.47 49.59 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.949 0.404 . . . . 73.299999999999997 110.053 176.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.453 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 67.7 m-20 -63.51 -29.82 71.03 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.246 -0.434 . . . . 61.109999999999999 111.25 177.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.419 ' O ' ' HG2' ' A' ' 77' ' ' LYS . 34.5 ttm180 -56.9 -58.24 8.99 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.111 -0.495 . . . . 75.200000000000003 111.247 174.447 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.448 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 49.5 tt0 -63.56 -40.75 97.79 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.983 0.421 . . . . 72.409999999999997 110.417 177.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.453 ' HB3' ' HA ' ' A' ' 72' ' ' ASP . 84.2 tttt -48.99 -52.95 22.04 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.77 -0.65 . . . . 75.349999999999994 112.075 176.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -63.07 -39.13 93.8 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.059 0.392 . . . . 45.240000000000002 112.059 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 75.0 mmtt -64.35 -36.37 83.9 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.122 0.487 . . . . 74.329999999999998 111.004 177.34 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.587 HD13 HD11 ' A' ' 91' ' ' ILE . 73.4 mt -69.48 -52.38 27.15 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.093 -0.503 . . . . 44.340000000000003 111.414 178.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -52.78 -45.03 66.95 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.968 0.413 . . . . 63.109999999999999 111.529 177.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.69 -16.47 57.41 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.285 0.476 . . . . 62.350000000000001 112.285 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.555 ' HB3' HH22 ' A' ' 56' ' ' ARG . 28.2 mm-40 -104.57 13.15 32.17 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.025 0.38 . . . . 63.25 112.025 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.91 6.79 88.67 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.156 -0.545 . . . . 74.5 113.539 178.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.659 HD11 HH12 ' A' ' 56' ' ' ARG . 57.5 mt -88.39 149.51 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 O-C-N 122.475 -0.427 . . . . 70.329999999999998 110.656 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.437 ' HG2' ' CE2' ' A' ' 96' ' ' TYR . 12.4 pt-20 -97.83 130.31 44.75 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.191 0.52 . . . . 45.509999999999998 111.548 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.426 HG21 ' HA ' ' A' ' 75' ' ' LYS . 45.4 t -110.42 100.85 11.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 116.186 -0.461 . . . . 74.150000000000006 110.951 174.154 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.578 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 47.0 m -58.82 153.7 16.51 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.331 -0.395 . . . . 63.530000000000001 110.788 176.174 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.473 ' HG3' ' N ' ' A' ' 88' ' ' ILE . 10.8 pt-20 -40.46 -46.79 2.51 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 114.663 1.357 . . . . 63.119999999999997 114.663 -167.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.473 ' N ' ' HG3' ' A' ' 87' ' ' GLU . 2.6 pp -90.13 21.29 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-O 121.192 0.52 . . . . 75.200000000000003 112.197 -176.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.61 51.74 7.02 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 116.04 -0.527 . . . . 73.129999999999995 113.391 -178.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.578 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 62.2 tttp -118.7 135.98 54.19 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 117.34 0.57 . . . . 71.5 112.42 179.509 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.587 HD11 HD13 ' A' ' 78' ' ' LEU . 52.7 mt -113.93 138.24 44.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 123.028 0.531 . . . . 72.340000000000003 110.968 178.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.26 92.92 1.42 Allowed 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.851 0.357 . . . . 54.130000000000003 111.568 177.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.488 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 45.3 mt -53.23 -60.47 3.25 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.517 0.562 . . . . 73.530000000000001 112.517 -178.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -62.36 1.23 0.36 Allowed 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.192 0.812 . . . . 73.219999999999999 113.192 -172.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.438 ' HD2' ' CE2' ' A' ' 96' ' ' TYR . 9.1 tmtm? -112.9 -34.71 5.67 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 122.104 -0.373 . . . . 75.209999999999994 110.954 173.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.438 ' CE2' ' HD2' ' A' ' 95' ' ' LYS . 97.6 m-85 -108.85 5.79 24.83 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.364 0.505 . . . . 45.140000000000001 112.364 -177.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 50.9 tttm -63.31 133.13 53.64 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.144 0.497 . . . . 74.049999999999997 111.759 -174.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 16.0 t90 -57.28 125.12 21.34 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.046 -0.525 . . . . 63.109999999999999 111.827 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -107.24 90.39 5.61 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 116.061 -0.518 . . . . 74.549999999999997 110.918 177.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.61 -19.77 41.66 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.636 2.224 . . . . 71.5 112.595 178.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 85.0 mt -107.02 -175.5 2.81 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.354 -0.385 . . . . 63.409999999999997 110.974 178.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 . . . . . 0 C--O 1.254 1.331 0 CA-C-N 116.38 -0.373 . . . . 72.019999999999996 111.58 178.956 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 120.646 0.26 . . . . 63.109999999999999 111.231 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -61.56 156.39 19.8 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.609 0.596 . . . . 75.040000000000006 112.609 -175.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -52.03 -37.69 54.39 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.928 -0.578 . . . . 64.340000000000003 112.244 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -53.66 -49.25 68.34 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.22 0.533 . . . . 75.239999999999995 110.607 177.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 77.8 mt -67.21 -45.75 75.93 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.601 -0.727 . . . . 71.25 111.218 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.9 t -55.79 -47.58 79.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.027 0.441 . . . . 74.120000000000005 111.655 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -67.16 -51.29 55.56 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.335 0.494 . . . . 65.230000000000004 112.335 -177.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.462 ' O ' HG13 ' A' ' 12' ' ' ILE . 33.5 pt -60.79 -42.72 93.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 O-C-N 122.154 -0.341 . . . . 62.0 111.576 -177.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -62.85 -43.83 97.76 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.061 0.458 . . . . 73.5 110.941 177.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.97 -39.64 66.15 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.983 -0.553 . . . . 44.539999999999999 111.725 177.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 67.6 t -69.68 -39.49 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 120.966 0.412 . . . . 55.219999999999999 111.521 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.523 ' HB ' HD11 ' A' ' 52' ' ' LEU . 82.8 mt -59.3 -33.87 52.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 116.21 -0.45 . . . . 32.229999999999997 111.955 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 83.0 m-70 -55.37 -25.28 34.31 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 113.171 0.804 . . . . 75.019999999999996 113.171 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -80.7 1.51 29.84 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.071 0.767 . . . . 73.450000000000003 113.071 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 57.2 mt -83.34 111.44 31.23 Favored Pre-proline 0 CA--C 1.543 0.676 0 O-C-N 121.961 -0.462 . . . . 73.230000000000004 110.943 177.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.85 157.72 57.49 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.675 2.25 . . . . 72.310000000000002 113.312 -176.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.8 tttp -62.67 94.81 0.07 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.218 0.532 . . . . 73.099999999999994 111.734 -177.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.465 ' H ' ' CZ ' ' A' ' 56' ' ' ARG . . . 142.94 -28.74 2.12 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-N 116.054 -0.521 . . . . 50.130000000000003 112.473 178.105 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -95.66 165.49 12.29 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.273 0.558 . . . . 61.399999999999999 112.067 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.7 m -141.43 159.68 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.677 -0.692 . . . . 72.329999999999998 110.482 176.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 94.1 p -138.35 -179.37 5.76 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.817 0.341 . . . . 61.329999999999998 111.023 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 51.2 p -106.21 155.91 18.99 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.855 0.36 . . . . 65.129999999999995 111.971 -179.546 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.403 ' HB2' ' HB1' ' A' ' 36' ' ' ALA . 52.7 m-85 -54.91 -38.59 67.82 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.944 0.402 . . . . 72.310000000000002 110.945 177.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.26 -52.75 51.41 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-N 115.788 -0.642 . . . . 42.100000000000001 113.18 178.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -56.37 -48.3 77.13 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.905 0.383 . . . . 72.519999999999996 111.513 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.6 mm -58.75 -49.29 83.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 116.292 -0.413 . . . . 55.25 111.258 178.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.473 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -59.93 -45.28 93.09 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.965 0.412 . . . . 63.32 111.973 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -57.79 -52.53 65.07 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.788 0.328 . . . . 74.530000000000001 111.408 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 72.7 mtm -66.65 -28.18 68.27 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.399 -0.364 . . . . 71.530000000000001 111.879 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.72 -30.44 64.18 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.027 0.442 . . . . 62.350000000000001 111.417 176.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.71 13.15 19.33 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.333 -0.46 . . . . 71.209999999999994 113.057 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.473 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 76.3 m-85 -127.74 66.78 71.59 Favored Pre-proline 0 CA--C 1.543 0.679 0 O-C-N 122.61 -0.347 . . . . 63.109999999999999 111.714 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.71 144.73 60.86 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.224 1.95 . . . . 71.340000000000003 112.41 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.77 -11.78 65.56 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 121.032 -0.604 . . . . 71.310000000000002 113.523 -177.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -99.4 19.16 16.07 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 122.394 -0.474 . . . . 62.409999999999997 111.757 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.403 ' HB1' ' HB2' ' A' ' 23' ' ' TYR . . . -53.26 -42.92 66.99 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.263 0.468 . . . . 72.430000000000007 112.263 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -57.0 -37.51 71.75 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.009 0.374 . . . . 74.319999999999993 112.009 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -72.43 -31.9 65.87 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 120.653 0.264 . . . . 74.439999999999998 111.296 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.406 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 61.1 t -56.7 -51.78 62.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 120.887 0.375 . . . . 71.120000000000005 110.335 173.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -57.48 -42.41 93.88 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 121.219 -0.515 . . . . 32.329999999999998 113.039 176.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.518 ' HB3' ' NZ ' ' A' ' 41' ' ' LYS . 8.9 mtpm? -60.22 -34.54 73.81 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.795 0.331 . . . . 75.439999999999998 111.753 178.443 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.9 -41.75 59.13 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.324 -0.398 . . . . 33.229999999999997 111.475 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 39' ' ' VAL . 86.2 mt -65.66 -42.15 91.71 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.316 -0.402 . . . . 75.219999999999999 111.908 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.28 -26.84 51.56 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 121.195 -0.526 . . . . 72.230000000000004 113.542 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -78.94 -20.15 50.0 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 122.584 -0.362 . . . . 70.049999999999997 111.751 -178.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 81.5 mt -68.03 147.17 98.43 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-O 120.851 0.357 . . . . 73.510000000000005 111.601 -179.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -84.13 177.53 5.88 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.693 2.262 . . . . 54.439999999999998 112.971 178.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.463 ' OE1' ' HD2' ' A' ' 73' ' ' ARG . 1.4 mp0 -71.72 -37.21 70.65 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.983 0.42 . . . . 44.109999999999999 111.156 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -94.38 43.54 2.35 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 121.371 -0.442 . . . . 71.420000000000002 113.344 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.0 t -84.19 159.75 20.97 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.99 0.424 . . . . 74.209999999999994 111.472 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 51' ' ' LYS . 37.1 ttmt -81.91 -12.91 58.19 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.435 0.635 . . . . 73.439999999999998 110.726 178.049 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.537 HD12 ' HD2' ' A' ' 53' ' ' PRO . 33.0 tp -107.05 126.05 31.09 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 115.735 -0.666 . . . . 61.240000000000002 110.983 179.028 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.537 ' HD2' HD12 ' A' ' 52' ' ' LEU . 57.0 Cg_endo -72.94 94.53 0.8 Allowed 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 121.205 1.27 . . . . 72.120000000000005 111.637 174.166 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 69.2 p-90 -86.66 -17.69 33.15 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.291 0.567 . . . . 73.549999999999997 111.673 -177.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.491 ' O ' HD21 ' A' ' 78' ' ' LEU . 37.4 p90 -73.88 -5.72 42.76 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.985 0.735 . . . . 62.350000000000001 112.985 -176.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.485 HH12 HD11 ' A' ' 83' ' ' ILE . 87.1 mtt-85 -99.24 12.92 34.83 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.771 0.656 . . . . 74.219999999999999 112.771 -177.129 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.4 t -123.11 112.76 35.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 121.263 0.554 . . . . 72.409999999999997 111.214 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.545 HD13 HD12 ' A' ' 91' ' ' ILE . 27.4 pt -122.04 -169.98 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-N 116.087 -0.506 . . . . 61.119999999999997 111.386 -178.236 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.412 HD21 ' HB2' ' A' ' 63' ' ' LYS . 32.9 p30 -85.22 167.75 15.39 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.83 -0.544 . . . . 73.319999999999993 112.048 -177.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.478 ' HA ' HG21 ' A' ' 22' ' ' THR . 50.3 p -66.3 -10.71 45.22 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.941 0.719 . . . . 74.140000000000001 112.941 -177.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -96.33 11.32 35.14 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.762 0.315 . . . . 51.439999999999998 111.628 179.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.33 39.0 87.89 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 116.438 -0.346 . . . . 72.510000000000005 113.53 176.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.457 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 56.4 mttp -139.45 157.97 44.93 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.208 0.528 . . . . 65.530000000000001 111.6 -178.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.435 HG23 ' OE1' ' A' ' 74' ' ' GLN . 59.2 mt -73.26 117.57 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.806 -0.634 . . . . 73.439999999999998 110.903 177.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.3 t -69.19 -33.01 72.69 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.06 0.457 . . . . 64.239999999999995 110.99 178.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.553 HD13 ' HB3' ' A' ' 70' ' ' ASP . 66.6 mt -65.08 148.28 51.95 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.162 -0.472 . . . . 71.219999999999999 111.118 177.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -130.25 149.38 51.97 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.965 0.412 . . . . 72.519999999999996 112.098 -176.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.15 -120.37 7.81 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-N 116.263 -0.426 . . . . 53.130000000000003 113.451 178.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -65.03 -46.19 82.34 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.943 0.402 . . . . 74.209999999999994 111.653 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.553 ' HB3' HD13 ' A' ' 66' ' ' LEU . 67.6 m-20 -59.38 -36.08 75.12 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.552 -0.294 . . . . 74.230000000000004 111.568 177.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.9 tt -62.99 -54.99 29.76 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.963 -0.384 . . . . 72.0 109.963 177.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -58.98 -32.88 70.05 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.134 0.492 . . . . 73.349999999999994 111.312 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.463 ' HD2' ' OE1' ' A' ' 48' ' ' GLU . 11.2 ttp180 -67.84 -51.95 42.55 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.005 -0.543 . . . . 64.239999999999995 111.572 -178.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.451 HE21 ' HA ' ' A' ' 55' ' ' PHE . 34.2 tt0 -62.87 -47.28 84.02 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.181 0.515 . . . . 72.340000000000003 110.216 174.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.0 tttt -47.77 -55.17 10.21 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.206 -0.906 . . . . 50.439999999999998 112.576 175.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -56.41 -42.7 78.43 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.087 0.403 . . . . 55.25 112.087 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -62.57 -42.02 99.3 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.093 0.473 . . . . 74.439999999999998 111.517 177.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.491 HD21 ' O ' ' A' ' 55' ' ' PHE . 81.2 mt -64.19 -44.1 93.05 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.204 -0.453 . . . . 63.539999999999999 111.767 178.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -55.48 -42.42 74.34 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.923 0.392 . . . . 70.549999999999997 111.111 176.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.93 -33.76 73.66 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.056 0.455 . . . . 71.230000000000004 111.833 177.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.437 ' HB3' HH22 ' A' ' 56' ' ' ARG . 8.2 mm-40 -83.6 1.72 40.83 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.377 -0.374 . . . . 72.409999999999997 111.952 -179.28 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.84 9.93 70.46 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 121.379 -0.439 . . . . 60.119999999999997 113.949 177.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.485 HD11 HH12 ' A' ' 56' ' ' ARG . 67.0 mt -89.15 136.18 24.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 117.023 0.411 . . . . 62.409999999999997 111.405 -178.066 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.465 ' O ' ' HG3' ' A' ' 84' ' ' GLU . 9.2 pt-20 -76.44 114.66 15.39 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.143 0.497 . . . . 62.310000000000002 111.79 178.267 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.8 t -101.54 105.05 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 120.965 0.412 . . . . 74.209999999999994 110.666 172.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.642 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 25.2 t -69.48 157.96 36.11 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.423 -0.353 . . . . 70.5 111.77 178.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -37.55 -56.55 1.02 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.638 1.347 . . . . 71.129999999999995 114.638 -168.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.445 HD11 ' HB2' ' A' ' 90' ' ' LYS . 2.7 pp -86.54 18.27 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 112.69 0.626 . . . . 71.129999999999995 112.69 -174.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.2 44.83 7.85 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.113 -0.565 . . . . 35.310000000000002 112.518 -177.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.642 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 0.6 OUTLIER -105.52 128.15 53.42 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 122.539 -0.389 . . . . 60.329999999999998 110.389 -179.602 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.545 HD12 HD13 ' A' ' 58' ' ' ILE . 62.3 mt -116.53 139.67 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.899 0.381 . . . . 43.240000000000002 111.118 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.58 92.61 4.08 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.925 0.393 . . . . 43.549999999999997 111.786 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.598 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 57.4 mt -59.79 -44.19 94.05 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.733 0.302 . . . . 71.420000000000002 111.251 178.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 80.9 mtt-85 -56.48 -12.52 1.76 Allowed 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 112.173 0.434 . . . . 74.099999999999994 112.173 -177.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -109.92 -42.37 4.25 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 120.964 0.411 . . . . 73.519999999999996 111.814 176.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -101.7 6.46 41.87 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.149 0.425 . . . . 72.219999999999999 112.149 -171.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.598 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 78.0 tttt -61.56 129.35 40.7 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.143 0.497 . . . . 71.310000000000002 111.914 -175.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 21.2 t90 -71.03 116.96 11.93 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.978 -0.555 . . . . 72.099999999999994 111.991 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -124.65 92.66 47.51 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 115.971 -0.559 . . . . 51.119999999999997 110.58 175.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -79.36 34.12 0.51 Allowed 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 122.959 2.44 . . . . 73.319999999999993 113.797 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 96.8 mt -132.55 97.57 4.12 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.528 0.566 . . . . 54.229999999999997 112.528 -176.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 . . . . . 0 C--O 1.251 1.153 0 CA-C-O 118.678 -0.677 . . . . 44.439999999999998 110.997 172.646 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 tpt . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 120.891 0.376 . . . . 62.340000000000003 110.897 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -75.86 150.53 37.6 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.744 0.646 . . . . 63.100000000000001 112.744 -174.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -51.19 -31.74 21.22 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.625 -0.716 . . . . 63.439999999999998 112.318 178.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -57.61 -55.54 33.48 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.848 0.356 . . . . 75.439999999999998 110.727 177.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 77.0 mt -59.97 -45.19 93.49 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.964 -0.562 . . . . 75.25 111.218 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 62.0 t -57.14 -52.62 53.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 116.178 -0.465 . . . . 55.539999999999999 112.053 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.426 ' O ' HG23 ' A' ' 11' ' ' VAL . 28.7 mm-40 -67.58 -44.71 77.5 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.727 0.64 . . . . 73.430000000000007 112.727 -175.143 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.42 ' O ' HG13 ' A' ' 12' ' ' ILE . 36.8 pt -63.33 -43.43 98.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 120.909 -0.316 . . . . 73.129999999999995 111.281 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -62.87 -44.98 94.65 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.943 0.401 . . . . 75.349999999999994 110.978 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.52 -37.22 62.6 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.08 -0.509 . . . . 71.439999999999998 111.793 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 7' ' ' GLN . 96.0 t -70.21 -42.65 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-O 120.929 0.395 . . . . 63.329999999999998 111.513 178.327 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.545 ' HB ' HD11 ' A' ' 52' ' ' LEU . 79.9 mt -59.19 -30.57 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 112.28 0.474 . . . . 74.340000000000003 112.28 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -60.85 -12.52 11.22 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 112.966 0.728 . . . . 75.140000000000001 112.966 178.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -90.77 -3.5 57.38 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.481 0.549 . . . . 72.420000000000002 112.481 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.404 HD12 HG23 ' A' ' 12' ' ' ILE . 56.0 mt -84.3 113.79 50.65 Favored Pre-proline 0 CA--C 1.544 0.741 0 O-C-N 122.184 -0.322 . . . . 70.140000000000001 111.44 -179.077 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -70.5 163.78 37.64 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.961 2.44 . . . . 72.200000000000003 113.843 -177.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.35 120.85 12.99 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.944 -0.571 . . . . 74.420000000000002 111.639 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.33 14.09 46.02 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.092 -0.575 . . . . 75.209999999999994 113.442 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -126.03 148.3 49.34 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.889 0.376 . . . . 70.340000000000003 111.18 176.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.0 m -125.32 149.11 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-O 121.122 0.487 . . . . 71.519999999999996 111.613 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 97.8 p -128.67 167.03 17.8 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.106 -0.497 . . . . 64.129999999999995 110.83 177.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.5 p -103.79 147.45 27.27 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.763 0.316 . . . . 74.239999999999995 111.378 177.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -52.16 -36.52 51.82 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.751 0.31 . . . . 74.219999999999999 111.766 178.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -57.35 -43.82 93.68 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 121.129 -0.558 . . . . 73.329999999999998 112.779 177.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' A' ' 29' ' ' MET . 41.7 mt-10 -65.11 -54.13 34.63 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.78 0.324 . . . . 73.450000000000003 111.112 177.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.8 mm -54.62 -51.12 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.3 -0.409 . . . . 72.150000000000006 111.889 -178.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.49 -46.19 84.0 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.945 0.402 . . . . 61.32 111.748 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -61.19 -48.38 81.82 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.781 0.324 . . . . 72.329999999999998 111.511 178.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.489 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 61.0 mtt -63.37 -30.1 71.29 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.096 0.474 . . . . 71.0 111.522 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.01 -19.57 58.55 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.158 -0.474 . . . . 74.209999999999994 111.858 178.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.57 23.26 12.49 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.191 -0.528 . . . . 72.329999999999998 113.154 -178.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -132.78 62.82 64.63 Favored Pre-proline 0 CA--C 1.542 0.648 0 O-C-N 122.48 -0.423 . . . . 75.200000000000003 111.064 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -62.5 119.82 7.09 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.27 1.98 . . . . 73.030000000000001 112.731 -177.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.44 -6.58 49.79 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.036 -0.602 . . . . 72.420000000000002 113.589 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -97.98 20.74 11.71 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 117.332 0.566 . . . . 63.119999999999997 111.375 177.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.8 -39.43 68.46 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.806 0.669 . . . . 74.040000000000006 112.806 -177.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -58.8 -34.89 72.01 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 120.924 0.392 . . . . 73.340000000000003 111.714 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -77.94 -28.25 49.51 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.687 -0.233 . . . . 65.230000000000004 111.408 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.3 t -59.66 -42.63 89.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.238 0.542 . . . . 71.150000000000006 110.12 172.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -62.7 -42.31 99.71 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 115.771 -0.65 . . . . 51.350000000000001 112.789 175.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -60.66 -41.82 95.78 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.049 0.452 . . . . 72.329999999999998 111.134 176.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.52 -54.47 45.07 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.177 -0.465 . . . . 55.219999999999999 111.418 178.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.49 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 80.6 mt -61.88 -38.53 88.66 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.932 0.396 . . . . 71.549999999999997 111.589 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.29 -17.77 70.65 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.339 -0.458 . . . . 72.109999999999999 113.396 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -101.07 2.84 40.79 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 122.416 -0.461 . . . . 73.230000000000004 111.391 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 69.9 mt -78.54 155.54 78.64 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-O 120.809 0.338 . . . . 61.200000000000003 111.321 176.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.509 ' HG2' ' HB2' ' A' ' 50' ' ' SER . 20.5 Cg_endo -61.02 140.76 91.7 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.116 1.877 . . . . 75.209999999999994 112.083 174.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.645 ' HG3' ' HD3' ' A' ' 73' ' ' ARG . 33.0 tt0 -43.52 -39.35 3.35 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.696 0.628 . . . . 71.310000000000002 112.696 -174.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -123.24 55.64 0.68 Allowed Glycine 0 CA--C 1.529 0.942 0 C-N-CA 121.098 -0.572 . . . . 74.340000000000003 113.491 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.509 ' HB2' ' HG2' ' A' ' 47' ' ' PRO . 37.8 t -63.5 168.2 4.86 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.427 0.632 . . . . 74.120000000000005 112.641 177.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -65.47 -32.66 74.39 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.309 0.576 . . . . 73.299999999999997 110.181 173.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.554 HD12 ' HD2' ' A' ' 53' ' ' PRO . 30.7 tp -84.48 127.04 67.49 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 115.641 -0.709 . . . . 64.409999999999997 110.894 177.375 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.554 ' HD2' HD12 ' A' ' 52' ' ' LEU . 61.5 Cg_endo -73.67 95.65 0.89 Allowed 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 121.396 1.398 . . . . 65.129999999999995 111.656 174.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.49 ' HB2' ' HB3' ' A' ' 43' ' ' LEU . 65.2 p-90 -79.52 -31.55 42.17 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.188 0.518 . . . . 74.340000000000003 111.891 -176.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.417 ' O ' HD21 ' A' ' 78' ' ' LEU . 27.3 p90 -63.6 -19.87 65.2 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.244 0.831 . . . . 71.230000000000004 113.244 -176.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.404 ' NH1' ' O ' ' A' ' 15' ' ' ILE . 98.5 mtt180 -77.76 2.07 18.14 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.497 0.554 . . . . 73.299999999999997 112.497 -177.257 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.4 t -122.22 125.62 73.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 O-C-N 121.9 -0.5 . . . . 62.439999999999998 111.426 179.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.625 HD11 HD21 ' A' ' 93' ' ' LEU . 33.8 pt -125.46 -171.39 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 120.978 0.418 . . . . 62.439999999999998 111.646 -179.111 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.429 HD21 ' HB2' ' A' ' 63' ' ' LYS . 33.8 p30 -73.03 171.65 12.48 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.243 0.544 . . . . 61.329999999999998 112.23 -179.063 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 46.6 p -79.69 8.52 6.46 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.074 0.464 . . . . 65.109999999999999 112.128 -179.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -95.64 -46.44 6.62 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.358 0.599 . . . . 74.140000000000001 110.944 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 121.33 32.38 1.06 Allowed Glycine 0 CA--C 1.522 0.475 0 CA-C-N 115.766 -0.652 . . . . 42.149999999999999 112.159 -175.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.429 ' HB2' HD21 ' A' ' 59' ' ' ASN . 98.4 mttt -138.67 163.14 32.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.092 0.472 . . . . 35.409999999999997 111.387 -177.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.506 HG23 ' OE1' ' A' ' 74' ' ' GLN . 65.3 mt -67.81 122.08 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 115.968 -0.56 . . . . 53.109999999999999 110.605 175.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.5 m -63.89 -41.83 97.61 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.166 0.508 . . . . 65.099999999999994 111.464 -178.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.513 HD13 ' HB3' ' A' ' 70' ' ' ASP . 86.6 mt -74.15 161.33 30.1 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.788 -0.642 . . . . 74.120000000000005 111.813 -178.198 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -130.18 177.11 7.55 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.8 0.333 . . . . 44.439999999999998 111.429 -178.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 57.38 -126.55 42.46 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 121.36 -0.447 . . . . 42.520000000000003 113.106 178.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 38.7 mtp180 -74.54 -32.13 62.35 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.171 0.51 . . . . 74.129999999999995 110.714 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.513 ' HB3' HD13 ' A' ' 66' ' ' LEU . 2.6 m-20 -60.02 -32.47 70.91 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.892 -0.595 . . . . 62.520000000000003 110.676 177.111 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.9 tt -63.28 -57.05 11.71 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.027 -0.533 . . . . 62.030000000000001 110.212 176.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -55.58 -36.87 67.35 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.902 0.382 . . . . 74.129999999999995 111.462 176.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.645 ' HD3' ' HG3' ' A' ' 48' ' ' GLU . 39.8 ttm180 -59.22 -58.87 6.71 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 116.383 -0.371 . . . . 71.519999999999996 111.65 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.506 ' OE1' HG23 ' A' ' 64' ' ' ILE . 53.6 tt0 -61.66 -41.01 96.94 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.708 0.289 . . . . 73.099999999999994 111.132 177.347 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -54.88 -58.67 6.66 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.259 -0.428 . . . . 74.129999999999995 111.72 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -52.9 -45.65 67.64 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.079 0.4 . . . . 64.0 112.079 -178.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -61.46 -30.53 70.65 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.853 0.359 . . . . 75.430000000000007 111.936 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.417 HD21 ' O ' ' A' ' 55' ' ' PHE . 94.8 mt -78.0 -42.08 33.84 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.046 0.45 . . . . 62.219999999999999 111.13 174.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -57.4 -39.4 76.02 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.913 0.387 . . . . 64.129999999999995 111.057 177.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.23 -24.39 63.13 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.119 -0.491 . . . . 73.430000000000007 111.929 178.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -95.38 -1.37 51.22 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 111.831 0.308 . . . . 73.510000000000005 111.831 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.24 12.89 44.05 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.512 -0.375 . . . . 75.340000000000003 113.689 177.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.418 ' HA ' ' CE1' ' A' ' 96' ' ' TYR . 66.6 mt -88.59 109.57 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 122.477 -0.425 . . . . 72.0 111.547 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -73.39 100.66 3.26 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.982 0.42 . . . . 75.329999999999998 111.465 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 58.2 t -92.41 130.45 41.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 120.901 0.381 . . . . 61.229999999999997 111.593 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.603 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 31.0 t -69.73 155.99 39.68 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.515 -0.311 . . . . 63.25 111.573 177.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.502 ' HG3' HG23 ' A' ' 88' ' ' ILE . 15.3 pt-20 -46.05 -49.84 15.85 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.034 1.124 . . . . 73.540000000000006 114.034 -169.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.502 HG23 ' HG3' ' A' ' 87' ' ' GLU . 2.9 pp -81.34 13.85 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 121.216 0.531 . . . . 74.420000000000002 112.326 -176.081 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.57 50.03 5.19 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 121.335 -0.459 . . . . 73.400000000000006 112.894 -178.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.603 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 14.4 tmtt? -117.27 129.63 56.03 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 122.326 -0.514 . . . . 65.430000000000007 111.197 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.507 HD12 HD13 ' A' ' 58' ' ' ILE . 60.6 mt -116.35 148.26 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.173 -0.467 . . . . 72.200000000000003 111.462 -177.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.32 99.96 8.16 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.886 0.374 . . . . 61.299999999999997 111.682 177.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.625 HD21 HD11 ' A' ' 58' ' ' ILE . 25.3 mt -69.64 -1.35 8.7 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.112 0.782 . . . . 74.150000000000006 113.112 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -98.05 -52.7 3.61 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.074 0.464 . . . . 74.150000000000006 111.181 173.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -69.28 -29.75 67.7 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.224 -0.444 . . . . 64.319999999999993 112.101 -177.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.418 ' CE1' ' HA ' ' A' ' 83' ' ' ILE . 90.5 m-85 -114.09 13.65 18.15 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 111.796 0.295 . . . . 62.119999999999997 111.796 -176.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.539 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 83.8 tttt -60.85 131.38 50.51 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 111.827 0.306 . . . . 73.209999999999994 111.827 -176.118 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 19.2 t90 -58.64 105.59 0.32 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.641 0.734 . . . . 74.5 111.151 176.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -113.45 95.29 35.5 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 115.348 -0.842 . . . . 73.420000000000002 110.723 177.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.39 1.86 5.71 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.511 2.141 . . . . 71.099999999999994 112.524 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 38.4 mt -99.24 -40.23 8.05 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.295 -0.411 . . . . 72.340000000000003 111.251 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 . . . . . 0 C--O 1.257 1.457 0 CA-C-O 118.855 -0.593 . . . . 64.439999999999998 111.772 -175.984 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.457 ' O ' HG23 ' A' ' 6' ' ' VAL . 3.8 m-20 . . . . . 0 N--CA 1.469 0.504 0 N-CA-C 112.42 0.526 . . . . 70.51 112.42 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.527 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 23.0 tp60 -52.97 -44.27 67.03 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.416 -0.357 . . . . 73.14 111.655 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -54.74 -50.72 67.7 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.095 0.474 . . . . 72.51 111.069 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.1 mt -61.11 -42.24 98.17 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.942 -0.572 . . . . 60.15 111.322 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 2' ' ' ASP . 64.8 t -59.51 -41.58 85.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.007 0.432 . . . . 74.12 111.35 177.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.527 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 25.8 mm-40 -66.29 -54.31 26.4 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.345 -0.388 . . . . 73.44 111.896 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.497 HG21 HG22 ' A' ' 39' ' ' VAL . 37.2 pt -63.31 -43.86 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 111.746 0.276 . . . . 64.34 111.746 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 12.5 m-30 -60.67 -45.23 94.92 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.742 0.306 . . . . 75.15 111.147 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.432 ' O ' ' NE2' ' A' ' 14' ' ' GLN . . . -52.36 -43.86 64.9 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.365 -0.379 . . . . 72.21 111.226 177.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 93.5 t -64.46 -47.14 90.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.339 -0.391 . . . . 61.51 111.356 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 8' ' ' ILE . 79.7 mt -55.69 -33.98 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 116.084 -0.507 . . . . 60.11 112.303 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 74.9 m-70 -61.21 -16.15 41.97 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 112.702 0.63 . . . . 71.03 112.702 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.432 ' NE2' ' O ' ' A' ' 10' ' ' ALA . 1.0 OUTLIER -82.88 -7.3 59.67 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.073 0.397 . . . . 70.2 112.073 177.925 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.434 HG21 ' HB3' ' A' ' 56' ' ' ARG . 56.1 mt -80.46 116.48 62.15 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 122.421 -0.174 . . . . 72.23 111.203 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -69.94 170.2 17.35 Favored 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 123.062 2.508 . . . . 72.25 113.764 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.9 tttp -65.79 121.0 14.03 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.078 -0.51 . . . . 55.02 111.362 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.27 17.59 45.91 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 121.017 -0.611 . . . . 73.51 113.901 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -119.94 146.28 45.96 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 117.103 0.451 . . . . 71.3 111.389 176.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 56' ' ' ARG . 34.6 m -130.0 140.24 49.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.142 0.496 . . . . 44.21 111.307 177.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 83.9 p -122.47 170.27 10.14 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.842 0.354 . . . . 74.25 111.1 177.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 44.4 p -95.83 147.5 23.58 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.005 0.431 . . . . 65.15 111.487 178.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -52.91 -32.9 47.85 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 116.289 -0.414 . . . . 71.43 111.993 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.78 -44.02 95.37 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 121.094 -0.574 . . . . 73.41 112.965 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 29' ' ' MET . 46.7 mt-10 -64.59 -44.9 89.18 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.811 0.338 . . . . 73.14 111.347 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.408 HD11 HD11 ' A' ' 15' ' ' ILE . 47.2 mm -60.58 -50.01 82.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 120.809 0.338 . . . . 62.41 111.307 177.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.5 -43.84 84.49 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.96 0.41 . . . . 71.23 111.517 177.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -59.21 -48.2 82.49 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.174 -0.466 . . . . 63.44 111.298 178.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.431 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 63.1 mtt -65.95 -28.75 69.15 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.878 0.371 . . . . 72.13 111.621 178.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.35 -20.55 51.1 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.928 0.394 . . . . 65.44 111.573 177.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.87 22.41 28.22 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.199 -0.524 . . . . 41.24 113.459 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -124.94 81.82 61.89 Favored Pre-proline 0 CA--C 1.543 0.68 0 O-C-N 122.393 -0.474 . . . . 74.43 111.79 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.62 131.72 37.03 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.732 2.288 . . . . 64.24 112.658 177.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.95 -8.46 79.77 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.014 -0.613 . . . . 63.44 113.649 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -89.68 22.6 2.99 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.482 0.549 . . . . 63.53 112.482 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.36 -57.58 11.24 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.012 0.434 . . . . 72.31 112.167 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 46.6 ttp180 -58.66 -32.3 68.97 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.008 0.433 . . . . 71.45 111.552 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.587 ' HA ' ' HE2' ' A' ' 41' ' ' LYS . 80.5 m-70 -65.2 -41.28 94.67 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.35 -0.386 . . . . 53.34 111.284 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.497 HG22 HG21 ' A' ' 8' ' ' ILE . 53.6 t -58.43 -37.95 67.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.264 0.554 . . . . 64.23 110.171 172.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.79 -37.66 95.01 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 115.808 -0.633 . . . . 33.11 112.999 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.587 ' HE2' ' HA ' ' A' ' 38' ' ' HIS . 41.1 mtmt -62.75 -47.27 84.26 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.006 0.431 . . . . 74.21 110.476 176.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.07 -51.42 66.41 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.869 -0.605 . . . . 72.41 111.921 -178.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.5 mt -63.56 -43.35 97.31 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.297 -0.41 . . . . 72.42 111.459 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.11 -22.72 72.69 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 120.853 -0.689 . . . . 61.51 112.884 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -79.85 -21.08 44.56 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.995 0.426 . . . . 73.32 111.277 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 91.6 mt -75.77 155.39 85.08 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 116.444 -0.344 . . . . 53.53 111.897 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.57 164.87 19.51 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.46 2.107 . . . . 64.22 112.192 174.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.503 ' HA ' ' HE ' ' A' ' 73' ' ' ARG . 0.8 OUTLIER -64.91 -26.57 68.37 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.211 0.448 . . . . 74.15 112.211 -175.203 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -131.88 64.38 0.61 Allowed Glycine 0 CA--C 1.528 0.857 0 C-N-CA 121.094 -0.574 . . . . 71.31 113.325 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.6 t -79.72 172.77 13.34 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.182 0.515 . . . . 72.42 111.772 178.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? -67.79 -28.94 68.03 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.17 -0.468 . . . . 61.52 110.78 174.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.529 HD12 ' HD2' ' A' ' 53' ' ' PRO . 33.0 tp -86.71 124.8 68.74 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 116.017 -0.538 . . . . 63.5 111.02 177.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.529 ' HD2' HD12 ' A' ' 52' ' ' LEU . 38.0 Cg_endo -67.19 95.08 0.36 Allowed 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 121.285 1.324 . . . . 52.51 111.386 173.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.417 ' HH2' ' HG2' ' A' ' 73' ' ' ARG . 65.9 p-90 -82.51 -30.49 29.78 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.685 -0.689 . . . . 74.43 111.716 -177.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.462 ' O ' HD21 ' A' ' 78' ' ' LEU . 11.9 p90 -67.32 -11.53 57.85 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.335 0.865 . . . . 74.5 113.335 -175.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.459 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 94.2 mtt180 -86.27 8.08 22.73 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.024 0.75 . . . . 72.52 113.024 -174.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 20.9 t -127.86 116.23 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 O-C-N 121.81 -0.556 . . . . 64.24 111.652 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.457 HG21 HD12 ' A' ' 91' ' ' ILE . 28.0 pt -118.98 -174.52 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 116.472 -0.331 . . . . 75.04 111.376 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 35.4 p30 -83.78 168.75 15.89 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.139 0.495 . . . . 74.41 111.906 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.1 t -67.93 -9.24 43.5 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.234 -0.439 . . . . 61.45 111.951 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -88.14 0.69 55.73 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.619 -0.264 . . . . 73.5 111.53 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.41 42.59 89.36 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 121.015 -0.612 . . . . 41.2 112.396 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -141.15 157.32 45.44 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.096 0.474 . . . . 74.01 111.378 -176.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 63.8 mt -73.34 128.07 35.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 116.258 -0.428 . . . . 72.34 111.001 177.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.9 p -74.29 -31.04 62.35 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 120.973 0.416 . . . . 71.43 111.408 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.47 HD13 ' HB3' ' A' ' 70' ' ' ASP . 92.5 mt -74.91 152.51 38.85 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.171 -0.468 . . . . 53.33 111.09 177.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -129.45 171.4 12.59 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.017 0.436 . . . . 72.11 111.973 -176.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 57.58 -128.75 48.23 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 116.24 -0.436 . . . . 64.54 113.327 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -61.71 -39.41 91.4 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 122.586 -0.361 . . . . 74.22 111.339 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.47 ' HB3' HD13 ' A' ' 66' ' ' LEU . 19.7 m-20 -65.43 -25.9 67.73 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.026 0.38 . . . . 62.42 112.026 -178.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.8 tt -64.11 -55.92 18.55 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.881 -0.414 . . . . 71.24 109.881 174.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.579 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 33.0 t70 -65.99 -27.04 67.84 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.997 0.427 . . . . 73.04 111.219 177.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.503 ' HE ' ' HA ' ' A' ' 48' ' ' GLU . 51.9 ttt180 -57.44 -55.11 39.06 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.245 0.545 . . . . 72.41 110.878 173.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -64.84 -41.95 95.31 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.129 0.49 . . . . 74.05 110.562 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.579 ' HB3' ' HA ' ' A' ' 72' ' ' ASP . 32.0 tttm -54.81 -55.14 33.35 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.67 -0.696 . . . . 71.11 112.37 178.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -58.74 -36.96 75.17 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.932 0.396 . . . . 61.35 111.499 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.485 ' HE2' ' O ' ' A' ' 48' ' ' GLU . 45.3 mmtm -64.16 -42.44 96.74 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.923 0.392 . . . . 64.44 111.224 174.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.512 HD22 HD12 ' A' ' 83' ' ' ILE . 95.9 mt -68.99 -31.89 71.05 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.916 0.389 . . . . 73.55 111.631 178.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 46.6 mt-10 -65.81 -30.54 71.19 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.886 0.374 . . . . 72.11 110.516 175.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.26 -11.86 60.16 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.321 0.581 . . . . 74.01 111.12 173.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -97.82 -11.31 23.44 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.917 -0.583 . . . . 62.33 111.137 176.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.91 50.4 5.22 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.494 -0.384 . . . . 74.2 113.098 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.512 HD12 HD22 ' A' ' 78' ' ' LEU . 71.4 mt -119.97 129.54 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 O-C-N 122.682 -0.305 . . . . 70.42 111.248 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -75.64 91.52 2.88 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.347 0.594 . . . . 74.0 111.438 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.2 t -96.68 121.1 46.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.624 -0.716 . . . . 73.04 110.837 177.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.595 ' OG ' ' HB3' ' A' ' 90' ' ' LYS . 6.3 p -72.91 151.27 41.98 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 122.331 -0.23 . . . . 71.1 110.644 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -42.36 -44.7 4.03 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.584 1.327 . . . . 53.11 114.584 -173.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.482 HD11 ' HB2' ' A' ' 90' ' ' LYS . 2.9 pp -81.1 9.53 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 112.461 0.541 . . . . 61.34 112.461 -176.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.57 45.59 5.75 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 121.622 -0.323 . . . . 54.42 113.624 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.595 ' HB3' ' OG ' ' A' ' 86' ' ' SER . 1.2 tmtp? -114.35 132.84 56.06 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-O 121.009 0.433 . . . . 74.41 111.425 -178.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.457 HD12 HG21 ' A' ' 58' ' ' ILE . 60.0 mt -127.08 138.8 53.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 116.152 -0.476 . . . . 64.55 111.426 -178.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.29 93.93 6.01 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.947 0.403 . . . . 71.04 111.838 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.552 ' O ' ' HG3' ' A' ' 97' ' ' LYS . 38.5 mt -53.79 -52.33 60.62 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.09 0.404 . . . . 75.11 112.09 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -52.82 -14.07 0.5 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.296 0.85 . . . . 73.4 113.296 -174.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -112.98 -33.91 5.9 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 122.03 -0.419 . . . . 74.4 112.068 175.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -99.33 0.32 42.67 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.808 1.04 . . . . 63.12 113.808 -173.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 93' ' ' LEU . 33.0 mtpt -57.18 138.18 54.94 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.213 0.53 . . . . 74.34 112.22 -178.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 16.3 t90 -64.96 105.26 0.99 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.692 -0.686 . . . . 60.5 111.268 175.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -112.09 99.53 46.29 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 116.1 -0.5 . . . . 74.4 110.653 175.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 CA--C 1.548 1.188 0 C-N-CA 122.948 2.432 . . . . 71.25 113.596 178.24 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 . . . . . 0 CA--C 1.536 0.43 0 CA-C-O 120.877 0.37 . . . . 55.41 111.354 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.566 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 52.5 tp60 -60.49 -33.21 72.28 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.385 -0.37 . . . . 63.13 111.236 -178.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -51.49 -49.69 61.34 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.265 0.555 . . . . 73.04 110.906 175.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.7 mt -61.67 -45.0 95.9 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.695 -0.684 . . . . 72.14 111.016 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.1 t -56.45 -41.11 71.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 120.958 0.409 . . . . 61.22 111.349 177.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 25.6 mm-40 -65.33 -58.94 4.66 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.316 -0.402 . . . . 74.52 111.758 -178.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.457 HG21 HG22 ' A' ' 39' ' ' VAL . 33.4 pt -61.02 -42.41 92.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 111.751 0.278 . . . . 72.2 111.751 -178.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -58.53 -49.78 76.17 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.794 0.331 . . . . 64.24 111.106 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.2 -39.94 67.12 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.326 -0.397 . . . . 70.3 111.916 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 7' ' ' GLN . 78.6 t -66.65 -42.5 89.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.058 0.456 . . . . 74.53 111.243 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.557 ' HB ' HD11 ' A' ' 52' ' ' LEU . 80.5 mt -61.85 -31.87 52.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 116.202 -0.453 . . . . 45.21 112.014 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -62.15 -15.44 45.92 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.312 0.486 . . . . 74.1 112.312 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -86.74 -5.85 59.0 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.471 0.545 . . . . 70.42 112.471 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.487 HD11 HD11 ' A' ' 26' ' ' ILE . 58.0 mt -81.21 117.96 70.32 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-O 120.677 0.275 . . . . 62.11 111.5 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.6 160.03 38.58 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.5 2.133 . . . . 72.21 113.082 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -62.9 131.03 47.37 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.318 -0.401 . . . . 53.14 111.359 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.89 2.04 61.3 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 120.88 -0.676 . . . . 73.03 113.55 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -122.13 148.31 45.06 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.075 0.464 . . . . 65.23 111.62 176.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.6 m -125.4 147.53 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-O 121.309 0.576 . . . . 64.0 111.374 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 44.4 t -123.2 174.51 7.23 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.199 -0.455 . . . . 73.24 110.355 175.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 67.6 p -105.82 147.44 28.66 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.598 0.237 . . . . 71.33 111.408 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -50.55 -36.75 35.86 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.129 0.49 . . . . 71.54 110.697 175.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.47 -48.0 85.24 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 115.735 -0.666 . . . . 52.44 113.243 177.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.438 ' O ' ' HG3' ' A' ' 29' ' ' MET . 44.3 mt-10 -64.81 -48.41 74.52 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 117.073 0.437 . . . . 74.2 111.893 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.487 HD11 HD11 ' A' ' 15' ' ' ILE . 49.0 mm -55.53 -49.4 73.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 121.085 0.469 . . . . 74.12 111.052 177.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.504 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -62.99 -42.76 99.93 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.213 -0.449 . . . . 35.3 111.488 177.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -59.82 -42.56 93.76 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.985 0.421 . . . . 73.13 111.431 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.438 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 66.0 mtt -70.07 -34.87 73.74 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.0 0.429 . . . . 64.15 111.044 178.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.28 -30.68 66.57 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.132 -0.485 . . . . 74.22 111.672 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.39 13.73 14.41 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.512 -0.375 . . . . 74.54 113.355 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.542 ' HB3' ' HB2' ' A' ' 35' ' ' TYR . 52.2 m-85 -128.55 63.1 63.37 Favored Pre-proline 0 CA--C 1.548 0.898 0 O-C-N 122.556 -0.379 . . . . 73.45 111.766 -178.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -55.96 -43.08 60.26 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.646 2.23 . . . . 60.25 113.408 -175.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.04 -22.66 78.73 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.186 -0.53 . . . . 70.33 113.116 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.542 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 90.2 m-85 -86.23 6.67 28.5 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 111.962 0.356 . . . . 74.34 111.962 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.47 -36.18 32.44 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.244 0.545 . . . . 44.21 111.407 177.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.472 ' O ' ' HG3' ' A' ' 41' ' ' LYS . 14.8 ptp180 -55.41 -43.55 75.37 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.848 -0.615 . . . . 74.22 111.416 175.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -72.55 -30.3 64.32 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.334 -0.394 . . . . 73.54 111.443 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.457 HG22 HG21 ' A' ' 8' ' ' ILE . 58.5 t -57.74 -52.28 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 120.899 0.38 . . . . 63.42 110.569 175.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.16 -37.72 93.33 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.081 -0.58 . . . . 63.51 113.039 176.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 37' ' ' ARG . 28.2 mtpp -65.05 -44.14 89.99 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 122.515 -0.403 . . . . 65.45 111.192 177.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.47 -52.36 61.7 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.437 -0.347 . . . . 75.13 111.788 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.433 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 88.9 mt -56.92 -34.46 67.99 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.873 0.368 . . . . 72.31 111.592 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.98 -8.15 33.81 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 121.397 -0.43 . . . . 73.33 114.077 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.415 ' ND2' ' O ' ' A' ' 41' ' ' LYS . 45.7 m-80 -93.41 -12.63 29.39 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 117.379 0.589 . . . . 54.3 112.108 178.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.556 HD12 ' HB3' ' A' ' 54' ' ' TRP . 94.1 mt -74.02 143.68 81.11 Favored Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 112.189 0.441 . . . . 75.23 112.189 -175.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.25 177.51 6.52 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 122.898 2.398 . . . . 74.14 114.094 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -57.79 -45.66 85.7 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.542 -0.754 . . . . 73.21 111.736 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -114.75 56.17 0.51 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.3 -0.476 . . . . 34.23 112.897 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.4 t -66.9 159.35 28.53 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.266 0.469 . . . . 73.31 112.266 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -71.44 -11.18 60.75 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.168 0.508 . . . . 71.42 111.148 175.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.557 HD11 ' HB ' ' A' ' 12' ' ' ILE . 42.0 tp -117.59 124.26 29.07 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 115.849 -0.614 . . . . 75.42 110.713 177.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.536 ' HD2' HD12 ' A' ' 52' ' ' LEU . 58.6 Cg_endo -72.3 95.26 0.76 Allowed 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 121.364 1.376 . . . . 71.35 112.115 176.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.556 ' HB3' HD12 ' A' ' 46' ' ' LEU . 65.7 p-90 -83.5 -32.43 25.96 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.176 0.513 . . . . 74.31 111.89 -177.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -56.7 -24.81 51.74 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.227 0.825 . . . . 65.12 113.227 -177.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -77.85 2.43 17.28 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.444 0.535 . . . . 72.34 112.444 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 18.8 t -115.59 107.87 23.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.239 0.542 . . . . 52.33 111.479 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.518 HG21 HD12 ' A' ' 91' ' ' ILE . 33.7 pt -108.89 -169.73 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 116.164 -0.471 . . . . 65.55 111.339 178.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.59 ' HB3' ' OG ' ' A' ' 65' ' ' SER . 30.9 p30 -93.44 171.79 8.68 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.737 0.643 . . . . 64.34 112.737 -175.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 48.2 t -72.03 -8.08 52.47 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.88 -0.6 . . . . 73.4 111.712 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -84.59 -6.37 59.36 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.496 -0.32 . . . . 74.0 111.502 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.05 31.94 54.08 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 121.006 -0.616 . . . . 45.24 112.084 -174.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.489 ' NZ ' ' HB3' ' A' ' 63' ' ' LYS . 9.5 mtpm? -139.93 173.27 11.69 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.534 0.683 . . . . 53.34 112.02 -176.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.483 HG23 ' OE1' ' A' ' 74' ' ' GLN . 73.8 mt -86.45 116.12 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.415 -0.812 . . . . 53.33 110.469 173.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.59 ' OG ' ' HB3' ' A' ' 59' ' ' ASN . 58.0 m -71.62 -31.92 67.43 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.055 0.391 . . . . 71.11 112.055 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 81.9 mt -72.56 121.94 20.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.038 0.447 . . . . 63.54 111.594 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -115.16 159.56 20.77 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.02 0.438 . . . . 54.24 111.042 177.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.36 -141.59 15.65 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.95 -0.643 . . . . 71.44 111.689 -172.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 69' ' ' ARG . 67.7 mtt-85 -72.45 -22.69 61.05 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 117.624 0.712 . . . . 73.15 110.782 177.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.562 ' HA ' ' HD2' ' A' ' 73' ' ' ARG . 23.3 m-20 -67.72 -23.3 65.26 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.017 -0.538 . . . . 64.1 111.561 177.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.4 tt -67.22 -56.07 11.43 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.87 0.366 . . . . 73.15 110.452 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.19 -27.79 68.94 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.536 -0.302 . . . . 73.24 111.802 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.562 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 97.5 mtt180 -57.33 -62.02 2.06 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.906 0.384 . . . . 50.41 111.223 172.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.483 ' OE1' HG23 ' A' ' 64' ' ' ILE . 55.5 tt0 -63.88 -40.69 97.11 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.315 -0.402 . . . . 73.22 111.584 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.455 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 58.9 tttm -57.58 -61.91 2.16 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 111.917 0.34 . . . . 74.33 111.917 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -57.59 -37.93 74.02 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 111.959 0.355 . . . . 73.45 111.959 -176.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -55.4 -49.34 72.6 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.023 0.44 . . . . 73.51 111.533 176.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.8 mt -70.02 -40.16 75.38 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.052 0.454 . . . . 71.54 111.265 -177.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 45.0 mt-10 -61.76 -35.21 77.44 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.996 0.427 . . . . 71.55 110.767 176.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.26 -31.99 71.8 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.294 -0.412 . . . . 43.15 111.486 176.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -81.49 -9.95 59.59 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.67 0.271 . . . . 71.03 111.679 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.86 27.28 8.45 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 121.346 -0.454 . . . . 72.01 113.386 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 68.4 mt -98.34 130.78 46.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 120.91 0.386 . . . . 71.15 111.83 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.414 ' HG3' ' OH ' ' A' ' 96' ' ' TYR . 45.0 mt-10 -67.62 118.6 11.12 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.447 -0.342 . . . . 70.31 111.243 175.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.9 t -128.57 109.5 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 120.785 0.326 . . . . 74.35 110.85 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.653 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 40.9 m -61.7 147.05 47.26 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.524 -0.307 . . . . 74.24 111.184 177.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.419 ' HG3' HG23 ' A' ' 88' ' ' ILE . 15.3 pt-20 -45.38 -44.65 12.04 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.952 1.093 . . . . 75.33 113.952 -170.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.419 HG23 ' HG3' ' A' ' 87' ' ' GLU . 2.8 pp -80.45 14.27 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 112.404 0.52 . . . . 74.31 112.404 -177.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.15 57.49 3.18 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 121.432 -0.413 . . . . 53.24 112.984 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.653 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 62.1 tttm -125.8 127.09 45.58 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 120.703 0.287 . . . . 71.44 111.334 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.518 HD12 HG21 ' A' ' 58' ' ' ILE . 56.0 mt -126.26 152.16 33.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-O 120.903 0.382 . . . . 74.23 111.469 -175.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -84.02 99.52 10.48 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.274 0.472 . . . . 73.01 112.274 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.568 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 23.4 mt -70.7 -1.61 11.92 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.041 0.756 . . . . 60.12 113.041 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 53.3 mtp85 -96.99 -42.03 8.1 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 122.067 -0.396 . . . . 73.13 111.302 173.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -76.66 -37.39 56.31 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.101 0.408 . . . . 74.13 112.101 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.414 ' OH ' ' HG3' ' A' ' 84' ' ' GLU . 84.6 m-85 -109.82 14.2 23.3 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.461 0.541 . . . . 73.52 112.461 -171.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.568 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 59.2 tttp -62.37 132.71 53.51 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 120.999 0.428 . . . . 64.14 111.613 -177.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 23.0 t90 -69.51 109.52 4.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.235 0.54 . . . . 72.1 111.568 176.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -115.23 98.09 49.7 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 115.713 -0.676 . . . . 53.51 110.758 174.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo . . . . . 0 CA--C 1.541 0.86 0 C-N-CA 122.629 2.219 . . . . 65.45 112.473 173.455 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.558 ' HB2' ' HG ' ' A' ' 5' ' ' LEU . 5.6 m-20 . . . . . 0 CA--C 1.536 0.437 0 CA-C-O 120.648 0.261 . . . . 62.12 111.438 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.437 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 14.3 mm100 -60.15 -25.9 65.87 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.625 0.25 . . . . 63.31 110.993 175.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -53.57 -50.66 65.08 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.171 0.51 . . . . 74.44 110.336 170.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.558 ' HG ' ' HB2' ' A' ' 2' ' ' ASP . 65.0 mt -62.39 -45.76 91.66 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.769 -0.65 . . . . 74.43 110.788 177.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.4 t -56.7 -43.56 79.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 116.018 -0.537 . . . . 65.44 111.797 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 30.2 mm-40 -68.27 -52.0 38.82 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.044 0.387 . . . . 63.31 112.044 -178.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.485 HG21 HG22 ' A' ' 39' ' ' VAL . 32.2 pt -59.6 -41.79 86.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 121.065 -0.254 . . . . 73.12 111.325 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -63.91 -44.21 93.63 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.124 0.488 . . . . 51.11 110.71 175.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.423 ' O ' ' NE2' ' A' ' 14' ' ' GLN . . . -56.5 -32.23 64.83 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.914 -0.585 . . . . 73.03 111.819 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 7' ' ' GLN . 88.3 t -73.35 -47.04 47.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.97 0.414 . . . . 60.43 111.492 176.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.592 ' HB ' HD11 ' A' ' 52' ' ' LEU . 80.9 mt -58.6 -31.69 44.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 112.888 0.699 . . . . 73.2 112.888 -175.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -60.7 -11.33 7.1 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 112.663 0.616 . . . . 75.42 112.663 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.423 ' NE2' ' O ' ' A' ' 10' ' ' ALA . 1.6 mp0 -92.23 -2.17 56.65 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.217 0.451 . . . . 72.12 112.217 178.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.511 HD11 HD11 ' A' ' 26' ' ' ILE . 53.7 mt -84.75 112.53 43.32 Favored Pre-proline 0 CA--C 1.541 0.634 0 O-C-N 122.221 -0.299 . . . . 64.02 110.591 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -72.37 165.4 32.79 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.471 2.114 . . . . 74.22 113.573 -177.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.472 ' HG3' ' OE1' ' A' ' 81' ' ' GLU . 61.5 tttm -59.73 133.35 56.02 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.861 -0.609 . . . . 72.11 112.08 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.96 -7.91 80.51 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-N 116.239 -0.437 . . . . 73.22 114.083 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -108.19 155.25 20.66 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 117.335 0.567 . . . . 74.5 112.034 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.5 m -134.17 159.26 42.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 115.965 -0.561 . . . . 74.44 111.468 178.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 44.6 t -139.24 175.28 9.69 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.948 0.404 . . . . 33.35 110.783 176.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.4 p -109.28 154.62 22.2 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.835 0.35 . . . . 64.22 111.551 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -52.92 -34.78 56.75 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.454 -0.339 . . . . 75.34 111.461 177.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.09 -51.32 54.07 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.334 -0.46 . . . . 63.22 112.86 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 29' ' ' MET . 41.3 mt-10 -58.93 -47.85 83.58 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.85 0.357 . . . . 73.35 111.257 178.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.511 HD11 HD11 ' A' ' 15' ' ' ILE . 49.7 mm -60.02 -47.63 91.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 116.42 -0.355 . . . . 70.15 111.579 178.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.23 -45.72 90.39 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.875 0.369 . . . . 73.3 111.907 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -61.96 -43.76 98.17 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.759 0.314 . . . . 74.41 111.453 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.425 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 64.8 mtt -67.06 -34.27 77.31 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.751 0.31 . . . . 75.54 111.248 178.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.74 -18.31 62.14 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.347 -0.388 . . . . 72.14 112.009 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.34 14.65 32.35 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 121.423 -0.418 . . . . 73.31 113.533 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -127.39 72.95 77.65 Favored Pre-proline 0 CA--C 1.541 0.632 0 O-C-N 122.38 -0.482 . . . . 62.53 111.276 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.21 97.34 0.84 Allowed 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.184 1.923 . . . . 65.22 112.969 -177.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 142.89 -35.25 1.72 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 120.803 -0.713 . . . . 74.32 113.258 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -84.06 34.57 0.51 Allowed 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.257 0.465 . . . . 74.31 112.257 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.77 -39.35 88.45 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.99 0.424 . . . . 72.22 111.676 -178.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.5 ttt85 -61.15 -29.33 69.72 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 116.363 -0.381 . . . . 75.55 111.525 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -76.65 -33.39 58.33 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.828 0.347 . . . . 75.44 110.705 177.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.485 HG22 HG21 ' A' ' 8' ' ' ILE . 47.3 t -58.46 -42.57 84.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 121.346 0.593 . . . . 61.11 109.706 170.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.97 -37.48 92.74 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 115.532 -0.758 . . . . 71.02 113.105 175.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -62.12 -44.52 96.46 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.017 0.437 . . . . 71.53 111.27 176.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.49 -55.21 25.89 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.099 0.476 . . . . 64.24 111.807 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.5 mt -65.64 -32.71 74.43 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.211 -0.45 . . . . 72.53 111.648 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.84 -15.77 62.82 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.322 -0.466 . . . . 73.1 113.18 177.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -89.59 -29.54 18.8 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 122.552 -0.381 . . . . 71.3 110.802 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 97.5 mt -61.8 112.19 5.74 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-O 120.988 0.423 . . . . 75.04 111.323 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -93.33 -170.1 0.24 Allowed 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.946 2.43 . . . . 65.53 114.597 -173.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -62.81 107.16 0.92 Allowed 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.206 -0.906 . . . . 62.22 111.171 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 128.11 -2.43 6.76 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 121.092 -0.575 . . . . 74.44 113.503 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.4 t -64.24 137.8 58.11 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.24 0.459 . . . . 75.42 112.24 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -68.9 -43.91 74.29 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.308 0.575 . . . . 75.34 110.618 175.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.592 HD11 ' HB ' ' A' ' 12' ' ' ILE . 35.9 tp -71.93 125.26 91.62 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.419 -0.809 . . . . 74.44 110.797 177.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.567 ' HD2' HD12 ' A' ' 52' ' ' LEU . 58.2 Cg_endo -71.98 94.95 0.73 Allowed 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 121.138 1.225 . . . . 75.0 111.757 176.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 60.9 p-90 -81.01 -30.95 34.84 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.754 -0.657 . . . . 71.33 111.338 -178.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -60.49 -16.82 40.61 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.649 0.611 . . . . 61.0 112.649 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.446 ' NH2' ' HA ' ' A' ' 17' ' ' LYS . 64.3 mtt-85 -78.3 -11.75 59.96 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.098 0.407 . . . . 75.32 112.098 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 22.7 t -111.71 120.21 61.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.278 0.561 . . . . 64.44 111.934 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.722 HD11 HD21 ' A' ' 93' ' ' LEU . 37.0 pt -120.48 -169.89 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 121.268 0.556 . . . . 63.13 111.731 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.9 p30 -89.78 172.65 8.76 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 121.221 0.534 . . . . 62.14 112.329 -176.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 63.4 p -72.27 -2.99 21.05 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 116.25 -0.432 . . . . 70.21 111.968 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -89.02 -12.0 42.61 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.969 0.414 . . . . 75.33 110.868 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.65 27.05 55.3 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.277 -0.487 . . . . 63.51 112.814 -177.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.522 ' NZ ' ' HB3' ' A' ' 63' ' ' LYS . 8.4 mtpm? -128.1 163.22 25.08 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.388 0.613 . . . . 70.24 112.324 -177.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.568 HG23 ' OE1' ' A' ' 74' ' ' GLN . 67.3 mt -71.39 116.4 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 115.428 -0.805 . . . . 73.1 109.728 170.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.1 m -75.17 -17.5 60.38 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.02 0.748 . . . . 75.22 113.02 -173.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 90.9 mt -77.23 176.33 8.86 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.107 0.48 . . . . 54.13 112.141 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.1 ptmm? -130.6 142.25 50.45 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.394 0.516 . . . . 73.14 112.394 -174.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 48.9 -124.26 12.26 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-N 115.947 -0.57 . . . . 61.43 114.076 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.463 ' HG3' ' H ' ' A' ' 69' ' ' ARG . 19.7 mtm180 -43.3 -53.68 5.07 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.805 0.812 . . . . 72.22 111.157 177.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.45 ' O ' ' HB2' ' A' ' 73' ' ' ARG . 4.3 m-20 -63.7 -34.1 77.11 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.784 -1.098 . . . . 72.42 111.507 -176.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.3 tt -63.72 -49.06 74.55 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 109.536 -0.542 . . . . 75.03 109.536 175.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.43 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 3.2 m-20 -63.88 -19.44 65.07 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.841 -0.618 . . . . 55.24 112.066 177.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.58 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 39.1 mmt180 -66.75 -59.49 3.52 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.034 0.445 . . . . 72.32 110.927 172.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.568 ' OE1' HG23 ' A' ' 64' ' ' ILE . 50.0 tt0 -58.99 -38.87 80.17 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.939 0.4 . . . . 74.11 110.225 177.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.514 ' HG3' HG11 ' A' ' 85' ' ' VAL . 81.2 tttt -59.66 -56.72 18.32 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.999 -0.546 . . . . 65.43 112.209 177.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.58 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 20.8 pt20 -54.27 -36.68 63.88 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 120.896 0.379 . . . . 74.31 111.64 -176.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -67.76 -49.38 62.8 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.945 0.403 . . . . 75.53 111.231 177.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 74' ' ' GLN . 64.8 mt -58.1 -45.36 87.35 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.241 -0.436 . . . . 73.22 111.375 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -62.9 -40.77 98.57 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.757 0.313 . . . . 73.25 110.976 177.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.03 -23.69 67.57 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.158 0.504 . . . . 62.04 111.216 175.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.472 ' OE1' ' HG3' ' A' ' 17' ' ' LYS . 42.1 mm-40 -80.43 -23.15 40.5 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.986 -0.552 . . . . 71.14 111.556 175.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.55 14.86 52.31 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 116.234 -0.439 . . . . 65.13 112.487 -174.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 76.9 mt -82.83 130.0 36.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 122.506 0.322 . . . . 63.51 111.007 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.412 ' HG3' ' OH ' ' A' ' 96' ' ' TYR . 51.6 mt-10 -66.95 92.83 0.24 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.314 0.578 . . . . 74.13 112.115 -177.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.514 HG11 ' HG3' ' A' ' 75' ' ' LYS . 61.2 t -90.49 113.89 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 115.897 -0.592 . . . . 73.03 110.91 174.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.542 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 39.6 t -66.23 142.1 57.82 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.502 -0.317 . . . . 74.35 111.034 174.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -42.37 -42.85 3.33 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.672 0.99 . . . . 65.33 113.672 -174.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.419 ' H ' HG13 ' A' ' 88' ' ' ILE . 2.8 pp -82.33 22.64 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 N-CA-C 112.481 0.548 . . . . 74.02 112.481 -178.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.24 57.97 7.06 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-N 116.428 -0.351 . . . . 52.24 113.36 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.542 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 84.2 tttt -132.28 149.91 52.27 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.769 0.319 . . . . 72.55 111.244 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.56 HD12 HD13 ' A' ' 58' ' ' ILE . 57.1 mt -125.16 150.49 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 120.861 0.362 . . . . 74.22 111.441 -177.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.9 92.68 7.85 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.804 0.335 . . . . 64.32 111.065 175.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.722 HD21 HD11 ' A' ' 58' ' ' ILE . 50.7 mt -59.25 -56.1 26.49 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.36 0.504 . . . . 75.11 112.36 -177.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 41.0 mtm-85 -56.16 -19.62 14.29 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.13 0.419 . . . . 70.01 112.13 -175.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -95.09 -29.0 14.81 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.491 -0.322 . . . . 51.32 111.796 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.412 ' OH ' ' HG3' ' A' ' 84' ' ' GLU . 91.8 m-85 -118.05 9.01 12.59 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.66 0.985 . . . . 74.22 113.66 -175.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.518 ' HG3' ' O ' ' A' ' 93' ' ' LEU . 24.9 mtpp -54.67 133.7 46.91 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 118.489 0.586 . . . . 71.33 112.142 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.409 ' HZ2' ' HB3' ' A' ' 14' ' ' GLN . 16.2 t90 -57.29 113.09 1.6 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.692 -0.685 . . . . 52.52 111.636 177.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 65.7 mt-30 -113.57 92.51 24.16 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 115.537 -0.756 . . . . 71.45 110.28 177.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo . . . . . 0 CA--C 1.54 0.82 0 C-N-CA 122.712 2.275 . . . . 70.5 114.078 -177.184 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.515 ' HB2' ' HG ' ' A' ' 5' ' ' LEU . 5.0 m-20 . . . . . 0 CA--C 1.543 0.709 0 N-CA-C 112.055 0.391 . . . . 73.1 112.055 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -58.32 -34.74 70.93 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.901 0.381 . . . . 64.3 110.314 173.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.435 ' O ' HG12 ' A' ' 8' ' ' ILE . 34.2 t80 -51.95 -49.97 62.13 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.786 -0.643 . . . . 74.21 111.174 174.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.515 ' HG ' ' HB2' ' A' ' 2' ' ' ASP . 84.3 mt -60.97 -52.11 66.41 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.01 -0.541 . . . . 75.24 111.064 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 40.0 t -55.85 -45.81 79.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 116.126 -0.488 . . . . 55.32 111.661 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.429 ' O ' HG23 ' A' ' 11' ' ' VAL . 26.8 mm-40 -63.36 -56.89 12.66 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.161 0.43 . . . . 73.3 112.161 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.514 ' O ' HG13 ' A' ' 12' ' ' ILE . 34.0 pt -58.44 -45.14 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 121.109 -0.237 . . . . 62.33 111.567 -178.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.402 ' N ' HG13 ' A' ' 8' ' ' ILE . 21.1 m-30 -60.64 -45.3 94.59 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.015 0.436 . . . . 71.12 111.016 178.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.1 -26.75 64.95 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.17 -0.468 . . . . 73.1 111.817 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 7' ' ' GLN . 99.2 t -80.99 -43.36 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-O 120.88 0.372 . . . . 73.43 111.213 176.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 8' ' ' ILE . 81.7 mt -54.91 -36.65 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 112.631 0.604 . . . . 73.41 112.631 -178.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -55.15 -19.43 7.69 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.895 0.702 . . . . 74.24 112.895 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -77.12 -23.36 51.77 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.561 0.578 . . . . 72.32 112.561 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.441 ' O ' ' NH1' ' A' ' 56' ' ' ARG . 38.9 mt -70.56 118.7 67.11 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 122.201 0.2 . . . . 74.24 111.495 -177.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -79.68 170.32 17.14 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 122.758 2.305 . . . . 61.44 114.005 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 49.7 tttp -64.02 135.41 56.42 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.992 -0.549 . . . . 64.14 111.294 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.438 ' H ' ' HB3' ' A' ' 81' ' ' GLU . . . 86.31 2.51 85.37 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.078 -0.582 . . . . 32.14 113.402 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.441 ' HB3' ' HA ' ' A' ' 98' ' ' TRP . 47.0 mmtm -118.23 145.44 45.0 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.103 0.478 . . . . 63.34 111.739 177.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.435 HG13 HD13 ' A' ' 83' ' ' ILE . 18.7 m -131.46 150.4 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 115.91 -0.586 . . . . 61.14 111.321 177.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 88.7 p -129.19 164.53 23.21 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.537 -0.302 . . . . 73.1 110.724 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.6 p -90.22 146.91 23.89 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.836 0.35 . . . . 73.04 111.62 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -49.57 -37.37 27.11 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.025 0.44 . . . . 71.15 111.3 176.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.05 -40.19 98.15 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 115.95 -0.568 . . . . 73.23 113.466 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -69.07 -50.54 47.43 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.983 0.392 . . . . 73.33 111.603 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.5 mm -59.35 -47.61 89.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 120.841 0.353 . . . . 75.13 110.965 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.546 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -60.81 -44.78 96.42 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.405 -0.361 . . . . 71.53 111.591 177.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -54.99 -51.34 66.53 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.977 0.418 . . . . 75.42 111.731 177.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 67.9 mtm -71.24 -27.3 63.37 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.07 -0.513 . . . . 74.34 112.049 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.44 -30.81 62.04 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.946 0.403 . . . . 73.1 111.521 176.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.07 17.04 10.52 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.405 -0.426 . . . . 73.44 113.243 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.546 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 53.1 m-85 -133.48 61.66 55.19 Favored Pre-proline 0 CA--C 1.549 0.91 0 O-C-N 122.665 -0.315 . . . . 75.24 111.237 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -52.0 -38.47 69.52 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.022 2.481 . . . . 75.33 114.307 -173.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.8 -1.32 86.97 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 121.133 -0.555 . . . . 72.24 113.619 -178.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.491 ' O ' HG23 ' A' ' 39' ' ' VAL . 11.2 m-85 -97.51 10.61 39.34 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.925 0.713 . . . . 73.24 112.925 -177.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.68 -50.18 34.38 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.565 0.698 . . . . 74.34 111.083 176.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -52.41 -44.43 65.39 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.299 -0.864 . . . . 74.51 111.697 172.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.407 ' HD2' ' HA ' ' A' ' 35' ' ' TYR . 99.2 m-70 -72.18 -26.17 61.96 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.381 -0.372 . . . . 74.25 111.725 -177.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 35' ' ' TYR . 58.9 t -62.83 -46.72 95.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 120.894 0.378 . . . . 63.11 110.295 174.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -57.48 -42.63 94.01 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.102 -0.571 . . . . 65.52 112.355 174.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -64.17 -37.49 87.66 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.898 0.38 . . . . 72.31 111.223 175.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.76 -44.26 81.89 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.321 -0.399 . . . . 64.2 112.065 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 39' ' ' VAL . 61.4 mt -63.61 -29.08 70.38 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.801 0.334 . . . . 71.45 111.355 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.43 -16.3 49.31 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 121.238 -0.506 . . . . 61.41 113.29 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -77.19 -21.45 53.91 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.011 0.434 . . . . 73.34 111.247 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 95.0 mt -89.8 135.75 30.12 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-O 121.058 0.456 . . . . 73.42 112.163 -175.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -81.88 178.56 6.37 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.83 2.353 . . . . 72.44 113.539 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.553 ' HB3' ' HG3' ' A' ' 73' ' ' ARG . 1.2 pm0 -86.19 23.46 1.53 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.95 -0.568 . . . . 75.35 112.211 -177.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -147.29 35.81 1.22 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 121.195 -0.526 . . . . 34.51 112.693 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 34.6 t -86.52 166.76 15.2 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.47 0.653 . . . . 74.43 112.759 -176.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -82.23 -10.27 59.19 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.374 -0.83 . . . . 64.12 111.4 176.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.537 HD12 ' HD2' ' A' ' 53' ' ' PRO . 41.3 tp -109.68 122.56 38.88 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 116.028 -0.533 . . . . 71.54 110.792 178.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.537 ' HD2' HD12 ' A' ' 52' ' ' LEU . 67.8 Cg_endo -76.1 94.3 1.02 Allowed 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 121.182 1.255 . . . . 62.11 111.716 175.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.412 ' HB2' HD22 ' A' ' 43' ' ' LEU . 53.3 p-90 -84.46 -33.92 23.54 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.72 -0.673 . . . . 73.42 111.707 -176.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.455 ' O ' HD21 ' A' ' 78' ' ' LEU . 9.6 p90 -56.73 -19.45 16.83 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.209 0.818 . . . . 71.25 113.209 -178.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.441 ' NH1' ' O ' ' A' ' 15' ' ' ILE . 98.0 mtt180 -73.53 4.9 4.29 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 112.31 0.485 . . . . 65.23 112.31 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.5 t -122.92 116.44 48.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 CA-C-O 121.22 0.534 . . . . 64.34 111.303 177.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.515 HG21 HD12 ' A' ' 91' ' ' ILE . 28.9 pt -120.18 -170.81 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 116.329 -0.396 . . . . 63.0 111.433 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.462 ' HB3' ' OG ' ' A' ' 65' ' ' SER . 32.5 p30 -86.74 169.72 12.39 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.375 0.607 . . . . 44.53 112.46 -176.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.2 m -63.8 -26.71 68.75 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.835 -0.621 . . . . 64.31 112.16 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -76.24 -7.59 55.22 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.257 0.466 . . . . 61.12 112.257 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.55 42.67 13.57 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 121.242 -0.504 . . . . 52.53 112.627 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.452 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 58.3 mtpt -140.94 171.08 14.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.993 0.425 . . . . 73.33 110.757 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 59.2 mt -84.56 122.69 38.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 116.407 -0.361 . . . . 71.55 110.661 176.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.462 ' OG ' ' HB3' ' A' ' 59' ' ' ASN . 58.4 m -81.77 -12.11 58.71 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.234 0.457 . . . . 55.24 112.234 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.6 mt -80.61 148.57 30.22 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.821 0.343 . . . . 74.32 110.79 174.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -116.5 157.78 24.66 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.249 0.463 . . . . 71.41 112.249 -176.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 55.2 -128.11 43.19 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 116.076 -0.511 . . . . 62.34 113.965 176.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -55.07 -44.64 74.98 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.134 0.492 . . . . 61.22 111.924 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -60.99 -32.93 72.48 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.965 -0.561 . . . . 72.34 111.624 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.0 tt -65.79 -53.28 42.38 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.817 0.342 . . . . 72.02 110.185 176.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -58.71 -34.18 71.03 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.802 0.334 . . . . 60.12 111.526 177.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.553 ' HG3' ' HB3' ' A' ' 48' ' ' GLU . 39.5 ttm180 -61.15 -56.37 21.56 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.098 0.475 . . . . 75.5 110.998 176.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -63.13 -41.81 99.37 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.062 0.458 . . . . 73.51 110.951 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.4 ' HG3' HG11 ' A' ' 85' ' ' VAL . 49.0 tttm -55.61 -61.78 2.13 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.864 -0.607 . . . . 61.45 111.804 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -54.74 -36.85 65.22 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.415 -0.357 . . . . 64.42 111.553 -175.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.439 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 73.4 mmtt -63.02 -43.87 97.51 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.846 0.355 . . . . 65.54 111.546 176.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.455 HD21 ' O ' ' A' ' 55' ' ' PHE . 96.2 mt -67.94 -33.55 74.9 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.902 0.382 . . . . 73.3 111.25 177.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -58.06 -41.97 84.45 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.347 0.594 . . . . 44.21 109.97 172.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.32 -21.28 66.69 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.692 -0.686 . . . . 72.31 111.897 177.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 77' ' ' LYS . 7.4 mm-40 -85.31 -10.11 56.83 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.832 0.348 . . . . 74.44 111.532 177.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.08 25.96 25.3 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.249 -0.5 . . . . 72.13 112.701 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.435 HD13 HG13 ' A' ' 20' ' ' VAL . 66.3 mt -102.49 146.06 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 120.972 0.415 . . . . 62.52 111.774 -177.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -88.43 95.47 10.23 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 111.776 0.288 . . . . 61.53 111.776 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.4 HG11 ' HG3' ' A' ' 75' ' ' LYS . 22.4 t -95.74 98.33 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-O 121.162 0.506 . . . . 74.34 110.218 173.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.569 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 50.4 m -56.88 152.52 12.59 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.838 -0.619 . . . . 64.01 112.333 -178.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.423 ' HG3' HG23 ' A' ' 88' ' ' ILE . 12.3 pt-20 -41.31 -36.87 0.88 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 115.037 1.495 . . . . 72.32 115.037 -171.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.452 HD11 ' HB2' ' A' ' 90' ' ' LYS . 2.9 pp -92.81 13.11 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 112.706 0.632 . . . . 64.21 112.706 -176.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.92 42.6 7.09 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 121.587 -0.34 . . . . 25.53 113.439 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.569 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 62.6 tttp -116.45 142.65 46.59 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 122.622 -0.34 . . . . 63.04 111.46 -177.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.515 HD12 HG21 ' A' ' 58' ' ' ILE . 62.2 mt -129.45 146.7 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 120.928 0.394 . . . . 61.13 111.607 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.85 97.35 10.15 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.94 0.4 . . . . 51.41 111.601 177.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.496 HD21 HD11 ' A' ' 58' ' ' ILE . 67.7 mt -60.31 -55.37 34.53 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.01 0.374 . . . . 61.43 112.01 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 29.6 mtp180 -57.11 -9.29 0.86 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.17 0.804 . . . . 73.21 113.17 -175.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -105.59 -37.86 6.63 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 111.751 0.278 . . . . 72.5 111.751 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -116.56 13.7 15.36 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.281 0.474 . . . . 70.23 112.281 -173.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 80.3 tttt -65.63 139.05 58.39 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.097 0.475 . . . . 63.51 111.46 -178.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.441 ' HA ' ' HB3' ' A' ' 19' ' ' LYS . 17.5 t90 -59.96 111.94 1.68 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.065 0.459 . . . . 75.14 111.432 178.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -107.25 92.42 8.02 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 116.096 -0.502 . . . . 65.02 111.001 177.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo . . . . . 0 CA--C 1.542 0.879 0 C-N-CA 122.579 2.186 . . . . 62.44 112.936 177.823 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 . . . . . 0 CA--C 1.539 0.551 0 CA-C-O 120.717 0.294 . . . . 70.12 111.267 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -52.8 -35.18 56.49 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.319 0.489 . . . . 65.54 112.319 -177.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -54.32 -49.61 69.3 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.245 0.545 . . . . 71.44 110.75 176.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 77.8 mt -65.71 -42.59 90.92 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.768 -0.651 . . . . 73.0 110.919 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 92.2 t -55.28 -46.56 78.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.362 -0.381 . . . . 62.23 111.559 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.427 ' O ' HG23 ' A' ' 11' ' ' VAL . 27.4 mm-40 -66.98 -56.39 10.36 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.252 0.464 . . . . 74.21 112.252 -177.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.502 ' O ' HG13 ' A' ' 12' ' ' ILE . 29.9 pt -58.66 -41.85 83.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 O-C-N 122.199 -0.313 . . . . 71.3 111.722 -178.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.414 ' CD1' HG13 ' A' ' 8' ' ' ILE . 9.0 m-30 -62.34 -43.7 98.2 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.813 0.34 . . . . 63.32 110.915 177.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.32 -28.34 64.96 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.018 0.437 . . . . 73.4 111.664 177.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 7' ' ' GLN . 57.6 t -80.66 -41.47 20.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 120.81 0.338 . . . . 72.43 110.998 176.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 8' ' ' ILE . 83.2 mt -61.23 -42.38 93.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 112.206 0.447 . . . . 75.44 112.206 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -59.94 -20.69 58.85 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.096 0.406 . . . . 74.31 112.096 178.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.48 -2.34 55.69 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.007 0.373 . . . . 71.14 112.007 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.566 HD11 HD11 ' A' ' 26' ' ' ILE . 61.0 mt -84.61 113.82 51.48 Favored Pre-proline 0 CA--C 1.543 0.673 0 O-C-N 122.374 -0.204 . . . . 71.23 110.472 175.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 15' ' ' ILE . 15.1 Cg_exo -69.54 147.66 64.79 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.003 2.468 . . . . 64.02 113.537 -178.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -52.2 120.02 5.01 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 116.021 -0.536 . . . . 72.12 111.791 176.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.69 -8.84 40.34 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.118 -0.563 . . . . 65.04 113.037 -177.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -115.18 152.1 33.23 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.985 0.421 . . . . 64.14 111.23 176.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.449 HG13 HD13 ' A' ' 83' ' ' ILE . 32.8 m -130.18 159.14 42.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-O 121.168 0.509 . . . . 53.35 110.962 177.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 45.4 t -138.98 168.44 19.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.997 0.427 . . . . 61.15 111.131 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.4 p -103.78 148.44 26.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.456 -0.338 . . . . 73.35 111.343 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.402 ' HE1' HD12 ' A' ' 43' ' ' LEU . 73.3 m-85 -51.72 -33.14 33.12 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.749 0.309 . . . . 74.44 111.394 175.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.16 -44.26 98.36 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.18 -0.533 . . . . 72.12 112.691 176.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.459 ' O ' ' HG3' ' A' ' 29' ' ' MET . 41.3 mt-10 -70.79 -49.57 45.14 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.575 0.226 . . . . 73.22 111.519 178.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.566 HD11 HD11 ' A' ' 15' ' ' ILE . 51.4 mm -56.07 -56.53 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 111.958 0.355 . . . . 70.32 111.958 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.435 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -58.97 -39.99 83.42 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.095 0.474 . . . . 73.2 111.305 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -60.82 -42.41 97.63 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.136 -0.484 . . . . 72.3 111.149 178.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.459 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 66.5 mtt -72.65 -36.26 67.93 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 120.898 0.38 . . . . 72.22 111.462 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.04 -21.28 65.02 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.981 0.42 . . . . 75.21 111.517 178.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.73 18.06 28.8 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.319 -0.467 . . . . 63.42 113.217 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.435 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 88.0 m-85 -123.44 85.94 52.28 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-O 120.783 0.325 . . . . 60.24 111.282 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.76 135.47 25.91 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.412 2.075 . . . . 73.42 112.672 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.5 -26.65 8.84 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.28 -0.486 . . . . 43.35 113.24 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -73.36 3.62 5.7 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 112.423 0.527 . . . . 65.11 112.423 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.0 -44.43 30.77 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.056 0.455 . . . . 45.52 112.027 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -63.43 -33.79 76.32 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 116.043 -0.526 . . . . 72.32 111.821 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -75.09 -34.61 61.77 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.799 0.333 . . . . 71.43 111.032 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.444 HG13 HD12 ' A' ' 8' ' ' ILE . 51.2 t -59.46 -40.11 80.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 121.118 0.485 . . . . 61.43 110.18 173.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.94 -41.01 99.19 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 115.92 -0.582 . . . . 54.12 112.665 174.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -57.98 -49.13 77.88 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.074 0.464 . . . . 74.01 110.424 174.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.71 -53.9 52.42 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.815 -0.629 . . . . 71.41 111.54 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.402 HD12 ' HE1' ' A' ' 23' ' ' TYR . 40.3 mt -62.98 -32.3 73.61 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.9 0.381 . . . . 75.42 111.03 178.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.97 -22.81 65.14 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.324 -0.465 . . . . 75.34 113.306 176.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.522 HD22 ' N ' ' A' ' 45' ' ' ASN . 0.8 OUTLIER -80.17 -20.13 45.52 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.841 0.353 . . . . 74.25 111.223 177.133 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 82.0 mt -76.94 140.66 67.03 Favored Pre-proline 0 CA--C 1.539 0.546 0 N-CA-C 112.255 0.465 . . . . 52.12 112.255 -178.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -88.48 172.95 4.7 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.941 2.427 . . . . 64.21 112.648 176.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.33 -31.36 72.49 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.489 -0.323 . . . . 54.12 111.859 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.02 52.43 4.39 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 120.96 -0.638 . . . . 75.54 113.101 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.8 t -102.32 142.38 33.63 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.131 0.419 . . . . 72.41 112.131 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -69.39 -35.76 76.1 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.24 0.543 . . . . 73.44 110.678 174.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.527 HD12 ' HD2' ' A' ' 53' ' ' PRO . 39.7 tp -80.92 121.49 80.93 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.884 -0.598 . . . . 73.35 110.733 175.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.527 ' HD2' HD12 ' A' ' 52' ' ' LEU . 60.8 Cg_endo -72.71 94.56 0.78 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 121.269 1.313 . . . . 65.51 111.725 176.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 55.7 p-90 -84.46 -25.36 28.99 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.201 0.524 . . . . 75.44 111.922 -177.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.548 ' HA ' ' HG3' ' A' ' 74' ' ' GLN . 29.9 p90 -62.97 -22.6 66.94 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.219 0.822 . . . . 72.34 113.219 -177.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -75.63 -3.46 34.62 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.455 0.539 . . . . 74.33 112.455 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.4 t -115.2 114.05 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 120.989 0.423 . . . . 65.42 111.673 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.629 HD11 HD21 ' A' ' 93' ' ' LEU . 39.1 pt -115.99 -171.09 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 120.942 0.401 . . . . 71.21 111.807 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 34.7 p30 -83.06 178.01 8.33 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.267 0.556 . . . . 74.01 112.1 -176.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 57.2 p -81.63 -1.31 46.13 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 116.229 -0.442 . . . . 75.13 111.98 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -86.94 -21.14 26.43 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.771 0.319 . . . . 65.45 111.372 177.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.08 22.67 24.63 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 121.257 -0.497 . . . . 72.24 112.212 -173.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.495 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 55.2 mtpt -129.4 172.77 11.18 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.126 0.488 . . . . 63.33 111.489 -177.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.687 HD11 HG11 ' A' ' 85' ' ' VAL . 55.3 mt -72.55 144.22 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.224 0.535 . . . . 72.3 111.329 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.4 p -88.47 -44.04 11.0 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.214 -0.448 . . . . 72.41 111.465 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.43 HD13 ' HB3' ' A' ' 70' ' ' ASP . 74.9 mt -76.42 159.87 30.06 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.291 0.567 . . . . 70.25 112.037 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -131.73 165.91 22.68 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.037 -0.529 . . . . 74.2 111.879 -175.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.04 -138.0 41.37 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-N 116.23 -0.441 . . . . 52.3 113.13 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 65.1 mtm180 -59.11 -26.59 64.82 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.925 0.393 . . . . 62.12 111.58 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.43 ' HB3' HD13 ' A' ' 66' ' ' LEU . 13.2 m-20 -73.21 -29.39 62.77 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.393 -0.367 . . . . 74.13 111.637 177.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.9 tt -62.26 -48.11 81.4 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 109.199 -0.667 . . . . 70.2 109.199 174.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.93 -43.24 95.05 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.887 -0.597 . . . . 72.2 111.364 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 73' ' ' ARG . 64.1 mtt180 -53.69 -57.49 10.64 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 120.805 0.336 . . . . 73.41 111.314 175.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.548 ' HG3' ' HA ' ' A' ' 55' ' ' PHE . 43.3 tt0 -62.88 -47.12 84.7 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.037 0.446 . . . . 65.42 111.094 -177.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.446 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 61.6 tttp -58.37 -60.7 3.37 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.967 -0.56 . . . . 61.21 111.978 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -62.14 -26.27 68.22 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.644 0.609 . . . . 63.13 112.644 -173.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -64.12 -48.73 74.98 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.207 0.527 . . . . 74.14 110.715 170.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.548 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 41.1 mt -61.04 -47.21 87.45 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.89 -0.595 . . . . 70.21 110.994 176.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 57.4 mm-40 -50.08 -39.67 43.18 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.719 -0.673 . . . . 75.35 111.02 175.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.38 -32.89 74.44 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.138 -0.483 . . . . 72.54 112.144 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -91.48 0.1 57.55 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 111.875 0.324 . . . . 74.44 111.875 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.24 5.81 59.15 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.351 -0.452 . . . . 64.01 113.247 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.548 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 61.4 mt -85.46 102.54 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 121.229 0.537 . . . . 71.2 110.617 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -78.69 110.62 13.99 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.683 0.623 . . . . 73.13 112.683 -171.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.687 HG11 HD11 ' A' ' 64' ' ' ILE . 40.3 t -97.41 121.12 47.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 116.096 -0.502 . . . . 73.53 111.988 -178.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.531 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 30.9 t -59.1 150.7 24.34 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.161 0.43 . . . . 71.23 112.161 177.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -50.42 -39.86 48.52 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.331 0.863 . . . . 75.55 113.331 -174.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.415 ' H ' HG13 ' A' ' 88' ' ' ILE . 2.8 pp -81.04 18.9 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-O 121.114 0.483 . . . . 74.32 111.859 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.72 50.25 9.49 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 116.164 -0.471 . . . . 32.12 113.407 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.531 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 50.1 tttm -125.25 149.4 48.04 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 122.423 -0.457 . . . . 72.51 112.073 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.57 HD12 HG21 ' A' ' 58' ' ' ILE . 49.1 mt -123.45 152.93 28.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.235 -0.439 . . . . 54.03 110.322 174.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -86.68 93.29 9.19 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.816 0.341 . . . . 63.1 111.141 176.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.629 HD21 HD11 ' A' ' 58' ' ' ILE . 51.0 mt -58.88 -53.96 52.48 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.039 0.385 . . . . 71.12 112.039 -178.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 21.7 ttp180 -56.18 -19.02 11.84 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-O 121.222 0.534 . . . . 54.21 111.606 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.465 ' O ' ' HD3' ' A' ' 95' ' ' LYS . 7.8 tmtt? -91.43 -45.13 8.72 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 116.501 -0.318 . . . . 63.0 110.985 177.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -107.92 10.37 28.48 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.902 0.704 . . . . 73.53 112.902 -170.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 59.1 tttp -58.9 132.23 53.36 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.413 0.523 . . . . 42.02 112.413 -172.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 17.0 t90 -58.51 105.56 0.31 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.937 -0.574 . . . . 75.11 112.181 -179.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -102.89 102.07 25.01 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 115.6 -0.727 . . . . 65.35 110.434 171.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo . . . . . 0 CA--C 1.54 0.777 0 C-N-CA 122.378 2.052 . . . . 50.04 112.871 177.798 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.434 ' O ' HG23 ' A' ' 6' ' ' VAL . 15.1 t70 . . . . . 0 CA--C 1.543 0.682 0 N-CA-C 112.553 0.575 . . . . 73.52 112.553 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -60.83 -27.72 68.27 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.881 0.697 . . . . 74.24 112.881 -175.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.414 ' O ' HG12 ' A' ' 8' ' ' ILE . 59.7 t80 -58.74 -51.64 69.1 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.23 0.538 . . . . 64.34 110.086 174.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 70.0 mt -67.47 -46.42 73.04 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.543 -0.753 . . . . 63.53 111.128 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 2' ' ' ASP . 94.1 t -54.39 -48.82 68.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 116.285 -0.416 . . . . 74.25 112.02 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.43 ' O ' HG23 ' A' ' 11' ' ' VAL . 30.8 mm-40 -68.62 -51.44 42.25 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.747 0.647 . . . . 72.01 112.747 -177.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.494 HD12 HG13 ' A' ' 39' ' ' VAL . 30.2 pt -58.92 -41.54 83.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 120.751 0.31 . . . . 61.31 111.368 -178.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -64.01 -44.45 92.55 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.081 0.467 . . . . 71.33 110.591 174.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.98 -20.4 37.89 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.316 0.487 . . . . 73.24 112.316 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 7' ' ' GLN . 59.1 t -83.8 -43.95 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 120.978 0.418 . . . . 65.34 111.03 174.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.571 ' HB ' HD11 ' A' ' 52' ' ' LEU . 72.7 mt -61.02 -30.77 48.3 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 112.655 0.613 . . . . 75.21 112.655 -177.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -55.64 -18.03 6.96 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 112.8 0.667 . . . . 60.04 112.8 178.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -91.18 -0.89 57.78 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.239 0.459 . . . . 74.02 112.239 -178.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.526 HD11 HD11 ' A' ' 26' ' ' ILE . 61.2 mt -87.28 113.54 54.38 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-O 120.417 0.151 . . . . 74.33 110.905 178.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -77.74 170.31 19.3 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.685 2.257 . . . . 75.03 113.87 -177.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.2 tttp -61.32 130.52 46.53 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.085 -0.507 . . . . 73.31 111.247 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.67 2.97 75.0 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.035 -0.603 . . . . 54.33 113.688 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -120.72 148.33 44.09 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 117.272 0.536 . . . . 63.51 111.315 176.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.6 m -128.69 157.27 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.224 0.535 . . . . 71.21 111.898 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.4 m -133.1 163.46 29.2 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.158 -0.474 . . . . 42.21 110.796 176.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 44.5 p -93.88 149.09 21.54 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.734 0.302 . . . . 62.0 111.416 178.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -51.12 -38.81 54.12 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.866 0.365 . . . . 75.1 111.19 177.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.23 -47.78 89.13 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-N 116.154 -0.475 . . . . 72.51 112.875 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.455 ' O ' ' HG3' ' A' ' 29' ' ' MET . 46.0 mt-10 -59.63 -55.63 32.01 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.705 0.288 . . . . 55.1 111.537 178.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.526 HD11 HD11 ' A' ' 15' ' ' ILE . 49.8 mm -53.57 -50.43 49.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 120.956 0.408 . . . . 75.4 111.784 -178.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.473 ' HB2' HG21 ' A' ' 39' ' ' VAL . . . -64.13 -45.78 87.03 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.889 0.376 . . . . 71.41 111.802 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.9 tttp -64.49 -35.83 82.2 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.508 -0.314 . . . . 75.32 111.4 -177.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.455 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 65.9 mtt -68.4 -43.44 77.26 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.054 0.454 . . . . 63.53 110.769 176.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.54 -23.03 66.77 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.03 -0.532 . . . . 65.33 111.963 178.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.12 31.7 4.61 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.473 -0.394 . . . . 60.54 113.414 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -129.73 89.32 46.8 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-O 120.874 0.368 . . . . 71.41 111.402 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -73.72 125.37 9.95 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.135 2.556 . . . . 63.14 113.124 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.33 -13.99 66.31 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 121.323 -0.465 . . . . 71.5 113.584 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.428 ' HA ' ' HD2' ' A' ' 38' ' ' HIS . 74.5 m-85 -84.58 10.57 10.72 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.838 0.681 . . . . 73.53 112.838 -176.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.48 -52.72 20.99 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.719 0.637 . . . . 52.24 112.719 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -65.69 -26.47 67.79 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.887 0.375 . . . . 73.22 111.872 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.428 ' HD2' ' HA ' ' A' ' 35' ' ' TYR . 99.5 m-70 -74.83 -32.28 61.9 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.95 0.405 . . . . 73.24 110.921 177.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.494 HG13 HD12 ' A' ' 8' ' ' ILE . 81.3 t -59.44 -40.46 81.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-O 121.252 0.549 . . . . 62.43 110.195 170.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -57.93 -41.99 94.55 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.869 -0.605 . . . . 71.31 112.732 174.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -56.68 -40.16 75.07 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.094 0.473 . . . . 71.22 111.218 175.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.1 -51.72 23.51 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.914 -0.585 . . . . 73.42 112.179 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.9 mt -60.65 -45.14 95.23 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.2 0.444 . . . . 64.45 112.2 -176.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.59 -20.93 64.32 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 120.692 -0.766 . . . . 55.23 113.05 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -83.63 -20.97 32.69 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 120.71 0.291 . . . . 74.01 111.489 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.454 HD12 ' HB3' ' A' ' 54' ' ' TRP . 94.4 mt -67.05 147.68 99.02 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 111.889 0.329 . . . . 73.43 111.889 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.548 ' HG2' ' HB3' ' A' ' 50' ' ' SER . 30.1 Cg_endo -63.56 165.54 17.71 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.402 2.068 . . . . 53.23 112.715 176.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.405 ' HG2' ' HE ' ' A' ' 73' ' ' ARG . 45.7 mt-10 -57.3 -41.14 79.28 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.584 0.587 . . . . 74.42 112.584 -177.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -128.43 60.27 0.67 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.981 -0.628 . . . . 70.01 113.744 -177.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.548 ' HB3' ' HG2' ' A' ' 47' ' ' PRO . 24.5 p -76.97 -178.7 5.07 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 122.459 -0.436 . . . . 72.33 110.878 176.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.429 ' NZ ' ' HB2' ' A' ' 51' ' ' LYS . 5.2 ttmp? -61.04 -28.52 69.12 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.065 0.46 . . . . 75.14 110.825 174.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.571 HD11 ' HB ' ' A' ' 12' ' ' ILE . 26.0 tp -103.38 130.78 22.92 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 116.017 -0.538 . . . . 73.53 111.812 -177.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.534 ' HD2' HD12 ' A' ' 52' ' ' LEU . 72.0 Cg_endo -79.42 95.89 1.06 Allowed 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 121.657 1.571 . . . . 70.44 111.511 170.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.454 ' HB3' HD12 ' A' ' 46' ' ' LEU . 64.8 p-90 -76.51 -28.77 56.53 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.162 -0.472 . . . . 74.32 112.202 -175.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.491 ' O ' HD21 ' A' ' 78' ' ' LEU . 24.8 p90 -60.7 -19.96 59.89 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.409 0.892 . . . . 62.32 113.409 -175.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -76.82 6.76 5.59 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.864 0.69 . . . . 54.22 112.864 -176.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 45.1 t -123.62 125.85 72.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 O-C-N 121.929 -0.482 . . . . 54.31 111.624 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.541 HG21 HD12 ' A' ' 91' ' ' ILE . 32.5 pt -127.35 -169.63 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 121.157 0.503 . . . . 74.23 111.357 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.414 ' HB3' ' OG ' ' A' ' 65' ' ' SER . 30.9 p30 -87.26 173.97 8.87 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.068 0.461 . . . . 64.03 111.824 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 33.3 p -84.79 9.74 13.32 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.965 0.412 . . . . 61.52 111.646 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -93.14 -14.79 26.75 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.003 0.43 . . . . 72.52 110.542 173.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.38 37.17 18.45 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 121.081 -0.58 . . . . 75.43 112.161 -174.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -137.35 167.71 21.06 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.645 0.736 . . . . 62.22 112.379 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.516 ' CG2' HD12 ' A' ' 71' ' ' LEU . 74.9 mt -83.68 108.53 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.109 -0.95 . . . . 54.12 110.209 172.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.414 ' OG ' ' HB3' ' A' ' 59' ' ' ASN . 71.2 m -69.7 -25.9 64.09 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.73 0.641 . . . . 54.13 112.73 -175.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.499 HD13 ' HB3' ' A' ' 70' ' ' ASP . 88.6 mt -64.78 124.38 21.82 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.696 0.284 . . . . 73.23 111.018 178.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -113.05 141.59 46.7 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.14 0.495 . . . . 63.14 111.211 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 107.88 -136.43 13.44 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.462 -0.655 . . . . 63.02 111.462 -173.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -81.76 -24.94 35.73 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 117.511 0.656 . . . . 64.1 110.896 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.499 ' HB3' HD13 ' A' ' 66' ' ' LEU . 7.8 m-20 -62.36 -24.83 67.58 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.121 -0.49 . . . . 72.44 111.936 176.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.516 HD12 ' CG2' ' A' ' 64' ' ' ILE . 16.2 tp -56.84 -60.65 3.26 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.414 0.626 . . . . 74.12 110.561 174.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.554 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 18.8 m-20 -67.03 -32.48 73.72 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.605 -0.725 . . . . 74.12 111.178 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.405 ' HE ' ' HG2' ' A' ' 48' ' ' GLU . 57.7 ttt180 -50.13 -59.01 4.33 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-O 121.3 0.572 . . . . 63.1 111.204 174.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -62.29 -43.55 98.58 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.007 -0.542 . . . . 63.44 110.7 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.43 ' HB3' ' HA ' ' A' ' 72' ' ' ASP . 76.4 tttt -50.0 -58.24 5.9 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.722 -0.672 . . . . 73.1 112.306 176.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.554 ' HG3' ' O ' ' A' ' 72' ' ' ASP . 96.0 mt-30 -52.75 -49.19 65.97 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.142 0.496 . . . . 74.25 111.467 -178.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -68.91 -27.06 65.43 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.5 0.556 . . . . 72.41 112.5 -177.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.495 HD13 HD11 ' A' ' 91' ' ' ILE . 57.6 mt -77.79 -39.03 45.3 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.169 0.433 . . . . 75.5 112.169 177.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -62.8 -30.69 71.66 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.025 0.441 . . . . 73.22 110.617 175.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.82 -20.06 66.19 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 116.04 -0.527 . . . . 40.34 111.483 174.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -86.98 2.67 48.72 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.201 -0.454 . . . . 73.25 111.443 177.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.2 15.67 71.37 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.092 -0.575 . . . . 74.41 112.832 -177.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 73.0 mt -92.1 124.5 44.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 120.959 0.409 . . . . 73.52 111.643 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.507 ' HG2' ' OH ' ' A' ' 96' ' ' TYR . 9.0 pt-20 -72.76 90.84 1.44 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.6 0.714 . . . . 70.01 111.308 175.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 62.3 t -85.73 112.53 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 116.071 -0.513 . . . . 51.1 110.477 176.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.571 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 42.1 t -61.26 142.57 56.73 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.757 -0.201 . . . . 73.32 111.055 178.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -48.52 -38.47 20.37 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.744 1.016 . . . . 73.44 113.744 -172.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.426 ' H ' HG13 ' A' ' 88' ' ' ILE . 2.8 pp -80.32 16.42 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 CA-C-O 121.083 0.468 . . . . 74.42 112.23 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.37 52.31 6.18 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 116.373 -0.376 . . . . 75.42 113.443 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.571 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 1.3 tmtp? -125.4 136.23 53.22 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.052 0.453 . . . . 72.44 111.214 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.541 HD12 HG21 ' A' ' 58' ' ' ILE . 69.7 mt -125.59 126.49 70.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 116.018 -0.537 . . . . 72.23 110.864 178.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.98 98.29 1.26 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 111.973 0.36 . . . . 73.41 111.973 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.453 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 86.2 mt -53.47 -53.22 54.6 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.337 -0.392 . . . . 64.21 111.838 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 18.5 ttm180 -56.21 -26.58 51.54 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 112.189 0.44 . . . . 75.22 112.189 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -89.66 -28.88 19.17 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.137 0.421 . . . . 70.22 112.137 -177.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.507 ' OH ' ' HG2' ' A' ' 84' ' ' GLU . 70.9 m-85 -124.73 12.76 8.57 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.658 0.614 . . . . 75.12 112.658 -174.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 63.6 tttp -60.08 131.5 51.02 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.093 0.473 . . . . 74.04 111.825 -177.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 19.8 t90 -56.15 124.26 17.27 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.954 -0.566 . . . . 74.14 111.735 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -108.82 88.87 5.78 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 116.035 -0.53 . . . . 74.0 111.029 176.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo . . . . . 0 CA--C 1.536 0.583 0 C-N-CA 122.02 1.814 . . . . 72.22 111.385 173.874 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 CA--C 1.539 0.547 0 N-CA-C 112.666 0.617 . . . . 71.4 112.666 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -57.0 -30.31 64.05 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.22 -0.446 . . . . 74.55 110.964 175.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -57.69 -52.39 65.62 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.041 0.448 . . . . 51.12 110.717 174.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.4 mt -63.8 -48.19 77.89 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.964 -0.562 . . . . 71.22 111.471 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 67.4 t -53.03 -49.52 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 120.931 0.396 . . . . 64.24 111.703 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.467 ' O ' HG23 ' A' ' 11' ' ' VAL . 28.9 mm-40 -67.28 -53.29 31.19 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.632 0.604 . . . . 74.52 112.632 -177.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.41 ' O ' HG13 ' A' ' 12' ' ' ILE . 35.9 pt -59.64 -41.62 85.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 O-C-N 122.148 -0.345 . . . . 45.42 111.468 -178.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.401 ' CD1' HG13 ' A' ' 8' ' ' ILE . 14.8 m-30 -63.69 -43.91 95.23 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.958 0.408 . . . . 74.33 110.818 177.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.75 -43.18 80.48 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.31 -0.405 . . . . 74.14 111.366 177.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 7' ' ' GLN . 74.3 t -61.74 -43.2 96.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 121.082 0.468 . . . . 70.33 110.742 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.473 ' HB ' HD11 ' A' ' 52' ' ' LEU . 72.6 mt -62.77 -37.26 78.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 116.146 -0.479 . . . . 71.04 111.645 177.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -64.22 -10.43 23.34 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.196 0.443 . . . . 74.53 112.196 176.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.46 -9.92 42.77 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.65 0.262 . . . . 73.05 111.667 177.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.427 HD11 HD11 ' A' ' 26' ' ' ILE . 54.9 mt -76.92 114.67 41.54 Favored Pre-proline 0 CA--C 1.543 0.684 0 O-C-N 122.448 -0.157 . . . . 75.42 110.831 177.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -60.62 150.25 82.95 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 122.734 2.289 . . . . 72.25 113.515 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 67.2 tttm -62.05 95.35 0.06 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.076 0.465 . . . . 64.14 111.255 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 139.11 -18.64 3.11 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 121.155 -0.545 . . . . 73.21 113.148 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -103.86 162.4 13.14 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.994 0.426 . . . . 71.2 111.676 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.7 m -136.29 156.2 35.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 122.932 0.493 . . . . 74.33 111.561 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 98.4 p -138.13 179.43 6.45 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 120.764 0.316 . . . . 71.22 111.15 178.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.8 p -110.72 153.12 25.74 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 120.991 0.424 . . . . 74.52 111.651 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.401 ' CE1' ' HA2' ' A' ' 40' ' ' GLY . 90.0 m-85 -53.48 -39.91 64.9 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.257 0.466 . . . . 73.3 112.257 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.16 -40.62 93.96 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.172 -0.537 . . . . 41.23 113.098 178.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -67.29 -51.61 50.73 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 122.493 -0.416 . . . . 71.4 111.396 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.427 HD11 HD11 ' A' ' 15' ' ' ILE . 50.5 mm -53.85 -51.53 43.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-N 116.141 -0.481 . . . . 73.21 111.397 178.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.02 -54.18 49.86 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.215 -0.448 . . . . 34.24 111.961 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.7 mtmp? -62.09 -41.48 98.24 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.083 0.401 . . . . 74.01 112.083 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 70.7 mtm -76.63 -10.39 59.35 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 111.995 0.369 . . . . 72.41 111.995 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.34 -14.39 33.21 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.091 0.472 . . . . 51.05 110.929 172.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.8 18.31 27.89 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 116.012 -0.54 . . . . 23.51 113.203 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -125.59 91.11 49.29 Favored Pre-proline 0 CA--C 1.544 0.741 0 O-C-N 122.522 -0.399 . . . . 75.35 111.397 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.01 137.12 26.03 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.861 2.374 . . . . 64.04 113.092 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.33 -6.18 52.42 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 121.261 -0.495 . . . . 70.42 113.968 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.424 ' HA ' ' HD2' ' A' ' 38' ' ' HIS . 61.0 m-85 -84.19 11.26 8.47 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.634 0.605 . . . . 62.24 112.634 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.25 -47.34 69.16 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.963 0.411 . . . . 74.1 111.895 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.0 ptt180 -57.86 -40.05 79.24 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.18 -0.464 . . . . 71.15 111.957 175.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.424 ' HD2' ' HA ' ' A' ' 35' ' ' TYR . 88.9 m-70 -67.84 -39.29 83.86 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.861 0.362 . . . . 73.4 111.19 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 35' ' ' TYR . 58.9 t -59.9 -42.62 89.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.013 0.435 . . . . 64.3 110.611 174.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.401 ' HA2' ' CE1' ' A' ' 23' ' ' TYR . . . -58.97 -41.56 96.41 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-N 116.078 -0.51 . . . . 54.51 112.718 176.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -61.65 -47.32 85.91 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 120.835 0.35 . . . . 64.51 111.085 176.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.6 -54.41 47.22 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.989 0.423 . . . . 45.43 111.727 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.4 mt -63.91 -32.62 74.21 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.846 0.355 . . . . 74.11 111.461 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.99 -13.99 62.7 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.439 -0.41 . . . . 73.43 113.507 178.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.484 HD22 ' N ' ' A' ' 45' ' ' ASN . 0.8 OUTLIER -93.53 -4.08 51.67 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 117.087 0.444 . . . . 63.14 111.945 177.17 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 94.2 mt -85.88 142.34 36.52 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 112.509 0.559 . . . . 71.4 112.509 -176.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.78 159.5 48.31 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.54 2.16 . . . . 73.44 112.27 173.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.59 -35.82 73.02 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.401 0.519 . . . . 63.1 112.401 -176.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -113.94 53.12 0.61 Allowed Glycine 0 CA--C 1.526 0.75 0 C-N-CA 121.23 -0.51 . . . . 45.32 112.913 178.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 90.9 p -72.93 -179.14 3.06 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 122.297 -0.531 . . . . 70.35 111.454 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -84.59 4.5 31.92 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.007 0.432 . . . . 73.23 111.425 176.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.554 HD12 ' HD2' ' A' ' 53' ' ' PRO . 35.6 tp -127.1 126.08 24.23 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 116.159 -0.473 . . . . 74.34 110.34 178.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.554 ' HD2' HD12 ' A' ' 52' ' ' LEU . 53.0 Cg_endo -70.1 94.36 0.56 Allowed 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 120.94 1.093 . . . . 62.1 111.879 176.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 68.1 p-90 -84.88 -29.7 25.02 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.305 0.574 . . . . 73.53 111.051 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.454 ' O ' HD21 ' A' ' 78' ' ' LEU . 33.6 p90 -61.56 -14.16 27.62 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.008 0.744 . . . . 71.23 113.008 -177.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 69.6 mtt-85 -85.34 7.95 20.52 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.108 0.41 . . . . 74.24 112.108 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.6 t -125.13 126.91 71.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 120.98 0.419 . . . . 53.11 111.521 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.609 HD11 HD21 ' A' ' 93' ' ' LEU . 34.9 pt -130.21 -172.11 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-N 116.444 -0.344 . . . . 64.04 111.504 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.421 HD21 ' HB2' ' A' ' 63' ' ' LYS . 34.6 p30 -84.96 175.39 9.1 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.217 0.532 . . . . 55.33 111.988 -178.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.2 p -72.51 -12.42 61.07 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.303 -0.408 . . . . 62.03 112.053 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -80.34 -16.32 54.83 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.633 0.254 . . . . 73.44 111.59 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.63 21.6 46.84 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 121.059 -0.591 . . . . 71.12 112.189 -174.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.505 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 62.1 mttp -118.67 159.64 23.27 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.112 0.482 . . . . 75.23 111.463 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 58.0 mt -67.23 130.03 32.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.242 -0.435 . . . . 71.24 110.525 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.6 p -64.78 -53.92 39.41 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.962 0.411 . . . . 63.14 111.589 -177.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.487 HD13 ' HB3' ' A' ' 70' ' ' ASP . 85.6 mt -63.48 150.73 43.09 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.253 0.549 . . . . 73.44 112.075 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.82 157.31 32.73 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.087 -0.506 . . . . 72.43 111.497 -176.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.96 -129.19 10.54 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.284 -0.484 . . . . 72.33 113.281 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.417 ' H ' ' HG3' ' A' ' 69' ' ' ARG . 9.0 mtm180 -54.61 -51.22 66.03 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 122.451 1.119 . . . . 74.43 110.515 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.571 ' HA ' ' HB3' ' A' ' 73' ' ' ARG . 3.6 m-20 -63.45 -18.47 63.79 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.121 -1.4 . . . . 75.13 112.293 -171.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.1 tt -65.55 -56.07 14.32 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 110.087 -0.338 . . . . 75.22 110.087 175.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -70.22 -26.3 63.8 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 122.315 -0.241 . . . . 65.34 111.013 178.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.571 ' HB3' ' HA ' ' A' ' 70' ' ' ASP . 29.4 ttm180 -57.2 -55.19 37.93 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.22 0.533 . . . . 74.4 110.751 171.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -64.56 -40.62 95.9 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.302 -0.408 . . . . 73.3 110.789 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.446 ' HG3' ' HB ' ' A' ' 85' ' ' VAL . 60.7 tttp -57.15 -56.94 15.34 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 111.931 0.345 . . . . 71.23 111.931 177.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -56.57 -34.36 67.05 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.505 0.193 . . . . 72.11 111.506 -177.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.5 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 75.6 mmtt -59.13 -47.42 85.35 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.165 0.507 . . . . 73.44 110.99 172.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.496 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 58.2 mt -68.85 -42.08 77.59 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.928 -0.578 . . . . 73.35 111.984 -178.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -55.1 -39.78 69.7 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.245 0.545 . . . . 70.32 110.86 176.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.65 -22.96 66.7 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.788 -0.642 . . . . 72.15 111.827 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 77' ' ' LYS . 4.9 mm-40 -94.33 -1.38 53.94 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 111.985 0.365 . . . . 73.5 111.985 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.07 19.83 51.84 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 120.851 -0.69 . . . . 74.1 113.37 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.496 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 65.4 mt -99.77 110.77 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 O-C-N 122.704 -0.291 . . . . 70.41 110.721 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -73.19 102.83 3.72 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.973 0.416 . . . . 75.14 111.815 -177.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.446 ' HB ' ' HG3' ' A' ' 75' ' ' LYS . 22.0 t -98.54 126.39 51.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 116.453 -0.34 . . . . 74.25 111.328 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.619 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 42.6 t -72.57 159.04 34.56 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 111.979 0.363 . . . . 65.14 111.979 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -38.98 -55.76 1.51 Allowed 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 114.748 1.388 . . . . 62.53 114.748 -171.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 pp -82.45 16.96 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 112.543 0.571 . . . . 53.42 112.543 -175.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.44 52.57 4.43 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 121.347 -0.454 . . . . 62.1 113.107 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.619 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 86.7 tttt -116.25 125.54 52.35 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 122.352 -0.499 . . . . 74.33 111.86 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.527 HD12 HD13 ' A' ' 58' ' ' ILE . 57.4 mt -113.95 138.46 43.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 116.274 -0.421 . . . . 74.03 111.342 -178.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.48 92.52 4.02 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.011 0.434 . . . . 53.32 111.071 176.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.609 HD21 HD11 ' A' ' 58' ' ' ILE . 82.0 mt -56.26 -48.95 75.55 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.384 -0.371 . . . . 65.2 111.732 -178.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -52.85 -22.05 4.97 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.877 0.695 . . . . 73.12 112.877 -176.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -102.67 -38.84 7.31 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.085 0.402 . . . . 64.14 112.085 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -101.68 3.83 40.11 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 111.968 0.359 . . . . 72.12 111.968 -172.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 57.4 tttp -59.51 141.59 54.47 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.042 0.448 . . . . 71.42 111.91 -175.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 16.2 t90 -60.75 119.47 8.22 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.258 0.551 . . . . 72.33 111.414 178.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -118.56 90.8 40.33 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 115.776 -0.647 . . . . 74.52 111.261 -178.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo . . . . . 0 CA--C 1.54 0.795 0 C-N-CA 122.778 2.319 . . . . 61.31 113.341 178.912 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 CA--C 1.54 0.561 0 N-CA-C 112.716 0.635 . . . . 73.44 112.716 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -56.41 -38.33 71.39 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.296 -0.411 . . . . 72.01 111.499 175.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -49.03 -50.78 34.63 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.121 0.486 . . . . 73.23 110.787 173.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 61.9 mt -63.7 -48.27 77.77 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.759 -0.655 . . . . 71.52 111.176 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 63.1 t -57.33 -41.09 77.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 116.32 -0.4 . . . . 61.53 111.997 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.49 ' O ' HG23 ' A' ' 11' ' ' VAL . 27.9 mm-40 -73.75 -49.57 24.87 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.195 0.443 . . . . 74.32 112.195 -177.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.44 ' O ' HG13 ' A' ' 12' ' ' ILE . 31.4 pt -59.7 -40.2 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 O-C-N 122.055 -0.403 . . . . 53.3 111.259 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -58.23 -48.11 81.42 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.035 0.445 . . . . 64.15 110.448 171.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.37 -17.31 42.66 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.041 -0.527 . . . . 73.51 112.407 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 7' ' ' GLN . 49.9 t -92.41 -50.16 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-O 120.808 0.337 . . . . 71.31 111.3 175.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.501 HD12 HD21 ' A' ' 52' ' ' LEU . 79.8 mt -57.85 -37.82 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 112.849 0.685 . . . . 74.15 112.849 -175.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 -58.23 -21.3 47.48 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.402 0.519 . . . . 74.14 112.402 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -83.28 -6.24 59.4 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.509 0.559 . . . . 64.35 112.509 -178.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 45.3 mt -78.27 122.9 85.81 Favored Pre-proline 0 CA--C 1.544 0.72 0 O-C-N 122.419 -0.175 . . . . 64.2 110.655 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -79.88 178.76 6.9 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.801 2.334 . . . . 65.34 114.176 -175.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.53 ' HE3' ' HA ' ' A' ' 81' ' ' GLU . 49.3 tptt -67.18 122.88 18.79 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.627 -0.715 . . . . 61.2 111.502 -178.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.549 ' HA2' ' HB3' ' A' ' 81' ' ' GLU . . . 91.12 3.5 69.9 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 114.407 0.523 . . . . 71.43 114.407 175.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -117.81 146.86 43.55 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 117.575 0.688 . . . . 73.32 111.648 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.6 m -129.13 157.62 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.172 0.51 . . . . 73.44 111.747 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 89.3 p -132.43 171.11 14.18 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.236 -0.438 . . . . 74.23 110.793 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.9 p -103.52 152.03 22.17 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.808 0.337 . . . . 74.14 111.697 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -49.46 -41.47 40.44 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.442 0.534 . . . . 72.33 112.442 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.7 -40.99 95.57 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 121.239 -0.505 . . . . 72.34 113.252 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -66.91 -55.17 15.82 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.64 0.257 . . . . 73.14 111.073 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.6 mm -54.11 -49.99 57.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.208 0.528 . . . . 53.41 111.365 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.53 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -59.8 -43.77 94.29 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.062 -0.517 . . . . 55.13 111.737 179.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -62.35 -45.57 92.6 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.79 0.329 . . . . 75.31 111.182 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 65.4 mtt -63.15 -37.1 85.88 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.406 -0.361 . . . . 74.12 111.167 178.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.29 -29.38 67.24 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.935 0.397 . . . . 62.11 111.673 176.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.48 10.05 27.96 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 116.282 -0.417 . . . . 75.24 112.935 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.53 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 26.8 m-85 -127.27 63.5 58.23 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 122.451 0.3 . . . . 70.3 111.152 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.69 -35.7 87.99 Favored 'Trans proline' 0 N--CA 1.483 0.862 0 C-N-CA 122.829 2.353 . . . . 63.33 114.181 -172.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -82.35 -7.96 86.93 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 121.06 -0.59 . . . . 72.44 113.59 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.448 ' CD1' ' HB3' ' A' ' 32' ' ' TYR . 23.0 m-85 -86.2 16.14 4.61 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.529 0.566 . . . . 72.34 112.529 -178.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.09 -43.58 61.09 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.216 0.532 . . . . 74.52 111.618 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -57.55 -40.25 78.47 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.781 -0.645 . . . . 72.33 111.855 175.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -75.35 -28.23 59.5 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.651 -0.25 . . . . 72.32 111.673 -178.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 35' ' ' TYR . 46.5 t -61.18 -43.85 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 109.814 -0.439 . . . . 53.03 109.814 173.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.02 -41.94 96.69 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 115.992 -0.549 . . . . 53.03 112.631 174.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.4 mttp -57.46 -53.83 53.75 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.975 0.417 . . . . 74.15 111.303 173.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.33 -47.64 78.35 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.165 -0.47 . . . . 73.3 112.08 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.437 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 79.8 mt -68.1 -41.39 81.88 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.861 0.362 . . . . 74.0 111.496 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.7 -18.79 62.09 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.156 -0.545 . . . . 73.04 113.374 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -86.06 -4.49 59.18 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 122.606 -0.349 . . . . 72.31 111.649 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 96.2 mt -92.61 121.53 65.99 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-O 120.761 0.315 . . . . 73.1 111.653 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.89 160.86 36.83 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.326 2.017 . . . . 63.31 112.469 177.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -67.13 119.32 11.85 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.287 0.565 . . . . 64.23 110.962 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 110.89 -2.51 28.74 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 115.983 -0.553 . . . . 62.32 112.673 -173.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 31.0 t -61.85 167.82 3.49 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.165 0.507 . . . . 62.3 112.162 177.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -66.93 -29.51 69.4 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.737 0.643 . . . . 53.23 112.737 -177.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.555 HD12 ' HD2' ' A' ' 53' ' ' PRO . 25.7 tp -102.46 131.84 22.03 Favored Pre-proline 0 N--CA 1.472 0.639 0 N-CA-C 111.558 0.207 . . . . 51.34 111.558 -178.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.555 ' HD2' HD12 ' A' ' 52' ' ' LEU . 59.4 Cg_endo -73.62 95.1 0.86 Allowed 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 121.591 1.527 . . . . 71.21 111.813 171.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.437 ' HB2' ' HB3' ' A' ' 43' ' ' LEU . 55.2 p-90 -81.35 -24.51 37.03 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.225 0.536 . . . . 71.5 112.222 -176.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.451 ' CG ' ' HB3' ' A' ' 77' ' ' LYS . 29.3 p90 -65.24 -17.99 64.94 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.381 0.882 . . . . 65.43 113.381 -175.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -83.23 7.33 16.58 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.545 0.572 . . . . 74.15 112.545 -177.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.6 t -123.19 117.93 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 121.029 0.443 . . . . 62.32 111.131 176.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.495 HD11 HD21 ' A' ' 93' ' ' LEU . 42.3 pt -123.21 -170.35 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 121.112 0.482 . . . . 65.21 111.714 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.7 p30 -86.28 163.48 17.69 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.078 0.466 . . . . 61.4 111.585 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 88.1 p -79.6 9.43 5.0 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 120.983 0.42 . . . . 55.23 111.665 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -93.61 -8.74 40.28 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.161 -0.472 . . . . 73.5 111.13 178.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.5 40.59 27.29 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.311 -0.471 . . . . 21.51 112.821 -177.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.627 ' HG2' ' HG2' ' A' ' 90' ' ' LYS . 53.5 mtpt -137.45 166.78 23.02 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.101 0.477 . . . . 73.53 111.441 178.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 63.6 mt -67.15 109.88 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.505 -0.554 . . . . 73.41 109.505 170.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.4 t -57.7 -40.09 78.72 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.143 -0.48 . . . . 74.41 112.013 -175.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.595 HD13 ' HB3' ' A' ' 70' ' ' ASP . 84.9 mt -76.78 160.15 29.53 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.995 0.426 . . . . 75.14 111.399 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -130.82 157.51 42.66 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.051 0.453 . . . . 75.44 111.869 -176.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.48 -130.19 31.51 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.267 -0.492 . . . . 62.13 113.398 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.418 ' H ' ' HG3' ' A' ' 69' ' ' ARG . 10.2 mtm180 -48.69 -50.93 31.1 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.902 0.858 . . . . 74.44 110.947 178.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.595 ' HB3' HD13 ' A' ' 66' ' ' LEU . 21.5 m-20 -70.72 -18.85 62.79 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 114.627 -1.17 . . . . 72.34 112.035 -172.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.0 tt -66.7 -51.07 60.18 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.608 -0.516 . . . . 73.1 109.608 174.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -61.6 -36.36 80.49 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.08 -0.509 . . . . 61.44 111.528 175.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.2 mtt180 -56.1 -62.81 1.45 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.51 0.195 . . . . 61.4 111.473 174.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.413 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 52.5 tt0 -58.83 -36.47 74.6 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.714 0.293 . . . . 74.01 111.086 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.497 ' HG3' HG11 ' A' ' 85' ' ' VAL . 79.2 tttt -52.46 -65.95 0.47 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.991 0.424 . . . . 74.11 111.62 174.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -63.18 -30.87 71.93 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.084 -0.507 . . . . 75.23 112.224 -175.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.451 ' HB3' ' CG ' ' A' ' 55' ' ' PHE . 72.3 mmtt -61.02 -45.89 92.98 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.974 0.416 . . . . 54.41 110.626 174.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.474 HD22 HD12 ' A' ' 83' ' ' ILE . 83.6 mt -72.17 -28.09 63.0 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.397 -0.365 . . . . 73.15 111.633 177.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.495 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 49.7 mt-10 -66.88 -28.06 68.02 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.067 0.46 . . . . 74.11 110.325 172.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.6 -23.66 59.95 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.165 0.507 . . . . 40.55 110.858 172.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.549 ' HB3' ' HA2' ' A' ' 18' ' ' GLY . 39.7 mm-40 -81.77 -26.25 34.61 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.024 -0.535 . . . . 61.1 110.989 174.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.85 37.18 4.26 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 116.304 -0.407 . . . . 75.32 113.057 -178.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.474 HD12 HD22 ' A' ' 78' ' ' LEU . 58.6 mt -105.8 136.98 37.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 112.301 0.482 . . . . 75.13 112.301 -176.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -67.95 93.7 0.43 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.887 0.375 . . . . 72.12 111.582 172.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.497 HG11 ' HG3' ' A' ' 75' ' ' LYS . 60.2 t -86.94 107.11 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 110.116 -0.328 . . . . 74.42 110.116 174.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.574 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 23.8 t -64.83 147.74 52.65 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.637 -0.256 . . . . 71.43 111.352 -177.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.453 ' HG3' ' N ' ' A' ' 88' ' ' ILE . 12.3 pt-20 -36.31 -55.76 0.8 Allowed 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 115.424 1.638 . . . . 64.44 115.424 -167.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.453 ' N ' ' HG3' ' A' ' 87' ' ' GLU . 2.8 pp -87.35 10.12 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 112.866 0.691 . . . . 74.45 112.866 -173.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 97.74 47.98 2.03 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 121.363 -0.446 . . . . 74.02 113.999 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.627 ' HG2' ' HG2' ' A' ' 63' ' ' LYS . 90.8 mttt -114.77 146.36 41.07 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 122.305 -0.526 . . . . 74.51 111.515 176.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.444 HD12 HG21 ' A' ' 58' ' ' ILE . 58.3 mt -130.97 138.77 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 115.873 -0.603 . . . . 73.15 111.137 -177.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.56 93.55 8.83 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.621 -0.263 . . . . 73.34 111.679 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.495 HD21 HD11 ' A' ' 58' ' ' ILE . 62.2 mt -53.97 -57.18 11.97 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 111.79 0.292 . . . . 72.32 111.79 177.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 52.9 ttp180 -46.25 -30.65 2.1 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.727 0.639 . . . . 64.41 112.727 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -90.59 -25.63 20.08 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 112.242 0.46 . . . . 72.4 112.242 -176.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -127.11 13.08 7.21 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 113.129 0.788 . . . . 75.4 113.129 -176.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 93' ' ' LEU . 55.2 tttm -64.61 125.98 26.44 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.029 0.443 . . . . 65.12 111.777 -175.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 22.4 t90 -58.94 113.8 2.26 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.853 0.686 . . . . 71.24 112.853 -175.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -107.71 92.41 8.73 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 115.909 -0.587 . . . . 63.23 110.481 172.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo . . . . . 0 CA--C 1.54 0.808 0 C-N-CA 122.585 2.19 . . . . 75.03 113.184 179.885 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.5 t70 . . . . . 0 CA--C 1.546 0.823 0 N-CA-C 112.742 0.645 . . . . 44.24 112.742 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -52.72 -39.57 62.18 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.677 0.621 . . . . 74.5 112.677 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -57.74 -48.71 78.84 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.898 0.38 . . . . 64.13 110.754 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.28 -46.58 89.76 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.034 -0.53 . . . . 54.33 111.26 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 73.2 t -56.48 -52.31 54.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 116.286 -0.415 . . . . 72.33 111.62 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -63.98 -49.85 70.87 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.947 0.721 . . . . 53.31 112.947 -176.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 36.9 pt -60.73 -41.76 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 O-C-N 122.114 -0.366 . . . . 65.25 111.401 -178.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -66.03 -41.78 90.48 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.747 0.308 . . . . 74.52 110.998 177.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.04 -37.95 69.93 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.011 0.434 . . . . 61.44 111.586 177.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 95.9 t -66.85 -41.85 88.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-O 121.015 0.436 . . . . 73.13 110.982 177.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.557 ' HB ' HD11 ' A' ' 52' ' ' LEU . 73.7 mt -62.5 -37.32 78.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 116.117 -0.492 . . . . 75.12 111.801 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -57.16 -21.17 30.91 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 122.194 -0.316 . . . . 70.02 111.717 174.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -87.46 -4.13 59.01 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 112.447 0.536 . . . . 74.21 112.447 -177.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.547 HD11 HD11 ' A' ' 26' ' ' ILE . 60.0 mt -76.32 122.26 86.44 Favored Pre-proline 0 CA--C 1.542 0.658 0 O-C-N 122.349 -0.219 . . . . 64.32 110.776 177.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -68.21 169.51 16.61 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.582 2.188 . . . . 74.5 112.782 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -67.24 149.46 50.39 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.035 0.445 . . . . 73.44 112.015 -177.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.99 -32.78 1.73 Allowed Glycine 0 CA--C 1.529 0.966 0 C-N-CA 121.337 -0.459 . . . . 52.3 113.839 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -77.75 159.92 28.74 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.447 0.641 . . . . 71.5 112.562 -177.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.5 m -130.54 156.33 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 115.543 -0.753 . . . . 54.42 110.621 177.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 51.0 m -133.3 155.95 48.48 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.07 0.462 . . . . 73.04 111.558 176.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.5 p -94.17 155.05 17.26 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.982 0.42 . . . . 72.22 111.282 176.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -55.8 -33.91 64.84 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.307 -0.406 . . . . 75.24 111.823 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.99 -43.47 97.35 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.195 -0.526 . . . . 75.03 112.832 178.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -62.36 -54.68 36.83 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.913 0.387 . . . . 73.32 111.11 177.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.547 HD11 HD11 ' A' ' 15' ' ' ILE . 50.1 mm -54.79 -49.74 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 116.208 -0.451 . . . . 71.32 111.464 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.07 -43.53 82.2 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.454 -0.339 . . . . 45.3 111.596 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.03 -56.1 22.47 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 111.752 0.279 . . . . 71.41 111.752 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -61.53 -25.63 67.41 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.148 0.425 . . . . 65.11 112.148 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.3 -21.22 53.87 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.042 0.386 . . . . 74.43 112.042 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.09 21.29 20.98 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.251 -0.499 . . . . 63.03 113.157 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -134.43 54.04 10.95 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 122.529 0.331 . . . . 73.54 111.74 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -62.25 132.45 38.86 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 121.983 1.789 . . . . 52.55 112.237 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.65 -28.38 15.74 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.146 -0.55 . . . . 43.42 113.008 -176.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -82.77 27.57 0.53 Allowed 'General case' 0 CA--C 1.542 0.662 0 O-C-N 122.452 -0.44 . . . . 72.3 111.989 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.09 -39.96 76.04 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.399 0.518 . . . . 74.35 112.399 -177.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -60.4 -32.02 70.93 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.946 0.403 . . . . 64.42 111.1 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -74.57 -41.05 61.21 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.309 -0.405 . . . . 70.33 110.791 177.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.2 t -56.2 -42.2 72.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.074 0.464 . . . . 63.32 110.641 175.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.26 -45.34 96.27 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-N 116.064 -0.516 . . . . 52.01 112.731 175.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -64.47 -33.34 75.66 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.938 0.399 . . . . 64.43 111.392 177.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.32 -48.12 71.34 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.298 -0.41 . . . . 71.2 111.435 177.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.1 mt -67.34 -38.96 85.67 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.948 0.404 . . . . 75.35 111.319 177.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.62 -13.21 50.22 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 121.145 -0.55 . . . . 51.32 113.142 176.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -93.9 -8.0 41.49 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 120.987 0.422 . . . . 73.23 111.186 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 70.6 mt -82.22 144.78 51.03 Favored Pre-proline 0 N--CA 1.472 0.634 0 N-CA-C 112.665 0.617 . . . . 71.22 112.665 -177.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.05 144.24 37.55 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.479 2.12 . . . . 63.13 111.733 172.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.548 ' HB3' ' HE ' ' A' ' 73' ' ' ARG . 16.6 pt-20 -65.04 -26.37 68.23 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 122.102 -0.374 . . . . 55.23 111.997 -176.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -88.37 20.96 27.57 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 121.066 -0.588 . . . . 52.45 113.856 177.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.9 t -73.1 150.29 42.39 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 117.083 0.442 . . . . 63.33 112.173 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -64.56 -46.3 83.39 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.275 0.559 . . . . 72.34 110.77 175.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.557 HD11 ' HB ' ' A' ' 12' ' ' ILE . 51.8 tp -58.22 117.16 17.91 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 115.602 -0.726 . . . . 61.43 111.382 175.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.49 ' HD2' HD12 ' A' ' 52' ' ' LEU . 58.9 Cg_endo -72.49 94.52 0.77 Allowed 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 121.465 1.443 . . . . 63.1 111.992 178.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 67.4 p-90 -82.79 -26.79 31.45 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.372 0.606 . . . . 73.44 110.964 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.523 ' HA ' ' HG3' ' A' ' 74' ' ' GLN . 29.1 p90 -62.27 -20.39 64.23 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.507 -0.769 . . . . 73.52 112.909 -176.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 79.9 mtt-85 -79.32 1.72 24.06 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.397 0.518 . . . . 70.12 112.397 -178.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 21' ' ' SER . 33.5 t -109.57 124.79 66.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 O-C-N 121.892 -0.505 . . . . 75.42 111.89 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.6 pt -132.91 177.04 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 116.414 -0.357 . . . . 71.42 111.564 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.454 HD21 ' HB2' ' A' ' 63' ' ' LYS . 36.7 p30 -80.61 177.78 8.78 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.773 0.657 . . . . 73.42 112.773 -174.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 76.0 p -67.3 -17.7 64.88 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.913 -0.585 . . . . 64.12 112.494 -177.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -83.58 -10.69 58.09 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.066 0.46 . . . . 72.32 111.13 177.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.67 49.42 14.32 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.88 -0.676 . . . . 73.4 111.665 -172.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.454 ' HB2' HD21 ' A' ' 59' ' ' ASN . 96.7 mttt -135.1 158.36 44.55 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.922 0.391 . . . . 63.24 111.015 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 67.9 mt -72.58 119.39 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.4 -0.364 . . . . 65.32 110.915 177.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.5 m -65.62 -44.2 87.25 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.804 0.335 . . . . 70.34 111.881 -178.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.436 ' HB3' ' HB3' ' A' ' 70' ' ' ASP . 84.7 mt -74.92 117.31 16.63 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.807 0.337 . . . . 71.23 110.896 178.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -108.78 169.87 8.39 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.847 0.356 . . . . 64.23 111.702 -177.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.02 -132.06 10.94 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 121.18 -0.533 . . . . 41.11 111.834 -173.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -81.59 -26.41 34.96 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 122.188 -0.595 . . . . 72.32 110.93 174.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.503 ' O ' ' HB3' ' A' ' 73' ' ' ARG . 17.6 m-20 -63.89 -17.33 63.09 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.994 0.426 . . . . 71.44 110.798 174.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.1 tt -65.11 -52.33 56.02 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.094 -0.503 . . . . 72.13 109.937 173.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.582 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 19.3 m-20 -63.59 -31.89 73.19 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.99 0.424 . . . . 64.04 111.359 176.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.548 ' HE ' ' HB3' ' A' ' 48' ' ' GLU . 70.8 ttt180 -51.1 -63.84 1.0 Allowed 'General case' 0 CA--C 1.547 0.832 0 CA-C-O 121.236 0.541 . . . . 74.03 110.897 173.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.523 ' HG3' ' HA ' ' A' ' 55' ' ' PHE . 48.1 tt0 -67.77 -43.64 79.35 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.093 0.473 . . . . 73.32 110.944 178.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.582 ' HB3' ' HA ' ' A' ' 72' ' ' ASP . 85.0 tttt -48.93 -60.94 2.34 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.702 -0.681 . . . . 73.2 112.149 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -65.02 -34.36 78.26 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.184 0.438 . . . . 63.4 112.184 -176.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -60.19 -29.67 68.86 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 120.605 -0.438 . . . . 74.31 111.373 172.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 80.5 mt -86.43 -34.37 20.15 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.227 -0.442 . . . . 73.43 111.548 175.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 35.7 mt-10 -66.08 -31.89 73.04 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 122.192 -0.317 . . . . 74.01 111.262 178.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.27 -25.86 62.28 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.222 0.534 . . . . 73.24 111.187 174.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.435 ' HB2' HG13 ' A' ' 83' ' ' ILE . 14.1 mm-40 -80.05 -26.15 39.84 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.347 0.594 . . . . 64.12 111.066 176.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 99.88 22.82 11.49 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 115.906 -0.588 . . . . 63.12 112.29 -172.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.435 HG13 ' HB2' ' A' ' 81' ' ' GLU . 73.1 mt -83.86 125.72 40.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.011 0.434 . . . . 65.32 111.169 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.408 ' HG2' ' CE2' ' A' ' 96' ' ' TYR . 11.6 pt-20 -72.24 99.07 2.3 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.583 0.706 . . . . 75.14 112.145 -177.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.429 HG11 ' HG3' ' A' ' 75' ' ' LYS . 44.7 t -100.14 111.15 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 115.994 -0.548 . . . . 74.12 110.879 178.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.587 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 40.3 t -67.12 158.22 31.71 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.278 -0.419 . . . . 61.14 111.629 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -43.69 -53.43 5.8 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 114.281 1.215 . . . . 71.24 114.281 -170.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.445 HD11 ' HB2' ' A' ' 90' ' ' LYS . 2.8 pp -79.47 12.96 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 112.524 0.565 . . . . 75.22 112.524 -176.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.51 48.97 5.09 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-N 116.365 -0.38 . . . . 64.21 112.986 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.587 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 61.3 tttm -116.19 123.46 47.84 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 120.992 0.425 . . . . 74.11 111.941 -178.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 64.6 mt -116.27 142.92 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 122.769 0.428 . . . . 63.2 111.33 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.25 101.84 5.6 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 111.896 0.332 . . . . 44.3 111.896 178.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.4 ' O ' ' N ' ' A' ' 97' ' ' LYS . 57.5 mt -54.54 -62.54 1.59 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.15 0.426 . . . . 54.14 112.15 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 45.3 mtm180 -49.88 -29.9 9.03 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.311 0.485 . . . . 71.33 112.311 -176.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -79.94 -35.27 38.01 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.083 -0.508 . . . . 73.42 111.581 -176.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.408 ' CE2' ' HG2' ' A' ' 84' ' ' GLU . 98.8 m-85 -115.71 5.98 14.35 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.292 0.479 . . . . 74.41 112.292 -177.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.4 ' N ' ' O ' ' A' ' 93' ' ' LEU . 55.5 tttm -59.32 133.82 56.44 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.074 0.464 . . . . 65.53 111.971 -174.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 13.6 t90 -55.2 114.29 1.72 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.995 -0.548 . . . . 64.11 111.491 178.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -109.45 91.83 10.69 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 116.157 -0.474 . . . . 60.44 110.44 175.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo . . . . . 0 CA--C 1.537 0.628 0 C-N-CA 122.221 1.947 . . . . 75.43 112.082 177.963 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.416 ' O ' HG23 ' A' ' 6' ' ' VAL . 3.9 m-20 . . . . . 0 N--CA 1.475 0.777 0 N-CA-C 112.248 0.462 . . . . 73.43 112.248 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.494 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 17.4 mm100 -55.21 -37.47 67.16 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.346 0.498 . . . . 61.24 112.346 -177.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -55.86 -54.48 44.1 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.231 0.538 . . . . 72.22 110.603 176.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 68.9 mt -62.74 -44.72 95.46 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.556 -0.747 . . . . 54.13 111.201 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 2' ' ' ASP . 85.5 t -57.11 -52.27 58.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 112.078 0.399 . . . . 61.11 112.078 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 28.6 mm-40 -62.32 -51.08 69.09 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.156 0.428 . . . . 72.41 112.156 -175.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.54 HD12 HG13 ' A' ' 39' ' ' VAL . 31.4 pt -59.55 -45.69 93.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 111.633 0.235 . . . . 73.14 111.633 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 19.6 m-30 -63.98 -41.33 97.56 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.132 0.491 . . . . 62.25 110.886 177.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.47 -20.4 63.11 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.87 -0.605 . . . . 30.1 111.798 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 7' ' ' GLN . 99.2 t -85.71 -41.0 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 120.745 0.307 . . . . 65.43 111.05 173.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 8' ' ' ILE . 79.3 mt -55.28 -41.23 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 112.664 0.616 . . . . 72.32 112.664 -177.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -58.38 -12.52 3.9 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 113.424 0.898 . . . . 74.04 113.424 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -85.64 -7.46 58.81 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 112.079 0.4 . . . . 63.21 112.079 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 63.8 mt -75.71 119.77 78.62 Favored Pre-proline 0 CA--C 1.542 0.661 0 O-C-N 122.407 -0.183 . . . . 74.01 110.696 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -76.75 161.1 33.94 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.545 2.164 . . . . 51.43 113.269 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 45.3 tttp -63.88 107.84 1.32 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.253 -0.431 . . . . 64.33 111.235 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 128.87 -15.61 5.9 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.923 -0.656 . . . . 72.21 113.483 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -116.6 163.42 16.12 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.386 0.612 . . . . 61.3 112.254 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.4 m -135.82 162.75 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-N 115.444 -0.798 . . . . 74.43 110.895 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 89.0 p -137.36 171.02 15.11 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.747 0.308 . . . . 42.54 110.613 175.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 40.2 p -107.05 154.03 21.73 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.829 0.347 . . . . 71.44 111.541 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.433 ' HE1' HD12 ' A' ' 43' ' ' LEU . 54.2 m-85 -50.65 -41.25 55.15 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 116.223 -0.444 . . . . 71.21 112.074 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -57.66 -41.6 93.81 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 121.23 -0.51 . . . . 74.2 112.912 178.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 29' ' ' MET . 42.2 mt-10 -65.93 -52.63 48.2 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.655 0.264 . . . . 71.31 111.063 178.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 44.4 mm -56.54 -47.33 82.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 120.984 0.421 . . . . 73.35 111.571 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.84 -45.97 90.13 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.34 -0.391 . . . . 75.53 111.593 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -61.04 -41.61 96.9 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 111.768 0.284 . . . . 73.03 111.768 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.477 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 64.8 mtt -67.86 -34.76 77.31 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.634 0.254 . . . . 43.41 111.477 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.69 -27.28 50.72 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.877 0.37 . . . . 73.32 111.731 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.81 44.99 1.84 Allowed Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.442 -0.409 . . . . 41.01 113.644 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -137.41 83.09 26.89 Favored Pre-proline 0 CA--C 1.544 0.716 0 O-C-N 122.412 -0.464 . . . . 74.22 111.576 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.4 126.49 14.31 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 122.791 2.327 . . . . 72.54 113.024 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.19 -8.71 79.22 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 121.396 -0.431 . . . . 54.52 113.709 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -94.35 11.13 31.58 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.569 0.581 . . . . 70.44 112.569 -177.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.81 -47.7 70.6 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.208 0.527 . . . . 52.11 111.457 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.8 ptt180 -53.44 -38.02 63.13 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.678 -0.692 . . . . 75.03 112.119 174.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -69.49 -35.89 76.0 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.781 0.324 . . . . 65.04 111.203 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.54 HG13 HD12 ' A' ' 8' ' ' ILE . 55.5 t -57.42 -39.65 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 121.195 0.521 . . . . 72.4 110.378 174.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.31 -40.9 99.25 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 116.031 -0.531 . . . . 42.12 112.528 174.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -58.95 -38.0 78.04 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.031 0.443 . . . . 74.53 111.089 175.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.95 -55.34 19.74 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.87 -0.605 . . . . 71.13 111.838 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.433 HD12 ' HE1' ' A' ' 23' ' ' TYR . 68.0 mt -62.47 -32.27 73.12 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.67 0.271 . . . . 61.54 111.536 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.72 -21.54 58.34 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 121.192 -0.528 . . . . 75.03 113.542 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -84.4 -10.56 57.43 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.091 0.472 . . . . 62.54 110.977 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.452 HD11 HD23 ' A' ' 52' ' ' LEU . 97.5 mt -87.5 139.96 31.79 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 116.361 -0.381 . . . . 73.24 111.924 -178.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -88.08 173.31 4.95 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.701 2.267 . . . . 60.21 112.667 175.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.767 ' HB3' ' HD3' ' A' ' 73' ' ' ARG . 9.7 pt-20 -67.48 -12.86 61.31 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.785 0.326 . . . . 73.34 111.82 177.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -96.78 32.84 6.18 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 121.353 -0.451 . . . . 43.23 113.445 176.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.8 t -95.45 135.36 37.18 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 122.294 -0.533 . . . . 52.2 111.507 177.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -70.14 -28.57 65.46 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.923 0.392 . . . . 52.2 111.185 174.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.526 HD12 ' HD2' ' A' ' 53' ' ' PRO . 48.5 tp -72.78 117.65 61.31 Favored Pre-proline 0 C--O 1.237 0.423 0 CA-C-N 116.219 -0.446 . . . . 73.31 110.441 176.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.526 ' HD2' HD12 ' A' ' 52' ' ' LEU . 44.5 Cg_endo -67.1 95.32 0.36 Allowed 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 121.562 1.508 . . . . 75.21 112.496 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 -80.81 -31.54 35.6 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.406 0.622 . . . . 70.25 110.723 177.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.481 ' O ' HD21 ' A' ' 78' ' ' LEU . 20.8 p90 -63.25 -21.89 66.52 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.242 0.83 . . . . 72.25 113.242 -178.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -84.4 -1.25 55.25 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.6 0.593 . . . . 71.23 112.6 -177.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.8 t -118.11 106.97 20.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-O 121.342 0.592 . . . . 71.14 111.58 -178.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.567 HD11 HD21 ' A' ' 93' ' ' LEU . 28.6 pt -112.67 -169.64 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 121.263 0.554 . . . . 63.12 112.114 -177.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 28.2 p30 -95.23 170.3 9.48 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.545 0.572 . . . . 52.0 112.545 -175.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 31.1 t -63.62 -17.88 63.35 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 112.46 0.541 . . . . 72.2 112.46 -178.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -75.75 -14.62 60.33 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.058 0.456 . . . . 60.41 111.113 177.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.99 43.64 33.06 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.036 -0.602 . . . . 52.12 111.934 -174.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.409 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 89.7 mttt -133.85 162.45 31.98 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.164 0.507 . . . . 74.55 111.596 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.415 HG23 ' OE1' ' A' ' 74' ' ' GLN . 66.5 mt -70.13 119.03 15.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 115.759 -0.655 . . . . 72.32 110.178 172.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.0 m -67.16 -27.75 67.55 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.198 0.444 . . . . 72.11 112.198 -177.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.533 HD13 ' HB3' ' A' ' 70' ' ' ASP . 77.1 mt -77.33 165.93 23.81 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.144 0.497 . . . . 64.42 111.727 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -133.68 148.96 51.53 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.066 0.46 . . . . 72.32 112.084 -171.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.34 -123.82 30.36 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-N 116.081 -0.509 . . . . 73.54 113.553 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 48.0 mtp180 -64.72 -38.96 92.77 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.175 0.512 . . . . 63.23 110.924 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.533 ' HB3' HD13 ' A' ' 66' ' ' LEU . 4.3 m-20 -60.49 -30.19 69.55 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.949 -0.568 . . . . 72.32 111.233 176.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.1 tt -65.74 -59.09 4.26 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.351 -0.386 . . . . 73.22 110.784 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -69.13 -21.63 64.01 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 122.267 -0.271 . . . . 72.43 111.468 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.767 ' HD3' ' HB3' ' A' ' 48' ' ' GLU . 35.9 ttm180 -61.91 -52.27 64.75 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.069 0.461 . . . . 61.55 110.319 172.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.415 ' OE1' HG23 ' A' ' 64' ' ' ILE . 53.5 tt0 -60.63 -39.45 88.28 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.1 -0.5 . . . . 72.14 110.714 178.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.464 ' HG3' ' HB ' ' A' ' 85' ' ' VAL . 85.5 tttt -57.73 -53.08 62.26 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.081 -0.509 . . . . 62.43 111.236 176.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -55.75 -39.59 71.38 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.948 0.404 . . . . 70.25 111.441 178.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.457 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 69.0 mmtt -58.59 -48.5 80.73 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.189 -0.46 . . . . 75.54 111.415 173.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.481 HD21 ' O ' ' A' ' 55' ' ' PHE . 85.6 mt -66.28 -39.87 89.69 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.247 -0.433 . . . . 72.05 111.934 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 46.2 mt-10 -64.15 -26.64 68.62 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.948 0.404 . . . . 73.34 110.909 177.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.57 -14.53 60.8 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.234 -0.439 . . . . 52.14 111.576 174.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 77' ' ' LYS . 22.5 mm-40 -103.6 10.06 37.11 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 111.855 0.317 . . . . 74.24 111.855 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.46 30.49 40.49 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 121.066 -0.588 . . . . 51.52 113.535 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.1 mt -112.04 138.67 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 O-C-N 122.449 -0.442 . . . . 74.13 111.383 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.476 ' HB2' ' OH ' ' A' ' 96' ' ' TYR . 40.1 mt-10 -100.47 114.33 27.83 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.826 0.346 . . . . 73.33 110.696 175.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.464 ' HB ' ' HG3' ' A' ' 75' ' ' LYS . 79.7 t -107.63 131.44 57.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 116.398 -0.365 . . . . 73.24 111.177 -178.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.562 ' OG ' ' HB3' ' A' ' 90' ' ' LYS . 25.6 p -74.32 148.0 41.76 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.88 0.372 . . . . 62.44 111.412 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.417 ' HG3' ' N ' ' A' ' 88' ' ' ILE . 12.4 pt-20 -42.59 -53.92 4.19 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.891 1.441 . . . . 74.3 114.891 -166.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.417 ' N ' ' HG3' ' A' ' 87' ' ' GLU . 2.8 pp -73.59 11.92 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 112.868 0.692 . . . . 75.13 112.868 -175.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.43 50.79 4.36 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 121.426 -0.416 . . . . 71.35 113.127 177.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.574 ' HD3' ' N ' ' A' ' 91' ' ' ILE . 6.6 tmtm? -122.88 138.58 54.62 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 122.446 -0.443 . . . . 64.51 110.488 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.574 ' N ' ' HD3' ' A' ' 90' ' ' LYS . 66.6 mt -121.2 132.34 70.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 120.883 0.373 . . . . 62.53 111.463 -178.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.86 93.51 2.66 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.899 0.38 . . . . 71.13 111.454 177.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.567 HD21 HD11 ' A' ' 58' ' ' ILE . 63.4 mt -51.99 -49.58 63.02 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.024 0.75 . . . . 71.12 113.024 -176.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -49.87 -44.52 49.82 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 121.256 0.55 . . . . 75.33 111.829 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -76.29 -34.25 59.08 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.718 -0.673 . . . . 63.31 112.367 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.476 ' OH ' ' HB2' ' A' ' 84' ' ' GLU . 78.8 m-85 -112.28 14.63 20.51 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.273 0.471 . . . . 73.01 112.273 -172.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 61.9 tttp -65.02 130.05 41.94 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.095 0.474 . . . . 44.45 111.943 -177.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 19.7 t90 -62.51 113.73 3.12 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.979 -0.555 . . . . 73.23 111.195 175.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -113.33 92.64 23.41 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 116.4 -0.364 . . . . 71.55 110.524 176.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo . . . . . 0 C--N 1.354 0.855 0 C-N-CA 122.731 2.288 . . . . 72.42 112.938 -179.0 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 . . . . . 0 CA--C 1.542 0.64 0 N-CA-C 112.043 0.386 . . . . 74.21 112.043 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.435 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 62.3 mm-40 -53.61 -32.39 50.93 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.618 0.599 . . . . 42.34 112.618 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.405 ' O ' HG12 ' A' ' 8' ' ' ILE . 73.0 t80 -55.61 -48.9 74.15 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.247 0.546 . . . . 63.25 109.993 173.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 72.2 mt -67.07 -46.91 72.89 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.523 -0.762 . . . . 74.31 111.162 178.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 85.3 t -52.38 -50.24 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.8 0.334 . . . . 75.13 111.847 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.435 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 26.3 mm-40 -63.71 -52.7 59.35 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.157 0.428 . . . . 62.21 112.157 -177.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.419 ' O ' HG13 ' A' ' 12' ' ' ILE . 31.6 pt -65.32 -45.67 92.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 O-C-N 122.315 -0.241 . . . . 72.03 111.647 -178.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.405 ' CD1' HG13 ' A' ' 8' ' ' ILE . 14.2 m-30 -61.1 -43.28 99.13 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.755 0.312 . . . . 71.3 111.069 178.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.74 -43.08 65.49 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.439 -0.346 . . . . 75.0 111.383 177.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 7' ' ' GLN . 61.4 t -64.36 -42.4 95.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 121.142 0.496 . . . . 63.22 111.182 177.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.517 ' HB ' HD11 ' A' ' 52' ' ' LEU . 73.7 mt -62.85 -32.59 56.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 116.016 -0.538 . . . . 72.43 112.086 -178.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 72.3 m-70 -60.58 -22.25 63.51 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.299 0.481 . . . . 75.15 112.299 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -77.31 -14.07 59.81 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.256 0.465 . . . . 75.03 112.256 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.515 HD11 HD11 ' A' ' 26' ' ' ILE . 51.4 mt -75.08 113.76 28.3 Favored Pre-proline 0 CA--C 1.542 0.662 0 O-C-N 122.455 -0.153 . . . . 71.1 111.122 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -69.89 175.23 8.49 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.016 2.477 . . . . 72.22 113.751 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -67.81 140.13 56.61 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.92 -0.582 . . . . 64.13 111.768 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.76 17.25 71.04 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.188 -0.529 . . . . 70.23 113.378 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -118.3 141.18 48.79 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.688 0.28 . . . . 71.43 110.579 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.9 m -122.52 146.47 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.433 0.635 . . . . 63.33 112.284 -177.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.4 t -134.51 178.28 7.11 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.692 -0.685 . . . . 61.34 110.217 175.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 72.7 p -115.05 150.57 35.69 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.079 0.466 . . . . 70.25 111.835 -177.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.407 ' HE1' HD12 ' A' ' 43' ' ' LEU . 70.9 m-85 -51.8 -36.6 48.41 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.086 -0.506 . . . . 75.01 112.163 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.62 -51.0 60.47 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 121.014 -0.612 . . . . 71.01 113.039 178.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.415 ' O ' ' HE2' ' A' ' 29' ' ' MET . 47.1 mt-10 -55.65 -48.14 75.49 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.0 0.429 . . . . 73.11 111.135 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.515 HD11 HD11 ' A' ' 15' ' ' ILE . 49.9 mm -61.42 -54.17 38.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 116.115 -0.493 . . . . 65.45 111.746 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.56 -48.66 78.72 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.227 0.454 . . . . 44.45 112.227 -178.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -60.24 -43.1 96.38 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.677 0.275 . . . . 74.23 111.589 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.415 ' HE2' ' O ' ' A' ' 25' ' ' GLU . 77.7 mtm -73.35 -21.78 60.46 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 111.901 0.334 . . . . 75.22 111.901 178.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.58 -28.41 33.82 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.961 0.41 . . . . 73.03 111.186 174.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.94 29.09 5.06 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.298 -0.477 . . . . 74.34 113.468 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -134.43 79.93 53.13 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-O 120.893 0.378 . . . . 74.54 111.169 178.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.01 126.89 14.38 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.364 2.043 . . . . 74.32 112.614 -178.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.38 -22.85 36.47 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.175 -0.535 . . . . 73.14 113.274 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -78.61 12.19 2.17 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.36 0.504 . . . . 72.51 112.36 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.05 -44.37 61.09 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.021 0.438 . . . . 63.11 111.777 177.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 30.7 ptt-85 -58.37 -39.66 80.18 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 116.24 -0.436 . . . . 74.4 111.922 177.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -70.77 -34.53 71.91 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.662 0.268 . . . . 64.34 111.015 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.5 t -57.94 -43.39 84.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 CA-C-O 121.13 0.49 . . . . 72.11 110.267 172.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.47 -38.65 95.17 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-N 115.838 -0.619 . . . . 54.12 112.905 175.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -62.17 -47.27 85.25 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.982 0.42 . . . . 71.44 110.873 175.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.93 -45.65 89.88 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.017 -0.538 . . . . 65.05 111.668 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.588 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 58.2 mt -68.64 -38.49 80.53 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.908 0.385 . . . . 60.24 111.352 178.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.7 -15.76 66.97 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.268 -0.491 . . . . 70.21 113.081 176.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -76.6 -23.11 53.43 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.174 0.511 . . . . 74.35 110.52 175.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 82.6 mt -81.27 143.84 52.91 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 115.956 -0.566 . . . . 72.13 111.966 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -86.52 -176.7 2.11 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.708 2.272 . . . . 60.12 112.587 174.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.404 ' HG3' ' H ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -69.06 -23.58 64.06 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 122.131 -0.356 . . . . 74.04 111.937 178.662 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -90.02 39.39 3.11 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.534 -0.365 . . . . 74.23 113.43 177.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.0 t -93.03 140.08 29.85 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 122.437 -0.449 . . . . 64.43 111.404 177.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -72.42 -42.28 65.25 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.227 0.537 . . . . 75.23 110.29 175.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.517 HD11 ' HB ' ' A' ' 12' ' ' ILE . 33.3 tp -67.01 118.79 58.89 Favored Pre-proline 0 CA--C 1.535 0.404 0 CA-C-N 115.616 -0.72 . . . . 53.23 110.707 173.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.69 94.64 0.53 Allowed 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 121.392 1.394 . . . . 40.4 111.972 177.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.588 ' HB2' ' HB3' ' A' ' 43' ' ' LEU . 58.4 p-90 -84.96 -33.39 22.65 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.565 0.698 . . . . 74.31 111.0 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -59.91 -20.55 57.98 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.296 -0.865 . . . . 73.31 112.911 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.409 ' NH1' ' O ' ' A' ' 15' ' ' ILE . 95.8 mtt180 -79.98 -1.14 38.25 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.426 0.528 . . . . 74.23 112.426 -178.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.3 t -117.01 118.24 58.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 121.038 0.447 . . . . 74.53 111.744 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.558 HG21 HD12 ' A' ' 91' ' ' ILE . 35.6 pt -127.58 -169.87 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 116.347 -0.388 . . . . 74.54 111.521 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 32.1 p30 -84.44 163.64 19.35 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 120.94 0.4 . . . . 73.54 111.857 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 69.2 m -66.02 -15.44 63.03 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.573 0.583 . . . . 65.2 112.573 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -77.32 -12.59 59.97 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.741 0.305 . . . . 72.32 111.473 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.26 37.08 12.94 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 121.225 -0.512 . . . . 74.1 112.621 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -138.96 162.28 35.28 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.3 0.572 . . . . 70.12 111.91 -179.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.499 HG23 ' OE1' ' A' ' 74' ' ' GLN . 70.7 mt -69.28 139.71 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 115.725 -0.67 . . . . 63.33 110.886 175.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 89.1 p -90.18 -50.37 6.03 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.155 0.503 . . . . 73.42 111.345 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 83.9 mt -64.08 142.92 58.24 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.816 -0.629 . . . . 73.42 111.951 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -118.06 171.59 7.99 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.004 0.431 . . . . 71.31 111.234 177.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.78 -138.96 20.9 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.884 -0.674 . . . . 51.34 112.33 -176.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -74.97 -26.08 59.32 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.086 0.47 . . . . 73.15 111.474 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.65 -28.04 69.63 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.914 0.388 . . . . 74.13 111.284 176.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.1 tt -63.35 -60.97 2.68 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.273 -0.421 . . . . 63.42 110.625 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.405 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 3.9 p30 -64.15 -28.49 69.8 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 122.324 -0.235 . . . . 42.14 111.234 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -58.53 -53.74 54.88 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.902 0.382 . . . . 72.45 111.534 176.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.499 ' OE1' HG23 ' A' ' 64' ' ' ILE . 53.9 tt0 -59.38 -40.63 87.16 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.974 0.416 . . . . 75.31 110.884 177.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -60.13 -53.86 52.71 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.177 -0.465 . . . . 73.05 112.075 177.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' A' ' 72' ' ' ASP . 27.4 mm-40 -53.55 -42.46 67.52 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.15 0.5 . . . . 45.14 111.821 -178.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -59.61 -48.71 80.6 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.024 -0.534 . . . . 54.14 111.597 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.512 HD22 HD12 ' A' ' 83' ' ' ILE . 89.8 mt -67.69 -43.23 80.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.175 -0.466 . . . . 75.43 111.581 -177.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -57.03 -42.18 79.94 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.942 0.401 . . . . 64.33 110.861 175.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.34 -33.97 71.79 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.271 -0.422 . . . . 71.13 111.414 176.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -86.94 5.74 35.62 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.808 0.337 . . . . 74.21 111.678 178.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.01 30.89 16.06 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 114.238 0.455 . . . . 63.02 114.238 174.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.512 HD12 HD22 ' A' ' 78' ' ' LEU . 69.4 mt -104.43 124.77 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 117.129 0.464 . . . . 73.32 111.723 178.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.8 103.18 4.26 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.503 0.668 . . . . 71.1 111.601 177.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.2 t -95.78 117.13 39.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.309 -0.405 . . . . 75.42 111.099 178.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.587 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 41.4 t -67.87 151.15 47.61 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.938 0.399 . . . . 75.22 112.056 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -40.16 -56.55 1.89 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.322 1.231 . . . . 74.21 114.322 -171.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.431 ' H ' HG13 ' A' ' 88' ' ' ILE . 2.8 pp -80.15 22.92 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 N-CA-C 112.961 0.726 . . . . 61.03 112.961 -174.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.06 46.97 11.99 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.17 -0.538 . . . . 74.33 112.925 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.587 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 1.4 tmtp? -116.74 133.15 56.36 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.91 0.386 . . . . 73.53 110.765 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.558 HD12 HG21 ' A' ' 58' ' ' ILE . 60.2 mt -121.29 142.4 37.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 120.978 0.418 . . . . 63.35 111.356 -176.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.58 94.87 4.42 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.98 0.419 . . . . 42.24 112.039 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.614 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 39.3 mt -63.0 -13.31 33.64 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 116.077 -0.51 . . . . 65.12 112.334 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -90.27 -48.76 6.94 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.076 0.465 . . . . 75.41 111.59 175.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.99 -22.65 65.9 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.768 0.655 . . . . 64.41 112.768 -175.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -128.28 15.11 6.69 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.293 0.479 . . . . 53.31 112.293 -176.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.614 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 85.0 tttt -56.29 128.98 38.44 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.478 0.547 . . . . 73.32 112.478 -175.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 16.5 t90 -57.3 114.87 2.37 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.105 -0.498 . . . . 75.34 111.351 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -105.07 96.42 11.05 Favored Pre-proline 0 CA--C 1.543 0.694 0 CA-C-N 116.209 -0.45 . . . . 74.42 110.217 174.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo . . . . . 0 CA--C 1.54 0.814 0 C-N-CA 123.16 2.574 . . . . 70.23 113.98 -178.715 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.47 0.532 0 N-CA-C 112.483 0.549 . . . . 60.35 112.483 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -57.87 -28.12 63.87 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.814 0.34 . . . . 72.12 111.149 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -57.15 -50.67 72.09 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.0 0.429 . . . . 72.32 110.651 173.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 76.9 mt -64.57 -44.7 89.88 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.857 -0.61 . . . . 73.14 110.902 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.0 t -57.1 -49.48 79.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 116.113 -0.494 . . . . 64.03 111.648 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.433 ' O ' HG23 ' A' ' 11' ' ' VAL . 32.3 mm-40 -62.65 -52.7 62.31 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.527 0.566 . . . . 73.51 112.527 -178.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.504 HD12 HG13 ' A' ' 39' ' ' VAL . 25.3 pt -60.73 -44.2 96.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 111.757 0.28 . . . . 72.14 111.757 -177.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.9 m-30 -63.16 -43.61 97.8 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.175 0.512 . . . . 74.53 110.797 177.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.91 -30.38 61.51 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.007 -0.542 . . . . 62.12 111.959 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 7' ' ' GLN . 59.4 t -75.87 -41.77 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 121.017 0.437 . . . . 63.12 111.459 176.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 8' ' ' ILE . 71.2 mt -57.22 -34.93 46.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 112.214 0.45 . . . . 72.11 112.214 -177.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -59.2 -9.41 2.12 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 113.658 0.984 . . . . 74.34 113.658 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -92.9 -2.36 55.91 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 112.563 0.579 . . . . 64.11 112.563 178.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.409 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 50.1 mt -84.49 119.03 72.49 Favored Pre-proline 0 CA--C 1.543 0.71 0 O-C-N 122.331 -0.231 . . . . 53.23 111.188 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 15' ' ' ILE . 3.7 Cg_exo -77.94 171.1 17.8 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.392 2.728 . . . . 73.5 113.498 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -67.81 133.84 49.91 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.25 0.548 . . . . 72.22 111.885 -178.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.404 ' HA2' ' HB3' ' A' ' 81' ' ' GLU . . . 85.38 7.21 82.94 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 116.09 -0.505 . . . . 71.13 113.439 178.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -123.77 145.52 48.97 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.941 0.4 . . . . 72.01 111.119 178.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.415 HG12 ' HA ' ' A' ' 56' ' ' ARG . 34.2 m -133.2 154.99 40.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-O 120.979 0.419 . . . . 73.25 111.341 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 92.1 p -133.56 170.68 15.17 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.094 0.473 . . . . 75.11 111.036 177.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.2 p -98.72 152.31 19.81 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.102 0.477 . . . . 73.42 111.82 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.441 ' HE1' HD12 ' A' ' 43' ' ' LEU . 64.2 m-85 -55.06 -33.5 62.78 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.145 -0.48 . . . . 75.24 112.139 178.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -60.68 -38.18 94.7 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 120.988 -0.625 . . . . 73.11 112.772 177.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.421 ' O ' ' HG3' ' A' ' 29' ' ' MET . 42.2 mt-10 -71.2 -51.32 25.42 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.852 0.358 . . . . 71.01 111.309 178.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.2 mm -58.29 -49.83 80.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-N 116.338 -0.392 . . . . 70.24 111.827 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.58 -41.6 90.59 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.848 0.356 . . . . 72.34 111.596 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.6 ttmp? -60.01 -47.59 85.2 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.952 0.406 . . . . 74.41 111.03 178.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.421 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 62.0 mtt -67.22 -29.96 69.75 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.151 -0.477 . . . . 73.01 111.442 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.67 -20.49 53.63 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.131 0.419 . . . . 63.21 112.131 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.89 28.35 10.19 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.204 -0.522 . . . . 55.52 113.455 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -130.9 78.89 72.71 Favored Pre-proline 0 N--CA 1.47 0.552 0 O-C-N 122.48 -0.424 . . . . 72.22 110.89 177.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -66.71 115.08 3.38 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.666 2.244 . . . . 72.53 113.073 -176.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.93 -15.58 40.26 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.029 -0.605 . . . . 52.2 113.624 178.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.429 ' O ' HG23 ' A' ' 39' ' ' VAL . 34.0 m-85 -81.35 18.09 1.21 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.649 0.611 . . . . 55.33 112.649 -178.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.86 -54.59 18.5 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.31 0.485 . . . . 61.3 112.31 -178.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.449 ' O ' ' HG3' ' A' ' 41' ' ' LYS . 33.1 ttm180 -57.74 -38.81 75.98 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.026 0.441 . . . . 75.12 111.614 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.609 ' HA ' ' HE3' ' A' ' 41' ' ' LYS . 81.6 m-70 -68.39 -32.5 72.61 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.282 -0.417 . . . . 73.31 111.704 -177.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.504 HG13 HD12 ' A' ' 8' ' ' ILE . 56.9 t -60.57 -40.91 85.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 121.156 0.503 . . . . 41.21 109.886 171.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.82 -44.94 95.45 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 115.947 -0.569 . . . . 55.3 112.804 176.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.609 ' HE3' ' HA ' ' A' ' 38' ' ' HIS . 8.5 mtmp? -63.04 -22.23 66.71 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.992 0.425 . . . . 71.14 111.3 178.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.33 -45.88 17.06 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.432 -0.349 . . . . 73.43 111.442 176.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.441 HD12 ' HE1' ' A' ' 23' ' ' TYR . 66.7 mt -65.51 -35.15 80.03 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 111.976 0.362 . . . . 74.33 111.976 -179.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.4 -20.81 38.62 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 121.248 -0.501 . . . . 75.44 113.834 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -81.83 -21.19 37.75 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.804 0.335 . . . . 72.31 111.832 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 78.7 mt -67.56 142.64 96.36 Favored Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 112.018 0.377 . . . . 64.32 112.018 -178.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.72 -175.73 2.83 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.681 2.254 . . . . 65.35 113.202 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -76.19 -38.45 56.55 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.989 -0.551 . . . . 65.31 110.635 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -95.72 57.69 1.58 Allowed Glycine 0 CA--C 1.528 0.852 0 CA-C-N 116.018 -0.537 . . . . 72.33 113.729 -178.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.2 t -102.37 159.29 15.55 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 122.32 -0.518 . . . . 63.22 111.303 173.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -85.85 -15.58 41.42 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.221 0.534 . . . . 71.24 110.527 176.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.463 HD12 ' HD2' ' A' ' 53' ' ' PRO . 55.9 tp -93.35 116.3 66.28 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 115.908 -0.587 . . . . 73.11 110.829 178.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.463 ' HD2' HD12 ' A' ' 52' ' ' LEU . 61.6 Cg_endo -74.04 94.4 0.89 Allowed 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 121.251 1.301 . . . . 63.11 112.299 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.409 ' HB2' ' HB3' ' A' ' 43' ' ' LEU . 54.9 p-90 -80.11 -30.33 39.11 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.372 0.606 . . . . 71.53 111.318 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -59.93 -22.63 62.68 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.617 -0.72 . . . . 74.34 112.876 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.415 ' HA ' HG12 ' A' ' 20' ' ' VAL . 97.8 mtt180 -79.61 -0.94 35.8 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.584 0.587 . . . . 73.43 112.584 -177.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.9 t -118.63 109.59 27.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.062 0.458 . . . . 65.32 110.892 178.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.528 HD11 HD21 ' A' ' 93' ' ' LEU . 32.9 pt -114.98 -172.48 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 116.221 -0.445 . . . . 72.0 111.983 -176.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.411 HD21 ' HB2' ' A' ' 63' ' ' LYS . 32.1 p30 -81.32 165.71 21.14 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.207 0.527 . . . . 71.52 112.08 -176.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 80.4 p -70.61 -2.73 15.23 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.809 0.67 . . . . 75.52 112.809 -175.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -94.16 -9.37 36.63 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.042 0.386 . . . . 74.45 112.042 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.3 44.33 13.71 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 120.667 -0.778 . . . . 62.45 112.393 -176.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.411 ' HB2' HD21 ' A' ' 59' ' ' ASN . 98.6 mttt -133.46 172.29 12.91 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 122.753 0.421 . . . . 73.04 110.588 179.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.556 HD11 HG11 ' A' ' 85' ' ' VAL . 66.7 mt -67.7 118.73 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 109.938 -0.393 . . . . 63.54 109.938 173.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.6 p -71.07 -33.58 70.37 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.414 0.524 . . . . 73.13 112.414 -172.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.572 HD13 ' HB3' ' A' ' 70' ' ' ASP . 85.7 mt -79.85 -174.61 4.48 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.119 0.485 . . . . 75.13 111.755 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -147.25 161.7 40.42 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.884 0.373 . . . . 64.13 111.758 -176.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 60.45 -134.94 49.98 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.173 -0.537 . . . . 73.44 112.969 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 49.9 mtp180 -62.51 -33.5 75.0 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.112 0.482 . . . . 75.25 110.95 178.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.572 ' HB3' HD13 ' A' ' 66' ' ' LEU . 7.8 m-20 -62.38 -30.27 71.07 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.218 -0.446 . . . . 73.13 111.458 176.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.479 ' HG ' HG21 ' A' ' 64' ' ' ILE . 10.2 tt -59.66 -54.98 40.16 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.011 0.434 . . . . 43.32 110.662 177.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -71.58 -21.78 61.82 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 111.812 0.301 . . . . 50.33 111.812 177.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.514 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 15.0 ttp180 -66.55 -50.35 63.43 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.385 0.612 . . . . 74.4 110.408 174.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.416 ' HB2' HD12 ' A' ' 66' ' ' LEU . 63.9 tt0 -63.38 -42.18 98.82 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.896 -0.593 . . . . 73.41 110.597 175.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.422 ' HG3' HG11 ' A' ' 85' ' ' VAL . 33.0 ttpt -60.81 -50.15 74.63 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.023 -0.535 . . . . 61.03 111.941 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.514 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 19.9 pt20 -60.29 -38.0 82.25 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.964 0.411 . . . . 54.42 111.354 -177.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -63.93 -34.01 77.01 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 120.887 0.375 . . . . 74.55 111.129 174.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.43 HD22 HD12 ' A' ' 83' ' ' ILE . 96.9 mt -78.56 -30.05 46.63 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.282 -0.417 . . . . 73.1 111.98 178.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -68.82 -28.06 66.41 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 121.964 -0.46 . . . . 70.33 110.408 174.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.41 -23.79 65.59 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.262 0.553 . . . . 61.34 110.798 171.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.404 ' HB3' ' HA2' ' A' ' 18' ' ' GLY . 15.4 mm-40 -81.94 -9.04 59.7 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.818 -0.628 . . . . 70.21 111.319 175.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.61 21.87 55.07 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.39 -0.433 . . . . 72.1 112.891 -177.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.43 HD12 HD22 ' A' ' 78' ' ' LEU . 64.6 mt -89.63 127.79 42.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 121.023 0.439 . . . . 75.01 112.102 -177.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -78.5 97.2 5.64 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.054 0.454 . . . . 73.15 111.012 176.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.556 HG11 HD11 ' A' ' 64' ' ' ILE . 41.2 t -94.89 119.58 43.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.714 0.292 . . . . 73.05 110.811 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.55 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 49.7 m -61.14 141.31 57.55 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 110.388 -0.227 . . . . 62.24 110.388 177.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -54.36 -32.96 58.1 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 113.379 0.881 . . . . 73.41 113.379 -170.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.417 HD11 ' HB2' ' A' ' 90' ' ' LYS . 2.8 pp -75.22 -2.83 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 112.244 0.461 . . . . 71.04 112.244 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.28 43.46 2.77 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 116.212 -0.449 . . . . 60.44 113.966 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.55 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 61.3 tttm -115.35 131.14 57.02 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 117.62 0.71 . . . . 60.31 112.018 -178.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.49 HD12 HG21 ' A' ' 58' ' ' ILE . 56.6 mt -119.12 115.58 48.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.976 -0.556 . . . . 74.22 110.89 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.31 93.61 0.23 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.475 0.546 . . . . 64.2 112.475 -177.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.572 ' O ' ' HG3' ' A' ' 97' ' ' LYS . 76.1 mt -56.33 -46.31 79.97 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.609 -0.269 . . . . 74.13 111.255 177.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 63.8 mtp180 -51.05 -19.93 1.24 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.415 0.524 . . . . 71.15 112.415 -177.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -106.22 -36.7 6.8 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 111.922 0.341 . . . . 74.44 111.922 176.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -105.49 13.76 29.63 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.636 0.976 . . . . 72.42 113.636 -172.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.572 ' HG3' ' O ' ' A' ' 93' ' ' LEU . 41.8 mtpt -56.14 138.77 49.2 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.553 0.575 . . . . 70.34 112.553 178.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 14.9 t90 -69.14 115.02 7.94 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.007 -0.542 . . . . 74.33 110.692 173.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -102.74 96.05 7.11 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-N 116.075 -0.511 . . . . 74.23 111.166 176.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo . . . . . 0 CA--C 1.542 0.904 0 C-N-CA 122.628 2.219 . . . . 53.43 112.762 175.74 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.483 ' O ' HG23 ' A' ' 6' ' ' VAL . 12.2 t70 . . . . . 0 CA--C 1.544 0.74 0 N-CA-C 112.09 0.404 . . . . 72.32 112.09 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -56.81 -40.12 75.42 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.632 0.604 . . . . 63.51 112.632 -178.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -58.1 -47.79 82.15 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.18 0.514 . . . . 72.2 110.477 177.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 85.9 mt -61.07 -47.14 87.71 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.724 -0.671 . . . . 50.02 110.801 177.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 2' ' ' ASP . 94.1 t -53.91 -50.13 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.173 -0.467 . . . . 74.24 111.648 178.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.453 ' O ' HG23 ' A' ' 11' ' ' VAL . 27.8 mm-40 -64.67 -50.21 67.92 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.375 0.509 . . . . 73.02 112.375 -176.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.459 ' O ' HG13 ' A' ' 12' ' ' ILE . 38.5 pt -64.93 -44.15 96.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 121.019 -0.272 . . . . 63.21 111.554 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.415 ' N ' HG13 ' A' ' 8' ' ' ILE . 21.8 m-30 -65.19 -42.51 93.52 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.813 0.339 . . . . 74.04 111.133 178.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.85 -40.1 69.29 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.454 -0.339 . . . . 63.34 111.67 178.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 7' ' ' GLN . 86.9 t -67.59 -41.63 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 120.917 0.389 . . . . 65.41 111.297 178.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.557 ' HB ' HD11 ' A' ' 52' ' ' LEU . 80.4 mt -59.17 -32.25 47.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 116.405 -0.361 . . . . 73.42 111.819 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -61.15 -18.51 58.46 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.131 0.419 . . . . 75.22 112.131 176.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -83.3 -9.17 59.25 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.531 0.567 . . . . 73.31 112.531 178.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.498 HD11 HD11 ' A' ' 26' ' ' ILE . 54.8 mt -74.46 116.27 51.46 Favored Pre-proline 0 CA--C 1.542 0.669 0 O-C-N 122.203 -0.311 . . . . 54.44 111.055 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -64.29 157.55 53.58 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.114 2.543 . . . . 65.22 113.514 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -65.54 120.77 13.5 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.21 -0.45 . . . . 74.3 111.495 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.34 17.07 56.27 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 120.988 -0.625 . . . . 73.1 113.22 -176.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -121.11 149.93 42.0 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 122.621 -0.341 . . . . 42.33 111.22 175.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.425 HG11 HD13 ' A' ' 91' ' ' ILE . 33.6 m -128.08 145.38 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 121.535 0.683 . . . . 73.21 111.795 -178.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 94.8 p -128.98 177.82 6.84 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.871 -0.604 . . . . 73.31 110.555 175.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.4 p -111.6 154.77 24.37 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.811 0.338 . . . . 62.01 111.376 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.432 ' HB2' ' HB1' ' A' ' 36' ' ' ALA . 74.8 m-85 -54.72 -40.12 68.92 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.852 0.358 . . . . 71.32 111.446 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -57.73 -44.7 94.02 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.268 -0.491 . . . . 72.1 113.043 177.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' A' ' 29' ' ' MET . 49.8 mt-10 -63.27 -54.0 44.05 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.731 0.3 . . . . 73.33 111.181 178.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.498 HD11 HD11 ' A' ' 15' ' ' ILE . 46.4 mm -54.3 -53.1 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 120.818 0.342 . . . . 72.5 111.72 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.99 -46.72 82.06 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.422 -0.354 . . . . 64.34 111.674 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -60.99 -42.95 99.41 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.781 0.324 . . . . 50.42 111.584 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.43 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 64.6 mtt -68.39 -30.67 69.64 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.043 0.449 . . . . 54.34 111.236 178.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.06 -19.65 59.9 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.197 -0.456 . . . . 71.4 111.914 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.24 15.18 24.21 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.137 -0.554 . . . . 61.34 113.014 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.434 ' HB3' ' CD1' ' A' ' 35' ' ' TYR . 69.5 m-85 -128.37 63.94 65.6 Favored Pre-proline 0 CA--C 1.548 0.873 0 O-C-N 122.55 -0.382 . . . . 70.03 111.54 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -61.72 110.94 1.05 Allowed 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.484 2.123 . . . . 60.3 112.568 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 123.64 -24.76 6.37 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 121.238 -0.506 . . . . 62.15 112.922 -177.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.461 ' O ' HG23 ' A' ' 39' ' ' VAL . 58.2 m-85 -79.96 30.54 0.26 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.242 0.46 . . . . 74.31 112.242 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.432 ' HB1' ' HB2' ' A' ' 23' ' ' TYR . . . -55.24 -64.88 0.7 Allowed 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.452 0.538 . . . . 74.11 112.452 -177.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -54.7 -31.69 58.41 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.361 0.504 . . . . 74.42 112.361 177.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 78.1 m-70 -65.63 -40.27 92.37 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.749 0.309 . . . . 70.2 111.11 178.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 35' ' ' TYR . 67.9 t -57.14 -45.18 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.097 0.475 . . . . 62.44 110.243 173.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -57.8 -42.98 94.81 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 116.037 -0.529 . . . . 31.53 112.714 175.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -62.15 -33.02 73.71 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.071 0.462 . . . . 70.32 111.154 176.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.0 -42.78 66.03 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.202 -0.454 . . . . 61.14 111.449 177.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 39' ' ' VAL . 90.0 mt -62.38 -33.32 74.51 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.907 0.384 . . . . 74.44 111.483 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.62 -12.39 46.63 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 121.405 -0.426 . . . . 74.31 113.458 176.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -85.8 -15.81 40.82 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.135 0.493 . . . . 52.4 110.953 177.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.521 HD11 HD23 ' A' ' 52' ' ' LEU . 90.8 mt -81.68 148.12 60.9 Favored Pre-proline 0 N--CA 1.47 0.563 0 N-CA-C 112.42 0.526 . . . . 74.13 112.42 -177.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.52 163.2 32.33 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.39 2.06 . . . . 70.44 112.125 173.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.562 ' HG2' ' HE ' ' A' ' 73' ' ' ARG . 42.2 mt-10 -57.02 -52.88 63.5 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 111.984 0.364 . . . . 51.2 111.984 -178.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -93.62 54.61 2.34 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.039 -0.601 . . . . 73.34 113.294 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.7 t -79.6 156.39 27.7 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.866 0.365 . . . . 73.41 111.556 178.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -67.12 -26.54 66.74 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.389 0.614 . . . . 63.34 110.313 174.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.557 HD11 ' HB ' ' A' ' 12' ' ' ILE . 55.3 tp -92.78 117.75 67.68 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 115.5 -0.773 . . . . 74.13 110.802 176.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.547 ' HD2' HD12 ' A' ' 52' ' ' LEU . 56.8 Cg_endo -71.77 96.58 0.77 Allowed 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 121.639 1.56 . . . . 61.14 112.47 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 60.9 p-90 -80.52 -25.25 38.81 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.34 0.591 . . . . 65.53 112.153 -178.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -68.65 -12.71 61.71 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.625 0.972 . . . . 54.54 113.625 -174.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -87.06 1.55 52.56 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.6 0.593 . . . . 75.22 112.6 -175.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.8 t -109.75 108.83 26.35 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 CA-C-O 121.266 0.555 . . . . 41.42 111.659 -178.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.535 HD13 HD12 ' A' ' 91' ' ' ILE . 18.2 pt -113.6 -170.81 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-N 116.093 -0.503 . . . . 73.1 111.964 -178.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.7 p30 -90.19 175.41 7.15 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.022 0.439 . . . . 73.33 111.991 -177.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 87.6 p -64.26 -22.58 67.0 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.376 0.509 . . . . 74.14 112.376 -176.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -82.27 -12.76 57.84 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.851 0.357 . . . . 75.0 111.546 -179.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.64 30.6 20.91 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.163 -0.541 . . . . 54.35 112.804 -177.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.408 ' HE3' HD13 ' A' ' 88' ' ' ILE . 56.6 mtpt -125.6 163.28 23.09 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.11 0.481 . . . . 75.24 111.864 -177.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 52.7 mt -75.95 130.38 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 116.09 -0.504 . . . . 41.11 111.685 -177.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.3 m -80.26 -30.5 38.42 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.393 -0.367 . . . . 73.22 111.756 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.438 HD12 ' HB2' ' A' ' 74' ' ' GLN . 75.3 mt -72.1 151.99 42.66 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.123 0.487 . . . . 62.12 111.564 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -129.33 153.32 47.96 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.191 -0.458 . . . . 73.34 111.89 -174.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 62.27 -129.06 42.7 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 121.283 -0.484 . . . . 71.2 113.415 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -66.03 -30.14 70.62 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.816 0.341 . . . . 74.01 111.781 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.54 ' HA ' ' HD3' ' A' ' 73' ' ' ARG . 9.6 m-20 -68.92 -31.03 69.63 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.888 0.375 . . . . 74.21 111.237 177.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.7 tt -61.32 -42.01 97.97 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 109.524 -0.547 . . . . 44.35 109.524 173.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -59.3 -43.5 92.6 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.984 -0.553 . . . . 74.4 111.173 176.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.562 ' HE ' ' HG2' ' A' ' 48' ' ' GLU . 79.9 mtp180 -50.62 -56.14 13.15 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.332 0.587 . . . . 74.13 111.338 176.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.438 ' HB2' HD12 ' A' ' 66' ' ' LEU . 43.7 tt0 -65.87 -42.63 90.11 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.069 -0.514 . . . . 74.13 111.065 -177.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -61.61 -50.63 71.79 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.14 0.422 . . . . 73.44 112.14 -178.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.401 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 13.7 pt20 -58.46 -39.05 78.84 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.757 0.313 . . . . 73.02 111.294 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -62.92 -43.75 97.93 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 120.809 0.338 . . . . 75.03 111.36 176.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 75.8 mt -66.42 -48.78 68.94 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.291 -0.413 . . . . 74.52 111.683 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -54.55 -31.48 56.58 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.116 0.484 . . . . 54.15 111.327 176.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.46 -26.76 64.74 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.636 0.606 . . . . 63.41 112.636 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -102.44 9.03 39.92 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.417 0.525 . . . . 74.14 112.417 -176.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.92 41.98 7.37 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 120.938 -0.648 . . . . 61.32 113.644 176.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 68.2 mt -117.21 128.5 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 O-C-N 122.648 -0.325 . . . . 71.21 111.052 177.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -78.64 103.36 8.53 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.732 0.301 . . . . 71.04 111.424 177.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.9 t -90.62 105.21 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 120.826 0.346 . . . . 75.33 110.985 175.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.523 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 50.0 m -56.61 144.35 32.32 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.475 -0.33 . . . . 43.01 110.997 177.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.497 ' HG3' ' N ' ' A' ' 88' ' ' ILE . 12.3 pt-20 -43.2 -44.19 5.06 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 113.867 1.062 . . . . 61.45 113.867 -171.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.497 ' N ' ' HG3' ' A' ' 87' ' ' GLU . 2.6 pp -78.72 9.69 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 112.625 0.602 . . . . 73.3 112.625 -176.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.87 55.67 2.91 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 116.292 -0.413 . . . . 44.11 113.084 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.523 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 49.1 tttm -127.61 150.1 49.88 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.166 0.508 . . . . 65.31 112.256 177.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.535 HD12 HD13 ' A' ' 58' ' ' ILE . 50.2 mt -124.15 156.8 31.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-N 115.695 -0.684 . . . . 63.31 110.228 176.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.42 ' HB3' ' HB3' ' A' ' 95' ' ' LYS . . . -85.37 102.65 13.59 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.028 0.442 . . . . 74.24 111.796 178.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.656 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 40.2 mt -71.07 -8.32 52.55 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.241 0.83 . . . . 63.54 113.241 -177.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -97.58 -11.06 24.09 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.337 0.589 . . . . 72.23 111.015 174.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.42 ' HB3' ' HB3' ' A' ' 92' ' ' ALA . 27.8 tptp -106.31 -35.39 7.17 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.672 0.619 . . . . 70.03 112.672 -172.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -127.52 15.02 7.11 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.15 0.426 . . . . 74.15 112.15 -175.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.656 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 63.9 tttp -60.14 135.25 57.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.732 0.301 . . . . 63.54 111.727 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 17.7 t90 -65.6 96.86 0.28 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.024 0.44 . . . . 65.15 110.983 176.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -98.66 99.8 8.28 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 116.032 -0.531 . . . . 52.42 110.885 173.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo . . . . . 0 CA--C 1.544 0.979 0 C-N-CA 122.685 2.256 . . . . 75.11 112.969 176.387 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 . . . . . 0 CA--C 1.54 0.578 0 N-CA-C 112.579 0.585 . . . . 75.02 112.579 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.4 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 74.3 mm-40 -56.28 -27.83 56.63 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.472 -0.331 . . . . 73.32 111.569 176.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.431 ' O ' HG12 ' A' ' 8' ' ' ILE . 90.7 t80 -54.96 -52.22 63.72 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.211 0.529 . . . . 72.35 110.027 172.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 58.0 mt -65.56 -49.79 67.56 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.373 -0.831 . . . . 74.3 110.988 178.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 85.3 t -53.64 -50.99 47.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 116.119 -0.491 . . . . 73.54 111.979 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 31.4 mm-40 -62.37 -54.95 32.97 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.295 0.48 . . . . 72.1 112.295 -177.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.537 HD12 HG13 ' A' ' 39' ' ' VAL . 31.4 pt -61.43 -42.98 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 120.641 0.258 . . . . 35.34 111.693 -177.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.434 ' HA ' HD12 ' A' ' 12' ' ' ILE . 17.6 m-30 -62.58 -43.75 98.03 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.962 0.411 . . . . 53.22 111.265 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.85 -41.99 68.06 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.131 -0.486 . . . . 73.15 111.432 178.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 55.2 t -66.95 -36.51 77.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 121.047 0.451 . . . . 74.23 111.362 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 8' ' ' ILE . 83.3 mt -61.12 -36.01 69.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 116.306 -0.406 . . . . 74.42 112.054 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -60.06 -22.38 62.63 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 112.324 0.49 . . . . 73.33 112.324 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -78.73 -5.7 53.9 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 112.792 0.664 . . . . 71.12 112.792 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.431 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 58.9 mt -76.53 122.02 85.9 Favored Pre-proline 0 CA--C 1.545 0.783 0 O-C-N 122.243 -0.286 . . . . 74.25 111.324 178.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 15' ' ' ILE . 6.3 Cg_exo -75.28 151.28 38.11 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.861 2.374 . . . . 63.43 112.681 177.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -58.18 110.37 0.93 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.477 0.656 . . . . 74.41 111.721 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.501 ' H ' ' NH1' ' A' ' 56' ' ' ARG . . . 131.55 -30.17 3.32 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.568 -0.742 . . . . 52.33 112.387 178.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -93.81 159.83 15.02 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.438 0.637 . . . . 75.22 112.328 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.1 m -130.35 148.22 33.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 115.214 -0.903 . . . . 71.11 110.353 174.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 95.4 p -119.37 159.88 23.35 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.951 0.405 . . . . 72.44 110.996 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 72.0 p -102.79 148.92 25.01 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.731 0.3 . . . . 62.21 111.371 176.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.43 ' HB2' ' HB1' ' A' ' 36' ' ' ALA . 53.5 m-85 -50.76 -39.77 53.19 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 111.909 0.337 . . . . 65.14 111.909 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.75 -33.99 80.3 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 121.275 -0.488 . . . . 72.32 113.213 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.418 ' HG3' ' OG1' ' A' ' 22' ' ' THR . 47.1 mt-10 -74.12 -54.48 7.71 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.785 0.326 . . . . 42.34 111.258 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.7 mm -56.4 -53.46 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 116.215 -0.448 . . . . 74.01 111.386 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.412 ' HB2' HG21 ' A' ' 39' ' ' VAL . . . -57.64 -51.88 67.71 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.874 0.369 . . . . 72.14 111.717 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -57.6 -48.76 78.5 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.883 0.373 . . . . 74.34 111.337 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 74.5 mtm -74.01 -8.3 55.6 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.173 0.434 . . . . 65.33 112.173 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.86 -9.27 26.67 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.892 0.377 . . . . 75.55 111.079 172.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.05 37.47 5.16 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 116.038 -0.528 . . . . 75.03 113.693 178.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -138.58 90.57 12.79 Favored Pre-proline 0 CA--C 1.542 0.639 0 O-C-N 122.564 -0.374 . . . . 72.11 111.268 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.59 127.86 9.88 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.478 2.118 . . . . 74.02 113.3 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.84 8.38 87.73 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 121.099 -0.572 . . . . 74.11 114.195 178.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -101.3 22.61 12.21 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 117.382 0.591 . . . . 74.13 111.974 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.43 ' HB1' ' HB2' ' A' ' 23' ' ' TYR . . . -56.47 -52.0 66.35 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.103 0.477 . . . . 42.55 111.855 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -55.96 -32.76 64.16 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.096 -0.502 . . . . 74.14 111.748 177.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.404 ' HA ' ' HD2' ' A' ' 41' ' ' LYS . 98.6 m-70 -74.79 -32.26 61.96 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.687 0.28 . . . . 73.23 111.463 -178.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.537 HG13 HD12 ' A' ' 8' ' ' ILE . 58.4 t -61.21 -40.31 85.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 121.138 0.494 . . . . 73.21 110.292 172.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.61 -37.81 94.0 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 121.133 -0.556 . . . . 72.32 112.484 173.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.404 ' HD2' ' HA ' ' A' ' 38' ' ' HIS . 66.1 mttm -61.27 -40.02 92.56 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.878 0.37 . . . . 54.43 111.006 174.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.48 -50.92 69.5 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.066 -0.515 . . . . 62.24 111.579 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.5 mt -63.42 -36.97 85.48 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.901 0.382 . . . . 74.4 111.309 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.98 -6.58 45.99 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 121.353 -0.451 . . . . 71.02 113.681 178.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -100.21 -6.5 25.99 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 120.98 0.419 . . . . 73.51 111.038 177.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 91.5 mt -79.52 152.23 75.32 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 112.542 0.571 . . . . 63.44 112.542 -176.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.516 ' HD2' ' HB2' ' A' ' 50' ' ' SER . 22.2 Cg_exo -64.04 148.31 91.51 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.644 2.229 . . . . 73.51 112.464 173.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -62.98 -12.17 23.88 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-O 121.08 0.466 . . . . 74.34 111.757 -178.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -135.97 47.71 0.96 Allowed Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.312 -0.47 . . . . 41.35 113.233 175.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.516 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 43.0 t -74.83 165.84 24.59 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.991 0.424 . . . . 63.43 112.071 176.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -74.02 -19.37 60.66 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.237 -0.438 . . . . 73.11 111.532 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.549 HD12 ' HD2' ' A' ' 53' ' ' PRO . 30.1 tp -89.45 126.4 58.45 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.281 -0.418 . . . . 72.01 111.144 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.549 ' HD2' HD12 ' A' ' 52' ' ' LEU . 60.1 Cg_endo -73.42 95.69 0.87 Allowed 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 121.379 1.386 . . . . 72.05 111.908 174.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 66.1 p-90 -80.5 -31.68 37.15 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.282 0.563 . . . . 72.43 111.187 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -60.5 -18.68 53.37 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.419 0.896 . . . . 72.0 113.419 -176.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.501 ' NH1' ' H ' ' A' ' 18' ' ' GLY . 90.1 mtt-85 -86.75 11.64 12.64 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.955 0.724 . . . . 71.01 112.955 -177.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.2 t -125.93 109.72 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-O 121.407 0.622 . . . . 72.23 111.742 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.513 HD13 HD12 ' A' ' 91' ' ' ILE . 18.9 pt -114.16 -174.56 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 CA-C-N 115.827 -0.624 . . . . 72.31 111.328 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.408 HD21 ' HB2' ' A' ' 63' ' ' LYS . 34.2 p30 -87.22 171.38 10.69 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.647 -0.658 . . . . 73.44 111.871 -177.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 71.1 p -65.07 -14.8 61.36 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 112.68 0.622 . . . . 63.02 112.68 -174.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -75.0 -30.19 61.09 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.127 0.489 . . . . 64.03 111.297 175.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.49 11.97 34.35 Favored Glycine 0 CA--C 1.521 0.467 0 CA-C-N 115.691 -0.686 . . . . 72.4 111.676 -170.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.471 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 97.7 mttt -103.22 155.71 18.24 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.338 0.59 . . . . 71.41 112.19 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 63.6 mt -73.21 129.02 36.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 115.748 -0.66 . . . . 55.23 110.527 174.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.5 t -67.87 -38.7 83.42 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 120.83 0.348 . . . . 70.4 111.798 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.416 HD13 ' HB3' ' A' ' 70' ' ' ASP . 84.4 mt -74.25 143.37 45.11 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.856 0.36 . . . . 73.45 111.169 178.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -125.37 161.72 26.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.132 0.492 . . . . 74.23 111.336 -177.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 77.54 -138.95 22.41 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.111 -0.566 . . . . 73.44 112.518 -176.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 68.9 mtm180 -61.36 -38.23 86.23 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.26 0.552 . . . . 72.12 111.515 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.416 ' HB3' HD13 ' A' ' 66' ' ' LEU . 4.5 m-20 -61.73 -26.78 68.27 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 116.101 -0.5 . . . . 73.13 111.61 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.6 tt -65.7 -61.37 2.12 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.503 -0.317 . . . . 63.05 111.098 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.505 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 3.3 p30 -64.75 -24.5 67.58 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.785 0.326 . . . . 64.21 111.467 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -60.53 -52.45 65.13 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.974 0.416 . . . . 72.0 110.688 173.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -62.63 -38.93 92.15 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.25 0.547 . . . . 72.04 110.579 176.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.559 ' HG3' ' HB ' ' A' ' 85' ' ' VAL . 48.0 tttp -52.18 -56.38 14.99 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.601 -0.727 . . . . 73.31 111.729 174.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -61.88 -35.76 79.27 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 111.969 0.359 . . . . 73.02 111.969 -178.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -59.59 -45.33 92.22 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.02 0.438 . . . . 75.33 111.219 175.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.6 mt -71.79 -45.47 61.47 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.13 -0.486 . . . . 73.24 112.177 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -68.7 -26.31 65.22 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 122.17 -0.331 . . . . 71.14 111.786 -178.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.77 -23.71 67.33 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.313 0.577 . . . . 52.31 110.966 172.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -87.42 -10.84 50.88 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.782 -0.644 . . . . 71.34 111.462 176.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 108.27 19.29 9.02 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 121.341 -0.457 . . . . 54.01 114.022 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 57.1 mt -99.98 159.19 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 O-C-N 122.187 -0.596 . . . . 62.25 111.498 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -105.52 117.71 34.72 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 122.209 -0.307 . . . . 71.42 110.988 177.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.559 ' HB ' ' HG3' ' A' ' 75' ' ' LYS . 39.2 t -119.94 114.22 43.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.793 0.33 . . . . 55.05 111.391 178.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.0 m -62.84 141.9 58.46 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 122.386 -0.196 . . . . 53.01 110.627 176.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -47.06 -42.08 17.99 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.626 0.973 . . . . 64.41 113.626 -172.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.417 HG13 ' H ' ' A' ' 88' ' ' ILE . 2.7 pp -74.66 8.52 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 112.553 0.575 . . . . 75.4 112.553 -178.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.92 51.52 3.77 Favored Glycine 0 CA--C 1.524 0.594 0 CA-C-N 116.305 -0.407 . . . . 51.31 113.706 176.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -128.96 137.3 51.3 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.145 0.498 . . . . 52.03 111.641 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.513 HD12 HD13 ' A' ' 58' ' ' ILE . 52.0 mt -127.62 141.66 45.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 115.716 -0.675 . . . . 70.53 110.382 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.19 93.5 4.59 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 122.215 -0.303 . . . . 71.03 111.654 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.499 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 94.2 mt -55.42 -53.21 59.09 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.667 0.27 . . . . 73.45 111.56 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -51.37 -15.22 0.37 Allowed 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 113.264 0.838 . . . . 73.41 113.264 -177.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.518 ' HE3' ' CE2' ' A' ' 96' ' ' TYR . 38.1 ttpt -113.13 -26.64 8.35 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 121.562 -0.711 . . . . 74.43 112.511 177.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.518 ' CE2' ' HE3' ' A' ' 95' ' ' LYS . 85.4 m-85 -117.92 11.31 13.42 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.361 0.504 . . . . 70.22 112.361 -176.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 57.2 tttm -65.55 134.68 53.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.085 0.469 . . . . 72.44 111.733 -176.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 22.5 t90 -66.36 96.51 0.36 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.185 0.516 . . . . 71.03 111.517 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -105.73 93.68 7.73 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 115.804 -0.634 . . . . 71.41 110.608 173.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo . . . . . 0 CA--C 1.544 0.984 0 C-N-CA 122.839 2.359 . . . . 73.55 113.45 179.591 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 CA--C 1.541 0.599 0 N-CA-C 111.93 0.344 . . . . 63.22 111.93 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 52.8 tp60 -58.68 -31.45 68.21 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.887 0.375 . . . . 73.35 110.781 177.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -54.22 -50.27 67.54 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.256 -0.429 . . . . 75.3 110.688 171.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 76.7 mt -62.16 -46.54 88.51 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.747 -0.66 . . . . 74.35 111.24 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.9 t -56.7 -49.43 78.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.915 0.388 . . . . 75.44 111.66 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.435 ' O ' HG23 ' A' ' 11' ' ' VAL . 27.6 mm-40 -60.61 -55.99 26.68 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.349 0.5 . . . . 72.41 112.349 -178.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.511 ' O ' HG13 ' A' ' 12' ' ' ILE . 26.5 pt -59.37 -45.14 93.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 111.86 0.319 . . . . 70.21 111.86 -177.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -64.55 -41.93 96.02 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.983 0.421 . . . . 73.41 111.175 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.27 -37.56 69.98 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.247 -0.433 . . . . 71.24 111.317 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 7' ' ' GLN . 63.1 t -69.57 -36.98 73.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 121.095 0.474 . . . . 63.44 111.234 178.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 8' ' ' ILE . 75.1 mt -62.18 -34.25 62.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 116.122 -0.49 . . . . 72.13 112.168 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -60.82 -12.16 9.96 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 112.921 0.712 . . . . 70.42 112.921 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -87.52 -5.36 58.82 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 112.827 0.677 . . . . 63.34 112.827 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 56.2 mt -76.72 115.6 49.44 Favored Pre-proline 0 CA--C 1.546 0.802 0 O-C-N 122.101 -0.375 . . . . 63.4 111.448 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -67.82 159.34 53.25 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.909 2.406 . . . . 64.11 113.496 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -66.94 97.02 0.46 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.853 -0.612 . . . . 73.51 111.395 -176.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.476 ' H ' ' NH1' ' A' ' 56' ' ' ARG . . . 136.23 -22.19 3.42 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 121.222 -0.513 . . . . 70.55 113.045 176.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -98.42 164.73 12.16 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.144 0.497 . . . . 62.23 111.996 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.6 m -135.79 157.47 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.732 -0.667 . . . . 73.25 110.607 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 98.0 p -130.35 172.71 11.55 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.043 0.449 . . . . 75.4 110.965 178.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 46.4 p -108.26 152.39 24.68 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.91 0.386 . . . . 31.25 111.325 177.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.49 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 67.5 m-85 -55.32 -34.22 64.0 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.287 0.477 . . . . 75.11 112.287 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.3 -48.93 83.55 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.915 -0.66 . . . . 70.45 112.426 176.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -59.32 -52.45 65.6 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.849 0.357 . . . . 72.34 111.52 178.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.2 mm -59.61 -50.27 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 111.954 0.353 . . . . 64.53 111.954 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.449 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -58.67 -50.41 73.96 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.047 0.388 . . . . 74.13 112.047 -178.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -62.45 -44.05 97.34 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.647 0.26 . . . . 75.22 111.622 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 74.7 mtm -69.17 -24.14 64.03 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.591 0.234 . . . . 42.34 111.623 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.82 -20.98 44.82 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.026 0.441 . . . . 74.43 111.229 174.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.96 16.62 20.96 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 121.405 -0.426 . . . . 64.52 113.645 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.449 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 69.7 m-85 -126.93 89.33 52.33 Favored Pre-proline 0 CA--C 1.542 0.651 0 O-C-N 122.54 -0.388 . . . . 75.02 111.938 -177.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.24 141.85 40.25 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 122.437 2.091 . . . . 74.1 112.414 177.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.65 -37.17 2.46 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 121.003 -0.617 . . . . 73.02 113.637 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -63.8 -2.81 1.97 Allowed 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.744 0.646 . . . . 74.34 112.744 -178.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.49 ' HB1' ' HB3' ' A' ' 23' ' ' TYR . . . -48.02 -42.44 28.19 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.693 0.627 . . . . 34.25 112.693 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -59.05 -36.12 74.5 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.236 0.458 . . . . 72.15 112.236 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -72.65 -33.52 66.64 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.788 0.328 . . . . 74.41 110.755 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.489 HG13 HD12 ' A' ' 8' ' ' ILE . 60.6 t -58.02 -45.97 88.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 116.195 -0.457 . . . . 73.44 110.573 174.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.32 -45.4 96.2 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 121.15 -0.548 . . . . 64.43 113.0 176.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -64.79 -28.48 69.6 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.817 0.341 . . . . 64.21 111.261 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.65 -48.5 47.32 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.87 0.367 . . . . 71.22 111.077 174.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.561 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 44.6 mt -64.06 -40.0 95.31 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.864 0.364 . . . . 54.32 111.298 178.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.553 ' HA2' HD11 ' A' ' 66' ' ' LEU . . . -65.01 -13.85 58.06 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.155 -0.545 . . . . 55.14 112.924 176.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -86.79 -16.42 36.31 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 120.977 0.418 . . . . 72.54 110.962 177.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 95.7 mt -77.73 149.17 77.28 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 116.344 -0.389 . . . . 63.22 111.918 -178.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -77.2 165.93 27.16 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.537 2.158 . . . . 60.22 112.702 176.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.53 ' HB3' ' HD3' ' A' ' 73' ' ' ARG . 11.3 pt-20 -84.02 25.35 0.83 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.044 0.387 . . . . 64.45 112.044 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -141.87 19.59 2.54 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 121.195 -0.526 . . . . 50.23 113.482 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 56.4 p -81.11 155.75 26.11 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 117.085 0.442 . . . . 72.55 111.629 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -69.85 -21.35 63.36 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.325 0.583 . . . . 74.42 111.413 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.468 HD12 ' HD2' ' A' ' 53' ' ' PRO . 48.5 tp -87.42 116.3 65.65 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 115.882 -0.599 . . . . 74.31 111.388 178.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.468 ' HD2' HD12 ' A' ' 52' ' ' LEU . 64.2 Cg_endo -74.44 95.1 0.92 Allowed 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 121.419 1.413 . . . . 64.34 112.02 177.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.561 ' HB2' ' HB3' ' A' ' 43' ' ' LEU . 64.1 p-90 -83.78 -26.73 29.38 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.113 -0.494 . . . . 74.54 111.665 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -62.43 -12.98 24.9 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 113.102 0.779 . . . . 74.52 113.102 -178.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.486 HH22 ' HB3' ' A' ' 81' ' ' GLU . 80.4 mtt-85 -86.21 -13.23 47.53 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.846 0.684 . . . . 72.42 112.846 -178.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.7 t -102.74 99.81 9.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 120.97 0.414 . . . . 55.51 110.806 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.537 ' HA ' ' OG ' ' A' ' 65' ' ' SER . 44.8 pt -104.29 -170.23 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 121.303 0.573 . . . . 74.15 111.787 -178.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.1 p30 -89.38 158.96 17.56 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.199 0.523 . . . . 74.21 111.928 -177.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.7 p -66.01 -3.85 6.1 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.143 0.423 . . . . 60.32 112.143 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -86.55 -1.88 58.01 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 122.647 0.379 . . . . 63.43 111.896 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.78 31.88 67.17 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.147 -0.549 . . . . 42.31 112.69 -178.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -133.04 173.32 11.55 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.114 0.483 . . . . 74.01 111.324 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.611 HD11 HG11 ' A' ' 85' ' ' VAL . 38.1 mt -65.53 146.65 13.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 116.029 -0.532 . . . . 74.21 112.015 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.537 ' OG ' ' HA ' ' A' ' 58' ' ' ILE . 14.8 m -70.22 -47.86 59.58 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.002 -0.545 . . . . 75.21 111.91 -176.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.553 HD11 ' HA2' ' A' ' 44' ' ' GLY . 86.8 mt -103.54 158.2 16.53 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.084 -0.507 . . . . 54.35 111.794 -176.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.491 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 53.4 mtpt -120.24 163.66 17.44 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.02 0.438 . . . . 71.23 111.48 -178.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 77.53 -139.35 22.95 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 121.069 -0.586 . . . . 62.52 112.831 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -63.9 -34.95 79.11 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.206 0.526 . . . . 72.13 110.952 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -61.38 -27.77 68.76 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.764 -0.653 . . . . 72.03 111.195 177.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.491 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 10.1 tt -67.07 -48.31 68.64 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.103 -0.499 . . . . 72.14 110.663 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.58 ' HA ' ' HD3' ' A' ' 75' ' ' LYS . 11.9 m-20 -65.05 -34.22 77.9 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.68 0.276 . . . . 61.41 111.417 176.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.53 ' HD3' ' HB3' ' A' ' 48' ' ' GLU . 38.8 ttm180 -56.82 -50.71 71.55 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.108 0.48 . . . . 62.42 110.684 174.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.487 ' OE1' HG23 ' A' ' 64' ' ' ILE . 45.6 tt0 -66.84 -34.5 77.94 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.17 -0.468 . . . . 54.02 111.108 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.58 ' HD3' ' HA ' ' A' ' 72' ' ' ASP . 47.2 mtpt -55.7 -62.75 1.48 Allowed 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 120.963 0.411 . . . . 63.23 111.434 173.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -53.58 -37.57 63.08 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.795 -0.639 . . . . 74.33 112.053 -175.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -61.28 -53.51 55.83 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.027 0.442 . . . . 73.24 111.592 175.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.7 mt -65.26 -40.97 94.64 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.357 -0.383 . . . . 72.22 111.525 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -55.54 -44.63 76.93 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.152 0.501 . . . . 74.34 111.043 174.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.71 -31.86 71.13 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.008 -0.542 . . . . 70.43 111.278 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.486 ' HB3' HH22 ' A' ' 56' ' ' ARG . 14.1 mm-40 -87.65 9.85 20.02 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.562 0.578 . . . . 65.04 112.562 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.27 4.3 83.92 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.398 -0.43 . . . . 70.13 113.813 175.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 67.0 mt -87.39 132.79 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 O-C-N 122.6 -0.353 . . . . 71.1 111.171 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -87.99 101.01 13.35 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.918 0.39 . . . . 52.43 111.424 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.611 HG11 HD11 ' A' ' 64' ' ' ILE . 48.8 t -89.87 120.58 38.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 120.844 0.354 . . . . 74.14 110.731 176.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.589 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 36.5 m -68.18 146.2 53.62 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.595 -0.275 . . . . 74.45 111.1 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -41.22 -51.96 3.44 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 115.246 1.573 . . . . 53.23 115.246 -169.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 pp -75.01 -5.7 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 112.924 0.713 . . . . 73.52 112.924 -175.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 105.99 46.93 1.13 Allowed Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.29 -0.481 . . . . 73.32 113.171 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.589 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 48.5 tttm -116.81 139.65 50.35 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.829 0.347 . . . . 73.12 111.916 -178.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.464 HD12 HG21 ' A' ' 58' ' ' ILE . 65.8 mt -131.11 126.36 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 116.267 -0.424 . . . . 71.05 111.216 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.22 95.88 1.04 Allowed 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 111.958 0.355 . . . . 50.44 111.958 179.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.485 HD21 HD11 ' A' ' 58' ' ' ILE . 70.7 mt -56.24 -51.1 69.34 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 111.918 0.34 . . . . 73.23 111.918 179.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -61.71 -9.29 6.02 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.193 0.442 . . . . 63.02 112.193 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -107.92 -22.11 12.56 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 122.507 0.323 . . . . 73.04 111.608 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -127.92 13.67 6.82 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.241 0.46 . . . . 64.13 112.241 -177.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 65.1 tttp -62.99 131.41 48.55 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.535 0.568 . . . . 71.34 112.535 -175.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 20.4 t90 -72.64 109.82 6.55 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.101 -0.499 . . . . 71.33 111.024 174.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.445 ' HA ' ' HD2' ' A' ' 100' ' ' PRO . 20.8 mm-40 -108.72 93.7 12.69 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 115.982 -0.554 . . . . 64.12 110.735 176.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 99' ' ' GLN . 22.5 Cg_endo . . . . . 0 C--N 1.352 0.736 0 C-N-CA 122.971 2.447 . . . . 71.43 112.857 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 . . . . . 0 CA--C 1.54 0.558 0 N-CA-C 111.896 0.332 . . . . 63.53 111.896 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.422 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 26.4 mm-40 -60.19 -27.6 67.29 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.595 0.236 . . . . 64.03 111.363 176.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -52.59 -49.13 65.62 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.237 0.541 . . . . 72.22 110.222 172.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 73.1 mt -66.61 -47.54 72.36 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.485 -0.78 . . . . 51.1 111.055 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.7 t -55.19 -44.92 76.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.324 -0.398 . . . . 71.45 111.589 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 31.8 mm-40 -66.58 -52.28 47.14 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.208 0.447 . . . . 75.24 112.208 -178.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.423 ' O ' HG13 ' A' ' 12' ' ' ILE . 31.8 pt -60.73 -41.62 89.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 O-C-N 122.146 -0.346 . . . . 54.34 111.47 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 17.6 m-30 -61.72 -46.56 89.12 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.068 0.461 . . . . 74.42 110.705 176.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.28 -39.55 64.01 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.109 -0.496 . . . . 72.23 111.448 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 7' ' ' GLN . 92.1 t -65.25 -43.2 95.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 120.776 0.322 . . . . 74.53 111.476 178.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.551 ' HB ' HD11 ' A' ' 52' ' ' LEU . 72.8 mt -56.84 -33.97 42.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 120.927 0.394 . . . . 74.31 111.763 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -59.4 -16.94 26.36 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 113.22 0.822 . . . . 74.23 113.22 178.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.437 ' HB3' ' HZ2' ' A' ' 98' ' ' TRP . 2.0 mp0 -80.97 -11.7 59.52 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.375 0.509 . . . . 71.53 112.375 177.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.495 HD11 HD11 ' A' ' 26' ' ' ILE . 51.0 mt -75.33 115.3 44.0 Favored Pre-proline 0 N--CA 1.472 0.626 0 O-C-N 122.311 -0.243 . . . . 74.43 111.086 178.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 15' ' ' ILE . 19.6 Cg_exo -66.95 169.29 15.17 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.778 2.319 . . . . 72.32 113.523 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -70.06 115.65 9.51 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.822 -0.626 . . . . 74.01 110.891 -178.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.32 19.25 21.55 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 120.97 -0.633 . . . . 71.34 113.643 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -127.11 152.45 47.29 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 117.169 0.485 . . . . 73.01 111.347 176.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.6 m -128.04 150.04 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 121.136 0.493 . . . . 73.52 111.731 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.7 t -138.75 175.0 9.93 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.362 -0.381 . . . . 51.45 111.091 175.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 67.6 p -104.88 150.78 24.57 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.907 0.384 . . . . 75.51 111.988 -177.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.42 ' HE1' HD12 ' A' ' 43' ' ' LEU . 68.9 m-85 -52.54 -36.68 56.12 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.27 -0.423 . . . . 63.21 111.659 178.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -60.96 -48.25 87.23 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 116.086 -0.506 . . . . 55.11 112.789 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -61.14 -51.95 66.93 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.848 0.356 . . . . 65.41 111.107 178.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.495 HD11 HD11 ' A' ' 15' ' ' ILE . 49.4 mm -53.14 -53.31 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 121.131 0.491 . . . . 72.11 111.622 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.62 -44.63 96.11 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.157 0.504 . . . . 62.23 111.322 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.4 ttpp -62.46 -33.99 75.93 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.168 -0.469 . . . . 73.33 111.531 -178.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 67.2 mtt -72.99 -41.33 64.43 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.984 0.421 . . . . 73.1 111.161 175.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.73 -24.81 67.05 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.236 -0.438 . . . . 51.34 112.171 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.42 24.55 6.14 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.286 -0.483 . . . . 51.31 113.254 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -135.65 66.07 62.64 Favored Pre-proline 0 CA--C 1.543 0.674 0 O-C-N 122.665 -0.315 . . . . 74.5 111.57 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -61.91 138.28 72.78 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.588 2.192 . . . . 64.04 112.757 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.33 -27.8 9.96 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.274 -0.488 . . . . 54.01 113.127 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -79.88 22.94 0.47 Allowed 'General case' 0 N--CA 1.473 0.715 0 O-C-N 122.214 -0.58 . . . . 64.35 112.542 -177.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.93 -37.86 69.52 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.414 0.524 . . . . 74.33 112.414 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -58.82 -38.22 78.17 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.825 0.345 . . . . 70.14 111.782 178.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -69.74 -35.02 74.63 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.537 -0.301 . . . . 73.44 111.124 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.418 HG13 HD12 ' A' ' 8' ' ' ILE . 46.6 t -59.67 -44.5 93.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.002 0.43 . . . . 52.52 110.655 175.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.68 -40.58 98.71 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 121.169 -0.539 . . . . 74.12 112.718 176.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -67.0 -27.89 67.8 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.982 0.42 . . . . 74.33 111.157 175.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.89 -53.61 12.64 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.308 -0.406 . . . . 70.54 111.625 177.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.42 HD12 ' HE1' ' A' ' 23' ' ' TYR . 61.1 mt -61.13 -39.46 90.1 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.501 -0.318 . . . . 73.53 111.558 -179.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.45 -15.91 57.73 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 120.88 -0.676 . . . . 54.51 113.507 178.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -103.41 10.78 37.17 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 122.622 -0.34 . . . . 64.35 111.804 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 57.9 mt -86.12 155.89 57.65 Favored Pre-proline 0 N--CA 1.47 0.568 0 CA-C-O 120.999 0.428 . . . . 75.23 112.031 177.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.436 ' HG2' ' HB2' ' A' ' 50' ' ' SER . 55.2 Cg_endo -70.29 153.16 66.75 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.266 1.977 . . . . 70.14 111.819 172.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -49.28 -70.8 0.08 Allowed 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 121.239 0.542 . . . . 64.34 111.372 -176.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -91.53 59.46 2.96 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 121.201 -0.523 . . . . 70.14 113.364 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.436 ' HB2' ' HG2' ' A' ' 47' ' ' PRO . 40.2 t -70.25 165.41 22.27 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.028 0.442 . . . . 63.41 111.621 176.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -67.09 -24.73 65.98 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.234 0.54 . . . . 63.04 110.545 174.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.551 HD11 ' HB ' ' A' ' 12' ' ' ILE . 28.0 tp -90.37 126.8 55.37 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 115.722 -0.672 . . . . 73.24 111.747 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.534 ' HD2' HD12 ' A' ' 52' ' ' LEU . 74.0 Cg_endo -76.24 94.99 1.02 Allowed 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 121.574 1.516 . . . . 71.23 111.553 170.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 60.4 p-90 -83.71 -26.98 29.31 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.352 0.596 . . . . 54.11 111.678 -177.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -62.66 -13.95 37.99 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.571 0.952 . . . . 73.1 113.571 -177.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -86.36 3.57 43.0 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 112.541 0.571 . . . . 74.22 112.541 -178.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.8 t -116.62 123.23 71.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 121.194 0.521 . . . . 73.42 111.795 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.549 HG21 HD12 ' A' ' 91' ' ' ILE . 21.1 pt -126.97 -172.65 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 116.068 -0.514 . . . . 52.34 111.269 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.6 p30 -90.29 172.64 8.63 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.899 -0.501 . . . . 73.1 112.126 -177.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 43.9 m -63.32 -16.57 60.8 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 112.587 0.588 . . . . 72.11 112.587 -176.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -88.38 -2.71 58.75 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.809 0.338 . . . . 73.11 111.662 -178.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.63 40.75 58.5 Favored Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.977 -0.63 . . . . 64.23 112.358 -175.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -130.76 155.11 47.2 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.101 0.477 . . . . 71.0 111.387 -177.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.552 HG23 ' OE1' ' A' ' 74' ' ' GLN . 65.5 mt -77.2 130.78 35.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 116.252 -0.431 . . . . 74.44 110.966 176.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.9 m -73.17 -41.17 64.18 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 112.101 0.408 . . . . 74.52 112.101 -179.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.541 HD13 ' HB3' ' A' ' 70' ' ' ASP . 93.8 mt -73.15 146.15 45.85 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.453 -0.34 . . . . 74.3 110.789 178.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -116.2 157.09 25.39 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.17 0.509 . . . . 73.35 112.121 -176.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.6 -124.14 30.57 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 115.858 -0.61 . . . . 74.51 114.007 177.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.5 mtp180 -61.27 -46.96 88.19 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.948 0.404 . . . . 74.32 111.972 -177.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.541 ' HB3' HD13 ' A' ' 66' ' ' LEU . 15.1 m-20 -63.08 -29.59 70.93 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.85 0.357 . . . . 61.54 111.174 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.8 tt -63.88 -53.44 50.49 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.312 -0.404 . . . . 75.04 110.463 175.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -62.27 -30.2 70.96 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.303 -0.408 . . . . 64.43 111.22 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.557 ' O ' ' HG2' ' A' ' 77' ' ' LYS . 43.5 ttm180 -58.94 -60.38 3.96 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.743 0.306 . . . . 74.2 110.946 174.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.552 ' OE1' HG23 ' A' ' 64' ' ' ILE . 43.3 tt0 -55.73 -43.3 76.45 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.086 0.47 . . . . 71.15 110.962 177.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.415 ' HG3' ' HB ' ' A' ' 85' ' ' VAL . 31.5 tttm -55.07 -56.54 18.7 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.728 -0.669 . . . . 70.24 111.837 176.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -59.14 -37.97 78.54 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.154 0.427 . . . . 61.45 112.154 -178.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.557 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 75.0 mmtt -58.8 -46.46 87.52 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.934 0.397 . . . . 74.44 110.942 176.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.504 HD22 HD12 ' A' ' 83' ' ' ILE . 95.8 mt -71.26 -35.33 71.35 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.198 -0.455 . . . . 70.25 111.628 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -54.6 -41.16 69.61 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.075 0.464 . . . . 60.52 110.741 173.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.61 -8.18 39.6 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.419 0.526 . . . . 71.4 112.419 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -107.64 4.45 25.86 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.969 0.414 . . . . 63.03 111.47 177.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.67 5.17 63.25 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.285 -0.483 . . . . 52.11 113.926 177.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.504 HD12 HD22 ' A' ' 78' ' ' LEU . 66.4 mt -82.64 133.13 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 O-C-N 122.242 -0.563 . . . . 75.43 111.435 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -92.36 97.64 10.99 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.891 0.377 . . . . 72.3 111.455 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.415 ' HB ' ' HG3' ' A' ' 75' ' ' LYS . 44.8 t -91.22 124.53 43.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 120.883 0.373 . . . . 75.35 111.49 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.56 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 42.7 t -67.63 144.56 55.47 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 111.635 0.235 . . . . 62.32 111.635 177.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -41.94 -48.25 4.47 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.081 1.141 . . . . 75.45 114.081 -173.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.403 ' H ' HG13 ' A' ' 88' ' ' ILE . 2.8 pp -80.74 16.11 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 112.87 0.693 . . . . 73.44 112.87 -175.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.82 51.59 4.73 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 121.414 -0.422 . . . . 64.15 113.51 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.56 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 60.4 tttm -125.72 132.17 52.41 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 122.532 -0.393 . . . . 71.21 111.256 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.549 HD12 HG21 ' A' ' 58' ' ' ILE . 61.0 mt -124.09 134.41 66.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 120.934 0.397 . . . . 62.1 111.475 -177.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.8 100.22 1.14 Allowed 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 111.947 0.351 . . . . 65.44 111.947 178.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 39.4 mt -59.06 -62.27 2.01 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.355 0.502 . . . . 73.33 112.355 -178.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -50.19 -34.46 22.78 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 112.314 0.487 . . . . 73.21 112.314 -175.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -73.71 -47.29 40.56 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 112.32 0.489 . . . . 53.53 112.32 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -102.41 14.1 32.85 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 120.973 0.416 . . . . 73.2 111.528 -177.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -55.02 114.09 1.61 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.905 -0.589 . . . . 72.33 111.894 -175.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.437 ' HZ2' ' HB3' ' A' ' 14' ' ' GLN . 21.4 t90 -56.45 121.28 9.25 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.101 0.778 . . . . 65.15 113.101 -177.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.447 ' O ' ' HG3' ' A' ' 99' ' ' GLN . 12.9 pt20 -127.16 109.98 21.55 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 115.662 -0.699 . . . . 73.14 109.924 167.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo . . . . . 0 CA--C 1.538 0.686 0 C-N-CA 122.152 1.901 . . . . 63.3 112.27 174.945 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.47 ' O ' HG23 ' A' ' 6' ' ' VAL . 5.8 m-20 . . . . . 0 N--CA 1.472 0.626 0 N-CA-C 112.088 0.403 . . . . 74.14 112.088 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -57.66 -31.73 66.6 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.395 -0.366 . . . . 63.3 111.767 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.406 ' O ' HG12 ' A' ' 8' ' ' ILE . 53.2 t80 -54.83 -52.41 62.81 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.309 0.576 . . . . 72.14 110.49 172.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 72.5 mt -64.53 -45.32 87.7 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.629 -0.714 . . . . 70.12 111.17 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 2' ' ' ASP . 58.6 t -55.37 -51.49 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 120.931 0.396 . . . . 63.43 111.697 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.409 ' O ' HG23 ' A' ' 11' ' ' VAL . 28.3 mm-40 -65.27 -50.81 64.32 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 112.539 0.57 . . . . 65.11 112.539 -176.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.45 ' O ' HG13 ' A' ' 12' ' ' ILE . 32.6 pt -62.16 -45.55 98.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 O-C-N 122.192 -0.317 . . . . 62.33 111.58 -178.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.405 ' N ' HG13 ' A' ' 8' ' ' ILE . 19.5 m-30 -62.31 -43.37 98.98 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.081 0.467 . . . . 72.43 110.91 177.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.03 -48.15 67.83 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.927 -0.579 . . . . 61.32 111.413 178.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 7' ' ' GLN . 78.0 t -62.87 -41.84 94.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 120.795 0.331 . . . . 75.12 111.502 -179.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 8' ' ' ILE . 81.5 mt -57.4 -35.86 50.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 112.06 0.393 . . . . 71.34 112.06 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -56.72 -15.17 4.1 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.15 0.796 . . . . 71.5 113.15 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -86.79 -11.19 51.73 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.699 0.629 . . . . 72.11 112.699 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.494 HD11 HD11 ' A' ' 26' ' ' ILE . 52.1 mt -73.32 111.64 12.6 Favored Pre-proline 0 CA--C 1.543 0.679 0 O-C-N 122.245 -0.284 . . . . 71.13 110.677 178.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -81.57 178.05 6.99 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.635 2.223 . . . . 63.44 113.736 -175.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.4 tptt -58.56 140.92 53.49 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.842 -0.617 . . . . 75.35 111.482 -178.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.661 ' H ' ' NH2' ' A' ' 56' ' ' ARG . . . 82.45 -32.53 2.84 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 116.176 -0.465 . . . . 52.25 114.142 179.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -85.67 158.3 20.1 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.019 0.748 . . . . 73.04 113.019 -175.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.8 m -139.97 166.84 19.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 115.636 -0.711 . . . . 51.33 110.734 177.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.8 t -149.28 -178.66 6.52 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.448 -0.342 . . . . 72.43 110.314 176.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 72.3 p -112.53 158.7 19.61 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.391 0.515 . . . . 72.14 112.391 -177.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -54.34 -41.82 69.52 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.203 -0.453 . . . . 72.42 110.903 176.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.12 -47.5 89.46 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.911 -0.586 . . . . 75.41 113.094 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.432 ' O ' ' HE2' ' A' ' 29' ' ' MET . 34.5 mt-10 -55.9 -53.48 56.25 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.925 0.363 . . . . 71.4 111.389 177.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.494 HD11 HD11 ' A' ' 15' ' ' ILE . 49.3 mm -58.72 -49.62 82.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 120.834 0.35 . . . . 70.43 111.491 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.523 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -57.89 -49.04 78.09 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 120.995 0.426 . . . . 73.5 112.05 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.458 ' NZ ' ' HB3' ' A' ' 28' ' ' LYS . 9.4 mtpm? -62.71 -39.43 94.02 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.438 -0.346 . . . . 73.54 111.825 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.432 ' HE2' ' O ' ' A' ' 25' ' ' GLU . 72.5 mtm -79.48 -16.07 56.68 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.649 0.261 . . . . 72.13 111.657 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -85.85 -30.62 22.79 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.028 0.442 . . . . 74.11 111.363 174.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.41 12.23 10.96 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.286 -0.483 . . . . 42.04 113.448 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.523 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 71.1 m-85 -130.35 67.53 80.15 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 117.011 0.405 . . . . 73.44 111.062 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.48 -49.24 16.72 Favored 'Trans proline' 0 N--CA 1.482 0.819 0 C-N-CA 122.842 2.362 . . . . 65.12 114.096 -174.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -81.38 41.82 2.7 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.105 -0.569 . . . . 72.24 113.897 -177.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.41 ' O ' HG23 ' A' ' 39' ' ' VAL . 77.0 m-85 -141.26 21.42 2.24 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.668 0.618 . . . . 65.45 112.668 -178.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.35 -51.51 64.54 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.076 0.398 . . . . 63.23 112.076 -177.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -55.11 -36.89 66.2 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.873 0.368 . . . . 70.44 111.968 176.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -72.39 -37.45 68.72 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.553 -0.294 . . . . 72.13 111.367 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.457 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 99.7 t -56.85 -47.2 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 120.874 0.369 . . . . 64.23 110.7 175.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.26 -46.69 92.54 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.281 -0.485 . . . . 70.42 113.069 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.34 -36.63 82.81 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.984 0.421 . . . . 74.01 111.337 177.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.29 -40.39 95.86 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.978 0.418 . . . . 75.5 111.265 175.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.484 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 89.9 mt -69.75 -38.83 76.94 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.271 -0.422 . . . . 51.11 111.338 178.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.05 -13.55 48.97 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 121.285 -0.483 . . . . 72.43 113.337 178.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -90.59 -12.38 37.18 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 122.556 -0.379 . . . . 55.13 111.445 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 88.8 mt -66.43 133.58 94.4 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 112.116 0.413 . . . . 62.14 112.116 -178.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.95 161.33 39.08 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.661 2.241 . . . . 73.11 113.725 -177.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -61.96 -12.99 21.16 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.331 -0.85 . . . . 70.4 112.556 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -107.77 18.27 34.82 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 121.139 -0.553 . . . . 75.55 113.949 -179.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 41.6 t -79.79 152.96 29.48 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 117.413 0.606 . . . . 72.23 111.583 177.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -101.2 6.55 43.09 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.222 0.534 . . . . 55.33 110.938 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.517 HD12 ' HD2' ' A' ' 53' ' ' PRO . 56.4 tp -95.16 115.26 65.25 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 116.125 -0.488 . . . . 74.35 110.681 176.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.517 ' HD2' HD12 ' A' ' 52' ' ' LEU . 63.7 Cg_endo -73.66 95.0 0.86 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 121.39 1.394 . . . . 65.42 112.059 178.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.484 ' HB2' ' HB3' ' A' ' 43' ' ' LEU . 68.5 p-90 -89.07 -26.24 21.49 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.171 0.51 . . . . 75.45 111.426 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.442 ' O ' HD21 ' A' ' 78' ' ' LEU . 35.8 p90 -58.48 -21.79 52.78 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.007 -0.542 . . . . 65.24 112.299 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.661 ' NH2' ' H ' ' A' ' 18' ' ' GLY . 88.0 mtt-85 -81.31 5.78 16.23 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.086 0.402 . . . . 45.43 112.086 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 18.6 t -115.31 111.44 35.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-O 121.228 0.537 . . . . 64.35 111.195 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.586 HG21 HD12 ' A' ' 91' ' ' ILE . 20.2 pt -117.79 -169.06 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 122.835 0.454 . . . . 54.34 111.047 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -92.12 167.35 12.13 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.57 -0.706 . . . . 63.23 111.764 -178.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 80.8 p -59.13 -18.76 38.72 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 112.644 0.609 . . . . 42.13 112.644 -176.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -85.94 4.6 36.84 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.786 0.327 . . . . 74.23 111.702 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.03 38.21 88.31 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 121.122 -0.561 . . . . 20.24 112.426 -177.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.486 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 54.5 mtpt -131.55 156.9 44.94 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.511 0.672 . . . . 71.14 112.009 -176.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.551 HG23 ' OE1' ' A' ' 74' ' ' GLN . 68.4 mt -78.59 104.28 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 115.575 -0.739 . . . . 73.32 110.047 173.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.2 t -63.38 -25.37 68.26 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.398 -0.365 . . . . 50.32 111.845 -176.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.418 HD13 ' HB3' ' A' ' 70' ' ' ASP . 83.1 mt -74.99 145.17 42.72 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.354 -0.384 . . . . 72.22 110.873 177.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.45 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -133.86 171.41 14.21 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.16 0.505 . . . . 74.42 112.0 -175.128 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.5 -121.75 24.83 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.918 -0.658 . . . . 61.24 112.663 -177.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 69' ' ' ARG . 35.3 mtt180 -71.6 -33.88 69.38 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.019 0.438 . . . . 54.01 111.277 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 73' ' ' ARG . 25.4 m-20 -73.32 -18.19 61.22 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 111.959 0.355 . . . . 70.52 111.959 -178.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.45 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 6.8 tt -66.11 -55.03 18.49 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.949 -0.389 . . . . 75.1 109.949 177.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.559 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 19.8 m-20 -67.45 -26.16 66.25 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.766 0.317 . . . . 72.02 111.304 176.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.434 ' HB3' ' O ' ' A' ' 70' ' ' ASP . 76.0 ttt180 -53.31 -62.5 1.61 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.203 0.525 . . . . 73.51 110.493 173.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.551 ' OE1' HG23 ' A' ' 64' ' ' ILE . 48.6 tt0 -67.1 -46.71 73.4 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.202 -0.454 . . . . 62.13 111.356 177.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.559 ' HB3' ' HA ' ' A' ' 72' ' ' ASP . 47.1 tttm -51.97 -50.36 61.4 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.616 0.598 . . . . 70.5 112.616 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -71.0 -30.88 67.24 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 111.904 0.335 . . . . 74.12 111.904 -176.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -64.75 -35.08 79.91 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.07 0.462 . . . . 73.12 110.873 171.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.524 HD13 HD11 ' A' ' 91' ' ' ILE . 57.8 mt -70.15 -47.36 61.99 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.185 -0.461 . . . . 71.22 111.286 175.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -57.88 -31.22 66.51 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.193 -0.458 . . . . 52.21 111.389 176.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.55 -34.07 70.62 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.836 0.351 . . . . 74.34 111.32 173.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -88.09 -11.81 45.99 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 111.813 0.301 . . . . 63.42 111.813 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.77 54.76 3.15 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.285 -0.484 . . . . 71.52 113.029 -178.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.535 HD11 HH12 ' A' ' 56' ' ' ARG . 68.3 mt -116.2 137.06 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 122.605 0.362 . . . . 72.33 111.223 -179.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.461 ' HG3' ' OH ' ' A' ' 96' ' ' TYR . 66.9 mt-10 -66.71 92.98 0.23 Allowed 'General case' 0 N--CA 1.471 0.588 0 O-C-N 122.012 -0.43 . . . . 61.52 111.868 -179.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.42 HG11 ' HG3' ' A' ' 75' ' ' LYS . 42.9 t -89.99 102.79 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 120.815 0.341 . . . . 45.0 110.722 173.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.596 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 69.9 m -64.46 163.46 13.31 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.317 0.488 . . . . 53.31 112.317 -178.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -35.04 -58.09 0.54 Allowed 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 115.247 1.573 . . . . 54.32 115.247 -169.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.461 HD13 ' HE3' ' A' ' 63' ' ' LYS . 2.6 pp -92.82 23.06 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 112.505 0.557 . . . . 75.32 112.505 -174.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.71 47.8 7.03 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 121.266 -0.492 . . . . 74.22 112.604 -176.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.596 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 49.3 tttm -111.8 131.88 55.04 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 122.432 -0.452 . . . . 65.03 111.452 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.586 HD12 HG21 ' A' ' 58' ' ' ILE . 53.5 mt -116.46 135.87 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 120.921 0.391 . . . . 75.12 111.699 -176.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.99 93.92 1.42 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.948 0.404 . . . . 70.11 111.453 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.463 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 66.6 mt -54.24 -56.85 14.31 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.384 0.513 . . . . 74.14 112.384 -178.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -53.05 -28.21 23.54 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.522 0.564 . . . . 73.14 112.522 -177.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -84.52 -33.09 23.58 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.033 0.383 . . . . 64.24 112.033 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.461 ' OH ' ' HG3' ' A' ' 84' ' ' GLU . 80.3 m-85 -117.59 6.92 12.52 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.84 0.682 . . . . 73.42 112.84 -173.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 61.5 tttp -63.31 128.8 37.51 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.159 0.504 . . . . 74.4 112.209 -173.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 15.7 t90 -69.72 116.81 10.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.761 -0.654 . . . . 74.23 110.798 175.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.413 ' HA ' ' HD2' ' A' ' 100' ' ' PRO . 77.1 mt-30 -114.38 92.04 26.37 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 116.476 -0.329 . . . . 71.45 111.187 178.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 99' ' ' GLN . 36.7 Cg_endo . . . . . 0 CA--C 1.538 0.683 0 C-N-CA 122.514 2.143 . . . . 73.42 112.043 174.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 112.737 0.643 . . . . 74.33 112.737 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.591 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 22.2 mm-40 -53.74 -40.04 65.83 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.063 -0.517 . . . . 72.32 111.38 175.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.416 ' O ' HG12 ' A' ' 8' ' ' ILE . 64.5 t80 -50.42 -53.38 29.9 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.131 0.491 . . . . 61.42 111.105 177.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 59.5 mt -61.61 -46.55 89.34 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.748 -0.66 . . . . 65.05 111.182 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.4 t -60.44 -44.86 97.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 116.137 -0.483 . . . . 62.12 111.896 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.591 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 24.4 mm-40 -68.51 -52.1 35.89 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.014 0.376 . . . . 75.53 112.014 -176.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.499 ' O ' HG13 ' A' ' 12' ' ' ILE . 30.9 pt -58.16 -43.42 85.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 121.055 -0.258 . . . . 52.51 111.306 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.5 m-30 -63.34 -46.76 85.08 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.036 0.446 . . . . 74.33 110.671 175.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.35 -44.67 65.32 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.926 -0.579 . . . . 75.22 111.661 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 7' ' ' GLN . 99.7 t -63.48 -43.78 98.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 120.825 0.345 . . . . 74.01 111.4 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.551 ' HB ' HD11 ' A' ' 52' ' ' LEU . 72.6 mt -58.63 -32.09 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 112.161 0.43 . . . . 74.53 112.161 -178.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -60.55 -10.24 4.83 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.064 0.764 . . . . 60.32 113.064 178.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -92.86 -2.52 55.81 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 112.564 0.579 . . . . 71.23 112.564 178.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.412 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 55.3 mt -81.5 114.1 47.05 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-O 120.653 0.263 . . . . 64.45 111.176 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 15' ' ' ILE . 16.7 Cg_exo -68.55 171.47 13.04 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.926 2.417 . . . . 53.0 113.054 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 44.9 tttp -66.68 133.04 49.42 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.064 0.459 . . . . 64.32 111.25 -178.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.505 ' H ' ' NH2' ' A' ' 56' ' ' ARG . . . 95.19 -25.14 25.63 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 121.319 -0.467 . . . . 24.34 113.184 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -86.72 157.31 19.67 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.587 0.588 . . . . 71.01 112.587 -177.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.3 m -140.51 153.98 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.621 -0.718 . . . . 71.03 110.722 176.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.5 t -135.07 179.98 5.98 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 122.189 -0.319 . . . . 55.21 110.726 176.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.2 p -110.9 155.52 22.51 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.09 0.471 . . . . 72.25 112.14 -176.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -54.3 -34.87 61.88 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.197 -0.456 . . . . 73.52 111.978 177.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.98 -49.9 60.5 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.095 -0.574 . . . . 41.24 112.752 177.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -56.39 -53.84 52.63 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.0 0.428 . . . . 72.45 111.364 177.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.5 mm -56.63 -48.23 80.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-N 116.12 -0.491 . . . . 74.55 111.729 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.467 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -60.12 -49.39 77.81 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 120.88 0.371 . . . . 74.43 111.971 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -60.63 -36.63 79.1 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.9 0.381 . . . . 61.21 111.878 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 73.6 mtm -84.81 -9.71 57.89 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.746 0.308 . . . . 65.22 111.773 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.3 -11.5 32.3 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.933 0.396 . . . . 71.23 111.356 173.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.13 21.68 37.87 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 121.312 -0.47 . . . . 72.12 113.482 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.467 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 97.2 m-85 -133.59 77.78 63.71 Favored Pre-proline 0 CA--C 1.543 0.699 0 O-C-N 122.522 -0.399 . . . . 74.51 111.916 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.52 135.71 24.71 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.305 2.004 . . . . 73.23 112.712 178.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.63 -1.87 76.2 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 121.238 -0.506 . . . . 63.31 113.738 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -99.88 23.21 10.04 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 117.258 0.529 . . . . 70.0 112.29 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.65 -48.4 58.3 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.723 0.638 . . . . 34.41 112.723 -177.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.0 ttp180 -68.08 -32.42 72.73 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.738 0.304 . . . . 75.4 111.711 -178.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -67.99 -35.98 79.24 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.848 0.356 . . . . 64.0 110.993 178.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.451 HG22 HG21 ' A' ' 8' ' ' ILE . 47.1 t -60.01 -42.84 91.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 121.393 0.615 . . . . 74.13 109.851 172.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.31 -37.93 92.61 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 115.681 -0.69 . . . . 62.24 112.781 174.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -58.19 -50.76 72.39 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.139 0.495 . . . . 74.11 110.602 174.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.29 -46.75 82.85 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.66 -0.7 . . . . 73.34 112.125 -177.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 62.2 mt -65.17 -39.26 92.69 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.794 0.331 . . . . 75.34 111.596 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.7 -25.19 65.22 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 120.805 -0.712 . . . . 72.34 113.249 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -87.3 5.58 37.66 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 120.877 0.37 . . . . 63.42 111.84 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 97.0 mt -94.48 155.71 39.34 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-O 120.664 0.268 . . . . 64.1 111.084 176.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.9 160.47 46.82 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.241 1.961 . . . . 55.45 112.367 174.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -53.83 -41.46 67.4 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.174 0.435 . . . . 74.14 112.174 -174.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -124.77 65.51 0.54 Allowed Glycine 0 CA--C 1.526 0.735 0 C-N-CA 121.334 -0.46 . . . . 72.11 112.577 178.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.8 t -69.72 163.96 24.55 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.206 0.447 . . . . 63.04 112.206 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -60.38 -30.61 69.68 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.384 0.611 . . . . 74.25 110.259 173.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.553 HD12 ' HD2' ' A' ' 53' ' ' PRO . 48.5 tp -86.36 121.93 72.29 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 115.592 -0.731 . . . . 70.31 110.456 173.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.553 ' HD2' HD12 ' A' ' 52' ' ' LEU . 58.1 Cg_endo -72.95 94.9 0.81 Allowed 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 121.12 1.213 . . . . 72.54 111.745 177.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 69.2 p-90 -79.67 -31.28 41.36 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.978 -0.555 . . . . 71.44 111.605 -177.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.412 ' O ' HD21 ' A' ' 78' ' ' LEU . 31.7 p90 -62.81 -11.01 15.1 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.726 0.639 . . . . 72.34 112.726 -179.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.659 HH12 HD11 ' A' ' 83' ' ' ILE . 71.9 mtt-85 -90.2 9.33 28.9 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.142 0.423 . . . . 70.13 112.142 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.3 t -124.69 105.87 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.038 0.447 . . . . 71.53 111.004 176.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.488 HD13 HD12 ' A' ' 91' ' ' ILE . 22.3 pt -115.41 -170.19 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 121.069 0.461 . . . . 60.25 112.013 -176.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -88.1 169.99 11.46 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.896 0.379 . . . . 74.11 111.852 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 33.4 t -63.27 -24.51 67.9 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.494 0.553 . . . . 52.34 112.494 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -72.68 -10.34 59.68 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.73 0.3 . . . . 55.34 111.803 178.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.11 44.18 24.06 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.84 -0.695 . . . . 72.53 111.878 -175.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.428 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 99.6 mttt -135.93 159.54 41.37 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.936 0.398 . . . . 70.44 111.286 -178.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 61.5 mt -62.26 132.83 28.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.115 -0.493 . . . . 71.54 110.888 177.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.5 p -76.18 -47.68 23.28 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.866 0.365 . . . . 53.14 111.29 -178.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.607 ' HB3' ' HB3' ' A' ' 70' ' ' ASP . 76.6 mt -67.36 156.8 35.59 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.081 0.467 . . . . 54.42 111.584 178.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.494 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 13.7 ptmm? -131.83 162.36 30.77 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.18 0.437 . . . . 65.55 112.18 -172.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 61.97 -131.07 45.59 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 116.255 -0.43 . . . . 60.21 113.243 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 -54.18 -41.62 68.76 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.264 0.554 . . . . 71.44 111.35 175.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.607 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 2.1 m-20 -66.12 -27.69 68.24 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.78 -0.645 . . . . 74.02 111.99 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.494 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 7.3 tt -64.0 -53.47 49.59 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.949 0.404 . . . . 73.3 110.053 176.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.453 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 67.7 m-20 -63.51 -29.82 71.03 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.246 -0.434 . . . . 61.11 111.25 177.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.419 ' O ' ' HG2' ' A' ' 77' ' ' LYS . 34.5 ttm180 -56.9 -58.24 8.99 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.111 -0.495 . . . . 75.2 111.247 174.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.448 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 49.5 tt0 -63.56 -40.75 97.79 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.983 0.421 . . . . 72.41 110.417 177.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.453 ' HB3' ' HA ' ' A' ' 72' ' ' ASP . 84.2 tttt -48.99 -52.95 22.04 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.77 -0.65 . . . . 75.35 112.075 176.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -63.07 -39.13 93.8 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.059 0.392 . . . . 45.24 112.059 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 75.0 mmtt -64.35 -36.37 83.9 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.122 0.487 . . . . 74.33 111.004 177.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.587 HD13 HD11 ' A' ' 91' ' ' ILE . 73.4 mt -69.48 -52.38 27.15 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.093 -0.503 . . . . 44.34 111.414 178.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -52.78 -45.03 66.95 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.968 0.413 . . . . 63.11 111.529 177.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.69 -16.47 57.41 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.285 0.476 . . . . 62.35 112.285 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.555 ' HB3' HH22 ' A' ' 56' ' ' ARG . 28.2 mm-40 -104.57 13.15 32.17 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.025 0.38 . . . . 63.25 112.025 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.91 6.79 88.67 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.156 -0.545 . . . . 74.5 113.539 178.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.659 HD11 HH12 ' A' ' 56' ' ' ARG . 57.5 mt -88.39 149.51 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 O-C-N 122.475 -0.427 . . . . 70.33 110.656 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.437 ' HG2' ' CE2' ' A' ' 96' ' ' TYR . 12.4 pt-20 -97.83 130.31 44.75 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.191 0.52 . . . . 45.51 111.548 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.426 HG21 ' HA ' ' A' ' 75' ' ' LYS . 45.4 t -110.42 100.85 11.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 116.186 -0.461 . . . . 74.15 110.951 174.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.578 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 47.0 m -58.82 153.7 16.51 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.331 -0.395 . . . . 63.53 110.788 176.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.473 ' HG3' ' N ' ' A' ' 88' ' ' ILE . 10.8 pt-20 -40.46 -46.79 2.51 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 114.663 1.357 . . . . 63.12 114.663 -167.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.473 ' N ' ' HG3' ' A' ' 87' ' ' GLU . 2.6 pp -90.13 21.29 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-O 121.192 0.52 . . . . 75.2 112.197 -176.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.61 51.74 7.02 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 116.04 -0.527 . . . . 73.13 113.391 -178.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.578 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 62.2 tttp -118.7 135.98 54.19 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 117.34 0.57 . . . . 71.5 112.42 179.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.587 HD11 HD13 ' A' ' 78' ' ' LEU . 52.7 mt -113.93 138.24 44.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 123.028 0.531 . . . . 72.34 110.968 178.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.26 92.92 1.42 Allowed 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.851 0.357 . . . . 54.13 111.568 177.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.488 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 45.3 mt -53.23 -60.47 3.25 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.517 0.562 . . . . 73.53 112.517 -178.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -62.36 1.23 0.36 Allowed 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.192 0.812 . . . . 73.22 113.192 -172.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.438 ' HD2' ' CE2' ' A' ' 96' ' ' TYR . 9.1 tmtm? -112.9 -34.71 5.67 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 122.104 -0.373 . . . . 75.21 110.954 173.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.438 ' CE2' ' HD2' ' A' ' 95' ' ' LYS . 97.6 m-85 -108.85 5.79 24.83 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.364 0.505 . . . . 45.14 112.364 -177.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 50.9 tttm -63.31 133.13 53.64 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.144 0.497 . . . . 74.05 111.759 -174.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 16.0 t90 -57.28 125.12 21.34 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.046 -0.525 . . . . 63.11 111.827 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -107.24 90.39 5.61 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 116.061 -0.518 . . . . 74.55 110.918 177.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 CA--C 1.539 0.728 0 C-N-CA 122.636 2.224 . . . . 71.5 112.595 178.201 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 37.9 t70 . . . . . 0 CA--C 1.542 0.643 0 N-CA-C 112.609 0.596 . . . . 75.04 112.609 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -52.03 -37.69 54.39 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.928 -0.578 . . . . 64.34 112.244 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -53.66 -49.25 68.34 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.22 0.533 . . . . 75.24 110.607 177.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 77.8 mt -67.21 -45.75 75.93 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.601 -0.727 . . . . 71.25 111.218 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.9 t -55.79 -47.58 79.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.027 0.441 . . . . 74.12 111.655 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -67.16 -51.29 55.56 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.335 0.494 . . . . 65.23 112.335 -177.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.462 ' O ' HG13 ' A' ' 12' ' ' ILE . 33.5 pt -60.79 -42.72 93.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 O-C-N 122.154 -0.341 . . . . 62.0 111.576 -177.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -62.85 -43.83 97.76 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.061 0.458 . . . . 73.5 110.941 177.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.97 -39.64 66.15 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.983 -0.553 . . . . 44.54 111.725 177.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 67.6 t -69.68 -39.49 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 120.966 0.412 . . . . 55.22 111.521 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.523 ' HB ' HD11 ' A' ' 52' ' ' LEU . 82.8 mt -59.3 -33.87 52.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 116.21 -0.45 . . . . 32.23 111.955 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 83.0 m-70 -55.37 -25.28 34.31 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 113.171 0.804 . . . . 75.02 113.171 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -80.7 1.51 29.84 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.071 0.767 . . . . 73.45 113.071 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 57.2 mt -83.34 111.44 31.23 Favored Pre-proline 0 CA--C 1.543 0.676 0 O-C-N 121.961 -0.462 . . . . 73.23 110.943 177.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.85 157.72 57.49 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.675 2.25 . . . . 72.31 113.312 -176.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.8 tttp -62.67 94.81 0.07 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.218 0.532 . . . . 73.1 111.734 -177.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.465 ' H ' ' CZ ' ' A' ' 56' ' ' ARG . . . 142.94 -28.74 2.12 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-N 116.054 -0.521 . . . . 50.13 112.473 178.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -95.66 165.49 12.29 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.273 0.558 . . . . 61.4 112.067 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.7 m -141.43 159.68 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.677 -0.692 . . . . 72.33 110.482 176.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 94.1 p -138.35 -179.37 5.76 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.817 0.341 . . . . 61.33 111.023 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 51.2 p -106.21 155.91 18.99 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.855 0.36 . . . . 65.13 111.971 -179.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.403 ' HB2' ' HB1' ' A' ' 36' ' ' ALA . 52.7 m-85 -54.91 -38.59 67.82 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.944 0.402 . . . . 72.31 110.945 177.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.26 -52.75 51.41 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-N 115.788 -0.642 . . . . 42.1 113.18 178.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -56.37 -48.3 77.13 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.905 0.383 . . . . 72.52 111.513 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.6 mm -58.75 -49.29 83.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 116.292 -0.413 . . . . 55.25 111.258 178.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.473 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -59.93 -45.28 93.09 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.965 0.412 . . . . 63.32 111.973 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -57.79 -52.53 65.07 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.788 0.328 . . . . 74.53 111.408 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 72.7 mtm -66.65 -28.18 68.27 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.399 -0.364 . . . . 71.53 111.879 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.72 -30.44 64.18 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.027 0.442 . . . . 62.35 111.417 176.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.71 13.15 19.33 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.333 -0.46 . . . . 71.21 113.057 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.473 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 76.3 m-85 -127.74 66.78 71.59 Favored Pre-proline 0 CA--C 1.543 0.679 0 O-C-N 122.61 -0.347 . . . . 63.11 111.714 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.71 144.73 60.86 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.224 1.95 . . . . 71.34 112.41 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.77 -11.78 65.56 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 121.032 -0.604 . . . . 71.31 113.523 -177.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -99.4 19.16 16.07 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 122.394 -0.474 . . . . 62.41 111.757 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.403 ' HB1' ' HB2' ' A' ' 23' ' ' TYR . . . -53.26 -42.92 66.99 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.263 0.468 . . . . 72.43 112.263 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -57.0 -37.51 71.75 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.009 0.374 . . . . 74.32 112.009 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -72.43 -31.9 65.87 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 120.653 0.264 . . . . 74.44 111.296 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.406 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 61.1 t -56.7 -51.78 62.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 120.887 0.375 . . . . 71.12 110.335 173.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -57.48 -42.41 93.88 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 121.219 -0.515 . . . . 32.33 113.039 176.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.518 ' NZ ' ' HB3' ' A' ' 41' ' ' LYS . 8.9 mtpm? -60.22 -34.54 73.81 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.795 0.331 . . . . 75.44 111.753 178.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.9 -41.75 59.13 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.324 -0.398 . . . . 33.23 111.475 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 39' ' ' VAL . 86.2 mt -65.66 -42.15 91.71 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.316 -0.402 . . . . 75.22 111.908 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.28 -26.84 51.56 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 121.195 -0.526 . . . . 72.23 113.542 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -78.94 -20.15 50.0 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 122.584 -0.362 . . . . 70.05 111.751 -178.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 81.5 mt -68.03 147.17 98.43 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-O 120.851 0.357 . . . . 73.51 111.601 -179.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -84.13 177.53 5.88 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.693 2.262 . . . . 54.44 112.971 178.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.463 ' OE1' ' HD2' ' A' ' 73' ' ' ARG . 1.4 mp0 -71.72 -37.21 70.65 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.983 0.42 . . . . 44.11 111.156 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -94.38 43.54 2.35 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 121.371 -0.442 . . . . 71.42 113.344 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.0 t -84.19 159.75 20.97 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.99 0.424 . . . . 74.21 111.472 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 51' ' ' LYS . 37.1 ttmt -81.91 -12.91 58.19 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.435 0.635 . . . . 73.44 110.726 178.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.537 HD12 ' HD2' ' A' ' 53' ' ' PRO . 33.0 tp -107.05 126.05 31.09 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 115.735 -0.666 . . . . 61.24 110.983 179.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.537 ' HD2' HD12 ' A' ' 52' ' ' LEU . 57.0 Cg_endo -72.94 94.53 0.8 Allowed 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 121.205 1.27 . . . . 72.12 111.637 174.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 69.2 p-90 -86.66 -17.69 33.15 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.291 0.567 . . . . 73.55 111.673 -177.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.491 ' O ' HD21 ' A' ' 78' ' ' LEU . 37.4 p90 -73.88 -5.72 42.76 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.985 0.735 . . . . 62.35 112.985 -176.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.485 HH12 HD11 ' A' ' 83' ' ' ILE . 87.1 mtt-85 -99.24 12.92 34.83 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.771 0.656 . . . . 74.22 112.771 -177.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.4 t -123.11 112.76 35.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 121.263 0.554 . . . . 72.41 111.214 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.545 HD13 HD12 ' A' ' 91' ' ' ILE . 27.4 pt -122.04 -169.98 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-N 116.087 -0.506 . . . . 61.12 111.386 -178.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.412 HD21 ' HB2' ' A' ' 63' ' ' LYS . 32.9 p30 -85.22 167.75 15.39 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.83 -0.544 . . . . 73.32 112.048 -177.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.478 ' HA ' HG21 ' A' ' 22' ' ' THR . 50.3 p -66.3 -10.71 45.22 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.941 0.719 . . . . 74.14 112.941 -177.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -96.33 11.32 35.14 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.762 0.315 . . . . 51.44 111.628 179.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.33 39.0 87.89 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 116.438 -0.346 . . . . 72.51 113.53 176.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.457 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 56.4 mttp -139.45 157.97 44.93 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.208 0.528 . . . . 65.53 111.6 -178.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.435 HG23 ' OE1' ' A' ' 74' ' ' GLN . 59.2 mt -73.26 117.57 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.806 -0.634 . . . . 73.44 110.903 177.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.3 t -69.19 -33.01 72.69 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.06 0.457 . . . . 64.24 110.99 178.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.553 HD13 ' HB3' ' A' ' 70' ' ' ASP . 66.6 mt -65.08 148.28 51.95 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.162 -0.472 . . . . 71.22 111.118 177.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -130.25 149.38 51.97 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.965 0.412 . . . . 72.52 112.098 -176.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.15 -120.37 7.81 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-N 116.263 -0.426 . . . . 53.13 113.451 178.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -65.03 -46.19 82.34 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.943 0.402 . . . . 74.21 111.653 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.553 ' HB3' HD13 ' A' ' 66' ' ' LEU . 67.6 m-20 -59.38 -36.08 75.12 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.552 -0.294 . . . . 74.23 111.568 177.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.9 tt -62.99 -54.99 29.76 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.963 -0.384 . . . . 72.0 109.963 177.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -58.98 -32.88 70.05 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.134 0.492 . . . . 73.35 111.312 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.463 ' HD2' ' OE1' ' A' ' 48' ' ' GLU . 11.2 ttp180 -67.84 -51.95 42.55 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.005 -0.543 . . . . 64.24 111.572 -178.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.451 HE21 ' HA ' ' A' ' 55' ' ' PHE . 34.2 tt0 -62.87 -47.28 84.02 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.181 0.515 . . . . 72.34 110.216 174.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.0 tttt -47.77 -55.17 10.21 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.206 -0.906 . . . . 50.44 112.576 175.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -56.41 -42.7 78.43 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.087 0.403 . . . . 55.25 112.087 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -62.57 -42.02 99.3 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.093 0.473 . . . . 74.44 111.517 177.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.491 HD21 ' O ' ' A' ' 55' ' ' PHE . 81.2 mt -64.19 -44.1 93.05 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.204 -0.453 . . . . 63.54 111.767 178.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -55.48 -42.42 74.34 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.923 0.392 . . . . 70.55 111.111 176.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.93 -33.76 73.66 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.056 0.455 . . . . 71.23 111.833 177.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.437 ' HB3' HH22 ' A' ' 56' ' ' ARG . 8.2 mm-40 -83.6 1.72 40.83 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.377 -0.374 . . . . 72.41 111.952 -179.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.84 9.93 70.46 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 121.379 -0.439 . . . . 60.12 113.949 177.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.485 HD11 HH12 ' A' ' 56' ' ' ARG . 67.0 mt -89.15 136.18 24.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 117.023 0.411 . . . . 62.41 111.405 -178.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 84' ' ' GLU . 9.2 pt-20 -76.44 114.66 15.39 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.143 0.497 . . . . 62.31 111.79 178.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.8 t -101.54 105.05 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 120.965 0.412 . . . . 74.21 110.666 172.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.642 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 25.2 t -69.48 157.96 36.11 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.423 -0.353 . . . . 70.5 111.77 178.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -37.55 -56.55 1.02 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.638 1.347 . . . . 71.13 114.638 -168.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.445 HD11 ' HB2' ' A' ' 90' ' ' LYS . 2.7 pp -86.54 18.27 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 112.69 0.626 . . . . 71.13 112.69 -174.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.2 44.83 7.85 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.113 -0.565 . . . . 35.31 112.518 -177.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.642 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 0.6 OUTLIER -105.52 128.15 53.42 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 122.539 -0.389 . . . . 60.33 110.389 -179.602 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.545 HD12 HD13 ' A' ' 58' ' ' ILE . 62.3 mt -116.53 139.67 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.899 0.381 . . . . 43.24 111.118 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.58 92.61 4.08 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.925 0.393 . . . . 43.55 111.786 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.598 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 57.4 mt -59.79 -44.19 94.05 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.733 0.302 . . . . 71.42 111.251 178.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 80.9 mtt-85 -56.48 -12.52 1.76 Allowed 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 112.173 0.434 . . . . 74.1 112.173 -177.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -109.92 -42.37 4.25 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 120.964 0.411 . . . . 73.52 111.814 176.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -101.7 6.46 41.87 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.149 0.425 . . . . 72.22 112.149 -171.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.598 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 78.0 tttt -61.56 129.35 40.7 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.143 0.497 . . . . 71.31 111.914 -175.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 21.2 t90 -71.03 116.96 11.93 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.978 -0.555 . . . . 72.1 111.991 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -124.65 92.66 47.51 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 115.971 -0.559 . . . . 51.12 110.58 175.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo . . . . . 0 CA--C 1.545 1.06 0 C-N-CA 122.959 2.44 . . . . 73.32 113.797 -177.94 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 . . . . . 0 CA--C 1.539 0.527 0 N-CA-C 112.744 0.646 . . . . 63.1 112.744 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -51.19 -31.74 21.22 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.625 -0.716 . . . . 63.44 112.318 178.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -57.61 -55.54 33.48 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.848 0.356 . . . . 75.44 110.727 177.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 77.0 mt -59.97 -45.19 93.49 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.964 -0.562 . . . . 75.25 111.218 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 62.0 t -57.14 -52.62 53.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 116.178 -0.465 . . . . 55.54 112.053 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.426 ' O ' HG23 ' A' ' 11' ' ' VAL . 28.7 mm-40 -67.58 -44.71 77.5 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.727 0.64 . . . . 73.43 112.727 -175.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.42 ' O ' HG13 ' A' ' 12' ' ' ILE . 36.8 pt -63.33 -43.43 98.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 120.909 -0.316 . . . . 73.13 111.281 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -62.87 -44.98 94.65 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.943 0.401 . . . . 75.35 110.978 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.52 -37.22 62.6 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.08 -0.509 . . . . 71.44 111.793 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 7' ' ' GLN . 96.0 t -70.21 -42.65 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-O 120.929 0.395 . . . . 63.33 111.513 178.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.545 ' HB ' HD11 ' A' ' 52' ' ' LEU . 79.9 mt -59.19 -30.57 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 112.28 0.474 . . . . 74.34 112.28 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -60.85 -12.52 11.22 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 112.966 0.728 . . . . 75.14 112.966 178.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -90.77 -3.5 57.38 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.481 0.549 . . . . 72.42 112.481 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.404 ' O ' ' NH1' ' A' ' 56' ' ' ARG . 56.0 mt -84.3 113.79 50.65 Favored Pre-proline 0 CA--C 1.544 0.741 0 O-C-N 122.184 -0.322 . . . . 70.14 111.44 -179.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -70.5 163.78 37.64 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.961 2.44 . . . . 72.2 113.843 -177.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.35 120.85 12.99 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.944 -0.571 . . . . 74.42 111.639 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.33 14.09 46.02 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.092 -0.575 . . . . 75.21 113.442 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -126.03 148.3 49.34 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.889 0.376 . . . . 70.34 111.18 176.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.0 m -125.32 149.11 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-O 121.122 0.487 . . . . 71.52 111.613 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 97.8 p -128.67 167.03 17.8 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.106 -0.497 . . . . 64.13 110.83 177.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.5 p -103.79 147.45 27.27 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.763 0.316 . . . . 74.24 111.378 177.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -52.16 -36.52 51.82 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.751 0.31 . . . . 74.22 111.766 178.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -57.35 -43.82 93.68 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 121.129 -0.558 . . . . 73.33 112.779 177.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' A' ' 29' ' ' MET . 41.7 mt-10 -65.11 -54.13 34.63 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.78 0.324 . . . . 73.45 111.112 177.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.8 mm -54.62 -51.12 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.3 -0.409 . . . . 72.15 111.889 -178.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.49 -46.19 84.0 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.945 0.402 . . . . 61.32 111.748 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -61.19 -48.38 81.82 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.781 0.324 . . . . 72.33 111.511 178.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.489 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 61.0 mtt -63.37 -30.1 71.29 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.096 0.474 . . . . 71.0 111.522 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.01 -19.57 58.55 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.158 -0.474 . . . . 74.21 111.858 178.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.57 23.26 12.49 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.191 -0.528 . . . . 72.33 113.154 -178.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -132.78 62.82 64.63 Favored Pre-proline 0 CA--C 1.542 0.648 0 O-C-N 122.48 -0.423 . . . . 75.2 111.064 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -62.5 119.82 7.09 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.27 1.98 . . . . 73.03 112.731 -177.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.44 -6.58 49.79 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.036 -0.602 . . . . 72.42 113.589 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -97.98 20.74 11.71 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 117.332 0.566 . . . . 63.12 111.375 177.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.8 -39.43 68.46 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.806 0.669 . . . . 74.04 112.806 -177.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -58.8 -34.89 72.01 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 120.924 0.392 . . . . 73.34 111.714 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -77.94 -28.25 49.51 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.687 -0.233 . . . . 65.23 111.408 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.3 t -59.66 -42.63 89.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.238 0.542 . . . . 71.15 110.12 172.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -62.7 -42.31 99.71 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 115.771 -0.65 . . . . 51.35 112.789 175.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -60.66 -41.82 95.78 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.049 0.452 . . . . 72.33 111.134 176.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.52 -54.47 45.07 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.177 -0.465 . . . . 55.22 111.418 178.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.49 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 80.6 mt -61.88 -38.53 88.66 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.932 0.396 . . . . 71.55 111.589 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.29 -17.77 70.65 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.339 -0.458 . . . . 72.11 113.396 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -101.07 2.84 40.79 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 122.416 -0.461 . . . . 73.23 111.391 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 69.9 mt -78.54 155.54 78.64 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-O 120.809 0.338 . . . . 61.2 111.321 176.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.509 ' HG2' ' HB2' ' A' ' 50' ' ' SER . 20.5 Cg_endo -61.02 140.76 91.7 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.116 1.877 . . . . 75.21 112.083 174.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.645 ' HG3' ' HD3' ' A' ' 73' ' ' ARG . 33.0 tt0 -43.52 -39.35 3.35 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.696 0.628 . . . . 71.31 112.696 -174.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -123.24 55.64 0.68 Allowed Glycine 0 CA--C 1.529 0.942 0 C-N-CA 121.098 -0.572 . . . . 74.34 113.491 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.509 ' HB2' ' HG2' ' A' ' 47' ' ' PRO . 37.8 t -63.5 168.2 4.86 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.427 0.632 . . . . 74.12 112.641 177.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -65.47 -32.66 74.39 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.309 0.576 . . . . 73.3 110.181 173.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.554 HD12 ' HD2' ' A' ' 53' ' ' PRO . 30.7 tp -84.48 127.04 67.49 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 115.641 -0.709 . . . . 64.41 110.894 177.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.554 ' HD2' HD12 ' A' ' 52' ' ' LEU . 61.5 Cg_endo -73.67 95.65 0.89 Allowed 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 121.396 1.398 . . . . 65.13 111.656 174.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.49 ' HB2' ' HB3' ' A' ' 43' ' ' LEU . 65.2 p-90 -79.52 -31.55 42.17 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.188 0.518 . . . . 74.34 111.891 -176.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.417 ' O ' HD21 ' A' ' 78' ' ' LEU . 27.3 p90 -63.6 -19.87 65.2 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.244 0.831 . . . . 71.23 113.244 -176.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.404 ' NH1' ' O ' ' A' ' 15' ' ' ILE . 98.5 mtt180 -77.76 2.07 18.14 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.497 0.554 . . . . 73.3 112.497 -177.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.4 t -122.22 125.62 73.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 O-C-N 121.9 -0.5 . . . . 62.44 111.426 179.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.625 HD11 HD21 ' A' ' 93' ' ' LEU . 33.8 pt -125.46 -171.39 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 120.978 0.418 . . . . 62.44 111.646 -179.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.429 HD21 ' HB2' ' A' ' 63' ' ' LYS . 33.8 p30 -73.03 171.65 12.48 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.243 0.544 . . . . 61.33 112.23 -179.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 46.6 p -79.69 8.52 6.46 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.074 0.464 . . . . 65.11 112.128 -179.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -95.64 -46.44 6.62 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.358 0.599 . . . . 74.14 110.944 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 121.33 32.38 1.06 Allowed Glycine 0 CA--C 1.522 0.475 0 CA-C-N 115.766 -0.652 . . . . 42.15 112.159 -175.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.429 ' HB2' HD21 ' A' ' 59' ' ' ASN . 98.4 mttt -138.67 163.14 32.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.092 0.472 . . . . 35.41 111.387 -177.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.506 HG23 ' OE1' ' A' ' 74' ' ' GLN . 65.3 mt -67.81 122.08 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 115.968 -0.56 . . . . 53.11 110.605 175.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.5 m -63.89 -41.83 97.61 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.166 0.508 . . . . 65.1 111.464 -178.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.513 HD13 ' HB3' ' A' ' 70' ' ' ASP . 86.6 mt -74.15 161.33 30.1 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.788 -0.642 . . . . 74.12 111.813 -178.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -130.18 177.11 7.55 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.8 0.333 . . . . 44.44 111.429 -178.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 57.38 -126.55 42.46 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 121.36 -0.447 . . . . 42.52 113.106 178.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 38.7 mtp180 -74.54 -32.13 62.35 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.171 0.51 . . . . 74.13 110.714 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.513 ' HB3' HD13 ' A' ' 66' ' ' LEU . 2.6 m-20 -60.02 -32.47 70.91 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.892 -0.595 . . . . 62.52 110.676 177.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.9 tt -63.28 -57.05 11.71 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.027 -0.533 . . . . 62.03 110.212 176.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -55.58 -36.87 67.35 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.902 0.382 . . . . 74.13 111.462 176.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.645 ' HD3' ' HG3' ' A' ' 48' ' ' GLU . 39.8 ttm180 -59.22 -58.87 6.71 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 116.383 -0.371 . . . . 71.52 111.65 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.506 ' OE1' HG23 ' A' ' 64' ' ' ILE . 53.6 tt0 -61.66 -41.01 96.94 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.708 0.289 . . . . 73.1 111.132 177.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -54.88 -58.67 6.66 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.259 -0.428 . . . . 74.13 111.72 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -52.9 -45.65 67.64 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.079 0.4 . . . . 64.0 112.079 -178.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -61.46 -30.53 70.65 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.853 0.359 . . . . 75.43 111.936 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.417 HD21 ' O ' ' A' ' 55' ' ' PHE . 94.8 mt -78.0 -42.08 33.84 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.046 0.45 . . . . 62.22 111.13 174.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -57.4 -39.4 76.02 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.913 0.387 . . . . 64.13 111.057 177.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.23 -24.39 63.13 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.119 -0.491 . . . . 73.43 111.929 178.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -95.38 -1.37 51.22 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 111.831 0.308 . . . . 73.51 111.831 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.24 12.89 44.05 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.512 -0.375 . . . . 75.34 113.689 177.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.418 ' HA ' ' CE1' ' A' ' 96' ' ' TYR . 66.6 mt -88.59 109.57 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 122.477 -0.425 . . . . 72.0 111.547 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -73.39 100.66 3.26 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.982 0.42 . . . . 75.33 111.465 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 58.2 t -92.41 130.45 41.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 120.901 0.381 . . . . 61.23 111.593 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.603 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 31.0 t -69.73 155.99 39.68 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.515 -0.311 . . . . 63.25 111.573 177.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.502 ' HG3' HG23 ' A' ' 88' ' ' ILE . 15.3 pt-20 -46.05 -49.84 15.85 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.034 1.124 . . . . 73.54 114.034 -169.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.502 HG23 ' HG3' ' A' ' 87' ' ' GLU . 2.9 pp -81.34 13.85 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 121.216 0.531 . . . . 74.42 112.326 -176.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.57 50.03 5.19 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 121.335 -0.459 . . . . 73.4 112.894 -178.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.603 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 14.4 tmtt? -117.27 129.63 56.03 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 122.326 -0.514 . . . . 65.43 111.197 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.507 HD12 HD13 ' A' ' 58' ' ' ILE . 60.6 mt -116.35 148.26 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.173 -0.467 . . . . 72.2 111.462 -177.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.32 99.96 8.16 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.886 0.374 . . . . 61.3 111.682 177.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.625 HD21 HD11 ' A' ' 58' ' ' ILE . 25.3 mt -69.64 -1.35 8.7 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.112 0.782 . . . . 74.15 113.112 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -98.05 -52.7 3.61 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.074 0.464 . . . . 74.15 111.181 173.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -69.28 -29.75 67.7 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.224 -0.444 . . . . 64.32 112.101 -177.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.418 ' CE1' ' HA ' ' A' ' 83' ' ' ILE . 90.5 m-85 -114.09 13.65 18.15 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 111.796 0.295 . . . . 62.12 111.796 -176.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.539 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 83.8 tttt -60.85 131.38 50.51 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 111.827 0.306 . . . . 73.21 111.827 -176.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 19.2 t90 -58.64 105.59 0.32 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.641 0.734 . . . . 74.5 111.151 176.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -113.45 95.29 35.5 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 115.348 -0.842 . . . . 73.42 110.723 177.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo . . . . . 0 CA--C 1.538 0.717 0 C-N-CA 122.511 2.141 . . . . 71.1 112.524 179.05 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.8 tpt . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 120.565 0.221 . . . . 73.25 110.952 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.457 ' O ' HG23 ' A' ' 6' ' ' VAL . 3.8 m-20 -55.8 129.14 38.2 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.42 0.526 . . . . 70.51 112.42 -177.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.527 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 23.0 tp60 -52.97 -44.27 67.03 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.416 -0.357 . . . . 73.14 111.655 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -54.74 -50.72 67.7 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.095 0.474 . . . . 72.51 111.069 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.1 mt -61.11 -42.24 98.17 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.942 -0.572 . . . . 60.15 111.322 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 2' ' ' ASP . 64.8 t -59.51 -41.58 85.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.007 0.432 . . . . 74.12 111.35 177.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.527 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 25.8 mm-40 -66.29 -54.31 26.4 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.345 -0.388 . . . . 73.44 111.896 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.497 HG21 HG22 ' A' ' 39' ' ' VAL . 37.2 pt -63.31 -43.86 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 111.746 0.276 . . . . 64.34 111.746 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 12.5 m-30 -60.67 -45.23 94.92 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.742 0.306 . . . . 75.15 111.147 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.432 ' O ' ' NE2' ' A' ' 14' ' ' GLN . . . -52.36 -43.86 64.9 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.365 -0.379 . . . . 72.21 111.226 177.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 93.5 t -64.46 -47.14 90.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.339 -0.391 . . . . 61.51 111.356 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 8' ' ' ILE . 79.7 mt -55.69 -33.98 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 116.084 -0.507 . . . . 60.11 112.303 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 74.9 m-70 -61.21 -16.15 41.97 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 112.702 0.63 . . . . 71.03 112.702 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.432 ' NE2' ' O ' ' A' ' 10' ' ' ALA . 1.0 OUTLIER -82.88 -7.3 59.67 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.073 0.397 . . . . 70.2 112.073 177.925 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.434 HG21 ' HB3' ' A' ' 56' ' ' ARG . 56.1 mt -80.46 116.48 62.15 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 122.421 -0.174 . . . . 72.23 111.203 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -69.94 170.2 17.35 Favored 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 123.062 2.508 . . . . 72.25 113.764 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.9 tttp -65.79 121.0 14.03 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.078 -0.51 . . . . 55.02 111.362 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.27 17.59 45.91 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 121.017 -0.611 . . . . 73.51 113.901 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -119.94 146.28 45.96 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 117.103 0.451 . . . . 71.3 111.389 176.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 56' ' ' ARG . 34.6 m -130.0 140.24 49.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.142 0.496 . . . . 44.21 111.307 177.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 83.9 p -122.47 170.27 10.14 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.842 0.354 . . . . 74.25 111.1 177.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 44.4 p -95.83 147.5 23.58 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.005 0.431 . . . . 65.15 111.487 178.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -52.91 -32.9 47.85 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 116.289 -0.414 . . . . 71.43 111.993 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.78 -44.02 95.37 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 121.094 -0.574 . . . . 73.41 112.965 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 29' ' ' MET . 46.7 mt-10 -64.59 -44.9 89.18 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.811 0.338 . . . . 73.14 111.347 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.408 HD11 HD11 ' A' ' 15' ' ' ILE . 47.2 mm -60.58 -50.01 82.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 120.809 0.338 . . . . 62.41 111.307 177.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.5 -43.84 84.49 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.96 0.41 . . . . 71.23 111.517 177.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -59.21 -48.2 82.49 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.174 -0.466 . . . . 63.44 111.298 178.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.431 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 63.1 mtt -65.95 -28.75 69.15 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.878 0.371 . . . . 72.13 111.621 178.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.35 -20.55 51.1 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.928 0.394 . . . . 65.44 111.573 177.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.87 22.41 28.22 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.199 -0.524 . . . . 41.24 113.459 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -124.94 81.82 61.89 Favored Pre-proline 0 CA--C 1.543 0.68 0 O-C-N 122.393 -0.474 . . . . 74.43 111.79 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.62 131.72 37.03 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.732 2.288 . . . . 64.24 112.658 177.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.95 -8.46 79.77 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.014 -0.613 . . . . 63.44 113.649 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -89.68 22.6 2.99 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.482 0.549 . . . . 63.53 112.482 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.36 -57.58 11.24 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.012 0.434 . . . . 72.31 112.167 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 46.6 ttp180 -58.66 -32.3 68.97 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.008 0.433 . . . . 71.45 111.552 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.587 ' HA ' ' HE2' ' A' ' 41' ' ' LYS . 80.5 m-70 -65.2 -41.28 94.67 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.35 -0.386 . . . . 53.34 111.284 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.497 HG22 HG21 ' A' ' 8' ' ' ILE . 53.6 t -58.43 -37.95 67.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.264 0.554 . . . . 64.23 110.171 172.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.79 -37.66 95.01 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 115.808 -0.633 . . . . 33.11 112.999 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.587 ' HE2' ' HA ' ' A' ' 38' ' ' HIS . 41.1 mtmt -62.75 -47.27 84.26 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.006 0.431 . . . . 74.21 110.476 176.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.07 -51.42 66.41 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.869 -0.605 . . . . 72.41 111.921 -178.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.5 mt -63.56 -43.35 97.31 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.297 -0.41 . . . . 72.42 111.459 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.11 -22.72 72.69 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 120.853 -0.689 . . . . 61.51 112.884 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -79.85 -21.08 44.56 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.995 0.426 . . . . 73.32 111.277 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 91.6 mt -75.77 155.39 85.08 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 116.444 -0.344 . . . . 53.53 111.897 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.57 164.87 19.51 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.46 2.107 . . . . 64.22 112.192 174.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.503 ' HA ' ' HE ' ' A' ' 73' ' ' ARG . 0.8 OUTLIER -64.91 -26.57 68.37 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.211 0.448 . . . . 74.15 112.211 -175.203 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -131.88 64.38 0.61 Allowed Glycine 0 CA--C 1.528 0.857 0 C-N-CA 121.094 -0.574 . . . . 71.31 113.325 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.6 t -79.72 172.77 13.34 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.182 0.515 . . . . 72.42 111.772 178.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? -67.79 -28.94 68.03 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.17 -0.468 . . . . 61.52 110.78 174.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.529 HD12 ' HD2' ' A' ' 53' ' ' PRO . 33.0 tp -86.71 124.8 68.74 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 116.017 -0.538 . . . . 63.5 111.02 177.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.529 ' HD2' HD12 ' A' ' 52' ' ' LEU . 38.0 Cg_endo -67.19 95.08 0.36 Allowed 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 121.285 1.324 . . . . 52.51 111.386 173.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.417 ' HH2' ' HG2' ' A' ' 73' ' ' ARG . 65.9 p-90 -82.51 -30.49 29.78 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.685 -0.689 . . . . 74.43 111.716 -177.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.462 ' O ' HD21 ' A' ' 78' ' ' LEU . 11.9 p90 -67.32 -11.53 57.85 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.335 0.865 . . . . 74.5 113.335 -175.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.459 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 94.2 mtt180 -86.27 8.08 22.73 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.024 0.75 . . . . 72.52 113.024 -174.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 20.9 t -127.86 116.23 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 O-C-N 121.81 -0.556 . . . . 64.24 111.652 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.457 HG21 HD12 ' A' ' 91' ' ' ILE . 28.0 pt -118.98 -174.52 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 116.472 -0.331 . . . . 75.04 111.376 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 35.4 p30 -83.78 168.75 15.89 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.139 0.495 . . . . 74.41 111.906 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.1 t -67.93 -9.24 43.5 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.234 -0.439 . . . . 61.45 111.951 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -88.14 0.69 55.73 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.619 -0.264 . . . . 73.5 111.53 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.41 42.59 89.36 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 121.015 -0.612 . . . . 41.2 112.396 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -141.15 157.32 45.44 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.096 0.474 . . . . 74.01 111.378 -176.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 63.8 mt -73.34 128.07 35.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 116.258 -0.428 . . . . 72.34 111.001 177.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.9 p -74.29 -31.04 62.35 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 120.973 0.416 . . . . 71.43 111.408 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.47 HD13 ' HB3' ' A' ' 70' ' ' ASP . 92.5 mt -74.91 152.51 38.85 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.171 -0.468 . . . . 53.33 111.09 177.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -129.45 171.4 12.59 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.017 0.436 . . . . 72.11 111.973 -176.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 57.58 -128.75 48.23 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 116.24 -0.436 . . . . 64.54 113.327 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -61.71 -39.41 91.4 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 122.586 -0.361 . . . . 74.22 111.339 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.47 ' HB3' HD13 ' A' ' 66' ' ' LEU . 19.7 m-20 -65.43 -25.9 67.73 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.026 0.38 . . . . 62.42 112.026 -178.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.8 tt -64.11 -55.92 18.55 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.881 -0.414 . . . . 71.24 109.881 174.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.579 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 33.0 t70 -65.99 -27.04 67.84 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.997 0.427 . . . . 73.04 111.219 177.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.503 ' HE ' ' HA ' ' A' ' 48' ' ' GLU . 51.9 ttt180 -57.44 -55.11 39.06 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.245 0.545 . . . . 72.41 110.878 173.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -64.84 -41.95 95.31 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.129 0.49 . . . . 74.05 110.562 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.579 ' HB3' ' HA ' ' A' ' 72' ' ' ASP . 32.0 tttm -54.81 -55.14 33.35 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.67 -0.696 . . . . 71.11 112.37 178.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -58.74 -36.96 75.17 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.932 0.396 . . . . 61.35 111.499 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.485 ' HE2' ' O ' ' A' ' 48' ' ' GLU . 45.3 mmtm -64.16 -42.44 96.74 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.923 0.392 . . . . 64.44 111.224 174.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.512 HD22 HD12 ' A' ' 83' ' ' ILE . 95.9 mt -68.99 -31.89 71.05 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.916 0.389 . . . . 73.55 111.631 178.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 46.6 mt-10 -65.81 -30.54 71.19 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.886 0.374 . . . . 72.11 110.516 175.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.26 -11.86 60.16 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.321 0.581 . . . . 74.01 111.12 173.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -97.82 -11.31 23.44 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.917 -0.583 . . . . 62.33 111.137 176.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.91 50.4 5.22 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.494 -0.384 . . . . 74.2 113.098 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.512 HD12 HD22 ' A' ' 78' ' ' LEU . 71.4 mt -119.97 129.54 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 O-C-N 122.682 -0.305 . . . . 70.42 111.248 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -75.64 91.52 2.88 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.347 0.594 . . . . 74.0 111.438 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.2 t -96.68 121.1 46.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.624 -0.716 . . . . 73.04 110.837 177.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.595 ' OG ' ' HB3' ' A' ' 90' ' ' LYS . 6.3 p -72.91 151.27 41.98 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 122.331 -0.23 . . . . 71.1 110.644 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -42.36 -44.7 4.03 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.584 1.327 . . . . 53.11 114.584 -173.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.482 HD11 ' HB2' ' A' ' 90' ' ' LYS . 2.9 pp -81.1 9.53 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 112.461 0.541 . . . . 61.34 112.461 -176.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.57 45.59 5.75 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 121.622 -0.323 . . . . 54.42 113.624 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.595 ' HB3' ' OG ' ' A' ' 86' ' ' SER . 1.2 tmtp? -114.35 132.84 56.06 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-O 121.009 0.433 . . . . 74.41 111.425 -178.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.457 HD12 HG21 ' A' ' 58' ' ' ILE . 60.0 mt -127.08 138.8 53.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 116.152 -0.476 . . . . 64.55 111.426 -178.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.29 93.93 6.01 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.947 0.403 . . . . 71.04 111.838 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.552 ' O ' ' HG3' ' A' ' 97' ' ' LYS . 38.5 mt -53.79 -52.33 60.62 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.09 0.404 . . . . 75.11 112.09 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -52.82 -14.07 0.5 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.296 0.85 . . . . 73.4 113.296 -174.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -112.98 -33.91 5.9 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 122.03 -0.419 . . . . 74.4 112.068 175.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -99.33 0.32 42.67 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.808 1.04 . . . . 63.12 113.808 -173.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 93' ' ' LEU . 33.0 mtpt -57.18 138.18 54.94 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.213 0.53 . . . . 74.34 112.22 -178.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 16.3 t90 -64.96 105.26 0.99 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.692 -0.686 . . . . 60.5 111.268 175.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -112.09 99.53 46.29 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 116.1 -0.5 . . . . 74.4 110.653 175.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.25 32.22 0.17 Allowed 'Trans proline' 0 CA--C 1.548 1.188 0 C-N-CA 122.948 2.432 . . . . 71.25 113.596 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 59.7 mt -103.78 -1.76 27.42 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.959 0.409 . . . . 75.24 111.069 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 . . . . . 0 C--O 1.253 1.253 0 N-CA-C 112.055 0.391 . . . . 74.33 112.055 -179.213 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ttt . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 120.617 0.246 . . . . 73.14 111.187 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -71.09 134.17 46.83 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.877 0.37 . . . . 55.41 111.354 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.566 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 52.5 tp60 -60.49 -33.21 72.28 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.385 -0.37 . . . . 63.13 111.236 -178.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -51.49 -49.69 61.34 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.265 0.555 . . . . 73.04 110.906 175.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.7 mt -61.67 -45.0 95.9 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.695 -0.684 . . . . 72.14 111.016 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.1 t -56.45 -41.11 71.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 120.958 0.409 . . . . 61.22 111.349 177.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 25.6 mm-40 -65.33 -58.94 4.66 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.316 -0.402 . . . . 74.52 111.758 -178.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.457 HG21 HG22 ' A' ' 39' ' ' VAL . 33.4 pt -61.02 -42.41 92.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 111.751 0.278 . . . . 72.2 111.751 -178.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -58.53 -49.78 76.17 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.794 0.331 . . . . 64.24 111.106 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.2 -39.94 67.12 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.326 -0.397 . . . . 70.3 111.916 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 7' ' ' GLN . 78.6 t -66.65 -42.5 89.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.058 0.456 . . . . 74.53 111.243 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.557 ' HB ' HD11 ' A' ' 52' ' ' LEU . 80.5 mt -61.85 -31.87 52.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 116.202 -0.453 . . . . 45.21 112.014 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -62.15 -15.44 45.92 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.312 0.486 . . . . 74.1 112.312 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -86.74 -5.85 59.0 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.471 0.545 . . . . 70.42 112.471 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.487 HD11 HD11 ' A' ' 26' ' ' ILE . 58.0 mt -81.21 117.96 70.32 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-O 120.677 0.275 . . . . 62.11 111.5 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.6 160.03 38.58 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.5 2.133 . . . . 72.21 113.082 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -62.9 131.03 47.37 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.318 -0.401 . . . . 53.14 111.359 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.89 2.04 61.3 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 120.88 -0.676 . . . . 73.03 113.55 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -122.13 148.31 45.06 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.075 0.464 . . . . 65.23 111.62 176.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.6 m -125.4 147.53 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-O 121.309 0.576 . . . . 64.0 111.374 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 44.4 t -123.2 174.51 7.23 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.199 -0.455 . . . . 73.24 110.355 175.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 67.6 p -105.82 147.44 28.66 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.598 0.237 . . . . 71.33 111.408 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -50.55 -36.75 35.86 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.129 0.49 . . . . 71.54 110.697 175.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.47 -48.0 85.24 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 115.735 -0.666 . . . . 52.44 113.243 177.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.438 ' O ' ' HG3' ' A' ' 29' ' ' MET . 44.3 mt-10 -64.81 -48.41 74.52 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 117.073 0.437 . . . . 74.2 111.893 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.487 HD11 HD11 ' A' ' 15' ' ' ILE . 49.0 mm -55.53 -49.4 73.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 121.085 0.469 . . . . 74.12 111.052 177.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.504 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -62.99 -42.76 99.93 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.213 -0.449 . . . . 35.3 111.488 177.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -59.82 -42.56 93.76 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.985 0.421 . . . . 73.13 111.431 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.438 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 66.0 mtt -70.07 -34.87 73.74 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.0 0.429 . . . . 64.15 111.044 178.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.28 -30.68 66.57 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.132 -0.485 . . . . 74.22 111.672 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.39 13.73 14.41 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.512 -0.375 . . . . 74.54 113.355 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.542 ' HB3' ' HB2' ' A' ' 35' ' ' TYR . 52.2 m-85 -128.55 63.1 63.37 Favored Pre-proline 0 CA--C 1.548 0.898 0 O-C-N 122.556 -0.379 . . . . 73.45 111.766 -178.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -55.96 -43.08 60.26 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.646 2.23 . . . . 60.25 113.408 -175.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.04 -22.66 78.73 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.186 -0.53 . . . . 70.33 113.116 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.542 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 90.2 m-85 -86.23 6.67 28.5 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 111.962 0.356 . . . . 74.34 111.962 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.47 -36.18 32.44 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.244 0.545 . . . . 44.21 111.407 177.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.472 ' O ' ' HG3' ' A' ' 41' ' ' LYS . 14.8 ptp180 -55.41 -43.55 75.37 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.848 -0.615 . . . . 74.22 111.416 175.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -72.55 -30.3 64.32 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.334 -0.394 . . . . 73.54 111.443 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.457 HG22 HG21 ' A' ' 8' ' ' ILE . 58.5 t -57.74 -52.28 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 120.899 0.38 . . . . 63.42 110.569 175.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.16 -37.72 93.33 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.081 -0.58 . . . . 63.51 113.039 176.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 37' ' ' ARG . 28.2 mtpp -65.05 -44.14 89.99 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 122.515 -0.403 . . . . 65.45 111.192 177.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.47 -52.36 61.7 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.437 -0.347 . . . . 75.13 111.788 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.433 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 88.9 mt -56.92 -34.46 67.99 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.873 0.368 . . . . 72.31 111.592 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.98 -8.15 33.81 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 121.397 -0.43 . . . . 73.33 114.077 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.415 ' ND2' ' O ' ' A' ' 41' ' ' LYS . 45.7 m-80 -93.41 -12.63 29.39 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 117.379 0.589 . . . . 54.3 112.108 178.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.556 HD12 ' HB3' ' A' ' 54' ' ' TRP . 94.1 mt -74.02 143.68 81.11 Favored Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 112.189 0.441 . . . . 75.23 112.189 -175.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.25 177.51 6.52 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 122.898 2.398 . . . . 74.14 114.094 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -57.79 -45.66 85.7 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.542 -0.754 . . . . 73.21 111.736 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -114.75 56.17 0.51 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.3 -0.476 . . . . 34.23 112.897 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.4 t -66.9 159.35 28.53 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.266 0.469 . . . . 73.31 112.266 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -71.44 -11.18 60.75 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.168 0.508 . . . . 71.42 111.148 175.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.557 HD11 ' HB ' ' A' ' 12' ' ' ILE . 42.0 tp -117.59 124.26 29.07 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 115.849 -0.614 . . . . 75.42 110.713 177.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.536 ' HD2' HD12 ' A' ' 52' ' ' LEU . 58.6 Cg_endo -72.3 95.26 0.76 Allowed 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 121.364 1.376 . . . . 71.35 112.115 176.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.556 ' HB3' HD12 ' A' ' 46' ' ' LEU . 65.7 p-90 -83.5 -32.43 25.96 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.176 0.513 . . . . 74.31 111.89 -177.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -56.7 -24.81 51.74 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.227 0.825 . . . . 65.12 113.227 -177.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -77.85 2.43 17.28 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.444 0.535 . . . . 72.34 112.444 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 18.8 t -115.59 107.87 23.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.239 0.542 . . . . 52.33 111.479 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.518 HG21 HD12 ' A' ' 91' ' ' ILE . 33.7 pt -108.89 -169.73 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 116.164 -0.471 . . . . 65.55 111.339 178.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.59 ' HB3' ' OG ' ' A' ' 65' ' ' SER . 30.9 p30 -93.44 171.79 8.68 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.737 0.643 . . . . 64.34 112.737 -175.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 48.2 t -72.03 -8.08 52.47 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.88 -0.6 . . . . 73.4 111.712 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -84.59 -6.37 59.36 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.496 -0.32 . . . . 74.0 111.502 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.05 31.94 54.08 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 121.006 -0.616 . . . . 45.24 112.084 -174.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.489 ' NZ ' ' HB3' ' A' ' 63' ' ' LYS . 9.5 mtpm? -139.93 173.27 11.69 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.534 0.683 . . . . 53.34 112.02 -176.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.483 HG23 ' OE1' ' A' ' 74' ' ' GLN . 73.8 mt -86.45 116.12 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.415 -0.812 . . . . 53.33 110.469 173.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.59 ' OG ' ' HB3' ' A' ' 59' ' ' ASN . 58.0 m -71.62 -31.92 67.43 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.055 0.391 . . . . 71.11 112.055 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 81.9 mt -72.56 121.94 20.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.038 0.447 . . . . 63.54 111.594 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -115.16 159.56 20.77 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.02 0.438 . . . . 54.24 111.042 177.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.36 -141.59 15.65 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.95 -0.643 . . . . 71.44 111.689 -172.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 69' ' ' ARG . 67.7 mtt-85 -72.45 -22.69 61.05 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 117.624 0.712 . . . . 73.15 110.782 177.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.562 ' HA ' ' HD2' ' A' ' 73' ' ' ARG . 23.3 m-20 -67.72 -23.3 65.26 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.017 -0.538 . . . . 64.1 111.561 177.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.4 tt -67.22 -56.07 11.43 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.87 0.366 . . . . 73.15 110.452 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.19 -27.79 68.94 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.536 -0.302 . . . . 73.24 111.802 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.562 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 97.5 mtt180 -57.33 -62.02 2.06 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.906 0.384 . . . . 50.41 111.223 172.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.483 ' OE1' HG23 ' A' ' 64' ' ' ILE . 55.5 tt0 -63.88 -40.69 97.11 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.315 -0.402 . . . . 73.22 111.584 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.455 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 58.9 tttm -57.58 -61.91 2.16 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 111.917 0.34 . . . . 74.33 111.917 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -57.59 -37.93 74.02 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 111.959 0.355 . . . . 73.45 111.959 -176.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -55.4 -49.34 72.6 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.023 0.44 . . . . 73.51 111.533 176.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.8 mt -70.02 -40.16 75.38 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.052 0.454 . . . . 71.54 111.265 -177.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 45.0 mt-10 -61.76 -35.21 77.44 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.996 0.427 . . . . 71.55 110.767 176.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.26 -31.99 71.8 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.294 -0.412 . . . . 43.15 111.486 176.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -81.49 -9.95 59.59 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.67 0.271 . . . . 71.03 111.679 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.86 27.28 8.45 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 121.346 -0.454 . . . . 72.01 113.386 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 68.4 mt -98.34 130.78 46.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 120.91 0.386 . . . . 71.15 111.83 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.414 ' HG3' ' OH ' ' A' ' 96' ' ' TYR . 45.0 mt-10 -67.62 118.6 11.12 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.447 -0.342 . . . . 70.31 111.243 175.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.9 t -128.57 109.5 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 120.785 0.326 . . . . 74.35 110.85 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.653 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 40.9 m -61.7 147.05 47.26 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.524 -0.307 . . . . 74.24 111.184 177.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.419 ' HG3' HG23 ' A' ' 88' ' ' ILE . 15.3 pt-20 -45.38 -44.65 12.04 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.952 1.093 . . . . 75.33 113.952 -170.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.419 HG23 ' HG3' ' A' ' 87' ' ' GLU . 2.8 pp -80.45 14.27 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 112.404 0.52 . . . . 74.31 112.404 -177.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.15 57.49 3.18 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 121.432 -0.413 . . . . 53.24 112.984 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.653 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 62.1 tttm -125.8 127.09 45.58 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 120.703 0.287 . . . . 71.44 111.334 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.518 HD12 HG21 ' A' ' 58' ' ' ILE . 56.0 mt -126.26 152.16 33.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-O 120.903 0.382 . . . . 74.23 111.469 -175.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -84.02 99.52 10.48 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.274 0.472 . . . . 73.01 112.274 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.568 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 23.4 mt -70.7 -1.61 11.92 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.041 0.756 . . . . 60.12 113.041 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 53.3 mtp85 -96.99 -42.03 8.1 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 122.067 -0.396 . . . . 73.13 111.302 173.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -76.66 -37.39 56.31 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.101 0.408 . . . . 74.13 112.101 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.414 ' OH ' ' HG3' ' A' ' 84' ' ' GLU . 84.6 m-85 -109.82 14.2 23.3 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.461 0.541 . . . . 73.52 112.461 -171.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.568 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 59.2 tttp -62.37 132.71 53.51 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 120.999 0.428 . . . . 64.14 111.613 -177.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 23.0 t90 -69.51 109.52 4.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.235 0.54 . . . . 72.1 111.568 176.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -115.23 98.09 49.7 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 115.713 -0.676 . . . . 53.51 110.758 174.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.17 -12.26 33.93 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.629 2.219 . . . . 65.45 112.473 173.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 66.7 mt -109.68 124.64 51.56 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.12 -0.491 . . . . 71.51 110.494 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 C--O 1.254 1.302 0 CA-C-O 118.726 -0.654 . . . . 54.42 111.924 -178.342 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.5 tpt . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.714 0.292 . . . . 73.21 110.954 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.558 ' HB2' ' HG ' ' A' ' 5' ' ' LEU . 5.6 m-20 -63.88 127.99 33.83 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.604 -0.271 . . . . 62.12 111.438 178.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.437 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 14.3 mm100 -60.15 -25.9 65.87 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.625 0.25 . . . . 63.31 110.993 175.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -53.57 -50.66 65.08 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.171 0.51 . . . . 74.44 110.336 170.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.558 ' HG ' ' HB2' ' A' ' 2' ' ' ASP . 65.0 mt -62.39 -45.76 91.66 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.769 -0.65 . . . . 74.43 110.788 177.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.4 t -56.7 -43.56 79.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 116.018 -0.537 . . . . 65.44 111.797 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 30.2 mm-40 -68.27 -52.0 38.82 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.044 0.387 . . . . 63.31 112.044 -178.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.485 HG21 HG22 ' A' ' 39' ' ' VAL . 32.2 pt -59.6 -41.79 86.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 121.065 -0.254 . . . . 73.12 111.325 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -63.91 -44.21 93.63 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.124 0.488 . . . . 51.11 110.71 175.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.423 ' O ' ' NE2' ' A' ' 14' ' ' GLN . . . -56.5 -32.23 64.83 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.914 -0.585 . . . . 73.03 111.819 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 7' ' ' GLN . 88.3 t -73.35 -47.04 47.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.97 0.414 . . . . 60.43 111.492 176.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.592 ' HB ' HD11 ' A' ' 52' ' ' LEU . 80.9 mt -58.6 -31.69 44.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 112.888 0.699 . . . . 73.2 112.888 -175.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -60.7 -11.33 7.1 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 112.663 0.616 . . . . 75.42 112.663 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.423 ' NE2' ' O ' ' A' ' 10' ' ' ALA . 1.6 mp0 -92.23 -2.17 56.65 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.217 0.451 . . . . 72.12 112.217 178.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.511 HD11 HD11 ' A' ' 26' ' ' ILE . 53.7 mt -84.75 112.53 43.32 Favored Pre-proline 0 CA--C 1.541 0.634 0 O-C-N 122.221 -0.299 . . . . 64.02 110.591 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -72.37 165.4 32.79 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.471 2.114 . . . . 74.22 113.573 -177.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.472 ' HG3' ' OE1' ' A' ' 81' ' ' GLU . 61.5 tttm -59.73 133.35 56.02 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.861 -0.609 . . . . 72.11 112.08 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.96 -7.91 80.51 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-N 116.239 -0.437 . . . . 73.22 114.083 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -108.19 155.25 20.66 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 117.335 0.567 . . . . 74.5 112.034 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.5 m -134.17 159.26 42.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 115.965 -0.561 . . . . 74.44 111.468 178.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 44.6 t -139.24 175.28 9.69 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.948 0.404 . . . . 33.35 110.783 176.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.4 p -109.28 154.62 22.2 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.835 0.35 . . . . 64.22 111.551 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -52.92 -34.78 56.75 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.454 -0.339 . . . . 75.34 111.461 177.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.09 -51.32 54.07 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.334 -0.46 . . . . 63.22 112.86 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 29' ' ' MET . 41.3 mt-10 -58.93 -47.85 83.58 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.85 0.357 . . . . 73.35 111.257 178.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.511 HD11 HD11 ' A' ' 15' ' ' ILE . 49.7 mm -60.02 -47.63 91.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 116.42 -0.355 . . . . 70.15 111.579 178.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.23 -45.72 90.39 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.875 0.369 . . . . 73.3 111.907 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -61.96 -43.76 98.17 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.759 0.314 . . . . 74.41 111.453 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.425 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 64.8 mtt -67.06 -34.27 77.31 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.751 0.31 . . . . 75.54 111.248 178.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.74 -18.31 62.14 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.347 -0.388 . . . . 72.14 112.009 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.34 14.65 32.35 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 121.423 -0.418 . . . . 73.31 113.533 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -127.39 72.95 77.65 Favored Pre-proline 0 CA--C 1.541 0.632 0 O-C-N 122.38 -0.482 . . . . 62.53 111.276 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.21 97.34 0.84 Allowed 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.184 1.923 . . . . 65.22 112.969 -177.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 142.89 -35.25 1.72 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 120.803 -0.713 . . . . 74.32 113.258 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -84.06 34.57 0.51 Allowed 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.257 0.465 . . . . 74.31 112.257 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.77 -39.35 88.45 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.99 0.424 . . . . 72.22 111.676 -178.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.5 ttt85 -61.15 -29.33 69.72 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 116.363 -0.381 . . . . 75.55 111.525 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -76.65 -33.39 58.33 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.828 0.347 . . . . 75.44 110.705 177.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.485 HG22 HG21 ' A' ' 8' ' ' ILE . 47.3 t -58.46 -42.57 84.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 121.346 0.593 . . . . 61.11 109.706 170.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.97 -37.48 92.74 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 115.532 -0.758 . . . . 71.02 113.105 175.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -62.12 -44.52 96.46 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.017 0.437 . . . . 71.53 111.27 176.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.49 -55.21 25.89 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.099 0.476 . . . . 64.24 111.807 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.5 mt -65.64 -32.71 74.43 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.211 -0.45 . . . . 72.53 111.648 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.84 -15.77 62.82 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.322 -0.466 . . . . 73.1 113.18 177.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -89.59 -29.54 18.8 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 122.552 -0.381 . . . . 71.3 110.802 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 97.5 mt -61.8 112.19 5.74 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-O 120.988 0.423 . . . . 75.04 111.323 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -93.33 -170.1 0.24 Allowed 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.946 2.43 . . . . 65.53 114.597 -173.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -62.81 107.16 0.92 Allowed 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.206 -0.906 . . . . 62.22 111.171 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 128.11 -2.43 6.76 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 121.092 -0.575 . . . . 74.44 113.503 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.4 t -64.24 137.8 58.11 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.24 0.459 . . . . 75.42 112.24 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -68.9 -43.91 74.29 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.308 0.575 . . . . 75.34 110.618 175.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.592 HD11 ' HB ' ' A' ' 12' ' ' ILE . 35.9 tp -71.93 125.26 91.62 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.419 -0.809 . . . . 74.44 110.797 177.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.567 ' HD2' HD12 ' A' ' 52' ' ' LEU . 58.2 Cg_endo -71.98 94.95 0.73 Allowed 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 121.138 1.225 . . . . 75.0 111.757 176.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 60.9 p-90 -81.01 -30.95 34.84 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.754 -0.657 . . . . 71.33 111.338 -178.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -60.49 -16.82 40.61 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.649 0.611 . . . . 61.0 112.649 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.446 ' NH2' ' HA ' ' A' ' 17' ' ' LYS . 64.3 mtt-85 -78.3 -11.75 59.96 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.098 0.407 . . . . 75.32 112.098 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 22.7 t -111.71 120.21 61.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.278 0.561 . . . . 64.44 111.934 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.722 HD11 HD21 ' A' ' 93' ' ' LEU . 37.0 pt -120.48 -169.89 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 121.268 0.556 . . . . 63.13 111.731 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.9 p30 -89.78 172.65 8.76 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 121.221 0.534 . . . . 62.14 112.329 -176.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 63.4 p -72.27 -2.99 21.05 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 116.25 -0.432 . . . . 70.21 111.968 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -89.02 -12.0 42.61 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.969 0.414 . . . . 75.33 110.868 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.65 27.05 55.3 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.277 -0.487 . . . . 63.51 112.814 -177.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.522 ' NZ ' ' HB3' ' A' ' 63' ' ' LYS . 8.4 mtpm? -128.1 163.22 25.08 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.388 0.613 . . . . 70.24 112.324 -177.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.568 HG23 ' OE1' ' A' ' 74' ' ' GLN . 67.3 mt -71.39 116.4 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 115.428 -0.805 . . . . 73.1 109.728 170.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.1 m -75.17 -17.5 60.38 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.02 0.748 . . . . 75.22 113.02 -173.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 90.9 mt -77.23 176.33 8.86 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.107 0.48 . . . . 54.13 112.141 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.1 ptmm? -130.6 142.25 50.45 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.394 0.516 . . . . 73.14 112.394 -174.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 48.9 -124.26 12.26 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-N 115.947 -0.57 . . . . 61.43 114.076 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.463 ' HG3' ' H ' ' A' ' 69' ' ' ARG . 19.7 mtm180 -43.3 -53.68 5.07 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.805 0.812 . . . . 72.22 111.157 177.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.45 ' O ' ' HB2' ' A' ' 73' ' ' ARG . 4.3 m-20 -63.7 -34.1 77.11 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.784 -1.098 . . . . 72.42 111.507 -176.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.3 tt -63.72 -49.06 74.55 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 109.536 -0.542 . . . . 75.03 109.536 175.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.43 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 3.2 m-20 -63.88 -19.44 65.07 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.841 -0.618 . . . . 55.24 112.066 177.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.58 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 39.1 mmt180 -66.75 -59.49 3.52 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.034 0.445 . . . . 72.32 110.927 172.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.568 ' OE1' HG23 ' A' ' 64' ' ' ILE . 50.0 tt0 -58.99 -38.87 80.17 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.939 0.4 . . . . 74.11 110.225 177.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.514 ' HG3' HG11 ' A' ' 85' ' ' VAL . 81.2 tttt -59.66 -56.72 18.32 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.999 -0.546 . . . . 65.43 112.209 177.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.58 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 20.8 pt20 -54.27 -36.68 63.88 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 120.896 0.379 . . . . 74.31 111.64 -176.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -67.76 -49.38 62.8 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.945 0.403 . . . . 75.53 111.231 177.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 74' ' ' GLN . 64.8 mt -58.1 -45.36 87.35 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.241 -0.436 . . . . 73.22 111.375 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -62.9 -40.77 98.57 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.757 0.313 . . . . 73.25 110.976 177.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.03 -23.69 67.57 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.158 0.504 . . . . 62.04 111.216 175.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.472 ' OE1' ' HG3' ' A' ' 17' ' ' LYS . 42.1 mm-40 -80.43 -23.15 40.5 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.986 -0.552 . . . . 71.14 111.556 175.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.55 14.86 52.31 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 116.234 -0.439 . . . . 65.13 112.487 -174.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 76.9 mt -82.83 130.0 36.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 122.506 0.322 . . . . 63.51 111.007 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.412 ' HG3' ' OH ' ' A' ' 96' ' ' TYR . 51.6 mt-10 -66.95 92.83 0.24 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.314 0.578 . . . . 74.13 112.115 -177.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.514 HG11 ' HG3' ' A' ' 75' ' ' LYS . 61.2 t -90.49 113.89 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 115.897 -0.592 . . . . 73.03 110.91 174.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.542 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 39.6 t -66.23 142.1 57.82 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.502 -0.317 . . . . 74.35 111.034 174.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -42.37 -42.85 3.33 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.672 0.99 . . . . 65.33 113.672 -174.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.419 ' H ' HG13 ' A' ' 88' ' ' ILE . 2.8 pp -82.33 22.64 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 N-CA-C 112.481 0.548 . . . . 74.02 112.481 -178.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.24 57.97 7.06 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-N 116.428 -0.351 . . . . 52.24 113.36 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.542 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 84.2 tttt -132.28 149.91 52.27 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.769 0.319 . . . . 72.55 111.244 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.56 HD12 HD13 ' A' ' 58' ' ' ILE . 57.1 mt -125.16 150.49 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 120.861 0.362 . . . . 74.22 111.441 -177.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.9 92.68 7.85 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.804 0.335 . . . . 64.32 111.065 175.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.722 HD21 HD11 ' A' ' 58' ' ' ILE . 50.7 mt -59.25 -56.1 26.49 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.36 0.504 . . . . 75.11 112.36 -177.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 41.0 mtm-85 -56.16 -19.62 14.29 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.13 0.419 . . . . 70.01 112.13 -175.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -95.09 -29.0 14.81 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.491 -0.322 . . . . 51.32 111.796 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.412 ' OH ' ' HG3' ' A' ' 84' ' ' GLU . 91.8 m-85 -118.05 9.01 12.59 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.66 0.985 . . . . 74.22 113.66 -175.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.518 ' HG3' ' O ' ' A' ' 93' ' ' LEU . 24.9 mtpp -54.67 133.7 46.91 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 118.489 0.586 . . . . 71.33 112.142 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.409 ' HZ2' ' HB3' ' A' ' 14' ' ' GLN . 16.2 t90 -57.29 113.09 1.6 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.692 -0.685 . . . . 52.52 111.636 177.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 65.7 mt-30 -113.57 92.51 24.16 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 115.537 -0.756 . . . . 71.45 110.28 177.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -81.08 -5.32 12.88 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.712 2.275 . . . . 70.5 114.078 -177.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 82.4 mt -123.18 159.63 28.22 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.037 0.384 . . . . 75.44 112.037 -175.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 . . . . . 0 C--O 1.251 1.152 0 CA-C-O 118.727 -0.654 . . . . 51.32 110.803 175.092 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 tpt . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 120.593 0.235 . . . . 71.01 110.861 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.515 ' HB2' ' HG ' ' A' ' 5' ' ' LEU . 5.0 m-20 -64.89 138.99 58.71 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.055 0.391 . . . . 73.1 112.055 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -58.32 -34.74 70.93 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.901 0.381 . . . . 64.3 110.314 173.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.435 ' O ' HG12 ' A' ' 8' ' ' ILE . 34.2 t80 -51.95 -49.97 62.13 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.786 -0.643 . . . . 74.21 111.174 174.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.515 ' HG ' ' HB2' ' A' ' 2' ' ' ASP . 84.3 mt -60.97 -52.11 66.41 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.01 -0.541 . . . . 75.24 111.064 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 40.0 t -55.85 -45.81 79.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 116.126 -0.488 . . . . 55.32 111.661 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.429 ' O ' HG23 ' A' ' 11' ' ' VAL . 26.8 mm-40 -63.36 -56.89 12.66 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.161 0.43 . . . . 73.3 112.161 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.514 ' O ' HG13 ' A' ' 12' ' ' ILE . 34.0 pt -58.44 -45.14 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 121.109 -0.237 . . . . 62.33 111.567 -178.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.402 ' N ' HG13 ' A' ' 8' ' ' ILE . 21.1 m-30 -60.64 -45.3 94.59 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.015 0.436 . . . . 71.12 111.016 178.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.1 -26.75 64.95 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.17 -0.468 . . . . 73.1 111.817 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 7' ' ' GLN . 99.2 t -80.99 -43.36 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-O 120.88 0.372 . . . . 73.43 111.213 176.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 8' ' ' ILE . 81.7 mt -54.91 -36.65 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 112.631 0.604 . . . . 73.41 112.631 -178.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -55.15 -19.43 7.69 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.895 0.702 . . . . 74.24 112.895 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -77.12 -23.36 51.77 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.561 0.578 . . . . 72.32 112.561 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.441 ' O ' ' NH1' ' A' ' 56' ' ' ARG . 38.9 mt -70.56 118.7 67.11 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 122.201 0.2 . . . . 74.24 111.495 -177.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -79.68 170.32 17.14 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 122.758 2.305 . . . . 61.44 114.005 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 49.7 tttp -64.02 135.41 56.42 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.992 -0.549 . . . . 64.14 111.294 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.438 ' H ' ' HB3' ' A' ' 81' ' ' GLU . . . 86.31 2.51 85.37 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.078 -0.582 . . . . 32.14 113.402 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.441 ' HB3' ' HA ' ' A' ' 98' ' ' TRP . 47.0 mmtm -118.23 145.44 45.0 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.103 0.478 . . . . 63.34 111.739 177.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.435 HG13 HD13 ' A' ' 83' ' ' ILE . 18.7 m -131.46 150.4 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 115.91 -0.586 . . . . 61.14 111.321 177.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 88.7 p -129.19 164.53 23.21 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.537 -0.302 . . . . 73.1 110.724 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.6 p -90.22 146.91 23.89 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.836 0.35 . . . . 73.04 111.62 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -49.57 -37.37 27.11 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.025 0.44 . . . . 71.15 111.3 176.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.05 -40.19 98.15 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 115.95 -0.568 . . . . 73.23 113.466 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -69.07 -50.54 47.43 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.983 0.392 . . . . 73.33 111.603 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.5 mm -59.35 -47.61 89.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 120.841 0.353 . . . . 75.13 110.965 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.546 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -60.81 -44.78 96.42 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.405 -0.361 . . . . 71.53 111.591 177.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -54.99 -51.34 66.53 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.977 0.418 . . . . 75.42 111.731 177.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 67.9 mtm -71.24 -27.3 63.37 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.07 -0.513 . . . . 74.34 112.049 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.44 -30.81 62.04 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.946 0.403 . . . . 73.1 111.521 176.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.07 17.04 10.52 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.405 -0.426 . . . . 73.44 113.243 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.546 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 53.1 m-85 -133.48 61.66 55.19 Favored Pre-proline 0 CA--C 1.549 0.91 0 O-C-N 122.665 -0.315 . . . . 75.24 111.237 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -52.0 -38.47 69.52 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.022 2.481 . . . . 75.33 114.307 -173.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.8 -1.32 86.97 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 121.133 -0.555 . . . . 72.24 113.619 -178.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.491 ' O ' HG23 ' A' ' 39' ' ' VAL . 11.2 m-85 -97.51 10.61 39.34 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.925 0.713 . . . . 73.24 112.925 -177.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.68 -50.18 34.38 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.565 0.698 . . . . 74.34 111.083 176.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -52.41 -44.43 65.39 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.299 -0.864 . . . . 74.51 111.697 172.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.407 ' HD2' ' HA ' ' A' ' 35' ' ' TYR . 99.2 m-70 -72.18 -26.17 61.96 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.381 -0.372 . . . . 74.25 111.725 -177.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 35' ' ' TYR . 58.9 t -62.83 -46.72 95.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 120.894 0.378 . . . . 63.11 110.295 174.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -57.48 -42.63 94.01 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.102 -0.571 . . . . 65.52 112.355 174.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -64.17 -37.49 87.66 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.898 0.38 . . . . 72.31 111.223 175.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.76 -44.26 81.89 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.321 -0.399 . . . . 64.2 112.065 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 39' ' ' VAL . 61.4 mt -63.61 -29.08 70.38 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.801 0.334 . . . . 71.45 111.355 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.43 -16.3 49.31 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 121.238 -0.506 . . . . 61.41 113.29 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -77.19 -21.45 53.91 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.011 0.434 . . . . 73.34 111.247 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 95.0 mt -89.8 135.75 30.12 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-O 121.058 0.456 . . . . 73.42 112.163 -175.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -81.88 178.56 6.37 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.83 2.353 . . . . 72.44 113.539 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.553 ' HB3' ' HG3' ' A' ' 73' ' ' ARG . 1.2 pm0 -86.19 23.46 1.53 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.95 -0.568 . . . . 75.35 112.211 -177.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -147.29 35.81 1.22 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 121.195 -0.526 . . . . 34.51 112.693 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 34.6 t -86.52 166.76 15.2 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.47 0.653 . . . . 74.43 112.759 -176.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -82.23 -10.27 59.19 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.374 -0.83 . . . . 64.12 111.4 176.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.537 HD12 ' HD2' ' A' ' 53' ' ' PRO . 41.3 tp -109.68 122.56 38.88 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 116.028 -0.533 . . . . 71.54 110.792 178.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.537 ' HD2' HD12 ' A' ' 52' ' ' LEU . 67.8 Cg_endo -76.1 94.3 1.02 Allowed 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 121.182 1.255 . . . . 62.11 111.716 175.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.412 ' HB2' HD22 ' A' ' 43' ' ' LEU . 53.3 p-90 -84.46 -33.92 23.54 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.72 -0.673 . . . . 73.42 111.707 -176.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.455 ' O ' HD21 ' A' ' 78' ' ' LEU . 9.6 p90 -56.73 -19.45 16.83 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.209 0.818 . . . . 71.25 113.209 -178.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.441 ' NH1' ' O ' ' A' ' 15' ' ' ILE . 98.0 mtt180 -73.53 4.9 4.29 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 112.31 0.485 . . . . 65.23 112.31 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.5 t -122.92 116.44 48.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 CA-C-O 121.22 0.534 . . . . 64.34 111.303 177.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.515 HG21 HD12 ' A' ' 91' ' ' ILE . 28.9 pt -120.18 -170.81 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 116.329 -0.396 . . . . 63.0 111.433 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.462 ' HB3' ' OG ' ' A' ' 65' ' ' SER . 32.5 p30 -86.74 169.72 12.39 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.375 0.607 . . . . 44.53 112.46 -176.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.2 m -63.8 -26.71 68.75 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.835 -0.621 . . . . 64.31 112.16 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -76.24 -7.59 55.22 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.257 0.466 . . . . 61.12 112.257 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.55 42.67 13.57 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 121.242 -0.504 . . . . 52.53 112.627 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.452 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 58.3 mtpt -140.94 171.08 14.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.993 0.425 . . . . 73.33 110.757 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 59.2 mt -84.56 122.69 38.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 116.407 -0.361 . . . . 71.55 110.661 176.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.462 ' OG ' ' HB3' ' A' ' 59' ' ' ASN . 58.4 m -81.77 -12.11 58.71 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.234 0.457 . . . . 55.24 112.234 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.6 mt -80.61 148.57 30.22 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.821 0.343 . . . . 74.32 110.79 174.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -116.5 157.78 24.66 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.249 0.463 . . . . 71.41 112.249 -176.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 55.2 -128.11 43.19 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 116.076 -0.511 . . . . 62.34 113.965 176.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -55.07 -44.64 74.98 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.134 0.492 . . . . 61.22 111.924 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -60.99 -32.93 72.48 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.965 -0.561 . . . . 72.34 111.624 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.0 tt -65.79 -53.28 42.38 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.817 0.342 . . . . 72.02 110.185 176.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -58.71 -34.18 71.03 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.802 0.334 . . . . 60.12 111.526 177.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.553 ' HG3' ' HB3' ' A' ' 48' ' ' GLU . 39.5 ttm180 -61.15 -56.37 21.56 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.098 0.475 . . . . 75.5 110.998 176.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -63.13 -41.81 99.37 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.062 0.458 . . . . 73.51 110.951 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.4 ' HG3' HG11 ' A' ' 85' ' ' VAL . 49.0 tttm -55.61 -61.78 2.13 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.864 -0.607 . . . . 61.45 111.804 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -54.74 -36.85 65.22 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.415 -0.357 . . . . 64.42 111.553 -175.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.439 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 73.4 mmtt -63.02 -43.87 97.51 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.846 0.355 . . . . 65.54 111.546 176.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.455 HD21 ' O ' ' A' ' 55' ' ' PHE . 96.2 mt -67.94 -33.55 74.9 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.902 0.382 . . . . 73.3 111.25 177.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -58.06 -41.97 84.45 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.347 0.594 . . . . 44.21 109.97 172.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.32 -21.28 66.69 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.692 -0.686 . . . . 72.31 111.897 177.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 77' ' ' LYS . 7.4 mm-40 -85.31 -10.11 56.83 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.832 0.348 . . . . 74.44 111.532 177.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.08 25.96 25.3 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.249 -0.5 . . . . 72.13 112.701 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.435 HD13 HG13 ' A' ' 20' ' ' VAL . 66.3 mt -102.49 146.06 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 120.972 0.415 . . . . 62.52 111.774 -177.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -88.43 95.47 10.23 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 111.776 0.288 . . . . 61.53 111.776 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.4 HG11 ' HG3' ' A' ' 75' ' ' LYS . 22.4 t -95.74 98.33 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-O 121.162 0.506 . . . . 74.34 110.218 173.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.569 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 50.4 m -56.88 152.52 12.59 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.838 -0.619 . . . . 64.01 112.333 -178.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.423 ' HG3' HG23 ' A' ' 88' ' ' ILE . 12.3 pt-20 -41.31 -36.87 0.88 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 115.037 1.495 . . . . 72.32 115.037 -171.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.452 HD11 ' HB2' ' A' ' 90' ' ' LYS . 2.9 pp -92.81 13.11 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 112.706 0.632 . . . . 64.21 112.706 -176.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.92 42.6 7.09 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 121.587 -0.34 . . . . 25.53 113.439 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.569 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 62.6 tttp -116.45 142.65 46.59 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 122.622 -0.34 . . . . 63.04 111.46 -177.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.515 HD12 HG21 ' A' ' 58' ' ' ILE . 62.2 mt -129.45 146.7 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 120.928 0.394 . . . . 61.13 111.607 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.85 97.35 10.15 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.94 0.4 . . . . 51.41 111.601 177.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.496 HD21 HD11 ' A' ' 58' ' ' ILE . 67.7 mt -60.31 -55.37 34.53 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.01 0.374 . . . . 61.43 112.01 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 29.6 mtp180 -57.11 -9.29 0.86 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.17 0.804 . . . . 73.21 113.17 -175.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -105.59 -37.86 6.63 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 111.751 0.278 . . . . 72.5 111.751 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -116.56 13.7 15.36 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.281 0.474 . . . . 70.23 112.281 -173.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 80.3 tttt -65.63 139.05 58.39 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.097 0.475 . . . . 63.51 111.46 -178.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.441 ' HA ' ' HB3' ' A' ' 19' ' ' LYS . 17.5 t90 -59.96 111.94 1.68 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.065 0.459 . . . . 75.14 111.432 178.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -107.25 92.42 8.02 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 116.096 -0.502 . . . . 65.02 111.001 177.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.73 -31.85 5.02 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.579 2.186 . . . . 62.44 112.936 177.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 84.3 mt -98.29 111.36 23.73 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.824 0.345 . . . . 63.43 110.98 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 . . . . . 0 C--O 1.253 1.249 0 CA-C-O 118.742 -0.647 . . . . 62.4 111.723 -176.347 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 120.845 0.355 . . . . 63.24 111.037 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -69.42 118.35 12.19 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 122.172 -0.33 . . . . 70.12 111.267 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -52.8 -35.18 56.49 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.319 0.489 . . . . 65.54 112.319 -177.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -54.32 -49.61 69.3 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.245 0.545 . . . . 71.44 110.75 176.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 77.8 mt -65.71 -42.59 90.92 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.768 -0.651 . . . . 73.0 110.919 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 92.2 t -55.28 -46.56 78.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.362 -0.381 . . . . 62.23 111.559 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.427 ' O ' HG23 ' A' ' 11' ' ' VAL . 27.4 mm-40 -66.98 -56.39 10.36 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.252 0.464 . . . . 74.21 112.252 -177.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.502 ' O ' HG13 ' A' ' 12' ' ' ILE . 29.9 pt -58.66 -41.85 83.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 O-C-N 122.199 -0.313 . . . . 71.3 111.722 -178.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.414 ' CD1' HG13 ' A' ' 8' ' ' ILE . 9.0 m-30 -62.34 -43.7 98.2 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.813 0.34 . . . . 63.32 110.915 177.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.32 -28.34 64.96 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.018 0.437 . . . . 73.4 111.664 177.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 7' ' ' GLN . 57.6 t -80.66 -41.47 20.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 120.81 0.338 . . . . 72.43 110.998 176.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 8' ' ' ILE . 83.2 mt -61.23 -42.38 93.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 112.206 0.447 . . . . 75.44 112.206 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -59.94 -20.69 58.85 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.096 0.406 . . . . 74.31 112.096 178.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.48 -2.34 55.69 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.007 0.373 . . . . 71.14 112.007 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.566 HD11 HD11 ' A' ' 26' ' ' ILE . 61.0 mt -84.61 113.82 51.48 Favored Pre-proline 0 CA--C 1.543 0.673 0 O-C-N 122.374 -0.204 . . . . 71.23 110.472 175.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 15' ' ' ILE . 15.1 Cg_exo -69.54 147.66 64.79 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.003 2.468 . . . . 64.02 113.537 -178.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -52.2 120.02 5.01 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 116.021 -0.536 . . . . 72.12 111.791 176.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.69 -8.84 40.34 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.118 -0.563 . . . . 65.04 113.037 -177.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -115.18 152.1 33.23 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.985 0.421 . . . . 64.14 111.23 176.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.449 HG13 HD13 ' A' ' 83' ' ' ILE . 32.8 m -130.18 159.14 42.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-O 121.168 0.509 . . . . 53.35 110.962 177.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 45.4 t -138.98 168.44 19.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.997 0.427 . . . . 61.15 111.131 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.4 p -103.78 148.44 26.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.456 -0.338 . . . . 73.35 111.343 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.402 ' HE1' HD12 ' A' ' 43' ' ' LEU . 73.3 m-85 -51.72 -33.14 33.12 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.749 0.309 . . . . 74.44 111.394 175.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.16 -44.26 98.36 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.18 -0.533 . . . . 72.12 112.691 176.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.459 ' O ' ' HG3' ' A' ' 29' ' ' MET . 41.3 mt-10 -70.79 -49.57 45.14 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.575 0.226 . . . . 73.22 111.519 178.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.566 HD11 HD11 ' A' ' 15' ' ' ILE . 51.4 mm -56.07 -56.53 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 111.958 0.355 . . . . 70.32 111.958 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.435 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -58.97 -39.99 83.42 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.095 0.474 . . . . 73.2 111.305 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -60.82 -42.41 97.63 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.136 -0.484 . . . . 72.3 111.149 178.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.459 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 66.5 mtt -72.65 -36.26 67.93 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 120.898 0.38 . . . . 72.22 111.462 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.04 -21.28 65.02 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.981 0.42 . . . . 75.21 111.517 178.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.73 18.06 28.8 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.319 -0.467 . . . . 63.42 113.217 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.435 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 88.0 m-85 -123.44 85.94 52.28 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-O 120.783 0.325 . . . . 60.24 111.282 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.76 135.47 25.91 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.412 2.075 . . . . 73.42 112.672 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.5 -26.65 8.84 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.28 -0.486 . . . . 43.35 113.24 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -73.36 3.62 5.7 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 112.423 0.527 . . . . 65.11 112.423 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.0 -44.43 30.77 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.056 0.455 . . . . 45.52 112.027 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -63.43 -33.79 76.32 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 116.043 -0.526 . . . . 72.32 111.821 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -75.09 -34.61 61.77 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.799 0.333 . . . . 71.43 111.032 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.444 HG13 HD12 ' A' ' 8' ' ' ILE . 51.2 t -59.46 -40.11 80.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 121.118 0.485 . . . . 61.43 110.18 173.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.94 -41.01 99.19 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 115.92 -0.582 . . . . 54.12 112.665 174.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -57.98 -49.13 77.88 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.074 0.464 . . . . 74.01 110.424 174.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.71 -53.9 52.42 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.815 -0.629 . . . . 71.41 111.54 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.402 HD12 ' HE1' ' A' ' 23' ' ' TYR . 40.3 mt -62.98 -32.3 73.61 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.9 0.381 . . . . 75.42 111.03 178.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.97 -22.81 65.14 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.324 -0.465 . . . . 75.34 113.306 176.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.522 HD22 ' N ' ' A' ' 45' ' ' ASN . 0.8 OUTLIER -80.17 -20.13 45.52 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.841 0.353 . . . . 74.25 111.223 177.133 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 82.0 mt -76.94 140.66 67.03 Favored Pre-proline 0 CA--C 1.539 0.546 0 N-CA-C 112.255 0.465 . . . . 52.12 112.255 -178.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -88.48 172.95 4.7 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.941 2.427 . . . . 64.21 112.648 176.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.33 -31.36 72.49 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.489 -0.323 . . . . 54.12 111.859 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.02 52.43 4.39 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 120.96 -0.638 . . . . 75.54 113.101 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.8 t -102.32 142.38 33.63 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.131 0.419 . . . . 72.41 112.131 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -69.39 -35.76 76.1 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.24 0.543 . . . . 73.44 110.678 174.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.527 HD12 ' HD2' ' A' ' 53' ' ' PRO . 39.7 tp -80.92 121.49 80.93 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.884 -0.598 . . . . 73.35 110.733 175.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.527 ' HD2' HD12 ' A' ' 52' ' ' LEU . 60.8 Cg_endo -72.71 94.56 0.78 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 121.269 1.313 . . . . 65.51 111.725 176.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 55.7 p-90 -84.46 -25.36 28.99 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.201 0.524 . . . . 75.44 111.922 -177.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.548 ' HA ' ' HG3' ' A' ' 74' ' ' GLN . 29.9 p90 -62.97 -22.6 66.94 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.219 0.822 . . . . 72.34 113.219 -177.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -75.63 -3.46 34.62 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.455 0.539 . . . . 74.33 112.455 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.4 t -115.2 114.05 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 120.989 0.423 . . . . 65.42 111.673 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.629 HD11 HD21 ' A' ' 93' ' ' LEU . 39.1 pt -115.99 -171.09 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 120.942 0.401 . . . . 71.21 111.807 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 34.7 p30 -83.06 178.01 8.33 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.267 0.556 . . . . 74.01 112.1 -176.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 57.2 p -81.63 -1.31 46.13 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 116.229 -0.442 . . . . 75.13 111.98 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -86.94 -21.14 26.43 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.771 0.319 . . . . 65.45 111.372 177.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.08 22.67 24.63 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 121.257 -0.497 . . . . 72.24 112.212 -173.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.495 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 55.2 mtpt -129.4 172.77 11.18 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.126 0.488 . . . . 63.33 111.489 -177.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.687 HD11 HG11 ' A' ' 85' ' ' VAL . 55.3 mt -72.55 144.22 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.224 0.535 . . . . 72.3 111.329 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.4 p -88.47 -44.04 11.0 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.214 -0.448 . . . . 72.41 111.465 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.43 HD13 ' HB3' ' A' ' 70' ' ' ASP . 74.9 mt -76.42 159.87 30.06 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.291 0.567 . . . . 70.25 112.037 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -131.73 165.91 22.68 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.037 -0.529 . . . . 74.2 111.879 -175.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.04 -138.0 41.37 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-N 116.23 -0.441 . . . . 52.3 113.13 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 65.1 mtm180 -59.11 -26.59 64.82 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.925 0.393 . . . . 62.12 111.58 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.43 ' HB3' HD13 ' A' ' 66' ' ' LEU . 13.2 m-20 -73.21 -29.39 62.77 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.393 -0.367 . . . . 74.13 111.637 177.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.9 tt -62.26 -48.11 81.4 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 109.199 -0.667 . . . . 70.2 109.199 174.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.93 -43.24 95.05 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.887 -0.597 . . . . 72.2 111.364 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 73' ' ' ARG . 64.1 mtt180 -53.69 -57.49 10.64 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 120.805 0.336 . . . . 73.41 111.314 175.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.548 ' HG3' ' HA ' ' A' ' 55' ' ' PHE . 43.3 tt0 -62.88 -47.12 84.7 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.037 0.446 . . . . 65.42 111.094 -177.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.446 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 61.6 tttp -58.37 -60.7 3.37 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.967 -0.56 . . . . 61.21 111.978 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -62.14 -26.27 68.22 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.644 0.609 . . . . 63.13 112.644 -173.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -64.12 -48.73 74.98 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.207 0.527 . . . . 74.14 110.715 170.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.548 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 41.1 mt -61.04 -47.21 87.45 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.89 -0.595 . . . . 70.21 110.994 176.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 57.4 mm-40 -50.08 -39.67 43.18 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.719 -0.673 . . . . 75.35 111.02 175.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.38 -32.89 74.44 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.138 -0.483 . . . . 72.54 112.144 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -91.48 0.1 57.55 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 111.875 0.324 . . . . 74.44 111.875 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.24 5.81 59.15 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.351 -0.452 . . . . 64.01 113.247 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.548 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 61.4 mt -85.46 102.54 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 121.229 0.537 . . . . 71.2 110.617 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -78.69 110.62 13.99 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.683 0.623 . . . . 73.13 112.683 -171.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.687 HG11 HD11 ' A' ' 64' ' ' ILE . 40.3 t -97.41 121.12 47.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 116.096 -0.502 . . . . 73.53 111.988 -178.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.531 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 30.9 t -59.1 150.7 24.34 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.161 0.43 . . . . 71.23 112.161 177.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -50.42 -39.86 48.52 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.331 0.863 . . . . 75.55 113.331 -174.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.415 ' H ' HG13 ' A' ' 88' ' ' ILE . 2.8 pp -81.04 18.9 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-O 121.114 0.483 . . . . 74.32 111.859 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.72 50.25 9.49 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 116.164 -0.471 . . . . 32.12 113.407 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.531 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 50.1 tttm -125.25 149.4 48.04 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 122.423 -0.457 . . . . 72.51 112.073 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.57 HD12 HG21 ' A' ' 58' ' ' ILE . 49.1 mt -123.45 152.93 28.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.235 -0.439 . . . . 54.03 110.322 174.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -86.68 93.29 9.19 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.816 0.341 . . . . 63.1 111.141 176.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.629 HD21 HD11 ' A' ' 58' ' ' ILE . 51.0 mt -58.88 -53.96 52.48 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.039 0.385 . . . . 71.12 112.039 -178.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 21.7 ttp180 -56.18 -19.02 11.84 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-O 121.222 0.534 . . . . 54.21 111.606 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.465 ' O ' ' HD3' ' A' ' 95' ' ' LYS . 7.8 tmtt? -91.43 -45.13 8.72 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 116.501 -0.318 . . . . 63.0 110.985 177.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -107.92 10.37 28.48 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.902 0.704 . . . . 73.53 112.902 -170.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 59.1 tttp -58.9 132.23 53.36 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.413 0.523 . . . . 42.02 112.413 -172.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 17.0 t90 -58.51 105.56 0.31 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.937 -0.574 . . . . 75.11 112.181 -179.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -102.89 102.07 25.01 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 115.6 -0.727 . . . . 65.35 110.434 171.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -73.62 -22.15 18.42 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.378 2.052 . . . . 50.04 112.871 177.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 92.6 mt -123.11 100.25 6.78 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.488 -0.324 . . . . 43.32 111.431 -177.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 . . . . . 0 C--O 1.253 1.258 0 CA-C-O 118.743 -0.646 . . . . 62.23 111.887 -178.63 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.1 tpt . . . . . 0 N--CA 1.488 1.443 0 N-CA-C 110.234 -0.284 . . . . 74.41 110.234 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.434 ' O ' HG23 ' A' ' 6' ' ' VAL . 15.1 t70 -62.11 140.23 58.42 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.553 0.575 . . . . 73.52 112.553 -172.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -60.83 -27.72 68.27 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.881 0.697 . . . . 74.24 112.881 -175.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.414 ' O ' HG12 ' A' ' 8' ' ' ILE . 59.7 t80 -58.74 -51.64 69.1 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.23 0.538 . . . . 64.34 110.086 174.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 70.0 mt -67.47 -46.42 73.04 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.543 -0.753 . . . . 63.53 111.128 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 2' ' ' ASP . 94.1 t -54.39 -48.82 68.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 116.285 -0.416 . . . . 74.25 112.02 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.43 ' O ' HG23 ' A' ' 11' ' ' VAL . 30.8 mm-40 -68.62 -51.44 42.25 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.747 0.647 . . . . 72.01 112.747 -177.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.494 HD12 HG13 ' A' ' 39' ' ' VAL . 30.2 pt -58.92 -41.54 83.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 120.751 0.31 . . . . 61.31 111.368 -178.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -64.01 -44.45 92.55 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.081 0.467 . . . . 71.33 110.591 174.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.98 -20.4 37.89 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.316 0.487 . . . . 73.24 112.316 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 7' ' ' GLN . 59.1 t -83.8 -43.95 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 120.978 0.418 . . . . 65.34 111.03 174.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.571 ' HB ' HD11 ' A' ' 52' ' ' LEU . 72.7 mt -61.02 -30.77 48.3 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 112.655 0.613 . . . . 75.21 112.655 -177.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -55.64 -18.03 6.96 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 112.8 0.667 . . . . 60.04 112.8 178.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -91.18 -0.89 57.78 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.239 0.459 . . . . 74.02 112.239 -178.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.526 HD11 HD11 ' A' ' 26' ' ' ILE . 61.2 mt -87.28 113.54 54.38 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-O 120.417 0.151 . . . . 74.33 110.905 178.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -77.74 170.31 19.3 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.685 2.257 . . . . 75.03 113.87 -177.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.2 tttp -61.32 130.52 46.53 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.085 -0.507 . . . . 73.31 111.247 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.67 2.97 75.0 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.035 -0.603 . . . . 54.33 113.688 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -120.72 148.33 44.09 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 117.272 0.536 . . . . 63.51 111.315 176.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.6 m -128.69 157.27 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.224 0.535 . . . . 71.21 111.898 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.4 m -133.1 163.46 29.2 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.158 -0.474 . . . . 42.21 110.796 176.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 44.5 p -93.88 149.09 21.54 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.734 0.302 . . . . 62.0 111.416 178.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -51.12 -38.81 54.12 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.866 0.365 . . . . 75.1 111.19 177.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.23 -47.78 89.13 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-N 116.154 -0.475 . . . . 72.51 112.875 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.455 ' O ' ' HG3' ' A' ' 29' ' ' MET . 46.0 mt-10 -59.63 -55.63 32.01 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.705 0.288 . . . . 55.1 111.537 178.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.526 HD11 HD11 ' A' ' 15' ' ' ILE . 49.8 mm -53.57 -50.43 49.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 120.956 0.408 . . . . 75.4 111.784 -178.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.473 ' HB2' HG21 ' A' ' 39' ' ' VAL . . . -64.13 -45.78 87.03 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.889 0.376 . . . . 71.41 111.802 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.9 tttp -64.49 -35.83 82.2 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.508 -0.314 . . . . 75.32 111.4 -177.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.455 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 65.9 mtt -68.4 -43.44 77.26 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.054 0.454 . . . . 63.53 110.769 176.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.54 -23.03 66.77 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.03 -0.532 . . . . 65.33 111.963 178.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.12 31.7 4.61 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.473 -0.394 . . . . 60.54 113.414 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -129.73 89.32 46.8 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-O 120.874 0.368 . . . . 71.41 111.402 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -73.72 125.37 9.95 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.135 2.556 . . . . 63.14 113.124 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.33 -13.99 66.31 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 121.323 -0.465 . . . . 71.5 113.584 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.428 ' HA ' ' HD2' ' A' ' 38' ' ' HIS . 74.5 m-85 -84.58 10.57 10.72 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.838 0.681 . . . . 73.53 112.838 -176.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.48 -52.72 20.99 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.719 0.637 . . . . 52.24 112.719 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -65.69 -26.47 67.79 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.887 0.375 . . . . 73.22 111.872 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.428 ' HD2' ' HA ' ' A' ' 35' ' ' TYR . 99.5 m-70 -74.83 -32.28 61.9 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.95 0.405 . . . . 73.24 110.921 177.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.494 HG13 HD12 ' A' ' 8' ' ' ILE . 81.3 t -59.44 -40.46 81.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-O 121.252 0.549 . . . . 62.43 110.195 170.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -57.93 -41.99 94.55 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.869 -0.605 . . . . 71.31 112.732 174.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -56.68 -40.16 75.07 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.094 0.473 . . . . 71.22 111.218 175.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.1 -51.72 23.51 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.914 -0.585 . . . . 73.42 112.179 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.9 mt -60.65 -45.14 95.23 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.2 0.444 . . . . 64.45 112.2 -176.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.59 -20.93 64.32 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 120.692 -0.766 . . . . 55.23 113.05 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -83.63 -20.97 32.69 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 120.71 0.291 . . . . 74.01 111.489 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.454 HD12 ' HB3' ' A' ' 54' ' ' TRP . 94.4 mt -67.05 147.68 99.02 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 111.889 0.329 . . . . 73.43 111.889 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.548 ' HG2' ' HB3' ' A' ' 50' ' ' SER . 30.1 Cg_endo -63.56 165.54 17.71 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.402 2.068 . . . . 53.23 112.715 176.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.405 ' HG2' ' HE ' ' A' ' 73' ' ' ARG . 45.7 mt-10 -57.3 -41.14 79.28 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.584 0.587 . . . . 74.42 112.584 -177.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -128.43 60.27 0.67 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.981 -0.628 . . . . 70.01 113.744 -177.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.548 ' HB3' ' HG2' ' A' ' 47' ' ' PRO . 24.5 p -76.97 -178.7 5.07 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 122.459 -0.436 . . . . 72.33 110.878 176.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.429 ' NZ ' ' HB2' ' A' ' 51' ' ' LYS . 5.2 ttmp? -61.04 -28.52 69.12 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.065 0.46 . . . . 75.14 110.825 174.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.571 HD11 ' HB ' ' A' ' 12' ' ' ILE . 26.0 tp -103.38 130.78 22.92 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 116.017 -0.538 . . . . 73.53 111.812 -177.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.534 ' HD2' HD12 ' A' ' 52' ' ' LEU . 72.0 Cg_endo -79.42 95.89 1.06 Allowed 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 121.657 1.571 . . . . 70.44 111.511 170.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.454 ' HB3' HD12 ' A' ' 46' ' ' LEU . 64.8 p-90 -76.51 -28.77 56.53 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.162 -0.472 . . . . 74.32 112.202 -175.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.491 ' O ' HD21 ' A' ' 78' ' ' LEU . 24.8 p90 -60.7 -19.96 59.89 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.409 0.892 . . . . 62.32 113.409 -175.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -76.82 6.76 5.59 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.864 0.69 . . . . 54.22 112.864 -176.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 45.1 t -123.62 125.85 72.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 O-C-N 121.929 -0.482 . . . . 54.31 111.624 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.541 HG21 HD12 ' A' ' 91' ' ' ILE . 32.5 pt -127.35 -169.63 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 121.157 0.503 . . . . 74.23 111.357 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.414 ' HB3' ' OG ' ' A' ' 65' ' ' SER . 30.9 p30 -87.26 173.97 8.87 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.068 0.461 . . . . 64.03 111.824 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 33.3 p -84.79 9.74 13.32 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.965 0.412 . . . . 61.52 111.646 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -93.14 -14.79 26.75 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.003 0.43 . . . . 72.52 110.542 173.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.38 37.17 18.45 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 121.081 -0.58 . . . . 75.43 112.161 -174.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -137.35 167.71 21.06 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.645 0.736 . . . . 62.22 112.379 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.516 ' CG2' HD12 ' A' ' 71' ' ' LEU . 74.9 mt -83.68 108.53 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.109 -0.95 . . . . 54.12 110.209 172.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.414 ' OG ' ' HB3' ' A' ' 59' ' ' ASN . 71.2 m -69.7 -25.9 64.09 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.73 0.641 . . . . 54.13 112.73 -175.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.499 HD13 ' HB3' ' A' ' 70' ' ' ASP . 88.6 mt -64.78 124.38 21.82 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.696 0.284 . . . . 73.23 111.018 178.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -113.05 141.59 46.7 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.14 0.495 . . . . 63.14 111.211 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 107.88 -136.43 13.44 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.462 -0.655 . . . . 63.02 111.462 -173.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -81.76 -24.94 35.73 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 117.511 0.656 . . . . 64.1 110.896 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.499 ' HB3' HD13 ' A' ' 66' ' ' LEU . 7.8 m-20 -62.36 -24.83 67.58 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.121 -0.49 . . . . 72.44 111.936 176.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.516 HD12 ' CG2' ' A' ' 64' ' ' ILE . 16.2 tp -56.84 -60.65 3.26 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.414 0.626 . . . . 74.12 110.561 174.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.554 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 18.8 m-20 -67.03 -32.48 73.72 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.605 -0.725 . . . . 74.12 111.178 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.405 ' HE ' ' HG2' ' A' ' 48' ' ' GLU . 57.7 ttt180 -50.13 -59.01 4.33 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-O 121.3 0.572 . . . . 63.1 111.204 174.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -62.29 -43.55 98.58 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.007 -0.542 . . . . 63.44 110.7 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.43 ' HB3' ' HA ' ' A' ' 72' ' ' ASP . 76.4 tttt -50.0 -58.24 5.9 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.722 -0.672 . . . . 73.1 112.306 176.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.554 ' HG3' ' O ' ' A' ' 72' ' ' ASP . 96.0 mt-30 -52.75 -49.19 65.97 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.142 0.496 . . . . 74.25 111.467 -178.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -68.91 -27.06 65.43 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.5 0.556 . . . . 72.41 112.5 -177.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.495 HD13 HD11 ' A' ' 91' ' ' ILE . 57.6 mt -77.79 -39.03 45.3 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.169 0.433 . . . . 75.5 112.169 177.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -62.8 -30.69 71.66 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.025 0.441 . . . . 73.22 110.617 175.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.82 -20.06 66.19 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 116.04 -0.527 . . . . 40.34 111.483 174.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -86.98 2.67 48.72 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.201 -0.454 . . . . 73.25 111.443 177.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.2 15.67 71.37 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.092 -0.575 . . . . 74.41 112.832 -177.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 73.0 mt -92.1 124.5 44.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 120.959 0.409 . . . . 73.52 111.643 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.507 ' HG2' ' OH ' ' A' ' 96' ' ' TYR . 9.0 pt-20 -72.76 90.84 1.44 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.6 0.714 . . . . 70.01 111.308 175.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 62.3 t -85.73 112.53 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 116.071 -0.513 . . . . 51.1 110.477 176.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.571 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 42.1 t -61.26 142.57 56.73 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.757 -0.201 . . . . 73.32 111.055 178.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -48.52 -38.47 20.37 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.744 1.016 . . . . 73.44 113.744 -172.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.426 ' H ' HG13 ' A' ' 88' ' ' ILE . 2.8 pp -80.32 16.42 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 CA-C-O 121.083 0.468 . . . . 74.42 112.23 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.37 52.31 6.18 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 116.373 -0.376 . . . . 75.42 113.443 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.571 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 1.3 tmtp? -125.4 136.23 53.22 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.052 0.453 . . . . 72.44 111.214 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.541 HD12 HG21 ' A' ' 58' ' ' ILE . 69.7 mt -125.59 126.49 70.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 116.018 -0.537 . . . . 72.23 110.864 178.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.98 98.29 1.26 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 111.973 0.36 . . . . 73.41 111.973 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.453 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 86.2 mt -53.47 -53.22 54.6 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.337 -0.392 . . . . 64.21 111.838 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 18.5 ttm180 -56.21 -26.58 51.54 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 112.189 0.44 . . . . 75.22 112.189 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -89.66 -28.88 19.17 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.137 0.421 . . . . 70.22 112.137 -177.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.507 ' OH ' ' HG2' ' A' ' 84' ' ' GLU . 70.9 m-85 -124.73 12.76 8.57 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.658 0.614 . . . . 75.12 112.658 -174.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 63.6 tttp -60.08 131.5 51.02 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.093 0.473 . . . . 74.04 111.825 -177.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 19.8 t90 -56.15 124.26 17.27 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.954 -0.566 . . . . 74.14 111.735 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -108.82 88.87 5.78 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 116.035 -0.53 . . . . 74.0 111.029 176.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.63 -39.08 12.66 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.02 1.814 . . . . 72.22 111.385 173.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 87.2 mt -133.62 164.11 27.93 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.908 -0.587 . . . . 61.44 110.848 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 . . . . . 0 C--O 1.253 1.255 0 CA-C-O 118.637 -0.697 . . . . 55.55 111.67 174.071 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.6 tpt . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 120.793 0.33 . . . . 62.32 110.44 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -66.06 131.7 46.8 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.666 0.617 . . . . 71.4 112.666 -176.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -57.0 -30.31 64.05 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.22 -0.446 . . . . 74.55 110.964 175.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -57.69 -52.39 65.62 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.041 0.448 . . . . 51.12 110.717 174.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.4 mt -63.8 -48.19 77.89 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.964 -0.562 . . . . 71.22 111.471 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 67.4 t -53.03 -49.52 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 120.931 0.396 . . . . 64.24 111.703 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.467 ' O ' HG23 ' A' ' 11' ' ' VAL . 28.9 mm-40 -67.28 -53.29 31.19 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.632 0.604 . . . . 74.52 112.632 -177.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.41 ' O ' HG13 ' A' ' 12' ' ' ILE . 35.9 pt -59.64 -41.62 85.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 O-C-N 122.148 -0.345 . . . . 45.42 111.468 -178.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.401 ' CD1' HG13 ' A' ' 8' ' ' ILE . 14.8 m-30 -63.69 -43.91 95.23 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.958 0.408 . . . . 74.33 110.818 177.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.75 -43.18 80.48 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.31 -0.405 . . . . 74.14 111.366 177.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 7' ' ' GLN . 74.3 t -61.74 -43.2 96.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 121.082 0.468 . . . . 70.33 110.742 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.473 ' HB ' HD11 ' A' ' 52' ' ' LEU . 72.6 mt -62.77 -37.26 78.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 116.146 -0.479 . . . . 71.04 111.645 177.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -64.22 -10.43 23.34 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.196 0.443 . . . . 74.53 112.196 176.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.46 -9.92 42.77 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.65 0.262 . . . . 73.05 111.667 177.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.427 HD11 HD11 ' A' ' 26' ' ' ILE . 54.9 mt -76.92 114.67 41.54 Favored Pre-proline 0 CA--C 1.543 0.684 0 O-C-N 122.448 -0.157 . . . . 75.42 110.831 177.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -60.62 150.25 82.95 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 122.734 2.289 . . . . 72.25 113.515 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 67.2 tttm -62.05 95.35 0.06 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.076 0.465 . . . . 64.14 111.255 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 139.11 -18.64 3.11 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 121.155 -0.545 . . . . 73.21 113.148 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -103.86 162.4 13.14 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.994 0.426 . . . . 71.2 111.676 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.7 m -136.29 156.2 35.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 122.932 0.493 . . . . 74.33 111.561 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 98.4 p -138.13 179.43 6.45 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 120.764 0.316 . . . . 71.22 111.15 178.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.8 p -110.72 153.12 25.74 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 120.991 0.424 . . . . 74.52 111.651 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.401 ' CE1' ' HA2' ' A' ' 40' ' ' GLY . 90.0 m-85 -53.48 -39.91 64.9 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.257 0.466 . . . . 73.3 112.257 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.16 -40.62 93.96 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.172 -0.537 . . . . 41.23 113.098 178.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -67.29 -51.61 50.73 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 122.493 -0.416 . . . . 71.4 111.396 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.427 HD11 HD11 ' A' ' 15' ' ' ILE . 50.5 mm -53.85 -51.53 43.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-N 116.141 -0.481 . . . . 73.21 111.397 178.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.02 -54.18 49.86 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.215 -0.448 . . . . 34.24 111.961 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.7 mtmp? -62.09 -41.48 98.24 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.083 0.401 . . . . 74.01 112.083 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 70.7 mtm -76.63 -10.39 59.35 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 111.995 0.369 . . . . 72.41 111.995 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.34 -14.39 33.21 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.091 0.472 . . . . 51.05 110.929 172.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.8 18.31 27.89 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 116.012 -0.54 . . . . 23.51 113.203 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -125.59 91.11 49.29 Favored Pre-proline 0 CA--C 1.544 0.741 0 O-C-N 122.522 -0.399 . . . . 75.35 111.397 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.01 137.12 26.03 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.861 2.374 . . . . 64.04 113.092 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.33 -6.18 52.42 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 121.261 -0.495 . . . . 70.42 113.968 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.424 ' HA ' ' HD2' ' A' ' 38' ' ' HIS . 61.0 m-85 -84.19 11.26 8.47 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.634 0.605 . . . . 62.24 112.634 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.25 -47.34 69.16 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.963 0.411 . . . . 74.1 111.895 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.0 ptt180 -57.86 -40.05 79.24 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.18 -0.464 . . . . 71.15 111.957 175.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.424 ' HD2' ' HA ' ' A' ' 35' ' ' TYR . 88.9 m-70 -67.84 -39.29 83.86 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.861 0.362 . . . . 73.4 111.19 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 35' ' ' TYR . 58.9 t -59.9 -42.62 89.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.013 0.435 . . . . 64.3 110.611 174.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.401 ' HA2' ' CE1' ' A' ' 23' ' ' TYR . . . -58.97 -41.56 96.41 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-N 116.078 -0.51 . . . . 54.51 112.718 176.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -61.65 -47.32 85.91 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 120.835 0.35 . . . . 64.51 111.085 176.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.6 -54.41 47.22 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.989 0.423 . . . . 45.43 111.727 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.4 mt -63.91 -32.62 74.21 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.846 0.355 . . . . 74.11 111.461 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.99 -13.99 62.7 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.439 -0.41 . . . . 73.43 113.507 178.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.484 HD22 ' N ' ' A' ' 45' ' ' ASN . 0.8 OUTLIER -93.53 -4.08 51.67 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 117.087 0.444 . . . . 63.14 111.945 177.17 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 94.2 mt -85.88 142.34 36.52 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 112.509 0.559 . . . . 71.4 112.509 -176.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.78 159.5 48.31 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.54 2.16 . . . . 73.44 112.27 173.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.59 -35.82 73.02 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.401 0.519 . . . . 63.1 112.401 -176.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -113.94 53.12 0.61 Allowed Glycine 0 CA--C 1.526 0.75 0 C-N-CA 121.23 -0.51 . . . . 45.32 112.913 178.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 90.9 p -72.93 -179.14 3.06 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 122.297 -0.531 . . . . 70.35 111.454 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -84.59 4.5 31.92 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.007 0.432 . . . . 73.23 111.425 176.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.554 HD12 ' HD2' ' A' ' 53' ' ' PRO . 35.6 tp -127.1 126.08 24.23 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 116.159 -0.473 . . . . 74.34 110.34 178.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.554 ' HD2' HD12 ' A' ' 52' ' ' LEU . 53.0 Cg_endo -70.1 94.36 0.56 Allowed 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 120.94 1.093 . . . . 62.1 111.879 176.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 68.1 p-90 -84.88 -29.7 25.02 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.305 0.574 . . . . 73.53 111.051 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.454 ' O ' HD21 ' A' ' 78' ' ' LEU . 33.6 p90 -61.56 -14.16 27.62 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.008 0.744 . . . . 71.23 113.008 -177.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 69.6 mtt-85 -85.34 7.95 20.52 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.108 0.41 . . . . 74.24 112.108 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.6 t -125.13 126.91 71.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 120.98 0.419 . . . . 53.11 111.521 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.609 HD11 HD21 ' A' ' 93' ' ' LEU . 34.9 pt -130.21 -172.11 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-N 116.444 -0.344 . . . . 64.04 111.504 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.421 HD21 ' HB2' ' A' ' 63' ' ' LYS . 34.6 p30 -84.96 175.39 9.1 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.217 0.532 . . . . 55.33 111.988 -178.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.2 p -72.51 -12.42 61.07 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.303 -0.408 . . . . 62.03 112.053 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -80.34 -16.32 54.83 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.633 0.254 . . . . 73.44 111.59 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.63 21.6 46.84 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 121.059 -0.591 . . . . 71.12 112.189 -174.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.505 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 62.1 mttp -118.67 159.64 23.27 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.112 0.482 . . . . 75.23 111.463 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 58.0 mt -67.23 130.03 32.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.242 -0.435 . . . . 71.24 110.525 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.6 p -64.78 -53.92 39.41 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.962 0.411 . . . . 63.14 111.589 -177.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.487 HD13 ' HB3' ' A' ' 70' ' ' ASP . 85.6 mt -63.48 150.73 43.09 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.253 0.549 . . . . 73.44 112.075 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.82 157.31 32.73 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.087 -0.506 . . . . 72.43 111.497 -176.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.96 -129.19 10.54 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.284 -0.484 . . . . 72.33 113.281 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.417 ' H ' ' HG3' ' A' ' 69' ' ' ARG . 9.0 mtm180 -54.61 -51.22 66.03 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 122.451 1.119 . . . . 74.43 110.515 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.571 ' HA ' ' HB3' ' A' ' 73' ' ' ARG . 3.6 m-20 -63.45 -18.47 63.79 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.121 -1.4 . . . . 75.13 112.293 -171.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.1 tt -65.55 -56.07 14.32 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 110.087 -0.338 . . . . 75.22 110.087 175.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -70.22 -26.3 63.8 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 122.315 -0.241 . . . . 65.34 111.013 178.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.571 ' HB3' ' HA ' ' A' ' 70' ' ' ASP . 29.4 ttm180 -57.2 -55.19 37.93 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.22 0.533 . . . . 74.4 110.751 171.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -64.56 -40.62 95.9 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.302 -0.408 . . . . 73.3 110.789 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.446 ' HG3' ' HB ' ' A' ' 85' ' ' VAL . 60.7 tttp -57.15 -56.94 15.34 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 111.931 0.345 . . . . 71.23 111.931 177.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -56.57 -34.36 67.05 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.505 0.193 . . . . 72.11 111.506 -177.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.5 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 75.6 mmtt -59.13 -47.42 85.35 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.165 0.507 . . . . 73.44 110.99 172.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.496 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 58.2 mt -68.85 -42.08 77.59 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.928 -0.578 . . . . 73.35 111.984 -178.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -55.1 -39.78 69.7 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.245 0.545 . . . . 70.32 110.86 176.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.65 -22.96 66.7 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.788 -0.642 . . . . 72.15 111.827 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 77' ' ' LYS . 4.9 mm-40 -94.33 -1.38 53.94 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 111.985 0.365 . . . . 73.5 111.985 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.07 19.83 51.84 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 120.851 -0.69 . . . . 74.1 113.37 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.496 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 65.4 mt -99.77 110.77 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 O-C-N 122.704 -0.291 . . . . 70.41 110.721 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -73.19 102.83 3.72 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.973 0.416 . . . . 75.14 111.815 -177.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.446 ' HB ' ' HG3' ' A' ' 75' ' ' LYS . 22.0 t -98.54 126.39 51.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 116.453 -0.34 . . . . 74.25 111.328 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.619 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 42.6 t -72.57 159.04 34.56 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 111.979 0.363 . . . . 65.14 111.979 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -38.98 -55.76 1.51 Allowed 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 114.748 1.388 . . . . 62.53 114.748 -171.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 pp -82.45 16.96 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 112.543 0.571 . . . . 53.42 112.543 -175.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.44 52.57 4.43 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 121.347 -0.454 . . . . 62.1 113.107 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.619 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 86.7 tttt -116.25 125.54 52.35 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 122.352 -0.499 . . . . 74.33 111.86 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.527 HD12 HD13 ' A' ' 58' ' ' ILE . 57.4 mt -113.95 138.46 43.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 116.274 -0.421 . . . . 74.03 111.342 -178.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.48 92.52 4.02 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.011 0.434 . . . . 53.32 111.071 176.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.609 HD21 HD11 ' A' ' 58' ' ' ILE . 82.0 mt -56.26 -48.95 75.55 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.384 -0.371 . . . . 65.2 111.732 -178.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -52.85 -22.05 4.97 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.877 0.695 . . . . 73.12 112.877 -176.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -102.67 -38.84 7.31 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.085 0.402 . . . . 64.14 112.085 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -101.68 3.83 40.11 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 111.968 0.359 . . . . 72.12 111.968 -172.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 57.4 tttp -59.51 141.59 54.47 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.042 0.448 . . . . 71.42 111.91 -175.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 16.2 t90 -60.75 119.47 8.22 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.258 0.551 . . . . 72.33 111.414 178.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -118.56 90.8 40.33 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 115.776 -0.647 . . . . 74.52 111.261 -178.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -81.95 -7.39 12.25 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.778 2.319 . . . . 61.31 113.341 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 38.5 mt -96.0 8.77 42.81 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.797 0.332 . . . . 72.22 111.678 -176.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 119.09 -0.481 . . . . 74.14 111.992 -176.725 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 120.879 0.371 . . . . 73.51 110.743 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -59.37 153.83 18.13 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.716 0.635 . . . . 73.44 112.716 -176.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -56.41 -38.33 71.39 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.296 -0.411 . . . . 72.01 111.499 175.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -49.03 -50.78 34.63 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.121 0.486 . . . . 73.23 110.787 173.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 61.9 mt -63.7 -48.27 77.77 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.759 -0.655 . . . . 71.52 111.176 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 63.1 t -57.33 -41.09 77.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 116.32 -0.4 . . . . 61.53 111.997 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.49 ' O ' HG23 ' A' ' 11' ' ' VAL . 27.9 mm-40 -73.75 -49.57 24.87 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.195 0.443 . . . . 74.32 112.195 -177.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.44 ' O ' HG13 ' A' ' 12' ' ' ILE . 31.4 pt -59.7 -40.2 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 O-C-N 122.055 -0.403 . . . . 53.3 111.259 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -58.23 -48.11 81.42 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.035 0.445 . . . . 64.15 110.448 171.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.37 -17.31 42.66 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.041 -0.527 . . . . 73.51 112.407 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 7' ' ' GLN . 49.9 t -92.41 -50.16 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-O 120.808 0.337 . . . . 71.31 111.3 175.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.501 HD12 HD21 ' A' ' 52' ' ' LEU . 79.8 mt -57.85 -37.82 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 112.849 0.685 . . . . 74.15 112.849 -175.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 -58.23 -21.3 47.48 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.402 0.519 . . . . 74.14 112.402 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -83.28 -6.24 59.4 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.509 0.559 . . . . 64.35 112.509 -178.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 45.3 mt -78.27 122.9 85.81 Favored Pre-proline 0 CA--C 1.544 0.72 0 O-C-N 122.419 -0.175 . . . . 64.2 110.655 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -79.88 178.76 6.9 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.801 2.334 . . . . 65.34 114.176 -175.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.53 ' HE3' ' HA ' ' A' ' 81' ' ' GLU . 49.3 tptt -67.18 122.88 18.79 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.627 -0.715 . . . . 61.2 111.502 -178.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.549 ' HA2' ' HB3' ' A' ' 81' ' ' GLU . . . 91.12 3.5 69.9 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 114.407 0.523 . . . . 71.43 114.407 175.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -117.81 146.86 43.55 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 117.575 0.688 . . . . 73.32 111.648 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.6 m -129.13 157.62 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.172 0.51 . . . . 73.44 111.747 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 89.3 p -132.43 171.11 14.18 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.236 -0.438 . . . . 74.23 110.793 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.9 p -103.52 152.03 22.17 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.808 0.337 . . . . 74.14 111.697 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -49.46 -41.47 40.44 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.442 0.534 . . . . 72.33 112.442 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.7 -40.99 95.57 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 121.239 -0.505 . . . . 72.34 113.252 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -66.91 -55.17 15.82 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.64 0.257 . . . . 73.14 111.073 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.6 mm -54.11 -49.99 57.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.208 0.528 . . . . 53.41 111.365 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.53 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -59.8 -43.77 94.29 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.062 -0.517 . . . . 55.13 111.737 179.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -62.35 -45.57 92.6 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.79 0.329 . . . . 75.31 111.182 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 65.4 mtt -63.15 -37.1 85.88 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.406 -0.361 . . . . 74.12 111.167 178.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.29 -29.38 67.24 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.935 0.397 . . . . 62.11 111.673 176.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.48 10.05 27.96 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 116.282 -0.417 . . . . 75.24 112.935 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.53 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 26.8 m-85 -127.27 63.5 58.23 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 122.451 0.3 . . . . 70.3 111.152 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.69 -35.7 87.99 Favored 'Trans proline' 0 N--CA 1.483 0.862 0 C-N-CA 122.829 2.353 . . . . 63.33 114.181 -172.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -82.35 -7.96 86.93 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 121.06 -0.59 . . . . 72.44 113.59 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.448 ' CD1' ' HB3' ' A' ' 32' ' ' TYR . 23.0 m-85 -86.2 16.14 4.61 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.529 0.566 . . . . 72.34 112.529 -178.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.09 -43.58 61.09 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.216 0.532 . . . . 74.52 111.618 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -57.55 -40.25 78.47 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.781 -0.645 . . . . 72.33 111.855 175.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -75.35 -28.23 59.5 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.651 -0.25 . . . . 72.32 111.673 -178.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 35' ' ' TYR . 46.5 t -61.18 -43.85 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 109.814 -0.439 . . . . 53.03 109.814 173.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.02 -41.94 96.69 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 115.992 -0.549 . . . . 53.03 112.631 174.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.4 mttp -57.46 -53.83 53.75 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.975 0.417 . . . . 74.15 111.303 173.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.33 -47.64 78.35 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.165 -0.47 . . . . 73.3 112.08 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.437 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 79.8 mt -68.1 -41.39 81.88 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.861 0.362 . . . . 74.0 111.496 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.7 -18.79 62.09 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.156 -0.545 . . . . 73.04 113.374 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -86.06 -4.49 59.18 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 122.606 -0.349 . . . . 72.31 111.649 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 96.2 mt -92.61 121.53 65.99 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-O 120.761 0.315 . . . . 73.1 111.653 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.89 160.86 36.83 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.326 2.017 . . . . 63.31 112.469 177.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -67.13 119.32 11.85 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.287 0.565 . . . . 64.23 110.962 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 110.89 -2.51 28.74 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 115.983 -0.553 . . . . 62.32 112.673 -173.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 31.0 t -61.85 167.82 3.49 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.165 0.507 . . . . 62.3 112.162 177.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -66.93 -29.51 69.4 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.737 0.643 . . . . 53.23 112.737 -177.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.555 HD12 ' HD2' ' A' ' 53' ' ' PRO . 25.7 tp -102.46 131.84 22.03 Favored Pre-proline 0 N--CA 1.472 0.639 0 N-CA-C 111.558 0.207 . . . . 51.34 111.558 -178.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.555 ' HD2' HD12 ' A' ' 52' ' ' LEU . 59.4 Cg_endo -73.62 95.1 0.86 Allowed 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 121.591 1.527 . . . . 71.21 111.813 171.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.437 ' HB2' ' HB3' ' A' ' 43' ' ' LEU . 55.2 p-90 -81.35 -24.51 37.03 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.225 0.536 . . . . 71.5 112.222 -176.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.451 ' CG ' ' HB3' ' A' ' 77' ' ' LYS . 29.3 p90 -65.24 -17.99 64.94 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.381 0.882 . . . . 65.43 113.381 -175.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -83.23 7.33 16.58 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.545 0.572 . . . . 74.15 112.545 -177.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.6 t -123.19 117.93 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 121.029 0.443 . . . . 62.32 111.131 176.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.495 HD11 HD21 ' A' ' 93' ' ' LEU . 42.3 pt -123.21 -170.35 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 121.112 0.482 . . . . 65.21 111.714 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.7 p30 -86.28 163.48 17.69 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.078 0.466 . . . . 61.4 111.585 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 88.1 p -79.6 9.43 5.0 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 120.983 0.42 . . . . 55.23 111.665 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -93.61 -8.74 40.28 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.161 -0.472 . . . . 73.5 111.13 178.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.5 40.59 27.29 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.311 -0.471 . . . . 21.51 112.821 -177.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.627 ' HG2' ' HG2' ' A' ' 90' ' ' LYS . 53.5 mtpt -137.45 166.78 23.02 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.101 0.477 . . . . 73.53 111.441 178.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 63.6 mt -67.15 109.88 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.505 -0.554 . . . . 73.41 109.505 170.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.4 t -57.7 -40.09 78.72 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.143 -0.48 . . . . 74.41 112.013 -175.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.595 HD13 ' HB3' ' A' ' 70' ' ' ASP . 84.9 mt -76.78 160.15 29.53 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.995 0.426 . . . . 75.14 111.399 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -130.82 157.51 42.66 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.051 0.453 . . . . 75.44 111.869 -176.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.48 -130.19 31.51 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.267 -0.492 . . . . 62.13 113.398 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.418 ' H ' ' HG3' ' A' ' 69' ' ' ARG . 10.2 mtm180 -48.69 -50.93 31.1 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.902 0.858 . . . . 74.44 110.947 178.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.595 ' HB3' HD13 ' A' ' 66' ' ' LEU . 21.5 m-20 -70.72 -18.85 62.79 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 114.627 -1.17 . . . . 72.34 112.035 -172.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.0 tt -66.7 -51.07 60.18 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.608 -0.516 . . . . 73.1 109.608 174.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -61.6 -36.36 80.49 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.08 -0.509 . . . . 61.44 111.528 175.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.2 mtt180 -56.1 -62.81 1.45 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.51 0.195 . . . . 61.4 111.473 174.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.413 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 52.5 tt0 -58.83 -36.47 74.6 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.714 0.293 . . . . 74.01 111.086 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.497 ' HG3' HG11 ' A' ' 85' ' ' VAL . 79.2 tttt -52.46 -65.95 0.47 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.991 0.424 . . . . 74.11 111.62 174.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -63.18 -30.87 71.93 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.084 -0.507 . . . . 75.23 112.224 -175.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.451 ' HB3' ' CG ' ' A' ' 55' ' ' PHE . 72.3 mmtt -61.02 -45.89 92.98 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.974 0.416 . . . . 54.41 110.626 174.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.474 HD22 HD12 ' A' ' 83' ' ' ILE . 83.6 mt -72.17 -28.09 63.0 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.397 -0.365 . . . . 73.15 111.633 177.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.495 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 49.7 mt-10 -66.88 -28.06 68.02 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.067 0.46 . . . . 74.11 110.325 172.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.6 -23.66 59.95 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.165 0.507 . . . . 40.55 110.858 172.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.549 ' HB3' ' HA2' ' A' ' 18' ' ' GLY . 39.7 mm-40 -81.77 -26.25 34.61 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.024 -0.535 . . . . 61.1 110.989 174.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.85 37.18 4.26 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 116.304 -0.407 . . . . 75.32 113.057 -178.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.474 HD12 HD22 ' A' ' 78' ' ' LEU . 58.6 mt -105.8 136.98 37.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 112.301 0.482 . . . . 75.13 112.301 -176.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -67.95 93.7 0.43 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.887 0.375 . . . . 72.12 111.582 172.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.497 HG11 ' HG3' ' A' ' 75' ' ' LYS . 60.2 t -86.94 107.11 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 110.116 -0.328 . . . . 74.42 110.116 174.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.574 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 23.8 t -64.83 147.74 52.65 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.637 -0.256 . . . . 71.43 111.352 -177.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.453 ' HG3' ' N ' ' A' ' 88' ' ' ILE . 12.3 pt-20 -36.31 -55.76 0.8 Allowed 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 115.424 1.638 . . . . 64.44 115.424 -167.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.453 ' N ' ' HG3' ' A' ' 87' ' ' GLU . 2.8 pp -87.35 10.12 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 112.866 0.691 . . . . 74.45 112.866 -173.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 97.74 47.98 2.03 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 121.363 -0.446 . . . . 74.02 113.999 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.627 ' HG2' ' HG2' ' A' ' 63' ' ' LYS . 90.8 mttt -114.77 146.36 41.07 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 122.305 -0.526 . . . . 74.51 111.515 176.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.444 HD12 HG21 ' A' ' 58' ' ' ILE . 58.3 mt -130.97 138.77 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 115.873 -0.603 . . . . 73.15 111.137 -177.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.56 93.55 8.83 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.621 -0.263 . . . . 73.34 111.679 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.495 HD21 HD11 ' A' ' 58' ' ' ILE . 62.2 mt -53.97 -57.18 11.97 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 111.79 0.292 . . . . 72.32 111.79 177.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 52.9 ttp180 -46.25 -30.65 2.1 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.727 0.639 . . . . 64.41 112.727 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -90.59 -25.63 20.08 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 112.242 0.46 . . . . 72.4 112.242 -176.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -127.11 13.08 7.21 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 113.129 0.788 . . . . 75.4 113.129 -176.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 93' ' ' LEU . 55.2 tttm -64.61 125.98 26.44 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.029 0.443 . . . . 65.12 111.777 -175.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 22.4 t90 -58.94 113.8 2.26 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.853 0.686 . . . . 71.24 112.853 -175.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -107.71 92.41 8.73 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 115.909 -0.587 . . . . 63.23 110.481 172.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -61.35 -34.0 88.0 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.585 2.19 . . . . 75.03 113.184 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 89.1 mt -125.88 -74.15 0.61 Allowed 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.54 0.209 . . . . 60.22 111.554 -177.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 . . . . . 0 C--O 1.256 1.401 0 CA-C-O 118.938 -0.553 . . . . 71.35 111.795 -179.551 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ttt . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.59 0.233 . . . . 61.02 110.851 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -64.15 141.29 58.82 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 112.742 0.645 . . . . 44.24 112.742 -175.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -52.72 -39.57 62.18 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.677 0.621 . . . . 74.5 112.677 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -57.74 -48.71 78.84 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.898 0.38 . . . . 64.13 110.754 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.28 -46.58 89.76 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.034 -0.53 . . . . 54.33 111.26 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 73.2 t -56.48 -52.31 54.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 116.286 -0.415 . . . . 72.33 111.62 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -63.98 -49.85 70.87 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.947 0.721 . . . . 53.31 112.947 -176.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 36.9 pt -60.73 -41.76 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 O-C-N 122.114 -0.366 . . . . 65.25 111.401 -178.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -66.03 -41.78 90.48 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.747 0.308 . . . . 74.52 110.998 177.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.04 -37.95 69.93 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.011 0.434 . . . . 61.44 111.586 177.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 95.9 t -66.85 -41.85 88.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-O 121.015 0.436 . . . . 73.13 110.982 177.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.557 ' HB ' HD11 ' A' ' 52' ' ' LEU . 73.7 mt -62.5 -37.32 78.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 116.117 -0.492 . . . . 75.12 111.801 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -57.16 -21.17 30.91 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 122.194 -0.316 . . . . 70.02 111.717 174.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -87.46 -4.13 59.01 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 112.447 0.536 . . . . 74.21 112.447 -177.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.547 HD11 HD11 ' A' ' 26' ' ' ILE . 60.0 mt -76.32 122.26 86.44 Favored Pre-proline 0 CA--C 1.542 0.658 0 O-C-N 122.349 -0.219 . . . . 64.32 110.776 177.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -68.21 169.51 16.61 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.582 2.188 . . . . 74.5 112.782 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -67.24 149.46 50.39 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.035 0.445 . . . . 73.44 112.015 -177.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.99 -32.78 1.73 Allowed Glycine 0 CA--C 1.529 0.966 0 C-N-CA 121.337 -0.459 . . . . 52.3 113.839 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -77.75 159.92 28.74 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.447 0.641 . . . . 71.5 112.562 -177.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.5 m -130.54 156.33 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 115.543 -0.753 . . . . 54.42 110.621 177.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 51.0 m -133.3 155.95 48.48 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.07 0.462 . . . . 73.04 111.558 176.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.5 p -94.17 155.05 17.26 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.982 0.42 . . . . 72.22 111.282 176.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -55.8 -33.91 64.84 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.307 -0.406 . . . . 75.24 111.823 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.99 -43.47 97.35 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.195 -0.526 . . . . 75.03 112.832 178.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -62.36 -54.68 36.83 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.913 0.387 . . . . 73.32 111.11 177.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.547 HD11 HD11 ' A' ' 15' ' ' ILE . 50.1 mm -54.79 -49.74 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 116.208 -0.451 . . . . 71.32 111.464 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.07 -43.53 82.2 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.454 -0.339 . . . . 45.3 111.596 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.03 -56.1 22.47 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 111.752 0.279 . . . . 71.41 111.752 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -61.53 -25.63 67.41 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.148 0.425 . . . . 65.11 112.148 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.3 -21.22 53.87 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.042 0.386 . . . . 74.43 112.042 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.09 21.29 20.98 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.251 -0.499 . . . . 63.03 113.157 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -134.43 54.04 10.95 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 122.529 0.331 . . . . 73.54 111.74 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -62.25 132.45 38.86 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 121.983 1.789 . . . . 52.55 112.237 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.65 -28.38 15.74 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.146 -0.55 . . . . 43.42 113.008 -176.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -82.77 27.57 0.53 Allowed 'General case' 0 CA--C 1.542 0.662 0 O-C-N 122.452 -0.44 . . . . 72.3 111.989 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.09 -39.96 76.04 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.399 0.518 . . . . 74.35 112.399 -177.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -60.4 -32.02 70.93 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.946 0.403 . . . . 64.42 111.1 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -74.57 -41.05 61.21 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.309 -0.405 . . . . 70.33 110.791 177.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.2 t -56.2 -42.2 72.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.074 0.464 . . . . 63.32 110.641 175.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.26 -45.34 96.27 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-N 116.064 -0.516 . . . . 52.01 112.731 175.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -64.47 -33.34 75.66 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.938 0.399 . . . . 64.43 111.392 177.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.32 -48.12 71.34 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.298 -0.41 . . . . 71.2 111.435 177.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.1 mt -67.34 -38.96 85.67 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.948 0.404 . . . . 75.35 111.319 177.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.62 -13.21 50.22 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 121.145 -0.55 . . . . 51.32 113.142 176.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -93.9 -8.0 41.49 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 120.987 0.422 . . . . 73.23 111.186 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 70.6 mt -82.22 144.78 51.03 Favored Pre-proline 0 N--CA 1.472 0.634 0 N-CA-C 112.665 0.617 . . . . 71.22 112.665 -177.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.05 144.24 37.55 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.479 2.12 . . . . 63.13 111.733 172.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.548 ' HB3' ' HE ' ' A' ' 73' ' ' ARG . 16.6 pt-20 -65.04 -26.37 68.23 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 122.102 -0.374 . . . . 55.23 111.997 -176.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -88.37 20.96 27.57 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 121.066 -0.588 . . . . 52.45 113.856 177.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.9 t -73.1 150.29 42.39 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 117.083 0.442 . . . . 63.33 112.173 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -64.56 -46.3 83.39 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.275 0.559 . . . . 72.34 110.77 175.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.557 HD11 ' HB ' ' A' ' 12' ' ' ILE . 51.8 tp -58.22 117.16 17.91 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 115.602 -0.726 . . . . 61.43 111.382 175.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.49 ' HD2' HD12 ' A' ' 52' ' ' LEU . 58.9 Cg_endo -72.49 94.52 0.77 Allowed 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 121.465 1.443 . . . . 63.1 111.992 178.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 67.4 p-90 -82.79 -26.79 31.45 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.372 0.606 . . . . 73.44 110.964 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.523 ' HA ' ' HG3' ' A' ' 74' ' ' GLN . 29.1 p90 -62.27 -20.39 64.23 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.507 -0.769 . . . . 73.52 112.909 -176.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 79.9 mtt-85 -79.32 1.72 24.06 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.397 0.518 . . . . 70.12 112.397 -178.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 21' ' ' SER . 33.5 t -109.57 124.79 66.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 O-C-N 121.892 -0.505 . . . . 75.42 111.89 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.6 pt -132.91 177.04 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 116.414 -0.357 . . . . 71.42 111.564 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.454 HD21 ' HB2' ' A' ' 63' ' ' LYS . 36.7 p30 -80.61 177.78 8.78 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.773 0.657 . . . . 73.42 112.773 -174.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 76.0 p -67.3 -17.7 64.88 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.913 -0.585 . . . . 64.12 112.494 -177.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -83.58 -10.69 58.09 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.066 0.46 . . . . 72.32 111.13 177.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.67 49.42 14.32 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.88 -0.676 . . . . 73.4 111.665 -172.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.454 ' HB2' HD21 ' A' ' 59' ' ' ASN . 96.7 mttt -135.1 158.36 44.55 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.922 0.391 . . . . 63.24 111.015 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 67.9 mt -72.58 119.39 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.4 -0.364 . . . . 65.32 110.915 177.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.5 m -65.62 -44.2 87.25 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.804 0.335 . . . . 70.34 111.881 -178.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.436 ' HB3' ' HB3' ' A' ' 70' ' ' ASP . 84.7 mt -74.92 117.31 16.63 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.807 0.337 . . . . 71.23 110.896 178.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -108.78 169.87 8.39 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.847 0.356 . . . . 64.23 111.702 -177.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.02 -132.06 10.94 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 121.18 -0.533 . . . . 41.11 111.834 -173.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -81.59 -26.41 34.96 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 122.188 -0.595 . . . . 72.32 110.93 174.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.503 ' O ' ' HB3' ' A' ' 73' ' ' ARG . 17.6 m-20 -63.89 -17.33 63.09 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.994 0.426 . . . . 71.44 110.798 174.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.1 tt -65.11 -52.33 56.02 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.094 -0.503 . . . . 72.13 109.937 173.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.582 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 19.3 m-20 -63.59 -31.89 73.19 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.99 0.424 . . . . 64.04 111.359 176.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.548 ' HE ' ' HB3' ' A' ' 48' ' ' GLU . 70.8 ttt180 -51.1 -63.84 1.0 Allowed 'General case' 0 CA--C 1.547 0.832 0 CA-C-O 121.236 0.541 . . . . 74.03 110.897 173.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.523 ' HG3' ' HA ' ' A' ' 55' ' ' PHE . 48.1 tt0 -67.77 -43.64 79.35 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.093 0.473 . . . . 73.32 110.944 178.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.582 ' HB3' ' HA ' ' A' ' 72' ' ' ASP . 85.0 tttt -48.93 -60.94 2.34 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.702 -0.681 . . . . 73.2 112.149 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -65.02 -34.36 78.26 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.184 0.438 . . . . 63.4 112.184 -176.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -60.19 -29.67 68.86 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 120.605 -0.438 . . . . 74.31 111.373 172.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 80.5 mt -86.43 -34.37 20.15 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.227 -0.442 . . . . 73.43 111.548 175.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 35.7 mt-10 -66.08 -31.89 73.04 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 122.192 -0.317 . . . . 74.01 111.262 178.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.27 -25.86 62.28 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.222 0.534 . . . . 73.24 111.187 174.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.435 ' HB2' HG13 ' A' ' 83' ' ' ILE . 14.1 mm-40 -80.05 -26.15 39.84 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.347 0.594 . . . . 64.12 111.066 176.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 99.88 22.82 11.49 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 115.906 -0.588 . . . . 63.12 112.29 -172.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.435 HG13 ' HB2' ' A' ' 81' ' ' GLU . 73.1 mt -83.86 125.72 40.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.011 0.434 . . . . 65.32 111.169 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.408 ' HG2' ' CE2' ' A' ' 96' ' ' TYR . 11.6 pt-20 -72.24 99.07 2.3 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.583 0.706 . . . . 75.14 112.145 -177.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.429 HG11 ' HG3' ' A' ' 75' ' ' LYS . 44.7 t -100.14 111.15 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 115.994 -0.548 . . . . 74.12 110.879 178.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.587 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 40.3 t -67.12 158.22 31.71 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.278 -0.419 . . . . 61.14 111.629 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -43.69 -53.43 5.8 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 114.281 1.215 . . . . 71.24 114.281 -170.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.445 HD11 ' HB2' ' A' ' 90' ' ' LYS . 2.8 pp -79.47 12.96 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 112.524 0.565 . . . . 75.22 112.524 -176.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.51 48.97 5.09 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-N 116.365 -0.38 . . . . 64.21 112.986 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.587 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 61.3 tttm -116.19 123.46 47.84 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 120.992 0.425 . . . . 74.11 111.941 -178.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 64.6 mt -116.27 142.92 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 122.769 0.428 . . . . 63.2 111.33 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.25 101.84 5.6 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 111.896 0.332 . . . . 44.3 111.896 178.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.4 ' O ' ' N ' ' A' ' 97' ' ' LYS . 57.5 mt -54.54 -62.54 1.59 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.15 0.426 . . . . 54.14 112.15 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 45.3 mtm180 -49.88 -29.9 9.03 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.311 0.485 . . . . 71.33 112.311 -176.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -79.94 -35.27 38.01 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.083 -0.508 . . . . 73.42 111.581 -176.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.408 ' CE2' ' HG2' ' A' ' 84' ' ' GLU . 98.8 m-85 -115.71 5.98 14.35 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.292 0.479 . . . . 74.41 112.292 -177.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.4 ' N ' ' O ' ' A' ' 93' ' ' LEU . 55.5 tttm -59.32 133.82 56.44 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.074 0.464 . . . . 65.53 111.971 -174.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 13.6 t90 -55.2 114.29 1.72 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.995 -0.548 . . . . 64.11 111.491 178.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -109.45 91.83 10.69 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 116.157 -0.474 . . . . 60.44 110.44 175.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -77.51 -9.4 17.35 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 122.221 1.947 . . . . 75.43 112.082 177.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 74.6 mt -89.96 99.06 12.14 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.868 -0.605 . . . . 65.2 110.832 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 C--O 1.256 1.424 0 CA-C-N 115.905 -0.588 . . . . 72.33 112.39 -179.378 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.9 tpt . . . . . 0 N--CA 1.486 1.371 0 N-CA-C 110.423 -0.214 . . . . 74.43 110.423 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.416 ' O ' HG23 ' A' ' 6' ' ' VAL . 3.9 m-20 -49.47 128.63 17.68 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.248 0.462 . . . . 73.43 112.248 -177.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.494 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 17.4 mm100 -55.21 -37.47 67.16 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.346 0.498 . . . . 61.24 112.346 -177.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -55.86 -54.48 44.1 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.231 0.538 . . . . 72.22 110.603 176.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 68.9 mt -62.74 -44.72 95.46 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.556 -0.747 . . . . 54.13 111.201 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 2' ' ' ASP . 85.5 t -57.11 -52.27 58.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 112.078 0.399 . . . . 61.11 112.078 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 28.6 mm-40 -62.32 -51.08 69.09 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.156 0.428 . . . . 72.41 112.156 -175.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.54 HD12 HG13 ' A' ' 39' ' ' VAL . 31.4 pt -59.55 -45.69 93.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 111.633 0.235 . . . . 73.14 111.633 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 19.6 m-30 -63.98 -41.33 97.56 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.132 0.491 . . . . 62.25 110.886 177.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.47 -20.4 63.11 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.87 -0.605 . . . . 30.1 111.798 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 7' ' ' GLN . 99.2 t -85.71 -41.0 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 120.745 0.307 . . . . 65.43 111.05 173.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 8' ' ' ILE . 79.3 mt -55.28 -41.23 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 112.664 0.616 . . . . 72.32 112.664 -177.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -58.38 -12.52 3.9 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 113.424 0.898 . . . . 74.04 113.424 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -85.64 -7.46 58.81 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 112.079 0.4 . . . . 63.21 112.079 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 63.8 mt -75.71 119.77 78.62 Favored Pre-proline 0 CA--C 1.542 0.661 0 O-C-N 122.407 -0.183 . . . . 74.01 110.696 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -76.75 161.1 33.94 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.545 2.164 . . . . 51.43 113.269 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 45.3 tttp -63.88 107.84 1.32 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.253 -0.431 . . . . 64.33 111.235 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 128.87 -15.61 5.9 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.923 -0.656 . . . . 72.21 113.483 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -116.6 163.42 16.12 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.386 0.612 . . . . 61.3 112.254 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.4 m -135.82 162.75 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-N 115.444 -0.798 . . . . 74.43 110.895 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 89.0 p -137.36 171.02 15.11 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.747 0.308 . . . . 42.54 110.613 175.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 40.2 p -107.05 154.03 21.73 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.829 0.347 . . . . 71.44 111.541 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.433 ' HE1' HD12 ' A' ' 43' ' ' LEU . 54.2 m-85 -50.65 -41.25 55.15 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 116.223 -0.444 . . . . 71.21 112.074 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -57.66 -41.6 93.81 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 121.23 -0.51 . . . . 74.2 112.912 178.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 29' ' ' MET . 42.2 mt-10 -65.93 -52.63 48.2 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.655 0.264 . . . . 71.31 111.063 178.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 44.4 mm -56.54 -47.33 82.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 120.984 0.421 . . . . 73.35 111.571 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.84 -45.97 90.13 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.34 -0.391 . . . . 75.53 111.593 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -61.04 -41.61 96.9 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 111.768 0.284 . . . . 73.03 111.768 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.477 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 64.8 mtt -67.86 -34.76 77.31 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.634 0.254 . . . . 43.41 111.477 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.69 -27.28 50.72 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.877 0.37 . . . . 73.32 111.731 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.81 44.99 1.84 Allowed Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.442 -0.409 . . . . 41.01 113.644 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -137.41 83.09 26.89 Favored Pre-proline 0 CA--C 1.544 0.716 0 O-C-N 122.412 -0.464 . . . . 74.22 111.576 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.4 126.49 14.31 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 122.791 2.327 . . . . 72.54 113.024 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.19 -8.71 79.22 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 121.396 -0.431 . . . . 54.52 113.709 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -94.35 11.13 31.58 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.569 0.581 . . . . 70.44 112.569 -177.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.81 -47.7 70.6 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.208 0.527 . . . . 52.11 111.457 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.8 ptt180 -53.44 -38.02 63.13 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.678 -0.692 . . . . 75.03 112.119 174.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -69.49 -35.89 76.0 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.781 0.324 . . . . 65.04 111.203 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.54 HG13 HD12 ' A' ' 8' ' ' ILE . 55.5 t -57.42 -39.65 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 121.195 0.521 . . . . 72.4 110.378 174.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.31 -40.9 99.25 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 116.031 -0.531 . . . . 42.12 112.528 174.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -58.95 -38.0 78.04 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.031 0.443 . . . . 74.53 111.089 175.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.95 -55.34 19.74 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.87 -0.605 . . . . 71.13 111.838 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.433 HD12 ' HE1' ' A' ' 23' ' ' TYR . 68.0 mt -62.47 -32.27 73.12 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.67 0.271 . . . . 61.54 111.536 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.72 -21.54 58.34 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 121.192 -0.528 . . . . 75.03 113.542 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -84.4 -10.56 57.43 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.091 0.472 . . . . 62.54 110.977 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.452 HD11 HD23 ' A' ' 52' ' ' LEU . 97.5 mt -87.5 139.96 31.79 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 116.361 -0.381 . . . . 73.24 111.924 -178.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -88.08 173.31 4.95 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.701 2.267 . . . . 60.21 112.667 175.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.767 ' HB3' ' HD3' ' A' ' 73' ' ' ARG . 9.7 pt-20 -67.48 -12.86 61.31 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.785 0.326 . . . . 73.34 111.82 177.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -96.78 32.84 6.18 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 121.353 -0.451 . . . . 43.23 113.445 176.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.8 t -95.45 135.36 37.18 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 122.294 -0.533 . . . . 52.2 111.507 177.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -70.14 -28.57 65.46 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.923 0.392 . . . . 52.2 111.185 174.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.526 HD12 ' HD2' ' A' ' 53' ' ' PRO . 48.5 tp -72.78 117.65 61.31 Favored Pre-proline 0 C--O 1.237 0.423 0 CA-C-N 116.219 -0.446 . . . . 73.31 110.441 176.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.526 ' HD2' HD12 ' A' ' 52' ' ' LEU . 44.5 Cg_endo -67.1 95.32 0.36 Allowed 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 121.562 1.508 . . . . 75.21 112.496 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 -80.81 -31.54 35.6 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.406 0.622 . . . . 70.25 110.723 177.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.481 ' O ' HD21 ' A' ' 78' ' ' LEU . 20.8 p90 -63.25 -21.89 66.52 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.242 0.83 . . . . 72.25 113.242 -178.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -84.4 -1.25 55.25 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.6 0.593 . . . . 71.23 112.6 -177.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.8 t -118.11 106.97 20.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-O 121.342 0.592 . . . . 71.14 111.58 -178.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.567 HD11 HD21 ' A' ' 93' ' ' LEU . 28.6 pt -112.67 -169.64 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 121.263 0.554 . . . . 63.12 112.114 -177.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 28.2 p30 -95.23 170.3 9.48 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.545 0.572 . . . . 52.0 112.545 -175.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 31.1 t -63.62 -17.88 63.35 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 112.46 0.541 . . . . 72.2 112.46 -178.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -75.75 -14.62 60.33 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.058 0.456 . . . . 60.41 111.113 177.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.99 43.64 33.06 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.036 -0.602 . . . . 52.12 111.934 -174.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.409 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 89.7 mttt -133.85 162.45 31.98 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.164 0.507 . . . . 74.55 111.596 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.415 HG23 ' OE1' ' A' ' 74' ' ' GLN . 66.5 mt -70.13 119.03 15.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 115.759 -0.655 . . . . 72.32 110.178 172.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.0 m -67.16 -27.75 67.55 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.198 0.444 . . . . 72.11 112.198 -177.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.533 HD13 ' HB3' ' A' ' 70' ' ' ASP . 77.1 mt -77.33 165.93 23.81 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.144 0.497 . . . . 64.42 111.727 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -133.68 148.96 51.53 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.066 0.46 . . . . 72.32 112.084 -171.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.34 -123.82 30.36 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-N 116.081 -0.509 . . . . 73.54 113.553 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 48.0 mtp180 -64.72 -38.96 92.77 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.175 0.512 . . . . 63.23 110.924 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.533 ' HB3' HD13 ' A' ' 66' ' ' LEU . 4.3 m-20 -60.49 -30.19 69.55 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.949 -0.568 . . . . 72.32 111.233 176.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.1 tt -65.74 -59.09 4.26 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.351 -0.386 . . . . 73.22 110.784 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -69.13 -21.63 64.01 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 122.267 -0.271 . . . . 72.43 111.468 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.767 ' HD3' ' HB3' ' A' ' 48' ' ' GLU . 35.9 ttm180 -61.91 -52.27 64.75 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.069 0.461 . . . . 61.55 110.319 172.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.415 ' OE1' HG23 ' A' ' 64' ' ' ILE . 53.5 tt0 -60.63 -39.45 88.28 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.1 -0.5 . . . . 72.14 110.714 178.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.464 ' HG3' ' HB ' ' A' ' 85' ' ' VAL . 85.5 tttt -57.73 -53.08 62.26 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.081 -0.509 . . . . 62.43 111.236 176.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -55.75 -39.59 71.38 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.948 0.404 . . . . 70.25 111.441 178.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.457 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 69.0 mmtt -58.59 -48.5 80.73 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.189 -0.46 . . . . 75.54 111.415 173.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.481 HD21 ' O ' ' A' ' 55' ' ' PHE . 85.6 mt -66.28 -39.87 89.69 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.247 -0.433 . . . . 72.05 111.934 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 46.2 mt-10 -64.15 -26.64 68.62 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.948 0.404 . . . . 73.34 110.909 177.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.57 -14.53 60.8 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.234 -0.439 . . . . 52.14 111.576 174.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 77' ' ' LYS . 22.5 mm-40 -103.6 10.06 37.11 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 111.855 0.317 . . . . 74.24 111.855 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.46 30.49 40.49 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 121.066 -0.588 . . . . 51.52 113.535 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.1 mt -112.04 138.67 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 O-C-N 122.449 -0.442 . . . . 74.13 111.383 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.476 ' HB2' ' OH ' ' A' ' 96' ' ' TYR . 40.1 mt-10 -100.47 114.33 27.83 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.826 0.346 . . . . 73.33 110.696 175.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.464 ' HB ' ' HG3' ' A' ' 75' ' ' LYS . 79.7 t -107.63 131.44 57.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 116.398 -0.365 . . . . 73.24 111.177 -178.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.562 ' OG ' ' HB3' ' A' ' 90' ' ' LYS . 25.6 p -74.32 148.0 41.76 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.88 0.372 . . . . 62.44 111.412 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.417 ' HG3' ' N ' ' A' ' 88' ' ' ILE . 12.4 pt-20 -42.59 -53.92 4.19 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.891 1.441 . . . . 74.3 114.891 -166.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.417 ' N ' ' HG3' ' A' ' 87' ' ' GLU . 2.8 pp -73.59 11.92 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 112.868 0.692 . . . . 75.13 112.868 -175.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.43 50.79 4.36 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 121.426 -0.416 . . . . 71.35 113.127 177.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.574 ' HD3' ' N ' ' A' ' 91' ' ' ILE . 6.6 tmtm? -122.88 138.58 54.62 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 122.446 -0.443 . . . . 64.51 110.488 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.574 ' N ' ' HD3' ' A' ' 90' ' ' LYS . 66.6 mt -121.2 132.34 70.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 120.883 0.373 . . . . 62.53 111.463 -178.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.86 93.51 2.66 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.899 0.38 . . . . 71.13 111.454 177.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.567 HD21 HD11 ' A' ' 58' ' ' ILE . 63.4 mt -51.99 -49.58 63.02 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.024 0.75 . . . . 71.12 113.024 -176.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -49.87 -44.52 49.82 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 121.256 0.55 . . . . 75.33 111.829 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -76.29 -34.25 59.08 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.718 -0.673 . . . . 63.31 112.367 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.476 ' OH ' ' HB2' ' A' ' 84' ' ' GLU . 78.8 m-85 -112.28 14.63 20.51 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.273 0.471 . . . . 73.01 112.273 -172.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 61.9 tttp -65.02 130.05 41.94 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.095 0.474 . . . . 44.45 111.943 -177.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 19.7 t90 -62.51 113.73 3.12 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.979 -0.555 . . . . 73.23 111.195 175.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -113.33 92.64 23.41 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 116.4 -0.364 . . . . 71.55 110.524 176.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.6 -22.83 74.4 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.731 2.288 . . . . 72.42 112.938 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 71.5 mt -79.71 94.73 5.79 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.449 -0.341 . . . . 65.12 110.436 176.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 C--O 1.255 1.359 0 CA-C-O 118.549 -0.738 . . . . 75.24 111.555 -179.684 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 120.81 0.338 . . . . 72.44 111.313 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -65.82 141.84 58.15 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.342 -0.39 . . . . 74.21 112.043 -176.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.435 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 62.3 mm-40 -53.61 -32.39 50.93 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.618 0.599 . . . . 42.34 112.618 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.405 ' O ' HG12 ' A' ' 8' ' ' ILE . 73.0 t80 -55.61 -48.9 74.15 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.247 0.546 . . . . 63.25 109.993 173.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 72.2 mt -67.07 -46.91 72.89 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.523 -0.762 . . . . 74.31 111.162 178.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 85.3 t -52.38 -50.24 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.8 0.334 . . . . 75.13 111.847 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.435 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 26.3 mm-40 -63.71 -52.7 59.35 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.157 0.428 . . . . 62.21 112.157 -177.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.419 ' O ' HG13 ' A' ' 12' ' ' ILE . 31.6 pt -65.32 -45.67 92.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 O-C-N 122.315 -0.241 . . . . 72.03 111.647 -178.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.405 ' CD1' HG13 ' A' ' 8' ' ' ILE . 14.2 m-30 -61.1 -43.28 99.13 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.755 0.312 . . . . 71.3 111.069 178.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.74 -43.08 65.49 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.439 -0.346 . . . . 75.0 111.383 177.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 7' ' ' GLN . 61.4 t -64.36 -42.4 95.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 121.142 0.496 . . . . 63.22 111.182 177.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.517 ' HB ' HD11 ' A' ' 52' ' ' LEU . 73.7 mt -62.85 -32.59 56.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 116.016 -0.538 . . . . 72.43 112.086 -178.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 72.3 m-70 -60.58 -22.25 63.51 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.299 0.481 . . . . 75.15 112.299 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -77.31 -14.07 59.81 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.256 0.465 . . . . 75.03 112.256 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.515 HD11 HD11 ' A' ' 26' ' ' ILE . 51.4 mt -75.08 113.76 28.3 Favored Pre-proline 0 CA--C 1.542 0.662 0 O-C-N 122.455 -0.153 . . . . 71.1 111.122 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -69.89 175.23 8.49 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.016 2.477 . . . . 72.22 113.751 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -67.81 140.13 56.61 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.92 -0.582 . . . . 64.13 111.768 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.76 17.25 71.04 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.188 -0.529 . . . . 70.23 113.378 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -118.3 141.18 48.79 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.688 0.28 . . . . 71.43 110.579 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.9 m -122.52 146.47 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.433 0.635 . . . . 63.33 112.284 -177.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.4 t -134.51 178.28 7.11 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.692 -0.685 . . . . 61.34 110.217 175.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 72.7 p -115.05 150.57 35.69 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.079 0.466 . . . . 70.25 111.835 -177.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.407 ' HE1' HD12 ' A' ' 43' ' ' LEU . 70.9 m-85 -51.8 -36.6 48.41 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.086 -0.506 . . . . 75.01 112.163 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.62 -51.0 60.47 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 121.014 -0.612 . . . . 71.01 113.039 178.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.415 ' O ' ' HE2' ' A' ' 29' ' ' MET . 47.1 mt-10 -55.65 -48.14 75.49 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.0 0.429 . . . . 73.11 111.135 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.515 HD11 HD11 ' A' ' 15' ' ' ILE . 49.9 mm -61.42 -54.17 38.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 116.115 -0.493 . . . . 65.45 111.746 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.56 -48.66 78.72 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.227 0.454 . . . . 44.45 112.227 -178.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -60.24 -43.1 96.38 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.677 0.275 . . . . 74.23 111.589 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.415 ' HE2' ' O ' ' A' ' 25' ' ' GLU . 77.7 mtm -73.35 -21.78 60.46 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 111.901 0.334 . . . . 75.22 111.901 178.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.58 -28.41 33.82 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.961 0.41 . . . . 73.03 111.186 174.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.94 29.09 5.06 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.298 -0.477 . . . . 74.34 113.468 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -134.43 79.93 53.13 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-O 120.893 0.378 . . . . 74.54 111.169 178.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.01 126.89 14.38 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.364 2.043 . . . . 74.32 112.614 -178.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.38 -22.85 36.47 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.175 -0.535 . . . . 73.14 113.274 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -78.61 12.19 2.17 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.36 0.504 . . . . 72.51 112.36 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.05 -44.37 61.09 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.021 0.438 . . . . 63.11 111.777 177.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 30.7 ptt-85 -58.37 -39.66 80.18 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 116.24 -0.436 . . . . 74.4 111.922 177.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -70.77 -34.53 71.91 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.662 0.268 . . . . 64.34 111.015 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.5 t -57.94 -43.39 84.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 CA-C-O 121.13 0.49 . . . . 72.11 110.267 172.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.47 -38.65 95.17 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-N 115.838 -0.619 . . . . 54.12 112.905 175.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -62.17 -47.27 85.25 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.982 0.42 . . . . 71.44 110.873 175.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.93 -45.65 89.88 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.017 -0.538 . . . . 65.05 111.668 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.588 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 58.2 mt -68.64 -38.49 80.53 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.908 0.385 . . . . 60.24 111.352 178.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.7 -15.76 66.97 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.268 -0.491 . . . . 70.21 113.081 176.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -76.6 -23.11 53.43 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.174 0.511 . . . . 74.35 110.52 175.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 82.6 mt -81.27 143.84 52.91 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 115.956 -0.566 . . . . 72.13 111.966 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -86.52 -176.7 2.11 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.708 2.272 . . . . 60.12 112.587 174.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.404 ' HG3' ' H ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -69.06 -23.58 64.06 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 122.131 -0.356 . . . . 74.04 111.937 178.662 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -90.02 39.39 3.11 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.534 -0.365 . . . . 74.23 113.43 177.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.0 t -93.03 140.08 29.85 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 122.437 -0.449 . . . . 64.43 111.404 177.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -72.42 -42.28 65.25 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.227 0.537 . . . . 75.23 110.29 175.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.517 HD11 ' HB ' ' A' ' 12' ' ' ILE . 33.3 tp -67.01 118.79 58.89 Favored Pre-proline 0 CA--C 1.535 0.404 0 CA-C-N 115.616 -0.72 . . . . 53.23 110.707 173.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.69 94.64 0.53 Allowed 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 121.392 1.394 . . . . 40.4 111.972 177.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.588 ' HB2' ' HB3' ' A' ' 43' ' ' LEU . 58.4 p-90 -84.96 -33.39 22.65 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.565 0.698 . . . . 74.31 111.0 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -59.91 -20.55 57.98 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.296 -0.865 . . . . 73.31 112.911 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.409 ' NH1' ' O ' ' A' ' 15' ' ' ILE . 95.8 mtt180 -79.98 -1.14 38.25 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.426 0.528 . . . . 74.23 112.426 -178.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.3 t -117.01 118.24 58.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 121.038 0.447 . . . . 74.53 111.744 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.558 HG21 HD12 ' A' ' 91' ' ' ILE . 35.6 pt -127.58 -169.87 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 116.347 -0.388 . . . . 74.54 111.521 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 32.1 p30 -84.44 163.64 19.35 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 120.94 0.4 . . . . 73.54 111.857 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 69.2 m -66.02 -15.44 63.03 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.573 0.583 . . . . 65.2 112.573 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -77.32 -12.59 59.97 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.741 0.305 . . . . 72.32 111.473 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.26 37.08 12.94 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 121.225 -0.512 . . . . 74.1 112.621 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -138.96 162.28 35.28 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.3 0.572 . . . . 70.12 111.91 -179.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.499 HG23 ' OE1' ' A' ' 74' ' ' GLN . 70.7 mt -69.28 139.71 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 115.725 -0.67 . . . . 63.33 110.886 175.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 89.1 p -90.18 -50.37 6.03 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.155 0.503 . . . . 73.42 111.345 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 83.9 mt -64.08 142.92 58.24 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.816 -0.629 . . . . 73.42 111.951 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -118.06 171.59 7.99 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.004 0.431 . . . . 71.31 111.234 177.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.78 -138.96 20.9 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.884 -0.674 . . . . 51.34 112.33 -176.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -74.97 -26.08 59.32 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.086 0.47 . . . . 73.15 111.474 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.65 -28.04 69.63 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.914 0.388 . . . . 74.13 111.284 176.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.1 tt -63.35 -60.97 2.68 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.273 -0.421 . . . . 63.42 110.625 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.405 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 3.9 p30 -64.15 -28.49 69.8 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 122.324 -0.235 . . . . 42.14 111.234 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -58.53 -53.74 54.88 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.902 0.382 . . . . 72.45 111.534 176.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.499 ' OE1' HG23 ' A' ' 64' ' ' ILE . 53.9 tt0 -59.38 -40.63 87.16 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.974 0.416 . . . . 75.31 110.884 177.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -60.13 -53.86 52.71 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.177 -0.465 . . . . 73.05 112.075 177.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' A' ' 72' ' ' ASP . 27.4 mm-40 -53.55 -42.46 67.52 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.15 0.5 . . . . 45.14 111.821 -178.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -59.61 -48.71 80.6 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.024 -0.534 . . . . 54.14 111.597 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.512 HD22 HD12 ' A' ' 83' ' ' ILE . 89.8 mt -67.69 -43.23 80.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.175 -0.466 . . . . 75.43 111.581 -177.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -57.03 -42.18 79.94 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.942 0.401 . . . . 64.33 110.861 175.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.34 -33.97 71.79 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.271 -0.422 . . . . 71.13 111.414 176.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -86.94 5.74 35.62 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.808 0.337 . . . . 74.21 111.678 178.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.01 30.89 16.06 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 114.238 0.455 . . . . 63.02 114.238 174.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.512 HD12 HD22 ' A' ' 78' ' ' LEU . 69.4 mt -104.43 124.77 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 117.129 0.464 . . . . 73.32 111.723 178.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.8 103.18 4.26 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.503 0.668 . . . . 71.1 111.601 177.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.2 t -95.78 117.13 39.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.309 -0.405 . . . . 75.42 111.099 178.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.587 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 41.4 t -67.87 151.15 47.61 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.938 0.399 . . . . 75.22 112.056 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -40.16 -56.55 1.89 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.322 1.231 . . . . 74.21 114.322 -171.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.431 ' H ' HG13 ' A' ' 88' ' ' ILE . 2.8 pp -80.15 22.92 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 N-CA-C 112.961 0.726 . . . . 61.03 112.961 -174.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.06 46.97 11.99 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.17 -0.538 . . . . 74.33 112.925 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.587 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 1.4 tmtp? -116.74 133.15 56.36 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.91 0.386 . . . . 73.53 110.765 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.558 HD12 HG21 ' A' ' 58' ' ' ILE . 60.2 mt -121.29 142.4 37.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 120.978 0.418 . . . . 63.35 111.356 -176.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.58 94.87 4.42 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.98 0.419 . . . . 42.24 112.039 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.614 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 39.3 mt -63.0 -13.31 33.64 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 116.077 -0.51 . . . . 65.12 112.334 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -90.27 -48.76 6.94 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.076 0.465 . . . . 75.41 111.59 175.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.99 -22.65 65.9 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.768 0.655 . . . . 64.41 112.768 -175.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -128.28 15.11 6.69 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.293 0.479 . . . . 53.31 112.293 -176.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.614 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 85.0 tttt -56.29 128.98 38.44 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.478 0.547 . . . . 73.32 112.478 -175.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 16.5 t90 -57.3 114.87 2.37 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.105 -0.498 . . . . 75.34 111.351 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -105.07 96.42 11.05 Favored Pre-proline 0 CA--C 1.543 0.694 0 CA-C-N 116.209 -0.45 . . . . 74.42 110.217 174.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -68.55 -0.91 6.56 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.16 2.574 . . . . 70.23 113.98 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 85.1 mt 63.39 74.04 0.43 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.34 0.59 . . . . 73.51 111.518 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 . . . . . 0 C--O 1.251 1.168 0 CA-C-O 118.001 -1.0 . . . . 74.01 111.494 179.944 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 tpt . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 120.727 0.299 . . . . 72.42 110.991 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.03 129.8 31.85 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.483 0.549 . . . . 60.35 112.483 -176.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -57.87 -28.12 63.87 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.814 0.34 . . . . 72.12 111.149 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -57.15 -50.67 72.09 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.0 0.429 . . . . 72.32 110.651 173.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 76.9 mt -64.57 -44.7 89.88 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.857 -0.61 . . . . 73.14 110.902 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.0 t -57.1 -49.48 79.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 116.113 -0.494 . . . . 64.03 111.648 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.433 ' O ' HG23 ' A' ' 11' ' ' VAL . 32.3 mm-40 -62.65 -52.7 62.31 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.527 0.566 . . . . 73.51 112.527 -178.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.504 HD12 HG13 ' A' ' 39' ' ' VAL . 25.3 pt -60.73 -44.2 96.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 111.757 0.28 . . . . 72.14 111.757 -177.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.9 m-30 -63.16 -43.61 97.8 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.175 0.512 . . . . 74.53 110.797 177.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.91 -30.38 61.51 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.007 -0.542 . . . . 62.12 111.959 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 7' ' ' GLN . 59.4 t -75.87 -41.77 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 121.017 0.437 . . . . 63.12 111.459 176.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 8' ' ' ILE . 71.2 mt -57.22 -34.93 46.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 112.214 0.45 . . . . 72.11 112.214 -177.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -59.2 -9.41 2.12 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 113.658 0.984 . . . . 74.34 113.658 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -92.9 -2.36 55.91 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 112.563 0.579 . . . . 64.11 112.563 178.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.409 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 50.1 mt -84.49 119.03 72.49 Favored Pre-proline 0 CA--C 1.543 0.71 0 O-C-N 122.331 -0.231 . . . . 53.23 111.188 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 15' ' ' ILE . 3.7 Cg_exo -77.94 171.1 17.8 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.392 2.728 . . . . 73.5 113.498 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -67.81 133.84 49.91 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.25 0.548 . . . . 72.22 111.885 -178.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.404 ' HA2' ' HB3' ' A' ' 81' ' ' GLU . . . 85.38 7.21 82.94 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 116.09 -0.505 . . . . 71.13 113.439 178.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -123.77 145.52 48.97 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.941 0.4 . . . . 72.01 111.119 178.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.415 HG12 ' HA ' ' A' ' 56' ' ' ARG . 34.2 m -133.2 154.99 40.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-O 120.979 0.419 . . . . 73.25 111.341 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 92.1 p -133.56 170.68 15.17 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.094 0.473 . . . . 75.11 111.036 177.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.2 p -98.72 152.31 19.81 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.102 0.477 . . . . 73.42 111.82 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.441 ' HE1' HD12 ' A' ' 43' ' ' LEU . 64.2 m-85 -55.06 -33.5 62.78 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.145 -0.48 . . . . 75.24 112.139 178.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -60.68 -38.18 94.7 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 120.988 -0.625 . . . . 73.11 112.772 177.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.421 ' O ' ' HG3' ' A' ' 29' ' ' MET . 42.2 mt-10 -71.2 -51.32 25.42 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.852 0.358 . . . . 71.01 111.309 178.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.2 mm -58.29 -49.83 80.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-N 116.338 -0.392 . . . . 70.24 111.827 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.58 -41.6 90.59 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.848 0.356 . . . . 72.34 111.596 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.6 ttmp? -60.01 -47.59 85.2 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.952 0.406 . . . . 74.41 111.03 178.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.421 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 62.0 mtt -67.22 -29.96 69.75 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.151 -0.477 . . . . 73.01 111.442 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.67 -20.49 53.63 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.131 0.419 . . . . 63.21 112.131 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.89 28.35 10.19 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.204 -0.522 . . . . 55.52 113.455 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -130.9 78.89 72.71 Favored Pre-proline 0 N--CA 1.47 0.552 0 O-C-N 122.48 -0.424 . . . . 72.22 110.89 177.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -66.71 115.08 3.38 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.666 2.244 . . . . 72.53 113.073 -176.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.93 -15.58 40.26 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.029 -0.605 . . . . 52.2 113.624 178.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.429 ' O ' HG23 ' A' ' 39' ' ' VAL . 34.0 m-85 -81.35 18.09 1.21 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.649 0.611 . . . . 55.33 112.649 -178.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.86 -54.59 18.5 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.31 0.485 . . . . 61.3 112.31 -178.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.449 ' O ' ' HG3' ' A' ' 41' ' ' LYS . 33.1 ttm180 -57.74 -38.81 75.98 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.026 0.441 . . . . 75.12 111.614 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.609 ' HA ' ' HE3' ' A' ' 41' ' ' LYS . 81.6 m-70 -68.39 -32.5 72.61 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.282 -0.417 . . . . 73.31 111.704 -177.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.504 HG13 HD12 ' A' ' 8' ' ' ILE . 56.9 t -60.57 -40.91 85.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 121.156 0.503 . . . . 41.21 109.886 171.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.82 -44.94 95.45 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 115.947 -0.569 . . . . 55.3 112.804 176.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.609 ' HE3' ' HA ' ' A' ' 38' ' ' HIS . 8.5 mtmp? -63.04 -22.23 66.71 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.992 0.425 . . . . 71.14 111.3 178.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.33 -45.88 17.06 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.432 -0.349 . . . . 73.43 111.442 176.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.441 HD12 ' HE1' ' A' ' 23' ' ' TYR . 66.7 mt -65.51 -35.15 80.03 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 111.976 0.362 . . . . 74.33 111.976 -179.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.4 -20.81 38.62 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 121.248 -0.501 . . . . 75.44 113.834 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -81.83 -21.19 37.75 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.804 0.335 . . . . 72.31 111.832 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 78.7 mt -67.56 142.64 96.36 Favored Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 112.018 0.377 . . . . 64.32 112.018 -178.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.72 -175.73 2.83 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.681 2.254 . . . . 65.35 113.202 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -76.19 -38.45 56.55 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.989 -0.551 . . . . 65.31 110.635 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -95.72 57.69 1.58 Allowed Glycine 0 CA--C 1.528 0.852 0 CA-C-N 116.018 -0.537 . . . . 72.33 113.729 -178.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.2 t -102.37 159.29 15.55 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 122.32 -0.518 . . . . 63.22 111.303 173.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -85.85 -15.58 41.42 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.221 0.534 . . . . 71.24 110.527 176.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.463 HD12 ' HD2' ' A' ' 53' ' ' PRO . 55.9 tp -93.35 116.3 66.28 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 115.908 -0.587 . . . . 73.11 110.829 178.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.463 ' HD2' HD12 ' A' ' 52' ' ' LEU . 61.6 Cg_endo -74.04 94.4 0.89 Allowed 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 121.251 1.301 . . . . 63.11 112.299 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.409 ' HB2' ' HB3' ' A' ' 43' ' ' LEU . 54.9 p-90 -80.11 -30.33 39.11 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.372 0.606 . . . . 71.53 111.318 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -59.93 -22.63 62.68 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.617 -0.72 . . . . 74.34 112.876 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.415 ' HA ' HG12 ' A' ' 20' ' ' VAL . 97.8 mtt180 -79.61 -0.94 35.8 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.584 0.587 . . . . 73.43 112.584 -177.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.9 t -118.63 109.59 27.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.062 0.458 . . . . 65.32 110.892 178.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.528 HD11 HD21 ' A' ' 93' ' ' LEU . 32.9 pt -114.98 -172.48 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 116.221 -0.445 . . . . 72.0 111.983 -176.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.411 HD21 ' HB2' ' A' ' 63' ' ' LYS . 32.1 p30 -81.32 165.71 21.14 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.207 0.527 . . . . 71.52 112.08 -176.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 80.4 p -70.61 -2.73 15.23 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.809 0.67 . . . . 75.52 112.809 -175.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -94.16 -9.37 36.63 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.042 0.386 . . . . 74.45 112.042 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.3 44.33 13.71 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 120.667 -0.778 . . . . 62.45 112.393 -176.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.411 ' HB2' HD21 ' A' ' 59' ' ' ASN . 98.6 mttt -133.46 172.29 12.91 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 122.753 0.421 . . . . 73.04 110.588 179.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.556 HD11 HG11 ' A' ' 85' ' ' VAL . 66.7 mt -67.7 118.73 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 109.938 -0.393 . . . . 63.54 109.938 173.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.6 p -71.07 -33.58 70.37 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.414 0.524 . . . . 73.13 112.414 -172.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.572 HD13 ' HB3' ' A' ' 70' ' ' ASP . 85.7 mt -79.85 -174.61 4.48 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.119 0.485 . . . . 75.13 111.755 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -147.25 161.7 40.42 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.884 0.373 . . . . 64.13 111.758 -176.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 60.45 -134.94 49.98 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.173 -0.537 . . . . 73.44 112.969 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 49.9 mtp180 -62.51 -33.5 75.0 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.112 0.482 . . . . 75.25 110.95 178.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.572 ' HB3' HD13 ' A' ' 66' ' ' LEU . 7.8 m-20 -62.38 -30.27 71.07 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.218 -0.446 . . . . 73.13 111.458 176.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.479 ' HG ' HG21 ' A' ' 64' ' ' ILE . 10.2 tt -59.66 -54.98 40.16 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.011 0.434 . . . . 43.32 110.662 177.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -71.58 -21.78 61.82 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 111.812 0.301 . . . . 50.33 111.812 177.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.514 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 15.0 ttp180 -66.55 -50.35 63.43 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.385 0.612 . . . . 74.4 110.408 174.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.416 ' HB2' HD12 ' A' ' 66' ' ' LEU . 63.9 tt0 -63.38 -42.18 98.82 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.896 -0.593 . . . . 73.41 110.597 175.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.422 ' HG3' HG11 ' A' ' 85' ' ' VAL . 33.0 ttpt -60.81 -50.15 74.63 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.023 -0.535 . . . . 61.03 111.941 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.514 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 19.9 pt20 -60.29 -38.0 82.25 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.964 0.411 . . . . 54.42 111.354 -177.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -63.93 -34.01 77.01 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 120.887 0.375 . . . . 74.55 111.129 174.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.43 HD22 HD12 ' A' ' 83' ' ' ILE . 96.9 mt -78.56 -30.05 46.63 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.282 -0.417 . . . . 73.1 111.98 178.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -68.82 -28.06 66.41 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 121.964 -0.46 . . . . 70.33 110.408 174.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.41 -23.79 65.59 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.262 0.553 . . . . 61.34 110.798 171.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.404 ' HB3' ' HA2' ' A' ' 18' ' ' GLY . 15.4 mm-40 -81.94 -9.04 59.7 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.818 -0.628 . . . . 70.21 111.319 175.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.61 21.87 55.07 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.39 -0.433 . . . . 72.1 112.891 -177.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.43 HD12 HD22 ' A' ' 78' ' ' LEU . 64.6 mt -89.63 127.79 42.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 121.023 0.439 . . . . 75.01 112.102 -177.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -78.5 97.2 5.64 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.054 0.454 . . . . 73.15 111.012 176.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.556 HG11 HD11 ' A' ' 64' ' ' ILE . 41.2 t -94.89 119.58 43.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.714 0.292 . . . . 73.05 110.811 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.55 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 49.7 m -61.14 141.31 57.55 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 110.388 -0.227 . . . . 62.24 110.388 177.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -54.36 -32.96 58.1 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 113.379 0.881 . . . . 73.41 113.379 -170.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.417 HD11 ' HB2' ' A' ' 90' ' ' LYS . 2.8 pp -75.22 -2.83 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 112.244 0.461 . . . . 71.04 112.244 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.28 43.46 2.77 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 116.212 -0.449 . . . . 60.44 113.966 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.55 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 61.3 tttm -115.35 131.14 57.02 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 117.62 0.71 . . . . 60.31 112.018 -178.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.49 HD12 HG21 ' A' ' 58' ' ' ILE . 56.6 mt -119.12 115.58 48.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.976 -0.556 . . . . 74.22 110.89 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.31 93.61 0.23 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.475 0.546 . . . . 64.2 112.475 -177.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.572 ' O ' ' HG3' ' A' ' 97' ' ' LYS . 76.1 mt -56.33 -46.31 79.97 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.609 -0.269 . . . . 74.13 111.255 177.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 63.8 mtp180 -51.05 -19.93 1.24 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.415 0.524 . . . . 71.15 112.415 -177.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -106.22 -36.7 6.8 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 111.922 0.341 . . . . 74.44 111.922 176.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -105.49 13.76 29.63 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.636 0.976 . . . . 72.42 113.636 -172.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.572 ' HG3' ' O ' ' A' ' 93' ' ' LEU . 41.8 mtpt -56.14 138.77 49.2 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.553 0.575 . . . . 70.34 112.553 178.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 14.9 t90 -69.14 115.02 7.94 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.007 -0.542 . . . . 74.33 110.692 173.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -102.74 96.05 7.11 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-N 116.075 -0.511 . . . . 74.23 111.166 176.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.588 ' HB2' ' HG2' ' A' ' 102' ' ' GLU . 62.9 Cg_endo -71.92 -9.52 24.83 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.628 2.219 . . . . 53.43 112.762 175.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 93.8 mt 60.79 24.42 14.33 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.604 0.594 . . . . 73.32 112.604 175.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.588 ' HG2' ' HB2' ' A' ' 100' ' ' PRO . 7.6 pt-20 . . . . . 0 C--O 1.255 1.346 0 CA-C-O 119.192 -0.432 . . . . 75.11 111.972 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 tpt . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 120.68 0.276 . . . . 54.15 110.673 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.483 ' O ' HG23 ' A' ' 6' ' ' VAL . 12.2 t70 -60.37 133.56 56.21 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 112.09 0.404 . . . . 72.32 112.09 -176.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -56.81 -40.12 75.42 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.632 0.604 . . . . 63.51 112.632 -178.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -58.1 -47.79 82.15 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.18 0.514 . . . . 72.2 110.477 177.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 85.9 mt -61.07 -47.14 87.71 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.724 -0.671 . . . . 50.02 110.801 177.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 2' ' ' ASP . 94.1 t -53.91 -50.13 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.173 -0.467 . . . . 74.24 111.648 178.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.453 ' O ' HG23 ' A' ' 11' ' ' VAL . 27.8 mm-40 -64.67 -50.21 67.92 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.375 0.509 . . . . 73.02 112.375 -176.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.459 ' O ' HG13 ' A' ' 12' ' ' ILE . 38.5 pt -64.93 -44.15 96.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 121.019 -0.272 . . . . 63.21 111.554 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.415 ' N ' HG13 ' A' ' 8' ' ' ILE . 21.8 m-30 -65.19 -42.51 93.52 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.813 0.339 . . . . 74.04 111.133 178.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.85 -40.1 69.29 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.454 -0.339 . . . . 63.34 111.67 178.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 7' ' ' GLN . 86.9 t -67.59 -41.63 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 120.917 0.389 . . . . 65.41 111.297 178.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.557 ' HB ' HD11 ' A' ' 52' ' ' LEU . 80.4 mt -59.17 -32.25 47.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 116.405 -0.361 . . . . 73.42 111.819 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -61.15 -18.51 58.46 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.131 0.419 . . . . 75.22 112.131 176.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -83.3 -9.17 59.25 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.531 0.567 . . . . 73.31 112.531 178.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.498 HD11 HD11 ' A' ' 26' ' ' ILE . 54.8 mt -74.46 116.27 51.46 Favored Pre-proline 0 CA--C 1.542 0.669 0 O-C-N 122.203 -0.311 . . . . 54.44 111.055 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -64.29 157.55 53.58 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.114 2.543 . . . . 65.22 113.514 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -65.54 120.77 13.5 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.21 -0.45 . . . . 74.3 111.495 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.34 17.07 56.27 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 120.988 -0.625 . . . . 73.1 113.22 -176.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -121.11 149.93 42.0 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 122.621 -0.341 . . . . 42.33 111.22 175.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.425 HG11 HD13 ' A' ' 91' ' ' ILE . 33.6 m -128.08 145.38 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 121.535 0.683 . . . . 73.21 111.795 -178.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 94.8 p -128.98 177.82 6.84 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.871 -0.604 . . . . 73.31 110.555 175.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.4 p -111.6 154.77 24.37 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.811 0.338 . . . . 62.01 111.376 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.432 ' HB2' ' HB1' ' A' ' 36' ' ' ALA . 74.8 m-85 -54.72 -40.12 68.92 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.852 0.358 . . . . 71.32 111.446 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -57.73 -44.7 94.02 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.268 -0.491 . . . . 72.1 113.043 177.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' A' ' 29' ' ' MET . 49.8 mt-10 -63.27 -54.0 44.05 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.731 0.3 . . . . 73.33 111.181 178.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.498 HD11 HD11 ' A' ' 15' ' ' ILE . 46.4 mm -54.3 -53.1 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 120.818 0.342 . . . . 72.5 111.72 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.99 -46.72 82.06 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.422 -0.354 . . . . 64.34 111.674 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -60.99 -42.95 99.41 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.781 0.324 . . . . 50.42 111.584 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.43 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 64.6 mtt -68.39 -30.67 69.64 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.043 0.449 . . . . 54.34 111.236 178.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.06 -19.65 59.9 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.197 -0.456 . . . . 71.4 111.914 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.24 15.18 24.21 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.137 -0.554 . . . . 61.34 113.014 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.434 ' HB3' ' CD1' ' A' ' 35' ' ' TYR . 69.5 m-85 -128.37 63.94 65.6 Favored Pre-proline 0 CA--C 1.548 0.873 0 O-C-N 122.55 -0.382 . . . . 70.03 111.54 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -61.72 110.94 1.05 Allowed 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.484 2.123 . . . . 60.3 112.568 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 123.64 -24.76 6.37 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 121.238 -0.506 . . . . 62.15 112.922 -177.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.461 ' O ' HG23 ' A' ' 39' ' ' VAL . 58.2 m-85 -79.96 30.54 0.26 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.242 0.46 . . . . 74.31 112.242 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.432 ' HB1' ' HB2' ' A' ' 23' ' ' TYR . . . -55.24 -64.88 0.7 Allowed 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.452 0.538 . . . . 74.11 112.452 -177.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -54.7 -31.69 58.41 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.361 0.504 . . . . 74.42 112.361 177.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 78.1 m-70 -65.63 -40.27 92.37 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.749 0.309 . . . . 70.2 111.11 178.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 35' ' ' TYR . 67.9 t -57.14 -45.18 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.097 0.475 . . . . 62.44 110.243 173.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -57.8 -42.98 94.81 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 116.037 -0.529 . . . . 31.53 112.714 175.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -62.15 -33.02 73.71 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.071 0.462 . . . . 70.32 111.154 176.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.0 -42.78 66.03 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.202 -0.454 . . . . 61.14 111.449 177.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 39' ' ' VAL . 90.0 mt -62.38 -33.32 74.51 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.907 0.384 . . . . 74.44 111.483 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.62 -12.39 46.63 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 121.405 -0.426 . . . . 74.31 113.458 176.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -85.8 -15.81 40.82 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.135 0.493 . . . . 52.4 110.953 177.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.521 HD11 HD23 ' A' ' 52' ' ' LEU . 90.8 mt -81.68 148.12 60.9 Favored Pre-proline 0 N--CA 1.47 0.563 0 N-CA-C 112.42 0.526 . . . . 74.13 112.42 -177.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.52 163.2 32.33 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.39 2.06 . . . . 70.44 112.125 173.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.562 ' HG2' ' HE ' ' A' ' 73' ' ' ARG . 42.2 mt-10 -57.02 -52.88 63.5 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 111.984 0.364 . . . . 51.2 111.984 -178.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -93.62 54.61 2.34 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.039 -0.601 . . . . 73.34 113.294 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.7 t -79.6 156.39 27.7 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.866 0.365 . . . . 73.41 111.556 178.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -67.12 -26.54 66.74 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.389 0.614 . . . . 63.34 110.313 174.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.557 HD11 ' HB ' ' A' ' 12' ' ' ILE . 55.3 tp -92.78 117.75 67.68 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 115.5 -0.773 . . . . 74.13 110.802 176.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.547 ' HD2' HD12 ' A' ' 52' ' ' LEU . 56.8 Cg_endo -71.77 96.58 0.77 Allowed 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 121.639 1.56 . . . . 61.14 112.47 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 60.9 p-90 -80.52 -25.25 38.81 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.34 0.591 . . . . 65.53 112.153 -178.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -68.65 -12.71 61.71 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.625 0.972 . . . . 54.54 113.625 -174.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -87.06 1.55 52.56 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.6 0.593 . . . . 75.22 112.6 -175.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.8 t -109.75 108.83 26.35 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 CA-C-O 121.266 0.555 . . . . 41.42 111.659 -178.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.535 HD13 HD12 ' A' ' 91' ' ' ILE . 18.2 pt -113.6 -170.81 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-N 116.093 -0.503 . . . . 73.1 111.964 -178.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.7 p30 -90.19 175.41 7.15 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.022 0.439 . . . . 73.33 111.991 -177.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 87.6 p -64.26 -22.58 67.0 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.376 0.509 . . . . 74.14 112.376 -176.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -82.27 -12.76 57.84 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.851 0.357 . . . . 75.0 111.546 -179.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.64 30.6 20.91 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.163 -0.541 . . . . 54.35 112.804 -177.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.408 ' HE3' HD13 ' A' ' 88' ' ' ILE . 56.6 mtpt -125.6 163.28 23.09 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.11 0.481 . . . . 75.24 111.864 -177.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 52.7 mt -75.95 130.38 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 116.09 -0.504 . . . . 41.11 111.685 -177.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.3 m -80.26 -30.5 38.42 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.393 -0.367 . . . . 73.22 111.756 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.438 HD12 ' HB2' ' A' ' 74' ' ' GLN . 75.3 mt -72.1 151.99 42.66 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.123 0.487 . . . . 62.12 111.564 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -129.33 153.32 47.96 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.191 -0.458 . . . . 73.34 111.89 -174.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 62.27 -129.06 42.7 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 121.283 -0.484 . . . . 71.2 113.415 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -66.03 -30.14 70.62 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.816 0.341 . . . . 74.01 111.781 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.54 ' HA ' ' HD3' ' A' ' 73' ' ' ARG . 9.6 m-20 -68.92 -31.03 69.63 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.888 0.375 . . . . 74.21 111.237 177.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.7 tt -61.32 -42.01 97.97 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 109.524 -0.547 . . . . 44.35 109.524 173.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -59.3 -43.5 92.6 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.984 -0.553 . . . . 74.4 111.173 176.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.562 ' HE ' ' HG2' ' A' ' 48' ' ' GLU . 79.9 mtp180 -50.62 -56.14 13.15 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.332 0.587 . . . . 74.13 111.338 176.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.438 ' HB2' HD12 ' A' ' 66' ' ' LEU . 43.7 tt0 -65.87 -42.63 90.11 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.069 -0.514 . . . . 74.13 111.065 -177.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -61.61 -50.63 71.79 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.14 0.422 . . . . 73.44 112.14 -178.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.401 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 13.7 pt20 -58.46 -39.05 78.84 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.757 0.313 . . . . 73.02 111.294 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -62.92 -43.75 97.93 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 120.809 0.338 . . . . 75.03 111.36 176.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 75.8 mt -66.42 -48.78 68.94 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.291 -0.413 . . . . 74.52 111.683 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -54.55 -31.48 56.58 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.116 0.484 . . . . 54.15 111.327 176.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.46 -26.76 64.74 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.636 0.606 . . . . 63.41 112.636 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -102.44 9.03 39.92 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.417 0.525 . . . . 74.14 112.417 -176.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.92 41.98 7.37 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 120.938 -0.648 . . . . 61.32 113.644 176.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 68.2 mt -117.21 128.5 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 O-C-N 122.648 -0.325 . . . . 71.21 111.052 177.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -78.64 103.36 8.53 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.732 0.301 . . . . 71.04 111.424 177.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.9 t -90.62 105.21 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 120.826 0.346 . . . . 75.33 110.985 175.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.523 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 50.0 m -56.61 144.35 32.32 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.475 -0.33 . . . . 43.01 110.997 177.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.497 ' HG3' ' N ' ' A' ' 88' ' ' ILE . 12.3 pt-20 -43.2 -44.19 5.06 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 113.867 1.062 . . . . 61.45 113.867 -171.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.497 ' N ' ' HG3' ' A' ' 87' ' ' GLU . 2.6 pp -78.72 9.69 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 112.625 0.602 . . . . 73.3 112.625 -176.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.87 55.67 2.91 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 116.292 -0.413 . . . . 44.11 113.084 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.523 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 49.1 tttm -127.61 150.1 49.88 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.166 0.508 . . . . 65.31 112.256 177.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.535 HD12 HD13 ' A' ' 58' ' ' ILE . 50.2 mt -124.15 156.8 31.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-N 115.695 -0.684 . . . . 63.31 110.228 176.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.42 ' HB3' ' HB3' ' A' ' 95' ' ' LYS . . . -85.37 102.65 13.59 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.028 0.442 . . . . 74.24 111.796 178.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.656 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 40.2 mt -71.07 -8.32 52.55 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.241 0.83 . . . . 63.54 113.241 -177.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -97.58 -11.06 24.09 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.337 0.589 . . . . 72.23 111.015 174.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.42 ' HB3' ' HB3' ' A' ' 92' ' ' ALA . 27.8 tptp -106.31 -35.39 7.17 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.672 0.619 . . . . 70.03 112.672 -172.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -127.52 15.02 7.11 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.15 0.426 . . . . 74.15 112.15 -175.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.656 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 63.9 tttp -60.14 135.25 57.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.732 0.301 . . . . 63.54 111.727 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 17.7 t90 -65.6 96.86 0.28 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.024 0.44 . . . . 65.15 110.983 176.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -98.66 99.8 8.28 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 116.032 -0.531 . . . . 52.42 110.885 173.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.35 -4.47 11.87 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.685 2.256 . . . . 75.11 112.969 176.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 90.4 mt 63.12 21.27 12.77 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.054 0.542 . . . . 75.43 112.444 175.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 . . . . . 0 C--O 1.255 1.368 0 CA-C-O 118.399 -0.81 . . . . 43.11 111.736 178.476 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.9 tpt . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 120.616 0.246 . . . . 75.31 110.515 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -60.36 138.63 57.94 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.579 0.585 . . . . 75.02 112.579 -175.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.4 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 74.3 mm-40 -56.28 -27.83 56.63 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.472 -0.331 . . . . 73.32 111.569 176.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.431 ' O ' HG12 ' A' ' 8' ' ' ILE . 90.7 t80 -54.96 -52.22 63.72 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.211 0.529 . . . . 72.35 110.027 172.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 58.0 mt -65.56 -49.79 67.56 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.373 -0.831 . . . . 74.3 110.988 178.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 85.3 t -53.64 -50.99 47.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 116.119 -0.491 . . . . 73.54 111.979 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 31.4 mm-40 -62.37 -54.95 32.97 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.295 0.48 . . . . 72.1 112.295 -177.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.537 HD12 HG13 ' A' ' 39' ' ' VAL . 31.4 pt -61.43 -42.98 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 120.641 0.258 . . . . 35.34 111.693 -177.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.434 ' HA ' HD12 ' A' ' 12' ' ' ILE . 17.6 m-30 -62.58 -43.75 98.03 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.962 0.411 . . . . 53.22 111.265 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.85 -41.99 68.06 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.131 -0.486 . . . . 73.15 111.432 178.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 55.2 t -66.95 -36.51 77.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 121.047 0.451 . . . . 74.23 111.362 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 8' ' ' ILE . 83.3 mt -61.12 -36.01 69.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 116.306 -0.406 . . . . 74.42 112.054 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -60.06 -22.38 62.63 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 112.324 0.49 . . . . 73.33 112.324 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -78.73 -5.7 53.9 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 112.792 0.664 . . . . 71.12 112.792 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.431 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 58.9 mt -76.53 122.02 85.9 Favored Pre-proline 0 CA--C 1.545 0.783 0 O-C-N 122.243 -0.286 . . . . 74.25 111.324 178.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 15' ' ' ILE . 6.3 Cg_exo -75.28 151.28 38.11 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.861 2.374 . . . . 63.43 112.681 177.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -58.18 110.37 0.93 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.477 0.656 . . . . 74.41 111.721 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.501 ' H ' ' NH1' ' A' ' 56' ' ' ARG . . . 131.55 -30.17 3.32 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.568 -0.742 . . . . 52.33 112.387 178.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -93.81 159.83 15.02 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.438 0.637 . . . . 75.22 112.328 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.1 m -130.35 148.22 33.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 115.214 -0.903 . . . . 71.11 110.353 174.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 95.4 p -119.37 159.88 23.35 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.951 0.405 . . . . 72.44 110.996 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 72.0 p -102.79 148.92 25.01 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.731 0.3 . . . . 62.21 111.371 176.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.43 ' HB2' ' HB1' ' A' ' 36' ' ' ALA . 53.5 m-85 -50.76 -39.77 53.19 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 111.909 0.337 . . . . 65.14 111.909 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.75 -33.99 80.3 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 121.275 -0.488 . . . . 72.32 113.213 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.418 ' HG3' ' OG1' ' A' ' 22' ' ' THR . 47.1 mt-10 -74.12 -54.48 7.71 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.785 0.326 . . . . 42.34 111.258 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.7 mm -56.4 -53.46 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 116.215 -0.448 . . . . 74.01 111.386 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.412 ' HB2' HG21 ' A' ' 39' ' ' VAL . . . -57.64 -51.88 67.71 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.874 0.369 . . . . 72.14 111.717 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -57.6 -48.76 78.5 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.883 0.373 . . . . 74.34 111.337 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 74.5 mtm -74.01 -8.3 55.6 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.173 0.434 . . . . 65.33 112.173 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.86 -9.27 26.67 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.892 0.377 . . . . 75.55 111.079 172.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.05 37.47 5.16 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 116.038 -0.528 . . . . 75.03 113.693 178.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -138.58 90.57 12.79 Favored Pre-proline 0 CA--C 1.542 0.639 0 O-C-N 122.564 -0.374 . . . . 72.11 111.268 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.59 127.86 9.88 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.478 2.118 . . . . 74.02 113.3 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.84 8.38 87.73 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 121.099 -0.572 . . . . 74.11 114.195 178.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -101.3 22.61 12.21 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 117.382 0.591 . . . . 74.13 111.974 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.43 ' HB1' ' HB2' ' A' ' 23' ' ' TYR . . . -56.47 -52.0 66.35 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.103 0.477 . . . . 42.55 111.855 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -55.96 -32.76 64.16 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.096 -0.502 . . . . 74.14 111.748 177.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.404 ' HA ' ' HD2' ' A' ' 41' ' ' LYS . 98.6 m-70 -74.79 -32.26 61.96 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.687 0.28 . . . . 73.23 111.463 -178.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.537 HG13 HD12 ' A' ' 8' ' ' ILE . 58.4 t -61.21 -40.31 85.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 121.138 0.494 . . . . 73.21 110.292 172.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.61 -37.81 94.0 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 121.133 -0.556 . . . . 72.32 112.484 173.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.404 ' HD2' ' HA ' ' A' ' 38' ' ' HIS . 66.1 mttm -61.27 -40.02 92.56 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.878 0.37 . . . . 54.43 111.006 174.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.48 -50.92 69.5 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.066 -0.515 . . . . 62.24 111.579 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.5 mt -63.42 -36.97 85.48 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.901 0.382 . . . . 74.4 111.309 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.98 -6.58 45.99 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 121.353 -0.451 . . . . 71.02 113.681 178.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -100.21 -6.5 25.99 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 120.98 0.419 . . . . 73.51 111.038 177.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 91.5 mt -79.52 152.23 75.32 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 112.542 0.571 . . . . 63.44 112.542 -176.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.516 ' HD2' ' HB2' ' A' ' 50' ' ' SER . 22.2 Cg_exo -64.04 148.31 91.51 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.644 2.229 . . . . 73.51 112.464 173.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -62.98 -12.17 23.88 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-O 121.08 0.466 . . . . 74.34 111.757 -178.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -135.97 47.71 0.96 Allowed Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.312 -0.47 . . . . 41.35 113.233 175.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.516 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 43.0 t -74.83 165.84 24.59 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.991 0.424 . . . . 63.43 112.071 176.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -74.02 -19.37 60.66 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.237 -0.438 . . . . 73.11 111.532 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.549 HD12 ' HD2' ' A' ' 53' ' ' PRO . 30.1 tp -89.45 126.4 58.45 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.281 -0.418 . . . . 72.01 111.144 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.549 ' HD2' HD12 ' A' ' 52' ' ' LEU . 60.1 Cg_endo -73.42 95.69 0.87 Allowed 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 121.379 1.386 . . . . 72.05 111.908 174.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 66.1 p-90 -80.5 -31.68 37.15 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.282 0.563 . . . . 72.43 111.187 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -60.5 -18.68 53.37 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.419 0.896 . . . . 72.0 113.419 -176.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.501 ' NH1' ' H ' ' A' ' 18' ' ' GLY . 90.1 mtt-85 -86.75 11.64 12.64 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.955 0.724 . . . . 71.01 112.955 -177.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.2 t -125.93 109.72 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-O 121.407 0.622 . . . . 72.23 111.742 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.513 HD13 HD12 ' A' ' 91' ' ' ILE . 18.9 pt -114.16 -174.56 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 CA-C-N 115.827 -0.624 . . . . 72.31 111.328 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.408 HD21 ' HB2' ' A' ' 63' ' ' LYS . 34.2 p30 -87.22 171.38 10.69 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.647 -0.658 . . . . 73.44 111.871 -177.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 71.1 p -65.07 -14.8 61.36 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 112.68 0.622 . . . . 63.02 112.68 -174.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -75.0 -30.19 61.09 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.127 0.489 . . . . 64.03 111.297 175.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.49 11.97 34.35 Favored Glycine 0 CA--C 1.521 0.467 0 CA-C-N 115.691 -0.686 . . . . 72.4 111.676 -170.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.471 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 97.7 mttt -103.22 155.71 18.24 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.338 0.59 . . . . 71.41 112.19 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 63.6 mt -73.21 129.02 36.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 115.748 -0.66 . . . . 55.23 110.527 174.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.5 t -67.87 -38.7 83.42 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 120.83 0.348 . . . . 70.4 111.798 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.416 HD13 ' HB3' ' A' ' 70' ' ' ASP . 84.4 mt -74.25 143.37 45.11 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.856 0.36 . . . . 73.45 111.169 178.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -125.37 161.72 26.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.132 0.492 . . . . 74.23 111.336 -177.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 77.54 -138.95 22.41 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.111 -0.566 . . . . 73.44 112.518 -176.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 68.9 mtm180 -61.36 -38.23 86.23 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.26 0.552 . . . . 72.12 111.515 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.416 ' HB3' HD13 ' A' ' 66' ' ' LEU . 4.5 m-20 -61.73 -26.78 68.27 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 116.101 -0.5 . . . . 73.13 111.61 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.6 tt -65.7 -61.37 2.12 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.503 -0.317 . . . . 63.05 111.098 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.505 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 3.3 p30 -64.75 -24.5 67.58 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.785 0.326 . . . . 64.21 111.467 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -60.53 -52.45 65.13 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.974 0.416 . . . . 72.0 110.688 173.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -62.63 -38.93 92.15 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.25 0.547 . . . . 72.04 110.579 176.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.559 ' HG3' ' HB ' ' A' ' 85' ' ' VAL . 48.0 tttp -52.18 -56.38 14.99 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.601 -0.727 . . . . 73.31 111.729 174.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -61.88 -35.76 79.27 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 111.969 0.359 . . . . 73.02 111.969 -178.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -59.59 -45.33 92.22 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.02 0.438 . . . . 75.33 111.219 175.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.6 mt -71.79 -45.47 61.47 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.13 -0.486 . . . . 73.24 112.177 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -68.7 -26.31 65.22 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 122.17 -0.331 . . . . 71.14 111.786 -178.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.77 -23.71 67.33 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.313 0.577 . . . . 52.31 110.966 172.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -87.42 -10.84 50.88 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.782 -0.644 . . . . 71.34 111.462 176.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 108.27 19.29 9.02 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 121.341 -0.457 . . . . 54.01 114.022 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 57.1 mt -99.98 159.19 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 O-C-N 122.187 -0.596 . . . . 62.25 111.498 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -105.52 117.71 34.72 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 122.209 -0.307 . . . . 71.42 110.988 177.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.559 ' HB ' ' HG3' ' A' ' 75' ' ' LYS . 39.2 t -119.94 114.22 43.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.793 0.33 . . . . 55.05 111.391 178.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.0 m -62.84 141.9 58.46 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 122.386 -0.196 . . . . 53.01 110.627 176.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -47.06 -42.08 17.99 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.626 0.973 . . . . 64.41 113.626 -172.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.417 HG13 ' H ' ' A' ' 88' ' ' ILE . 2.7 pp -74.66 8.52 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 112.553 0.575 . . . . 75.4 112.553 -178.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.92 51.52 3.77 Favored Glycine 0 CA--C 1.524 0.594 0 CA-C-N 116.305 -0.407 . . . . 51.31 113.706 176.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -128.96 137.3 51.3 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.145 0.498 . . . . 52.03 111.641 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.513 HD12 HD13 ' A' ' 58' ' ' ILE . 52.0 mt -127.62 141.66 45.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 115.716 -0.675 . . . . 70.53 110.382 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.19 93.5 4.59 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 122.215 -0.303 . . . . 71.03 111.654 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.499 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 94.2 mt -55.42 -53.21 59.09 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.667 0.27 . . . . 73.45 111.56 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -51.37 -15.22 0.37 Allowed 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 113.264 0.838 . . . . 73.41 113.264 -177.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.518 ' HE3' ' CE2' ' A' ' 96' ' ' TYR . 38.1 ttpt -113.13 -26.64 8.35 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 121.562 -0.711 . . . . 74.43 112.511 177.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.518 ' CE2' ' HE3' ' A' ' 95' ' ' LYS . 85.4 m-85 -117.92 11.31 13.42 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.361 0.504 . . . . 70.22 112.361 -176.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 57.2 tttm -65.55 134.68 53.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.085 0.469 . . . . 72.44 111.733 -176.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 22.5 t90 -66.36 96.51 0.36 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.185 0.516 . . . . 71.03 111.517 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -105.73 93.68 7.73 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 115.804 -0.634 . . . . 71.41 110.608 173.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -69.78 7.52 0.98 Allowed 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 122.839 2.359 . . . . 73.55 113.45 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 73.5 mt -119.14 140.8 49.54 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 122.502 0.321 . . . . 74.54 111.02 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 C--O 1.251 1.166 0 CA-C-O 118.829 -0.605 . . . . 73.23 111.733 178.021 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptm . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.72 0.295 . . . . 61.02 110.742 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -64.88 149.17 50.03 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.412 -0.358 . . . . 63.22 111.93 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 52.8 tp60 -58.68 -31.45 68.21 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.887 0.375 . . . . 73.35 110.781 177.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -54.22 -50.27 67.54 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.256 -0.429 . . . . 75.3 110.688 171.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 76.7 mt -62.16 -46.54 88.51 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.747 -0.66 . . . . 74.35 111.24 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.9 t -56.7 -49.43 78.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.915 0.388 . . . . 75.44 111.66 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.435 ' O ' HG23 ' A' ' 11' ' ' VAL . 27.6 mm-40 -60.61 -55.99 26.68 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.349 0.5 . . . . 72.41 112.349 -178.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.511 ' O ' HG13 ' A' ' 12' ' ' ILE . 26.5 pt -59.37 -45.14 93.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 111.86 0.319 . . . . 70.21 111.86 -177.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -64.55 -41.93 96.02 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.983 0.421 . . . . 73.41 111.175 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.27 -37.56 69.98 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.247 -0.433 . . . . 71.24 111.317 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 7' ' ' GLN . 63.1 t -69.57 -36.98 73.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 121.095 0.474 . . . . 63.44 111.234 178.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 8' ' ' ILE . 75.1 mt -62.18 -34.25 62.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 116.122 -0.49 . . . . 72.13 112.168 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -60.82 -12.16 9.96 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 112.921 0.712 . . . . 70.42 112.921 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -87.52 -5.36 58.82 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 112.827 0.677 . . . . 63.34 112.827 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 56.2 mt -76.72 115.6 49.44 Favored Pre-proline 0 CA--C 1.546 0.802 0 O-C-N 122.101 -0.375 . . . . 63.4 111.448 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -67.82 159.34 53.25 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.909 2.406 . . . . 64.11 113.496 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -66.94 97.02 0.46 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.853 -0.612 . . . . 73.51 111.395 -176.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.476 ' H ' ' NH1' ' A' ' 56' ' ' ARG . . . 136.23 -22.19 3.42 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 121.222 -0.513 . . . . 70.55 113.045 176.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -98.42 164.73 12.16 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.144 0.497 . . . . 62.23 111.996 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.6 m -135.79 157.47 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.732 -0.667 . . . . 73.25 110.607 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 98.0 p -130.35 172.71 11.55 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.043 0.449 . . . . 75.4 110.965 178.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 46.4 p -108.26 152.39 24.68 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.91 0.386 . . . . 31.25 111.325 177.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.49 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 67.5 m-85 -55.32 -34.22 64.0 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.287 0.477 . . . . 75.11 112.287 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.3 -48.93 83.55 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.915 -0.66 . . . . 70.45 112.426 176.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -59.32 -52.45 65.6 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.849 0.357 . . . . 72.34 111.52 178.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.2 mm -59.61 -50.27 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 111.954 0.353 . . . . 64.53 111.954 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.449 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -58.67 -50.41 73.96 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.047 0.388 . . . . 74.13 112.047 -178.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -62.45 -44.05 97.34 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.647 0.26 . . . . 75.22 111.622 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 74.7 mtm -69.17 -24.14 64.03 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.591 0.234 . . . . 42.34 111.623 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.82 -20.98 44.82 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.026 0.441 . . . . 74.43 111.229 174.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.96 16.62 20.96 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 121.405 -0.426 . . . . 64.52 113.645 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.449 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 69.7 m-85 -126.93 89.33 52.33 Favored Pre-proline 0 CA--C 1.542 0.651 0 O-C-N 122.54 -0.388 . . . . 75.02 111.938 -177.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.24 141.85 40.25 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 122.437 2.091 . . . . 74.1 112.414 177.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.65 -37.17 2.46 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 121.003 -0.617 . . . . 73.02 113.637 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -63.8 -2.81 1.97 Allowed 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.744 0.646 . . . . 74.34 112.744 -178.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.49 ' HB1' ' HB3' ' A' ' 23' ' ' TYR . . . -48.02 -42.44 28.19 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.693 0.627 . . . . 34.25 112.693 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -59.05 -36.12 74.5 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.236 0.458 . . . . 72.15 112.236 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -72.65 -33.52 66.64 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.788 0.328 . . . . 74.41 110.755 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.489 HG13 HD12 ' A' ' 8' ' ' ILE . 60.6 t -58.02 -45.97 88.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 116.195 -0.457 . . . . 73.44 110.573 174.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.32 -45.4 96.2 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 121.15 -0.548 . . . . 64.43 113.0 176.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -64.79 -28.48 69.6 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.817 0.341 . . . . 64.21 111.261 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.65 -48.5 47.32 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.87 0.367 . . . . 71.22 111.077 174.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.561 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 44.6 mt -64.06 -40.0 95.31 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.864 0.364 . . . . 54.32 111.298 178.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.553 ' HA2' HD11 ' A' ' 66' ' ' LEU . . . -65.01 -13.85 58.06 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.155 -0.545 . . . . 55.14 112.924 176.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -86.79 -16.42 36.31 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 120.977 0.418 . . . . 72.54 110.962 177.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 95.7 mt -77.73 149.17 77.28 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 116.344 -0.389 . . . . 63.22 111.918 -178.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -77.2 165.93 27.16 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.537 2.158 . . . . 60.22 112.702 176.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.53 ' HB3' ' HD3' ' A' ' 73' ' ' ARG . 11.3 pt-20 -84.02 25.35 0.83 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.044 0.387 . . . . 64.45 112.044 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -141.87 19.59 2.54 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 121.195 -0.526 . . . . 50.23 113.482 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 56.4 p -81.11 155.75 26.11 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 117.085 0.442 . . . . 72.55 111.629 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -69.85 -21.35 63.36 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.325 0.583 . . . . 74.42 111.413 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.468 HD12 ' HD2' ' A' ' 53' ' ' PRO . 48.5 tp -87.42 116.3 65.65 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 115.882 -0.599 . . . . 74.31 111.388 178.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.468 ' HD2' HD12 ' A' ' 52' ' ' LEU . 64.2 Cg_endo -74.44 95.1 0.92 Allowed 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 121.419 1.413 . . . . 64.34 112.02 177.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.561 ' HB2' ' HB3' ' A' ' 43' ' ' LEU . 64.1 p-90 -83.78 -26.73 29.38 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.113 -0.494 . . . . 74.54 111.665 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -62.43 -12.98 24.9 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 113.102 0.779 . . . . 74.52 113.102 -178.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.486 HH22 ' HB3' ' A' ' 81' ' ' GLU . 80.4 mtt-85 -86.21 -13.23 47.53 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.846 0.684 . . . . 72.42 112.846 -178.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.7 t -102.74 99.81 9.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 120.97 0.414 . . . . 55.51 110.806 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.537 ' HA ' ' OG ' ' A' ' 65' ' ' SER . 44.8 pt -104.29 -170.23 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 121.303 0.573 . . . . 74.15 111.787 -178.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.1 p30 -89.38 158.96 17.56 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.199 0.523 . . . . 74.21 111.928 -177.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.7 p -66.01 -3.85 6.1 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.143 0.423 . . . . 60.32 112.143 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -86.55 -1.88 58.01 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 122.647 0.379 . . . . 63.43 111.896 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.78 31.88 67.17 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.147 -0.549 . . . . 42.31 112.69 -178.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -133.04 173.32 11.55 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.114 0.483 . . . . 74.01 111.324 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.611 HD11 HG11 ' A' ' 85' ' ' VAL . 38.1 mt -65.53 146.65 13.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 116.029 -0.532 . . . . 74.21 112.015 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.537 ' OG ' ' HA ' ' A' ' 58' ' ' ILE . 14.8 m -70.22 -47.86 59.58 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.002 -0.545 . . . . 75.21 111.91 -176.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.553 HD11 ' HA2' ' A' ' 44' ' ' GLY . 86.8 mt -103.54 158.2 16.53 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.084 -0.507 . . . . 54.35 111.794 -176.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.491 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 53.4 mtpt -120.24 163.66 17.44 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.02 0.438 . . . . 71.23 111.48 -178.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 77.53 -139.35 22.95 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 121.069 -0.586 . . . . 62.52 112.831 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -63.9 -34.95 79.11 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.206 0.526 . . . . 72.13 110.952 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -61.38 -27.77 68.76 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.764 -0.653 . . . . 72.03 111.195 177.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.491 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 10.1 tt -67.07 -48.31 68.64 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.103 -0.499 . . . . 72.14 110.663 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.58 ' HA ' ' HD3' ' A' ' 75' ' ' LYS . 11.9 m-20 -65.05 -34.22 77.9 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.68 0.276 . . . . 61.41 111.417 176.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.53 ' HD3' ' HB3' ' A' ' 48' ' ' GLU . 38.8 ttm180 -56.82 -50.71 71.55 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.108 0.48 . . . . 62.42 110.684 174.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.487 ' OE1' HG23 ' A' ' 64' ' ' ILE . 45.6 tt0 -66.84 -34.5 77.94 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.17 -0.468 . . . . 54.02 111.108 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.58 ' HD3' ' HA ' ' A' ' 72' ' ' ASP . 47.2 mtpt -55.7 -62.75 1.48 Allowed 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 120.963 0.411 . . . . 63.23 111.434 173.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -53.58 -37.57 63.08 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.795 -0.639 . . . . 74.33 112.053 -175.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -61.28 -53.51 55.83 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.027 0.442 . . . . 73.24 111.592 175.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.7 mt -65.26 -40.97 94.64 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.357 -0.383 . . . . 72.22 111.525 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -55.54 -44.63 76.93 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.152 0.501 . . . . 74.34 111.043 174.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.71 -31.86 71.13 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.008 -0.542 . . . . 70.43 111.278 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.486 ' HB3' HH22 ' A' ' 56' ' ' ARG . 14.1 mm-40 -87.65 9.85 20.02 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.562 0.578 . . . . 65.04 112.562 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.27 4.3 83.92 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.398 -0.43 . . . . 70.13 113.813 175.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 67.0 mt -87.39 132.79 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 O-C-N 122.6 -0.353 . . . . 71.1 111.171 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -87.99 101.01 13.35 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.918 0.39 . . . . 52.43 111.424 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.611 HG11 HD11 ' A' ' 64' ' ' ILE . 48.8 t -89.87 120.58 38.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 120.844 0.354 . . . . 74.14 110.731 176.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.589 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 36.5 m -68.18 146.2 53.62 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.595 -0.275 . . . . 74.45 111.1 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -41.22 -51.96 3.44 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 115.246 1.573 . . . . 53.23 115.246 -169.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 pp -75.01 -5.7 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 112.924 0.713 . . . . 73.52 112.924 -175.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 105.99 46.93 1.13 Allowed Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.29 -0.481 . . . . 73.32 113.171 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.589 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 48.5 tttm -116.81 139.65 50.35 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.829 0.347 . . . . 73.12 111.916 -178.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.464 HD12 HG21 ' A' ' 58' ' ' ILE . 65.8 mt -131.11 126.36 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 116.267 -0.424 . . . . 71.05 111.216 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.22 95.88 1.04 Allowed 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 111.958 0.355 . . . . 50.44 111.958 179.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.485 HD21 HD11 ' A' ' 58' ' ' ILE . 70.7 mt -56.24 -51.1 69.34 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 111.918 0.34 . . . . 73.23 111.918 179.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -61.71 -9.29 6.02 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.193 0.442 . . . . 63.02 112.193 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -107.92 -22.11 12.56 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 122.507 0.323 . . . . 73.04 111.608 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -127.92 13.67 6.82 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.241 0.46 . . . . 64.13 112.241 -177.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 65.1 tttp -62.99 131.41 48.55 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.535 0.568 . . . . 71.34 112.535 -175.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 20.4 t90 -72.64 109.82 6.55 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.101 -0.499 . . . . 71.33 111.024 174.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.445 ' HA ' ' HD2' ' A' ' 100' ' ' PRO . 20.8 mm-40 -108.72 93.7 12.69 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 115.982 -0.554 . . . . 64.12 110.735 176.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 99' ' ' GLN . 22.5 Cg_endo -60.59 -31.26 92.02 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.971 2.447 . . . . 71.43 112.857 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 99' ' ' GLN . 65.7 mt 61.39 25.73 15.64 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.202 0.445 . . . . 73.13 112.202 177.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 . . . . . 0 C--O 1.256 1.4 0 CA-C-O 118.704 -0.665 . . . . 74.3 111.283 178.631 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.4 tpt . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 120.823 0.344 . . . . 65.24 111.069 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -71.2 131.67 43.86 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.408 -0.36 . . . . 63.53 111.896 -177.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.422 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 26.4 mm-40 -60.19 -27.6 67.29 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.595 0.236 . . . . 64.03 111.363 176.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -52.59 -49.13 65.62 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.237 0.541 . . . . 72.22 110.222 172.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 73.1 mt -66.61 -47.54 72.36 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.485 -0.78 . . . . 51.1 111.055 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.7 t -55.19 -44.92 76.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.324 -0.398 . . . . 71.45 111.589 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 31.8 mm-40 -66.58 -52.28 47.14 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.208 0.447 . . . . 75.24 112.208 -178.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.423 ' O ' HG13 ' A' ' 12' ' ' ILE . 31.8 pt -60.73 -41.62 89.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 O-C-N 122.146 -0.346 . . . . 54.34 111.47 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 17.6 m-30 -61.72 -46.56 89.12 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.068 0.461 . . . . 74.42 110.705 176.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.28 -39.55 64.01 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.109 -0.496 . . . . 72.23 111.448 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 7' ' ' GLN . 92.1 t -65.25 -43.2 95.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 120.776 0.322 . . . . 74.53 111.476 178.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.551 ' HB ' HD11 ' A' ' 52' ' ' LEU . 72.8 mt -56.84 -33.97 42.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 120.927 0.394 . . . . 74.31 111.763 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -59.4 -16.94 26.36 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 113.22 0.822 . . . . 74.23 113.22 178.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.437 ' HB3' ' HZ2' ' A' ' 98' ' ' TRP . 2.0 mp0 -80.97 -11.7 59.52 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.375 0.509 . . . . 71.53 112.375 177.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.495 HD11 HD11 ' A' ' 26' ' ' ILE . 51.0 mt -75.33 115.3 44.0 Favored Pre-proline 0 N--CA 1.472 0.626 0 O-C-N 122.311 -0.243 . . . . 74.43 111.086 178.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 15' ' ' ILE . 19.6 Cg_exo -66.95 169.29 15.17 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.778 2.319 . . . . 72.32 113.523 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -70.06 115.65 9.51 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.822 -0.626 . . . . 74.01 110.891 -178.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.32 19.25 21.55 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 120.97 -0.633 . . . . 71.34 113.643 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -127.11 152.45 47.29 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 117.169 0.485 . . . . 73.01 111.347 176.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.6 m -128.04 150.04 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 121.136 0.493 . . . . 73.52 111.731 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.7 t -138.75 175.0 9.93 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.362 -0.381 . . . . 51.45 111.091 175.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 67.6 p -104.88 150.78 24.57 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.907 0.384 . . . . 75.51 111.988 -177.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.42 ' HE1' HD12 ' A' ' 43' ' ' LEU . 68.9 m-85 -52.54 -36.68 56.12 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.27 -0.423 . . . . 63.21 111.659 178.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -60.96 -48.25 87.23 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 116.086 -0.506 . . . . 55.11 112.789 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -61.14 -51.95 66.93 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.848 0.356 . . . . 65.41 111.107 178.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.495 HD11 HD11 ' A' ' 15' ' ' ILE . 49.4 mm -53.14 -53.31 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 121.131 0.491 . . . . 72.11 111.622 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.62 -44.63 96.11 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.157 0.504 . . . . 62.23 111.322 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.4 ttpp -62.46 -33.99 75.93 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.168 -0.469 . . . . 73.33 111.531 -178.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 67.2 mtt -72.99 -41.33 64.43 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.984 0.421 . . . . 73.1 111.161 175.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.73 -24.81 67.05 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.236 -0.438 . . . . 51.34 112.171 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.42 24.55 6.14 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.286 -0.483 . . . . 51.31 113.254 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -135.65 66.07 62.64 Favored Pre-proline 0 CA--C 1.543 0.674 0 O-C-N 122.665 -0.315 . . . . 74.5 111.57 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -61.91 138.28 72.78 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.588 2.192 . . . . 64.04 112.757 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.33 -27.8 9.96 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.274 -0.488 . . . . 54.01 113.127 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -79.88 22.94 0.47 Allowed 'General case' 0 N--CA 1.473 0.715 0 O-C-N 122.214 -0.58 . . . . 64.35 112.542 -177.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.93 -37.86 69.52 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.414 0.524 . . . . 74.33 112.414 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -58.82 -38.22 78.17 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.825 0.345 . . . . 70.14 111.782 178.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -69.74 -35.02 74.63 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.537 -0.301 . . . . 73.44 111.124 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.418 HG13 HD12 ' A' ' 8' ' ' ILE . 46.6 t -59.67 -44.5 93.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.002 0.43 . . . . 52.52 110.655 175.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.68 -40.58 98.71 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 121.169 -0.539 . . . . 74.12 112.718 176.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -67.0 -27.89 67.8 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.982 0.42 . . . . 74.33 111.157 175.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.89 -53.61 12.64 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.308 -0.406 . . . . 70.54 111.625 177.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.42 HD12 ' HE1' ' A' ' 23' ' ' TYR . 61.1 mt -61.13 -39.46 90.1 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.501 -0.318 . . . . 73.53 111.558 -179.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.45 -15.91 57.73 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 120.88 -0.676 . . . . 54.51 113.507 178.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -103.41 10.78 37.17 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 122.622 -0.34 . . . . 64.35 111.804 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 57.9 mt -86.12 155.89 57.65 Favored Pre-proline 0 N--CA 1.47 0.568 0 CA-C-O 120.999 0.428 . . . . 75.23 112.031 177.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.436 ' HG2' ' HB2' ' A' ' 50' ' ' SER . 55.2 Cg_endo -70.29 153.16 66.75 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.266 1.977 . . . . 70.14 111.819 172.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -49.28 -70.8 0.08 Allowed 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 121.239 0.542 . . . . 64.34 111.372 -176.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -91.53 59.46 2.96 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 121.201 -0.523 . . . . 70.14 113.364 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.436 ' HB2' ' HG2' ' A' ' 47' ' ' PRO . 40.2 t -70.25 165.41 22.27 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.028 0.442 . . . . 63.41 111.621 176.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -67.09 -24.73 65.98 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.234 0.54 . . . . 63.04 110.545 174.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.551 HD11 ' HB ' ' A' ' 12' ' ' ILE . 28.0 tp -90.37 126.8 55.37 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 115.722 -0.672 . . . . 73.24 111.747 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.534 ' HD2' HD12 ' A' ' 52' ' ' LEU . 74.0 Cg_endo -76.24 94.99 1.02 Allowed 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 121.574 1.516 . . . . 71.23 111.553 170.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 60.4 p-90 -83.71 -26.98 29.31 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.352 0.596 . . . . 54.11 111.678 -177.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -62.66 -13.95 37.99 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.571 0.952 . . . . 73.1 113.571 -177.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -86.36 3.57 43.0 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 112.541 0.571 . . . . 74.22 112.541 -178.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.8 t -116.62 123.23 71.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 121.194 0.521 . . . . 73.42 111.795 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.549 HG21 HD12 ' A' ' 91' ' ' ILE . 21.1 pt -126.97 -172.65 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 116.068 -0.514 . . . . 52.34 111.269 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.6 p30 -90.29 172.64 8.63 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.899 -0.501 . . . . 73.1 112.126 -177.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 43.9 m -63.32 -16.57 60.8 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 112.587 0.588 . . . . 72.11 112.587 -176.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -88.38 -2.71 58.75 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.809 0.338 . . . . 73.11 111.662 -178.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.63 40.75 58.5 Favored Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.977 -0.63 . . . . 64.23 112.358 -175.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -130.76 155.11 47.2 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.101 0.477 . . . . 71.0 111.387 -177.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.552 HG23 ' OE1' ' A' ' 74' ' ' GLN . 65.5 mt -77.2 130.78 35.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 116.252 -0.431 . . . . 74.44 110.966 176.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.9 m -73.17 -41.17 64.18 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 112.101 0.408 . . . . 74.52 112.101 -179.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.541 HD13 ' HB3' ' A' ' 70' ' ' ASP . 93.8 mt -73.15 146.15 45.85 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.453 -0.34 . . . . 74.3 110.789 178.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -116.2 157.09 25.39 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.17 0.509 . . . . 73.35 112.121 -176.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.6 -124.14 30.57 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 115.858 -0.61 . . . . 74.51 114.007 177.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.5 mtp180 -61.27 -46.96 88.19 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.948 0.404 . . . . 74.32 111.972 -177.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.541 ' HB3' HD13 ' A' ' 66' ' ' LEU . 15.1 m-20 -63.08 -29.59 70.93 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.85 0.357 . . . . 61.54 111.174 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.8 tt -63.88 -53.44 50.49 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.312 -0.404 . . . . 75.04 110.463 175.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -62.27 -30.2 70.96 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.303 -0.408 . . . . 64.43 111.22 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.557 ' O ' ' HG2' ' A' ' 77' ' ' LYS . 43.5 ttm180 -58.94 -60.38 3.96 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.743 0.306 . . . . 74.2 110.946 174.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.552 ' OE1' HG23 ' A' ' 64' ' ' ILE . 43.3 tt0 -55.73 -43.3 76.45 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.086 0.47 . . . . 71.15 110.962 177.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.415 ' HG3' ' HB ' ' A' ' 85' ' ' VAL . 31.5 tttm -55.07 -56.54 18.7 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.728 -0.669 . . . . 70.24 111.837 176.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -59.14 -37.97 78.54 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.154 0.427 . . . . 61.45 112.154 -178.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.557 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 75.0 mmtt -58.8 -46.46 87.52 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.934 0.397 . . . . 74.44 110.942 176.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.504 HD22 HD12 ' A' ' 83' ' ' ILE . 95.8 mt -71.26 -35.33 71.35 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.198 -0.455 . . . . 70.25 111.628 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -54.6 -41.16 69.61 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.075 0.464 . . . . 60.52 110.741 173.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.61 -8.18 39.6 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.419 0.526 . . . . 71.4 112.419 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -107.64 4.45 25.86 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.969 0.414 . . . . 63.03 111.47 177.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.67 5.17 63.25 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.285 -0.483 . . . . 52.11 113.926 177.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.504 HD12 HD22 ' A' ' 78' ' ' LEU . 66.4 mt -82.64 133.13 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 O-C-N 122.242 -0.563 . . . . 75.43 111.435 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -92.36 97.64 10.99 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.891 0.377 . . . . 72.3 111.455 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.415 ' HB ' ' HG3' ' A' ' 75' ' ' LYS . 44.8 t -91.22 124.53 43.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 120.883 0.373 . . . . 75.35 111.49 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.56 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 42.7 t -67.63 144.56 55.47 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 111.635 0.235 . . . . 62.32 111.635 177.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -41.94 -48.25 4.47 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.081 1.141 . . . . 75.45 114.081 -173.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.403 ' H ' HG13 ' A' ' 88' ' ' ILE . 2.8 pp -80.74 16.11 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 112.87 0.693 . . . . 73.44 112.87 -175.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.82 51.59 4.73 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 121.414 -0.422 . . . . 64.15 113.51 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.56 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 60.4 tttm -125.72 132.17 52.41 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 122.532 -0.393 . . . . 71.21 111.256 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.549 HD12 HG21 ' A' ' 58' ' ' ILE . 61.0 mt -124.09 134.41 66.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 120.934 0.397 . . . . 62.1 111.475 -177.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.8 100.22 1.14 Allowed 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 111.947 0.351 . . . . 65.44 111.947 178.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 39.4 mt -59.06 -62.27 2.01 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.355 0.502 . . . . 73.33 112.355 -178.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -50.19 -34.46 22.78 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 112.314 0.487 . . . . 73.21 112.314 -175.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -73.71 -47.29 40.56 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 112.32 0.489 . . . . 53.53 112.32 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -102.41 14.1 32.85 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 120.973 0.416 . . . . 73.2 111.528 -177.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -55.02 114.09 1.61 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.905 -0.589 . . . . 72.33 111.894 -175.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.437 ' HZ2' ' HB3' ' A' ' 14' ' ' GLN . 21.4 t90 -56.45 121.28 9.25 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.101 0.778 . . . . 65.15 113.101 -177.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.447 ' O ' ' HG3' ' A' ' 99' ' ' GLN . 12.9 pt20 -127.16 109.98 21.55 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 115.662 -0.699 . . . . 73.14 109.924 167.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.0 -7.02 17.98 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.152 1.901 . . . . 63.3 112.27 174.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 64.2 mt -120.51 111.68 18.0 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.121 -0.491 . . . . 41.41 111.381 -175.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 . . . . . 0 C--O 1.251 1.169 0 CA-C-O 118.814 -0.612 . . . . 65.14 111.171 174.495 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.8 tpt . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.638 0.256 . . . . 74.52 110.968 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.47 ' O ' HG23 ' A' ' 6' ' ' VAL . 5.8 m-20 -57.25 130.25 45.37 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.088 0.403 . . . . 74.14 112.088 -179.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -57.66 -31.73 66.6 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.395 -0.366 . . . . 63.3 111.767 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.406 ' O ' HG12 ' A' ' 8' ' ' ILE . 53.2 t80 -54.83 -52.41 62.81 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.309 0.576 . . . . 72.14 110.49 172.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 72.5 mt -64.53 -45.32 87.7 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.629 -0.714 . . . . 70.12 111.17 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 2' ' ' ASP . 58.6 t -55.37 -51.49 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 120.931 0.396 . . . . 63.43 111.697 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.409 ' O ' HG23 ' A' ' 11' ' ' VAL . 28.3 mm-40 -65.27 -50.81 64.32 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 112.539 0.57 . . . . 65.11 112.539 -176.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.45 ' O ' HG13 ' A' ' 12' ' ' ILE . 32.6 pt -62.16 -45.55 98.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 O-C-N 122.192 -0.317 . . . . 62.33 111.58 -178.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.405 ' N ' HG13 ' A' ' 8' ' ' ILE . 19.5 m-30 -62.31 -43.37 98.98 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.081 0.467 . . . . 72.43 110.91 177.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.03 -48.15 67.83 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.927 -0.579 . . . . 61.32 111.413 178.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 7' ' ' GLN . 78.0 t -62.87 -41.84 94.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 120.795 0.331 . . . . 75.12 111.502 -179.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 8' ' ' ILE . 81.5 mt -57.4 -35.86 50.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 112.06 0.393 . . . . 71.34 112.06 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -56.72 -15.17 4.1 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.15 0.796 . . . . 71.5 113.15 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -86.79 -11.19 51.73 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.699 0.629 . . . . 72.11 112.699 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.494 HD11 HD11 ' A' ' 26' ' ' ILE . 52.1 mt -73.32 111.64 12.6 Favored Pre-proline 0 CA--C 1.543 0.679 0 O-C-N 122.245 -0.284 . . . . 71.13 110.677 178.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -81.57 178.05 6.99 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.635 2.223 . . . . 63.44 113.736 -175.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.4 tptt -58.56 140.92 53.49 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.842 -0.617 . . . . 75.35 111.482 -178.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.661 ' H ' ' NH2' ' A' ' 56' ' ' ARG . . . 82.45 -32.53 2.84 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 116.176 -0.465 . . . . 52.25 114.142 179.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -85.67 158.3 20.1 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.019 0.748 . . . . 73.04 113.019 -175.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.8 m -139.97 166.84 19.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 115.636 -0.711 . . . . 51.33 110.734 177.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.8 t -149.28 -178.66 6.52 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.448 -0.342 . . . . 72.43 110.314 176.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 72.3 p -112.53 158.7 19.61 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.391 0.515 . . . . 72.14 112.391 -177.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -54.34 -41.82 69.52 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.203 -0.453 . . . . 72.42 110.903 176.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.12 -47.5 89.46 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.911 -0.586 . . . . 75.41 113.094 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.432 ' O ' ' HE2' ' A' ' 29' ' ' MET . 34.5 mt-10 -55.9 -53.48 56.25 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.925 0.363 . . . . 71.4 111.389 177.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.494 HD11 HD11 ' A' ' 15' ' ' ILE . 49.3 mm -58.72 -49.62 82.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 120.834 0.35 . . . . 70.43 111.491 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.523 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -57.89 -49.04 78.09 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 120.995 0.426 . . . . 73.5 112.05 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.458 ' NZ ' ' HB3' ' A' ' 28' ' ' LYS . 9.4 mtpm? -62.71 -39.43 94.02 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.438 -0.346 . . . . 73.54 111.825 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.432 ' HE2' ' O ' ' A' ' 25' ' ' GLU . 72.5 mtm -79.48 -16.07 56.68 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.649 0.261 . . . . 72.13 111.657 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -85.85 -30.62 22.79 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.028 0.442 . . . . 74.11 111.363 174.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.41 12.23 10.96 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.286 -0.483 . . . . 42.04 113.448 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.523 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 71.1 m-85 -130.35 67.53 80.15 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 117.011 0.405 . . . . 73.44 111.062 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.48 -49.24 16.72 Favored 'Trans proline' 0 N--CA 1.482 0.819 0 C-N-CA 122.842 2.362 . . . . 65.12 114.096 -174.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -81.38 41.82 2.7 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.105 -0.569 . . . . 72.24 113.897 -177.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.41 ' O ' HG23 ' A' ' 39' ' ' VAL . 77.0 m-85 -141.26 21.42 2.24 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.668 0.618 . . . . 65.45 112.668 -178.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.35 -51.51 64.54 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.076 0.398 . . . . 63.23 112.076 -177.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -55.11 -36.89 66.2 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.873 0.368 . . . . 70.44 111.968 176.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -72.39 -37.45 68.72 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.553 -0.294 . . . . 72.13 111.367 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.457 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 99.7 t -56.85 -47.2 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 120.874 0.369 . . . . 64.23 110.7 175.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.26 -46.69 92.54 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.281 -0.485 . . . . 70.42 113.069 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.34 -36.63 82.81 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.984 0.421 . . . . 74.01 111.337 177.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.29 -40.39 95.86 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.978 0.418 . . . . 75.5 111.265 175.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.484 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 89.9 mt -69.75 -38.83 76.94 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.271 -0.422 . . . . 51.11 111.338 178.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.05 -13.55 48.97 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 121.285 -0.483 . . . . 72.43 113.337 178.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -90.59 -12.38 37.18 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 122.556 -0.379 . . . . 55.13 111.445 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 88.8 mt -66.43 133.58 94.4 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 112.116 0.413 . . . . 62.14 112.116 -178.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.95 161.33 39.08 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.661 2.241 . . . . 73.11 113.725 -177.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -61.96 -12.99 21.16 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.331 -0.85 . . . . 70.4 112.556 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -107.77 18.27 34.82 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 121.139 -0.553 . . . . 75.55 113.949 -179.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 41.6 t -79.79 152.96 29.48 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 117.413 0.606 . . . . 72.23 111.583 177.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -101.2 6.55 43.09 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.222 0.534 . . . . 55.33 110.938 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.517 HD12 ' HD2' ' A' ' 53' ' ' PRO . 56.4 tp -95.16 115.26 65.25 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 116.125 -0.488 . . . . 74.35 110.681 176.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.517 ' HD2' HD12 ' A' ' 52' ' ' LEU . 63.7 Cg_endo -73.66 95.0 0.86 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 121.39 1.394 . . . . 65.42 112.059 178.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.484 ' HB2' ' HB3' ' A' ' 43' ' ' LEU . 68.5 p-90 -89.07 -26.24 21.49 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.171 0.51 . . . . 75.45 111.426 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.442 ' O ' HD21 ' A' ' 78' ' ' LEU . 35.8 p90 -58.48 -21.79 52.78 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.007 -0.542 . . . . 65.24 112.299 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.661 ' NH2' ' H ' ' A' ' 18' ' ' GLY . 88.0 mtt-85 -81.31 5.78 16.23 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.086 0.402 . . . . 45.43 112.086 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 18.6 t -115.31 111.44 35.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-O 121.228 0.537 . . . . 64.35 111.195 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.586 HG21 HD12 ' A' ' 91' ' ' ILE . 20.2 pt -117.79 -169.06 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 122.835 0.454 . . . . 54.34 111.047 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -92.12 167.35 12.13 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.57 -0.706 . . . . 63.23 111.764 -178.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 80.8 p -59.13 -18.76 38.72 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 112.644 0.609 . . . . 42.13 112.644 -176.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -85.94 4.6 36.84 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.786 0.327 . . . . 74.23 111.702 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.03 38.21 88.31 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 121.122 -0.561 . . . . 20.24 112.426 -177.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.486 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 54.5 mtpt -131.55 156.9 44.94 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.511 0.672 . . . . 71.14 112.009 -176.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.551 HG23 ' OE1' ' A' ' 74' ' ' GLN . 68.4 mt -78.59 104.28 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 115.575 -0.739 . . . . 73.32 110.047 173.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.2 t -63.38 -25.37 68.26 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.398 -0.365 . . . . 50.32 111.845 -176.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.418 HD13 ' HB3' ' A' ' 70' ' ' ASP . 83.1 mt -74.99 145.17 42.72 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.354 -0.384 . . . . 72.22 110.873 177.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.45 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -133.86 171.41 14.21 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.16 0.505 . . . . 74.42 112.0 -175.128 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.5 -121.75 24.83 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.918 -0.658 . . . . 61.24 112.663 -177.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 69' ' ' ARG . 35.3 mtt180 -71.6 -33.88 69.38 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.019 0.438 . . . . 54.01 111.277 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 73' ' ' ARG . 25.4 m-20 -73.32 -18.19 61.22 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 111.959 0.355 . . . . 70.52 111.959 -178.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.45 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 6.8 tt -66.11 -55.03 18.49 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.949 -0.389 . . . . 75.1 109.949 177.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.559 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 19.8 m-20 -67.45 -26.16 66.25 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.766 0.317 . . . . 72.02 111.304 176.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.434 ' HB3' ' O ' ' A' ' 70' ' ' ASP . 76.0 ttt180 -53.31 -62.5 1.61 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.203 0.525 . . . . 73.51 110.493 173.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.551 ' OE1' HG23 ' A' ' 64' ' ' ILE . 48.6 tt0 -67.1 -46.71 73.4 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.202 -0.454 . . . . 62.13 111.356 177.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.559 ' HB3' ' HA ' ' A' ' 72' ' ' ASP . 47.1 tttm -51.97 -50.36 61.4 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.616 0.598 . . . . 70.5 112.616 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -71.0 -30.88 67.24 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 111.904 0.335 . . . . 74.12 111.904 -176.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -64.75 -35.08 79.91 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.07 0.462 . . . . 73.12 110.873 171.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.524 HD13 HD11 ' A' ' 91' ' ' ILE . 57.8 mt -70.15 -47.36 61.99 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.185 -0.461 . . . . 71.22 111.286 175.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -57.88 -31.22 66.51 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.193 -0.458 . . . . 52.21 111.389 176.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.55 -34.07 70.62 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.836 0.351 . . . . 74.34 111.32 173.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -88.09 -11.81 45.99 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 111.813 0.301 . . . . 63.42 111.813 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.77 54.76 3.15 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.285 -0.484 . . . . 71.52 113.029 -178.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.535 HD11 HH12 ' A' ' 56' ' ' ARG . 68.3 mt -116.2 137.06 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 122.605 0.362 . . . . 72.33 111.223 -179.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.461 ' HG3' ' OH ' ' A' ' 96' ' ' TYR . 66.9 mt-10 -66.71 92.98 0.23 Allowed 'General case' 0 N--CA 1.471 0.588 0 O-C-N 122.012 -0.43 . . . . 61.52 111.868 -179.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.42 HG11 ' HG3' ' A' ' 75' ' ' LYS . 42.9 t -89.99 102.79 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 120.815 0.341 . . . . 45.0 110.722 173.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.596 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 69.9 m -64.46 163.46 13.31 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.317 0.488 . . . . 53.31 112.317 -178.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -35.04 -58.09 0.54 Allowed 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 115.247 1.573 . . . . 54.32 115.247 -169.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.461 HD13 ' HE3' ' A' ' 63' ' ' LYS . 2.6 pp -92.82 23.06 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 112.505 0.557 . . . . 75.32 112.505 -174.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.71 47.8 7.03 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 121.266 -0.492 . . . . 74.22 112.604 -176.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.596 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 49.3 tttm -111.8 131.88 55.04 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 122.432 -0.452 . . . . 65.03 111.452 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.586 HD12 HG21 ' A' ' 58' ' ' ILE . 53.5 mt -116.46 135.87 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 120.921 0.391 . . . . 75.12 111.699 -176.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.99 93.92 1.42 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.948 0.404 . . . . 70.11 111.453 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.463 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 66.6 mt -54.24 -56.85 14.31 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.384 0.513 . . . . 74.14 112.384 -178.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -53.05 -28.21 23.54 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.522 0.564 . . . . 73.14 112.522 -177.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -84.52 -33.09 23.58 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.033 0.383 . . . . 64.24 112.033 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.461 ' OH ' ' HG3' ' A' ' 84' ' ' GLU . 80.3 m-85 -117.59 6.92 12.52 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.84 0.682 . . . . 73.42 112.84 -173.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 61.5 tttp -63.31 128.8 37.51 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.159 0.504 . . . . 74.4 112.209 -173.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 15.7 t90 -69.72 116.81 10.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.761 -0.654 . . . . 74.23 110.798 175.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.413 ' HA ' ' HD2' ' A' ' 100' ' ' PRO . 77.1 mt-30 -114.38 92.04 26.37 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 116.476 -0.329 . . . . 71.45 111.187 178.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 99' ' ' GLN . 36.7 Cg_endo -65.72 -32.7 46.5 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.514 2.143 . . . . 73.42 112.043 174.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 81.2 mt -77.39 118.05 19.47 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.879 -0.6 . . . . 75.53 110.655 176.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 C--O 1.252 1.228 0 N-CA-C 112.115 0.413 . . . . 74.35 112.115 -176.453 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.9 tpt . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 120.876 0.37 . . . . 52.33 110.975 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -74.5 155.11 38.32 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.737 0.643 . . . . 74.33 112.737 -175.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.591 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 22.2 mm-40 -53.74 -40.04 65.83 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.063 -0.517 . . . . 72.32 111.38 175.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.416 ' O ' HG12 ' A' ' 8' ' ' ILE . 64.5 t80 -50.42 -53.38 29.9 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.131 0.491 . . . . 61.42 111.105 177.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 59.5 mt -61.61 -46.55 89.34 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.748 -0.66 . . . . 65.05 111.182 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.4 t -60.44 -44.86 97.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 116.137 -0.483 . . . . 62.12 111.896 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.591 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 24.4 mm-40 -68.51 -52.1 35.89 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.014 0.376 . . . . 75.53 112.014 -176.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.499 ' O ' HG13 ' A' ' 12' ' ' ILE . 30.9 pt -58.16 -43.42 85.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 121.055 -0.258 . . . . 52.51 111.306 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.5 m-30 -63.34 -46.76 85.08 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.036 0.446 . . . . 74.33 110.671 175.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.35 -44.67 65.32 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.926 -0.579 . . . . 75.22 111.661 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 7' ' ' GLN . 99.7 t -63.48 -43.78 98.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 120.825 0.345 . . . . 74.01 111.4 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.551 ' HB ' HD11 ' A' ' 52' ' ' LEU . 72.6 mt -58.63 -32.09 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 112.161 0.43 . . . . 74.53 112.161 -178.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -60.55 -10.24 4.83 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.064 0.764 . . . . 60.32 113.064 178.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -92.86 -2.52 55.81 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 112.564 0.579 . . . . 71.23 112.564 178.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.412 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 55.3 mt -81.5 114.1 47.05 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-O 120.653 0.263 . . . . 64.45 111.176 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 15' ' ' ILE . 16.7 Cg_exo -68.55 171.47 13.04 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.926 2.417 . . . . 53.0 113.054 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 44.9 tttp -66.68 133.04 49.42 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.064 0.459 . . . . 64.32 111.25 -178.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.505 ' H ' ' NH2' ' A' ' 56' ' ' ARG . . . 95.19 -25.14 25.63 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 121.319 -0.467 . . . . 24.34 113.184 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -86.72 157.31 19.67 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.587 0.588 . . . . 71.01 112.587 -177.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.3 m -140.51 153.98 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.621 -0.718 . . . . 71.03 110.722 176.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.5 t -135.07 179.98 5.98 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 122.189 -0.319 . . . . 55.21 110.726 176.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.2 p -110.9 155.52 22.51 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.09 0.471 . . . . 72.25 112.14 -176.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -54.3 -34.87 61.88 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.197 -0.456 . . . . 73.52 111.978 177.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.98 -49.9 60.5 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.095 -0.574 . . . . 41.24 112.752 177.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -56.39 -53.84 52.63 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.0 0.428 . . . . 72.45 111.364 177.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.5 mm -56.63 -48.23 80.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-N 116.12 -0.491 . . . . 74.55 111.729 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.467 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -60.12 -49.39 77.81 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 120.88 0.371 . . . . 74.43 111.971 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -60.63 -36.63 79.1 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.9 0.381 . . . . 61.21 111.878 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 73.6 mtm -84.81 -9.71 57.89 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.746 0.308 . . . . 65.22 111.773 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.3 -11.5 32.3 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.933 0.396 . . . . 71.23 111.356 173.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.13 21.68 37.87 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 121.312 -0.47 . . . . 72.12 113.482 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.467 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 97.2 m-85 -133.59 77.78 63.71 Favored Pre-proline 0 CA--C 1.543 0.699 0 O-C-N 122.522 -0.399 . . . . 74.51 111.916 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.52 135.71 24.71 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.305 2.004 . . . . 73.23 112.712 178.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.63 -1.87 76.2 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 121.238 -0.506 . . . . 63.31 113.738 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -99.88 23.21 10.04 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 117.258 0.529 . . . . 70.0 112.29 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.65 -48.4 58.3 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.723 0.638 . . . . 34.41 112.723 -177.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.0 ttp180 -68.08 -32.42 72.73 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.738 0.304 . . . . 75.4 111.711 -178.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -67.99 -35.98 79.24 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.848 0.356 . . . . 64.0 110.993 178.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.451 HG22 HG21 ' A' ' 8' ' ' ILE . 47.1 t -60.01 -42.84 91.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 121.393 0.615 . . . . 74.13 109.851 172.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.31 -37.93 92.61 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 115.681 -0.69 . . . . 62.24 112.781 174.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -58.19 -50.76 72.39 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.139 0.495 . . . . 74.11 110.602 174.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.29 -46.75 82.85 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.66 -0.7 . . . . 73.34 112.125 -177.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 62.2 mt -65.17 -39.26 92.69 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.794 0.331 . . . . 75.34 111.596 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.7 -25.19 65.22 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 120.805 -0.712 . . . . 72.34 113.249 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -87.3 5.58 37.66 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 120.877 0.37 . . . . 63.42 111.84 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 97.0 mt -94.48 155.71 39.34 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-O 120.664 0.268 . . . . 64.1 111.084 176.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.9 160.47 46.82 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.241 1.961 . . . . 55.45 112.367 174.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -53.83 -41.46 67.4 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.174 0.435 . . . . 74.14 112.174 -174.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -124.77 65.51 0.54 Allowed Glycine 0 CA--C 1.526 0.735 0 C-N-CA 121.334 -0.46 . . . . 72.11 112.577 178.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.8 t -69.72 163.96 24.55 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.206 0.447 . . . . 63.04 112.206 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -60.38 -30.61 69.68 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.384 0.611 . . . . 74.25 110.259 173.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.553 HD12 ' HD2' ' A' ' 53' ' ' PRO . 48.5 tp -86.36 121.93 72.29 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 115.592 -0.731 . . . . 70.31 110.456 173.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.553 ' HD2' HD12 ' A' ' 52' ' ' LEU . 58.1 Cg_endo -72.95 94.9 0.81 Allowed 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 121.12 1.213 . . . . 72.54 111.745 177.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 69.2 p-90 -79.67 -31.28 41.36 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.978 -0.555 . . . . 71.44 111.605 -177.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.412 ' O ' HD21 ' A' ' 78' ' ' LEU . 31.7 p90 -62.81 -11.01 15.1 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.726 0.639 . . . . 72.34 112.726 -179.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.659 HH12 HD11 ' A' ' 83' ' ' ILE . 71.9 mtt-85 -90.2 9.33 28.9 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.142 0.423 . . . . 70.13 112.142 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.3 t -124.69 105.87 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.038 0.447 . . . . 71.53 111.004 176.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.488 HD13 HD12 ' A' ' 91' ' ' ILE . 22.3 pt -115.41 -170.19 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 121.069 0.461 . . . . 60.25 112.013 -176.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -88.1 169.99 11.46 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.896 0.379 . . . . 74.11 111.852 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 33.4 t -63.27 -24.51 67.9 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.494 0.553 . . . . 52.34 112.494 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -72.68 -10.34 59.68 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.73 0.3 . . . . 55.34 111.803 178.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.11 44.18 24.06 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.84 -0.695 . . . . 72.53 111.878 -175.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.428 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 99.6 mttt -135.93 159.54 41.37 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.936 0.398 . . . . 70.44 111.286 -178.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 61.5 mt -62.26 132.83 28.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.115 -0.493 . . . . 71.54 110.888 177.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.5 p -76.18 -47.68 23.28 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.866 0.365 . . . . 53.14 111.29 -178.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.607 ' HB3' ' HB3' ' A' ' 70' ' ' ASP . 76.6 mt -67.36 156.8 35.59 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.081 0.467 . . . . 54.42 111.584 178.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.494 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 13.7 ptmm? -131.83 162.36 30.77 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.18 0.437 . . . . 65.55 112.18 -172.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 61.97 -131.07 45.59 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 116.255 -0.43 . . . . 60.21 113.243 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 -54.18 -41.62 68.76 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.264 0.554 . . . . 71.44 111.35 175.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.607 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 2.1 m-20 -66.12 -27.69 68.24 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.78 -0.645 . . . . 74.02 111.99 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.494 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 7.3 tt -64.0 -53.47 49.59 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.949 0.404 . . . . 73.3 110.053 176.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.453 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 67.7 m-20 -63.51 -29.82 71.03 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.246 -0.434 . . . . 61.11 111.25 177.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.419 ' O ' ' HG2' ' A' ' 77' ' ' LYS . 34.5 ttm180 -56.9 -58.24 8.99 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.111 -0.495 . . . . 75.2 111.247 174.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.448 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 49.5 tt0 -63.56 -40.75 97.79 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.983 0.421 . . . . 72.41 110.417 177.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.453 ' HB3' ' HA ' ' A' ' 72' ' ' ASP . 84.2 tttt -48.99 -52.95 22.04 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.77 -0.65 . . . . 75.35 112.075 176.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -63.07 -39.13 93.8 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.059 0.392 . . . . 45.24 112.059 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 75.0 mmtt -64.35 -36.37 83.9 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.122 0.487 . . . . 74.33 111.004 177.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.587 HD13 HD11 ' A' ' 91' ' ' ILE . 73.4 mt -69.48 -52.38 27.15 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.093 -0.503 . . . . 44.34 111.414 178.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -52.78 -45.03 66.95 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.968 0.413 . . . . 63.11 111.529 177.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.69 -16.47 57.41 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.285 0.476 . . . . 62.35 112.285 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.555 ' HB3' HH22 ' A' ' 56' ' ' ARG . 28.2 mm-40 -104.57 13.15 32.17 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.025 0.38 . . . . 63.25 112.025 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.91 6.79 88.67 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.156 -0.545 . . . . 74.5 113.539 178.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.659 HD11 HH12 ' A' ' 56' ' ' ARG . 57.5 mt -88.39 149.51 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 O-C-N 122.475 -0.427 . . . . 70.33 110.656 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.437 ' HG2' ' CE2' ' A' ' 96' ' ' TYR . 12.4 pt-20 -97.83 130.31 44.75 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.191 0.52 . . . . 45.51 111.548 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.426 HG21 ' HA ' ' A' ' 75' ' ' LYS . 45.4 t -110.42 100.85 11.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 116.186 -0.461 . . . . 74.15 110.951 174.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.578 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 47.0 m -58.82 153.7 16.51 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.331 -0.395 . . . . 63.53 110.788 176.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.473 ' HG3' ' N ' ' A' ' 88' ' ' ILE . 10.8 pt-20 -40.46 -46.79 2.51 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 114.663 1.357 . . . . 63.12 114.663 -167.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.473 ' N ' ' HG3' ' A' ' 87' ' ' GLU . 2.6 pp -90.13 21.29 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-O 121.192 0.52 . . . . 75.2 112.197 -176.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.61 51.74 7.02 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 116.04 -0.527 . . . . 73.13 113.391 -178.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.578 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 62.2 tttp -118.7 135.98 54.19 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 117.34 0.57 . . . . 71.5 112.42 179.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.587 HD11 HD13 ' A' ' 78' ' ' LEU . 52.7 mt -113.93 138.24 44.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 123.028 0.531 . . . . 72.34 110.968 178.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.26 92.92 1.42 Allowed 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.851 0.357 . . . . 54.13 111.568 177.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.488 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 45.3 mt -53.23 -60.47 3.25 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.517 0.562 . . . . 73.53 112.517 -178.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -62.36 1.23 0.36 Allowed 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.192 0.812 . . . . 73.22 113.192 -172.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.438 ' HD2' ' CE2' ' A' ' 96' ' ' TYR . 9.1 tmtm? -112.9 -34.71 5.67 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 122.104 -0.373 . . . . 75.21 110.954 173.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.438 ' CE2' ' HD2' ' A' ' 95' ' ' LYS . 97.6 m-85 -108.85 5.79 24.83 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.364 0.505 . . . . 45.14 112.364 -177.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 50.9 tttm -63.31 133.13 53.64 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.144 0.497 . . . . 74.05 111.759 -174.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 16.0 t90 -57.28 125.12 21.34 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.046 -0.525 . . . . 63.11 111.827 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -107.24 90.39 5.61 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 116.061 -0.518 . . . . 74.55 110.918 177.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.61 -19.77 41.66 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.636 2.224 . . . . 71.5 112.595 178.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 85.0 mt -107.02 -175.5 2.81 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.354 -0.385 . . . . 63.41 110.974 178.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 . . . . . 0 C--O 1.254 1.331 0 CA-C-N 116.38 -0.373 . . . . 72.02 111.58 178.956 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 120.646 0.26 . . . . 63.11 111.231 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -61.56 156.39 19.8 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.609 0.596 . . . . 75.04 112.609 -175.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -52.03 -37.69 54.39 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.928 -0.578 . . . . 64.34 112.244 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -53.66 -49.25 68.34 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.22 0.533 . . . . 75.24 110.607 177.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 77.8 mt -67.21 -45.75 75.93 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.601 -0.727 . . . . 71.25 111.218 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.9 t -55.79 -47.58 79.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.027 0.441 . . . . 74.12 111.655 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -67.16 -51.29 55.56 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.335 0.494 . . . . 65.23 112.335 -177.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.462 ' O ' HG13 ' A' ' 12' ' ' ILE . 33.5 pt -60.79 -42.72 93.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 O-C-N 122.154 -0.341 . . . . 62.0 111.576 -177.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -62.85 -43.83 97.76 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.061 0.458 . . . . 73.5 110.941 177.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.97 -39.64 66.15 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.983 -0.553 . . . . 44.54 111.725 177.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 67.6 t -69.68 -39.49 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 120.966 0.412 . . . . 55.22 111.521 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.523 ' HB ' HD11 ' A' ' 52' ' ' LEU . 82.8 mt -59.3 -33.87 52.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 116.21 -0.45 . . . . 32.23 111.955 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 83.0 m-70 -55.37 -25.28 34.31 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 113.171 0.804 . . . . 75.02 113.171 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -80.7 1.51 29.84 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.071 0.767 . . . . 73.45 113.071 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 57.2 mt -83.34 111.44 31.23 Favored Pre-proline 0 CA--C 1.543 0.676 0 O-C-N 121.961 -0.462 . . . . 73.23 110.943 177.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.85 157.72 57.49 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.675 2.25 . . . . 72.31 113.312 -176.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.8 tttp -62.67 94.81 0.07 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.218 0.532 . . . . 73.1 111.734 -177.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.465 ' H ' ' CZ ' ' A' ' 56' ' ' ARG . . . 142.94 -28.74 2.12 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-N 116.054 -0.521 . . . . 50.13 112.473 178.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -95.66 165.49 12.29 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.273 0.558 . . . . 61.4 112.067 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.7 m -141.43 159.68 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.677 -0.692 . . . . 72.33 110.482 176.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 94.1 p -138.35 -179.37 5.76 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.817 0.341 . . . . 61.33 111.023 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 51.2 p -106.21 155.91 18.99 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.855 0.36 . . . . 65.13 111.971 -179.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.403 ' HB2' ' HB1' ' A' ' 36' ' ' ALA . 52.7 m-85 -54.91 -38.59 67.82 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.944 0.402 . . . . 72.31 110.945 177.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.26 -52.75 51.41 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-N 115.788 -0.642 . . . . 42.1 113.18 178.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -56.37 -48.3 77.13 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.905 0.383 . . . . 72.52 111.513 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.6 mm -58.75 -49.29 83.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 116.292 -0.413 . . . . 55.25 111.258 178.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.473 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -59.93 -45.28 93.09 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.965 0.412 . . . . 63.32 111.973 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -57.79 -52.53 65.07 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.788 0.328 . . . . 74.53 111.408 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 72.7 mtm -66.65 -28.18 68.27 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.399 -0.364 . . . . 71.53 111.879 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.72 -30.44 64.18 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.027 0.442 . . . . 62.35 111.417 176.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.71 13.15 19.33 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.333 -0.46 . . . . 71.21 113.057 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.473 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 76.3 m-85 -127.74 66.78 71.59 Favored Pre-proline 0 CA--C 1.543 0.679 0 O-C-N 122.61 -0.347 . . . . 63.11 111.714 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.71 144.73 60.86 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.224 1.95 . . . . 71.34 112.41 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.77 -11.78 65.56 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 121.032 -0.604 . . . . 71.31 113.523 -177.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -99.4 19.16 16.07 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 122.394 -0.474 . . . . 62.41 111.757 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.403 ' HB1' ' HB2' ' A' ' 23' ' ' TYR . . . -53.26 -42.92 66.99 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.263 0.468 . . . . 72.43 112.263 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -57.0 -37.51 71.75 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.009 0.374 . . . . 74.32 112.009 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -72.43 -31.9 65.87 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 120.653 0.264 . . . . 74.44 111.296 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.406 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 61.1 t -56.7 -51.78 62.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 120.887 0.375 . . . . 71.12 110.335 173.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -57.48 -42.41 93.88 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 121.219 -0.515 . . . . 32.33 113.039 176.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.518 ' NZ ' ' HB3' ' A' ' 41' ' ' LYS . 8.9 mtpm? -60.22 -34.54 73.81 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.795 0.331 . . . . 75.44 111.753 178.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.9 -41.75 59.13 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.324 -0.398 . . . . 33.23 111.475 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 39' ' ' VAL . 86.2 mt -65.66 -42.15 91.71 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.316 -0.402 . . . . 75.22 111.908 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.28 -26.84 51.56 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 121.195 -0.526 . . . . 72.23 113.542 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -78.94 -20.15 50.0 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 122.584 -0.362 . . . . 70.05 111.751 -178.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 81.5 mt -68.03 147.17 98.43 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-O 120.851 0.357 . . . . 73.51 111.601 -179.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -84.13 177.53 5.88 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.693 2.262 . . . . 54.44 112.971 178.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.463 ' OE1' ' HD2' ' A' ' 73' ' ' ARG . 1.4 mp0 -71.72 -37.21 70.65 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.983 0.42 . . . . 44.11 111.156 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -94.38 43.54 2.35 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 121.371 -0.442 . . . . 71.42 113.344 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.0 t -84.19 159.75 20.97 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.99 0.424 . . . . 74.21 111.472 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 51' ' ' LYS . 37.1 ttmt -81.91 -12.91 58.19 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.435 0.635 . . . . 73.44 110.726 178.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.537 HD12 ' HD2' ' A' ' 53' ' ' PRO . 33.0 tp -107.05 126.05 31.09 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 115.735 -0.666 . . . . 61.24 110.983 179.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.537 ' HD2' HD12 ' A' ' 52' ' ' LEU . 57.0 Cg_endo -72.94 94.53 0.8 Allowed 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 121.205 1.27 . . . . 72.12 111.637 174.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 69.2 p-90 -86.66 -17.69 33.15 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.291 0.567 . . . . 73.55 111.673 -177.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.491 ' O ' HD21 ' A' ' 78' ' ' LEU . 37.4 p90 -73.88 -5.72 42.76 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.985 0.735 . . . . 62.35 112.985 -176.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.485 HH12 HD11 ' A' ' 83' ' ' ILE . 87.1 mtt-85 -99.24 12.92 34.83 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.771 0.656 . . . . 74.22 112.771 -177.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.4 t -123.11 112.76 35.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 121.263 0.554 . . . . 72.41 111.214 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.545 HD13 HD12 ' A' ' 91' ' ' ILE . 27.4 pt -122.04 -169.98 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-N 116.087 -0.506 . . . . 61.12 111.386 -178.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.412 HD21 ' HB2' ' A' ' 63' ' ' LYS . 32.9 p30 -85.22 167.75 15.39 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.83 -0.544 . . . . 73.32 112.048 -177.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.478 ' HA ' HG21 ' A' ' 22' ' ' THR . 50.3 p -66.3 -10.71 45.22 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.941 0.719 . . . . 74.14 112.941 -177.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -96.33 11.32 35.14 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.762 0.315 . . . . 51.44 111.628 179.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.33 39.0 87.89 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 116.438 -0.346 . . . . 72.51 113.53 176.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.457 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 56.4 mttp -139.45 157.97 44.93 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.208 0.528 . . . . 65.53 111.6 -178.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.435 HG23 ' OE1' ' A' ' 74' ' ' GLN . 59.2 mt -73.26 117.57 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.806 -0.634 . . . . 73.44 110.903 177.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.3 t -69.19 -33.01 72.69 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.06 0.457 . . . . 64.24 110.99 178.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.553 HD13 ' HB3' ' A' ' 70' ' ' ASP . 66.6 mt -65.08 148.28 51.95 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.162 -0.472 . . . . 71.22 111.118 177.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -130.25 149.38 51.97 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.965 0.412 . . . . 72.52 112.098 -176.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.15 -120.37 7.81 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-N 116.263 -0.426 . . . . 53.13 113.451 178.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -65.03 -46.19 82.34 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.943 0.402 . . . . 74.21 111.653 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.553 ' HB3' HD13 ' A' ' 66' ' ' LEU . 67.6 m-20 -59.38 -36.08 75.12 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.552 -0.294 . . . . 74.23 111.568 177.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.9 tt -62.99 -54.99 29.76 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.963 -0.384 . . . . 72.0 109.963 177.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -58.98 -32.88 70.05 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.134 0.492 . . . . 73.35 111.312 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.463 ' HD2' ' OE1' ' A' ' 48' ' ' GLU . 11.2 ttp180 -67.84 -51.95 42.55 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.005 -0.543 . . . . 64.24 111.572 -178.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.451 HE21 ' HA ' ' A' ' 55' ' ' PHE . 34.2 tt0 -62.87 -47.28 84.02 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.181 0.515 . . . . 72.34 110.216 174.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.0 tttt -47.77 -55.17 10.21 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.206 -0.906 . . . . 50.44 112.576 175.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -56.41 -42.7 78.43 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.087 0.403 . . . . 55.25 112.087 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -62.57 -42.02 99.3 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.093 0.473 . . . . 74.44 111.517 177.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.491 HD21 ' O ' ' A' ' 55' ' ' PHE . 81.2 mt -64.19 -44.1 93.05 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.204 -0.453 . . . . 63.54 111.767 178.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -55.48 -42.42 74.34 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.923 0.392 . . . . 70.55 111.111 176.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.93 -33.76 73.66 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.056 0.455 . . . . 71.23 111.833 177.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.437 ' HB3' HH22 ' A' ' 56' ' ' ARG . 8.2 mm-40 -83.6 1.72 40.83 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.377 -0.374 . . . . 72.41 111.952 -179.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.84 9.93 70.46 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 121.379 -0.439 . . . . 60.12 113.949 177.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.485 HD11 HH12 ' A' ' 56' ' ' ARG . 67.0 mt -89.15 136.18 24.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 117.023 0.411 . . . . 62.41 111.405 -178.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 84' ' ' GLU . 9.2 pt-20 -76.44 114.66 15.39 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.143 0.497 . . . . 62.31 111.79 178.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.8 t -101.54 105.05 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 120.965 0.412 . . . . 74.21 110.666 172.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.642 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 25.2 t -69.48 157.96 36.11 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.423 -0.353 . . . . 70.5 111.77 178.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -37.55 -56.55 1.02 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.638 1.347 . . . . 71.13 114.638 -168.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.445 HD11 ' HB2' ' A' ' 90' ' ' LYS . 2.7 pp -86.54 18.27 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 112.69 0.626 . . . . 71.13 112.69 -174.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.2 44.83 7.85 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.113 -0.565 . . . . 35.31 112.518 -177.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.642 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 0.6 OUTLIER -105.52 128.15 53.42 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 122.539 -0.389 . . . . 60.33 110.389 -179.602 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.545 HD12 HD13 ' A' ' 58' ' ' ILE . 62.3 mt -116.53 139.67 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.899 0.381 . . . . 43.24 111.118 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.58 92.61 4.08 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.925 0.393 . . . . 43.55 111.786 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.598 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 57.4 mt -59.79 -44.19 94.05 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.733 0.302 . . . . 71.42 111.251 178.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 80.9 mtt-85 -56.48 -12.52 1.76 Allowed 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 112.173 0.434 . . . . 74.1 112.173 -177.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -109.92 -42.37 4.25 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 120.964 0.411 . . . . 73.52 111.814 176.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -101.7 6.46 41.87 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.149 0.425 . . . . 72.22 112.149 -171.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.598 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 78.0 tttt -61.56 129.35 40.7 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.143 0.497 . . . . 71.31 111.914 -175.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 21.2 t90 -71.03 116.96 11.93 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.978 -0.555 . . . . 72.1 111.991 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -124.65 92.66 47.51 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 115.971 -0.559 . . . . 51.12 110.58 175.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -79.36 34.12 0.51 Allowed 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 122.959 2.44 . . . . 73.32 113.797 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 96.8 mt -132.55 97.57 4.12 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.528 0.566 . . . . 54.23 112.528 -176.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 . . . . . 0 C--O 1.251 1.153 0 CA-C-O 118.678 -0.677 . . . . 44.44 110.997 172.646 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 tpt . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 120.891 0.376 . . . . 62.34 110.897 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -75.86 150.53 37.6 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.744 0.646 . . . . 63.1 112.744 -174.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -51.19 -31.74 21.22 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.625 -0.716 . . . . 63.44 112.318 178.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -57.61 -55.54 33.48 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.848 0.356 . . . . 75.44 110.727 177.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 77.0 mt -59.97 -45.19 93.49 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.964 -0.562 . . . . 75.25 111.218 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 62.0 t -57.14 -52.62 53.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 116.178 -0.465 . . . . 55.54 112.053 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.426 ' O ' HG23 ' A' ' 11' ' ' VAL . 28.7 mm-40 -67.58 -44.71 77.5 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.727 0.64 . . . . 73.43 112.727 -175.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.42 ' O ' HG13 ' A' ' 12' ' ' ILE . 36.8 pt -63.33 -43.43 98.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 120.909 -0.316 . . . . 73.13 111.281 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -62.87 -44.98 94.65 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.943 0.401 . . . . 75.35 110.978 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.52 -37.22 62.6 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.08 -0.509 . . . . 71.44 111.793 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 7' ' ' GLN . 96.0 t -70.21 -42.65 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-O 120.929 0.395 . . . . 63.33 111.513 178.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.545 ' HB ' HD11 ' A' ' 52' ' ' LEU . 79.9 mt -59.19 -30.57 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 112.28 0.474 . . . . 74.34 112.28 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -60.85 -12.52 11.22 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 112.966 0.728 . . . . 75.14 112.966 178.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -90.77 -3.5 57.38 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.481 0.549 . . . . 72.42 112.481 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.404 ' O ' ' NH1' ' A' ' 56' ' ' ARG . 56.0 mt -84.3 113.79 50.65 Favored Pre-proline 0 CA--C 1.544 0.741 0 O-C-N 122.184 -0.322 . . . . 70.14 111.44 -179.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -70.5 163.78 37.64 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.961 2.44 . . . . 72.2 113.843 -177.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.35 120.85 12.99 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.944 -0.571 . . . . 74.42 111.639 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.33 14.09 46.02 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.092 -0.575 . . . . 75.21 113.442 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -126.03 148.3 49.34 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.889 0.376 . . . . 70.34 111.18 176.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.0 m -125.32 149.11 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-O 121.122 0.487 . . . . 71.52 111.613 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 97.8 p -128.67 167.03 17.8 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.106 -0.497 . . . . 64.13 110.83 177.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.5 p -103.79 147.45 27.27 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.763 0.316 . . . . 74.24 111.378 177.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -52.16 -36.52 51.82 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.751 0.31 . . . . 74.22 111.766 178.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -57.35 -43.82 93.68 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 121.129 -0.558 . . . . 73.33 112.779 177.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' A' ' 29' ' ' MET . 41.7 mt-10 -65.11 -54.13 34.63 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.78 0.324 . . . . 73.45 111.112 177.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.8 mm -54.62 -51.12 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.3 -0.409 . . . . 72.15 111.889 -178.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.49 -46.19 84.0 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.945 0.402 . . . . 61.32 111.748 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -61.19 -48.38 81.82 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.781 0.324 . . . . 72.33 111.511 178.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.489 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 61.0 mtt -63.37 -30.1 71.29 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.096 0.474 . . . . 71.0 111.522 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.01 -19.57 58.55 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.158 -0.474 . . . . 74.21 111.858 178.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.57 23.26 12.49 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.191 -0.528 . . . . 72.33 113.154 -178.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -132.78 62.82 64.63 Favored Pre-proline 0 CA--C 1.542 0.648 0 O-C-N 122.48 -0.423 . . . . 75.2 111.064 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -62.5 119.82 7.09 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.27 1.98 . . . . 73.03 112.731 -177.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.44 -6.58 49.79 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.036 -0.602 . . . . 72.42 113.589 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -97.98 20.74 11.71 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 117.332 0.566 . . . . 63.12 111.375 177.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.8 -39.43 68.46 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.806 0.669 . . . . 74.04 112.806 -177.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -58.8 -34.89 72.01 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 120.924 0.392 . . . . 73.34 111.714 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -77.94 -28.25 49.51 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.687 -0.233 . . . . 65.23 111.408 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.3 t -59.66 -42.63 89.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.238 0.542 . . . . 71.15 110.12 172.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -62.7 -42.31 99.71 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 115.771 -0.65 . . . . 51.35 112.789 175.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -60.66 -41.82 95.78 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.049 0.452 . . . . 72.33 111.134 176.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.52 -54.47 45.07 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.177 -0.465 . . . . 55.22 111.418 178.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.49 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 80.6 mt -61.88 -38.53 88.66 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.932 0.396 . . . . 71.55 111.589 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.29 -17.77 70.65 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.339 -0.458 . . . . 72.11 113.396 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -101.07 2.84 40.79 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 122.416 -0.461 . . . . 73.23 111.391 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 69.9 mt -78.54 155.54 78.64 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-O 120.809 0.338 . . . . 61.2 111.321 176.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.509 ' HG2' ' HB2' ' A' ' 50' ' ' SER . 20.5 Cg_endo -61.02 140.76 91.7 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.116 1.877 . . . . 75.21 112.083 174.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.645 ' HG3' ' HD3' ' A' ' 73' ' ' ARG . 33.0 tt0 -43.52 -39.35 3.35 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.696 0.628 . . . . 71.31 112.696 -174.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -123.24 55.64 0.68 Allowed Glycine 0 CA--C 1.529 0.942 0 C-N-CA 121.098 -0.572 . . . . 74.34 113.491 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.509 ' HB2' ' HG2' ' A' ' 47' ' ' PRO . 37.8 t -63.5 168.2 4.86 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.427 0.632 . . . . 74.12 112.641 177.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -65.47 -32.66 74.39 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.309 0.576 . . . . 73.3 110.181 173.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.554 HD12 ' HD2' ' A' ' 53' ' ' PRO . 30.7 tp -84.48 127.04 67.49 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 115.641 -0.709 . . . . 64.41 110.894 177.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.554 ' HD2' HD12 ' A' ' 52' ' ' LEU . 61.5 Cg_endo -73.67 95.65 0.89 Allowed 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 121.396 1.398 . . . . 65.13 111.656 174.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.49 ' HB2' ' HB3' ' A' ' 43' ' ' LEU . 65.2 p-90 -79.52 -31.55 42.17 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.188 0.518 . . . . 74.34 111.891 -176.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.417 ' O ' HD21 ' A' ' 78' ' ' LEU . 27.3 p90 -63.6 -19.87 65.2 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.244 0.831 . . . . 71.23 113.244 -176.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.404 ' NH1' ' O ' ' A' ' 15' ' ' ILE . 98.5 mtt180 -77.76 2.07 18.14 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.497 0.554 . . . . 73.3 112.497 -177.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.4 t -122.22 125.62 73.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 O-C-N 121.9 -0.5 . . . . 62.44 111.426 179.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.625 HD11 HD21 ' A' ' 93' ' ' LEU . 33.8 pt -125.46 -171.39 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 120.978 0.418 . . . . 62.44 111.646 -179.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.429 HD21 ' HB2' ' A' ' 63' ' ' LYS . 33.8 p30 -73.03 171.65 12.48 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.243 0.544 . . . . 61.33 112.23 -179.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 46.6 p -79.69 8.52 6.46 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.074 0.464 . . . . 65.11 112.128 -179.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -95.64 -46.44 6.62 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.358 0.599 . . . . 74.14 110.944 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 121.33 32.38 1.06 Allowed Glycine 0 CA--C 1.522 0.475 0 CA-C-N 115.766 -0.652 . . . . 42.15 112.159 -175.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.429 ' HB2' HD21 ' A' ' 59' ' ' ASN . 98.4 mttt -138.67 163.14 32.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.092 0.472 . . . . 35.41 111.387 -177.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.506 HG23 ' OE1' ' A' ' 74' ' ' GLN . 65.3 mt -67.81 122.08 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 115.968 -0.56 . . . . 53.11 110.605 175.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.5 m -63.89 -41.83 97.61 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.166 0.508 . . . . 65.1 111.464 -178.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.513 HD13 ' HB3' ' A' ' 70' ' ' ASP . 86.6 mt -74.15 161.33 30.1 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.788 -0.642 . . . . 74.12 111.813 -178.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -130.18 177.11 7.55 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.8 0.333 . . . . 44.44 111.429 -178.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 57.38 -126.55 42.46 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 121.36 -0.447 . . . . 42.52 113.106 178.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 38.7 mtp180 -74.54 -32.13 62.35 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.171 0.51 . . . . 74.13 110.714 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.513 ' HB3' HD13 ' A' ' 66' ' ' LEU . 2.6 m-20 -60.02 -32.47 70.91 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.892 -0.595 . . . . 62.52 110.676 177.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.9 tt -63.28 -57.05 11.71 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.027 -0.533 . . . . 62.03 110.212 176.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -55.58 -36.87 67.35 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.902 0.382 . . . . 74.13 111.462 176.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.645 ' HD3' ' HG3' ' A' ' 48' ' ' GLU . 39.8 ttm180 -59.22 -58.87 6.71 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 116.383 -0.371 . . . . 71.52 111.65 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.506 ' OE1' HG23 ' A' ' 64' ' ' ILE . 53.6 tt0 -61.66 -41.01 96.94 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.708 0.289 . . . . 73.1 111.132 177.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -54.88 -58.67 6.66 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.259 -0.428 . . . . 74.13 111.72 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -52.9 -45.65 67.64 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.079 0.4 . . . . 64.0 112.079 -178.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -61.46 -30.53 70.65 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.853 0.359 . . . . 75.43 111.936 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.417 HD21 ' O ' ' A' ' 55' ' ' PHE . 94.8 mt -78.0 -42.08 33.84 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.046 0.45 . . . . 62.22 111.13 174.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -57.4 -39.4 76.02 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.913 0.387 . . . . 64.13 111.057 177.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.23 -24.39 63.13 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.119 -0.491 . . . . 73.43 111.929 178.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -95.38 -1.37 51.22 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 111.831 0.308 . . . . 73.51 111.831 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.24 12.89 44.05 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.512 -0.375 . . . . 75.34 113.689 177.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.418 ' HA ' ' CE1' ' A' ' 96' ' ' TYR . 66.6 mt -88.59 109.57 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 122.477 -0.425 . . . . 72.0 111.547 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -73.39 100.66 3.26 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.982 0.42 . . . . 75.33 111.465 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 58.2 t -92.41 130.45 41.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 120.901 0.381 . . . . 61.23 111.593 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.603 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 31.0 t -69.73 155.99 39.68 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.515 -0.311 . . . . 63.25 111.573 177.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.502 ' HG3' HG23 ' A' ' 88' ' ' ILE . 15.3 pt-20 -46.05 -49.84 15.85 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.034 1.124 . . . . 73.54 114.034 -169.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.502 HG23 ' HG3' ' A' ' 87' ' ' GLU . 2.9 pp -81.34 13.85 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 121.216 0.531 . . . . 74.42 112.326 -176.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.57 50.03 5.19 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 121.335 -0.459 . . . . 73.4 112.894 -178.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.603 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 14.4 tmtt? -117.27 129.63 56.03 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 122.326 -0.514 . . . . 65.43 111.197 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.507 HD12 HD13 ' A' ' 58' ' ' ILE . 60.6 mt -116.35 148.26 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.173 -0.467 . . . . 72.2 111.462 -177.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.32 99.96 8.16 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.886 0.374 . . . . 61.3 111.682 177.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.625 HD21 HD11 ' A' ' 58' ' ' ILE . 25.3 mt -69.64 -1.35 8.7 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.112 0.782 . . . . 74.15 113.112 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -98.05 -52.7 3.61 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.074 0.464 . . . . 74.15 111.181 173.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -69.28 -29.75 67.7 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.224 -0.444 . . . . 64.32 112.101 -177.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.418 ' CE1' ' HA ' ' A' ' 83' ' ' ILE . 90.5 m-85 -114.09 13.65 18.15 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 111.796 0.295 . . . . 62.12 111.796 -176.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.539 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 83.8 tttt -60.85 131.38 50.51 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 111.827 0.306 . . . . 73.21 111.827 -176.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 19.2 t90 -58.64 105.59 0.32 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.641 0.734 . . . . 74.5 111.151 176.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -113.45 95.29 35.5 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 115.348 -0.842 . . . . 73.42 110.723 177.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.39 1.86 5.71 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.511 2.141 . . . . 71.1 112.524 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 38.4 mt -99.24 -40.23 8.05 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.295 -0.411 . . . . 72.34 111.251 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 . . . . . 0 C--O 1.257 1.457 0 CA-C-O 118.855 -0.593 . . . . 64.44 111.772 -175.984 . . . . . . . . 0 0 . 1 stop_ save_